PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	DELGUSTE, P; AUBERTTULKENS, G; RODENSTEIN, DO				DELGUSTE, P; AUBERTTULKENS, G; RODENSTEIN, DO			UPPER AIRWAY-OBSTRUCTION DURING NASAL INTERMITTENT POSITIVE-PRESSURE HYPERVENTILATION IN SLEEP	LANCET			English	Note							VENTILATION; NIGHT	Episodes of apnoea for up to 1 min were observed in association with hypocapnia caused by passive nasal intermittent positive-pressure mechanical hyperventilation in 3 of 4 patients during sleep. Apnoea seemed to be caused by complete upper airways obstruction; we suggest that this finding was caused by active glottic closure. Avoidance of excessive hypocapnia during positive-pressure ventilation might help to avoid central-nervous-system mediated apnoeic episodes.	CATHOLIC UNIV LOUVAIN,CLIN ST LUC,SPEECH PATHOL & AUDIOL UNIT,B-1200 BRUSSELS,BELGIUM; CATHOLIC UNIV LOUVAIN,CLIN ST LUC,REHABIL UNIT,B-1200 BRUSSELS,BELGIUM; CATHOLIC UNIV LOUVAIN,CLIN ST LUC,ELECTROPHYSIOL UNIT,B-1200 BRUSSELS,BELGIUM	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain								HECKMATT JZ, 1990, LANCET, V335, P579, DOI 10.1016/0140-6736(90)90357-B; HENKE KG, 1988, AM REV RESPIR DIS, V138, P8, DOI 10.1164/ajrccm/138.1.8; MEDURI GU, 1989, CHEST, V95, P865, DOI 10.1378/chest.95.4.865; ONAL E, 1986, J APPL PHYSIOL, V61, P1438, DOI 10.1152/jappl.1986.61.4.1438; REMMERS JE, 1990, J APPL PHYSIOL, V68, P1286, DOI 10.1152/jappl.1990.68.3.1286; RODENSTEIN DO, 1989, EUR RESPIR J, V2, P473; WEIL JV, 1987, AM REV RESPIR DIS, V136, P755, DOI 10.1164/ajrccm/136.3.755	7	35	36	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1295	1297		10.1016/0140-6736(91)92593-Q	http://dx.doi.org/10.1016/0140-6736(91)92593-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682687				2022-12-28	WOS:A1991GR02300005
J	PEREIRA, JH; PALANDE, DD; SUBRAMANIAN, A; NARAYANAKUMAR, TS; CURTIS, J; TURK, JL				PEREIRA, JH; PALANDE, DD; SUBRAMANIAN, A; NARAYANAKUMAR, TS; CURTIS, J; TURK, JL			DENATURED AUTOLOGOUS MUSCLE GRAFT IN LEPROSY	LANCET			English	Note							PERIPHERAL-NERVE REPAIR	Autologous muscle grafts were used to repair 12 mixed peripheral nerves (9 posterior tibial, 3 median) in 10 patients with leprosy who had total anaesthesia and analgesia of the area supplied by the nerve. Postoperatively, 7 patients reported improved sensation in the foot or hand, with a return of vibration sense and joint position sense in 11 and of perception of a 10 g pin in 5; the ability to sweat in the affected area was also restored in 7.	ROYAL COLL SURG ENGLAND,DEPT PATHOL,35-43 LINCOLNS INN FIELDS,LONDON WC2A 3PN,ENGLAND; SACRED HEART LEPROSY CTR,TAMIL NADU 612401,INDIA	Royal College of Surgeons of England								ANTIA JH, 1970, INT J LEPROSY, V38, P12; FAWCETT JW, 1986, J NEUROSURG, V65, P354, DOI 10.3171/jns.1986.65.3.0354; GLASBY MA, 1986, NEURO-ORTHOPEDICS, V2, P21; GSCHMEISSNER SE, 1991, J BONE JOINT SURG BR, V73, P688, DOI 10.1302/0301-620X.73B4.2071663; NAPIER JR, 1949, BRAIN, V72, P63, DOI 10.1093/brain/72.1.63; NORRIS RW, 1988, J BONE JOINT SURG BR, V70, P530, DOI 10.1302/0301-620X.70B4.3403592; PEREIRA JH, 1990, J BONE JOINT SURG BR, V72, P874, DOI 10.1302/0301-620X.72B5.2170419; PEREIRA JH, IN PRESS J HAND SURG; Rao K S, 1987, Indian J Lepr, V59, P442	9	43	43	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1239	1240		10.1016/0140-6736(91)92105-B	http://dx.doi.org/10.1016/0140-6736(91)92105-B			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682647				2022-12-28	WOS:A1991GQ16600007
J	DESBOIS, C; AUBERT, D; LEGRAND, C; PAIN, B; SAMARUT, J				DESBOIS, C; AUBERT, D; LEGRAND, C; PAIN, B; SAMARUT, J			A NOVEL MECHANISM OF ACTION FOR V-ERBA - ABROGATION OF THE INACTIVATION OF TRANSCRIPTION FACTOR AP-1 BY RETINOIC ACID AND THYROID-HORMONE RECEPTORS	CELL			English	Article							RAT GROWTH-HORMONE; NEGATIVE REGULATION; RESPONSIVE ELEMENT; C-ERBA; GLUCOCORTICOID RECEPTOR; RETROVIRAL VECTORS; GENE-TRANSCRIPTION; FUNCTIONAL DOMAINS; JUN; EXPRESSION	Ligand-activated retinoic acid receptor-alpha (RAR-alpha) and c-ErbA-alpha repress the AP-1-mediated transcriptional activation of the interstitial collagenase gene promoter by specifically decreasing the activity of the AP-1 transcription factor. On the other hand, the v-ErbA oncoprotein fails to repress the AP-1 activity and acts as a dominant negative oncoprotein by overcoming the repression of the AP-1 activity induced by RAR-alpha and c-ErbA-alpha. This maintenance by v-ErbA of a fully active AP-1 complex is correlated with the abrogation by this same oncogene product of the growth-inhibitory response of chicken embryo fibroblasts to retinoic acid treatment. This new mechanism of action of v-ErbA together with its previously discovered dominant repressor effect on transcription of thyroid hormone-activated target genes may explain the contribution of the v-erbA oncogene to sarcomatogenic and leukemogenic transformation.	ECOLE NORMALE SUPER LYON,INRA,BIOL MOLEC & CELLULAIRE LAB,CNRS,UMR49,F-69364 LYONS 07,FRANCE	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE	DESBOIS, C (corresponding author), UNIV CLAUDE BERNARD LYON 1,FAC MED ALEXIS CARREL,CNRS,UMR30,F-69372 LYONS 08,FRANCE.		Aubert, dominique/AAH-5854-2019; Samarut, Jacques/AAD-2587-2019; Morris, Christelle/M-8168-2014; Pain, Bertrand/A-7686-2015	Morris, Christelle/0000-0003-1575-4609; Pain, Bertrand/0000-0002-1210-8444; Aubert, Denise/0000-0002-1442-3384				AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENCHAIBI M, 1989, VIROLOGY, V169, P15, DOI 10.1016/0042-6822(89)90036-6; CLARK SD, 1987, J CLIN INVEST, V80, P1280, DOI 10.1172/JCI113203; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DESBOIS C, 1991, IN PRESS ONCOGENE; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DIAZ JJ, 1989, ONCOL RES, V1, P163; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1988, MOL ENDOCRINOL, V2, P902, DOI 10.1210/mend-2-10-902; FRISCH SM, 1987, P NATL ACAD SCI USA, V84, P2600, DOI 10.1073/pnas.84.9.2600; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GREEN S, 1986, NATURE, V324, P615, DOI 10.1038/324615a0; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JANSSON M, 1987, ONCOGENE, V1, P167; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NICHOLSON RC, 1990, EMBO J, V9, P4443, DOI 10.1002/j.1460-2075.1990.tb07895.x; NIELSEN DA, 1983, P NATL ACAD SCI-BIOL, V80, P5198, DOI 10.1073/pnas.80.17.5198; OFFRINGA R, 1990, CELL, V62, P527, DOI 10.1016/0092-8674(90)90017-9; Oppenheimer J. H., 1983, MOL BASIS THYROID HO; PAIN B, 1990, New Biologist, V2, P284; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SAUS J, 1988, J BIOL CHEM, V263, P6742; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SPORN MB, 1991, MOL ENDOCRINOL, V5, P3, DOI 10.1210/mend-5-1-3; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; URIER G, 1989, EMBO J, V8, P1447, DOI 10.1002/j.1460-2075.1989.tb03527.x; VANDAM H, 1990, MOL CELL BIOL, V10, P5857, DOI 10.1128/MCB.10.11.5857; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	58	161	163	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					731	740		10.1016/0092-8674(91)90068-A	http://dx.doi.org/10.1016/0092-8674(91)90068-A			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1682056				2022-12-28	WOS:A1991GQ40700010
J	GIRON, JA; HO, ASY; SCHOOLNIK, GK				GIRON, JA; HO, ASY; SCHOOLNIK, GK			AN INDUCIBLE BUNDLE-FORMING PILUS OF ENTEROPATHOGENIC ESCHERICHIA-COLI	SCIENCE			English	Article							O-ANTIGENIC POLYSACCHARIDE; VIBRIO-CHOLERAE; HEP-2 CELLS; FIMBRIAL ADHESINS; ADHERENCE FACTOR; DIARRHEA; STRAINS; INFANTS; PILIN; GENE	Enteropathogenic Escherichia coli (EPEC), a cause of childhood diarrhea, grow on the surface of the small intestine and on cultured epithelial cells as colonies of adherent bacteria. When propagated on solid medium containing blood or attached to HEp-2 cells, EPEC express ropelike bundles of filaments, termed bundle-forming pili (BFP), that create a network of fibers that bind together the individual organisms. BFP were found to be expressed by five EPEC serogroups, each harboring a approximately 92-kilobase plasmid previously known to be important for virulence in humans. When two of these strains were cured of this plasmid, they neither expressed BFP nor grew as adherent colonies. An antiserum to BFP reduced the capacity of EPEC to infect cultured epithelial cells. BFP are composed of a repeating subunit of 19,500 daltons, the amino-terminal amino acid sequence of this subunit is homologous to that of the toxin-coregulated pilin of Vibrio cholerae.	STANFORD UNIV, BECKMAN CTR B239, HOWARD HUGHES MED INST, DEPT MICROBIOL & IMMUNOL, STANFORD, CA 94305 USA	Howard Hughes Medical Institute; Stanford University					NIDDK NIH HHS [DK 38707] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK038707] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRADE JRC, 1989, J MED MICROBIOL, V28, P49, DOI 10.1099/00222615-28-1-49; BALDINI MM, 1983, J PEDIATR GASTR NUTR, V2, P534, DOI 10.1097/00005176-198302030-00023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINTON CC, 1959, NATURE, V183, P782, DOI 10.1038/183782a0; CLAUSEN CR, 1982, J PEDIATR-US, V100, P358, DOI 10.1016/S0022-3476(82)80429-0; CRAVIOTO A, 1979, CURR MICROBIOL, V3, P95, DOI 10.1007/BF02602439; ELLEMAN TC, 1988, MICROBIOL REV, V52, P233, DOI 10.1128/MMBR.52.2.233-247.1988; EVANS DJ, 1979, INFECT IMMUN, V23, P336, DOI 10.1128/IAI.23.2.336-346.1979; FAAST R, 1989, GENE, V85, P227, DOI 10.1016/0378-1119(89)90486-1; GAASTRA W, 1982, MICROBIOL REV, V46, P129, DOI 10.1128/MMBR.46.2.129-161.1982; GIRON JA, UNPUB; GOMES TAT, 1989, J INFECT DIS, V160, P131; HERMODSON MA, 1978, BIOCHEMISTRY-US, V17, P442, DOI 10.1021/bi00596a010; HO ASY, 1990, J EXP MED, V172, P795, DOI 10.1084/jem.172.3.795; KLEMM P, 1985, REV INFECT DIS, V7, P321; KNUTTON S, 1987, INFECT IMMUN, V55, P78, DOI 10.1128/IAI.55.1.78-85.1987; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE MM, 1985, J INFECT DIS, V152, P550, DOI 10.1093/infdis/152.3.550; LEVINE MM, 1987, J INFECT DIS, V155, P377, DOI 10.1093/infdis/155.3.377; NATARO JP, 1985, J INFECT DIS, V152, P560, DOI 10.1093/infdis/152.3.560; NELSON ET, 1976, INFECT IMMUN, V14, P527, DOI 10.1128/IAI.14.2.527-547.1976; NOVOTNY P, 1975, J MED MICROBIOL, V8, P413, DOI 10.1099/00222615-8-3-413; RILEY LW, 1987, INFECT IMMUN, V55, P2052, DOI 10.1128/IAI.55.9.2052-2056.1987; RILEY LW, 1990, MOL MICROBIOL, V4, P1661, DOI 10.1111/j.1365-2958.1990.tb00543.x; ROTHBAUM R, 1982, GASTROENTEROLOGY, V83, P441; SCALETSKY ICA, 1984, INFECT IMMUN, V45, P534, DOI 10.1128/IAI.45.2.534-536.1984; SCOTLAND SM, 1983, FEMS MICROBIOL LETT, V20, P191; SHAW CE, 1990, INFECT IMMUN, V58, P3042, DOI 10.1128/IAI.58.9.3042-3049.1990; SWANSON J, 1985, J EXP MED, V162, P729, DOI 10.1084/jem.162.2.729; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; ULSHEN MH, 1980, NEW ENGL J MED, V302, P99, DOI 10.1056/NEJM198001103020207	32	495	504	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	1991	254	5032					710	713		10.1126/science.1683004	http://dx.doi.org/10.1126/science.1683004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1683004				2022-12-28	WOS:A1991GN47400041
J	BOBO, L; MUNOZ, B; VISCIDI, R; QUINN, T; MKOCHA, H; WEST, S				BOBO, L; MUNOZ, B; VISCIDI, R; QUINN, T; MKOCHA, H; WEST, S			DIAGNOSIS OF CHLAMYDIA-TRACHOMATIS EYE INFECTION IN TANZANIA BY POLYMERASE CHAIN-REACTION ENZYME-IMMUNOASSAY	LANCET			English	Article							FIELD; DNA; REINFECTION	Detection of Chlamydia trachomatis eye infection is largely unsatisfactory by standard laboratory methods. A polymerase chain reaction/enzyme immunoassay (PCR-EIA) that had previously been successful for diagnosis of genital C trachomatis infection was compared with direct antibody immunofluorescence (DFA) for detection of the organism in conjunctival scrapes. 234 Tanzanian children aged 1-7 years living in a village that had had no previous trachoma control programme were classified clinically as having no sign of trachoma (0) n = 97, follicular trachoma (TF) n = 100, or intense inflammatory trachoma with or without TF (TI +/- TF) n = 37. PCR-EIA detected C trachomatis in 24%, 54%, and 95% of subjects, respectively, compared with elementary body (EB) detection by DFA of 1%, 28%, and 60%, respectively. Overall prevalence of chlamydial eye infection was 22% by DFA compared with 48% by PCR-EIA. Of subjects with chlamydial DNA at pretreatment, 103 (92%) had no detectable chlamydial DNA at the end of 4 weeks of ocular tetracycline. The findings show that PCR-EIA is likely to affect trachoma diagnosis and epidemiology because of the increased sensitivity for detection of C trachomatis in all clinical groups; the less stringent requirements for specimen collection and transport make this method suitable for field use. Moreover, the semi-quantitative aspect of PCR-EIA may be useful for monitoring a decrease in chlamydial DNA after treatment.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DIV INFECT DIS,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,WILMER INST,DANA CTR PREVENT OPHTHALMOL,BALTIMORE,MD 21205; NIAID,IMMUNOREGULAT LAB,BETHESDA,MD 20892; KONGWA TRACHOMA PROJECT,KONGWA,TANZANIA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	BOBO, L (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.			Viscidi, Raphael/0000-0002-7906-8002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI016959, N01AI052579] Funding Source: NIH RePORTER; NIAID NIH HHS [2 PO1 AI 16959-09, N01 AI 52579] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOBO L, 1990, J CLIN MICROBIOL, V28, P1968, DOI 10.1128/JCM.28.9.1968-1973.1990; CLAAS HCJ, 1991, J CLIN MICROBIOL, V29, P42, DOI 10.1128/JCM.29.1.42-45.1991; COUTLEE F, 1990, AIDS RES HUM RETROV, V6, P775, DOI 10.1089/aid.1990.6.775; DAROUGAR S, 1980, BRIT J OPHTHALMOL, V64, P276, DOI 10.1136/bjo.64.4.276; Dawson CR, 1981, GUIDE TRACHOMA CONTR; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; MABEY DCW, 1987, LANCET, V2, P1491; PETERSON EM, 1989, J CLIN MICROBIOL, V27, P2359, DOI 10.1128/JCM.27.10.2359-2363.1989; SCHACHTER J, 1978, B WORLD HEALTH ORGAN, V56, P629; SHANKAR P, 1991, LANCET, V337, P5, DOI 10.1016/0140-6736(91)93328-7; STEPHENS RS, 1986, J BACTERIOL, V168, P1277, DOI 10.1128/jb.168.3.1277-1282.1986; TAYLOR HR, 1982, INVEST OPHTH VIS SCI, V23, P507; TAYLOR HR, 1987, B WORLD HEALTH ORGAN, V65, P485; TAYLOR HR, 1989, INVEST OPHTH VIS SCI, V30, P1823; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; ULRICH PP, 1989, J INFECT DIS, V160, P37, DOI 10.1093/infdis/160.1.37; WATKINS NG, 1986, P NATL ACAD SCI USA, V83, P7480, DOI 10.1073/pnas.83.19.7480; WEST SK, 1990, BRIT J OPHTHALMOL, V74, P12, DOI 10.1136/bjo.74.1.12; WILDE J, 1990, J CLIN MICROBIOL, V28, P1300, DOI 10.1128/JCM.28.6.1300-1307.1990; WILSON MC, 1986, ARCH OPHTHALMOL-CHIC, V104, P688	20	79	80	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					847	850		10.1016/0140-6736(91)91502-L	http://dx.doi.org/10.1016/0140-6736(91)91502-L			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681215				2022-12-28	WOS:A1991GH94500004
J	MACINTYRE, S; SOOMAN, A				MACINTYRE, S; SOOMAN, A			NON-PATERNITY AND PRENATAL GENETIC SCREENING	LANCET			English	Editorial Material							CYSTIC-FIBROSIS GENE				MACINTYRE, S (corresponding author), MRC,MED SOCIOL UNIT,6 LILYBANK GARDENS,GLASGOW G12 8QQ,SCOTLAND.		Macintyre, Sally/P-6246-2014; Ellaway, Anne/A-3065-2009					ASHTON GC, 1980, AM J HUM GENET, V32, P601; BELLIS MA, 1990, ANIM BEHAV, V40, P997, DOI 10.1016/S0003-3472(05)81008-5; EDWARDS J H, 1957, Br J Prev Soc Med, V11, P79; EMERY AEH, 1983, ELEMENTS MED GENETIC; GOODFELLOW PN, 1989, NATURE, V341, P102, DOI 10.1038/341102a0; Johnstone JM, 1954, BRIT J PREV SOC MED, V8, P117; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; SALMON D, 1980, AM J HUM GENET, V32, P432; SCHACHT LE, 1963, 2ND P INT C HUM GEN, P894; STEWART AD, 1989, NATURE, V341, P696, DOI 10.1038/341696b0; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777; WOLSTENHOLME GEW, 1973, CIBA FDN S LOND DEC, P66	12	85	87	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					869	871		10.1016/0140-6736(91)91513-T	http://dx.doi.org/10.1016/0140-6736(91)91513-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681226				2022-12-28	WOS:A1991GH94500015
J	PIACQUADIO, K; HOLLINGSWORTH, DR; MURPHY, H				PIACQUADIO, K; HOLLINGSWORTH, DR; MURPHY, H			EFFECTS OF INUTERO EXPOSURE TO ORAL HYPOGLYCEMIC DRUGS	LANCET			English	Article							DIABETIC MOTHERS; MALFORMATIONS; INFANTS; PREGNANCY	The observation that several Mexican-American women were taking oral hypoglycaemic agents while pregnant led to a study to confirm reports of associations between these agents and congenital abnormalities. 20 non-insulin-dependent (NIDDM) pregnant diabetic women with exposure to oral hypoglycaemic drugs during embryogenesis and 40 pregnant NIDDM women matched for age, race, parity, weight, and glycaemic control but not exposed to oral hypoglycaemic drugs were followed up. 10 infants (50%) in the exposed group had congenital malformations, compared with only 6 (15%) in the control group (p < 0.002). 5 (25%) infants in the exposed group had ear malformations, anomalies not commonly described in diabetic embryopathy. Hyperbilirubinemia (p < 0.04), polycythaemia, and hyperviscosity requiring partial exchange transfusions (p < 0.03) were commoner among babies in the exposed than in the control group. 3 babies in the exposed group but none in the comparison group had severe prolonged neonatal hypoglycaemia lasting 2, 4, and 7 days; 2 of the 3 had been exposed for 22 and 28 weeks during gestation, whereas the third had been exposed throughout the first trimester. Although exposure to oral hypoglycaemic drugs during fetal life seems to be associated with congenital malformations and neonatal hypoglycaemia, a large, prospective study is needed to exclude the confounding effect of maternal metabolic derangement secondary to diabetes.	UNIV CALIF SAN DIEGO,DEPT REPROD MED & MED 0802,LA JOLLA,CA 92093; USN HOSP,DEPT OBSTET & GYNECOL,SAN DIEGO,CA 92134	University of California System; University of California San Diego; United States Department of Defense; United States Navy			Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713				ADAM PAJ, 1968, PEDIATRICS, V42, P819; CALDERA R, 1970, Annales de Pediatrie (Paris), V17, P432; CAMPBELL GD, 1961, LANCET, V1, P891; Chung C S, 1975, Birth Defects Orig Artic Ser, V11, P1; COETZEE EJ, 1988, CONTROVERSIES DIABET, P56; DEMEYER R, 1958, SOC BELGE ENDOCRINOL, V19, P167; DEROT M, 1962, B MEM SOC MED HOP P, V113, P426; DOLGER H, 1962, DIABETES, V11, P97; FERNER RE, 1989, Q J MED, V73, P987; GHANEM MH, 1960, ALEXANDRIA MED J, V6, P14; GREENE MF, 1989, TERATOLOGY, V39, P225, DOI 10.1002/tera.1420390303; GRIX A, 1982, BIRTH DEFECTS-ORIG, V18, P55; JACKSON WPU, 1962, DIABETES, V11, P98; JOHNSON JP, 1982, AM J MED GENET, V13, P125, DOI 10.1002/ajmg.1320130204; KEMBALL ML, 1970, ARCH DIS CHILD, V45, P696, DOI 10.1136/adc.45.243.696; LARSSON Y, 1960, LANCET, V2, P1424; LAZAROW A, 1962, DIABETES, V11, P103; MALINS JM, 1964, BRIT MED J, V2, P187, DOI 10.1136/bmj.2.5402.187; MILLER DI, 1962, DIABETES, V11, P93; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; MILLS JL, 1982, TERATOLOGY, V25, P385, DOI 10.1002/tera.1420250316; MOORE KL, 1973, DEV HUMAN CLIN ORIEN, P346; MOSS J M, 1965, Med Ann Dist Columbia, V34, P253; SCHIFF D, 1970, J PEDIATR-US, V77, P457, DOI 10.1016/S0022-3476(70)80015-4; STOWERS JM, 1975, CARBOHYD METABOL, P205; SUTHERLAND HW, 1973, BMJ-BRIT MED J, V3, P9, DOI 10.1136/bmj.3.5870.9; TUCHMANNDUPLESS.H, 1975, DRUG EFFECTS FETUS S, P198; Wilson JG, 1973, ENV BIRTH DEFECTS; ZUCKER P, 1968, PEDIATRICS, V42, P824	29	85	87	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					866	869		10.1016/0140-6736(91)91512-S	http://dx.doi.org/10.1016/0140-6736(91)91512-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681225				2022-12-28	WOS:A1991GH94500014
J	HOLOHAN, TV				HOLOHAN, TV			LAPAROSCOPIC CHOLECYSTECTOMY	LANCET			English	Review							LITHOTRIPSY; GALLSTONES; CHOLECYSTOSTOMY				HOLOHAN, TV (corresponding author), US PHS,AGCY HLTH CARE POLICY & RES,OFF HLTH TECHNOL ASSESSMENT,ROCKVILLE,MD 20857, USA.							DION YM, 1990, CAN J SURG, V33, P483; Dubois F, 1991, Surg Laparosc Endosc, V1, P52; DUBOIS F, 1990, ANN SURG, V211, P60, DOI 10.1097/00000658-199001000-00010; GADACZ TR, 1990, SURG CLIN N AM, V70, P1249; Kusminsky R E, 1990, W V Med J, V86, P336; MERRILL JR, 1988, AM SURGEON, V54, P256; MYERS WC, 1991, NEW ENGL J MED, V324, P1073; OREILLY MJ, IN PRESS SURG LAPARO; PERISSAT J, 1990, SURG ENDOSC-ULTRAS, V4, P1, DOI 10.1007/BF00591401; PERISSAT J, 1989, ENDOSCOPY, V21, P373, DOI 10.1055/s-2007-1012994; PETERS JH, 1991, ANN SURG, V213, P3, DOI 10.1097/00000658-199101000-00002; PHILLIPS EH, 1990, AM SURGEON, V56, P792; REDDICK E J, 1989, Surgical Endoscopy, V3, P131, DOI 10.1007/BF00591357; REDDICK EJ, 1990, AM J SURG, V160, P485, DOI 10.1016/S0002-9610(05)81009-8; SACKMANN M, 1991, ANN INTERN MED, V114, P290, DOI 10.7326/0003-4819-114-4-290; SCHOENFIELD LJ, 1990, NEW ENGL J MED, V323, P1239, DOI 10.1056/NEJM199011013231804; SCHWARTZ SI, 1984, PRINCIPLES SURGERY; SEMM K, 1983, ENDOSCOPY, V15, P59, DOI 10.1055/s-2007-1021466; Snow L L, 1990, Ala Med, V59, P18; Spaw A T, 1991, Surg Laparosc Endosc, V1, P2; TOMPKINS RK, 1990, ARCH SURG-CHICAGO, V125, P1245; WAY LW, 1990, NEW ENGL J MED, V323, P1273, DOI 10.1056/NEJM199011013231810; ZUCKER KA, 1991, AM J SURG, V161, P36, DOI 10.1016/0002-9610(91)90358-K; 1990, DRUG EVALUATIONS; 1990, HLTH CARE FINANCING, V3	25	59	59	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					801	803		10.1016/0140-6736(91)90678-I	http://dx.doi.org/10.1016/0140-6736(91)90678-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681171				2022-12-28	WOS:A1991GG97900015
J	MONREAL, M; OLIVE, A; LAFOZ, E; DELRIO, L				MONREAL, M; OLIVE, A; LAFOZ, E; DELRIO, L			HEPARINS, COUMARIN, AND BONE-DENSITY	LANCET			English	Letter									RADIOACT ISOTOPES CTR, BARCELONA, SPAIN		MONREAL, M (corresponding author), HOSP GERMANS TRIAS & PUJOL, INTERNAL MED SERV, E-08916 BARCELONA, SPAIN.							CERMEER C, 1991, THROMB HAEMOSTASIS, V66, P153; DAHLMAN T, 1990, BRIT J OBSTET GYNAEC, V97, P221, DOI 10.1111/j.1471-0528.1990.tb01785.x; FIORE CE, 1990, SOUTH MED J, V83, P538, DOI 10.1097/00007611-199005000-00013; GRIFFITH GC, 1965, J AMER MED ASSOC, V193, P91, DOI 10.1001/jama.1965.03090020005001; MILLER WILLIAM E., 1966, CLEVELAND CLIN QUART, V33, P31; MONREAL M, 1990, HAEMOSTASIS, V20, P204; SQUIRES JW, 1979, JAMA-J AM MED ASSOC, V241, P2417, DOI 10.1001/jama.241.22.2417; WISE PH, 1990, BRIT MED J, V12, P110	8	57	57	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	1991	338	8768					706	706		10.1016/0140-6736(91)91292-3	http://dx.doi.org/10.1016/0140-6736(91)91292-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679513				2022-12-28	WOS:A1991GF10500059
J	ROCHE, PW; THEUVENET, WJ; BRITTON, WJ				ROCHE, PW; THEUVENET, WJ; BRITTON, WJ			RISK-FACTORS FOR TYPE-1 REACTIONS IN BORDERLINE LEPROSY PATIENTS	LANCET			English	Article							PHENOLIC GLYCOLIPID-I; MYCOBACTERIUM-LEPRAE; RESPONSES; ANTIGENS	Type-1 or reversal reactions are the major cause of nerve damage and disability in leprosy. We wished to determine whether there were any clinical or laboratory markers that identified patients with an increased risk of type-1 reaction. 42 (31%) of 136 Nepalese borderline leprosy patients (97 male, 39 female; age range 7-73 years) had a type-1 reaction during the first 2 years of multi-drug therapy. Before therapy, 41 (98%) of the 42 patients were seropositive for antibodies to one of three mycobacterial antigens. Seropositivity for IgM antiphenolic-glycolipid-1 (PGL-1) antibodies, but not IgG anti-lipoarabinomannan or anti-Mycobacterium leprae 35 kDa protein antibodies, was significantly associated with subsequent manifestation of a type-1 reaction (p < 0.001). The concentration of IgM anti-PGL-1 antibodies in serum was significantly higher in patients in whom a type-1 reaction developed. The risk attributable to anti-PGL-1 seropositivity was independent of leprosy class, skin smear positivity, and the presence of other anti-M leprae antibodies (adjusted odds ratio = 8.7, p < 0.001). In the 87 patients who had a lepromin test, anti-PGL-1 seropositivity and lepromin reactivity were significant independent risk factors for subsequent reaction. 78% of patients with positive lepromin reactivity and IgM anti-PGL-1 antibodies had type-1 reactions. Patients with these risk factors should be carefully monitored during antimicrobial therapy to permit early initiation of anti-inflammatory treatment thus minimising permanent nerve damage and resultant disability.	UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA; ANANDABAN LEPROSY HOSP,MYCOBACTERIAL RES LAB,KATMANDU,NEPAL	University of Sydney								BARNETSON RS, 1985, BRIT MED J, V4, P435; BECZBLEUMINK M, 1989, INT J LEPR OTHER MYC, V57, P540; BRETT SJ, 1984, INFECT IMMUN, V46, P802, DOI 10.1128/IAI.46.3.802-808.1984; BRETT SJ, 1986, CLIN EXP IMMUNOL, V64, P476; CHANTEAU S, 1989, INT J LEPROSY, V57, P735; FRANZBLAU SG, 1987, FEMS MICROBIOL LETT, V48, P407, DOI 10.1111/j.1574-6968.1987.tb02633.x; GAYLORD H, 1987, ANNU REV MICROBIOL, V41, P645; HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981; JOB CK, 1989, INT J LEPROSY, V57, P532; LEVIS WR, 1987, J INFECT DIS, V56, P763; MISTRY Y, 1989, J BIOSCIENCE, V14, P37, DOI 10.1007/BF02703520; PFALTZGRAFF RE, 1985, LEPROSY, P166; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; ROCHE PW, 1991, AM J TROP MED HYG, V44, P702, DOI 10.4269/ajtmh.1991.44.702; ROCHE PW, 1991, T ROY SOC TROP MED H, V85, P299, DOI 10.1016/0035-9203(91)90065-7; ROCHE PW, 1990, INT J LEPROSY, V58, P319; ROCHE PW, 1990, INT J LEPROSY, V58, P480; SINHA S, 1985, INT J LEPROSY, V53, P33; SRINIVASAN H, 1982, LEPROSY INDIA, V56, P412; 1982, WHO TECHNICAL REPORT, V675; 1988, WHO TECHNICAL REPORT, V768; 1986, LANCET, V1, P533	22	51	52	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					654	657		10.1016/0140-6736(91)91232-J	http://dx.doi.org/10.1016/0140-6736(91)91232-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679473				2022-12-28	WOS:A1991GF10500003
J	BRODER, S; MITSUYA, H; YARCHOAN, R; PAVLAKIS, GN				BRODER, S; MITSUYA, H; YARCHOAN, R; PAVLAKIS, GN			ANTIRETROVIRAL THERAPY IN AIDS	ANNALS OF INTERNAL MEDICINE			English	Review									NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	BRODER, S (corresponding author), NCI, CLIN ONCOL BRANCH, 9000 ROCKVILLE PIKE, BLDG 31, ROOM 11A48, BETHESDA, MD 20892 USA.				OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMS DI, 1989, ANN INTERN MED, V110, P183, DOI 10.7326/0003-4819-110-3-183; AHLUWALIA G, 1987, BIOCHEM PHARMACOL, V36, P3797, DOI 10.1016/0006-2952(87)90440-0; AHLUWALIA G, 1988, 1988 P AM ASS CANC R, P349; AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; ARYA SK, 1987, P NATL ACAD SCI USA, V84, P5429, DOI 10.1073/pnas.84.15.5429; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BALZARINI J, 1988, BIOCHEM PHARMACOL, V37, P897, DOI 10.1016/0006-2952(88)90178-5; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; BRODER S, 1986, PROG ALLERGY, V37, P224; BRODER S, 1985, ANNU REV IMMUNOL, V3, P321, DOI 10.1146/annurev.iy.03.040185.001541; BUTLER K, 1989, 29TH INT C ANT AG CH, P106; BYRN RA, 1990, NATURE, V242, P1166; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; CHAUDHARY VK, 1988, NATURE, V335, P369, DOI 10.1038/335369a0; CLAPHAM PR, 1989, NATURE, V337, P368, DOI 10.1038/337368a0; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; COOLEY TP, 1990, NEW ENGL J MED, V322, P1340, DOI 10.1056/NEJM199005103221902; COONEY DA, 1986, BIOCHEM PHARMACOL, V35, P2065, DOI 10.1016/0006-2952(86)90571-X; COPELAND TD, 1988, GENE ANAL TECH, V5, P109, DOI 10.1016/0735-0651(88)90010-6; CULLEN BR, 1988, J VIROL, V62, P2498, DOI 10.1128/JVI.62.7.2498-2501.1988; DAAR ES, 1990, 6 INT C AIDS SAN FRA, V3, P117; DAHLBERG JE, 1987, P NATL ACAD SCI USA, V84, P2469, DOI 10.1073/pnas.84.8.2469; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; DEBOUCK C, 1987, P NATL ACAD SCI USA, V84, P8903, DOI 10.1073/pnas.84.24.8903; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; DOURNON E, 1988, LANCET, V2, P1297; DU DL, 1989, EXP HEMATOL, V17, P519; ERICKSON J, 1990, SCIENCE, V249, P527, DOI 10.1126/science.2200122; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1988, CONTROL OF HUMAN RETROVIRUS GENE EXPRESSION, P71; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; FISHER AG, 1987, SCIENCE, V237, P888, DOI 10.1126/science.3497453; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; FRANCHINI G, 1986, P NATL ACAD SCI USA, V83, P5282, DOI 10.1073/pnas.83.14.5282; FRANCHINI G, 1988, AIDS RES HUM RETROV, V4, P243, DOI 10.1089/aid.1988.4.243; FRIEDMAN AD, 1988, NATURE, V335, P452, DOI 10.1038/335452a0; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; GAIL MH, 1990, J ACQ IMMUN DEF SYND, V3, P296; GALLO R, 1988, NATURE, V333, P504, DOI 10.1038/333504a0; GALLO RC, 1988, SCI AM, V259, P40, DOI 10.1038/scientificamerican1088-40; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GOTTLIEB M, 1989, 5TH P INT C AIDS MON, P212; GUSTAFSON KR, 1989, J NATL CANCER I, V81, P1254, DOI 10.1093/jnci/81.16.1254; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; HAMMES SR, 1989, P NATL ACAD SCI USA, V86, P9549, DOI 10.1073/pnas.86.23.9549; HARTMAN NR, 1990, AIDS RES HUM RETROV, V6, P805, DOI 10.1089/aid.1990.6.805; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; HENDERSON LE, 1988, SCIENCE, V241, P199, DOI 10.1126/science.3388031; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; ITO M, 1987, ANTIVIR RES, V7, P361, DOI 10.1016/0166-3542(87)90018-0; KAHN JO, 1990, ANN INTERN MED, V112, P254, DOI 10.7326/0003-4819-112-4; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KAPPES JC, 1988, J VIROL, V62, P3501, DOI 10.1128/JVI.62.9.3501-3505.1988; KASSIANIDES C, 1989, GASTROENTEROLOGY, V97, P1275, DOI 10.1016/0016-5085(89)91699-5; KIM SY, 1989, P NATL ACAD SCI USA, V86, P9544, DOI 10.1073/pnas.86.23.9544; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KNIGHT DM, 1987, SCIENCE, V236, P837, DOI 10.1126/science.3033827; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; LAMBERT JS, 1990, NEW ENGL J MED, V112, P254; LARDER BA, 1989, P NATL ACAD SCI USA, V86, P4803, DOI 10.1073/pnas.86.13.4803; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LINBLAD G, 1973, ACTA PHARMACOL TOX, V32, P246; LOONEY DJ, 1990, J ACQ IMMUN DEF SYND, V3, P649; LORENTSEN KJ, 1989, ANN INTERN MED, V111, P561, DOI 10.7326/0003-4819-111-7-561; LUCIW PA, 1987, P NATL ACAD SCI USA, V84, P1434, DOI 10.1073/pnas.84.5.1434; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MALLORY A, 1980, GASTROENTEROLOGY, V78, P813, DOI 10.1016/0016-5085(80)90689-7; MARTIN P, 1989, P DIS DIS WEEK A, V3, P11; MATSUDA Z, 1988, P NATL ACAD SCI USA, V85, P6968, DOI 10.1073/pnas.85.18.6968; MATSUKURA M, 1989, P NATL ACAD SCI USA, V86, P4244, DOI 10.1073/pnas.86.11.4244; MATSUKURA M, 1987, P NATL ACAD SCI USA, V84, P7706, DOI 10.1073/pnas.84.21.7706; MATSUSHITA S, 1987, J CLIN INVEST, V80, P394, DOI 10.1172/JCI113085; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; MCQUADE TJ, 1990, SCIENCE, V247, P454, DOI 10.1126/science.2405486; MERIGAN TC, 1989, ANN INTERN MED, V110, P189, DOI 10.7326/0003-4819-110-3-189; MERMER B, 1990, NUCLEIC ACIDS RES, V18, P2037, DOI 10.1093/nar/18.8.2037; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; MITSUYA H, 1987, NATURE, V325, P773, DOI 10.1038/325773a0; MITSUYA H, 1987, P NATL ACAD SCI USA, V84, P2033, DOI 10.1073/pnas.84.7.2033; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; MITSUYA H, 1988, AIDS RES HUM RETROV, V4, P107, DOI 10.1089/aid.1988.4.107; MITSUYA H, 1988, ISI ATLAS-IMMUNOL, V1, P85; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MITSUYA H, 1989, MECHANISMS ACTION TH, P331; MOLINA JM, 1989, NEW ENGL J MED, V321, P1478; MONTGOMERY AB, 1989, AM REV RESPIR DIS, V139, P1548, DOI 10.1164/ajrccm/139.6.1548; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NAKASHIMA H, 1987, ANTIMICROB AGENTS CH, V31, P1524, DOI 10.1128/AAC.31.10.1524; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; NUTT RF, 1988, P NATL ACAD SCI USA, V85, P7129, DOI 10.1073/pnas.85.19.7129; PAVLAKIS G N, 1990, New Biologist, V2, P20; PERNO CF, 1989, J EXP MED, V169, P933, DOI 10.1084/jem.169.3.933; PERNO CF, 1990, J EXP MED, V171, P1043, DOI 10.1084/jem.171.4.1043; PERNO CF, 1988, J EXP MED, V168, P1111, DOI 10.1084/jem.168.3.1111; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; PIZZO PA, 1988, NEW ENGL J MED, V319, P889, DOI 10.1056/NEJM198810063191401; PLUDA JM, 1990, ANN INTERN MED, V113, P276, DOI 10.7326/0003-4819-113-4-276; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RICHMAN DD, 1990, REV INFECT DIS, V12, pS507; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; RICHMAN DD, 1987, J EXP MED, V166, P1144, DOI 10.1084/jem.166.4.1144; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; ROSSMANN MG, 1988, P NATL ACAD SCI USA, V85, P4625, DOI 10.1073/pnas.85.13.4625; RUPRECHT RM, 1986, NATURE, V323, P467, DOI 10.1038/323467a0; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; SCHMITT FA, 1988, NEW ENGL J MED, V319, P1573, DOI 10.1056/NEJM198812153192404; SCHOOLEY RT, 1990, ANN INTERN MED, V112, P247, DOI 10.7326/0003-4819-112-4-247; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; SCHWARTZ MS, 1989, AM J GASTROENTEROL, V84, P459; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SHARPE AH, 1987, SCIENCE, V236, P1671, DOI 10.1126/science.3037694; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; TATENO M, 1989, P NATL ACAD SCI USA, V86, P4287, DOI 10.1073/pnas.86.11.4287; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; TILL MA, 1988, SCIENCE, V242, P1166, DOI 10.1126/science.2847316; TOH H, 1983, NATURE, V305, P827, DOI 10.1038/305827a0; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; TRAUNECKER A, 1988, NATURE, V331, P84, DOI 10.1038/331084a0; TRAVARES L, 1987, CANCER RES, V47, P3190; TRONO D, 1989, CELL, V59, P113, DOI 10.1016/0092-8674(89)90874-X; UEDA K, 1989, VIROLOGY, V169, P213, DOI 10.1016/0042-6822(89)90057-3; UENO R, 1987, LANCET, V1, P1379; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WEBER IT, 1989, SCIENCE, V243, P928, DOI 10.1126/science.2537531; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279; WONGSTAAL F, 1987, AIDS RES HUM RETROV, V3, P33, DOI 10.1089/aid.1987.3.33; WRIGHT CM, 1986, SCIENCE, V234, P988, DOI 10.1126/science.3490693; YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106; YARCHOAN R, 1990, LANCET, V336, P526, DOI 10.1016/0140-6736(90)92085-V; YARCHOAN R, 1986, LANCET, V1, P575; YARCHOAN R, 1988, LANCET, V1, P76; YARCHOAN R, 1987, NEW ENGL J MED, V316, P557, DOI 10.1056/NEJM198702263160925; YARCHOAN R, 1989, PHARMACOL THERAPEUT, V40, P329, DOI 10.1016/0163-7258(89)90083-1; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4; YARCHOAN R, 1989, FUNDAMENTAL IMMUNOLO, P1059; YARCHOAN R, 1989, 5TH INT C AIDS MONTR, P406; YARCHOAN R, 1989, 5TH INT C AIDS MONTR, P564; ZAMECNIK PC, 1986, P NATL ACAD SCI USA, V83, P4143, DOI 10.1073/pnas.83.12.4143; 1990, AIDS NEW YORK STATE, P92; [No title captured]	170	60	63	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	1990	113	8					604	618		10.7326/0003-4819-113-8-604	http://dx.doi.org/10.7326/0003-4819-113-8-604			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED339	1698042				2022-12-28	WOS:A1990ED33900009
J	FLANAGAN, JG; LEDER, P				FLANAGAN, JG; LEDER, P			THE KIT LIGAND - A CELL-SURFACE MOLECULE ALTERED IN STEEL MUTANT FIBROBLASTS	CELL			English	Article									HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	FLANAGAN, JG (corresponding author), HOWARD HUGHES MED INST,BOSTON,MA 02115, USA.		Flanagan, John/AAM-2995-2020					ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Fernley H.N., 1971, ENZYMES, V4, P417; FUJITA J, 1988, BLOOD, V72, P463; FUJITA J, 1989, P NATL ACAD SCI USA, V86, P2888, DOI 10.1073/pnas.86.8.2888; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; HARLOW E, 1988, ANTIBODIES LABORATOR; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JEMMERSON R, 1983, HUMAN ALKALINE PHOSP, P105; KARASUYAMA H, 1988, J EXP MED, V167, P1377, DOI 10.1084/jem.167.4.1377; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; LANDRETH KS, 1984, J IMMUNOL, V132, P2724; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; LEVISCHAFFER F, 1987, J IMMUNOL, V139, P3431; LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454; MAJUMDER S, 1988, MOL CELL BIOL, V8, P4896, DOI 10.1128/MCB.8.11.4896; MORRISONGRAHAM K, 1989, TRENDS GENET, V5, P116, DOI 10.1016/0168-9525(89)90042-5; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; NAKAYAMA H, 1988, DEVELOPMENT, V102, P117; NAKAYAMA H, 1988, DEVELOPMENT, V102, P107; NOCKA, IN PRESS EMBO J; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; PFEFFER S, 1985, NATURE, V313, P184, DOI 10.1038/313184a0; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ES, 1984, AM J MED GENET, V18, P621, DOI 10.1002/ajmg.1320180410; SARVELLA PATRICIA A., 1956, JOUR HEREDITY, V47, P123; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; YARDEN Y, 1989, P NATL ACAD SCI USA, V86, P3179, DOI 10.1073/pnas.86.9.3179; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZOELLNER HFA, 1989, J HISTOCHEM CYTOCHEM, V37, P1893, DOI 10.1177/37.12.2584695; 1990, CELL, V63	42	764	818	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 5	1990	63	1					185	194		10.1016/0092-8674(90)90299-T	http://dx.doi.org/10.1016/0092-8674(90)90299-T			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EB461	1698555				2022-12-28	WOS:A1990EB46100019
J	WRIGHT, SD; RAMOS, RA; TOBIAS, PS; ULEVITCH, RJ; MATHISON, JC				WRIGHT, SD; RAMOS, RA; TOBIAS, PS; ULEVITCH, RJ; MATHISON, JC			CD14, A RECEPTOR FOR COMPLEXES OF LIPOPOLYSACCHARIDE (LPS) AND LPS BINDING-PROTEIN	SCIENCE			English	Article									SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,LA JOLLA,CA 92037	Scripps Research Institute	WRIGHT, SD (corresponding author), ROCKEFELLER UNIV,CELLULAR PHYSIOL & IMMUNOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.		Ulevitch, Richard J/Q-3393-2017		NIAID NIH HHS [AI 15136, AI 22003, AI 24775] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024775, R01AI015136, R01AI022003] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASHMUN RA, 1987, BLOOD, V69, P886; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; DESCH CE, 1989, LYMPHOKINE RES, V8, P141; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FERRERO E, 1988, NUCLEIC ACIDS RES, V16, P4173, DOI 10.1093/nar/16.9.4173; FLEIT HB, 1982, P NATL ACAD SCI-BIOL, V79, P3275, DOI 10.1073/pnas.79.10.3275; GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876; HAZIOT A, 1988, J IMMUNOL, V141, P547; KUDRYK B, 1984, MOL IMMUNOL, V21, P89, DOI 10.1016/0161-5890(84)90093-2; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; MICHL J, 1979, J EXP MED, V150, P607, DOI 10.1084/jem.150.3.607; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; SHERRY B, 1988, J CELL BIOL, V107, P1269, DOI 10.1083/jcb.107.4.1269; SIMMONS DL, 1989, BLOOD, V73, P284; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; TOBIAS PS, 1989, J BIOL CHEM, V264, P10867; TODD RF, 1982, HYBRIDOMA, V1, P329, DOI 10.1089/hyb.1.1982.1.329; ULEVITCH RJ, UNPUB; VANVOORHIS WC, 1983, J EXP MED, V158, P126, DOI 10.1084/jem.158.1.126; WRIGHT S, UNPUB; Wright S D, 1986, Methods Enzymol, V132, P204; WRIGHT SD, 1990, J IMMUNOL, V144, P2566; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149	27	3546	3689	2	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 21	1990	249	4975					1431	1433		10.1126/science.1698311	http://dx.doi.org/10.1126/science.1698311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ451	1698311				2022-12-28	WOS:A1990DZ45100044
J	VISKOCHIL, D; BUCHBERG, AM; XU, GF; CAWTHON, RM; STEVENS, J; WOLFF, RK; CULVER, M; CAREY, JC; COPELAND, NG; JENKINS, NA; WHITE, R; OCONNELL, P				VISKOCHIL, D; BUCHBERG, AM; XU, GF; CAWTHON, RM; STEVENS, J; WOLFF, RK; CULVER, M; CAREY, JC; COPELAND, NG; JENKINS, NA; WHITE, R; OCONNELL, P			DELETIONS AND A TRANSLOCATION INTERRUPT A CLONED GENE AT THE NEUROFIBROMATOSIS TYPE-1 LOCUS	CELL			English	Article									UNIV UTAH, HOWARD HUGHES MED INST, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; NCI, FREDERICK CANC RES & DEV CTR, APPL BIOSCI LABS, BASIC RES PROGRAM, FREDERICK, MD 21701 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	VISKOCHIL, D (corresponding author), UNIV UTAH, DEPT PEDIAT, SALT LAKE CITY, UT 84132 USA.			Buchberg, Arthur/0000-0002-0543-5631	PHS HHS [N01-CQ-74101] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BUCHBERG AM, 1990, IN PRESS MOL CELL BI; CAWTHON RM, 1990, IN PRESS GENOMICS; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; FRIEDMAN KD, 1988, NUCLEIC ACIDS RES, V16, P8718, DOI 10.1093/nar/16.17.8718; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GOLDGAR DE, 1989, AM J HUM GENET, V44, P6; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; MENON AG, 1989, GENOMICS, V5, P245, DOI 10.1016/0888-7543(89)90053-0; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OCONNELL P, 1989, AM J HUM GENET, V44, P51; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; OCONNELL P, 1990, IN PRESS GENOMICS; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SELDEN RF, 1989, CURRENT PROTOCOLS MO	24	890	913	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	1990	62	1					187	192		10.1016/0092-8674(90)90252-A	http://dx.doi.org/10.1016/0092-8674(90)90252-A			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN533	1694727				2022-12-28	WOS:A1990DN53300023
J	RONNETT, GV; HESTER, LD; NYE, JS; CONNORS, K; SNYDER, SH				RONNETT, GV; HESTER, LD; NYE, JS; CONNORS, K; SNYDER, SH			HUMAN CORTICAL NEURONAL CELL-LINE - ESTABLISHMENT FROM A PATIENT WITH UNILATERAL MEGALENCEPHALY	SCIENCE			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI PHARMACOL & MOLEC SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Nye, Jeffrey/G-6520-2012	Nye, Jeffrey/0000-0002-6056-281X	NIDA NIH HHS [DA 00074, DA 00266] Funding Source: Medline; NIMH NIH HHS [MH 18501] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018501, R37MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		DAMBSKA M, 1984, BRAIN DEV-JPN, V6, P60, DOI 10.1016/S0387-7604(84)80012-1; FRESHNEY RI, 1987, CULTURE ANIMAL CELLS, P175; GOODMAN R, 1986, DEV MED CHILD NEUROL, V28, P251; HOKFELT T, 1984, SCIENCE, V225, P1326, DOI 10.1126/science.6147896; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; MIKHAEL MA, 1978, J COMPUT ASSIST TOMO, V2, P291, DOI 10.1097/00004728-197807000-00009; PAHLMAN S, 1986, LAB INVEST, V54, P554; Sieber-Blum M, 1982, Prog Clin Biol Res, V85 Pt B, P485; SPEICHER DW, 1980, P NATL ACAD SCI-BIOL, V77, P5673, DOI 10.1073/pnas.77.10.5673	9	114	128	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 4	1990	248	4955					603	605		10.1126/science.1692158	http://dx.doi.org/10.1126/science.1692158			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB956	1692158				2022-12-28	WOS:A1990DB95600037
J	MONK, M; HOLDING, C				MONK, M; HOLDING, C			AMPLIFICATION OF A BETA-HEMOGLOBIN SEQUENCE IN INDIVIDUAL HUMAN OOCYTES AND POLAR BODIES	LANCET			English	Article											MONK, M (corresponding author), UNIV LONDON UNIV COLL, MRC, MAMMALIAN DEV UNIT, WOLFSON HOUSE, 4 STEPHENSON WAY, LONDON NW1 2HE, ENGLAND.							CAO A, 1989, MOL PROBES TECHNOLOG, P43; EMBURY SH, 1987, NEW ENGL J MED, V316, P656, DOI 10.1056/NEJM198703123161103; HOLDING C, 1989, LANCET, V2, P532; MARCOTTA C, 1977, J BIOL CHEM, V252, P5040; MONK M, 1987, LANCET, V2, P423; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Orkin S., 1987, MOL BASIS BLOOD DISE, P106; SERJEANT GR, 1985, SICKLE CELL DISEASE	8	62	63	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	1990	335	8696					985	988		10.1016/0140-6736(90)91060-N	http://dx.doi.org/10.1016/0140-6736(90)91060-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB072	1691429				2022-12-28	WOS:A1990DB07200001
J	SISODIA, SS; KOO, EH; BEYREUTHER, K; UNTERBECK, A; PRICE, DL				SISODIA, SS; KOO, EH; BEYREUTHER, K; UNTERBECK, A; PRICE, DL			EVIDENCE THAT BETA-AMYLOID PROTEIN IN ALZHEIMERS-DISEASE IS NOT DERIVED BY NORMAL PROCESSING	SCIENCE			English	Article									JOHNS HOPKINS UNIV, SCH MED, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROSCI, BALTIMORE, MD 21205 USA; UNIV HEIDELBERG, CTR MOLEC BIOL, W-6900 HEIDELBERG, GERMANY	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Ruprecht Karls University Heidelberg	SISODIA, SS (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, BALTIMORE, MD 21205 USA.				NATIONAL INSTITUTE ON AGING [R35AG007914, P50AG005146, R01AG003359] Funding Source: NIH RePORTER; NIA NIH HHS [AG 05146, AG 07914, AG 03359] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DESAUVAGE F, 1989, SCIENCE, V245, P651, DOI 10.1126/science.2569763; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; Maniatis T., 1982, MOL CLONING; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MULLERHILL B, 1989, ANNU REV BIOCHEM, V58, P287; MUNRO S, 1984, EMBO J, V3, P3087, DOI 10.1002/j.1460-2075.1984.tb02263.x; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; PALMERT MR, 1989, BIOCHEM BIOPH RES CO, V165, P182, DOI 10.1016/0006-291X(89)91052-8; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1986, ANNU REV NEUROSCI, V9, P489; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; SISODIA SS, UNPUB; SUBRAMANI S, 1981, MOL CELL BIOL, V1, P854, DOI 10.1128/MCB.1.9.854; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WEIS JJ, 1988, J EXP MED, V167, P1047, DOI 10.1084/jem.167.3.1047; WISNIEWSKI HM, 1976, J NEUROL SCI, V27, P173, DOI 10.1016/0022-510X(76)90059-9; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729	28	857	888	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	1990	248	4954					492	495		10.1126/science.1691865	http://dx.doi.org/10.1126/science.1691865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA756	1691865				2022-12-28	WOS:A1990DA75600047
J	KARLSSON, O; THOR, S; NORBERG, T; OHLSSON, H; EDLUND, T				KARLSSON, O; THOR, S; NORBERG, T; OHLSSON, H; EDLUND, T			INSULIN GENE ENHANCER BINDING-PROTEIN ISL-1 IS A MEMBER OF A NOVEL CLASS OF PROTEINS CONTAINING BOTH A HOMEODOMAIN AND A CYS-HIS DOMAIN	NATURE			English	Article									UMEA UNIV,DEPT MICROBIOL,S-90187 UMEA,SWEDEN	Umea University			Thor, Stefan/Y-5804-2019	Thor, Stefan/0000-0001-5095-541X; Edlund, Helena/0000-0002-3553-7348				ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FERGUSON EL, 1987, NATURE, V326, P260; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; KARLSSON O, 1989, MOL CELL BIOL, V9, P823, DOI 10.1128/MCB.9.2.823; KARLSSON O, 1987, P NATL ACAD SCI USA, V79, P6453; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; LERNMARK A, 1976, J CELL BIOL, V71, P606, DOI 10.1083/jcb.71.2.606; MADSEN OD, 1986, J CELL BIOL, V103, P2025, DOI 10.1083/jcb.103.5.2025; MIHARA H, 1988, SCIENCE, V242, P925, DOI 10.1126/science.2903553; ODENWALD WF, 1989, GENE DEV, V3, P158, DOI 10.1101/gad.3.2.158; OHLSSON H, 1988, P NATL ACAD SCI USA, V85, P4228, DOI 10.1073/pnas.85.12.4228; SCOTT PM, 1989, BBA REV CANCER, V989, P25; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; STRATOWA C, 1986, P NATL ACAD SCI USA, V83, P4292, DOI 10.1073/pnas.83.12.4292; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2	21	645	696	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 26	1990	344	6269					879	882		10.1038/344879a0	http://dx.doi.org/10.1038/344879a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA751	1691825				2022-12-28	WOS:A1990DA75100062
J	EVERHART, JE; DIBISCEGLIE, AM; MURRAY, LM; ALTER, HJ; MELPOLDER, JJ; KUO, G; HOOFNAGLE, JH				EVERHART, JE; DIBISCEGLIE, AM; MURRAY, LM; ALTER, HJ; MELPOLDER, JJ; KUO, G; HOOFNAGLE, JH			RISK FOR NON-A, NON-B (TYPE-C) HEPATITIS THROUGH SEXUAL OR HOUSEHOLD CONTACT WITH CHRONIC CARRIERS	ANNALS OF INTERNAL MEDICINE			English	Note									CHIRON CORP, EMERYVILLE, CA USA; NIH, BETHESDA, MD 20205 USA	Novartis; National Institutes of Health (NIH) - USA								ALTER HJ, 1981, JAMA-J AM MED ASSOC, V246, P630, DOI 10.1001/jama.246.6.630; ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; ALTER MJ, 1982, J INFECT DIS, V145, P886, DOI 10.1093/infdis/145.6.886; ALTER MJ, 1989, JAMA-J AM MED ASSOC, V262, P1201, DOI 10.1001/jama.262.9.1201; ARMITAGE P, 1971, STATISTICAL METHODS, P111; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; DIENSTAG JL, 1983, GASTROENTEROLOGY, V85, P439; KAHN RA, 1982, AM J EPIDEMIOL, V115, P929, DOI 10.1093/oxfordjournals.aje.a113380; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467	10	259	260	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	1990	112	7					544	545		10.7326/0003-4819-112-7-544	http://dx.doi.org/10.7326/0003-4819-112-7-544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW001	1690526				2022-12-28	WOS:A1990CW00100010
J	MONACO, S; BONETTI, B; FERRARI, S; MORETTO, G; NARDELLI, E; TEDESCO, F; MOLLNES, TE; NOBILEORAZIO, E; MANFREDINI, E; BONAZZI, L; RIZZUTO, N				MONACO, S; BONETTI, B; FERRARI, S; MORETTO, G; NARDELLI, E; TEDESCO, F; MOLLNES, TE; NOBILEORAZIO, E; MANFREDINI, E; BONAZZI, L; RIZZUTO, N			COMPLEMENT-MEDIATED DEMYELINATION IN PATIENTS WITH IGM MONOCLONAL GAMMOPATHY AND POLYNEUROPATHY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV TRIESTE,IST PATOL GEN,TRIESTE,ITALY; UNIV VERONA,IST NEUROL,I-37134 VERONA,ITALY; UNIV VERONA,IST CHIM & MICROSCOPIA CLIN,I-37134 VERONA,ITALY; NATL HOSP NORWAY,INST IMMUNOL & RHEUMATOL,OSLO 1,NORWAY; UNIV MILAN,CTR DINO FERRARI,IST CLIN NEUROL,I-20122 MILAN,ITALY	University of Trieste; University of Verona; University of Verona; University of Oslo; National Hospital Norway; University of Milan			Tedesco, Francesco/F-1929-2011; Mollnes, Tom/ABI-5183-2020; Bonetti, Bruno/F-1431-2013; Nobile-Orazio, Eduardo/B-7915-2013; Monaco, Salvatore/K-4659-2018	Nobile-Orazio, Eduardo/0000-0003-2624-8138; Monaco, Salvatore/0000-0003-3191-8597; ferrari, sergio/0000-0003-3855-5135; BONETTI, Bruno/0000-0002-3944-4165				BRAUN PE, 1982, J NEUROCHEM, V39, P1261, DOI 10.1111/j.1471-4159.1982.tb12563.x; DALAKAS MC, 1981, ANN NEUROL, V10, P45, DOI 10.1002/ana.410100109; DYCK PJ, 1984, PERIPHERAL NEUROPATH, P760; FRAIL DE, 1984, MOL IMMUNOL, V21, P721, DOI 10.1016/0161-5890(84)90024-5; HAYS AP, 1987, NEUROLOGY, V37, P242, DOI 10.1212/WNL.37.2.242; HAYS AP, 1988, J NEUROIMMUNOL, V18, P231, DOI 10.1016/0165-5728(88)90101-4; IMAGAWA DK, 1983, P NATL ACAD SCI-BIOL, V80, P6647, DOI 10.1073/pnas.80.21.6647; JOHNSON AB, 1979, LAB INVEST, V40, P568; KELLY JJ, 1988, ARCH NEUROL-CHICAGO, V45, P1355, DOI 10.1001/archneur.1988.00520360073015; KELLY JJ, 1985, MUSCLE NERVE, V8, P138, DOI 10.1002/mus.880080210; KING RHM, 1984, ACTA NEUROPATHOL, V63, P319, DOI 10.1007/BF00687340; KOSKI CL, 1987, J CLIN INVEST, V80, P1492, DOI 10.1172/JCI113231; LATOV N, 1988, CRIT REV NEUROBIOL, V3, P301; LATOV N, 1987, POLYNEUROPATHIES ASS, P51; MENDELL JR, 1985, ANN NEUROL, V17, P243, DOI 10.1002/ana.410170305; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; MOLLNES TE, 1987, SCAND J IMMUNOL, V26, P381, DOI 10.1111/j.1365-3083.1987.tb02270.x; MONACO S, 1985, P NATL ACAD SCI USA, V82, P920, DOI 10.1073/pnas.82.3.920; MORETTO G, 1987, ACTA NEUROPATHOL, V73, P344, DOI 10.1007/BF00688257; NOBILEORAZIO E, 1984, NEUROLOGY, V34, P1336, DOI 10.1212/WNL.34.10.1336; NOBILEORAZIO E, 1987, NEUROLOGY, V37, P1506, DOI 10.1212/WNL.37.9.1506; SHY ME, 1984, J IMMUNOL, V133, P2509; STECK AJ, 1983, NEUROLOGY, V33, P19, DOI 10.1212/WNL.33.1.19; STECK AJ, 1985, SPRINGER SEMIN IMMUN, V8, P29; STECK AJ, 1987, ANN NEUROL, V22, P764, DOI 10.1002/ana.410220614; STEFANSSON K, 1983, ACTA NEUROPATHOL, V59, P255, DOI 10.1007/BF00691490; STERNBERGER LA, 1978, IMMUNOCYTOCHEMISTRY; TAKATSU M, 1985, ANN NEUROL, V18, P173, DOI 10.1002/ana.410180203; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAPP BD, 1982, J CELL BIOL, V92, P877, DOI 10.1083/jcb.92.3.877	31	136	137	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	1990	322	10					649	652		10.1056/NEJM199003083221002	http://dx.doi.org/10.1056/NEJM199003083221002			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR781	1689461				2022-12-28	WOS:A1990CR78100002
J	WILKINSON, DG; BHATT, S; HERRMANN, BG				WILKINSON, DG; BHATT, S; HERRMANN, BG			EXPRESSION PATTERN OF THE MOUSE T-GENE AND ITS ROLE IN MESODERM FORMATION	NATURE			English	Article									NATL INST MED RES,EUKARYOT MOLEC GENET LAB,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research				Wilkinson, David/0000-0001-6757-7080				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEDDINGTON RSP, 1981, J EMBRYOL EXP MORPH, V64, P87; BEDDINGTON RSP, 1982, J EMBRYOL EXP MORPH, V69, P265; BEDDINGTON RSP, 1987, DEV MAMMALS, V5, P1; BELLAIRS R, 1986, ANAT EMBRYOL, V174, P1, DOI 10.1007/BF00318331; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUJIMOTO H, 1983, DIFFERENTIATION, V25, P44; Gluecksohn-Schoenheimer S, 1944, P NATL ACAD SCI USA, V30, P134, DOI 10.1073/pnas.30.6.134; GRUNEBERG H, 1958, J EMBRYOL EXP MORPH, V6, P424; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; PATERNO GD, 1989, DEVELOPMENT, V106, P79; SEARLE AG, 1966, GENET RES, V7, P86, DOI 10.1017/S0016672300009496; Slack J, 1983, EGG EMBRYO; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH JC, 1988, DEVELOPMENT, V103, P591; SNELL GEORGE D., 1966, P205; TAM PPL, 1987, DEVELOPMENT, V99, P109; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; YANAGISAWA KO, 1977, J EMBRYOL EXP MORPH, V40, P277; YANAGISAWA KO, 1981, DEV BIOL, V87, P242, DOI 10.1016/0012-1606(81)90147-0	24	708	727	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 15	1990	343	6259					657	659		10.1038/343657a0	http://dx.doi.org/10.1038/343657a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN989	1689462				2022-12-28	WOS:A1990CN98900069
J	TAN, JC; NOCKA, K; RAY, P; TRAKTMAN, P; BESMER, P				TAN, JC; NOCKA, K; RAY, P; TRAKTMAN, P; BESMER, P			THE DOMINANT W42 SPOTTING PHENOTYPE RESULTS FROM A MISSENSE MUTATION IN THE C-KIT RECEPTOR KINASE	SCIENCE			English	Article									SLOAN KETTERING MEM CANC CTR,MOLEC BIOL PROGRAM,NEW YORK,NY 10021; CORNELL UNIV,GRAD SCH MED SCI,MOLEC BIOL PROGRAM,NEW YORK,NY 10021; CORNELL UNIV,GRAD SCH MED SCI,DEPT CELL BIOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University				Traktman, Paula/0000-0002-6517-0225	NATIONAL CANCER INSTITUTE [P01CA016599, R01CA032926] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA-16599, R01-CA-32926] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUJITA J, 1988, J CELL PHYSIOL, V134, P78, DOI 10.1002/jcp.1041340109; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1981, GENETICS, V97, P337; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LYON MF, 1984, GENET RES, V44, P161, DOI 10.1017/S0016672300026367; MAJUMDER S, 1988, MOL CELL BIOL, V8, P4896, DOI 10.1128/MCB.8.11.4896; MORAN MF, 1988, ONCOGENE, V3, P665; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOCKA K, UNPUB; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Silvers W.K., 1979, COAT COLORS MICE, P206; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	22	274	282	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 12	1990	247	4939					209	212		10.1126/science.1688471	http://dx.doi.org/10.1126/science.1688471			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH520	1688471				2022-12-28	WOS:A1990CH52000035
J	FINE, PEM				FINE, PEM			MENINGOCOCCAL VACCINE TRIAL IN NORWAY	LANCET			English	Letter							EFFICACY				FINE, PEM (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,LONDON WC1E 7HT,ENGLAND.							BJUNE, 1991, LANCET, V338, P1093; CARTWRIGHT KAV, 1991, EPIDEMIOL INFECT, V106, P133, DOI 10.1017/S0950268800056491; FINE PEM, 1987, REV INFECT DIS, V9, P866; HABER M, 1991, INT J EPIDEMIOL, V21, P300; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87	6	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1456	1457		10.1016/0140-6736(91)92755-Q	http://dx.doi.org/10.1016/0140-6736(91)92755-Q			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683438				2022-12-28	WOS:A1991GT90400033
J	LEE, JA; LEE, HA; SADLER, PJ				LEE, JA; LEE, HA; SADLER, PJ			UREMIA - IS UREA MORE IMPORTANT THAN WE THINK	LANCET			English	Note							TRIMETHYLAMINE; ANTIDIURESIS; OSMOLYTES; KIDNEY; HUMANS	Urea is accumulated as an osmolyte by some groups of animals even though it impairs protein function. These organisms can withstand high internal urea concentrations because they also accumulate other low-molecular-weight osmolytes, the methylamines, which can offset the effects of urea on proteins. Methylamines have also been found in the medulla of the mammalian kidney (where urea concentrations are high) and in the plasma of human subjects with chronic renal failure. These findings suggest that previous investigations of the potential contribution of urea to the syndrome of uraemia may have been confounded because of the presence of variable concentrations of protective substances. That naturally occurring methylamines or related substances may prove to have a useful therapeutic role in uraemia is also possible.	ST MARYS HOSP,DEPT RENAL MED,PORTSMOUTH PO3 6AQ,HANTS,ENGLAND; UNIV LONDON BIRKBECK COLL,DEPT CHEM,CHRISTOPHER INGOLD LABS & GORDON HOUSE,LONDON WC1E 7HX,ENGLAND	University of London; Birkbeck University London	LEE, JA (corresponding author), UNIV NEWCASTLE UPON TYNE,ROYAL VICTORIA INFIRM,DEPT PATHOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND.							ALWAIZ M, 1987, CLIN PHARMACOL THER, V42, P608, DOI 10.1038/clpt.1987.207; ALWAIZ M, 1987, CLIN PHARMACOL THER, V42, P588, DOI 10.1038/clpt.1987.201; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; BALABAN RS, 1987, KIDNEY INT, V31, P562, DOI 10.1038/ki.1987.36; BALABAN RS, 1983, AM J PHYSIOL, V245, pC438; BARSOTTI G, 1989, NUTR TREATMENT CHRON, P33; BATES JR, 1986, MAGNETIC RESONANCE M, V3, P849; BECK F, 1984, KIDNEY INT, V25, P397, DOI 10.1038/ki.1984.30; BELL JD, 1991, MAGN RESON MED, V17, P414, DOI 10.1002/mrm.1910170213; BELL JD, 1991, BIOCHIM BIOPHYS ACTA, V1096, P101, DOI 10.1016/0925-4439(91)90046-C; Bollman JL, 1927, P SOC EXP BIOL MED, V24, P923; BONAVENTURA J, 1974, SCIENCE, V186, P57, DOI 10.1126/science.186.4158.57; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; BROWN JCC, 1989, MAGNET RESON MED, V11, P193, DOI 10.1002/mrm.1910110207; CHAMBERLIN ME, 1989, AM J PHYSIOL, V257, pC159, DOI 10.1152/ajpcell.1989.257.2.C159; DAVIES SEC, 1988, CLIN CHIM ACTA, V178, P241, DOI 10.1016/0009-8981(88)90232-X; DIAMOND JR, 1990, AM J PHYSIOL, V258, pF1, DOI 10.1152/ajprenal.1990.258.1.F1; GILBOE DD, 1964, P SOC EXP BIOL MED, V115, P633; GUTMAN Y, 1971, BIOCHIM BIOPHYS ACTA, V233, P133, DOI 10.1016/0005-2736(71)90365-8; HUTCHINGS RH, 1966, ANN INTERN MED, V65, P275, DOI 10.7326/0003-4819-65-2-275; KNOCHEL JP, 1976, KIDNEY, P1448; MERRILL JP, 1953, AM J MED, V14, P519; SILIGARDI G, IN PRESS INT J PEPTI; Somero G. N., 1986, NEWS PHYSIOL SCI, V1, P9; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; WILLS MR, 1978, METABOLIC CONSEQUENC; YANCEY PH, 1989, AM J PHYSIOL, V257, pF602, DOI 10.1152/ajprenal.1989.257.4.F602; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	29	25	26	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1438	1440		10.1016/0140-6736(91)92733-I	http://dx.doi.org/10.1016/0140-6736(91)92733-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683430				2022-12-28	WOS:A1991GT90400014
J	BUCHWALD, H				BUCHWALD, H			GASTRIC DECONTAMINATION IN PATIENT WITH GASTRIC STAPLING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											BUCHWALD, H (corresponding author), UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 4	1991	266	21					3040	3040						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR775	1687926				2022-12-28	WOS:A1991GR77500042
J	TAYLOR, JE; HENDERSON, IS; STEWART, WK; BELCH, JJF				TAYLOR, JE; HENDERSON, IS; STEWART, WK; BELCH, JJF			ERYTHROPOIETIN AND SPONTANEOUS PLATELET-AGGREGATION IN HEMODIALYSIS-PATIENTS	LANCET			English	Note							RECOMBINANT-HUMAN-ERYTHROPOIETIN; RENAL-FAILURE; BLOOD	Erythropoietin significantly, reversibly, and reproducibly increased in-vitro whole-blood spontaneous platelet aggregation in 15 patients on haemodialysis. During erythropoietin treatment, spontaneous platelet aggregation was significantly higher in these subjects than in non-uraemic controls; concomitant treatment with 300 mg aspirin daily reversed platelet hyperaggregability. Erythropoietin may promote thrombosis by an effect on platelet function.	UNIV DUNDEE, NINEWELLS HOSP & MED SCH, DEPT MED, DUNDEE DD1 9SY, SCOTLAND	University of Dundee	TAYLOR, JE (corresponding author), UNIV DUNDEE, NINEWELLS HOSP & MED SCH, RENAL UNIT, DUNDEE DD1 9SY, SCOTLAND.		Belch, Jill/AAE-9189-2019	Belch, Jill/0000-0001-8280-6689				DIMINNO G, 1985, AM J MED, V79, P552, DOI 10.1016/0002-9343(85)90051-8; HEIDENREICH S, 1991, KIDNEY INT, V39, P259, DOI 10.1038/ki.1991.31; HOCKEN AG, 1982, NEPHRON, V32, P28, DOI 10.1159/000182727; KINDLER J, 1989, NEPHROL DIAL TRANSPL, V4, P345, DOI 10.1093/oxfordjournals.ndt.a091888; RAINE AEG, 1988, LANCET, V1, P97; SANIABADI AR, 1987, ATHEROSCLEROSIS, V66, P175, DOI 10.1016/0021-9150(87)90061-X; SANIABADI AR, 1989, ATHEROSCLEROSIS, V76, P149, DOI 10.1016/0021-9150(89)90098-1; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; VANGEET C, 1990, THROMB HAEMOSTASIS, V64, P7; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6	10	60	63	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	1991	338	8779					1361	1362		10.1016/0140-6736(91)92239-X	http://dx.doi.org/10.1016/0140-6736(91)92239-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682739				2022-12-28	WOS:A1991GR77300006
J	ROSENSTEIN, Y; PARK, JK; HAHN, WC; ROSEN, FS; BIERER, BE; BURAKOFF, SJ				ROSENSTEIN, Y; PARK, JK; HAHN, WC; ROSEN, FS; BIERER, BE; BURAKOFF, SJ			CD43, A MOLECULE DEFECTIVE IN WISKOTT-ALDRICH SYNDROME, BINDS ICAM-1	NATURE			English	Article								THE protein CD43 (also known as sialophorin, leukosialin, large sialoglycoprotein or gp115) is expressed on the surface of T lymphocytes, monocytes, neutrophils, platelets and some B lymphocytes 1-6. Expression of CD43 is deficient and/or defective in the X-chromosome-linked immunodeficiency disorder Wiscott-Aldrich syndrome 7, suggesting that CD43 might have a role in T-cell activation. We have shown that expression of human CD43 in an HLA-DR-specific murine T-cell hybridoma enhances the antigen-specific response to stimulation by the human lymphoblastoid cell line Daudi, and that Daudi cells bind specifically to purified immobilized CD43 (ref. 8). These data indicate that the specific interaction of CD43 with a ligand on the surface of Daudi cells might contribute to T-cell activation. Here we report evidence that intercellular adhesion molecule-1 (ICAM-1, or CD54), is a ligand for CD43.	HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, CTR BLOOD RES, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV HEMATOL ONCOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	ROSENSTEIN, Y (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA.			Bierer, Barbara/0000-0001-6448-8170				ARDMAN B, 1990, J EXP MED, V172, P1151, DOI 10.1084/jem.172.4.1151; AXELSSON B, 1988, J IMMUNOL, V141, P2912; BEYERS AD, 1989, IMMUNOL REV, V111, P59, DOI 10.1111/j.1600-065X.1989.tb00542.x; BIERER BE, 1988, P NATL ACAD SCI USA, V85, P1154; BORCHE L, 1987, EUR J IMMUNOL, V17, P1523, DOI 10.1002/eji.1830171023; BROWN WRA, 1981, NATURE, V289, P456, DOI 10.1038/289456a0; CARLSSON SR, 1986, J BIOL CHEM, V261, P2779; CLARK EA, 1986, HUM IMMUNOL, V16, P100, DOI 10.1016/0198-8859(86)90039-X; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; DIAMOND MS, 1991, CELL, V65, P961, DOI 10.1016/0092-8674(91)90548-D; DORKEN B, 1989, LEUCOCYTE TYPING 4, P3; GAHMBERG CG, 1976, J CELL BIOL, V68, P642, DOI 10.1083/jcb.68.3.642; GOLDSTEIN SAN, 1986, J IMMUNOL, V137, P3383; GORGA JC, 1986, CELL IMMUNOL, V103, P160, DOI 10.1016/0008-8749(86)90077-8; HAHN WC, 1991, J IMMUNOL, V147, P14; JOHNSTON SC, 1990, J IMMUNOL, V145, P1181; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; MENTZER SJ, 1987, J EXP MED, V165, P1383, DOI 10.1084/jem.165.5.1383; NONG YH, 1989, J EXP MED, V170, P259, DOI 10.1084/jem.170.1.259; PARK JK, 1991, NATURE, V350, P706, DOI 10.1038/350706a0; PARKMAN R, 1981, LANCET, V2, P1387; REMOLDODONNELL E, 1987, BLOOD, V70, P104; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SANCHEZMADRID F, 1982, CELL IMMUNOL, V73, P1, DOI 10.1016/0008-8749(82)90431-2; SILVERMAN LB, 1989, J IMMUNOL, V142, P4194; SPRINGER TA, 1987, REV IMMUNOL, P223; STAUNTON DE, 1990, CELL, V61, P242; STOLL M, 1989, LEUCOCYTE TYPING 4, P605; TAKAI Y, 1987, P NATL ACAD SCI USA, V84, P6864, DOI 10.1073/pnas.84.19.6864; WICKEN M, 1988, SCAND J IMMUNOL, V28, P457	33	258	264	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 21	1991	354	6350					233	235		10.1038/354233a0	http://dx.doi.org/10.1038/354233a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1683685				2022-12-28	WOS:A1991GQ94800050
J	GMUR, J; BURGER, J; SCHANZ, U; FEHR, J; SCHAFFNER, A				GMUR, J; BURGER, J; SCHANZ, U; FEHR, J; SCHAFFNER, A			SAFETY OF STRINGENT PROPHYLACTIC PLATELET TRANSFUSION POLICY FOR PATIENTS WITH ACUTE-LEUKEMIA	LANCET			English	Article							THROMBOCYTOPENIA	Early studies suggested that the risk of haemorrhagic complications become unacceptable when platelet counts drop below 20 x 10(9)/l. Because there are insufficient data to define 20 x 10(9)/l as the threshold for prophylactic platelet transfusions, the practicability of a more restrictive transfusion policy has been assessed prospectively in 102 consecutive patients being treated for acute leukaemia. Besides platelet count, the transfusion protocol took into consideration factors such as presence of bleeding, fever, coagulation disorders, and intention to do therapeutic procedures. 31 major bleeding episodes occurred on 1.9% of the study days when platelet counts were 10 x 10(9)/l or less and on 0-07% of study days when counts were 10-20 x 10(9)/l. The findings indicate that the threshold for prophylactic transfusions can safely be set at 5 x 10(9)/l in patients without fever or bleeding manifestations and at 10 x 10(9)/l in patients with such signs. For patients with coagulation disorders or anatomical lesions, or for those on heparin, the threshold should be at least 20 x 10(9)/l. Such a restrictive platelet transfusion policy, which is applicable not only to thrombocytopenia associated with acute leukaemia but also to other forms of hypoproliferative thrombocytopenia, reduces exposure of such patients to blood donors and results in substantial health-care savings.			GMUR, J (corresponding author), UNIV HOSP ZURICH, DEPT INTERNAL MED, RAMISTR 100, CH-8091 ZURICH, SWITZERLAND.							ADERKA D, 1986, AM J MED SCI, V291, P147, DOI 10.1097/00000441-198603000-00001; BERNSTEIN MJ, 1987, JAMA-J AM MED ASSOC, V257, P1777; BISHOP JF, 1988, BLOOD, V71, P383; DUTCHER JP, 1981, BLOOD, V57, P395; GAYDOS LA, 1962, NEW ENGL J MED, V266, P905, DOI 10.1056/NEJM196205032661802; GMUR J, 1990, PROG CLIN BIOL RES, P45; GMUR J, 1983, BLOOD, V62, P473; MURPHY S, 1982, AM J HEMATOL, V12, P347, DOI 10.1002/ajh.2830120406; SCOTT E, 1985, TRANSFUSION, V25, P469; SILVER SS, 1987, CAN MED ASSOC J, V137, P128; SLICHTER SJ, 1978, CLIN HAEMATOL, V7, P523; SOLOMON J, 1978, LANCET, V1, P267	12	252	255	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	1991	338	8777					1223	1226		10.1016/0140-6736(91)92098-M	http://dx.doi.org/10.1016/0140-6736(91)92098-M			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682642				2022-12-28	WOS:A1991GQ16600001
J	NORMAN, JE; THONG, KJ; BAIRD, DT				NORMAN, JE; THONG, KJ; BAIRD, DT			UTERINE CONTRACTILITY AND INDUCTION OF ABORTION IN EARLY-PREGNANCY BY MISOPROSTOL AND MIFEPRISTONE	LANCET			English	Article							PROSTAGLANDIN; TERMINATION; ANALOG; PGE2	A combination of the antiprogestagen mifepristone and an exogenous prostaglandin given by intramuscular injection or intravaginal pessary is a highly effective means of inducing abortion in early pregnancy. However, the search for a stable oral prostaglandin preparation has been largely unsuccessful. The effect of misoprostol, an orally active prostaglandin used to treat peptic ulcer, on uterine contractility was investigated in 33 women in early pregnancy (under 56 days' amenorrhoea). After administration of misoprostol in doses ranging from 200-mu-g to 600-mu-g, there was a significant increase in uterine pressure. In a second group of women who were given 200-1000-mu-g misoprostol 48 h after the administration of 200 mg mifepristone, there was a significant increase in the amplitude and frequency of uterine contractions. Complete abortion took place in 18 of the 21 women who received misoprostol after mifepristone, but in only 2 of 40 women given misoprostol alone. Our findings show that misoprostol increases uterine activity in early pregnancy and suggest that, in combination with mifepristone, it may be a highly effective method of inducing therapeutic abortion.	UNIV EDINBURGH,CTR REPROD BIOL,DEPT OBSTET & GYNAECOL,37 CHALMERS ST,EDINBURGH EH3 9EY,SCOTLAND	University of Edinburgh			Norman, Jane/B-2347-2010	Norman, Jane/0000-0001-6031-6953				AUBENY E, 1991, CR ACAD SCI III-VIE, V312, P539; BYGDEMAN M, 1985, CONTRACEPTION, V32, P45, DOI 10.1016/0010-7824(85)90115-5; COLLINS PW, 1985, DIGEST DIS SCI, V30, pS114, DOI 10.1007/BF01309395; DAJANI EZ, 1975, PROSTAGLANDINS, V10, P733, DOI 10.1016/S0090-6980(75)80023-2; DUBOIS C, 1988, CR ACAD SCI III-VIE, V306, P57; EULER AR, 1989, PROSTAG LEUKOTR ESS, V38, P91, DOI 10.1016/0952-3278(89)90091-4; FONSECA W, 1991, LANCET, P56; JI G, 1988, CONTRACEPTION, V38, P675; KALRA PA, 1989, LANCET, V1, P1460; KRIM SMM, 1971, J OBSTET GYN BR COMM, V78, P289; NORMAN JE, IN PRESS HUM REPROD; RABE T, 1987, GEBURTSH FRAUENHEILK, V47, P324, DOI 10.1055/s-2008-1035830; RODGER MW, 1987, LANCET, V2, P1415; SONTAG SJ, 1985, DIGEST DIS SCI, V30, pS159, DOI 10.1007/BF01309403; SWAHN ML, 1989, HUM REPROD, V4, P21, DOI 10.1093/oxfordjournals.humrep.a136838; SWAHN ML, 1990, CONTRACEPTION, V41, P461, DOI 10.1016/0010-7824(90)90056-2; VANLOOK PFA, 1989, OXFORD REV REPROD B, V11, P1; 1991, LANCET, V337, P969; 1989, CUR PROBLEMS, V27, P2	19	197	208	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1233	1236		10.1016/0140-6736(91)92102-8	http://dx.doi.org/10.1016/0140-6736(91)92102-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682644				2022-12-28	WOS:A1991GQ16600004
J	KOTEN, JW; DENOTTER, W				KOTEN, JW; DENOTTER, W			ARE OMENTAL MILKY SPOTS AN INTESTINAL THYMUS	LANCET			English	Note								It is suggested that omental milky spots in young children, which in later life gradually transform into fatty tissue and only reappear during intraperitoneal infection, might influence the development of gastrointestinal immunity.	ACAD ZIEKENHUIS,DEPT EXPTL PATHOL,HEIDELBERGLAAN 100,3584 CX UTRECHT,NETHERLANDS									Dux K., 1988, OMENTUM RES CLIN APP, P19; Liebermann-Meffert D, 1983, GREATER OMENTUM ANAT, P1; LIEBERMANNMEFFE.D, 1991, 4TH INT S BIOL IMM S; SHIMOTSUMA M, 1989, ACTA ANAT, V136, P211; SHIMOTSUMA M, 1991, 4TH INT S BIOL IMM S	5	21	22	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1189	1190		10.1016/0140-6736(91)92043-2	http://dx.doi.org/10.1016/0140-6736(91)92043-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682602				2022-12-28	WOS:A1991GP03400015
J	FERRARI, R; PANZALI, AF; POOLEWILSON, PA; ANAND, IS				FERRARI, R; PANZALI, AF; POOLEWILSON, PA; ANAND, IS			PLASMA CGRP-LIKE IMMUNOREACTIVITY IN TREATED AND UNTREATED CONGESTIVE-HEART-FAILURE	LANCET			English	Letter							GENE-RELATED PEPTIDE		UNIV BRESCIA,DEPT CHEM,I-25100 BRESCIA,ITALY; NATL HEART & LUNG INST,DEPT CARDIAC MED,LONDON SW3,ENGLAND; POSTGRAD INST MED EDUC & RES,DEPT CARDIOL,CHANDIGARH 160012,INDIA	University of Brescia; Imperial College London; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	FERRARI, R (corresponding author), UNIV BRESCIA,DEPT CARDIOL,I-25100 BRESCIA,ITALY.		FERRARI, ROBERTO/ABD-5169-2020	Ferrari, Roberto/0000-0003-2046-9175				ANAND IS, 1991, J AM COLL CARDIOL, V17, P208, DOI 10.1016/0735-1097(91)90729-S; CHANDRASHEKHAR Y, 1991, AM J CARDIOL, V17, P1; FERRARI R, 1989, CLIN CHEM, V35, P331; FRANCOCERECEDA A, 1987, CIRC RES, V60, P393, DOI 10.1161/01.RES.60.3.393; MAIR J, 1990, LANCET, V335, P168, DOI 10.1016/0140-6736(90)90040-C; MULDERRY PK, 1985, NEUROSCIENCE, V14, P947, DOI 10.1016/0306-4522(85)90156-3	6	30	32	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1084	1084		10.1016/0140-6736(91)91944-P	http://dx.doi.org/10.1016/0140-6736(91)91944-P			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681388				2022-12-28	WOS:A1991GM25300048
J	LUNN, PG; NORTHROPCLEWES, CA; DOWNES, RM				LUNN, PG; NORTHROPCLEWES, CA; DOWNES, RM			INTESTINAL PERMEABILITY, MUCOSAL INJURY, AND GROWTH FALTERING IN GAMBIAN INFANTS	LANCET			English	Article							AUTOMATED ENZYMATIC ASSAYS; CATCH-UP GROWTH; DIARRHEA; LACTULOSE; MANNITOL; PROBES; URINE	There is controversy over whether children in developing countries can catch up on their growth rates after bouts of diarrhoea. A factor influencing catch-up growth is the extent and duration of mucosal injury. To explore the relation between intestinal disease and growth performance, a non-invasive test of intestinal integrity, the lactulose:mannitol permeability test, was done regularly on children aged 2-15 months, whose growth was monitored over a mean of 7.5 months. The study revealed persistent abnormalities in the small bowel mucosa of 2-15 month old Gambian infants and a negative correlation between these abnormalities and growth. Up to 43% of observed growth faltering can be explained on the basis of these long-term intestinal lesions.	MRC,DUNN NUTR CTR,KENEBA,SENEGAMBIA		LUNN, PG (corresponding author), MRC,DUNN NUTR CTR,CAMBRIDGE CB4 1XJ,ENGLAND.							BEHRENS RH, 1987, AM J CLIN NUTR, V45, P1433, DOI 10.1093/ajcn/45.6.1433; BRIEND A, 1990, LANCET, V335, P1157, DOI 10.1016/0140-6736(90)91159-8; BRIEND A, 1989, LANCET, V2, P319; BRUNSER O, 1990, NESTLE NUTR WORKS SE, V19, P261; ELIA M, 1987, CLIN SCI, V73, P197, DOI 10.1042/cs0730197; FORD RP, 1985, J PAEDIATRIC GASTROE, V4, P468; HAMMILL PVV, 1979, AM J CLIN NUTR, V32, P607; KEUSCH GT, 1990, NESTLE NUTR WORKS SE, V19, P37; LEBENTHAL E, 1986, NESTLE NUTRITION WOR, V6, P5; LIFSCHITZ C, 1985, J PEDIATR GASTR NUTR, V4, P520, DOI 10.1097/00005176-198508000-00003; LUNN PG, 1989, CLIN CHIM ACTA, V183, P163, DOI 10.1016/0009-8981(89)90332-X; LUNN PG, 1991, T ROY SOC TROP MED H, V85, P8, DOI 10.1016/0035-9203(91)90137-N; MOY RJD, 1990, LANCET, V335, P600; NORTHROP CA, 1990, CLIN CHIM ACTA, V187, P79, DOI 10.1016/0009-8981(90)90333-N; Prentice A., 1990, BREASTFEEDING NUTR I, P87; ROWLAND S G J G, 1985, Journal of Diarrhoeal Diseases Research, V3, P7; ROY SK, IN PRESS J PEDIATR G; SCHORLING JB, 1990, LANCET, V335, P599, DOI 10.1016/0140-6736(90)90378-I; SULLIVAN PB, IN PRESS J PEDIATR G; 1985, LANCET, V1, P256	20	266	271	0	13	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					907	910		10.1016/0140-6736(91)91772-M	http://dx.doi.org/10.1016/0140-6736(91)91772-M			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681266				2022-12-28	WOS:A1991GJ89900003
J	SALGAME, P; ABRAMS, JS; CLAYBERGER, C; GOLDSTEIN, H; CONVIT, J; MODLIN, RL; BLOOM, BR				SALGAME, P; ABRAMS, JS; CLAYBERGER, C; GOLDSTEIN, H; CONVIT, J; MODLIN, RL; BLOOM, BR			DIFFERING LYMPHOKINE PROFILES OF FUNCTIONAL SUBSETS OF HUMAN CD4 AND CD8 T-CELL CLONES	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; SUSCEPTIBLE BALB/C MICE; CHIMERA PRODUCE IL-5; HOST-REACTIVE CD4+; LYMPHOCYTE-T; IFN-GAMMA; INTERFERON-GAMMA; CUTANEOUS LEISHMANIASIS; MURINE LEISHMANIASIS; MONOCLONAL-ANTIBODY	Functional subsets of human T cells were delineated by analyzing patterns of lymphokines produced by clones from individuals with leprosy and by T cell clones of known function. CD4 clones from individuals with strong cell-mediated immunity produced predominantly interferon-gamma, whereas those clones that enhanced antibody formation produced interleukin-4. CD8 cytotoxic T cells secreted interferon-gamma. Interleukin-4 was produced by CD8 T suppressor clones from immunologically unresponsive individuals with leprosy and was found to be necessary for suppression in vitro. Both the classic reciprocal relation between antibody formation and cell-mediated immunity and resistance or susceptibility to certain infections may be explained by T cell subsets differing in patterns of lymphokine production.	DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT IMMUNOL, PALO ALTO, CA 94304 USA; INST BIOMED, CARACAS, VENEZUELA; STANFORD UNIV, MED CTR, DEPT CARDIOVASC SURG, PALO ALTO, CA 94304 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MICROBIOL & IMMUNOL, BRONX, NY 10461 USA; UNIV CALIF LOS ANGELES, SCH MED, DIV DERMATOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT MICROBIOL & IMMUNOL, LOS ANGELES, CA 90024 USA	Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Stanford University; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	SALGAME, P (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, HOWARD HUGHES MED INST, BRONX, NY 10461 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020111, P01AI026491] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-26491, AI-20111, AI-07118] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE M, 1980, INT J LEPROSY, V51, P387; ABRAMS JM, UNPUB; ASHERSON GL, 1966, IMMUNOLOGY, V10, P179; AWWAD M, 1988, J EXP MED, V168, P2193, DOI 10.1084/jem.168.6.2193; BACCHETTA R, 1990, J IMMUNOL, V144, P902; BATTISTO JR, 1962, P SOC EXP BIOL MED, V111, P111; BLOOM BR, 1983, REV INFECT DIS, V5, P765; BOREL Y, 1966, J EXP MED, V123, P585, DOI 10.1084/jem.123.4.585; CHERWINSKI HM, 1987, J EXP MED, V166, P1229, DOI 10.1084/jem.166.5.1229; CLAYBERGER C, 1985, J EXP MED, V162, P1709, DOI 10.1084/jem.162.5.1709; Crowle A J, 1966, Clin Exp Immunol, V1, P323; DAMLE NK, 1984, J IMMUNOL, V132, P644; FERNANDEZBOTRAN R, 1988, J EXP MED, V168, P543, DOI 10.1084/jem.168.2.543; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; GOLDSTEIN H, 1990, J IMMUNOL, V145, P952; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; HILL JO, 1989, J EXP MED, V169, P1819, DOI 10.1084/jem.169.5.1819; HOWARD JG, 1981, J EXP MED, V153, P557, DOI 10.1084/jem.153.3.557; KARPUS WJ, 1991, J IMMUNOL, V146, P1163; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KING CL, 1990, J CLIN INVEST, V85, P1810, DOI 10.1172/JCI114639; LAMB JR, 1982, J IMMUNOL, V128, P233; LEHN M, 1989, J IMMUNOL, V143, P3020; LI SG, 1990, EUR J IMMUNOL, V20, P1281, DOI 10.1002/eji.1830200613; MAGGI E, 1988, EUR J IMMUNOL, V18, P1045, DOI 10.1002/eji.1830180712; MAGGI E, 1991, J IMMUNOL, V146, P1169; MARTINEZ OM, 1990, J IMMUNOL, V144, P2211; MEHRA V, 1989, J IMMUNOL, V142, P2873; MODLIN RL, 1983, J AM ACAD DERMATOL, V8, P182, DOI 10.1016/S0190-9622(83)70021-6; MODLIN RL, 1988, P NATL ACAD SCI USA, V85, P1213, DOI 10.1073/pnas.85.4.1213; MODLIN RL, 1986, NATURE, V322, P459, DOI 10.1038/322459a0; MODLIN RL, 1986, J IMMUNOL, V137, P2831; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; MOSMANN TR, 1991, IMMUNOPARASITOL TOD, pA49; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSSMANN TR, 1989, ANNU REV IMMUNOL, V145, P73; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; PALIARD X, 1988, J IMMUNOL, V141, P849; PARISH CR, 1972, TRANSPLANT REV-DENMA, V13, P35; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; PELEMAN R, 1989, J EXP MED, V170, P1751, DOI 10.1084/jem.170.5.1751; POND L, 1989, J IMMUNOL, V143, P4232; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; SADICK MD, 1990, J EXP MED, V171, P115, DOI 10.1084/jem.171.1.115; SALGAME P, 1991, P NATL ACAD SCI USA, V88, P2598, DOI 10.1073/pnas.88.6.2598; Salgame P, 1989, Int Immunol, V1, P121, DOI 10.1093/intimm/1.2.121; TITUS RG, 1985, J IMMUNOL, V135, P2108; UMETSU DT, 1988, J IMMUNOL, V140, P4211; VANVOORHIS WC, 1982, NEW ENGL J MED, V307, P1593, DOI 10.1056/NEJM198212233072601; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	53	1052	1076	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	1991	254	5029					279	282		10.1126/science.1681588	http://dx.doi.org/10.1126/science.1681588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ642	1681588				2022-12-28	WOS:A1991GJ64200037
J	VANDENBROUCKEGRAULS, CMJE; VANDENBROUCKE, JP				VANDENBROUCKEGRAULS, CMJE; VANDENBROUCKE, JP			EFFECT OF SELECTIVE DECONTAMINATION OF THE DIGESTIVE-TRACT ON RESPIRATORY-TRACT INFECTIONS AND MORTALITY IN THE INTENSIVE-CARE UNIT	LANCET			English	Article							GRAM-NEGATIVE BACILLI; CRITICALLY ILL PATIENTS; COLONIZATION; PREVENTION; PNEUMONIA; SURVEILLANCE; PROPHYLAXIS; VENTILATION; POLYMYXIN	To assess the effect of selective decontamination of the digestive tract on respiratory tract infections and survival of patients treated in an intensive care unit, we carried out a meta-analysis of clinical studies comparing patients treated with selective decontamination with untreated controls. From eleven trials (1489 patients), differences between observed and expected respiratory tract infections and mortality were compared, and odds ratios (ORs) calculated. Analysis was done according to study design. With respect to the risk for respiratory tract infections, the studies with historical controls and the randomised trials showed a protective effect of selective decontamination. Historical control studies yielded an OR of 0.21 (95% confidence limits [CL] 0.15 to 0.29, p < 0.05) and randomised trials an OR of 0.12 (95% CL 0.08 to 0.19, p < 0.05). By contrast, the mortality benefit was less clear. Studies with historical controls and randomised trials showed that mortality was not significantly different between treatment and control patients. The evidence from these studies is at best consistent with a very limited effect of selective decontamination of the digestive tract on survival of patients in the intensive care unit, despite a clear preventive effect on the occurrence of respiratory tract infections.	STATE UNIV UTRECHT HOSP,INFECT DIS LAB,3511 GV UTRECHT,NETHERLANDS; LEIDEN UNIV,DEPT CLIN EPIDEMIOL,2300 RA LEIDEN,NETHERLANDS	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC	VANDENBROUCKEGRAULS, CMJE (corresponding author), UNIV HOSP UTRECHT,DEPT CLIN MICROBIOL,POB 85500,3508 GA UTRECHT,NETHERLANDS.		Vandenbroucke, Jan/AAM-3928-2020; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke, Jan/0000-0001-5668-6716; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597				AERDTS SJA, 1989, THESIS MAASTRICHT NE; BRUNBUISSON C, 1989, ANN INTERN MED, V110, P873, DOI 10.7326/0003-4819-110-11-873; CRAVEN DE, 1986, AM REV RESPIR DIS, V133, P792; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; GREENFIELD S, 1973, J CLIN INVEST, V52, P2935, DOI 10.1172/JCI107490; HARTENAUER U, 1990, INFECTION, V18, pS22, DOI 10.1007/BF01644483; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; JOHNSON WG, 1988, ANNU REV RESP DIS, V137, P265; KERVER AJH, 1988, CRIT CARE MED, V16, P1087, DOI 10.1097/00003246-198811000-00001; KLASTERSKY J, 1975, CHEST, V68, P302, DOI 10.1378/chest.68.3.302; KONRAD F, 1989, ANAESTHESIST, V38, P99; LEDINGHAM IM, 1988, LANCET, V1, P785; MCCLELLAND P, 1990, CRIT CARE MED, V18, P935, DOI 10.1097/00003246-199009000-00006; ROSE HD, 1975, AM J EPIDEMIOL, V101, P495, DOI 10.1093/oxfordjournals.aje.a112120; STEVENS RM, 1974, ARCH INTERN MED, V134, P106, DOI 10.1001/archinte.134.1.106; STOUTENBEEK CP, 1984, INTENS CARE MED, V10, P185, DOI 10.1007/BF00259435; TETTEROO GWM, 1990, LANCET, V335, P704, DOI 10.1016/0140-6736(90)90813-K; ULRICH C, 1989, INTENS CARE MED, V15, P424, DOI 10.1007/BF00255597; UNERTL K, 1987, INTENS CARE MED, V13, P106; VERHOEF J, 1991, EUR J CLIN MICROBIOL, V10, P477, DOI 10.1007/BF01963932; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1988, BRIT MED J, V296, P320	22	156	158	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					859	862		10.1016/0140-6736(91)91510-2	http://dx.doi.org/10.1016/0140-6736(91)91510-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681223				2022-12-28	WOS:A1991GH94500012
J	VICKERS, D; AHMAD, T; COULTHARD, MG				VICKERS, D; AHMAD, T; COULTHARD, MG			DIAGNOSIS OF URINARY-TRACT INFECTION IN CHILDREN - FRESH URINE MICROSCOPY OR CULTURE	LANCET			English	Article							BACTERIURIA	Fresh unspun and unstained urine specimens from 342 children with previous urinary tract infection (UTI) or symptoms compatible with a UTI were examined by microscopy at a magnification of x 400 in a mirrored counting chamber by a clinician, and sent for culture in a microbiology laboratory; 200 samples were also plated onto dip-slides. When microscopy and culture results were discrepant, further urine samples were collected until a diagnosis of UTI (24) or sterile urine (318) could be confirmed. Initial microscopy correctly identified 23 of 24 UTIs and 286 of 318 sterile urines; 1 false-positive result was caused by vaginal contamination with lactobacilli. 32 specimens (9%) gave an equivocal result on microscopy; the 1 other true-positive result was identified correctly on microscopy of the next urine specimen obtained. Culture of the initial urines correctly identified all 24 UTIs, but only 82% of the negative samples. Of the samples from uninfected children, 35 (11%) showed a mixed growth which was sterile on repeat sampling, and 21 (6.6%) initially grew a false-positive pure growth of more than 10(5) colony-forming units/ml of one organism. True UTIs were associated with bacterial counts above 10(7)/ml. Microscopy by a clinician represents a cheaper, quicker, and more reliable screening test for UTI in children than does routine culture in a microbiology laboratory.	ROYAL VICTORIA INFIRM, DEPT CHILD HLTH, NEWCASTLE UPON TYNE NE1 4LP, TYNE & WEAR, ENGLAND	Newcastle University - UK								[Anonymous], 1991, J ROY COLL PHYS LOND, V25, P36; FLANAGAN PG, 1989, LANCET, V1, P1117, DOI 10.1016/S0140-6736(89)92392-1; HALLETT RJ, 1976, LANCET, V2, P1107; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; KASS EH, 1957, ARCH INTERN MED, V100, P709, DOI 10.1001/archinte.1957.00260110025004; KIERKEGAARD H, 1980, SCAND J CLIN LAB INV, V40, P259, DOI 10.3109/00365518009095576; LITTLEWOOD JM, 1977, ARCH DIS CHILD, V52, P894, DOI 10.1136/adc.52.11.894; PYLKKANEN J, 1979, ACTA PAEDIATR SCAND, V68, P341, DOI 10.1111/j.1651-2227.1979.tb05017.x; RANSLEY PG, 1981, KIDNEY INT, V20, P733, DOI 10.1038/ki.1981.204; ROBINS DG, 1975, LANCET, V1, P476; STANSFELD JM, 1962, ARCH DIS CHILD, V37, P257, DOI 10.1136/adc.37.193.257; STANSFELD JM, 1953, ARCH DIS CHILD, V28, P386, DOI 10.1136/adc.28.141.386	12	44	45	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 28	1991	338	8770					767	770		10.1016/0140-6736(91)90662-9	http://dx.doi.org/10.1016/0140-6736(91)90662-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681158				2022-12-28	WOS:A1991GG97900001
J	COHN, KH; WANG, FS; DESOTOLAPAIX, F; SOLOMON, WB; PATTERSON, LG; ARNOLD, MR; WEIMAR, J; FELDMAN, JG; LEVY, AT; LEONE, A; STEEG, PS				COHN, KH; WANG, FS; DESOTOLAPAIX, F; SOLOMON, WB; PATTERSON, LG; ARNOLD, MR; WEIMAR, J; FELDMAN, JG; LEVY, AT; LEONE, A; STEEG, PS			ASSOCIATION OF NM23-H1 ALLELIC DELETIONS WITH DISTANT METASTASES IN COLORECTAL-CARCINOMA	LANCET			English	Note							INDICATORS	A prospective study analysed the prognostic value of nm23-H1 allelic deletions in colorectal cancer. Of 21 patients with no evidence of distant metastases at initial operation, 11 showed nm23-H1 allelic deletions (including 1 homozygous deletion); 10 had no nm23-H1 deletions. After median follow-up of 25 months, distant metastases had developed in 8 of 11 (73%) patients with nm23-H1 deletions but in only 2 of 10 (20%) without nm23-H1 deletions (p < 0.03). Tests with probe YNZ 22.1, near p53, showed no significant association with distant metastases. nm23-H1 may be, or may be located near, a late-acting suppressor gene in colorectal carcinoma, in which deletions may have prognostic value.	SUNY HLTH SCI CTR,DEPT MED,BROOKLYN,NY; SUNY HLTH SCI CTR,DEPT SURG,BROOKLYN,NY; SUNY HLTH SCI CTR,DEPT PREVENT MED & COMMUNITY HLTH,BROOKLYN,NY; NCI,PATHOL LAB,BETHESDA,MD 20892; VET ADM MED CTR,DEPT PATHOL,BROOKLYN,NY 11209	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA)	COHN, KH (corresponding author), VET ADM MED CTR,DEPT SURG 112,800 POLY PL,BROOKLYN,NY 11209, USA.		leone, alvaro/AAQ-7051-2020; Leone, Alvaro/K-6410-2016	Leone, Alvaro/0000-0003-3815-9052				BEVILACQUA G, 1989, CANCER RES, V49, P5185; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; HAMMSDAHL E, 1988, J SURG ONCOL, V37, P109; HAUT M, 1991, J NATL CANCER I, V83, P712, DOI 10.1093/jnci/83.10.712; HENNESSY C, 1991, J NATL CANCER I, V83, P281, DOI 10.1093/jnci/83.4.281; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEONE A, 1991, CANCER RES, V51, P2490; MEHTA CR, 1988, J AM STAT ASSOC, V83, P999; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; WIGGERS T, 1988, CANCER, V61, P386, DOI 10.1002/1097-0142(19880115)61:2<386::AID-CNCR2820610231>3.0.CO;2-J	10	154	164	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					722	724		10.1016/0140-6736(91)91444-Y	http://dx.doi.org/10.1016/0140-6736(91)91444-Y			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679868				2022-12-28	WOS:A1991GG10400005
J	GLAUSER, MP; ZANETTI, G; BAUMGARTNER, JD; COHEN, J				GLAUSER, MP; ZANETTI, G; BAUMGARTNER, JD; COHEN, J			SEPTIC SHOCK - PATHOGENESIS	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; MENINGOCOCCAL DISEASE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; FACTOR CACHECTIN; BINDING-PROTEIN; LPS BINDING; ACTIVATION; ENDOTOXIN; CELLS		HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT BACTERIOL,INFECT DIS UNIT,LONDON W12 0HS,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND	Imperial College London; Imperial College London	GLAUSER, MP (corresponding author), CHU VAUDOIS,DEPT MED,DIV INFECT DIS,CH-1011 LAUSANNE,SWITZERLAND.							BAGBY GJ, 1990, J INFECT DIS, V163, P83; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; CALANDRA T, 1988, J INFECT DIS, V158, P312, DOI 10.1093/infdis/158.2.312; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; COLMAN RW, 1989, NEW ENGL J MED, V320, P1207, DOI 10.1056/NEJM198905043201809; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; GALANOS C, 1990, ENDOTOXIN ADV EXPT M, P603; GIRARDIN E, 1988, NEW ENGL J MED, V319, P397, DOI 10.1056/NEJM198808183190703; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; HACKSHAW KV, 1990, CRIT CARE MED, V18, P47, DOI 10.1097/00003246-199001000-00012; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; HARAKUGE S, 1990, J BIOL CHEM, V265, P6606; ISPAHANI P, 1987, Q J MED, V63, P427; JACOB HS, 1981, J LAB CLIN MED, V98, P645; KALTER ES, 1983, J INFECT DIS, V148, P682, DOI 10.1093/infdis/148.4.682; LEI MG, 1988, J IMMUNOL, V141, P996; MCINTYRE KW, 1991, J EXP MED, V173, P931, DOI 10.1084/jem.173.4.931; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; REINES HD, 1982, LANCET, V2, P174; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SPIKA JS, 1982, J INFECT DIS, V146, P227, DOI 10.1093/infdis/146.2.227; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STUTZ P, IN PRESS INFECTIOUS; VANDERPOLL T, 1990, NEW ENGL J MED, V322, P1622, DOI 10.1056/NEJM199006073222302; VANE JR, 1990, NEW ENGL J MED, V323, P27; WAAGE A, 1987, LANCET, V1, P355; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816; WARR TA, 1990, BLOOD, V75, P1481; WRIGHT SD, 1990, J IMMUNOL, V144, P2566; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	33	651	685	0	14	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					732	736		10.1016/0140-6736(91)91452-Z	http://dx.doi.org/10.1016/0140-6736(91)91452-Z			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679876				2022-12-28	WOS:A1991GG10400013
J	MASSEFSKI, W; REDFIELD, AG; HARE, DR; MILLER, C				MASSEFSKI, W; REDFIELD, AG; HARE, DR; MILLER, C			MOLECULAR-STRUCTURE OF CHARYBDOTOXIN, A PORE-DIRECTED INHIBITOR OF POTASSIUM-ION CHANNELS	SCIENCE			English	Article									HARE RES INC,WOODINVILLE,WA 98072; BRANDEIS UNIV,GRAD DEPT BIOCHEM & PHYS,WALTHAM,MA 02254	Brandeis University	MASSEFSKI, W (corresponding author), BRANDEIS UNIV,GRAD DEPT BIOCHEM,HOWARD HUGHES MED INST,WALTHAM,MA 02254, USA.			Massefski, Walter/0000-0003-4728-4218	NCRR NIH HHS [RR0031] Funding Source: Medline; NIGMS NIH HHS [GM-31768, GM-20168] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020168, R37GM020168, R37GM031768, R01GM031768] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; CARBONE E, 1987, PFLUG ARCH EUR J PHY, V408, P423, DOI 10.1007/BF00585064; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; ENGLANDER SW, 1987, BIOCHEMISTRY-US, V26, P5953, DOI 10.1021/bi00393a001; GARCIA ML, 1990, BIOPHYS J, V57, pA118; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; LUCCHESI K, 1989, J MEMBRANE BIOL, V109, P269, DOI 10.1007/BF01870284; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8087, DOI 10.1021/bi00446a019; MILLER C, 1988, NEURON, V1, P1003, DOI 10.1016/0896-6273(88)90157-2; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MOCZYDLOWSKI E, 1988, J MEMBRANE BIOL, V105, P95, DOI 10.1007/BF02009164; SMITH C, 1986, J BIOL CHEM, V261, P4607; SMITH C, 1988, THESIS BRANDEIS U WA; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; SUMMERS MF, 1990, BIOCHEMISTRY-US, V29, P329, DOI 10.1021/bi00454a005; TOYOSHIMA C, 1988, NATURE, V336, P247, DOI 10.1038/336247a0; VERGARA C, 1984, BIOPHYS J, V45, P73, DOI 10.1016/S0006-3495(84)84114-4; VILLARROEL A, 1988, PFLUG ARCH EUR J PHY, V413, P118, DOI 10.1007/BF00582521; Wuthrich K., 1986, NMR PROTEINS NUCL AC	23	26	27	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 3	1990	249	4968					521	524		10.1126/science.1696395	http://dx.doi.org/10.1126/science.1696395			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR811	1696395				2022-12-28	WOS:A1990DR81100035
J	MASUKATA, H; TOMIZAWA, J				MASUKATA, H; TOMIZAWA, J			A MECHANISM OF FORMATION OF A PERSISTENT HYBRID BETWEEN ELONGATING RNA AND TEMPLATE DNA	CELL			English	Article									NIDDKD,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								APPLEYARD RK, 1954, GENETICS, V39, P440; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MASUKATA H, 1987, CELL, V51, P1123, DOI 10.1016/0092-8674(87)90598-8; MASUKATA H, 1986, CELL, V44, P125, DOI 10.1016/0092-8674(86)90491-5; MASUKATA H, 1984, CELL, V36, P513, DOI 10.1016/0092-8674(84)90244-7; OHMORI H, 1987, J MOL BIOL, V198, P223, DOI 10.1016/0022-2836(87)90308-1; SELZER G, 1983, CELL, V32, P119, DOI 10.1016/0092-8674(83)90502-0; TOMIZAWA J, 1987, CELL, V51, P623, DOI 10.1016/0092-8674(87)90131-0; TOMIZAWA J, 1982, CELL, V31, P575, DOI 10.1016/0092-8674(82)90313-0; TOMIZAWA J, 1985, CELL, V40, P527, DOI 10.1016/0092-8674(85)90201-6; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; ZVEREV VV, 1985, PLASMID, V14, P192, DOI 10.1016/0147-619X(85)90002-2	14	94	94	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 27	1990	62	2					331	338		10.1016/0092-8674(90)90370-T	http://dx.doi.org/10.1016/0092-8674(90)90370-T			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR202	1695550				2022-12-28	WOS:A1990DR20200013
J	ALLEGRETTA, M; NICKLAS, JA; SRIRAM, S; ALBERTINI, RJ				ALLEGRETTA, M; NICKLAS, JA; SRIRAM, S; ALBERTINI, RJ			T-CELLS RESPONSIVE TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS	SCIENCE			English	Article									UNIV VERMONT,DEPT NEUROL,BURLINGTON,VT 05405	University of Vermont	ALLEGRETTA, M (corresponding author), UNIV VERMONT,GENET LAB,BURLINGTON,VT 05401, USA.				NATIONAL CANCER INSTITUTE [R01CA030688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K07NS000849] Funding Source: NIH RePORTER; NCI NIH HHS [CA30688-07] Funding Source: Medline; NINDS NIH HHS [NS00849] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHAORBEA H, 1989, ANNU REV IMMUNOL, V7, P371, DOI 10.1146/annurev.iy.07.040189.002103; ALBERTINI RJ, 1985, NATURE, V316, P369, DOI 10.1038/316369a0; ALBERTINI RJ, 1982, P NATL ACAD SCI-BIOL, V79, P6617, DOI 10.1073/pnas.79.21.6617; ALBERTINI RJ, IN PRESS MUTATION EN; ALLEGRETTA M, UNPUB; AMMENHEUSER MM, 1988, MUTAT RES, V204, P509, DOI 10.1016/0165-1218(88)90045-6; BERRICHE S, 1988, J NEUROL, V4, P234; BROSTOFF SW, 1984, J IMMUNOL, V133, P1938; BURNS FR, 1989, J EXP MED, V169, P27, DOI 10.1084/jem.169.1.27; FALLIS RJ, 1987, J NEUROIMMUNOL, V14, P205, DOI 10.1016/0165-5728(87)90055-5; HAFLER DA, 1987, J IMMUNOL, V139, P68; HAFLER DA, 1985, NEW ENGL J MED, V312, P1405, DOI 10.1056/NEJM198505303122201; KERMAN RH, 1988, J NEUROIMMUNOL, V18, P325, DOI 10.1016/0165-5728(88)90053-7; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; NICKLAS JA, 1988, ENVIRON MOL MUTAGEN, V12, P271, DOI 10.1002/em.2860120302; NICKLAS JA, 1986, MUTAT RES, V173, P65; ONEILL JP, 1989, ENVIRON MOL MUTAGEN, V13, P289, DOI 10.1002/em.2850130403; ONEILL JP, 1987, MUTAGENESIS, V2, P87, DOI 10.1093/mutage/2.2.87; OSHIRO Y, 1970, ARCH BIOCHEM BIOPHYS, V138, P392, DOI 10.1016/0003-9861(70)90361-9; RICHERT JR, 1988, NEUROLOGY, V38, P739, DOI 10.1212/WNL.38.5.739; SESHADRI R, 1983, MUTAT RES, V110, P141, DOI 10.1016/0027-5107(83)90023-4; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; Waksman B H, 1988, Ann N Y Acad Sci, V540, P13, DOI 10.1111/j.1749-6632.1988.tb27047.x; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0	24	402	417	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 9	1990	247	4943					718	721		10.1126/science.1689076	http://dx.doi.org/10.1126/science.1689076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM843	1689076				2022-12-28	WOS:A1990CM84300041
J	STRANG, G; LATOUF, S; COMMERFORD, P; RODITI, D; DUNCANTRAILL, G; BARLOW, D; FORDER, A				STRANG, G; LATOUF, S; COMMERFORD, P; RODITI, D; DUNCANTRAILL, G; BARLOW, D; FORDER, A			BEDSIDE CULTURE TO CONFIRM TUBERCULOUS PERICARDITIS	LANCET			English	Letter							SPECIMENS		GROOTE SCHUUR HOSP, CARDIAC CLIN, ZA-7925 CAPE TOWN, SOUTH AFRICA; GROOTE SCHUUR HOSP, DEPT MED MICROBIOL, ZA-7925 CAPE TOWN, SOUTH AFRICA	University of Cape Town; University of Cape Town	STRANG, G (corresponding author), CECILIA MAKIWANE HOSP, MDANTSANE, SOUTH AFRICA.							FADDA G, 1984, J CLIN MICROBIOL, V19, P720, DOI 10.1128/JCM.19.5.720-721.1984; MITCHISON DA, 1983, J CLIN PATHOL, V36, P1357, DOI 10.1136/jcp.36.12.1357; STRANG JIG, 1984, CLIN CARDIOL, V7, P667, DOI 10.1002/clc.4960071208; STRANG JIG, 1988, LANCET, V2, P759; Whalen G, 1987, J R Coll Surg Edinb, V32, P139	5	19	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	1991	338	8782-3					1600	1601		10.1016/0140-6736(91)92433-3	http://dx.doi.org/10.1016/0140-6736(91)92433-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1684009				2022-12-28	WOS:A1991GW03600056
J	KISERUD, T; EIKNES, SH; BLAAS, HGK; HELLEVIK, LR				KISERUD, T; EIKNES, SH; BLAAS, HGK; HELLEVIK, LR			ULTRASONOGRAPHIC VELOCIMETRY OF THE FETAL DUCTUS VENOSUS	LANCET			English	Article							PHYSIOLOGY; ANATOMY; LIVER; BLOOD; FLOWS; LAMBS	In fetal lambs, the ductus venosus shunts well-oxygenated blood directly to the heart, a pattern expected to be found also in the human fetus. We aimed to describe the human ductus venosus in a longitudinal sonographic study of two-dimensional imaging, colour flow mapping, and pulsed doppler velocimetry every 3-4 weeks during the second half of pregnancy. The fetuses of 29 healthy women were studied. The ductus venosus and its blood flow were identified and recorded for later analysis that included maximum velocity tracing. In the 184 examinations analysed, the ductus venosus appeared as a narrow vessel projecting a high-velocity jet posteriorly to reach the foramen ovale. The mean peak velocity in the ductus venosus increased from 65 cm/s in week 18 to 75 cm/s at term. Low values of the time-averaged maximum velocity were found in 2 fetuses with cardiovascular abnormalities (1 supraventricular tachycardia, 1 congestive heart failure), as a result of reversed flow in the ductus venosus during atrial systole. The high peak velocity in the ductus venosus, which is comparable with arterial velocities, probably gives the blood sufficient momentum to reach the foramen ovale without extensive mixing with deoxygenated blood. Velocimetry of the ductus venosus carries new diagnostic possibilities.			KISERUD, T (corresponding author), TRONDHEIM REG & UNIV HOSP,DEPT GYNECOL & OBSTET,NATL CTR FETAL DIAG & THERAPY,N-7006 TRONDHEIM,NORWAY.			Kiserud, Torvid/0000-0003-1825-1660				BARCLAY AE, 1942, BRIT J RADIOL, V15, P66; Barclay AE, 1944, FOETAL CIRCULATION C; Barcroft J., 1946, RESEARCHES PRENATAL; BEHRMAN RE, 1970, AM J OBSTET GYNECOL, V108, P956, DOI 10.1016/0002-9378(70)90341-8; CHAKO AW, 1953, ANAT REC, V115, P151; CHAMPETIER J, 1989, SURG RADIOL ANAT, V11, P53, DOI 10.1007/BF02102248; CHINN DH, 1982, RADIOLOGY, V144, P153, DOI 10.1148/radiology.144.1.7089248; DAWES GS, 1984, AM J OBSTET GYNECOL, V84, P1634; Dawes GS, 1968, FETAL NEONATAL PHYSL; EDELSTONE D I, 1980, Journal of Developmental Physiology (Eynsham), V2, P219; EDELSTONE DI, 1978, CIRC RES, V42, P426, DOI 10.1161/01.RES.42.3.426; EDELSTONE DI, 1979, AM J PHYSIOL, V237, pH724, DOI 10.1152/ajpheart.1979.237.6.H724; EIKNES SH, 1981, RECENT ADV PRENATAL, P113; GUDMUNDSSON S, 1991, AM J OBSTET GYNECOL, V164, P33, DOI 10.1016/0002-9378(91)90618-2; MEYER WW, 1966, ARCH DIS CHILD, V41, P597, DOI 10.1136/adc.41.220.597; NICOLINI U, 1989, AM J OBSTET GYNECOL, V160, P1139, DOI 10.1016/0002-9378(89)90176-2; REED KL, 1990, CIRCULATION, V81, P498, DOI 10.1161/01.CIR.81.2.498; STAUDACH A, 1987, SECTIONAL FETAL ANAT; WEINER CP, 1989, AM J OBSTET GYNECOL, V161, P714, DOI 10.1016/0002-9378(89)90387-6	19	199	215	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1412	1414		10.1016/0140-6736(91)92720-M	http://dx.doi.org/10.1016/0140-6736(91)92720-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683418				2022-12-28	WOS:A1991GT90400002
J	POUCHOT, J; LOMBRAIL, P; SITBON, P; CALLANQUIN, M; VINCENEUX, P				POUCHOT, J; LOMBRAIL, P; SITBON, P; CALLANQUIN, M; VINCENEUX, P			SEDATIVE AND HYPNOTIC WITHDRAWAL STATES IN INPATIENTS	LANCET			English	Letter									UNIV PARIS 07,HOP BICHAT,DEPT PUBL HLTH,F-75221 PARIS 05,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	POUCHOT, J (corresponding author), UNIV PARIS 07,HOP LOUIS MOURIER,DEPT INTERNAL MED & PHARM,F-92700 COLOMBES,FRANCE.			LOMBRAIL, Pierre/0000-0002-5436-2475				MOSS, 1991, LANCET, V338, P575	1	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					1022	1022		10.1016/0140-6736(91)91886-Y	http://dx.doi.org/10.1016/0140-6736(91)91886-Y			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681329				2022-12-28	WOS:A1991GK97400048
J	OMATA, M; YOKOSUKA, O; TAKANO, S; KATO, N; HOSODA, K; IMAZEKI, F; TADA, M; ITO, Y; OHTO, M				OMATA, M; YOKOSUKA, O; TAKANO, S; KATO, N; HOSODA, K; IMAZEKI, F; TADA, M; ITO, Y; OHTO, M			RESOLUTION OF ACUTE HEPATITIS-C AFTER THERAPY WITH NATURAL BETA INTERFERON	LANCET			English	Note							POLYMERASE CHAIN-REACTION; NON-B-HEPATITIS; NON-A; VIRUS	To test whether interferon can prevent acute non-A, non-B hepatitis from becoming chronic, a prospective controlled trial was conducted in 25 patients; 11 were treated for an average of 30 days with a mean of 52 megaunits of interferon and 14 acted as controls. 4 patients in the treatment group who continued to have raised serum aminotransferase concentrations after a year's follow-up were given a second course of interferon. Follow-up at 3 years has revealed that all but 1 of those treated showed normal serum aminotransferase, whereas only 3 controls showed such change (p < 0.02). Serum hepatitis C virus RNA became undetectable in 10 of 11 treated and in only 1 of 12 control patients, which suggests that interferon prevents the progression of acute non-A, non-B hepatitis to chronicity by eradicating HCV.			OMATA, M (corresponding author), CHIBA UNIV,SCH MED,DEPT MED,CHIBA 280,JAPAN.							DIENSTAG JL, 1983, GASTROENTEROLOGY, V85, P439; GARSON JA, 1990, LANCET, V335, P1419, DOI 10.1016/0140-6736(90)91446-H; HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503; HOUGHTON M, 1990, Patent No. 903028660; KATO N, 1990, J CLIN INVEST, V86, P1764, DOI 10.1172/JCI114903; KIYOSAWA K, 1984, AM J GASTROENTEROL, V79, P777; KOBAYASHI S, 1981, HERPES VIRUS CLIN PH, P286; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; OKAMOTO H, 1990, JPN J EXP MED, V60, P167; Omata M, 1981, Liver, V1, P201	10	190	193	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					914	915		10.1016/0140-6736(91)91774-O	http://dx.doi.org/10.1016/0140-6736(91)91774-O			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681268				2022-12-28	WOS:A1991GJ89900005
J	GOADSBY, PJ; ZAGAMI, AS; DONNAN, GA; SYMINGTON, G; ANTHONY, M; BLADIN, PF; LANCE, JW				GOADSBY, PJ; ZAGAMI, AS; DONNAN, GA; SYMINGTON, G; ANTHONY, M; BLADIN, PF; LANCE, JW			ORAL SUMATRIPTAN IN ACUTE MIGRAINE	LANCET			English	Note							AGONIST	The efficacy in acute migraine of oral sumatriptan was assessed in a double-blind, randomised, placebo-controlled, crossover study of 61 patients (mean age 39 [SD 10] years). 41 completed treatment of four attacks, two with sumatriptan 100 mg and two with placebo. The response rate (reduction in headache from moderate or severe to mild or absent at 2 h) was 51% (45/89) with sumatriptan and 10% (9/93) with placebo (p < 0.01); rescue medication was needed at 2 h in 41% and 88%, respectively. Of 28 patients headache-free at 2 h, 11 (39%) had recurrent headache within 24 h. There were no substantial side-effects. Thus, sumatriptan is an effective well-tolerated treatment for acute migraine attacks.	PRINCE WALES HOSP,DEPT NEUROL,SYDNEY,NSW,AUSTRALIA; AUSTIN HOSP,HEIDELBERG,VIC 3084,AUSTRALIA; REPATRIAT GEN HOSP,MELBOURNE,AUSTRALIA	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	GOADSBY, PJ (corresponding author), PRINCE HENRY HOSP,DEPT NEUROL,CLIN SCI BLDG,LITTLE BAY,NSW 2036,AUSTRALIA.		Goadsby, Peter J/Z-1970-2019; DONNAN, GEOFFREY A/A-9947-2008; Goadsby, Peter J/B-2267-2009	Goadsby, Peter J/0000-0003-3260-5904; Donnan, Geoffrey/0000-0001-6324-3403; ZAGAMI, ALESSANDRO S/0000-0002-4346-0790				ANTHONY M, 1969, RESEARCH CLINICAL ST, V2, P29; BRADLEY PB, 1986, NEUROPHARMACOLOGY, V25, P563, DOI 10.1016/0028-3908(86)90207-8; DAHLOF C, 1989, CEPHALALGIA S10, V9, P351; DOENICKE A, 1988, LANCET, V1, P1309; FOZARD JR, 1975, J PHARM PHARMACOL, V27, P297, DOI 10.1111/j.2042-7158.1975.tb09448.x; HAMBLIN MW, 1987, J PHARMACOL EXP THER, V243, P989; KIMBALL RW, 1960, NEUROLOGY, V10, P107, DOI 10.1212/WNL.10.2.107; OLESEN J, 1988, Cephalalgia, V8, P1; SICUTERI F, 1961, INT ARCH ALLER A IMM, V19, P55, DOI 10.1159/000229194; 1991, ER NEUROL, V31, P314	10	109	109	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					782	783		10.1016/0140-6736(91)90666-D	http://dx.doi.org/10.1016/0140-6736(91)90666-D			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681162				2022-12-28	WOS:A1991GG97900005
J	GRIGG, JM; SAVILL, JS; SARRAF, C; HASLETT, C; SILVERMAN, M				GRIGG, JM; SAVILL, JS; SARRAF, C; HASLETT, C; SILVERMAN, M			NEUTROPHIL APOPTOSIS AND CLEARANCE FROM NEONATAL LUNGS	LANCET			English	Article							CELL-DEATH; INFLAMMATION; MACROPHAGES; PHAGOCYTOSIS; ELASTASE	8 newborn babies with airways inflammation, who were mechanically ventilated, underwent bronchoalveolar lavage to examine the fate of neutrophils in the inflamed airways. Light microscopy and electronmicroscopy showed evidence of neutrophil apoptosis and ingestion of intact neutrophils by macrophages in specimens from all 8 infants. Neutrophil apoptosis, without the local release of intracellular contents that promote inflammation, might represent a mechanism by which tissue injury is reduced during the resolution of neonatal pulmonary inflammation.	HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOPATHOL,LONDON W12 0HS,ENGLAND; CITY HOSP EDINBURGH,DEPT RESP MED,EDINBURGH EH10 5SB,MIDLOTHIAN,SCOTLAND	Imperial College London; Imperial College London	GRIGG, JM (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT PAEDIAT,DU CANE RD,LONDON W12 0NN,ENGLAND.			Grigg, Jonathan/0000-0003-3109-6028				HASLETT C, 1989, CURR OPIN IMMUNOL, V2, P10, DOI 10.1016/0952-7915(89)90091-5; HENSON PM, 1978, J IMMUNOL, V121, P851; MEAGHER L, 1989, BIOCHEM SOC T, V17, P608, DOI 10.1042/bst0170608; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; OGDEN BE, 1984, AM REV RESPIR DIS, V130, P817; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SHELLITO J, 1987, AM J PATHOL, V129, P567; VARTIO T, 1981, J BIOL CHEM, V256, P471; Wyllie A H, 1980, Int Rev Cytol, V68, P251	10	189	190	1	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					720	722		10.1016/0140-6736(91)91443-X	http://dx.doi.org/10.1016/0140-6736(91)91443-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679867				2022-12-28	WOS:A1991GG10400004
J	VALERIUS, NH; KOCH, C; HOIBY, N				VALERIUS, NH; KOCH, C; HOIBY, N			PREVENTION OF CHRONIC PSEUDOMONAS-AERUGINOSA COLONIZATION IN CYSTIC-FIBROSIS BY EARLY TREATMENT	LANCET			English	Note							INFECTION; THERAPY	To assess whether chronic pulmonary colonisation with Pseudomonas aeruginosa in cystic fibrosis is preventable, 26 patients who had never received anti-pseudomonas chemotherapy were randomly allocated to groups receiving either no anti-pseudomonas chemotherapy or oral ciprofloxacin and aerosol inhalations of colistin twice daily for 3 weeks, whenever Ps aeruginosa was isolated from routine sputum cultures. During the 27 months of the trial, infection with Ps aeruginosa became chronic in significantly fewer treated than untreated subjects (2 [14%] vs 7 [58%]; p < 0.05) and there were significantly fewer Ps aeruginosa isolates in routine sputum cultures in the treated group (49/214 [23%] vs 64/158 [41%]; p = 0.0006). Thus, chronic colonisation with Ps aeruginosa can be prevented in cystic fibrosis by early institution of anti-pseudomonas chemotherapy.	UNIV COPENHAGEN,RIGSHOSP,DEPT PEDIAT GGK,DK-2100 COPENHAGEN,DENMARK; UNIV COPENHAGEN,RIGSHOSP,DEPT CLIN MICROBIOL,DK-2100 COPENHAGEN,DENMARK	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen								HODSON ME, 1988, CHEST, V94, pS156; HOIBY N, 1977, SCAND J RESPIR DIS, V58, P65; HOIBY N, 1982, ACTA PAEDIATR SC   S, V301, P75; JENSEN T, 1987, EUR J CLIN MICROBIOL, V6, P618, DOI 10.1007/BF02013055; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; LITTLEWOOD JM, 1985, LANCET, V1, P865, DOI 10.1016/S0140-6736(85)92222-6; Marks M I, 1989, Antibiot Chemother (1971), V42, P229; MICHEL BC, 1988, CHEST, V94, pS129, DOI 10.1378/chest.94.2.129S; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x	9	378	390	0	17	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					725	726		10.1016/0140-6736(91)91446-2	http://dx.doi.org/10.1016/0140-6736(91)91446-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679870				2022-12-28	WOS:A1991GG10400007
J	FALLON, AM				FALLON, AM			DNA-MEDIATED GENE-TRANSFER - APPLICATIONS TO MOSQUITOS	NATURE			English	Article							AEDES-ALBOPICTUS CELLS; ANOPHELES-GAMBIAE; TRANSIENT EXPRESSION; INTEGRATION; DROSOPHILA; VECTOR				FALLON, AM (corresponding author), UNIV MINNESOTA,ENTOMOL,1980 FOLWELL AVE,ST PAUL,MN 55108, USA.							BESANSKY NJ, 1990, MOL CELL BIOL, V10, P863, DOI 10.1128/MCB.10.3.863; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; DOBENS L, 1991, MOL CELL BIOL, V11, P1846, DOI 10.1128/MCB.11.4.1846; DURBIN JE, 1985, GENE, V36, P173, DOI 10.1016/0378-1119(85)90082-4; DURBIN JE, 1988, BIOCHIM BIOPHYS ACTA, V950, P182, DOI 10.1016/0167-4781(88)90010-3; Fallon A. M., 1987, Advances in Cell Culture, V5, P97; GERENDAY A, 1989, INSECT BIOCHEM, V19, P679, DOI 10.1016/0020-1790(89)90104-2; HENDRICKS MB, 1989, BIO-TECHNOL, V7, P1271; JAMES AA, 1954, GENE, V75, P7389; KJER KM, 1991, ARCH INSECT BIOCHEM, V16, P189, DOI 10.1002/arch.940160305; MCGRANE V, 1988, AM J TROP MED HYG, V39, P502, DOI 10.4269/ajtmh.1988.39.502; MENTO SJ, 1978, SOMAT CELL GENET, V4, P179, DOI 10.1007/BF01538983; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x; QIAN S, 1988, P NATL ACAD SCI USA, V85, P9601, DOI 10.1073/pnas.85.24.9601; ROMANS P, 1991, J MED ENTOMOL, V28, P147, DOI 10.1093/jmedent/28.1.147; SHOTKOSKI FA, IN PRESS EUR J BIOCH; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; TATEM J, 1986, VIRUS RES, V5, P121, DOI 10.1016/0168-1702(86)90012-2; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131	21	17	18	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 29	1991	352	6338					828	829		10.1038/352828a0	http://dx.doi.org/10.1038/352828a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC964	1679196				2022-12-28	WOS:A1991GC96400068
J	NADEL, AS; GREEN, JK; HOLMES, LB; FRIGOLETTO, FD; BENACERRAF, BR				NADEL, AS; GREEN, JK; HOLMES, LB; FRIGOLETTO, FD; BENACERRAF, BR			ABSENCE OF NEED FOR AMNIOCENTESIS IN PATIENTS WITH ELEVATED LEVELS OF MATERNAL SERUM ALPHA-FETOPROTEIN AND NORMAL ULTRASONOGRAPHIC EXAMINATIONS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									BRIGHAM & WOMENS HOSP,DEPT NEWBORN MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT RADIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	NADEL, AS (corresponding author), BRIGHAM & WOMENS HOSP,DEPT OBSTET & GYNECOL,75 FRANCIS ST,BOSTON,MA 02115, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024560] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 24560] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS MJ, 1984, AM J OBSTET GYNECOL, V148, P241, DOI 10.1016/S0002-9378(84)80062-9; AULA P, 1978, AM J DIS CHILD, V132, P984, DOI 10.1001/archpedi.1978.02120350048008; CUNNINGHAM FG, 1989, WILLIAMS OBSTETRICS, P584; DRUGAN A, 1988, OBSTET GYNECOL, V72, P627; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Milunsky A., 1986, GENETIC DISORDERS FE, P453; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; NICOLAIDES KH, 1986, LANCET, V2, P72; NORIO R, 1988, POPULATION STRUCTURE, P600; PAUKER SP, 1977, YALE J BIOL MED, V50, P275; RICHARDS DS, 1988, OBSTET GYNECOL, V71, P203; Romero R., 1988, PRENATAL DIAGNOSIS C; SIMPSON JL, 1989, MATERNAL FETAL MED P, P78; TABOR A, 1986, LANCET, V1, P1287; VANDENHOF MC, 1990, AM J OBSTET GYNECOL, V162, P322, DOI 10.1016/0002-9378(90)90378-K; Weinstein MC, 1980, CLIN DECISION ANAL	16	79	84	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	1990	323	9					557	561		10.1056/NEJM199008303230901	http://dx.doi.org/10.1056/NEJM199008303230901			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW219	1696358				2022-12-28	WOS:A1990DW21900001
J	PATERSON, Y; ENGLANDER, SW; RODER, H				PATERSON, Y; ENGLANDER, SW; RODER, H			AN ANTIBODY-BINDING SITE ON CYTOCHROME-C DEFINED BY HYDROGEN-EXCHANGE AND 2-DIMENSIONAL NMR	SCIENCE			English	Article									UNIV PENN, DEPT BIOCHEM & BIOPHYS, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	PATERSON, Y (corresponding author), UNIV PENN, DEPT MICROBIOL, PHILADELPHIA, PA 19104 USA.		Roder, Heinrich/B-3455-2009	Roder, Heinrich/0000-0003-1860-2491; Paterson, Yvonne/0000-0002-9406-4958	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035926, R01GM031847] Funding Source: NIH RePORTER; NCRR NIH HHS [S07-RR-05415-28] Funding Source: Medline; NIGMS NIH HHS [GM 31847, R01 GM031847, GM 35926] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; ANGLISTER J, 1989, BIOCHEMISTRY-US, V28, P3360, DOI 10.1021/bi00434a035; ANGLISTER J, 1988, BIOCHEMISTRY-US, V27, P717, DOI 10.1021/bi00402a034; ANGLISTER J, 1987, BIOCHEMISTRY-US, V26, P6058, DOI 10.1021/bi00393a017; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; BRANDT P, 1987, BIOCHEMISTRY-US, V26, P3156, DOI 10.1021/bi00385a032; BURNENS A, 1987, SCIENCE, V235, P780, DOI 10.1126/science.2433768; BUSHNELL GW, IN PRESS J MOL BIOL; CARBONE FR, 1985, J IMMUNOL, V135, P2609; COLLAWN JF, 1988, J BIOL CHEM, V263, P8625; COLMAN PM, 1988, ADV IMMUNOL, V43, P99; CONNOLLY ML, 1985, COMPUT CHEM, V9, P1, DOI 10.1016/0097-8485(85)80011-5; COOPER HM, 1987, J BIOL CHEM, V262, P11591; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; ENGLANDER JJ, 1987, BIOCHEMISTRY-US, V26, P1846, DOI 10.1021/bi00381a009; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; ENGLANDER SW, 1975, ANN NY ACAD SCI, V244, P10, DOI 10.1111/j.1749-6632.1975.tb41518.x; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; FENG Y, 1989, BIOCHEMISTRY-US, V28, P195, DOI 10.1021/bi00427a027; GOETZE AM, 1978, BIOCHEMISTRY-US, V17, P1733, DOI 10.1021/bi00602a023; JEMMERSON R, 1986, SCIENCE, V232, P1001, DOI 10.1126/science.2422757; JEMMERSON R, 1986, BIOTECHNIQUES, V4, P1818; KOOISTRA DA, 1978, BIOCHEMISTRY-US, V17, P345, DOI 10.1021/bi00595a024; KUWAJIMA K, 1983, J MOL BIOL, V169, P299, DOI 10.1016/S0022-2836(83)80185-5; LOUIE G, 1988, J MOL BIOL, V201, P765, DOI 10.1016/0022-2836(88)90473-1; MARKLEY JL, 1989, METHOD ENZYMOL, V176, P12; NAGAYAMA K, 1980, J MAGN RESON, V40, P321, DOI 10.1016/0022-2364(80)90255-3; O'Donnell T. J., 1981, Computer Graphics, V15, P133, DOI 10.1145/965161.806799; OERTLE M, 1989, EUR J BIOCHEM, V182, P699, DOI 10.1111/j.1432-1033.1989.tb14881.x; PATERSON Y, 1989, IMMUNE RESPONSE TO STRUCTURALLY DEFINED PROTEINS : THE LYSOZYME MODEL, P177; RODER H, UNPUB; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; TAKANO T, 1981, J MOL BIOL, V153, P95, DOI 10.1016/0022-2836(81)90529-5; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2; WAND AJ, 1989, BIOCHEMISTRY-US, V28, P186, DOI 10.1021/bi00427a026; WAND AJ, 1986, BIOCHEMISTRY-US, V25, P1107, DOI 10.1021/bi00353a025; WAND AJ, 1986, BIOCHEMISTRY-US, V25, P1100, DOI 10.1021/bi00353a024; WOODWARD C, 1982, MOL CELL BIOCHEM, V48, P135, DOI 10.1007/BF00421225; WUTHRICH K, 1989, SCIENCE, V243, P45, DOI 10.1126/science.2911719; Wuthrich K., 1986, NMR PROTEINS NUCL AC	42	169	174	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	1990	249	4970					755	759		10.1126/science.1697101	http://dx.doi.org/10.1126/science.1697101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV088	1697101	Green Accepted			2022-12-28	WOS:A1990DV08800024
J	BROWN, JW				BROWN, JW			SIMILAR CAGE-SHAPED STRUCTURES FOR THE RNA COMPONENTS OF ALL RIBONUCLEASE-P AND RIBONUCLEASE MRP ENZYMES	CELL			English	Letter											BROWN, JW (corresponding author), INDIANA UNIV, DEPT BIOL, BLOOMINGTON, IN 47405 USA.				NIGMS NIH HHS [GM19422] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019422, R37GM019422] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; BAER M, 1989, NUCLEIC ACIDS MOL BI, V3, P231; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BENNETT JL, 1990, MOL CELL BIOL, V10, P2191, DOI 10.1128/MCB.10.5.2191; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; FORSTER AC, 1990, IN PRESS SCIENCE; GOLD HA, 1989, SCIENCE, V245, P1377, DOI 10.1126/science.2476849; GUERRIERTAKADA C, 1986, CELL, V45, P177, DOI 10.1016/0092-8674(86)90381-8; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; KOSKI RA, 1976, CELL, V9, P101, DOI 10.1016/0092-8674(76)90056-8; KRUPP G, 1986, EMBO J, V5, P1697, DOI 10.1002/j.1460-2075.1986.tb04413.x; LAWRENCE NP, 1987, P NATL ACAD SCI USA, V84, P6825, DOI 10.1073/pnas.84.19.6825; LEE JY, 1989, MOL CELL BIOL, V9, P2536, DOI 10.1128/MCB.9.6.2536; MILLER DL, 1983, CELL, V34, P911, DOI 10.1016/0092-8674(83)90548-2; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6865, DOI 10.1093/nar/17.17.6865; NICHOLS M, 1988, P NATL ACAD SCI USA, V85, P1379, DOI 10.1073/pnas.85.5.1379; PACE NR, 1990, J BIOL CHEM, V265, P3587; REICH C, 1986, J BIOL CHEM, V261, P7888; SHIRAISHI H, 1988, EMBO J, V7, P3817, DOI 10.1002/j.1460-2075.1988.tb03266.x; VIOQUE A, 1988, J MOL BIOL, V202, P835, DOI 10.1016/0022-2836(88)90562-1; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; YUAN Y, 1989, J BIOL CHEM, V264, P14835	26	136	137	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	1990	62	3					407	409		10.1016/0092-8674(90)90003-W	http://dx.doi.org/10.1016/0092-8674(90)90003-W			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1696176	hybrid			2022-12-28	WOS:A1990DU44500003
J	WILSON, JB; WEINBERG, W; JOHNSON, R; YUSPA, S; LEVINE, AJ				WILSON, JB; WEINBERG, W; JOHNSON, R; YUSPA, S; LEVINE, AJ			EXPRESSION OF THE BNLF-1 ONCOGENE OF EPSTEIN-BARR-VIRUS IN THE SKIN OF TRANSGENIC MICE INDUCES HYPERPLASIA AND ABERRANT EXPRESSION OF KERATIN-6	CELL			English	Article									NCI,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WILSON, JB (corresponding author), PRINCETON UNIV,DEPT BIOL,PRINCETON,NJ 08544, USA.		Wilson, Joanna B/B-4466-2009		NCI NIH HHS [CA49271-02, CA38757-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049271, R01CA038757, R37CA038757] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAICHWAL VR, 1988, ONCOGENE, V2, P461; BAICHWAL VR, 1987, J VIROL, V61, P866, DOI 10.1128/JVI.61.3.866-875.1987; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAMBAUGH T, 1980, P NATL ACAD SCI-BIOL, V77, P2999, DOI 10.1073/pnas.77.5.2999; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; Epstein M. A., 1986, EPSTEIN BARR VIRUS R; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; GREENHALGH DA, 1988, CARCINOGENESIS, V1, P134; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; HAMMERSCHMIDT W, 1989, J VIROL, V63, P2469, DOI 10.1128/JVI.63.6.2469-2475.1989; HENNESSY K, 1984, P NATL ACAD SCI-BIOL, V81, P7207, DOI 10.1073/pnas.81.22.7207; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HUDSON GS, 1985, J VIROL, V53, P528, DOI 10.1128/JVI.53.2.528-535.1985; IMLER JL, 1987, MOL CELL BIOL, V7, P2558, DOI 10.1128/MCB.7.7.2558; KNAPP B, 1987, J BIOL CHEM, V262, P938; LIAU G, 1985, J BIOL CHEM, V260, P531; LIEBOWITZ D, 1986, J VIROL, V58, P233, DOI 10.1128/JVI.58.1.233-237.1986; LIEBOWITZ D, 1987, MOL CELL BIOL, V7, P2299, DOI 10.1128/MCB.7.7.2299; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; ROOP DR, 1985, ANN NY ACAD SCI, V455, P426, DOI 10.1111/j.1749-6632.1985.tb50426.x; ROOP DR, 1987, DIFFERENTIATION, V35, P143, DOI 10.1111/j.1432-0436.1987.tb00162.x; ROOP DR, 1984, J BIOL CHEM, V259, P8037; ROOP DR, 1983, P NATL ACAD SCI-BIOL, V80, P716, DOI 10.1073/pnas.80.3.716; SCHMIDT A, 1984, J BIOL CHEM, V229, P7411; SIXBEY JW, 1987, J GEN VIROL, V68, P805, DOI 10.1099/0022-1317-68-3-805; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; TYNDALL C, 1981, NUCLEIC ACIDS RES, V9, P6231, DOI 10.1093/nar/9.23.6231; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG D, 1988, J VIROL, V62, P4173, DOI 10.1128/JVI.62.11.4173-4184.1988; WANG D, 1988, J VIROL, V62, P2337, DOI 10.1128/JVI.62.7.2337-2346.1988; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397	37	221	227	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 29	1990	61	7					1315	1327		10.1016/0092-8674(90)90695-B	http://dx.doi.org/10.1016/0092-8674(90)90695-B			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM156	1694724				2022-12-28	WOS:A1990DM15600019
J	DECKER, CJ; SOLLNERWEBB, B				DECKER, CJ; SOLLNERWEBB, B			RNA EDITING INVOLVES INDISCRIMINATE U CHANGES THROUGHOUT PRECISELY DEFINED EDITING DOMAINS	CELL			English	Article									JOHNS HOPKINS UNIV,SCH MED,HUMAN GENET PROGRAM,BALTIMORE,MD 21205	Johns Hopkins University	DECKER, CJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.				NIGMS NIH HHS [GM-34231] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034231] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; BAKALARA N, 1989, J BIOL CHEM, V264, P18679; BENNE R, 1989, BIOCHIM BIOPHYS ACTA, V1007, P131, DOI 10.1016/0167-4781(89)90031-6; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BENNE R, 1983, NUCLEIC ACIDS RES, V11, P6925, DOI 10.1093/nar/11.20.6925; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; CAMPBELL DA, 1989, MOL BIOCHEM PARASIT, V36, P197, DOI 10.1016/0166-6851(89)90192-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; ENGLUND PT, 1982, ANNU REV BIOCHEM, V51, P695, DOI 10.1146/annurev.bi.51.070182.003403; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; GRUNBERGMANAGO M, 1963, PROGR NUCL ACIDS RES, P93; HEPPEL LA, 1963, J BIOL CHEM, V238, P357; HIRSCH M, 1974, CELL, V1, P31, DOI 10.1016/0092-8674(74)90152-4; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; SIMPSON L, 1986, INT REV CYTOL, V99, P119; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; STUART K, 1989, PARASITOL TODAY, V5, P5, DOI 10.1016/0169-4758(89)90211-1; Stuart K., 1988, Molecular genetics of parasitic protozoa., P143; STUART K, 1989, EXP PARASITOL, V68, P486, DOI 10.1016/0014-4894(89)90135-5; STUART K, 1989, GENE, V82, P155, DOI 10.1016/0378-1119(89)90040-1; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; VANDERSPEK H, 1988, EMBO J, V7, P2509, DOI 10.1002/j.1460-2075.1988.tb03098.x; VOLLOCH V, 1990, NATURE, V343, P482, DOI 10.1038/343482a0; WHITE TC, 1987, NUCLEIC ACIDS RES, V15, P3275, DOI 10.1093/nar/15.8.3275	32	122	124	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 15	1990	61	6					1001	1011		10.1016/0092-8674(90)90065-M	http://dx.doi.org/10.1016/0092-8674(90)90065-M			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK145	1693545	hybrid			2022-12-28	WOS:A1990DK14500010
J	WUCHERPFENNIG, KW; OTA, K; ENDO, N; SEIDMAN, JG; ROSENZWEIG, A; WEINER, HL; HAFLER, DA				WUCHERPFENNIG, KW; OTA, K; ENDO, N; SEIDMAN, JG; ROSENZWEIG, A; WEINER, HL; HAFLER, DA			SHARED HUMAN T-CELL RECEPTOR V-BETA USAGE TO IMMUNODOMINANT REGIONS OF MYELIN BASIC-PROTEIN	SCIENCE			English	Article									HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Harvard University; Harvard Medical School	WUCHERPFENNIG, KW (corresponding author), BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,DEPT MED,DIV NEUROL,BOSTON,MA 02115, USA.				NHLBI NIH HHS [1 K11 HL 02228-01] Funding Source: Medline; NINDS NIH HHS [NS 00981, R01 NS 24247] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL002228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024247, K08NS000981] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; ALLEGRETTA M, 1990, SCIENCE, V247, P718, DOI 10.1126/science.1689076; Alvord EC, 1984, EXPT ALLERGIC ENCEPH; BENNUN A, 1982, J IMMUNOL, V129, P303; BURNS FR, 1989, J EXP MED, V169, P27, DOI 10.1084/jem.169.1.27; CONCANNON P, 1986, P NATL ACAD SCI USA, V83, P6598, DOI 10.1073/pnas.83.17.6598; HAFLER DA, 1988, J EXP MED, V167, P1313, DOI 10.1084/jem.167.4.1313; HAFLER DA, 1989, IMMUNOL TODAY, V10, P104, DOI 10.1016/0167-5699(89)90236-3; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; KIMURA N, 1986, J EXP MED, V164, P739, DOI 10.1084/jem.164.3.739; KIMURA N, 1987, EUR J IMMUNOL, V17, P37; LAI E, 1988, NATURE, V331, P543, DOI 10.1038/331543a0; MARTIN R, 1990, NEUROLOGY, V40, P391; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; MOKHTARIAN F, 1984, NATURE, V309, P356, DOI 10.1038/309356a0; MORETTA A, 1983, J EXP MED, V157, P743, DOI 10.1084/jem.157.2.743; OLERUP O, 1989, P NATL ACAD SCI USA, V86, P7113, DOI 10.1073/pnas.86.18.7113; OTA K, 1990, FASEB J, V4, pA1857; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SVEJGAARD A, 1983, IMMUNOL REV, V70, P193, DOI 10.1111/j.1600-065X.1983.tb00715.x; TILLINGHAST JP, 1986, SCIENCE, V233, P879, DOI 10.1126/science.3755549; TOYONAGA B, 1985, P NATL ACAD SCI USA, V82, P8624, DOI 10.1073/pnas.82.24.8624; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	26	452	485	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 25	1990	248	4958					1016	1019		10.1126/science.1693015	http://dx.doi.org/10.1126/science.1693015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF144	1693015				2022-12-28	WOS:A1990DF14400037
J	JOHNSON, IS; ROGERS, C; BISWAS, B; AHMEDZAI, S				JOHNSON, IS; ROGERS, C; BISWAS, B; AHMEDZAI, S			WHAT DO HOSPICES DO - A SURVEY OF HOSPICES IN THE UNITED-KINGDOM AND REPUBLIC-OF-IRELAND	BRITISH MEDICAL JOURNAL			English	Article											JOHNSON, IS (corresponding author), LEICESTERSHIRE HOSPICE,LEICESTER LE3 9QE,ENGLAND.		biswas, biswajit/N-8291-2019	biswas, biswajit/0000-0002-3448-3827; Ahmedzai, Sam/0000-0002-2028-8510				ALDERSON MR, 1973, BRIT MED J, V1, P170, DOI 10.1136/bmj.1.5846.170; [Anonymous], 1980, REPORT WORKING GROUP; Hill F, 1984, Health Trends, V16, P9; LUNT B, 1980, TERMINAL CANCER CARE; PORTER KRO, 1973, BRIT MED J, V1, P40, DOI 10.1136/bmj.1.5844.40; SMITH T, 1985, BRIT MED J, V291, P1670, DOI 10.1136/bmj.291.6510.1670; WARD AWM, 1985, HOME CARE SERVICES T; WILKES E, 1965, LANCET, V1, P799; 1988, 1988 DIRECTORY HOSPI	9	20	20	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 24	1990	300	6727					791	793		10.1136/bmj.300.6727.791	http://dx.doi.org/10.1136/bmj.300.6727.791			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW227	1691031	Bronze, Green Published			2022-12-28	WOS:A1990CW22700025
J	GEORGE, PJM; IRVING, JD; MANTELL, BS; RUDD, RM				GEORGE, PJM; IRVING, JD; MANTELL, BS; RUDD, RM			COVERED EXPANDABLE METAL STENT FOR RECURRENT TRACHEAL OBSTRUCTION	LANCET			English	Article									LONDON HOSP,DEPT RADIOTHERAPY,LONDON E1 1BB,ENGLAND	University of London; Queen Mary University London	GEORGE, PJM (corresponding author), LONDON CHEST HOSP,DEPT THORAC MED,LONDON E2 9JX,ENGLAND.							HETZEL MR, 1985, THORAX, V40, P341, DOI 10.1136/thx.40.5.341; MACHA HN, 1987, THORAX, V42, P511, DOI 10.1136/thx.42.7.511; SCHRAY MF, 1988, CHEST, V93, P264, DOI 10.1378/chest.93.2.264; SIMONDS AK, 1989, THORAX, V44, P680, DOI 10.1136/thx.44.8.680; WALLACE MJ, 1986, RADIOLOGY, V158, P309, DOI 10.1148/radiology.158.2.3941857; WESTABY S, 1982, J THORAC CARDIOV SUR, V83, P414	6	45	50	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					582	584		10.1016/0140-6736(90)90358-C	http://dx.doi.org/10.1016/0140-6736(90)90358-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1689793				2022-12-28	WOS:A1990CT65300012
J	SURTEES, R; LEONARD, J; AUSTIN, S				SURTEES, R; LEONARD, J; AUSTIN, S			ASSOCIATION OF DEMYELINATION WITH DEFICIENCY OF CEREBROSPINAL-FLUID S-ADENOSYLMETHIONINE IN INBORN-ERRORS OF METHYL-TRANSFER PATHWAY	LANCET			English	Article							SUBACUTE COMBINED DEGENERATION; CENTRAL-NERVOUS-SYSTEM; METHIONINE; CORD; TRANSMETHYLATION; VITAMIN-B12; NEUROPATHY; CBLE	Long-term deficiency of cobalamin or folate causes a demyelinating disease of the brain and spinal cord. A reduced supply of methyl groups has been implicated as its cause. To examine the mechanisms of demyelination in human beings, we have studied three children with sequential inborn errors of the methyl-transfer pathway. One child had abnormal methylfolate metabolism, one abnormal methylcobalamin metabolism, and one hypermethioninaemia probably caused by methionine adenosyltransferase deficiency. Magnetic resonance imaging of the brain and measurement of cerebrospinal-fluid concentrations of 5-methyltetrahydrofolate, methionine, and S-adenosylmethionine were carried out before and after 6-12 months of appropriate treatment. Each patient had abnormal myelination before treatment; the scans suggested demyelination. The only consistent biochemical abnormality in the cerebrospinal fluid was a low concentration of S-adenosylmethionine. Treatment led to substantial clinical improvement, apparent remyelination, and increases in cerebrospinal-fluid S-adenosylmethionine concentration into the normal range. Cerebrospinal-fluid concentrations of S-adenosylmethionine and methionine were significantly lower in eight other children with errors of the methyl-transfer pathway than in an age-matched reference population (mean [95% confidence interval] standard deviation score -1.81 [0.57], p < 0.001 for S-adenosyl methionine and -1.82 [0.19], p < 0.001 for methionine). The concentrations of these metabolites increased to within the reference range on treatment. We have shown that demyelination is associated with cerebrospinal-fluid S-adenosylmethionine deficiency and that restoration of S-adenosylmethionine is associated with remyelination.	INST CHILD HLTH, DEPT RADIOL, LONDON WC1N 1EH, ENGLAND	University of London; University College London	SURTEES, R (corresponding author), INST CHILD HLTH, DEPT CHILD HLTH, 30 GUILFORD ST, LONDON WC1N 1EH, ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams RD, 1944, NEW ENGL J MED, V231, P1, DOI 10.1056/NEJM194407062310101; ALMARDINI H, 1988, CLIN CHIM ACTA, V176, P83, DOI 10.1016/0009-8981(88)90177-5; CARMEL R, 1988, NEW ENGL J MED, V318, P1738, DOI 10.1056/NEJM198806303182607; CLAYTON PT, 1986, J NEUROL NEUROSUR PS, V49, P920, DOI 10.1136/jnnp.49.8.920; DAYAN AD, 1974, J NEUROL SCI, V23, P117, DOI 10.1016/0022-510X(74)90147-6; DELAHABA G, 1959, J BIOL CHEM, V234, P603; FINN JP, 1989, 8TH ANN M SOC MAGN R, P722; GAHL WA, 1987, AM J HUM GENET, V40, P39; GANDY G, 1973, J PHYSIOL-LONDON, V233, pP1; HALL CA, 1989, CLIN INVEST MED, V12, P262; HALL CA, 1990, AM J HEMATOL, V34, P121, DOI 10.1002/ajh.2830340208; HYLAND K, 1988, NEUROLOGY, V38, P459, DOI 10.1212/WNL.38.3.459; LEVER EG, 1986, J NEUROL NEUROSUR PS, V49, P1203, DOI 10.1136/jnnp.49.10.1203; LOMBARDINI JB, 1970, MOL PHARMACOL, V6, P481; MAHONEY MJ, 1987, ACTA PAEDIATR SCAND, V76, P689, DOI 10.1111/j.1651-2227.1987.tb10551.x; MCKEEVER MP, 1991, CLIN SCI, V81, P551, DOI 10.1042/cs0810551; MITSUI KI, 1988, J BIOL CHEM, V263, P11211; ROBERTSON DM, 1971, ARCH NEUROL-CHICAGO, V24, P203, DOI 10.1001/archneur.1971.00480330031002; ROSENBLATT DS, 1989, CLIN INVEST MED, V12, P270; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P693; Russell JSR, 1900, BRAIN, V23, P39, DOI 10.1093/brain/23.1.39; SCHATZ RA, 1981, J NEUROCHEM, V36, P1739, DOI 10.1111/j.1471-4159.1981.tb00426.x; SCOTT JM, 1981, LANCET, V2, P334; SURTEES R, 1989, ANAL BIOCHEM, V181, P331, DOI 10.1016/0003-2697(89)90252-2; SURTEES R, 1990, BIOCHEM MED METAB B, V44, P192, DOI 10.1016/0885-4505(90)90060-E; TALLAN HH, 1979, BIOCHEM MED METAB B, V21, P129, DOI 10.1016/0006-2944(79)90064-4; VANDERWESTHUYZEN J, 1982, LIFE SCI, V31, P2001, DOI 10.1016/0024-3205(82)90039-X; VIEIRAMAKINGS E, 1990, BIOCHEM J, V266, P707, DOI 10.1042/bj2660707; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; WEIR DG, 1988, J NEUROCHEM, V51, P1949, DOI 10.1111/j.1471-4159.1988.tb01184.x	30	199	206	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	1991	338	8782-3					1550	1554		10.1016/0140-6736(91)92373-A	http://dx.doi.org/10.1016/0140-6736(91)92373-A			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683972				2022-12-28	WOS:A1991GW03600004
J	WINSA, B; ADAMI, HO; BERGSTROM, R; GAMSTEDT, A; DAHLBERG, PA; ADAMSON, U; JANSSON, R; KARLSSON, A				WINSA, B; ADAMI, HO; BERGSTROM, R; GAMSTEDT, A; DAHLBERG, PA; ADAMSON, U; JANSSON, R; KARLSSON, A			STRESSFUL LIFE EVENTS AND GRAVES-DISEASE	LANCET			English	Article							AUTOIMMUNE THYROID-DISEASE; THYROTOXICOSIS; ASSOCIATION; ANTIGENS; HLA	The role of stressful life events in the onset of Graves' disease (toxic diffuse goitre) is controversial. However, the numerous early clinical reports that supported such an association were not adequately controlled and specificity of the diagnosis could be questioned. Later studies have not shown a causal relation, but these studies were small, did not have proper controls, or epidemiological methods were inappropriate. To assess possible associations between life events, heredity, social support, and Graves' disease, we have done a population-based case-control study in a defined area with about 1 million inhabitants. Over 2 years, 208 (95%) of 219 eligible patients with newly-diagnosed Graves' disease and 372 (80%) of all selected matched controls answered an identical mailed questionnaire about marital status, occupation, drinking and smoking habits, physical activity, familial occurrence of thyroid disease, life events, social support, and personality. Compared with controls, patients claimed to have had more negative life events in the 12 months preceding the diagnosis, and negative life-event scores were also significantly higher (odds ratio 6.3, 95% confidence interval 2.7-14.7, for the category with the highest negative score). Individuals who had relatives with thyroid disease (especially first-degree and second-degree relatives) were more likely to have Graves' disease (3.6, 2.2-5.9). Slightly more patients than controls were divorced (1.8, 1.0-3.3) and reported a less frequent intake of alcohol (0.4, 0.2-0.8). When results were adjusted for possible confounding factors in multivariate analyses, risk estimates were almost unchanged. These findings indicate that negative life events and hereditary factors may be risk factors for Graves' disease.	OREBRO MED CTR HOSP,DEPT INTERNAL MED,OREBRO,SWEDEN; VASTERAS HOSP,DEPT INTERNAL MED,VASTERAS,SWEDEN; DANDERYD HOSP,DEPT INTERNAL MED,S-18288 DANDERYD,SWEDEN; UNIV UPPSALA,DEPT STAT,S-75105 UPPSALA,SWEDEN; UNIV UPPSALA,CANC EPIDEMIOL UNIT,S-75105 UPPSALA,SWEDEN	Vasteras Central Hospital; Danderyds Hospital; Uppsala University; Uppsala University	WINSA, B (corresponding author), UNIV HOSP UPPSALA,DEPT INTERNAL MED,S-75185 UPPSALA,SWEDEN.							ALLANNIC H, 1980, J CLIN ENDOCR METAB, V51, P863, DOI 10.1210/jcem-51-4-863; BARTELS ED, 1941, HEREDITY GRAVES DISE; BENNETT AW, 1961, ARCH GEN PSYCHIAT, V4, P160; BLOOM BL, 1978, PSYCHOL BULL, V85, P867, DOI 10.1037/0033-2909.85.4.867; BRESLOW NE, 1980, STATISTICAL METHODS; CROISET G, 1987, LIFE SCI, V40, P775, DOI 10.1016/0024-3205(87)90305-5; FARID NR, 1979, J CLIN INVEST, V63, P108, DOI 10.1172/JCI109263; GRAY J, 1985, Q J MED, V54, P153; GRELLAND R, 1946, ACTA MED SCAND, V125, P108; HADDEN DR, 1974, LANCET, V2, P577; HIRSCH BJ, 1980, AM J COMMUN PSYCHOL, V8, P63; JENKINS CD, 1965, JENKINS ACTIVITY SUR; KURITZ SJ, 1988, BIOMETRICS, V44, P355, DOI 10.2307/2531850; LIDZ T, 1955, PSYCHOSOM MED, V17, P420, DOI 10.1097/00006842-195511000-00002; MEULENGRACHT E, 1949, ARCH INTERN MED, V83, P119, DOI 10.1001/archinte.1949.00220310002001; PICCININI LA, 1987, CLIN ENDOCRINOL, V26, P253, DOI 10.1111/j.1365-2265.1987.tb00783.x; ROBINSON N, 1989, DIABETIC MED, V6, P53, DOI 10.1111/j.1464-5491.1989.tb01139.x; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; SASAZUKI T, 1977, TISSUE ANTIGENS, V10, P21; SKILLERN PG, 1972, MAYO CLIN PROC, V47, P848; Stein M, 1985, J IMMUNOL, V135, p827s; TAMAI H, 1985, J CLIN ENDOCR METAB, V60, P62, DOI 10.1210/jcem-60-1-62; UNO H, 1981, NATURE, V292, P768, DOI 10.1038/292768a0; VIALETTES B, 1989, DIABETES METAB, V15, P45; VOLPE R, 1985, AUTOIMMUNITY ENDOCRI, P109; WEETMAN AP, 1984, ENDOCR REV, V5, P309, DOI 10.1210/edrv-5-2-309; WEISMAN SA, 1958, ANN INTERN MED, V48, P747, DOI 10.7326/0003-4819-48-4-747; WINSA B, 1990, ACTA ENDOCRINOL-COP, V122, P722, DOI 10.1530/acta.0.1220722	29	162	168	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1475	1479		10.1016/0140-6736(91)92298-G	http://dx.doi.org/10.1016/0140-6736(91)92298-G			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV077	1683917				2022-12-28	WOS:A1991GV07700002
J	MULLINS, RJ; RUSSELL, A; MCGRATH, GJ; SMITH, R; SUTHERLAND, DC				MULLINS, RJ; RUSSELL, A; MCGRATH, GJ; SMITH, R; SUTHERLAND, DC			BREAST-FEEDING ANAPHYLAXIS	LANCET			English	Letter							RECURRENT ANAPHYLAXIS		ROYAL NEWCASTLE HOSP,NEWCASTLE,NSW 2300,AUSTRALIA; MAITLAND DIST HOSP,MAITLAND,NSW,AUSTRALIA; UNIV NEWCASTLE,DEPT MED,NEWCASTLE,NSW 2308,AUSTRALIA	University of Newcastle	MULLINS, RJ (corresponding author), JOHN HUNTER HOSP,DEPT CLIN IMMUNOL,RANKIN PK,NSW 2287,AUSTRALIA.			Smith, Roger/0000-0003-4720-0280				EMMOTT RS, 1990, ANAESTHESIA, V45, P62, DOI 10.1111/j.1365-2044.1990.tb14520.x; GEORGOURAS K, 1981, Australasian Journal of Dermatology, V22, P109, DOI 10.1111/j.1440-0960.1981.tb00039.x; MATTHEWS KP, 1980, J ALLERGY CLIN IMMUN, V66, P347; MEGGS WJ, 1984, NEW ENGL J MED, V311, P1236, DOI 10.1056/NEJM198411083111907; MITTMAN RJ, 1989, J ALLERGY CLIN IMMUN, V84, P304, DOI 10.1016/0091-6749(89)90412-0; MORASSUT P, 1989, SEMIN ARTHRITIS RHEU, V19, P22, DOI 10.1016/0049-0172(89)90084-X; SLATER JE, 1987, OBSTET GYNECOL, V70, P542; SLATER RM, 1985, ANAESTHESIA, V40, P655, DOI 10.1111/j.1365-2044.1985.tb10944.x	8	13	13	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1279	1280		10.1016/0140-6736(91)92152-R	http://dx.doi.org/10.1016/0140-6736(91)92152-R			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682680				2022-12-28	WOS:A1991GQ16600055
J	GALLI, M				GALLI, M			CRYOGLOBULINEMIA AND SEROLOGICAL MARKERS OF HEPATITIS VIRUSES	LANCET			English	Letter							ESSENTIAL MIXED CRYOGLOBULINEMIA; B VIRUS				GALLI, M (corresponding author), UNIV MILAN,INST INTERNAL MED INFECT DIS & IMMUNOPATHOL,I-20157 MILAN,ITALY.		Schena, Francesco Paolo/K-6982-2016; GALLI, MASSIMO/L-7282-2017	Schena, Francesco Paolo/0000-0001-7927-5207; GALLI, MASSIMO/0000-0001-8887-6215				CASATO, 1991, LANCET, V337, P104; CROVARI P, 1979, B I SIEROTER MILAN, V58, P35; DIENSTAG JL, 1977, NEW ENGL J MED, V297, P946; DURAND, 1991, LANCET, V337, P499; GALLI M, 1980, LANCET, V1, P1093; GIUSTI G, 1989, INFECTION, V17, P237, DOI 10.1007/BF01639527; LEVO Y, 1977, NEW ENGL J MED, V296, P1501, DOI 10.1056/NEJM197706302962605; POPP JW, 1980, ANN INTERN MED, V92, P379, DOI 10.7326/0003-4819-92-3-379	8	24	24	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					758	759		10.1016/0140-6736(91)91478-D	http://dx.doi.org/10.1016/0140-6736(91)91478-D			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679889				2022-12-28	WOS:A1991GG10400035
J	WRIGHT, D; MACKENZIE, SJ; BUCHAN, I; CAIRNS, CS; PRICE, LE				WRIGHT, D; MACKENZIE, SJ; BUCHAN, I; CAIRNS, CS; PRICE, LE			CRITICAL INCIDENTS IN THE INTENSIVE THERAPY UNIT	LANCET			English	Article								Preventable mishaps in an intensive therapy unit were studied over 12 months by the critical incident technique. Staff were encouraged to complete confidential questionnaires describing incidents in which they had participated or had observed. This allowed classification of the events and examination of the views of staff on causes, detection, and prevention. 110 (80%) of 137 events were felt to have been due to human error; the remainder were due to equipment failure. Inexperience with equipment and shortage of trained staff were the factors most often felt to contribute to incidents. The critical incident technique is a useful way of improving standards of clinical care.			WRIGHT, D (corresponding author), WESTERN GEN HOSP,INTENS THERAPY UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							COOPER JB, 1978, ANESTHESIOLOGY, V49, P399, DOI 10.1097/00000542-197812000-00004; FLANAGAN JC, 1954, PSYCHOL BULL, V51, P327, DOI 10.1037/h0061470; VINCENT CA, 1989, BMJ-BRIT MED J, V299, P1150, DOI 10.1136/bmj.299.6708.1150; WILLINGHAM JJ, 1985, AUDITING-J PRACT TH, V5, P57; 1988, LANCET, V1, P1373	5	63	67	1	9	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					676	678		10.1016/0140-6736(91)91243-N	http://dx.doi.org/10.1016/0140-6736(91)91243-N			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GF105	1679483				2022-12-28	WOS:A1991GF10500014
J	DRUMM, ML; POPE, HA; CLIFF, WH; ROMMENS, JM; MARVIN, SA; TSUI, LC; COLLINS, FS; FRIZZELL, RA; WILSON, JM				DRUMM, ML; POPE, HA; CLIFF, WH; ROMMENS, JM; MARVIN, SA; TSUI, LC; COLLINS, FS; FRIZZELL, RA; WILSON, JM			CORRECTION OF THE CYSTIC-FIBROSIS DEFECT INVITRO BY RETROVIRUS-MEDIATED GENE-TRANSFER	CELL			English	Article									UNIV MICHIGAN,HOWARD HUGHES MED INST,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV ALABAMA,GREGORY FLEMING JAMES CYST FIBROSIS RES CTR,BIRMINGHAM,AL 35233; UNIV ALABAMA,DEPT PHYSIOL & BIOPHYS,BIRMINGHAM,AL 35233; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,DEPT BIOL CHEM,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Howard Hughes Medical Institute; University of Michigan System; University of Michigan	DRUMM, ML (corresponding author), UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,DEPT INTERNAL MED,ANN ARBOR,MI 48109, USA.		Tsui, Lap-chee/A-1081-2010; Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131	NIDDK NIH HHS [DK41330, DK38518, DK08260] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041330, F32DK008260, P01DK038518] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOAT TF, 1976, ARCH BIOCHEM BIOPHYS, V177, P95, DOI 10.1016/0003-9861(76)90419-7; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; CHENG PW, 1989, J CLIN INVEST, V84, P68, DOI 10.1172/JCI114171; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; FRIZZELL RA, 1987, TRENDS NEUROSCI, V10, P190, DOI 10.1016/0166-2236(87)90144-5; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KEREM B, 1990, IN PRESS P NATL ACAD; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; TAUSSIG LM, 1984, CYSTIC FIBROSIS, P1; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, pC358; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; WILSON JM, 1990, P NATL ACAD SCI USA, V87, P439, DOI 10.1073/pnas.87.1.439; WILSON JM, 1990, SCIENCE, V248, P1413, DOI 10.1126/science.1972597; WILSON JM, 1988, P NATL ACAD SCI USA, V85, P4421, DOI 10.1073/pnas.85.12.4421; 1990, AM J HUM GENET, V47, P359	30	562	593	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 21	1990	62	6					1227	1233		10.1016/0092-8674(90)90398-X	http://dx.doi.org/10.1016/0092-8674(90)90398-X			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA117	1698126	Green Published			2022-12-28	WOS:A1990EA11700019
J	STURM, NR; SIMPSON, L				STURM, NR; SIMPSON, L			KINETOPLAST DNA MINICIRCLES ENCODE GUIDE RNAS FOR EDITING OF CYTOCHROME-OXIDASE SUBUNIT-III MESSENGER-RNA	CELL			English	Article									UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	STURM, NR (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024, USA.				NIAID NIH HHS [AI09102] Funding Source: Medline; NIGMS NIH HHS [GM07104] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI009102, R37AI009102] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARROIS M, 1981, P NATL ACAD SCI-BIOL, V78, P3323, DOI 10.1073/pnas.78.6.3323; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BORST P, 1987, MOL BIOCHEM PARASIT, V23, P31, DOI 10.1016/0166-6851(87)90184-8; DONELSON JE, 1979, PLASMID, V2, P572, DOI 10.1016/0147-619X(79)90055-6; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; FOUTS DL, 1979, NUCLEIC ACIDS RES, V6, P3785, DOI 10.1093/nar/6.12.3785; FRASCH ACC, 1980, BIOCHIM BIOPHYS ACTA, V607, P397, DOI 10.1016/0005-2787(80)90150-1; KIDANE GZ, 1984, GENE, V27, P265, DOI 10.1016/0378-1119(84)90071-4; MCCUTCHAN TF, 1984, SCIENCE, V225, P625, DOI 10.1126/science.6330899; MOREL C, 1980, P NATL ACAD SCI-BIOL, V77, P6810, DOI 10.1073/pnas.77.11.6810; MUHICH ML, 1986, NUCLEIC ACIDS RES, V14, P5531, DOI 10.1093/nar/14.13.5531; RAY DS, 1989, MOL CELL BIOL, V9, P1365, DOI 10.1128/MCB.9.3.1365; ROHRER SP, 1987, CELL, V49, P625, DOI 10.1016/0092-8674(87)90538-1; SIMPSON AM, 1985, NUCLEIC ACIDS RES, V13, P5977, DOI 10.1093/nar/13.16.5977; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; SIMPSON L, 1970, J PROTOZOOL, V17, P511, DOI 10.1111/j.1550-7408.1970.tb04719.x; SIMPSON L, 1986, INT REV CYTOL, V99, P119; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SIMPSON L, 1978, CELL, V14, P169, DOI 10.1016/0092-8674(78)90311-2; STUART K, 1983, MOL BIOCHEM PARASIT, V9, P93, DOI 10.1016/0166-6851(83)90103-2; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M	21	188	191	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 1	1990	61	5					879	884		10.1016/0092-8674(90)90198-N	http://dx.doi.org/10.1016/0092-8674(90)90198-N			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DG090	1693097				2022-12-28	WOS:A1990DG09000017
J	ENDOW, SA; HENIKOFF, S; SOLERNIEDZIELA, L				ENDOW, SA; HENIKOFF, S; SOLERNIEDZIELA, L			MEDIATION OF MEIOTIC AND EARLY MITOTIC CHROMOSOME SEGREGATION IN DROSOPHILA BY A PROTEIN RELATED TO KINESIN	NATURE			English	Article									FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	Fred Hutchinson Cancer Center	ENDOW, SA (corresponding author), DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710, USA.			Endow, Sharyn A./0000-0002-0907-8889; Henikoff, Steven/0000-0002-7621-8685				BAKER BS, 1975, GENETICS, V80, P267; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; COOPER KW, 1964, P NATL ACAD SCI USA, V52, P1248, DOI 10.1073/pnas.52.5.1248; DAVIS DG, 1969, GENETICS, V61, P577; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; GORBSKY GJ, 1988, J CELL BIOL, V104, P9; HENIKOFF S, 1988, NUCLEIC ACIDS RES, V16, P6191, DOI 10.1093/nar/16.13.6191; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; NICKLAS RB, 1989, J CELL BIOL, V109, P2245, DOI 10.1083/jcb.109.5.2245; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; STUDIER FW, IN PRESS METH ENZYM; Sturtevant AH, 1929, Z WISS ZOOL ABT A, V135, P323; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; YAMAMOTO AH, 1989, EMBO J, V8, P3543, DOI 10.1002/j.1460-2075.1989.tb08526.x; YANG JT, 1988, P NATL ACAD SCI USA, V85, P1864, DOI 10.1073/pnas.85.6.1864; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	24	227	229	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 3	1990	345	6270					81	83		10.1038/345081a0	http://dx.doi.org/10.1038/345081a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB957	1691829				2022-12-28	WOS:A1990DB95700063
J	HOPKINS, PM; ELLIS, FR; HALSALL, PJ				HOPKINS, PM; ELLIS, FR; HALSALL, PJ			EVIDENCE FOR RELATED MYOPATHIES IN EXERTIONAL HEAT-STROKE AND MALIGNANT HYPERTHERMIA	LANCET			English	Note								Malignant hyperthermia may be a human stress syndrome, of which heat stroke is one manifestation. Two men in military service who had episodes of exertional heat stroke, and their immediate family members, were tested for susceptibility to malignant hyperthermia by in-vitro contracture tests on skeletal muscle samples. Muscle from both patients had a normal response to caffeine but an abnormal response to halothane. Muscle from the father of one patient had an abnormal response to halothane, and that from the father of the second patient had an abnormal response to ryanodine. The results indicate that clinical heat stroke may be associated with an underlying inherited abnormality of skeletal muscle that is similar, but not identical, to that of malignant hyperthermia.			HOPKINS, PM (corresponding author), UNIV LEEDS, ST JAMES HOSP, DEPT CLIN MED, MALIGNANT HYPERTHERMIA INVEST UNIT, LEEDS LS9 7TF, W YORKSHIRE, ENGLAND.		Hopkins, Philip/ABE-5970-2020	Hopkins, Philip/0000-0002-8127-1739				ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267; ELLIS FR, 1985, RECENT ADV ANAESTHES, V15, P173; HOPKINS PM, 1991, BRIT J ANAESTH, V66, P611, DOI 10.1093/bja/66.5.611; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; KNOCHEL JP, 1989, DM-DIS MON, V35, P306; LEHMANNHORN F, 1990, BRIT J ANAESTH, V65, P692, DOI 10.1093/bja/65.5.692; Wingard D, 1978, 2ND INT S MAL HYP, P363	7	80	84	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	1991	338	8781					1491	1492		10.1016/0140-6736(91)92304-K	http://dx.doi.org/10.1016/0140-6736(91)92304-K			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683922				2022-12-28	WOS:A1991GV07700008
J	KOSTIS, JB; WILSON, AC				KOSTIS, JB; WILSON, AC			LACK OF HYPOTENSION WITH LOVASTATIN AND PRAVASTATIN	LANCET			English	Letter											KOSTIS, JB (corresponding author), UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,NEW BRUNSWICK,NJ 08903, USA.							FRENCH J, 1989, LANCET, V2, P807	1	1	1	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1339	1339		10.1016/0140-6736(91)92646-J	http://dx.doi.org/10.1016/0140-6736(91)92646-J			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682723				2022-12-28	WOS:A1991GR02300051
J	BAETEN, CGMI; KONSTEN, J; SPAANS, F; VISSER, R; HABETS, AMMC; BOURGEOIS, IM; WAGENMAKERS, AJM; SOETERS, PB				BAETEN, CGMI; KONSTEN, J; SPAANS, F; VISSER, R; HABETS, AMMC; BOURGEOIS, IM; WAGENMAKERS, AJM; SOETERS, PB			DYNAMIC GRACILOPLASTY FOR TREATMENT OF FECAL INCONTINENCE	LANCET			English	Article							FECAL INCONTINENCE; NEOANAL SPHINCTER; GRACILIS MUSCLE; SKELETAL-MUSCLE; CONSTRUCTION; TRANSFORMATION; TRANSPOSITION; NEOSPHINCTER; STIMULATION; NEORECTUM	Serious faecal incontinence due to anal sphincter damage should be treated by surgery. Graciloplasty has had limited success because the gracilis is a fast-twitch muscle and fatigues quickly. A favourable outcome in a patient who had dynamic (electrically stimulated) graciloplasty encouraged us to further assess this procedure. Gracilis muscle transposition was done in ten patients with complete anal incontinence due to anal atresia, sphincter damage, or neurogenic causes, and who had had several other unsuccessful treatments. 6 weeks after muscle transposition, intramuscular leads were implanted and connected to an implantable electric stimulator. Eight patients became continent, one patient still has a diverting colostomy, and a fistula developed in the other patient. Anal sphincter pressure improved from 35 mm Hg without stimulation to 62 mm Hg with stimulation at 8 weeks (mean increase 28 mm Hg [95% confidence interval 18, 36), p < 0.01). Retention time of a phosphate enema increased from 22 to 281 s (mean increase 259 s (82, 436], p < 0.01). Defaecography showed that the new sphincter was functioning. Defaecation was possible when the stimulator was turned "off" with a magnet. Dynamic graciloplasty can restore continence and it improves quality of life in faecally incontinent patients for whom other treatments have been unsuccessful.	UNIV LIMBURG HOSP,DEPT CLIN NEUROPHYSIOL,6202 AZ MAASTRICHT,NETHERLANDS; BAKKEN RES CTR,MAASTRICHT,NETHERLANDS; UNIV LIMBURG,DEPT HUMAN BIOL,6200 MD MAASTRICHT,NETHERLANDS	Maastricht University; Maastricht University Medical Centre (MUMC); Medtronic Bakken Research Center B.V.; Hasselt University; Maastricht University	BAETEN, CGMI (corresponding author), UNIV LIMBURG HOSP,DEPT SURG,POB 5800,6202 AZ MAASTRICHT,NETHERLANDS.		Wagenmakers, Anton/H-7625-2014	Wagenmakers, Anton/0000-0003-1916-3822				BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646; BAETEN CGMI, 1990, BRIT J SURG, V77, P473, DOI 10.1002/bjs.1800770433; CARPENTIER A, 1986, BIOMECHANICAL CARDIA, P85; CAVINA E, 1990, INT J COLORECTAL DIS, V5, P6, DOI 10.1007/BF00496141; CHACHQUES JC, 1986, BIOMECHANICAL CARDIA, P59; CHRISTIANSEN J, 1990, BRIT J SURG, V77, P1039, DOI 10.1002/bjs.1800770928; CORMAN ML, 1979, DIS COLON RECTUM, V22, P290, DOI 10.1007/BF02609307; EDSTROM L, 1986, MUSCLE NERVE, V9, P104, DOI 10.1002/mus.880090203; EISENBERG BR, 1984, CELL TISSUE RES, V238, P221; HALLAN RI, 1990, BRIT J SURG, V77, P208, DOI 10.1002/bjs.1800770226; HAVENITH MG, 1990, HISTOCHEMISTRY, V93, P497, DOI 10.1007/BF00266407; LEIGH RJ, 1982, LANCET, V1, P1349; PETTE D, 1984, MED SCI SPORT EXER, V16, P517; PICKRELL KL, 1952, ANN SURG, V135, P853, DOI 10.1097/00000658-195206000-00010; SALMONS S, 1981, MUSCLE NERVE, V4, P94, DOI 10.1002/mus.880040204; WILLIAMS NS, 1989, BRIT J SURG, V76, P1191, DOI 10.1002/bjs.1800761124; WILLIAMS NS, 1990, ANN ROY COLL SURG, V72, P108	17	177	182	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1163	1165		10.1016/0140-6736(91)92030-6	http://dx.doi.org/10.1016/0140-6736(91)92030-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682590				2022-12-28	WOS:A1991GP03400002
J	EINSELE, H; EHNINGER, G; STEIDLE, M; VALLBRACHT, A; MULLER, M; SCHMIDT, H; SAAL, JG; WALLER, HD; MULLER, CA				EINSELE, H; EHNINGER, G; STEIDLE, M; VALLBRACHT, A; MULLER, M; SCHMIDT, H; SAAL, JG; WALLER, HD; MULLER, CA			POLYMERASE CHAIN-REACTION TO EVALUATE ANTIVIRAL THERAPY FOR CYTOMEGALOVIRUS DISEASE	LANCET			English	Article							VIRUS PNEUMONIA; IMMUNOCOMPROMISED PATIENTS; HYBRIDIZATION TECHNIQUES; MARROW TRANSPLANTATION; GANCICLOVIR TREATMENT; RECIPIENTS; INFECTION; GLOBULIN; INVITRO	A sensitive and specific method to monitor suppression of cytomegalovirus (CMV) replication is essential in patients treated with ganciclovir after allogeneic bone-marrow transplantation. In this study, antiviral therapy of eighteen episodes of symptomatic CMV infection in 15 such patients were followed up clinically and by virus culture and polymerase chain reaction (PCR). Clinical improvement, culture, and PCR were assessed for their ability to predict the efficacy of ganciclovir therapy in each patient. In eleven successfully treated episodes of CMV disease (disappearance of symptoms and improvement in biochemical variables) clinical improvement was associated with an effective suppression of virus replication as shown by negative culture and PCR assays of blood and urine specimens obtained after antiviral therapy. 1 patient who did not improve clinically when receiving antiviral therapy remained both culture positive and PCR positive for CMV. 6 patients with early relapse of CMV disease or who died after an initial clinical improvement were PCR positive but culture negative after termination of therapy. Demonstration of CMV in blood and urine by PCR after stopping antiviral therapy (even when culture is negative) points to incomplete suppression of virus replication. The findings show that PCR is a better predictor of the efficacy of antiviral therapy than are culture or clinical assessment.	UNIV TUBINGEN,DEPT INTERNAL MED,TRANSPLANTAT IMMUNOL & IMMUNOHAEMATOL SECT,W-7400 TUBINGEN 1,GERMANY; UNIV TUBINGEN,DEPT VIROL,W-7400 TUBINGEN 1,GERMANY	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen								BUHLES WC, 1988, REV INFECT DIS, V10, pS495; CHACHOUA A, 1987, ANN INTERN MED, V107, P133, DOI 10.7326/0003-4819-107-2-133; CHENG YC, 1983, P NATL ACAD SCI-BIOL, V80, P2767, DOI 10.1073/pnas.80.9.2767; EINSELE H, 1988, BONE MARROW TRANSPL, V3, P607; EINSELE H, 1991, BLOOD, V77, P1104; EINSELE H, 1989, J VIROL METHODS, V26, P91, DOI 10.1016/0166-0934(89)90077-3; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; ERICE A, 1987, JAMA-J AM MED ASSOC, V257, P3082, DOI 10.1001/jama.257.22.3082; ERICE A, 1989, NEW ENGL J MED, V320, P289, DOI 10.1056/NEJM198902023200505; FAULDS D, 1990, DRUGS, V39, P597, DOI 10.2165/00003495-199039040-00008; FLETCHER CV, 1989, DICP ANN PHARMAC, V23, P5, DOI 10.1177/106002808902300101; JIWA NM, 1989, TRANSPLANTATION, V48, P72, DOI 10.1097/00007890-198907000-00017; KEAY S, 1988, REV INFECT DIS, V10, pS563; MAI M, 1989, TRANSPLANT P, V21, P2263; MAR EC, 1983, ANTIMICROB AGENTS CH, V24, P518, DOI 10.1128/AAC.24.4.518; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; MIYADA CG, 1987, METHOD ENZYMOL, V154, P94; REED EC, 1988, ANN INTERN MED, V109, P783, DOI 10.7326/0003-4819-109-10-783; REED EC, 1990, ANN INTERN MED, V112, P505, DOI 10.7326/0003-4819-112-7-505; SHEPP DH, 1985, ANN INTERN MED, V103, P368, DOI 10.7326/0003-4819-103-3-368	20	141	142	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1170	1172		10.1016/0140-6736(91)92032-W	http://dx.doi.org/10.1016/0140-6736(91)92032-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682592				2022-12-28	WOS:A1991GP03400004
J	CHESHIRE, IM; BLIGHT, A; RATCLIFFE, WA; PROOPS, DW; HEATH, DA				CHESHIRE, IM; BLIGHT, A; RATCLIFFE, WA; PROOPS, DW; HEATH, DA			PRODUCTION OF PARATHYROID-HORMONE-RELATED PROTEIN BY CHOLESTEATOMA CELLS IN CULTURE	LANCET			English	Note								Specimens of cholesteatoma were removed at surgery from five patients who had evidence of bone resorption. Parathyroid-hormone-related protein (PTHrP) was detected, by radioimmunoassay, in conditioned media from keratinocyte cultures derived from all five samples. Concentrations of PTHrP in conditioned media from secondary cultures were higher for the cholesteatoma cells than for normal keratinocytes from controls matched for age and sex. Thus, production of PTHrP by cholesteatoma may be a contributory factor in the bone destruction commonly associated with this disorder.	QUEEN ELIZABETH HOSP,WOLFSON RES LABS,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND; QUEEN ELIZABETH HOSP,DEPT OTOLARYNGOL,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND; QUEEN ELIZABETH HOSP,DEPT MED,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND	University of Birmingham; University of Birmingham; University of Birmingham	CHESHIRE, IM (corresponding author), BIRMINGHAM ACCID HOSP,SKIN CULTURE LAB,BATH ROW,BIRMINGHAM B15 1NA,W MIDLANDS,ENGLAND.							ATILLASOY EJ, 1991, J INVEST DERMATOL, V96, P277, DOI 10.1111/1523-1747.ep12464480; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; CHAN SDH, 1990, MOL ENDOCRINOL, V4, P638, DOI 10.1210/mend-4-4-638; Chole R. A., 1989, CHOLESTEATOMA MASTOI, P185; DEWHIRST FE, 1987, J BONE MINER RES, V2, P127; HEATH DA, 1990, LANCET, V335, P66, DOI 10.1016/0140-6736(90)90537-F; MERENDINO JJ, 1986, SCIENCE, V231, P388, DOI 10.1126/science.2417317; OCONNOR NE, 1984, SOFT HARD TISSUE REP, V2, P283; PROOPS DW, 1989, CHOLESTEATOMA MASTOI, P185; RATCLIFFE WA, 1990, J ENDOCRINOL, V127, P167, DOI 10.1677/joe.0.1270167	10	17	17	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1041	1043		10.1016/0140-6736(91)91902-7	http://dx.doi.org/10.1016/0140-6736(91)91902-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681357				2022-12-28	WOS:A1991GM25300005
J	AHMAD, T; VICKERS, D; CAMPBELL, S; COULTHARD, MG; PEDLER, S				AHMAD, T; VICKERS, D; CAMPBELL, S; COULTHARD, MG; PEDLER, S			URINE COLLECTION FROM DISPOSABLE NAPPIES	LANCET			English	Article								Urine was collected for microscopy and culture by standard use of sterile adhesive bags and by extraction from wet disposable nappies from 45 patients aged 1 to 23 months. Urine can readily be obtained by compression of wet nappy fibres within a 20 ml syringe if highly absorbent brands that contain gel beads are avoided. Red and white cell numbers were reduced on light microscopy of specimens obtained from nappies, but bacterial counts were unchanged. On culture, 6 children were shown to have urinary tract infections by both methods; of the children who did not have a urine infection, the contamination rate was lower from nappy collections (10/39 vs 17/39 from urine bags). Biochemical analysis of urine collected from 11 older children showed very close correlation for sodium, potassium, urea, and creatinine concentrations and osmolality between freshly voided urine and samples obtained after they were soaked into disposable nappies for 3 h and reclaimed, although there was greater variation for measurements of calcium and phosphate. Extraction of urine from disposable nappies put on within 4 h and which are not soiled by faeces is an inexpensive, rapid, and simple method to collect urine from young children for culture, microscopy for bacteria, and biochemical analysis.	ROYAL VICTORIA INFIRM,DEPT CHILD HLTH,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND; ROYAL VICTORIA INFIRM,DEPT MICROBIOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND	Newcastle University - UK; Newcastle University - UK			Campbell, Steve/D-2829-2012					BICKERS D, IN PRESS LANCET; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; ROBERTS SB, 1985, ARCH DIS CHILD, V60, P1018	3	41	41	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					674	676		10.1016/0140-6736(91)91242-M	http://dx.doi.org/10.1016/0140-6736(91)91242-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679482				2022-12-28	WOS:A1991GF10500013
J	PHILLIPS, HS; HAINS, JM; LARAMEE, GR; ROSENTHAL, A; WINSLOW, JW				PHILLIPS, HS; HAINS, JM; LARAMEE, GR; ROSENTHAL, A; WINSLOW, JW			WIDESPREAD EXPRESSION OF BDNF BUT NOT NT3 BY TARGET AREAS OF BASAL FOREBRAIN CHOLINERGIC NEURONS	SCIENCE			English	Article											PHILLIPS, HS (corresponding author), GENENTECH INC,DEPT DEV BIOL,S SAN FRANCISCO,CA 94080, USA.							AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; CAIN G, 1986, RAT BRAIN STEREOTAXI; DAVIES AM, 1988, TRENDS NEUROSCI, V11, P243, DOI 10.1016/0166-2236(88)90099-9; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; HARDY JA, 1986, NEUROBIOL AGING, V7, P489, DOI 10.1016/0197-4580(86)90086-2; HEFTI F, 1989, NEUROBIOL AGING, V10, P515, DOI 10.1016/0197-4580(89)90118-8; HEFTI F, 1989, SCIENCE, V243, P11; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; KNUSEL B, UNPUB; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MARX J, 1990, SCIENCE, V247, P408, DOI 10.1126/science.2405484; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; REYES PF, 1987, ARCH NEUROL-CHICAGO, V44, P644, DOI 10.1001/archneur.1987.00520180062017; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; TALAMO BR, 1989, NATURE, V337, P736, DOI 10.1038/337736a0; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203	22	493	512	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 12	1990	250	4978					290	294		10.1126/science.1688328	http://dx.doi.org/10.1126/science.1688328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC457	1688328				2022-12-28	WOS:A1990EC45700039
J	GOLDBERG, MA; BRUGNARA, C; DOVER, GJ; SCHAPIRA, L; CHARACHE, S; BUNN, HF				GOLDBERG, MA; BRUGNARA, C; DOVER, GJ; SCHAPIRA, L; CHARACHE, S; BUNN, HF			TREATMENT OF SICKLE-CELL-ANEMIA WITH HYDROXYUREA AND ERYTHROPOIETIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									BRIGHAM & WOMENS HOSP, DEPT MED, DIV HEMATOL, THORN 919, 75 FRANCIS ST, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University			Brugnara, Carlo/A-8041-2010; Schapira, Lidia/AAA-1293-2020	Brugnara, Carlo/0000-0001-8192-8713; 	NCRR NIH HHS [5-M01-RR-02635-05] Funding Source: Medline; NHLBI NIH HHS [R01-HL-42949-01, HL-15157-18] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL015157] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAM DJ, 1983, P NATL ACAD SCI-BIOL, V80, P324, DOI 10.1073/pnas.80.2.324; al-Khatti A, 1988, Trans Assoc Am Physicians, V101, P54; ALKHATTI A, 1988, BLOOD, V72, P817; ALKHATTI A, 1987, NEW ENGL J MED, V317, P415, DOI 10.1056/NEJM198708133170704; ALTER BP, 1985, BLOOD, V66, P373; BALLAS SK, 1989, AM J HEMATOL, V32, P104, DOI 10.1002/ajh.2830320206; BENESCH RE, 1980, P NATL ACAD SCI-BIOL, V77, P5130, DOI 10.1073/pnas.77.9.5130; BENESCH RE, 1978, ANAL BIOCHEM, V89, P162, DOI 10.1016/0003-2697(78)90737-6; BOOKCHIN RM, 1975, NATURE, V256, P667, DOI 10.1038/256667a0; BRUGNARA C, 1985, J CLIN INVEST, V75, P1608, DOI 10.1172/JCI111867; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; Bunn HF, 1986, HEMOGLOBIN MOL GENET; CERAMI A, 1971, P NATL ACAD SCI USA, V68, P1180, DOI 10.1073/pnas.68.6.1180; CHARACHE S, 1987, BLOOD, V69, P109; CHARACHE S, 1983, P NATL ACAD SCI-BIOL, V80, P4842, DOI 10.1073/pnas.80.15.4842; CLARK MR, 1980, BLOOD, V55, P823; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; DOVER G, 1989, HEMOGLOBIN SWITCHI B, P295; DOVER GJ, 1986, BLOOD, V67, P735; DOVER GJ, 1978, NEW ENGL J MED, V299, P1428, DOI 10.1056/NEJM197812282992603; DOVER GJ, 1978, BLOOD, V52, P664; DOVER GJ, 1987, BLOOD, V69, P1109; DOVER GJ, 1985, BLOOD, V66, P527; DOVER GJ, 1987, BLOOD S, V70, pA134; EATON WA, 1987, BLOOD, V70, P1245; EDELSTEIN SJ, 1981, J MOL BIOL, V150, P557, DOI 10.1016/0022-2836(81)90381-8; EGRIE JC, 1987, J IMMUNOL METHODS, V99, P235, DOI 10.1016/0022-1759(87)90133-5; EMBURY SH, 1986, ANNU REV MED, V37, P361; ESCHBACH JW, 1989, NEW ENGL J MED, V321, P158, DOI 10.1056/NEJM198907203210305; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; FABRY ME, 1982, BLOOD CELLS, V8, P9; GILL SJ, 1978, SCIENCE, V201, P362, DOI 10.1126/science.663663; GOLDBERG MA, 1977, J BIOL CHEM, V252, P3414; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HEBBEL RP, 1984, BLOOD, V64, P733; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; LETVIN NL, 1984, NEW ENGL J MED, V310, P869, DOI 10.1056/NEJM198404053101401; LEY TJ, 1983, BLOOD, V62, P370; NAGEL RL, 1988, GENETICALLY ABNORMAL, V1, P71; PADLAN EA, 1985, J BIOL CHEM, V260, P8280; PAPAYANNOPOULOU T, 1984, SCIENCE, V224, P617, DOI 10.1126/science.6200940; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; RODGERS GP, 1985, J LAB CLIN MED, V106, P30; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; ROSA RM, 1980, NEW ENGL J MED, V303, P1138, DOI 10.1056/NEJM198011133032002; SEWCHAND LS, 1983, BLOOD CELLS, V9, P147; SHERWOOD JB, 1986, BLOOD, V67, P46; SUMOZA A, 1986, BLOOD, V68, pA67; VEITH R, 1985, NEW ENGL J MED, V313, P1571, DOI 10.1056/NEJM198512193132503; WALDER JA, 1979, BIOCHEMISTRY-US, V18, P4265, DOI 10.1021/bi00587a001; WILSON JB, 1983, J LAB CLIN MED, V102, P174; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; WINSLOW RM, 1978, BIOCH CLIN ASPECTS H, P369	54	175	191	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 9	1990	323	6					366	372		10.1056/NEJM199008093230602	http://dx.doi.org/10.1056/NEJM199008093230602			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT008	1695325	Bronze			2022-12-28	WOS:A1990DT00800002
J	BORN, W; HALL, L; DALLAS, A; BOYMEL, J; SHINNICK, T; YOUNG, D; BRENNAN, P; OBRIEN, R				BORN, W; HALL, L; DALLAS, A; BOYMEL, J; SHINNICK, T; YOUNG, D; BRENNAN, P; OBRIEN, R			RECOGNITION OF A PEPTIDE ANTIGEN BY HEAT-SHOCK REACTIVE GAMMA-DELTA-LYMPHOCYTES-T	SCIENCE			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED,DEPT MED,DENVER,CO 80206; COLORADO STATE UNIV,DEPT MICROBIOL,FT COLLINS,CO 80523; CTR DIS CONTROL,DIV BACTERIAL DIS,ATLANTA,GA 30333; HAMMERSMITH HOSP,MRC,TB & RELATED INFECT UNIT,LONDON W12 0HS,ENGLAND	National Jewish Health; Colorado State University; Centers for Disease Control & Prevention - USA; Imperial College London	BORN, W (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,DENVER,CO 80206, USA.							ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1989, CELL, V56, P27; BORN W, 1987, NATURE, V330, P572, DOI 10.1038/330572a0; BORN W, UNPUB; BORN W, 1989, IMMUNOL TODAY, V10, P40; BUUS S, 1986, P NATL ACAD SCI USA, V83, P3968, DOI 10.1073/pnas.83.11.3968; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; FISCH P, 1990, J EXP MED, V171, P1567, DOI 10.1084/jem.171.5.1567; Hall L.S., 2021, UNPUB; HAPP MP, 1989, NATURE, V342, P696, DOI 10.1038/342696a0; HAREGEWOIN A, 1989, NATURE, V340, P309, DOI 10.1038/340309a0; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; JANIS EM, 1989, SCIENCE, V244, P713, DOI 10.1126/science.2524098; KYES S, COMMUNICATION; Lamb J R, 1989, Int Immunol, V1, P191, DOI 10.1093/intimm/1.2.191; LAMB JR, 1987, EMBO J, V6, P1245, DOI 10.1002/j.1460-2075.1987.tb02360.x; MATIS LA, 1987, NATURE, V330, P262, DOI 10.1038/330262a0; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGAI S, 1980, AM REV RESPIR DIS, V121, P551, DOI 10.1164/arrd.1980.121.3.551; OBRIEN R, UNPUB; OBRIEN RL, 1989, CELL, V57, P667, DOI 10.1016/0092-8674(89)90135-9; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; PICKETTS DJ, 1989, J BIOL CHEM, V264, P12001; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; RAMANUJAM R, 1990, P NATL ACAD SCI USA, V87, P1767; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; SHINNICK TM, 1987, J BACTERIOL, V169, P1080, DOI 10.1128/jb.169.3.1080-1088.1987; SHINNICK TM, 1987, INFECT IMMUN, V55, P1932, DOI 10.1128/IAI.55.8.1932-1935.1987; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; VIDOVIC D, 1989, NATURE, V340, P646, DOI 10.1038/340646a0; WATSON JD, 1989, IMMUNOL TODAY, V10, P218, DOI 10.1016/0167-5699(89)90253-3	36	308	309	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 6	1990	249	4964					67	69		10.1126/science.1695022	http://dx.doi.org/10.1126/science.1695022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM384	1695022				2022-12-28	WOS:A1990DM38400041
J	PULLEN, AM; WADE, T; MARRACK, P; KAPPLER, JW				PULLEN, AM; WADE, T; MARRACK, P; KAPPLER, JW			IDENTIFICATION OF THE REGION OF T-CELL RECEPTOR BETA-CHAIN THAT INTERACTS WITH THE SELF-SUPERANTIGEN MLS-1A	CELL			English	Article									UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	PULLEN, AM (corresponding author), NATL JEWISH CTR,HOWARD HUGHES MED INST,DEPT MED,DIV BASIC IMMUNOL,DENVER,CO 80206, USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R01AI018785, R56AI017134, R37AI018785, R01AI022259, R37AI017134] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22259, AI-18785, AI-17134] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALZARI PM, 1988, ANNU REV IMMUNOL, V6, P555; BECKER DM, 1985, NATURE, V317, P430, DOI 10.1038/317430a0; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BORN W, 1988, IMMUNOL RES, V7, P279, DOI 10.1007/BF02935533; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BURGERT HG, 1989, J EXP MED, V170, P1887, DOI 10.1084/jem.170.6.1887; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CHOU HS, 1987, P NATL ACAD SCI USA, V84, P1992, DOI 10.1073/pnas.84.7.1992; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; FESTENSTEIN H, 1974, TRANSPLANTATION, V18, P555, DOI 10.1097/00007890-197412000-00016; FESTENSTEIN H, 1973, TRANSPLANT REV-DENMA, V15, P62; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; HAPP MP, 1989, P NATL ACAD SCI USA, V86, P6293, DOI 10.1073/pnas.86.16.6293; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HASKINS K, 1983, J EXP MED, V157, P1149, DOI 10.1084/jem.157.4.1149; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; KABAT EA, 1987, INTRO SEQUENCES PROT; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; LANGFORD MP, 1978, INFECT IMMUN, V22, P62, DOI 10.1128/IAI.22.1.62-68.1978; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NICOLAS JF, 1987, EUR J IMMUNOL, V17, P1561, DOI 10.1002/eji.1830171106; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P742, DOI 10.1073/pnas.83.3.742; PATTEN P, 1984, NATURE, V312, P40, DOI 10.1038/312040a0; PEAVY DL, 1970, J IMMUNOL, V105, P1453; PECK AB, 1977, NATURE, V266, P840, DOI 10.1038/266840a0; PULLEN AM, 1990, J EXP MED, V171, P49, DOI 10.1084/jem.171.1.49; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; ROJO JM, 1988, J IMMUNOL, V140, P1081; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SCHIFFER M, 1986, P NATL ACAD SCI USA, V83, P4461, DOI 10.1073/pnas.83.12.4461; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; STAERZ UD, 1985, J IMMUNOL, V134, P3994; TAYLOR BA, 1987, ORIGIN INBRED MICE, P423; TOMONARI K, 1988, IMMUNOGENETICS, V28, P445, DOI 10.1007/BF00355377; WEICKERT MJ, 1989, EDITORIAL COMMENTS, P5; WHITE J, 1983, J IMMUNOL, V130, P1033; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WINOTO A, 1986, NATURE, V324, P679, DOI 10.1038/324679a0; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; YAGUE J, 1985, CELL, V42, P81, DOI 10.1016/S0092-8674(85)80103-3	56	272	280	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 29	1990	61	7					1365	1374		10.1016/0092-8674(90)90700-O	http://dx.doi.org/10.1016/0092-8674(90)90700-O			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM156	1694725				2022-12-28	WOS:A1990DM15600024
J	HIRSCH, RC; LAVINE, JE; CHANG, LJ; VARMUS, HE; GANEM, D				HIRSCH, RC; LAVINE, JE; CHANG, LJ; VARMUS, HE; GANEM, D			POLYMERASE GENE-PRODUCTS OF HEPATITIS-B VIRUSES ARE REQUIRED FOR GENOMIC RNA PACKAGING AS WELL AS FOR REVERSE TRANSCRIPTION	NATURE			English	Article									UNIV CALIF SAN FRANCISCO,MED CTR,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,MED CTR,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,MED CTR,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,MED CTR,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco								ADAM MA, 1988, J VIROL, V62, P3802, DOI 10.1128/JVI.62.10.3802-3806.1988; BARTENSCHLAGER R, 1988, EMBO J, V7, P4185, DOI 10.1002/j.1460-2075.1988.tb03315.x; BERG DE, 1989, MOBILE DNA, P185; BUSCHER M, 1985, CELL, V40, P717, DOI 10.1016/0092-8674(85)90220-X; CHANG LJ, 1989, NATURE, V337, P364, DOI 10.1038/337364a0; DICKSON C, 1982, RNA TUMOR VIRUSES, pCH6; EISENMAN RN, 1978, BIOCHIM BIOPHYS ACTA, V473, P187, DOI 10.1016/0304-419X(78)90014-8; ENDERS GH, 1987, J VIROL, V61, P35, DOI 10.1128/JVI.61.1.35-41.1987; FUETTERER J, 1987, TRENDS BIOCHEM SCI, V12, P92, DOI 10.1016/0968-0004(87)90044-2; GORELICK RJ, 1988, P NATL ACAD SCI USA, V85, P8420, DOI 10.1073/pnas.85.22.8420; HIRSCH R, 1988, VIROLOGY, V167, P136, DOI 10.1016/0042-6822(88)90062-1; LAVINE J, 1989, J VIROL, V63, P4257, DOI 10.1128/JVI.63.10.4257-4263.1989; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MERIC C, 1986, J VIROL, V60, P450; MOLNARKIMBER KL, 1983, J VIROL, V45, P165, DOI 10.1128/JVI.45.1.165-172.1983; MORISATO D, 1983, CELL, V32, P799, DOI 10.1016/0092-8674(83)90066-1; PRATS AC, 1988, EMBO J, V7, P1777, DOI 10.1002/j.1460-2075.1988.tb03008.x; SCHLICHT HJ, 1989, CELL, V56, P85, DOI 10.1016/0092-8674(89)90986-0; SHIELDS A, 1978, CELL, V14, P601, DOI 10.1016/0092-8674(78)90245-3; SPRENGEL R, 1985, J MED VIROL, V15, P323, DOI 10.1002/jmv.1890150402	20	275	285	1	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 5	1990	344	6266					552	555		10.1038/344552a0	http://dx.doi.org/10.1038/344552a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX595	1690862				2022-12-28	WOS:A1990CX59500070
J	BREEUWER, M; GOLDFARB, DS				BREEUWER, M; GOLDFARB, DS			FACILITATED NUCLEAR TRANSPORT OF HISTONE H1 AND OTHER SMALL NUCLEOPHILIC PROTEINS	CELL			English	Article											BREEUWER, M (corresponding author), UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14627, USA.							ADAM SA, 1989, NATURE, V337, P276, DOI 10.1038/337276a0; AKEY CW, 1989, J CELL BIOL, V109, P971, DOI 10.1083/jcb.109.3.971; AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955; BEAUERLE PA, 1988, SCIENCE, V242, P540; BONNER WM, 1975, J CELL BIOL, V64, P431, DOI 10.1083/jcb.64.2.431; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; COTTEN M, 1987, EMBO J, V6, P3945, DOI 10.1002/j.1460-2075.1987.tb02736.x; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; DINGWALL C, 1984, EMBO J, V3, P1933, DOI 10.1002/j.1460-2075.1984.tb02072.x; DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279; EBERHARDT NL, 1979, P NATL ACAD SCI USA, V76, P5005, DOI 10.1073/pnas.76.10.5005; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GOLDFARB DS, 1988, CELL BIOL INT REP, V12, P809, DOI 10.1016/0309-1651(88)90090-2; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; IMAMOTOSONOBE N, 1988, P NATL ACAD SCI USA, V85, P3426, DOI 10.1073/pnas.85.10.3426; Johns E W, 1977, Methods Cell Biol, V16, P183; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KUEHL L, 1985, J BIOL CHEM, V260, P361; LANDFORD RE, 1984, CELL, V37, P801; LANFORD RE, 1988, MOL CELL BIOL, V8, P2722, DOI 10.1128/MCB.8.7.2722; MATTAJ IW, 1985, CELL, V40, P111, DOI 10.1016/0092-8674(85)90314-9; MORELAND RB, 1987, MOL CELL BIOL, V7, P4048, DOI 10.1128/MCB.7.11.4048; NELSON M, 1989, MOL CELL BIOL, V9, P384, DOI 10.1128/MCB.9.2.384; NESTOR JJ, 1988, J MED CHEM, V31, P65, DOI 10.1021/jm00396a011; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; NEWPORT JW, 1987, ANNU REV BIOCHEM, V56, P535; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; ROARK DE, 1976, BIOCHEMISTRY-US, V15, P3019, DOI 10.1021/bi00659a013; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; SILVER P, 1989, J CELL BIOL, V109, P983, DOI 10.1083/jcb.109.3.983; SUGAWA H, 1985, EXP CELL RES, V159, P419, DOI 10.1016/S0014-4827(85)80015-X; TSUNEOKA M, 1986, J BIOL CHEM, V261, P1829; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63; van Holde KE., 1989, SPRINGER SERIES MOL; WHITE EM, 1989, J CELL BIOL, V109, P1983, DOI 10.1083/jcb.109.5.1983; WU LH, 1986, J CELL BIOL, V103, P465, DOI 10.1083/jcb.103.2.465; YAMASAKI L, 1989, J MOL CELL BIOL, V9, P3028; YONEDA Y, 1988, SCIENCE, V242, P275, DOI 10.1126/science.3051382; ZHAO LJ, 1988, CELL, V55, P1005, DOI 10.1016/0092-8674(88)90245-0	47	258	263	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAR 23	1990	60	6					999	1008		10.1016/0092-8674(90)90348-I	http://dx.doi.org/10.1016/0092-8674(90)90348-I			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CW002	1690602	hybrid			2022-12-28	WOS:A1990CW00200014
J	BOLDOGH, I; ABUBAKAR, S; ALBRECHT, T				BOLDOGH, I; ABUBAKAR, S; ALBRECHT, T			ACTIVATION OF PROTO-ONCOGENES - AN IMMEDIATE EARLY EVENT IN HUMAN CYTOMEGALOVIRUS-INFECTION	SCIENCE			English	Article									UNIV TEXAS,MED BRANCH,DEPT MICROBIOL,GALVESTON,TX 77550	University of Texas System; University of Texas Medical Branch Galveston			abubakar, sazaly/B-3957-2010	abubakar, sazaly/0000-0002-9267-1420				ALBRECHT T, 1976, J GEN VIROL, V30, P167, DOI 10.1099/0022-1317-30-2-167; ALBRECHT T, 1973, VIROLOGY, V55, P53, DOI 10.1016/S0042-6822(73)81007-4; ALBRECHT T, 1989, SUBCELLULAR BIOCH, V15, P153; ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; BOLDOGH I, 1978, ARCH VIROL, V58, P289, DOI 10.1007/BF01317821; BOLDOGH I, UNPUB; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DEMARCHI JM, 1977, VIROLOGY, V82, P93, DOI 10.1016/0042-6822(77)90035-6; EPSTEIN RL, 1984, VIROLOGY, V133, P46, DOI 10.1016/0042-6822(84)90424-0; GEDER L, 1976, SCIENCE, V192, P1134, DOI 10.1126/science.179143; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HUANG ES, 1973, J VIROL, V12, P1473, DOI 10.1128/JVI.12.6.1473-1481.1973; HUNNINGHAKE GW, 1989, J VIROL, V63, P3026, DOI 10.1128/JVI.63.7.3026-3033.1989; KARN J, 1989, ONCOGENE, V4, P773; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; MACNAB JCM, 1987, J GEN VIROL, V68, P2525, DOI 10.1099/0022-1317-68-10-2525; Maniatis T., 1982, MOL CLONING; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MORIKE M, 1988, ONCOGENE, V3, P151; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; OWEN TA, 1987, J BIOL CHEM, V262, P15111; PETRIE BL, 1988, PROG MED VIROL, V35, P21; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; REDFIELD DC, 1981, INFECT IMMUN, V32, P1216, DOI 10.1128/IAI.32.3.1216-1226.1981; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; ROESTER WJ, 1988, J BIOL CHEM, V163, P9063; ROSENBERG BH, 1981, J VIROL METHODS, V3, P167, DOI 10.1016/0166-0934(81)90051-3; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SCHEINFEST CW, 1988, MOL CELL BIOL, V8, P3080; Stagno S, 1984, Birth Defects Orig Artic Ser, V20, P65; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; STJEOR SC, 1974, J VIROL, V13, P353, DOI 10.1128/JVI.13.2.353-362.1974; TAYLOR HP, 1989, J VIROL, V63, P3991, DOI 10.1128/JVI.63.9.3991-3998.1989; VALYINAGY T, 1988, ARCH VIROL, V101, P199, DOI 10.1007/BF01311001; VRATI S, 1987, MOL BIOL REP, V1, P1; WATT RA, 1985, MOL CELL BIOL, V5, P448, DOI 10.1128/MCB.5.3.448; WUNNER WH, 1984, J VIROL, V50, P691, DOI 10.1128/JVI.50.3.691-697.1984	50	153	155	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 2	1990	247	4942					561	564		10.1126/science.1689075	http://dx.doi.org/10.1126/science.1689075			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM419	1689075				2022-12-28	WOS:A1990CM41900029
J	BLUM, B; BAKALARA, N; SIMPSON, L				BLUM, B; BAKALARA, N; SIMPSON, L			A MODEL FOR RNA EDITING IN KINETOPLASTID MITOCHONDRIA - GUIDE RNA MOLECULES TRANSCRIBED FROM MAXICIRCLE DNA PROVIDE THE EDITED INFORMATION	CELL			English	Article									UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	BLUM, B (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009102, R01AI009102] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; BAKALARA N, 1989, J BIOL CHEM, V264, P18679; BELLOFATTO V, 1989, SCIENCE, V244, P1167, DOI 10.1126/science.2499047; BENNE R, 1989, BIOCHIM BIOPHYS ACTA, V1007, P131, DOI 10.1016/0167-4781(89)90031-6; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GLOTZ C, 1981, NUCLEIC ACIDS RES, V9, P3287, DOI 10.1093/nar/9.14.3287; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; Maniatis T., 1982, MOL CLONING; MASUDA H, 1979, GENE, V6, P51, DOI 10.1016/0378-1119(79)90085-4; MILLER KG, 1981, CELL, V27, P165, DOI 10.1016/0092-8674(81)90370-6; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6865, DOI 10.1093/nar/17.17.6865; NICHOLS M, 1988, P NATL ACAD SCI USA, V85, P1379, DOI 10.1073/pnas.85.5.1379; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; REED R, 1988, CELL, V53, P949, DOI 10.1016/S0092-8674(88)90489-8; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; SIMPSON AM, 1985, NUCLEIC ACIDS RES, V13, P5977, DOI 10.1093/nar/13.16.5977; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; SIMPSON L, 1970, J PROTOZOOL, V17, P511, DOI 10.1111/j.1550-7408.1970.tb04719.x; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SIMPSON L, 1978, CELL, V14, P169, DOI 10.1016/0092-8674(78)90311-2; SIMPSON L, 1979, P NATL ACAD SCI USA, V76, P1585, DOI 10.1073/pnas.76.4.1585; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	30	483	494	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 26	1990	60	2					189	198		10.1016/0092-8674(90)90735-W	http://dx.doi.org/10.1016/0092-8674(90)90735-W			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL816	1688737				2022-12-28	WOS:A1990CL81600004
J	CANTEKIN, EI; MCGUIRE, TW; GRIFFITH, TL				CANTEKIN, EI; MCGUIRE, TW; GRIFFITH, TL			ANTIMICROBIAL THERAPY FOR OTITIS-MEDIA WITH EFFUSION (SECRETORY OTITIS-MEDIA)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; DECONGESTANT-ANTIHISTAMINE; ANTIBIOTIC-TREATMENT; RANDOMIZED TRIAL; CHILDREN; EFFICACY; IDENTIFICATION; TYMPANOMETRY; MICROBIOLOGY; AMOXICILLIN	Objective. - To determine the effectiveness of antimicrobial treatment for otitis media with effusion ("secretory" otitis media) in children. Data Source. - We report the reexamination of a previously published study by Mandel et al that evaluated the efficacy of a 2-week course of antimicrobials (amoxicillin trihydrate) with and without a 4-week course of an oral decongestant-antihistamine combination in a double-blind, placebo-controlled, randomized trial involving 518 infants and children with otitis media with effusion. Data Synthesis. - At 4 weeks, amoxicillin efficacy as determined by a tympanometric criterion (P = .121) or by a measure of improvement in hearing (P = .311) was insignificant. Only by otoscopic judgment, which is shown to contain a systematic bias as used in this clinical trial, could an argument be made for a marginal efficacy of amoxicillin at the 4-week end point. Logistic regression analyses of the combined effects of treatment and prognostic factors showed no significant differences between placebo- and antibiotic-treated groups for unilateral effusions and for bilateral effusions. When subjects with unilateral and bilateral effusions were combined, the estimated efficacy of antibiotic treatment was 12.3% by otoscopy (P = .014) and 4.8% by tympanometry (P = .171). We also demonstrate the sensitivity of outcome to diagnostic measures used and provide statistical evidence questioning the validity of otoscopic observations in this study. Six weeks after the termination of amoxicillin therapy, the recurrence of effusion was two to six times higher in the amoxicillin-treated children than in those treated with placebo (P = .001), and resolution of effusion was not significantly different among antibiotic and placebo groups (13.6% and 11.3%, respectively; P = .477). Conclusions. - Amoxicillin with and without decongestant-antihistamine combination is not effective for the treatment of persistent asymptomatic middle-ear effusions in infants and children.	UNIV PITTSBURGH,SCH MED,DEPT OTOLARYNGOL,PITTSBURGH,PA 15261; CARNEGIE MELLON UNIV,GRAD SCH IND ADM,PITTSBURGH,PA 15213; UNIV ARIZONA,COLL BUSINESS & PUBL ADM,TUCSON,AZ 85721	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; University of Arizona	CANTEKIN, EI (corresponding author), CHILDRENS HOSP PITTSBURGH,DEPT PEDIAT OTOLARYNGOL,125 DESOTO ST,PITTSBURGH,PA 15213, USA.		Griffith, Terri L/A-8471-2015	Griffith, Terri L/0000-0003-4400-3839	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016337] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-16337] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bluestone C.D., 1983, PEDIATRIC OTOLARYNGO, P356; BLUESTONE CD, 1979, ANN OTO RHINOL LARYN, V88, P13, DOI 10.1177/00034894790880S503; BLUESTONE CD, 1982, NEW ENGL J MED, V306, P1339; BROSTOFF LM, 1988, 4TH P INT S REC ADV, P47; BROWNING GG, 1990, BRIT MED J, V300, P1005, DOI 10.1136/bmj.300.6730.1005; Cantekin E I, 1990, Arch Otolaryngol Head Neck Surg, V116, P626; CANTEKIN EI, 1990, JAMA-J AM MED ASSOC, V263, P1427, DOI 10.1001/jama.263.10.1427; CANTEKIN EI, 1980, ANN OTO RHINOL LARYN, V89, P190, DOI 10.1177/00034894800890S344; CANTEKIN EI, 1983, NEW ENGL J MED, V308, P297, DOI 10.1056/NEJM198302103080601; CANTEKIN EI, 1983, ANN OTOL RHINOL S107, V92, P6; CHAN KH, 1988, ARCH OTOLARYNGOL, V114, P142; CORWIN MJ, 1986, INT J PEDIATR OTORHI, V11, P109, DOI 10.1016/S0165-5876(86)80005-2; ERNSTSON S, 1984, J LARYNGOL OTOL, V98, P767, DOI 10.1017/S0022215100147425; ERNSTSON S, 1985, ACTA OTOLARYNGOL S S, V424, P17; FRIA TJ, 1985, ARCH OTOLARYNGOL, V111, P10; FROOM J, 1990, BRIT MED J, V300, P582, DOI 10.1136/bmj.300.6724.582; GATES GA, 1986, OTOLARYNG HEAD NECK, V94, P350, DOI 10.1177/019459988609400316; GATES GA, 1986, ANN OTO RHINOL LARYN, V95, P46, DOI 10.1177/000348948609500110; HEALY GB, 1984, INT J PEDIATR OTORHI, V8, P13, DOI 10.1016/S0165-5876(84)80021-X; HEALY GB, 1977, LARYNGOSCOPE, V87, P1472, DOI 10.1288/00005537-197709000-00007; HOWIE VM, 1985, PEDIATRICS, V75, P8; LIU Y, 1976, ANN OTOL RHINOL LA S, V25, P245; MANDEL EM, 1987, NEW ENGL J MED, V316, P432, DOI 10.1056/NEJM198702193160803; MARKS NJ, 1981, J LARYNGOL OTOL, V95, P1003, DOI 10.1017/S0022215100091751; MAW AR, 1986, LANCET, V1, P1399; MYGIND N, 1981, CLIN OTOLARYNGOL, V6, P5, DOI 10.1111/j.1365-2273.1981.tb01781.x; OSTFELD E, 1988, 4TH P INT S REC ADV, P235; OTTEN FW, 1990, LARYNGOSCOPE, V110, P627; PARADISE JL, 1986, PEDIATRICS, V77, P88; RIDING KH, 1978, J PEDIATR-US, V93, P739, DOI 10.1016/S0022-3476(78)81069-5; ROHN DD, 1982, ANN OTOL RHINOL LA S, V92, P17; SUNDBERG L, 1984, ACTA OTOLARYNGOL S, V407, P26; Thalin A, 1986, P INT C AC SECR OT 1, P441; THOMSEN J, 1989, ARCH OTOLARYNGOL, V115, P447; VANBUCHEM FL, 1985, BRIT MED J, V290, P1033, DOI 10.1136/bmj.290.6474.1033; VANBUCHEM FL, 1981, LANCET, V2, P883; WHEELER MTK, 1986, LANCET, V1, P529; WRIGHT PF, 1985, INT J PEDIATR OTORHI, V10, P245, DOI 10.1016/S0165-5876(85)80071-9; 1988, FEDERAL RESPONSE MIS, P248; 1989, IS SCI SALE CONFLICT, P214	40	47	48	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3309	3317						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1683673				2022-12-28	WOS:A1991GU96400030
J	HARRIS, PC; THOMAS, S; RATCLIFFE, PJ; BREUNING, MH; COTO, E; LOPEZLARREA, C				HARRIS, PC; THOMAS, S; RATCLIFFE, PJ; BREUNING, MH; COTO, E; LOPEZLARREA, C			RAPID GENETIC-ANALYSIS OF FAMILIES WITH POLYCYSTIC KIDNEY DISEASE-1 BY MEANS OF A MICROSATELLITE MARKER	LANCET			English	Article							CHROMOSOME-16; MAP; POLYMORPHISMS; DIAGNOSIS; LOCUS; PKD1	Presymptomatic diagnosis of polycystic kidney disease 1 (PKD1) is possible by genetic linkage analysis with markers from both sides of the disease locus. The existing proximal markers are not informative in many families, so such analysis is difficult and time-consuming. We sought more useful length polymorphisms on the proximal side of the locus among simple sequence repeats (microsatellites). We identified two microsatellite polymorphisms that lie closer to the PKD1 locus than any previously described highly variable marker. One, SM7, is especially informative; we have found fourteen alleles and the observed heterozygosity in caucasians is 62.7%. Genetic linkage analysis in PKD1 families suggests that both of the markers lie proximal to the disease gene, closer than existing flanking markers. These polymorphisms can be simply assayed by polymerase chain reaction amplification of the variable regions, which generates DNA fragments that can be separated on non-denaturing acrylamide gels and directly examined after gel staining. This rapid, inexpensive, and non-radioactive method of linkage analysis allows the complete study of DNA samples within 8 h.	HOSP COVADONGA,SERV IMMUNOL,OVIEDO,SPAIN; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC	HARRIS, PC (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND.		Breuning, Martijn H/E-3429-2010	Ratcliffe, Peter/0000-0002-2853-806X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEAR JC, 1984, AM J MED GENET, V18, P45, DOI 10.1002/ajmg.1320180108; BREUNING MH, 1990, J MED GENET, V27, P614, DOI 10.1136/jmg.27.10.614; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; GERMINO GG, 1990, AM J HUM GENET, V46, P925; GILLESPIE GA, 1990, NUCLEIC ACIDS RES, V18, P7071, DOI 10.1093/nar/18.23.7071; GILLESPIE GAJ, 1991, P NATL ACAD SCI USA, V88, P4289, DOI 10.1073/pnas.88.10.4289; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HIMMELBAUER H, 1991, AM J HUM GENET, V48, P325; LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S; LITT M, 1989, AM J HUM GENET, V44, P397; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; PARFREY PS, 1990, NEW ENGL J MED, V323, P1085, DOI 10.1056/NEJM199010183231601; RAVINE D, 1991, LANCET, V337, P127, DOI 10.1016/0140-6736(91)90797-S; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388	16	74	79	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1484	1487		10.1016/0140-6736(91)92300-Q	http://dx.doi.org/10.1016/0140-6736(91)92300-Q			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683919				2022-12-28	WOS:A1991GV07700004
J	FLOYD, RA				FLOYD, RA			OXIDATIVE DAMAGE TO BEHAVIOR DURING AGING	SCIENCE			English	Editorial Material							GLUTAMINE-SYNTHETASE; FREE-RADICALS; ISCHEMIA; BRAIN				FLOYD, RA (corresponding author), OKLAHOMA MED RES FDN,MOLEC TOXICOL RES PROGRAM,OKLAHOMA CITY,OK 73104, USA.				NIA NIH HHS [AG09690] Funding Source: Medline; NINDS NIH HHS [NS23307] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009690] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; CARNEY JM, NIH AG09690 GRANTS; CARNEY JM, 1985, J BIOL CHEM, V260, P12600; FLOYD RA, 1990, FASEB J, V4, P2587, DOI 10.1096/fasebj.4.9.2189775; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; JANZEN EG, 1971, ACCOUNTS CHEM RES, V4, P31, DOI 10.1021/ar50037a005; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; OLIVER CN, 1987, J AM GERIATR SOC, V35, P947, DOI 10.1111/j.1532-5415.1987.tb02297.x; RIVETT AJ, 1985, J BIOL CHEM, V260, P300	11	98	103	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 13	1991	254	5038					1597	1597		10.1126/science.1684251	http://dx.doi.org/10.1126/science.1684251			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV073	1684251				2022-12-28	WOS:A1991GV07300032
J	SECKL, MJ; RUSTIN, GJS; NEWLANDS, ES; GWYTHER, SJ; BOMANJI, J				SECKL, MJ; RUSTIN, GJS; NEWLANDS, ES; GWYTHER, SJ; BOMANJI, J			PULMONARY-EMBOLISM, PULMONARY-HYPERTENSION, AND CHORIOCARCINOMA	LANCET			English	Article								A rare cause of pulmonary embolism and pulmonary artery hypertension in young women is choriocarcinoma growing in the pulmonary artery. This growth is reversible, and the disorder can be cured. We describe three patients with this feature who have been treated with appropriate high-risk chemotherapy and who are now in remission. Contrast-enhanced computed tomography can be used to identify major emboli, and progress of the disease can be monitored by serial ventilation/perfusion scans and measurement of serum human chorionic gonadotropin. Recognition of this rare syndrome is important because of the generally excellent outlook with appropriate treatment.	CHARING CROSS HOSP,DEPT MED ONCOL,FULHAM PALACE RD,LONDON W6 8RP,ENGLAND; CHARING CROSS HOSP,DEPT RADIOL,LONDON W6 8RP,ENGLAND; CHARING CROSS HOSP,DEPT NUCL MED,LONDON W6 8RP,ENGLAND	Imperial College London; Imperial College London; Imperial College London			Rustin, Gordon J. S./J-9763-2019					BAGSHAWE KD, 1959, LANCET, V1, P653; BAGSHAWE KD, 1989, BRIT J OBSTET GYNAEC, V96, P775; KELLY MP, 1990, GYNECOL ONCOL, V38, P149, DOI 10.1016/0090-8258(90)90031-F; NEWLANDS ES, 1991, BRIT J OBSTET GYNAEC, V98, P550, DOI 10.1111/j.1471-0528.1991.tb10369.x; SMITH DB, 1988, BRIT MED J, V297, P1119, DOI 10.1136/bmj.297.6656.1119	5	24	26	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1313	1315		10.1016/0140-6736(91)92603-Y	http://dx.doi.org/10.1016/0140-6736(91)92603-Y			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682695				2022-12-28	WOS:A1991GR02300014
J	HARARI, M; SHANN, F; SPOONER, V; MEISNER, S; CARNEY, M; DECAMPO, J				HARARI, M; SHANN, F; SPOONER, V; MEISNER, S; CARNEY, M; DECAMPO, J			CLINICAL SIGNS OF PNEUMONIA IN CHILDREN	LANCET			English	Article							RESPIRATORY-TRACT INFECTIONS; DIAGNOSIS; CRITERIA	Clinical and chest radiographic findings were recorded prospectively in 185 children with cough who attended an outpatient clinic in Papua New Guinea. Children were studied if they were between 8 weeks and 6 years of age; patients with wheeze, stridor, measles, or pertussis were excluded. 56 children (30%) had radiological evidence of pneumonia. The presence of either a respiratory rate greater-than-or-equal-to 50/min or chest indrawing, or of both signs, was a good indication of pneumonia, with a predictive power of 46% for a positive test and 83% for a negative test. A more complex definition of tachypnoea, as a respiratory rate greater-than-or-equal-to 40/min in children over 12 months old and greater-than-or-equal-to 50/min in infants, showed little additional diagnostic benefit.	ROYAL CHILDRENS HOSP, INTENS CARE UNIT, FLEMINGTON RD, PARKVILLE, VIC 3052, AUSTRALIA; GOROKA BASE HOSP, GOROKA, PAPUA N GUINEA	Royal Children's Hospital Melbourne			Campbell, Harry/E-2959-2010; Shann, Frank/C-9510-2011	Campbell, Harry/0000-0002-6169-6262; 				CAMPBELL H, 1989, LANCET, V1, P297, DOI 10.1016/S0140-6736(89)91308-1; CAMPBELL H, 1988, LANCET, V2, P742; CHERIAN T, 1988, LANCET, V2, P125; GRISKA L, 1984, PNEUMONIAS CLIN APPR, P23; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Leowski J, 1986, World Health Stat Q, V39, P138; LEVENTHAL JM, 1982, CLIN PEDIATR, V21, P730, DOI 10.1177/000992288202101205; MANSKI CF, 1977, ECONOMETRICA, V45, P1977, DOI 10.2307/1914121; SHANN F, 1989, PEDIATR INFECT DIS J, V8, P852, DOI 10.1097/00006454-198912000-00005; SHANN F, 1984, B WORLD HEALTH ORGAN, V62, P749; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; ZUKIN DD, 1986, ANN EMERG MED, V15, P792	12	78	82	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	1991	338	8772					928	930		10.1016/0140-6736(91)91785-S	http://dx.doi.org/10.1016/0140-6736(91)91785-S			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681277				2022-12-28	WOS:A1991GJ89900015
J	ANDERSSON, M; STORM, HH; MOURIDSEN, HT				ANDERSSON, M; STORM, HH; MOURIDSEN, HT			ADJUVANT CHEMOTHERAPY AND SUBSEQUENT MALIGNANT DISEASE	LANCET			English	Letter									DANISH BREAST CANC COOPERAT GRP,COPENHAGEN,DENMARK	Danish Breast Cancer Cooperative Group (DBCG)	ANDERSSON, M (corresponding author), DANISH CANC REGISTRY,INST CANC EPIDEMIOL,DK-2100 COPENHAGEN,DENMARK.			Storm, Hans/0000-0001-7223-8198				ARRIAGADA, 1991, LANCET, V338, P535	1	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					885	886		10.1016/0140-6736(91)91539-7	http://dx.doi.org/10.1016/0140-6736(91)91539-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681236				2022-12-28	WOS:A1991GH94500035
J	VANDERMAST, RC; FEKKES, D; MOLEMAN, P; PEPPLINKHUIZEN, L				VANDERMAST, RC; FEKKES, D; MOLEMAN, P; PEPPLINKHUIZEN, L			IS POSTOPERATIVE DELIRIUM RELATED TO REDUCED PLASMA TRYPTOPHAN	LANCET			English	Note								The cause of postoperative delirium is unknown. In 7 patients with postcardiotomy delirium (6 men, 1 woman; mean age 67 years), we observed a plasma concentration of tryptophan and a plasma tryptophan ratio significantly lower than in 8 non-delirious postoperative control patients. We suggest that the mental symptoms of postcardiotomy delirium are the consequence of a reduced cerebral tryptophan availability due to a catabolic state.			VANDERMAST, RC (corresponding author), DIJKZIGT ACAD HOSP, DEPT PSYCHIAT, DR MOLEWATERPLEIN 40, 3015 GD ROTTERDAM, NETHERLANDS.							BRUINVELS J, 1984, J PSYCHIAT RES, V18, P307, DOI 10.1016/0022-3956(84)90021-9; FERNSTROM JD, 1972, SCIENCE, V178, P414, DOI 10.1126/science.178.4059.414; FRANCIS J, 1990, JAMA-J AM MED ASSOC, V263, P1097, DOI 10.1001/jama.263.8.1097; LEHMANN J, 1982, ACTA PSYCHIAT SCAND, V65, P1; Lipowski Z.J, 1990, DELIRIUM ACUTE CONFU; ROGERS MP, 1989, INT J PSYCHIAT MED, V19, P109; SKAUG OE, 1989, TIDSSKRIFT NORSKE LA, V104, P97; SMITH LW, 1989, AM J PSYCHIAT, V146, P452	8	47	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	1991	338	8771					851	852		10.1016/0140-6736(91)91504-N	http://dx.doi.org/10.1016/0140-6736(91)91504-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681217				2022-12-28	WOS:A1991GH94500006
J	GLASS, RI; CLAESON, M; BLAKE, PA; WALDMAN, RJ; PIERCE, NF				GLASS, RI; CLAESON, M; BLAKE, PA; WALDMAN, RJ; PIERCE, NF			CHOLERA IN AFRICA - LESSONS ON TRANSMISSION AND CONTROL FOR LATIN-AMERICA	LANCET			English	Article							EPIDEMIC CHOLERA; VIBRIO-CHOLERAE; FOODS	In January, 1991, epidemic cholera emerged in Peru and spread to 7 other countries of Latin America. Cholera was introduced 20 years ago to Africa, where it spread rapidly to 30 of the 46 countries of the region and by 1990 accounted for 90% of all cases reported to the World Health Organisation. Many lessons from the cholera epidemic in Africa are relevant to efforts to control the disease in Latin America. Public health practices from the past - quarantine and cordon sanitaire to halt introduction of cholera by travellers, and vaccination and mass chemoprophylaxis to control epidemics - are ineffective in preventing spread of the disease. Cholera can be transmitted not only by contaminated water but also by food. Social phenomena such as mass migrations and burial practices may play a greater role than previously understood. While efforts to prevent the spread of cholera have been ineffective, cholera-associated mortality can be decreased with rehydration therapy. Since the current pandemic is unlikely to retreat soon, new strategies are urgently needed to control the spread of cholera through sanitary and behavioural interventions or improved vaccines.	CTR DIS CONTROL,BACTERIAL ENTER DIS BRANCH,ATLANTA,GA 30333; CTR DIS CONTROL,INT HLTH PROGRAM OFF,ATLANTA,GA 30333; WHO,DIARRHOEAL DIS CONTROL PROGRAMME,CH-1211 GENEVA 27,SWITZERLAND	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	GLASS, RI (corresponding author), CTR DIS CONTROL,VIRAL GASTROENTERITIS UNIT G04,1600 CLIFTON RD NE,ATLANTA,GA 30333, USA.							[Anonymous], 1991, Epidemiol Bull, V12, P1; BAINE WB, 1974, LANCET, V2, P1370; BLAKE PA, 1980, NEW ENGL J MED, V302, P305, DOI 10.1056/NEJM198002073020601; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; CLIFF JL, 1986, T ROY SOC TROP MED H, V80, P473, DOI 10.1016/0035-9203(86)90349-4; Feachem R, 1981, Trop Dis Bull, V78, P865; Feachem R G, 1982, Trop Dis Bull, V79, P1; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; GLASS RI, 1983, J INFECT DIS, V47, P204; GLASS RI, 1986, ADV RES CHOLERA RELA, P25; GOODGAME RW, 1975, ANN INTERN MED, V82, P101, DOI 10.7326/0003-4819-82-1-101; JOHNSTON JM, 1983, NEW ENGL J MED, V309, P523, DOI 10.1056/NEJM198309013090903; KOLVIN JL, 1982, J HYG-CAMBRIDGE, V89, P243, DOI 10.1017/S0022172400070777; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; LINDENBAUM J, 1967, B WORLD HEALTH ORGAN, V37, P529; LOWRY PW, 1989, ARCH INTERN MED, V149, P2079, DOI 10.1001/archinte.149.9.2079; MAHALANABIS D, 1973, JOHNS HOPKINS MED J, V132, P197; MAKUKUTU CA, 1986, APPL ENVIRON MICROB, V52, P824, DOI 10.1128/AEM.52.4.824-831.1986; MHALU FS, 1979, LANCET, V1, P345; MHALU FS, 1984, LANCET, V2, P82; POLLITZER R, 1959, WHO MONOGR SER, V43, P820; SALAMASO S, 1980, LANCET, V2, P1124; STLOUIS ME, 1990, AM J EPIDEMIOL, V131, P719; STOCK RF, 1976, 3 INT AFR I AFR ENV; TAUXE RV, 1988, EPIDEMIOL INFECT, V100, P279, DOI 10.1017/S0950268800067418; WOODWARD WE, 1971, AM J EPIDEMIOL, V96, P342; 1991, WKLY EPIDEMIOL REP, P55; 1991, WHOCDDSER804; 1990, RATIONAL USE DRUGS M	29	65	65	0	13	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					791	795		10.1016/0140-6736(91)90673-D	http://dx.doi.org/10.1016/0140-6736(91)90673-D			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681168				2022-12-28	WOS:A1991GG97900012
J	CHESTER, AH; ONEIL, GS; MONCADA, S; TADJKARIMI, S; YACOUB, MH				CHESTER, AH; ONEIL, GS; MONCADA, S; TADJKARIMI, S; YACOUB, MH			LOW BASAL AND STIMULATED RELEASE OF NITRIC-OXIDE IN ATHEROSCLEROTIC EPICARDIAL CORONARY-ARTERIES	LANCET			English	Article									HAREFIELD HOSP,NATL HEART & LUNG INST,THORAC & CARDIAC SURG UNIT,HAREFIELD UB9 6JH,MIDDX,ENGLAND; WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; GlaxoSmithKline; Wellcome Research Laboratories								AISAKA K, 1989, BIOCHEM BIOPH RES CO, V160, P881, DOI 10.1016/0006-291X(89)92517-5; BASSENGE E, 1988, PROG CARDIOVASC DIS, V30, P349, DOI 10.1016/0033-0620(88)90003-5; BOSSALLER C, 1987, J CLIN INVEST, V79, P170, DOI 10.1172/JCI112779; CHESTER AH, IN PRESS INT J CARDI; CHRISTIE MI, 1989, BRIT J PHARMACOL, V98, P397, DOI 10.1111/j.1476-5381.1989.tb12610.x; COLER J, 1989, BRIT J PHARMACOL, V97, P639; CROSSMAN DC, 1989, CIRCULATION, V80, P475, DOI 10.1161/01.CIR.80.3.475; FELETOU M, 1988, BRIT J PHARMACOL, V93, P515, DOI 10.1111/j.1476-5381.1988.tb10306.x; FORSTERMANN U, 1988, CIRC RES, V62, P185, DOI 10.1161/01.RES.62.2.185; GRIFFITH TM, 1984, J PHYSIOL-LONDON, V351, P13, DOI 10.1113/jphysiol.1984.sp015228; HABIB JB, 1986, CIRC RES, V58, P305, DOI 10.1161/01.RES.58.2.305; IP JH, 1989, CURR OPIN CARDIOL, V4, P772, DOI 10.1097/00001573-198912000-00002; LUSCHER TF, 1988, NEW ENGL J MED, V319, P462, DOI 10.1056/NEJM198808253190802; PALMER RMJ, 1987, NATURE, V327, P525; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; SCHOEFFTER P, 1988, BRIT J PHARMACOL, V95, P531, DOI 10.1111/j.1476-5381.1988.tb11674.x; THOM S, 1987, CLIN SCI, V73, P547, DOI 10.1042/cs0730547; VALLANCE P, 1989, CARDIOVASC RES, V23, P1053, DOI 10.1093/cvr/23.12.1053; VALLANCE P, 1989, LANCET, V2, P997; WHITTLE BJR, 1989, BRIT J PHARMACOL, V98, P646, DOI 10.1111/j.1476-5381.1989.tb12639.x	20	257	268	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					897	900		10.1016/0140-6736(90)92269-N	http://dx.doi.org/10.1016/0140-6736(90)92269-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1699098				2022-12-28	WOS:A1990EC45600003
J	STANDAERT, RF; GALAT, A; VERDINE, GL; SCHREIBER, SL				STANDAERT, RF; GALAT, A; VERDINE, GL; SCHREIBER, SL			MOLECULAR-CLONING AND OVEREXPRESSION OF THE HUMAN FK506-BINDING PROTEIN FKBP	NATURE			English	Article									HARVARD UNIV,DEPT CHEM,12 OXFORD ST,CAMBRIDGE,MA 02138	Harvard University			Standaert, Robert F./AAI-1532-2021; Standaert, Robert F/D-9467-2013	Standaert, Robert F/0000-0002-5684-1322				ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; CLINE TW, 1989, CELL, V59, P231, DOI 10.1016/0092-8674(89)90280-8; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUMONT FJ, 1990, J IMMUNOL, V144, P251; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FASMAN GD, 1989, PRACTICAL HDB BIOCH, P80; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HUNT T, 1989, CELL, V59, P949, DOI 10.1016/0092-8674(89)90747-2; INNIS MA, 1990, PCR PROTOCOLS; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; MACFERRIN KD, 1990, P NATL ACAD SCI USA, V87, P1937, DOI 10.1073/pnas.87.5.1937; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; OHARA O, 1989, P NATL ACAD SCI USA, V86, P5673, DOI 10.1073/pnas.86.15.5673; PERRY ACF, 1988, J BACTERIOL, V170, P1691, DOI 10.1128/jb.170.4.1691-1697.1988; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STARZL TE, 1989, LANCET, V2, P1000; STRUHL K, 1989, TRENDS BIOCHEM SCI, V14, P137, DOI 10.1016/0968-0004(89)90145-X; SWAIN CG, 1980, J CHEM INF COMP SCI, V20, P47, DOI 10.1021/ci60021a011; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; THOMSON AW, 1989, IMMUNOL TODAY, V10, P6, DOI 10.1016/0167-5699(89)90057-1; TOCCI MJ, 1989, J IMMUNOL, V143, P718; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; TUFTY RM, 1975, SCIENCE, V187, P167, DOI 10.1126/science.1111094	36	311	356	1	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 16	1990	346	6285					671	674		10.1038/346671a0	http://dx.doi.org/10.1038/346671a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU728	1696686				2022-12-28	WOS:A1990DU72800067
J	GRANFORS, K; JALKANEN, S; LINDBERG, AA; MAKIIKOLA, O; VONESSEN, R; LAHESMAARANTALA, R; ISOMAKI, H; SAARIO, R; ARNOLD, WJ; TOIVANEN, A				GRANFORS, K; JALKANEN, S; LINDBERG, AA; MAKIIKOLA, O; VONESSEN, R; LAHESMAARANTALA, R; ISOMAKI, H; SAARIO, R; ARNOLD, WJ; TOIVANEN, A			SALMONELLA LIPOPOLYSACCHARIDE IN SYNOVIAL-CELLS FROM PATIENTS WITH REACTIVE ARTHRITIS	LANCET			English	Article									KAROLINSKA INST,HUDDINGE HOSP,DEPT CLIN BACTERIOL,HUDDINGE,SWEDEN; RHEUMATISM FDN HOSP,HEINOLA,FINLAND; UNIV TURKU,DEPT MED,SF-20500 TURKU 50,FINLAND; LUTHERAN GEN HOSP,DIV MED,PK RIDGE,IL 60068	Karolinska Institutet; Rheumatism Foundation Hospital; University of Turku	GRANFORS, K (corresponding author), TURKU UNIV,DEPT MED MICROBIOL,SF-20520 TURKU,FINLAND.							BARTHOLOMEW LE, 1979, ARTHRITIS RHEUM, V22, P969, DOI 10.1002/art.1780220904; CARLIN NIA, 1987, MICROB PATHOGENESIS, V2, P171, DOI 10.1016/0882-4010(87)90019-2; FORD DK, 1985, ANN RHEUM DIS, V44, P701, DOI 10.1136/ard.44.10.701; GASTON JSH, 1989, CLIN EXP IMMUNOL, V76, P348; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; GRANFORS K, 1989, J INFECT DIS, V159, P1142, DOI 10.1093/infdis/159.6.1142; GRANFORS K, 1988, REACTIVE ARTHRITIS, P15; HOLLINGSWORTH JW, 1965, YALE J BIOL MED, V38, P241; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; ISHIKAWA H, 1986, J BONE JOINT SURG AM, V68A, P777, DOI 10.2106/00004623-198668050-00024; ISOMAKI O, 1989, LANCET, V1, P1411; JALKANEN S, 1986, SCIENCE, V233, P556, DOI 10.1126/science.3726548; JALKANEN S, 1989, SPRINGER SEMIN IMMUN, V11, P187; KEAT A, 1987, LANCET, V1, P72; LAHESMAARANTALA R, 1987, ANN RHEUM DIS, V46, P121, DOI 10.1136/ard.46.2.121; LAHESMAARANTALA R, 1987, ANN RHEUM DIS, V46, P510, DOI 10.1136/ard.46.7.510; NURMINEN M, 1983, SCIENCE, V220, P1279, DOI 10.1126/science.6344216; SCHUMACHER HR, 1988, ARTHRITIS RHEUM, V31, P937; STIMPSON SA, 1987, J EXP MED, V165, P1688, DOI 10.1084/jem.165.6.1688; TAYLORROBINSON D, 1988, ANN RHEUM DIS, V47, P295, DOI 10.1136/ard.47.4.295; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; VANDENBROEK MF, 1988, ARTHRITIS RHEUM-US, V31, P1077, DOI 10.1002/art.1780310825	22	302	302	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 24	1990	335	8691					685	688		10.1016/0140-6736(90)90804-E	http://dx.doi.org/10.1016/0140-6736(90)90804-E			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV305	1690327				2022-12-28	WOS:A1990CV30500004
J	BRAHAMS, D				BRAHAMS, D			EUTHANASIA IN THE NETHERLANDS	LANCET			English	Editorial Material																		BRAHAMS D, 1981, LANCET, V2, P1101; BRAHAMS D, 1989, LANCET, V2, P1407; Devlin P., 1985, EASING PASSING; LEENEN HJJ, 1990, BRIT MED J, V300, P69; LEVIN B, 1989, TIMES           1211; RIGHTER H, 1988, BRIT MED J, V297, P1593; Sluyters B, 1989, Med Leg J, V57 ( Pt 1), P34; 1988, EUTHANASIA REPORT RE; 1988, MED LEG J, V56, P179	9	5	5	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					591	592						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1689795				2022-12-28	WOS:A1990CT65300016
J	STERN, CD; CANNING, DR				STERN, CD; CANNING, DR			ORIGIN OF CELLS GIVING RISE TO MESODERM AND ENDODERM IN CHICK-EMBRYO	NATURE			English	Article											STERN, CD (corresponding author), DEPT HUMAN ANAT, S PARKS RD, OXFORD OX1 3QX, ENGLAND.		Stern, Claudio/AAZ-7381-2021; Stern, Claudio D/C-6265-2008	Stern, Claudio/0000-0002-9907-889X; Stern, Claudio D/0000-0002-9907-889X				ABO T, 1981, J IMMUNOL, V127, P1024; AZAR Y, 1979, J EMBRYOL EXP MORPH, V52, P79; AZAR Y, 1981, J EMBRYOL EXP MORPH, V61, P133; CANNING DR, 1988, DEVELOPMENT, V104, P643; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; EYALGILADI H, 1984, CELL DIFFER DEV, V14, P245, DOI 10.1016/0045-6039(84)90013-7; GOODMAN SL, 1981, J MICROSC-OXFORD, V123, P201, DOI 10.1111/j.1365-2818.1981.tb01295.x; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HUTSON JM, 1984, STAIN TECHNOL, V59, P105, DOI 10.3109/10520298409113839; MITRANI E, 1984, DIFFERENTIATION, V26, P107, DOI 10.1111/j.1432-0436.1984.tb01382.x; MITRANI E, 1981, NATURE, V289, P800, DOI 10.1038/289800a0; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NIEUWKOOP PD, 1985, EPIGENETIC NATURE EA; RICKMANN M, 1985, J EMBRYOL EXP MORPH, V90, P437; SMITH JC, 1989, DEVELOPMENT, V105, P665; STERN CD, 1987, DEVELOPMENT, V99, P261; TUCKER GC, 1984, CELL DIFFER DEV, V14, P223, DOI 10.1016/0045-6039(84)90049-6; Waddington CH, 1933, ROUX ARCH DEV BIOL, V128, P502, DOI 10.1007/BF00649862	19	126	126	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	1990	343	6255					273	275		10.1038/343273a0	http://dx.doi.org/10.1038/343273a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	1689008				2022-12-28	WOS:A1990CJ68200075
J	STEINHOFF, MC; AUERBACH, BS; NELSON, KE; VLAHOV, D; BECKER, RL; GRAHAM, NMH; SCHWARTZ, DH; LUCAS, AH; CHAISSON, RE				STEINHOFF, MC; AUERBACH, BS; NELSON, KE; VLAHOV, D; BECKER, RL; GRAHAM, NMH; SCHWARTZ, DH; LUCAS, AH; CHAISSON, RE			ANTIBODY-RESPONSES TO HAEMOPHILUS-INFLUENZAE TYPE-B VACCINES IN MEN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNE-DEFICIENCY SYNDROME; INTRAVENOUS DRUG-USERS; PERSISTENT GENERALIZED LYMPHADENOPATHY; AIDS-RELATED COMPLEX; CAPSULAR POLYSACCHARIDE; BACTERIAL PNEUMONIA; PNEUMOCOCCAL VACCINE; HOMOSEXUAL MEN; ADULT PATIENTS; IMMUNIZATION	Background. Persons with human immunodeficiency virus (HIV) infection are at increased risk for serious infections caused by Haemophilus influenzae, yet there are few data on their antibody responses to the H. influenzae type b vaccines. Methods. We evaluated antibody responses in 248 men who were randomly assigned to receive a single dose of either the H. influenzae type b polysaccharide (PRP) vaccine or the polysaccharide-mutant diphtheria toxoid conjugate vaccine (PRP-CRM). The subjects were stratified into four groups: seronegative men (67 subjects), men with asymptomatic HIV infection (79), men with symptomatic HIV infection (47), and men with the acquired immunodeficiency syndrome (AIDS) (55). Results. Before immunization, the subjects with AIDS had the lowest PRP-antibody titers; 40 percent had titers below the putative protective level (< 0.15-mu-g per milliliter). In the seronegative subjects, those with asymptomatic HIV infection, and those with symptomatic HIV infection the PRP-CRM vaccine led to a threefold greater increase in geometric mean antibody titers than did the PRP vaccine (P < 0.01). However, the subjects with AIDS had a greater antibody response to the PRP vaccine. The antibody response of HIV-seropositive men to the PRP-CRM vaccine correlated significantly with the number Of CD4 lymphocytes (r = 0.47, P < 0.0001, as compared with r = -0.01 for the PRP vaccine). In these HIV-infected men, both vaccines elicited the dominant anti-PRP idiotype described previously in populations not infected with HIV. Conclusions. Immunization with the PRP-CRM conjugate vaccine early in the course of HIV infection is likely to confer protection against disease caused by H. influenzae type b.	CHILDRENS HOSP OAKLAND RES INST,OAKLAND,CA; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT INT HLTH,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT IMMUNOL,BALTIMORE,MD 21218; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT INFECT DIS,BALTIMORE,MD 21218	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University								AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; ANDERSON P, 1985, J CLIN INVEST, V76, P52, DOI 10.1172/JCI111976; ANDERSON P, 1977, J INFECT DIS, V136, pS57, DOI 10.1093/infdis/136.Supplement.S57; ANDERSON P, 1989, PEDIATR INFECT DIS J, V8, pS50; ANDERSON P, 1984, J INFECT DIS, V149, P134; ANDERSON PW, 1989, J IMMUNOL, V142, P2464; ANDERSON PW, 1990, NEW GENERATION VACCI, P349; BALLET JJ, 1987, CLIN EXP IMMUNOL, V68, P479; BERNSTEIN LJ, 1985, PEDIATR INFECT DIS J, V4, P472, DOI 10.1097/00006454-198509000-00005; HUANG KL, 1987, JAMA-J AM MED ASSOC, V257, P2047, DOI 10.1001/jama.257.15.2047; INSEL RA, 1985, J IMMUNOL, V135, P2810; INSEL RA, 1986, MANUAL CLIN LABORATO, P379; JANOFF EN, 1988, J INFECT DIS, V158, P983, DOI 10.1093/infdis/158.5.983; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KATZ IR, 1986, CLIN IMMUNOL IMMUNOP, V39, P359, DOI 10.1016/0090-1229(86)90164-9; KEHRL JH, 1983, J CLIN INVEST, V71, P1032, DOI 10.1172/JCI110830; KLEIN RS, 1989, J INFECT DIS, V160, P826, DOI 10.1093/infdis/160.5.826; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LANE HC, 1985, NEW ENGL J MED, V313, P79, DOI 10.1056/NEJM198507113130204; LUCAS AH, 1988, J CLIN INVEST, V81, P480, DOI 10.1172/JCI113345; LUCAS AH, 1990, J CLIN INVEST, V85, P1158, DOI 10.1172/JCI114548; LUCAS AH, IN PRESS J CLIN INVE; MADORE DV, 1990, PEDIATRICS, V85, P331; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; OCHS HD, 1988, J CLIN IMMUNOL, V8, P57, DOI 10.1007/BF00915157; PAHWA SG, 1984, ANN INTERN MED, V101, P757, DOI 10.7326/0003-4819-101-6-757; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; RAGNI MV, 1987, J LAB CLIN MED, V109, P545; REDD SC, 1990, J INFECT DIS, V162, P1012, DOI 10.1093/infdis/162.5.1012; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; ROLSTON KVI, 1987, AM J MED, V83, P604, DOI 10.1016/0002-9343(87)90789-3; SCHLAMM HT, 1989, AM J MED, V86, P11, DOI 10.1016/0002-9343(89)90222-2; SCHNEERSON R, 1986, INFECT IMMUN, V52, P519, DOI 10.1128/IAI.52.2.519-528.1986; SCHREIBER JR, 1986, J INFECT DIS, V153, P8, DOI 10.1093/infdis/153.1.8; SELWYN PA, 1988, AIDS, V2, P267, DOI 10.1097/00002030-198808000-00005; SELWYN PA, 1989, AM J PUBLIC HEALTH, V79, P1358, DOI 10.2105/AJPH.79.10.1358; SIMBERKOFF M, 1989, 29TH INT C ANT AG CH, P174; SIMBERKOFF MS, 1984, AM REV RESPIR DIS, V130, P1174; STEINHOFF MC, 1990, 30TH INT C ANT AG CH, P187; Vlahov D, 1991, NIDA Res Monogr, V109, P75; WHIMBEY E, 1986, ANN INTERN MED, V104, P511, DOI 10.7326/0003-4819-104-4-511; WHITE S, 1985, CHEST, V87, P486, DOI 10.1378/chest.87.4.486; WITT DJ, 1987, AM J MED, V82, P900, DOI 10.1016/0002-9343(87)90150-1; 1990, GUIDE ADULT IMMUNIZA, P45; 1990, MMWR, V39, P925; 1987, MMWR S1, V36, pS1; 1988, AIDS S1, V2, pS183; 1988, MMWR, V37, P593	49	108	108	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1837	1842		10.1056/NEJM199112263252603	http://dx.doi.org/10.1056/NEJM199112263252603			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1683682				2022-12-28	WOS:A1991GW52800003
J	SZASZ, T				SZASZ, T			DIAGNOSES ARE NOT DISEASES	LANCET			English	Editorial Material											SZASZ, T (corresponding author), SUNY HLTH SCI CTR,SYRACUSE,NY 13210, USA.							FREUDENHEIM M, 1991, WALL STREET J   0924; FREUDENHEIM M, 1991, NY TIMES        0629, pA1; FREUDENHEIM M, 1991, NY TIMES        0923, pD4; GOLDMAN MJ, 1991, AM J PSYCHIAT, V148, P986; KAREL R, 1991, PSYCHIATTRIC NEWS, V26, P16; Polanyi M., 1969, KNOWING BEING; ROGERS W, 1982, W ROGERS TREASURY RE, P256; Szasz T. S., 1974, MYTH MENTAL ILLNESS; Szasz T.S., 1987, INSANITY IDEA ITS CO; 1980, DIAGNOSTIC STATISTIC; 1987, DIAGNOSTIC STATISTIC; 1991, LANCET, V338, P785	12	18	18	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1574	1576		10.1016/0140-6736(91)92387-H	http://dx.doi.org/10.1016/0140-6736(91)92387-H			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683983				2022-12-28	WOS:A1991GW03600016
J	FISCH, A; SALVANET, A; PRAZUCK, T; FORESTIER, F; GERBAUD, L; COSCAS, G; LAFAIX, C				FISCH, A; SALVANET, A; PRAZUCK, T; FORESTIER, F; GERBAUD, L; COSCAS, G; LAFAIX, C			EPIDEMIOLOGY OF INFECTIVE ENDOPHTHALMITIS IN FRANCE	LANCET			English	Article							POST-OPERATIVE ENDOPHTHALMITIS; HUMAN AQUEOUS-HUMOR; LENS	Data from retrospective studies of endophthalmitis vary widely with respect to incidence and to the pathogens implicated. To see whether we could provide more accurate data, we have done a prospective multicentre national survey of endophthalmitis over one year in France. Records of 36 241 operations and 1148 cases of ocular trauma from 64 centres specialising in eye surgery were analysed. There were 167 cases of endophthalmitis; incidence of postoperative endophthalmitis was 0.31 per 100 operations, and the risk after penetrating ocular trauma was 2.8%. In contrast with most previous studies, Staphylococcus epidermidis was the most frequently isolated organism, with gram-negative organisms accounting for only a small proportion of cases. Patients infected with streptococci had the least favourable outcome. The survey confirms data from retrospective studies showing that the incidence of postoperative or post-injury endophthalmitis is low. The low frequency means that large numbers of patients would be required for a trial of antibiotic efficacy, but such a trial is worthwhile because there are now antibiotics with good ocular bioavailability that are effective against most of the bacteria that cause endophthalmitis.	UNIV HOSP VILLENEUVE ST GEORGES,DEPT OPHTHALMOL,F-94190 VILLENEUVE ST GEO,FRANCE		FISCH, A (corresponding author), UNIV HOSP VILLENEUVE ST GEORGES,ETUD EPIDEMIOL & PROPHYLACT GRP,40 ALLEE SOURCE,F-94190 VILLENEUVE ST GEO,FRANCE.		GERBAUD, Laurent/ABY-4952-2022					ALLEN HF, 1974, ARCH OPHTHALMOL-CHIC, V91, P3, DOI 10.1001/archopht.1974.03900060007002; ALLEN HF, 1978, OPHTHALMOLOGY, V85, P386; ALLEN HF, 1978, OPHTHALMOLOGY, V85, P317; BOHIGIAN GM, 1986, AM J OPHTHALMOL, V101, P323; BRINTON GS, 1984, ARCH OPHTHALMOL-CHIC, V102, P547; CAMERON ME, 1978, OPHTHALMIC SURG LAS, V9, P52; DRIEBE WT, 1986, OPHTHALMOLOGY, V93, P442; FAHMY JA, 1975, ACTA OPHTHALMOL, V53, P522; FISCH A, 1987, J ANTIMICROB CHEMOTH, V20, P453, DOI 10.1093/jac/20.3.453; Forster RK, 1981, CLIN OPHTHALMOL, P1; GLEICHER DA, 1973, AM J OPHTHALMOL, V75, P769, DOI 10.1016/0002-9394(73)90879-9; MELTZER DW, 1981, ARCH OPHTHALMOL-CHIC, V98, P100; OLSON JC, 1983, OPHTHALMOLOGY, V90, P692; PULIAFITO CA, 1982, OPHTHALMOLOGY, V89, P921; ROWSEY JJ, 1982, OPHTHALMOLOGY, V89, P1055; SALVANET A, 1986, J ANTIMICROB CHEMOTH, V18, P199, DOI 10.1093/jac/18.2.199; SHRADER SK, 1990, J INFECT DIS, V162, P115, DOI 10.1093/infdis/162.1.115; WEBER DJ, 1986, REV INFECT DIS, V8, P12	18	109	115	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 30	1991	338	8779					1373	1376						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682746				2022-12-28	WOS:A1991GR77300013
J	SAUNDERS, N; PATERSON, C				SAUNDERS, N; PATERSON, C			EFFECT OF GESTATIONAL-AGE ON OBSTETRIC PERFORMANCE - WHEN IS TERM OVER	LANCET			English	Editorial Material							POSTDATE PREGNANCIES				SAUNDERS, N (corresponding author), ST MARYS HOSP,ACAD DEPT OBSTET & GYNAECOL,LONDON W2 1PG,ENGLAND.							ARIAS F, 1987, OBSTET GYNECOL, V70, P101; Ballantyne JW, 1922, J OBSTET GYNAECOL BR, V29, P177; Ballantyne JW, 1902, J OBSTET GYNAECOL BR, V2, P521; BOYD ME, 1988, AM J OBSTET GYNECOL, V158, P334, DOI 10.1016/0002-9378(88)90150-0; Crowley P., 1989, EFFECTIVE CARE PREGN, P776; EDEN RD, 1987, OBSTET GYNECOL, V69, P296; GIBSON GB, 1955, BRIT MED J, V2, P715, DOI 10.1136/bmj.2.4941.715; Kortenoever ME, 1950, OBSTET GYNECOL SURV, V5, P812; MARESH M, 1986, BRIT J OBSTET GYNAEC, V93, P1239, DOI 10.1111/j.1471-0528.1986.tb07858.x; MCCLUREBROWNE JC, 1963, JAMA-J AM MED ASSOC, V186, P1047; MEAD PB, 1964, AM J OBSTET GYNECOL, V89, P495; SHIME J, 1984, AM J OBSTET GYNECOL, V148, P547, DOI 10.1016/0002-9378(84)90745-2; USHER RH, 1988, AM J OBSTET GYNECOL, V158, P259, DOI 10.1016/0002-9378(88)90134-2; WALKER J, 1954, J OBSTET GYN BRIT EM, V61, P162; [No title captured]	15	29	29	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1190	1192		10.1016/0140-6736(91)92044-3	http://dx.doi.org/10.1016/0140-6736(91)92044-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682603				2022-12-28	WOS:A1991GP03400016
J	GIESECKE, J; RAMSTEDT, K; GRANATH, F; RIPA, T; RADO, G; WESTRELL, M				GIESECKE, J; RAMSTEDT, K; GRANATH, F; RIPA, T; RADO, G; WESTRELL, M			EFFICACY OF PARTNER NOTIFICATION FOR HIV-INFECTION	LANCET			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CHLAMYDIA-TRACHOMATIS INFECTION; CONTACT	Since 1985, partner notification has been part of Swedish policy to prevent the spread of human immunodeficiency virus (HIV) infection. Potentially infected partners of a newly diagnosed seropositive patient are notified either by the index patient or by the physician and referred for counselling. The efficacy of this strategy was assessed over 18 months in 1989-90. 365 HIV-seropositive index patients (91% of the 403 patients diagnosed in Sweden during the study period) reported 564 sexual or needle-sharing contacts. 390 contacts were located and counselled and HIV test results are known for 350 of them. In 53 of the 350 cases, previously unknown seropositivity was diagnosed. Partner notification for HIV should be viewed as a strategy to offer counselling and testing to a high-prevalence group of people. In a country where general HIV prevalence is low, the strategy is cost-effective for location and counselling of unknowingly seropositive individuals.	NATL BACTERIOL LAB,DEPT EPIDEMIOL,S-10521 STOCKHOLM,SWEDEN; GOTHENBURG UNIV,DEPT DERMATOVENEREOL,S-41124 GOTHENBURG,SWEDEN; HALMSTAD CTY HOSP,DEPT CLIN MICROBIOL,HALMSTAD,SWEDEN; KAROLINSKA INST,DANDERYD HOSP,DEPT INFECT DIS,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,SO HOSP,DEPT DERMATOVENEREOL,S-10401 STOCKHOLM 60,SWEDEN	University of Gothenburg; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet								ADLER MW, 1988, BRIT MED J, V296, P1420, DOI 10.1136/bmj.296.6634.1420; AVINS AL, 1989, AM J PUBLIC HEALTH, V79, P1544, DOI 10.2105/AJPH.79.11.1544; CLUMECK N, 1989, NEW ENGL J MED, V321, P1460, DOI 10.1056/NEJM198911233212107; FISH ANJ, 1989, EUR J OBSTET GYN R B, V31, P67, DOI 10.1016/0028-2243(89)90027-0; FRANZEN C, 1988, 4 INT C AIDS STOCKH; GIESECKE J, 1990, LANCET, P508; JONES JL, 1990, JAMA-J AM MED ASSOC, V264, P1284, DOI 10.1001/jama.264.10.1284; JUDSON FN, 1990, HOSP PRACT, V12, P63; KATZ BP, 1988, SEX TRANSM DIS, V15, P11, DOI 10.1097/00007435-198801000-00003; KRISTOFFERSEN J E, 1991, Tidsskrift for den Norske Laegeforening, V111, P432; MILLS A, 1978, BRIT J VENER DIS, V54, P192; OSBORN JE, 1988, NEW ENGL J MED, V318, P444, DOI 10.1056/NEJM198802183180710; PHILLIPS L, 1980, AM J PUBLIC HEALTH, V70, P705, DOI 10.2105/AJPH.70.7.705; POTTERAT JJ, 1989, AM J PUBLIC HEALTH, V79, P874, DOI 10.2105/AJPH.79.7.874; RAMSTEDT K, 1990, SEX TRANSM DIS, V17, P37, DOI 10.1097/00007435-199017010-00008; RAMSTEDT K, 1991, INT J STD AIDS, V2, P116; RAMSTEDT KM, 1985, SEX TRANSM DIS, V12, P209, DOI 10.1097/00007435-198510000-00008; RUTHERFORD GW, 1988, JAMA-J AM MED ASSOC, V259, P3609, DOI 10.1001/jama.259.24.3609; SATIN A, 1978, BRIT J VENER DIS, V54, P187; TOOMEY KE, 1989, AIDS, V3, pS57, DOI 10.1097/00002030-198901001-00009; WYKOFF RF, 1988, JAMA-J AM MED ASSOC, V259, P3563, DOI 10.1001/jama.259.24.3563; [No title captured]; 1988, MMWR, V37, P393; 1989, WHOGPAESR892; 1988, MMWR, V37, P401	25	49	50	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1096	1100		10.1016/0140-6736(91)91962-T	http://dx.doi.org/10.1016/0140-6736(91)91962-T			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682542				2022-12-28	WOS:A1991GM78400002
J	APPLEYARD, ME; MCDONALD, B				APPLEYARD, ME; MCDONALD, B			REDUCED ADRENAL-GLAND ACETYLCHOLINESTERASE ACTIVITY IN ALZHEIMERS-DISEASE	LANCET			English	Letter									RADCLIFFE INFIRM,DEPT NEUROPATHOL,OXFORD OX2 6HE,ENGLAND	Radcliffe Infirmary	APPLEYARD, ME (corresponding author), ROYAL FREE HOSP,SCH MED,DEPT PHYSIOL,LONDON NW3 2PF,ENGLAND.							APPLEYARD ME, 1991, BRIT J OPHTHALMOL, V75, P276, DOI 10.1136/bjo.75.5.276; APPLEYARD ME, 1987, BRAIN, V10, P1309; APPLEYARD ME, 1989, EUR J NEUROSCI, V2, P129; AVERBACK P, 1983, LANCET, V2, P1203; RAKONCZAY Z, 1988, PROG NEUROBIOL, V31, P311, DOI 10.1016/0301-0082(88)90017-2; SMITH AD, 1984, LANCET, V1, P513; SOMOGYI P, 1975, PROC R SOC SER B-BIO, V191, P271, DOI 10.1098/rspb.1975.0128	7	15	15	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1085	1086		10.1016/0140-6736(91)91947-S	http://dx.doi.org/10.1016/0140-6736(91)91947-S			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681391				2022-12-28	WOS:A1991GM25300051
J	MADDOCKS, JL; MACLACHLAN, J				MADDOCKS, JL; MACLACHLAN, J			APPLICATION OF NEW FLUORESCENT THIOL REAGENT TO DIAGNOSIS OF HOMOCYSTINURIA	LANCET			English	Note								A new fluorescent thiol reagent, dansylaminophenylmercuric acetate (DAPMA), was applied to the diagnosis of homocystinuria, a disorder which can be associated with vascular disease at an early age. DAPMA was added to urine containing metabisulphite and the resulting fluorescent derivatives were extracted on a cyclohexyl silica column and separated by thin-layer chromatography. 102 coded samples were tested. The derivative of homocysteine was easily identified in samples from 4 children with homocystinuria but was absent from all samples from normal subjects and patients with unrelated disorders. Other thiols (cysteine, acetylcysteine, mercaptolactate, thiosulphate, and thiocyanate) were also identified in urine from healthy fasting subjects.			MADDOCKS, JL (corresponding author), UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT MED & PHARMACOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND.							BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; CAHALANE S, 1990, HOMOCYSTEINAEMIA VAS, P20; HUXTABLE RJ, 1986, BIOCH SULPHUR, P359; MUDD SH, 1985, AM J HUM GENET, V37, P1; Mudd Sh, 1989, METABOLIC BASIS INHE, V1, P693; SORBO B, 1980, NATURAL SULFUR COMPO, P463; SPAETH GL, 1967, PEDIATRICS, V40, P586	7	7	7	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1043	1044		10.1016/0140-6736(91)91903-8	http://dx.doi.org/10.1016/0140-6736(91)91903-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681358				2022-12-28	WOS:A1991GM25300006
J	SARACCI, R; KOGEVINAS, M; BERTAZZI, PA; DEMESQUITA, BHB; COGGON, D; GREEN, LM; KAUPPINEN, T; LABBE, KA; LITTORIN, M; LYNGE, E; MATHEWS, JD; NEUBERGER, M; OSMAN, J; PEARCE, N; WINKELMANN, R				SARACCI, R; KOGEVINAS, M; BERTAZZI, PA; DEMESQUITA, BHB; COGGON, D; GREEN, LM; KAUPPINEN, T; LABBE, KA; LITTORIN, M; LYNGE, E; MATHEWS, JD; NEUBERGER, M; OSMAN, J; PEARCE, N; WINKELMANN, R			CANCER MORTALITY IN WORKERS EXPOSED TO CHLOROPHENOXY HERBICIDES AND CHLOROPHENOLS	LANCET			English	Article							SOFT-TISSUE SARCOMA; NON-HODGKINS-LYMPHOMA; FOLLOW-UP; PHENOXY HERBICIDES; DIOXIN EXPOSURE; CASE-REFERENT; RISK; 2,3,7,8-TCDD; MANUFACTURE; ACIDS	Epidemiological studies have revealed an increased risk of cancer, notably soft-tissue sarcomas and non-Hodgkin's lymphomas, in people occupationally exposed to chlorophenoxy herbicides, including those contaminated by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD). We report here a historical cohort study of mortality in an international register of 18910 production workers or sprayers from ten countries. Exposure was reconstructed through questionnaires, factory or spraying records, and job histories. Cause-specific national death rates were used as reference. No excess was observed in all-cause mortality, for all neoplasms, for the most common epithelial cancers, or for lymphomas. A statistically non-significant two-fold excess risk, based on 4 observed deaths, was noted for soft-tissue sarcoma with a standardised mortality ratio (SMR) of 196 and 95% confidence interval (CI) 53-502; this was concentrated as a six-fold statistically significant excess, occurring 10-19 years from first exposure in the cohort as a whole (SMR = 606 [165-1552]) and, for the same time period, as a nine-fold excess among sprayers (SMR = 882 [182-2579]). Risks appeared to be increased for cancers of the testicle, thyroid, other endocrine glands, and nose and nasal cavity, based on small numbers of deaths. The excess of soft-tissue sarcomas among sprayers is compatible with a causal role of chlorophenoxy herbicides but the excess does not seem to be specifically associated with those herbicides probably contaminated by TCDD.	UNIV MILAN,I-20122 MILAN,ITALY; NATL INST PUBL HLTH & ENVIRONM PROTECT,BILTHOVEN,NETHERLANDS; UNIV SOUTHAMPTON,MRC,ENVIRONM EPIDEMIOL UNIT,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND; ONTARIO HYDRO,TORONTO,ONTARIO,CANADA; UNIV TORONTO,DEPT PREVENT MED & BIOSTAT,TORONTO M5S 1A1,ONTARIO,CANADA; INST OCCUPAT HLTH,SF-00290 HELSINKI 29,FINLAND; UNIV LUND,S-22101 LUND,SWEDEN; DANISH CANC REGISTRY,COPENHAGEN,DENMARK; MENZIES SCH HLTH RES,CASUARINA,AUSTRALIA; INST ENVIRONM HYG,VIENNA,AUSTRIA; HLTH & SAFETY EXECUT,BOOTLE,MERSEYSIDE,ENGLAND; WELLINGTON CLIN SCH MED,WELLINGTON,NEW ZEALAND	University of Milan; Netherlands National Institute for Public Health & the Environment; University of Southampton; University of Toronto; Finnish Institute of Occupational Health; Lund University; Charles Darwin University; Menzies School of Health Research; University of Otago	SARACCI, R (corresponding author), INT AGCY RES CANC,ANALYT EPIDEMIOL UNIT,150 COURS ALBERT THOMAS,F-69372 LYONS,FRANCE.		bertazzi, pietro alberto/D-5039-2017; Kogevinas, Manolis/C-3918-2017	bertazzi, pietro alberto/0000-0003-3475-2449; Kogevinas, Manolis/0000-0002-9605-0461; Lynge, Elsebeth/0000-0003-4785-5236; Mathews, John/0000-0001-9029-7140	NIEHS NIH HHS [1-ES-95276] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES095276] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BERTAZZI PA, 1989, AM J EPIDEMIOL, V129, P1187, DOI 10.1093/oxfordjournals.aje.a115240; BOND GG, 1988, BRIT J IND MED, V45, P98; Checkoway H., 1989, RES METHODS OCCUPATI; COGGON D, 1991, BRIT J IND MED, V48, P173; COGGON D, 1986, SCAND J WORK ENV HEA, V12, P448, DOI 10.5271/sjweh.2113; COLEMAN MP, 1989, WHOIARC89006 INT REP; COOK RR, 1986, CHEMOSPHERE, V15, P1969; DALDERUP LM, 1983, LANCET, V2, P1134; ERIKSSON M, 1981, BRIT J IND MED, V38, P27; ERIKSSON M, 1990, J NATL CANCER I, V82, P486, DOI 10.1093/jnci/82.6.486; FINGERHUT MA, 1984, SCAND J WORK ENV HEA, V10, P299, DOI 10.5271/sjweh.2325; FINGERHUT MA, 1991, NEW ENGL J MED, V324, P212, DOI 10.1056/NEJM199101243240402; GREEN LM, 1991, BRIT J IND MED, V48, P234; HARDELL L, 1979, BRIT J CANCER, V39, P711, DOI 10.1038/bjc.1979.125; HARDELL L, 1981, BRIT J CANCER, V43, P169, DOI 10.1038/bjc.1981.25; HOAR SK, 1986, JAMA-J AM MED ASSOC, V256, P1141, DOI 10.1001/jama.256.9.1141; HUFF JE, 1991, CELL BIOL TOXICOL, V7, P67, DOI 10.1007/BF00121331; LILIENFELD DE, 1989, EPIDEMIOL REV, V11, P28, DOI 10.1093/oxfordjournals.epirev.a036044; LYNGE E, 1985, BRIT J CANCER, V52, P259, DOI 10.1038/bjc.1985.186; PEARCE NE, 1986, BRIT J IND MED, V43, P75; PERSSON B, 1989, BRIT J IND MED, V46, P516; SMITH AH, 1984, J NATL CANCER I, V72, P111; VINEIS P, 1987, SCAND J WORK ENV HEA, V13, P9, DOI 10.5271/sjweh.2077; WIGLE DT, 1990, J NATL CANCER I, V82, P575, DOI 10.1093/jnci/82.7.575; WIKLUND K, 1989, BRIT J IND MED, V46, P809; WOODS JS, 1987, J NATL CANCER I, V78, P899; ZHAM SH, 1990, EPIDEMIOLOGY, V1, P349; ZOBER A, 1990, INT ARCH OCC ENV HEA, V62, P139, DOI 10.1007/BF00383591; 1986, MONOGRAPHS EVALUATIO, V41, P395; 1987, IARC MONOGR S7, V1; 1967, MANUAL INT STATISTIC; 1990, AM J IND MED, V18, P39; 1957, MANUAL INT STATISTIC; 1978, MANUAL INT STATISTIC; 1986, MONOGRAPHS EVALUATIO, V41, P346; 1988, MMWR, V48, P733	36	196	200	0	26	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1027	1032		10.1016/0140-6736(91)91898-5	http://dx.doi.org/10.1016/0140-6736(91)91898-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681353				2022-12-28	WOS:A1991GM25300001
J	SCOTT, JK; SMITH, GP				SCOTT, JK; SMITH, GP			SEARCHING FOR PEPTIDE LIGANDS WITH AN EPITOPE LIBRARY	SCIENCE			English	Article									UNIV MISSOURI,DIV BIOL SCI,TUCKER HALL,COLUMBIA,MO 65211; UNIV MISSOURI,DEPT MED,COLUMBIA,MO 65212	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041478] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41478] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CWIRLA SE, IN PRESS P NATL ACAD; DAY LA, 1969, J MOL BIOL, V39, P265, DOI 10.1016/0022-2836(69)90316-7; DELACRUZ VF, 1988, J BIOL CHEM, V263, P4318; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; GEYSEN HM, 1986, CIBA F S, V119, P131; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LATHE R, 1984, DNA CELL BIOL, V3, P174; LIN TC, 1980, J BIOL CHEM, V215, P10331; Maniatis T., 1982, MOL CLONING; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NER SS, 1988, BIOTECHNIQUES, V6, P408; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; RICHARDS FF, 1975, SCIENCE, V187, P130, DOI 10.1126/science.46122; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT JK, 1990, ADV GENE TECHNOLOGY, P224; SMITH GP, 1988, VIROLOGY, V167, P156, DOI 10.1016/0042-6822(88)90065-7; SMITH GP, 1987, VECTORS SURVEY MOL C, P61; SUTRA EA, 1989, J BIOL CHEM, V264, P15721; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; WICKNER W, 1975, P NATL ACAD SCI USA, V72, P4749, DOI 10.1073/pnas.72.12.4749	23	1835	2882	3	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 27	1990	249	4967					386	390		10.1126/science.1696028	http://dx.doi.org/10.1126/science.1696028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ702	1696028				2022-12-28	WOS:A1990DQ70200033
J	TRAYNELIS, SF; CULLCANDY, SG				TRAYNELIS, SF; CULLCANDY, SG			PROTON INHIBITION OF N-METHYL-D-ASPARTATE RECEPTORS IN CEREBELLAR NEURONS	NATURE			English	Article											TRAYNELIS, SF (corresponding author), UNIV LONDON UNIV COLL,DEPT PHARMACOL,GOWER ST,LONDON WC1E 6BT,ENGLAND.			Cull-Candy, Stuart G/0000-0002-0831-8326	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALESTRINO M, 1988, J PHYSIOL-LONDON, V396, P247, DOI 10.1113/jphysiol.1988.sp016961; CHESLER M, 1988, NEUROSCIENCE, V27, P941, DOI 10.1016/0306-4522(88)90197-2; CIDON S, 1989, J BIOL CHEM, V264, P8281; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; CULLCANDY SG, 1988, J PHYSIOL-LONDON, V400, P189, DOI 10.1113/jphysiol.1988.sp017117; DINGLEDINE R, 1988, CRIT REV NEUROBIOL, V4, P1; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GRANTYN R, 1988, NEUROSCI LETT, V89, P198, DOI 10.1016/0304-3940(88)90381-3; GRUOL DL, 1980, BRAIN RES, V183, P247, DOI 10.1016/0006-8993(80)90138-9; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; MAYER ML, 1989, J PHYSIOL-LONDON, V415, P329, DOI 10.1113/jphysiol.1989.sp017724; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MORAD M, 1988, Society for Neuroscience Abstracts, V14, P791; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PATLAK JB, 1988, J GEN PHYSIOL, V92, P413, DOI 10.1085/jgp.92.4.413; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; PIETROBON D, 1988, NATURE, V333, P373, DOI 10.1038/333373a0; TANG C M, 1989, Society for Neuroscience Abstracts, V15, P326; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121	30	469	484	0	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 24	1990	345	6273					347	350		10.1038/345347a0	http://dx.doi.org/10.1038/345347a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF149	1692970				2022-12-28	WOS:A1990DF14900067
J	LAVER, WG; AIR, GM; WEBSTER, RG; SMITHGILL, SJ				LAVER, WG; AIR, GM; WEBSTER, RG; SMITHGILL, SJ			EPITOPES ON PROTEIN ANTIGENS - MISCONCEPTIONS AND REALITIES	CELL			English	Review									UNIV ALABAMA, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA; ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA; NCI, GENET LAB, BETHESDA, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	LAVER, WG (corresponding author), AUSTRALIAN NATL UNIV, JOHN CURTIN SCH MED RES, CANBERRA, ACT 2601, AUSTRALIA.			Air, Gillian/0000-0001-5724-3108				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; DAVIES DR, 1990, IN PRESS ANN REV BIO, V59; GOODMAN JW, 1989, ANTIGENIC DETERMINAN, P1; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; JEMMERSON R, 1989, MOL IMMUNOL, V26, P301, DOI 10.1016/0161-5890(89)90084-9; JERNE NK, 1960, ANNU REV MICROBIOL, V14, P341, DOI 10.1146/annurev.mi.14.100160.002013; LAVOIE TB, 1990, USE OF X-RAY CRYSTALLOGRAPHY IN THE DESIGN OF ANTIVIRAL AGENTS, P213; NOVOTNY J, 1990, IN PRESS MOL IMMUNOL; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; SELA M, 1969, SCIENCE, V166, P1365, DOI 10.1126/science.166.3911.1365; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; TULIP WR, 1990, COLD SPRING HARB SYM, V54, P257	13	480	517	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 18	1990	61	4					553	556		10.1016/0092-8674(90)90464-P	http://dx.doi.org/10.1016/0092-8674(90)90464-P			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE904	1693095				2022-12-28	WOS:A1990DE90400002
J	THUMMEL, CS; BURTIS, KC; HOGNESS, DS				THUMMEL, CS; BURTIS, KC; HOGNESS, DS			SPATIAL AND TEMPORAL PATTERNS OF E74 TRANSCRIPTION DURING DROSOPHILA DEVELOPMENT	CELL			English	Article									STANFORD UNIV,MED CTR,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305	Stanford University				Burtis, Kenneth/0000-0002-9644-3265				ASHBURNER M, 1972, CHROMOSOMA, V38, P255, DOI 10.1007/BF00290925; ASHBURNER M, 1974, DEV BIOL, V39, P141, DOI 10.1016/S0012-1606(74)80016-3; Ashburner M, 1974, Cold Spring Harb Symp Quant Biol, V38, P655; ASHBURNER M, 1976, INSECT DEV, P203; Bodenstein D, 1965, BIOL DROSOPHILA, P275; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; BURTIS KC, 1985, THESIS STANFORD U ST; CHAO AT, 1986, EMBO J, V5, P143, DOI 10.1002/j.1460-2075.1986.tb04188.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; GIETZ RD, 1985, DEV BIOL, V107, P142, DOI 10.1016/0012-1606(85)90383-5; HAFEN E, 1986, DROSOPHILA PRACTICAL, P139; HANDLER AM, 1982, DEV BIOL, V93, P73, DOI 10.1016/0012-1606(82)90240-8; HODGETTS RB, 1977, DEV BIOL, V60, P310, DOI 10.1016/0012-1606(77)90128-2; Kafatos F C, 1972, Curr Top Dev Biol, V7, P125, DOI 10.1016/S0070-2153(08)60071-X; KRAMINSKY GP, 1980, P NATL ACAD SCI-BIOL, V77, P4175, DOI 10.1073/pnas.77.7.4175; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; RICHARDS G, 1981, BIOL REV, V56, P501, DOI 10.1111/j.1469-185X.1981.tb00358.x; RICHARDS G, 1976, DEV BIOL, V54, P264, DOI 10.1016/0012-1606(76)90304-3; RICHARDS G, 1981, MOL CELL ENDOCRINOL, V21, P181, DOI 10.1016/0303-7207(81)90013-7; RICHARDS G, 1976, DEV BIOL, V54, P256, DOI 10.1016/0012-1606(76)90303-1; RICHARDS G, 1982, ROUX ARCH DEV BIOL, V191, P103, DOI 10.1007/BF00848447; RICHARDS GP, 1976, DEV BIOL, V48, P191, DOI 10.1016/0012-1606(76)90057-9; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROBB JA, 1969, J CELL BIOL, V41, P876, DOI 10.1083/jcb.41.3.876; SEED B, 1982, NUCLEIC ACIDS RES, V10, P1799, DOI 10.1093/nar/10.5.1799; SEGRAVES WA, 1990, IN PRESS GENES DEV; SEGRAVES WA, 1988, THESIS STANFORD U ST; UCKER DS, 1984, J BIOL CHEM, V259, P7416; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; Wolfner M.F., 1988, Drosophila Information Service, V67, P104	32	224	226	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					101	111		10.1016/0092-8674(90)90218-4	http://dx.doi.org/10.1016/0092-8674(90)90218-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	1690603				2022-12-28	WOS:A1990CY38200013
J	SCOTT, JES; LEE, REJ; HUNTER, EW; COULTHARD, MG; MATTHEWS, JNS				SCOTT, JES; LEE, REJ; HUNTER, EW; COULTHARD, MG; MATTHEWS, JNS			ULTRASOUND SCREENING OF NEWBORN URINARY-TRACT	LANCET			English	Article							REFLUX; INFANTS	A non-invasive method to screen newborn babies for ureteric reflux might allow the possibility of appropriate action to prevent reflux nephropathy. We have tested the sensitivity of ultrasound screening of the urinary tract. 1061 unselected newborn infants born during 1986 were examined by ultrasound and the findings were recorded on videotape. Babies with dilated renal collecting systems underwent further investigations (micturating cystourethrography, intravenous urography, or radioisotope study). With these methods, 11 children were found to have renal disorders. A postal follow-up survey was carried out when the children were 3 years old. 657 (62%) families responded. We searched for non-responders among children born in 1986 who had subsequently had a renal radioisotope investigation: 5 nonresponders were found among these children. Of the total, 24 children had had a urinary-tract infection: 3 more children with ureteric reflux were found; their neonatal ultrasound scans had suggested no abnormality. Thus, mom than half the children of this cohort in whom hydronephrosis or ureteric reflux developed had only slight dilatation (less than 5 mm) on the neonatal scan. On review of the original videotapes there was no difference in internal dimension between left and right kidneys: the internal dimension was 5 mm or less in both kidneys in 96.5% of babies and 4 mm or less in 93.3%. Routine renal ultrasound scanning of newborn babies is of no value in detecting those who may have ureteric reflux: the number of other renal abnormalities likely to be detected is small.	ROYAL VICTORIA INFIRM,DEPT RADIOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND; ROYAL VICTORIA INFIRM,DEPT CHILD HLTH,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT SURG,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; UNIV NEWCASTLE UPON TYNE,SCH MED,DIV MED STAT,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK			Matthews, John N S/H-7502-2013	Matthews, John N S/0000-0003-2559-037X				ANDERSON PAM, 1991, BRIT J UROL, V67, P267, DOI 10.1111/j.1464-410X.1991.tb15132.x; DIARD F, 1987, PEDIATR RADIOL, V17, P154, DOI 10.1007/BF02388097; FALKOFF GE, 1987, RADIOLOGY, V162, P343, DOI 10.1148/radiology.162.2.3541028; GORDON AC, 1990, BRIT J UROL, V65, P407, DOI 10.1111/j.1464-410X.1990.tb14766.x; HODSON C J, 1960, Clin Radiol, V11, P219, DOI 10.1016/S0009-9260(60)80047-5; MARSHALL JL, 1990, RADIOLOGY, V175, P355, DOI 10.1148/radiology.175.2.2183279; PLACKETT RL, 1981, ANAL CATEGORICAL DAT, P79; SCOTT JES, 1987, BRIT J UROL, V59, P291, DOI 10.1111/j.1464-410X.1987.tb04634.x; SCOTT JES, 1990, ARCH DIS CHILD-FETAL, V65, P361, DOI 10.1136/adc.65.4_Spec_No.361; STEINHART JM, 1988, PEDIATRICS, V82, P609; 1991, LANCET, V338, P1050	11	39	39	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1571	1573		10.1016/0140-6736(91)92385-F	http://dx.doi.org/10.1016/0140-6736(91)92385-F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683982				2022-12-28	WOS:A1991GW03600015
J	FORRESTER, JV				FORRESTER, JV			UVEITIS - PATHOGENESIS	LANCET			English	Article							EXPERIMENTAL AUTOIMMUNE UVEITIS; LEWIS RATS; LYMPHOCYTES; ANTIGEN; ENCEPHALOMYELITIS; RECOGNITION; MECHANISMS; RETINA; CELLS				FORRESTER, JV (corresponding author), UNIV ABERDEEN,DEPT OPHTHALMOL,ABERDEEN AB9 2ZD,SCOTLAND.							ACHAORBEA H, 1991, IMMUNOL TODAY, V12, P356, DOI 10.1016/0167-5699(91)90066-3; AMANO K, 1990, DIABETES, V39, P590, DOI 10.2337/diabetes.39.5.590; CANELLA B, 1991, LAB INVEST, V65, P23; CHAN CC, 1987, ARCH OPHTHALMOL-CHIC, V105, P1398, DOI 10.1001/archopht.1987.01060100100036; COHEN IR, 1988, SCI AM, V258, P34; COOKE A, 1991, CLIN EXP IMMUNOL, V83, P345; DESCHENES J, 1988, BRIT J OPHTHALMOL, V72, P83, DOI 10.1136/bjo.72.2.83; DONOSO LA, 1987, CURR EYE RES, V6, P1151, DOI 10.3109/02713688709034888; DOYER JM, 1986, FEBS LETT, V198, P208; DUKEELDER S, 1934, LANCET, V2, P100; FELTKAMP T E W, 1990, Eye (London), V4, P839; FORRESTER JV, 1990, CURR EYE RES, V9, P75, DOI 10.3109/02713689008999424; GERY I, 1986, PROGR RETINAL RES, V5, P75; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; KAPLAN HJ, 1984, ARCH OPHTHALMOL-CHIC, V102, P572; KILJSTRA A, 1990, EYE, V4, P732; LIVERSIDGE J, 1988, CURR EYE RES, V7, P1231, DOI 10.3109/02713688809033227; LIVERSIDGE J, 1990, IMMUNOLOGY, V71, P390; MERRYMAN CF, 1991, J IMMUNOL, V146, P75; MOCHIZUKI M, 1985, INVEST OPHTH VIS SCI, V26, P1; MULLERHERMELINK HK, 1984, ARCH OPHTHALMOL-CHIC, V102, P1353; PRIEM HA, 1988, AM J OPHTHALMOL, V105, P182, DOI 10.1016/0002-9394(88)90183-3; ROTHOVA A, 1991, LANCET, V337, P490, DOI 10.1016/0140-6736(91)93424-8; SANUI H, 1989, J EXP MED, V169, P1947, DOI 10.1084/jem.169.6.1947; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; WACKER WB, 1977, J IMMUNOL, V119, P1949; WAKEFIELD D, 1990, ARCH OPHTHALMOL-CHIC, V108, P219, DOI 10.1001/archopht.1990.01070040071033; WITMER R, 1978, AM J OPHTHALMOL, V86, P39, DOI 10.1016/0002-9394(78)90012-0; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; WRAITH DC, 1989, CELL, V57, P709, DOI 10.1016/0092-8674(89)90786-1	30	104	104	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1498	1501		10.1016/0140-6736(91)92309-P	http://dx.doi.org/10.1016/0140-6736(91)92309-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683927				2022-12-28	WOS:A1991GV07700013
J	YOUNG, LS; WIVIOTT, L; WU, M; KOLONOSKI, P; BOLAN, R; INDERLIED, CB				YOUNG, LS; WIVIOTT, L; WU, M; KOLONOSKI, P; BOLAN, R; INDERLIED, CB			AZITHROMYCIN FOR TREATMENT OF MYCOBACTERIUM-AVIUM-INTRACELLULARE COMPLEX INFECTION IN PATIENTS WITH AIDS	LANCET			English	Note							CP-62,993; INVITRO; INVIVO	Mycobacterium avium complex infection is common in patients with AIDS. Experimentally infected mice have been treated successfully with azithromycin, a macrolide antibiotic. We report an uncontrolled phase I study in which male homosexuals with AIDS and M avium complex disease were given 500 mg azithromycin per day orally for 10, 20, or 30 days. Quantitative blood cultures showed a mean reduction in mycobacteraemia from 118 colony forming units (cfu)/ml to 43 cfu/ml in 3 patients treated for 10 days, and from 2028 cfu/ml to 136 cfu/ml in 21 patients treated for 20 or 30 days. Of the patients treated for 20 or 30 days, 15 of 21 with fever pretreatment and 12 of 18 with night sweats pretreatment reported resolution of these symptoms. The principal side-effects were loose stools or diarrhoea, but these did not result in cessation of therapy. Azithromycin, as a single oral agent, safely reduced M avium complex bacteraemia and associated symptoms in almost 75% of patients treated for at least 20 days. Further studies are needed to assess emergence of resistance.	PACIFIC PRESBYTERIAN MED CTR,SAN FRANCISCO,CA; UNIV SO CALIF,CHILDRENS HOSP,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90027	California Pacific Medical Center; Children's Hospital Los Angeles; University of Southern California	YOUNG, LS (corresponding author), MED RES INST SAN FRANCISCO,KUZELL INST ARTHRITIS & INFECT DIS,22000 WEBSTER ST,SUITE 305,SAN FRANCISCO,CA 94115, USA.		Bolan, Robert/AAD-4716-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI072637] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-72637] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENSON CA, 1991, ARCH INTERN MED, V151, P582, DOI 10.1001/archinte.151.3.582; BLACK CM, 1990, J EXP MED, V172, P977, DOI 10.1084/jem.172.3.977; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; GIRARD AE, 1987, ANTIMICROB AGENTS CH, V31, P1948, DOI 10.1128/AAC.31.12.1948; GLADUE RP, 1990, ANTIMICROB AGENTS CH, V34, P1056, DOI 10.1128/AAC.34.6.1056; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; HOY J, 1990, J INFECT DIS, V161, P801, DOI 10.1093/infdis/161.4.801; INDERLIED CB, 1989, J INFECT DIS, V159, P994, DOI 10.1093/infdis/159.5.994; INDERLIED CB, 1987, ANTIMICROB AGENTS CH, V31, P1697, DOI 10.1128/AAC.31.11.1697	9	194	194	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1107	1109		10.1016/0140-6736(91)91965-W	http://dx.doi.org/10.1016/0140-6736(91)91965-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682544				2022-12-28	WOS:A1991GM78400005
J	LIPPINCOTTSCHWARTZ, J; YUAN, L; TIPPER, C; AMHERDT, M; ORCI, L; KLAUSNER, RD				LIPPINCOTTSCHWARTZ, J; YUAN, L; TIPPER, C; AMHERDT, M; ORCI, L; KLAUSNER, RD			BREFELDIN-AS EFFECTS ON ENDOSOMES, LYSOSOMES, AND THE TGN SUGGEST A GENERAL MECHANISM FOR REGULATING ORGANELLE STRUCTURE AND MEMBRANE TRAFFIC	CELL			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; TRANS-GOLGI NETWORK; ENDOPLASMIC-RETICULUM; IMMUNOELECTRON MICROSCOPY; INTRACELLULAR-TRANSPORT; CARCINOMA A431-CELLS; SECRETORY PROTEINS; PLASMA-MEMBRANE; RAT PANCREAS; TRANSFERRIN	Addition of brefeldin A (BFA) to most cells results in both the formation of extensive, uncoated membrane tubules through which Golgi components redistribute into the ER and the failure to transport molecules out of this mixed ER/Golgi system. In this study we provide evidence that suggests BFA's effects are not limited to the Golgi apparatus but are reiterated throughout the central vacuolar system. Addition of BFA to cells resulted in the tubulation of the endosomal system, the trans-Golgi network (TGN), and lysosomes. Tubule formation of these organelles was specific to BFA, shared near identical pharmacologic characteristics as Golgi tubules and resulted in targeted membrane fusion. Analogous to the mixing of the Golgi with the ER during BFA treatment, the TGN mixed with the recycling endosomal system. This mixed system remained functional with normal cycling between plasma membrane and endosomes, but traffic between endosomes and lysosomes was impaired.	UNIV GENEVA, INST HISTOL & EMBRYOL, DEPT MORPHOL, CH-1211 GENEVA 4, SWITZERLAND	University of Geneva	LIPPINCOTTSCHWARTZ, J (corresponding author), NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA.							ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; BURKE B, 1984, CELL, V36, P847, DOI 10.1016/0092-8674(84)90034-5; CHEGE NW, 1990, J CELL BIOL, V111, P893, DOI 10.1083/jcb.111.3.893; COOPER MS, 1990, CELL, V61, P135, DOI 10.1016/0092-8674(90)90221-Y; DABORA SL, 1988, CELL, V54, P27, DOI 10.1016/0092-8674(88)90176-6; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DIMENT S, 1988, J BIOL CHEM, V263, P6901; DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; HEUSER J, 1989, J CELL BIOL, V109, P1457, DOI 10.1083/jcb.109.4.1457; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; HSU VW, 1991, NATURE, V352, P441, DOI 10.1038/352441a0; HUNZIKER W, 1991, CELL, V67, P617, DOI 10.1016/0092-8674(91)90535-7; KLAUSNER RD, 1989, CELL, V57, P703, DOI 10.1016/0092-8674(89)90783-6; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KTISTAKIS NT, 1991, J CELL BIOL, V113, P1009, DOI 10.1083/jcb.113.5.1009; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; LUZIO JP, 1990, BIOCHEM J, V270, P97, DOI 10.1042/bj2700097; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOREMEN KW, 1985, J BIOL CHEM, V260, P6654; ORCI L, 1973, J ULTRA MOL STRUCT R, V43, P270, DOI 10.1016/S0022-5320(73)80039-5; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1987, CELL, V51, P1039, DOI 10.1016/0092-8674(87)90590-3; ORCI L, 1991, CELL, V64, P1183; SARASTE J, 1987, J CELL BIOL, V105, P2021, DOI 10.1083/jcb.105.5.2021; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; SWANSON J, 1987, J CELL BIOL, V104, P1217, DOI 10.1083/jcb.104.5.1217; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1, P101; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; YUAN L, 1987, J CELL BIOL, V105, P215, DOI 10.1083/jcb.105.1.215	48	746	751	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 1	1991	67	3					601	616		10.1016/0092-8674(91)90534-6	http://dx.doi.org/10.1016/0092-8674(91)90534-6			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1682055				2022-12-28	WOS:A1991GN66400016
J	YUDKIN, PL; ELLISON, GW; GHEZZI, A; GOODKIN, DE; HUGHES, RAC; MCPHERSON, K; MERTIN, J; MILANESE, C				YUDKIN, PL; ELLISON, GW; GHEZZI, A; GOODKIN, DE; HUGHES, RAC; MCPHERSON, K; MERTIN, J; MILANESE, C			OVERVIEW OF AZATHIOPRINE TREATMENT IN MULTIPLE-SCLEROSIS	LANCET			English	Article							DISABILITY STATUS SCALE; IMMUNOSUPPRESSIVE TREATMENT; CLINICAL-TRIAL; FINAL REPORT; PLACEBO; ACTH	The efficacy of azathioprine in the treatment of multiple sclerosis was assessed by meta-analysis of the results of all published blind, randomised, controlled trials. 793 patients were enrolled in 5 double-blind and 2 single-blind studies. After 1 year of treatment, the increase in Kurtzke disability status score was no different in treated and control groups, but at 2 years there was a small difference (-0.22; 95% confidence interval [CI] -0.43, 0.003) in favour of azathioprine treatment; this difference was sustained, but not increased, after 3 years. The probability of freedom from any relapse during 1, 2, and 3 years' treatment was significantly greater in the azathioprine-treated group (relative odds over 3 years 1.97; 95% CI 1.27, 3.04), but it is debatable whether the slight clinical benefits of azathioprine outweigh its side-effects.	UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT NEUROL,ST THOMAS ST,LONDON SE1 9RT,ENGLAND; RADCLIFFE INFIRM,DEPT PUBL HLTH & PRIMARY CARE,OXFORD OX2 6HE,ENGLAND; UNIV CALIF LOS ANGELES,SCH MED,DEPT NEUROL,LOS ANGELES,CA 90024; MELLEN CTR MULTIPLE SCLEROSIS TREATMENT & RES,CLEVELAND,OH; UNIV LONDON LONDON SCH HYG & TROP MED,DEPT PUBL HLTH & POLICY,LONDON WC1E 7HT,ENGLAND; THERAPIEZENTRUM BURGAU,BURGAU,GERMANY; IST NEUROCHIRURG C BESTA,I-20133 MILAN,ITALY; CTR STUDI SCLEROSI MULTIPLE,GALLARATE,ITALY	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Radcliffe Infirmary; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; London School of Hygiene & Tropical Medicine			ghezzi, angelo/AAJ-9606-2020					COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; ELLISON GW, 1989, NEUROLOGY, V39, P1018, DOI 10.1212/WNL.39.8.1018; FRANCIS DA, 1991, ARCH NEUROL-CHICAGO, V48, P299, DOI 10.1001/archneur.1991.00530150067020; Ghezzi A, 1989, RECENT ADV MULTIPLE; GOODKIN DE, 1991, NEUROLOGY, V41, P20, DOI 10.1212/WNL.41.1.20; GOODKIN DE, 1988, ARCH PHYS MED REHAB, V69, P850; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056/NEJM198301273080401; HOMMES OR, 1975, CLIN NEUROL NEUROSUR, V78, P59, DOI 10.1016/S0303-8467(75)80007-2; KINLEN LJ, 1985, AM J MED, V78, P44, DOI 10.1016/0002-9343(85)90245-1; KURTZKE JF, 1989, NEUROLOGY, V39, P291, DOI 10.1212/WNL.39.2.291; LHERMITTE F, 1984, REV NEUROL, V140, P553; MCALPINE D, 1952, Q J MED, V21, P135; MERTIN J, 1982, LANCET, V2, P351; MICKEY MR, 1984, NEUROLOGY, V34, P1343, DOI 10.1212/WNL.34.10.1343; MILANESE C, 1988, ITAL J NEUROL SCI, V9, P53, DOI 10.1007/BF02334408; NOSEWORTHY JH, 1990, NEUROLOGY, V40, P971, DOI 10.1212/WNL.40.6.971; PATZOLD U, 1978, NERVENARZT, V49, P285; PATZOLD U, 1982, J NEUROL SCI, V54, P377, DOI 10.1016/0022-510X(82)90201-5; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; ROSE AS, 1970, NEUROLOGY, V20, P1; ROSEN JA, 1979, J NEUROL NEUROSUR PS, V42, P338, DOI 10.1136/jnnp.42.4.338; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; SWINBURN WR, 1973, J NEUROL NEUROSUR PS, V36, P124, DOI 10.1136/jnnp.36.1.124; YUDKIN PL, 1989, LANCET, V2, P101; ZEEBERG IE, 1985, EUR NEUROL, V24, P435; 1988, LANCET, V2, P179	26	191	194	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1051	1055		10.1016/0140-6736(91)91909-E	http://dx.doi.org/10.1016/0140-6736(91)91909-E			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681364				2022-12-28	WOS:A1991GM25300012
J	HERSH, BS; POPOVICI, F; APETREI, RC; ZOLOTUSCA, L; BELDESCU, N; CALOMFIRESCU, A; JEZEK, Z; OXTOBY, MJ; GROMYKO, A; HEYMANN, DL				HERSH, BS; POPOVICI, F; APETREI, RC; ZOLOTUSCA, L; BELDESCU, N; CALOMFIRESCU, A; JEZEK, Z; OXTOBY, MJ; GROMYKO, A; HEYMANN, DL			ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN ROMANIA	LANCET			English	Article							HIV-1 INFECTION; VIRUS; CHILDREN; AIDS; SEROPOSITIVITY; KINSHASA; ZAIRE	After the initial description of acquired immunodeficiency syndrome (AIDS) in Romania in late 1989, national AIDS case surveillance was established with a modified version of the World Health Organisation (WHO) clinical case definition. This modified case definition requires that AIDS cases have both clinical and serological evidence of human immunodeficiency virus (HIV) infection. Before December, 1989, Romania had reported 13 AIDS cases to WHO. By Dec 31, 1990, 1168 AIDS cases were reported to Romania's Ministry of Health, of which 1094 (93.7%) occurred in children less than 13 years of age at diagnosis. Of these, 1086 (99.3%) were in infants and children less than 4 years of age, and 683 (62.4%) in abandoned children living in public institutions at the time of diagnosis. By Dec 31, 1990, 493 (45.1%) mothers of children with AIDS had been located and tested, and 37 (7.5%) were positive for HIV; 423 (38.7%) cases were in children who had received transfusions of unscreened blood, and 6 (0.5%) were in children with clotting disorders. HIV transmission through the improper use of needles and syringes is strongly suspected in most of the remaining 628 (57.4%) children with AIDS, most of whom had received multiple therapeutic injections. This outbreak demonstrates the serious potential for HIV transmission in medical facilities that intensively and improperly use parenteral therapy and have poor sterilisation technique.	MINIST HLTH,DEPT PREVENT MED,BUCHAREST,ROMANIA; WHO,GLOBAL PROGRAMME AIDS,CH-1211 GENEVA 27,SWITZERLAND; WHO,REG OFF EUROPE,GLOBAL PROGRAMME AIDS,COPENHAGEN,DENMARK	World Health Organization; World Health Organization	HERSH, BS (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,DIV HIV AIDS E47,ATLANTA,GA 30333, USA.							ALMOND M, 1988, DECLINE FALL ROMANIA; AUGER I, 1988, NATURE, V336, P575, DOI 10.1038/336575a0; BOHLEN C, 1990, NY TIMES        0208; BROOKMEYER R, 1989, BIOMETRICS, V45, P325, DOI 10.2307/2532057; DESJARLAIS DC, 1989, JAMA-J AM MED ASSOC, V261, P1008, DOI 10.1001/jama.261.7.1008; FRIEDLAND GH, 1987, NEW ENGL J MED, V317, P1125, DOI 10.1056/NEJM198710293171806; GREENBERG AE, 1988, JAMA-J AM MED ASSOC, V259, P545, DOI 10.1001/jama.259.4.545; LEPAGE P, 1986, LANCET, V2, P1103; MANN JM, 1986, LANCET, V2, P654; MOSKOFF W, 1980, ECON DEV CULT CHANGE, V28, P597, DOI 10.1086/451199; OXTOBY MJ, 1990, PEDIATR INFECT DIS J, V9, P609; PATRASCU IV, 1990, LANCET, V335, P672, DOI 10.1016/0140-6736(90)90466-I; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; RUDIN C, 1990, LANCET, V336, P1592, DOI 10.1016/0140-6736(90)93380-8; SOETERS R, 1989, TROP DOCT, V19, P124, DOI 10.1177/004947558901900310; WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406; 1991, WKLY EPIDEMIOL RES, V66, P109; 1986, WKLY EPIDEMIOL REC, V61, P69; 1990, WKLY EPIDEMIOL REC, V65, P56; 1990, WKLY EPIDEMIOL REC, V65, P1; 1990, HELSINKI WATCH ROMAN; 1990, HIV AIDS SURVEILLANC; 1989, 1989 M TECHN WORK GR	23	107	108	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					645	649		10.1016/0140-6736(91)91230-R	http://dx.doi.org/10.1016/0140-6736(91)91230-R			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679471				2022-12-28	WOS:A1991GF10500001
J	YAMASHINA, M; UEDA, E; KINOSHITA, T; TAKAMI, T; OJIMA, A; ONO, H; TANAKA, H; KONDO, N; ORII, T; OKADA, N; OKADA, H; INOUE, K; KITANI, T				YAMASHINA, M; UEDA, E; KINOSHITA, T; TAKAMI, T; OJIMA, A; ONO, H; TANAKA, H; KONDO, N; ORII, T; OKADA, N; OKADA, H; INOUE, K; KITANI, T			INHERITED COMPLETE DEFICIENCY OF 20-KILODALTON HOMOLOGOUS RESTRICTION FACTOR-(CD59) AS A CAUSE OF PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									GIFU UNIV,SCH MED,DEPT PEDIAT,GIFU 500,JAPAN; OSAKA UNIV,MICROBIAL DIS RES INST,DEPT CLIN RES,DIV INTERNAL MED,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT BACTERIOL,SUITA,OSAKA 565,JAPAN; GIFU PREFECTURAL GIFU HOSP,DEPT PEDIAT,GIFU,JAPAN; FUKUOKA UNIV,SCH MED,DEPT MICROBIOL,FUKUOKA 81401,JAPAN; NAGOYA CITY UNIV,SCH MED,DEPT MOLEC BIOL,NAGOYA,AICHI 467,JAPAN	Gifu University; Osaka University; Osaka University; Fukuoka University; Nagoya City University	YAMASHINA, M (corresponding author), GIFU UNIV,SCH MED,DEPT PATHOL,40 TSUKUBA MACHI,GIFU 500,JAPAN.		Kinoshita, Taroh/C-7353-2009					Bayer E A, 1979, Methods Enzymol, V62, P308; CHOW FL, 1986, BLOOD, V67, P893; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; DAVITZ MA, 1986, J EXP MED, V163, P1150, DOI 10.1084/jem.163.5.1150; DUSTIN ML, 1987, NATURE, V329, P846, DOI 10.1038/329846a0; FAMBROUGH DM, 1982, P NATL ACAD SCI-BIOL, V79, P1078, DOI 10.1073/pnas.79.4.1078; FASEL N, 1989, P NATL ACAD SCI USA, V86, P6858, DOI 10.1073/pnas.86.18.6858; GROUX H, 1989, J IMMUNOL, V142, P3013; HANSCH GM, 1988, BLOOD, V72, P1089; HANSCH GM, 1987, J CLIN INVEST, V80, P7, DOI 10.1172/JCI113065; HOLGUIN MH, 1989, J CLIN INVEST, V84, P1387, DOI 10.1172/JCI114311; HOLGUIN MH, 1989, J CLIN INVEST, V84, P7, DOI 10.1172/JCI114172; KINOSHITA T, 1985, J EXP MED, V162, P75, DOI 10.1084/jem.162.1.75; KINOSHITA T, 1986, J IMMUNOL, V136, P3390; LAMOYI E, 1980, J EXP MED, V152, P703, DOI 10.1084/jem.152.3.703; LIN RC, 1988, TRANSFUSION, V28, P427, DOI 10.1046/j.1537-2995.1988.28588337329.x; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558; MEDOF ME, 1987, J CLIN INVEST, V80, P165, DOI 10.1172/JCI113043; MEDOF ME, 1986, BIOCHEMISTRY-US, V25, P6740, DOI 10.1021/bi00370a003; MERRY AH, 1989, BRIT J HAEMATOL, V73, P248, DOI 10.1111/j.1365-2141.1989.tb00260.x; NICHOLSONWELLER A, 1985, NEW ENGL J MED, V312, P1091, DOI 10.1056/NEJM198504253121704; NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184; NICHOLSONWELLER A, 1983, P NATL ACAD SCI-BIOL, V80, P5066, DOI 10.1073/pnas.80.16.5066; OKADA H, 1989, BIOCHEM BIOPH RES CO, V162, P1553, DOI 10.1016/0006-291X(89)90852-8; OKADA N, 1989, J IMMUNOL, V143, P2262; Okada N, 1989, Int Immunol, V1, P205, DOI 10.1093/intimm/1.2.205; OKADA N, 1990, CLIN EXP IMMUNOL, V80, P109; ONO H, 1990, BLOOD, V75, P1746; PANGBURN MK, 1983, P NATL ACAD SCI-BIOL, V80, P5430, DOI 10.1073/pnas.80.17.5430; ROBERTS WL, 1987, P NATL ACAD SCI USA, V84, P7817, DOI 10.1073/pnas.84.22.7817; ROSSE WF, 1985, CLIN HAEMATOL, V14, P105; ROSSE WF, 1989, BLOOD REV, V3, P192, DOI 10.1016/0268-960X(89)90016-7; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SCHONERMARK S, 1986, J IMMUNOL, V136, P1772; SELVARAJ P, 1987, J EXP MED, V166, P1011, DOI 10.1084/jem.166.4.1011; STEFANOVA I, 1989, MOL IMMUNOL, V26, P153, DOI 10.1016/0161-5890(89)90097-7; SUGITA Y, 1988, J BIOCHEM-TOKYO, V104, P633, DOI 10.1093/oxfordjournals.jbchem.a122524; SUGITA Y, 1989, J BIOCHEM-TOKYO, V106, P555, DOI 10.1093/oxfordjournals.jbchem.a122893; SUGITA Y, 1989, J BIOCHEM-TOKYO, V106, P589, DOI 10.1093/oxfordjournals.jbchem.a122900; TELEN MJ, 1988, J EXP MED, V167, P1993, DOI 10.1084/jem.167.6.1993; YAMASHINA M, 1989, LAB INVEST, V60, P311; ZALMAN LS, 1986, P NATL ACAD SCI USA, V83, P6975, DOI 10.1073/pnas.83.18.6975; ZALMAN LS, 1987, J EXP MED, V165, P572, DOI 10.1084/jem.165.2.572	44	271	279	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 25	1990	323	17					1184	1189		10.1056/NEJM199010253231707	http://dx.doi.org/10.1056/NEJM199010253231707			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE011	1699124	Bronze			2022-12-28	WOS:A1990EE01100007
J	ZSEBO, KM; WILLIAMS, DA; GEISSLER, EN; BROUDY, VC; MARTIN, FH; ATKINS, HL; HSU, RY; BIRKETT, NC; OKINO, KH; MURDOCK, DC; JACOBSEN, FW; LANGLEY, KE; SMITH, KA; TAKEISHI, T; CATTANACH, BM; GALLI, SJ; SUGGS, SV				ZSEBO, KM; WILLIAMS, DA; GEISSLER, EN; BROUDY, VC; MARTIN, FH; ATKINS, HL; HSU, RY; BIRKETT, NC; OKINO, KH; MURDOCK, DC; JACOBSEN, FW; LANGLEY, KE; SMITH, KA; TAKEISHI, T; CATTANACH, BM; GALLI, SJ; SUGGS, SV			STEM-CELL FACTOR IS ENCODED AT THE SI-LOCUS OF THE MOUSE AND IS THE LIGAND FOR THE C-KIT TYROSINE KINASE RECEPTOR	CELL			English	Article									HARVARD UNIV,SCH MED,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,BOSTON,MA 02115; BETH ISRAEL HOSP,DEPT PATHOL,BOSTON,MA 02215; CHILDRENS HOSP MED CTR,DEPT PATHOL,BOSTON,MA 02115; UNIV WASHINGTON,DEPT HEMATOL,SEATTLE,WA 98195; MRC,RADIOBIOL UNIT,CHILTON,ENGLAND	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle	ZSEBO, KM (corresponding author), AMGEN INC,AMGEN CTR,THOUSAND OAKS,CA 91320, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R01AI022674, R37AI023990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045311] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23990, AI22674] Funding Source: Medline; NIGMS NIH HHS [GM45311] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUCHOWSKI A, 1984, CANCER BIOCHEM BIOPH, V7, P175; ALTUS MS, 1971, P SOC EXP BIOL MED, V138, P985; ANDRE C, 1989, ONCOGENE, V4, P1047; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BERNSTEIN SE, 1968, ANN NY ACAD SCI, V149, P475, DOI 10.1111/j.1749-6632.1968.tb15186.x; BERNSTEIN SE, 1970, AM J SURG, V119, P448, DOI 10.1016/0002-9610(70)90148-0; BOSSELMAN RA, 1989, J VIROL, V63, P2680, DOI 10.1128/JVI.63.6.2680-2689.1989; CATTANACH BM, 1988, MOUSE NEWS LETT, V80, P156; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEXTER TM, 1977, NATURE, V269, P412, DOI 10.1038/269412a0; EBBE S, 1973, BLOOD, V42, P865, DOI 10.1182/blood.V42.6.865.865; EBBE S, 1973, BLOOD, V42, P857, DOI 10.1182/blood.V42.6.857.857; EVANS EP, 1990, MOUSE GENOME, V86, P230; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIED W, 1973, BRIT J HAEMATOL, V24, P643, DOI 10.1111/j.1365-2141.1973.tb01690.x; FUJITA J, 1989, P NATL ACAD SCI USA, V86, P2888, DOI 10.1073/pnas.86.8.2888; GALLI SJ, 1987, BLOOD, V69, P1661; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1981, GENETICS, V97, P337; GEISSLER EN, 1988, P NATL ACAD SCI USA, V85, P9635, DOI 10.1073/pnas.85.24.9635; GEISSLER EN, 1983, EXP HEMATOL, V11, P461; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HARRISON DE, 1972, BRIT J HAEMATOL, V22, P155, DOI 10.1111/j.1365-2141.1972.tb08797.x; HARRISON DE, 1972, RADIAT RES, V52, P553, DOI 10.2307/3573514; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; JARBOE DJ, 1989, J IMMUNOL, V7, P2418; JAT PS, 1986, J VIROL, V59, P746, DOI 10.1128/JVI.59.3.746-750.1986; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, BLOOD, V53, P492; KITAMURA Y, 1989, MAST CELL BASOPHIL D, P229; LALLEY PA, 1978, P NATL ACAD SCI USA, V75, P2382, DOI 10.1073/pnas.75.5.2382; LALLEY PA, 1978, NATURE, V274, P160, DOI 10.1038/274160a0; LERNER C, 1990, EXP HEMATOL, V18, P114; LYONS K, 1989, P NATL ACAD SCI USA, V86, P4554, DOI 10.1073/pnas.86.12.4554; MANIATIS T, 1982, MOL CLONING LABORATO, P188; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; MAYER TC, 1968, DEV BIOL, V18, P62, DOI 10.1016/0012-1606(68)90023-7; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILBRANDT JD, 1983, MOL CELL BIOL, V3, P1266, DOI 10.1128/MCB.3.7.1266; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; NABEL G, 1981, NATURE, V291, P332, DOI 10.1038/291332a0; NAYLOR SL, 1984, SOMAT CELL MOLEC GEN, V10, P531, DOI 10.1007/BF01534857; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOCKA K, 1990, EMBO J, V9, P1810; PLOEMACHER RE, 1986, EXP HEMATOL, V14, P9; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; RIOS M, 1990, Experimental Hematology (Charlottesville), V18, P568; RUSCETTI FW, 1976, P SOC EXP BIOL MED, V152, P398; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ES, 1949, GENETICS, V34, P708; RUSSELL ES, 1968, ARCH BIOCHEM BIOPHYS, V125, P594, DOI 10.1016/0003-9861(68)90617-6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKAGUCHI AY, 1983, SOMAT CELL GENET, V9, P391, DOI 10.1007/BF01539146; SARVELLA PATRICIA A., 1956, JOUR HEREDITY, V47, P123; Silvers W.K., 1979, COAT COLORS MICE, P206; WILLIAMS DA, 1988, MOL CELL BIOL, V8, P3864, DOI 10.1128/MCB.8.9.3864; WOLF NS, 1974, CELL TISSUE KINET, V7, P89, DOI 10.1111/j.1365-2184.1974.tb00402.x; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	66	1354	1404	2	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 5	1990	63	1					213	224		10.1016/0092-8674(90)90302-U	http://dx.doi.org/10.1016/0092-8674(90)90302-U			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EB461	1698556				2022-12-28	WOS:A1990EB46100022
J	HOFFMANN, I; BIRNSTIEL, ML				HOFFMANN, I; BIRNSTIEL, ML			CELL CYCLE-DEPENDENT REGULATION OF HISTONE PRECURSOR MESSENGER-RNA PROCESSING BY MODULATION OF U7 SNRNA ACCESSIBILITY	NATURE			English	Article											HOFFMANN, I (corresponding author), RES INST MOLEC PATHOL,DR BOHR GASSE 7,A-1030 VIENNA,AUSTRIA.							BIRNSTIEL ML, 1988, STRUCTURE FUNCTION M, P155; COTTEN M, 1988, EMBO J, V7, P801, DOI 10.1002/j.1460-2075.1988.tb02878.x; COTTEN M, 1989, MOL CELL BIOL, V9, P4479, DOI 10.1128/MCB.9.10.4479; DELISLE AJ, 1983, MOL CELL BIOL, V3, P1920, DOI 10.1128/MCB.3.11.1920; GEORGIEV O, 1985, EMBO J, V4, P481, DOI 10.1002/j.1460-2075.1985.tb03654.x; GICK O, 1987, P NATL ACAD SCI USA, V84, P8937, DOI 10.1073/pnas.84.24.8937; GICK O, 1986, EMBO J, V5, P1319, DOI 10.1002/j.1460-2075.1986.tb04362.x; GILMARTIN GM, 1988, MOL CELL BIOL, V8, P1076, DOI 10.1128/MCB.8.3.1076; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; LUSCHER B, 1987, EMBO J, V6, P1721, DOI 10.1002/j.1460-2075.1987.tb02423.x; MARZLUFF WF, 1988, TRENDS BIOCHEM SCI, V13, P49, DOI 10.1016/0968-0004(88)90027-8; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; SCHAUFELE F, 1986, NATURE, V323, P777, DOI 10.1038/323777a0; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; SCHUMPERLI D, 1986, CELL, V45, P471, DOI 10.1016/0092-8674(86)90277-1; SOLDATI D, 1988, MOL CELL BIOL, V8, P1518, DOI 10.1128/MCB.8.4.1518; STRUB K, 1986, EMBO J, V5, P1675, DOI 10.1002/j.1460-2075.1986.tb04411.x; VASSEROT AP, 1989, P NATL ACAD SCI USA, V86, P4345, DOI 10.1073/pnas.86.12.4345	18	24	24	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 16	1990	346	6285					665	668		10.1038/346665a0	http://dx.doi.org/10.1038/346665a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU728	1696685				2022-12-28	WOS:A1990DU72800065
J	BAIN, J				BAIN, J			SCREENING IN PRACTICE - CHILD HEALTH SURVEILLANCE	BRITISH MEDICAL JOURNAL			English	Article											BAIN, J (corresponding author), ALDERMOOR HLTH CTR,FAC MED,SOUTHAMPTON SO1 6ST,ENGLAND.							Barber J H, 1976, Health Bull (Edinb), V34, P80; CURTISJENKINS G, 1982, BRIT MED J, V285, P1175, DOI 10.1136/bmj.285.6349.1175; CURTISJENKINS GH, 1978, BRIT MED J, V1, P1537; HALL DMB, 1989, HLTH ALL CHILDREN; 1988, HDB PREVENTIVE CARE; 1976, CMND6680; 1989, CMND555	7	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 26	1990	300	6736					1381	1382		10.1136/bmj.300.6736.1381	http://dx.doi.org/10.1136/bmj.300.6736.1381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG347	1695529	Green Published, Bronze			2022-12-28	WOS:A1990DG34700029
J	ELLIS, HM; SPANN, DR; POSAKONY, JW				ELLIS, HM; SPANN, DR; POSAKONY, JW			EXTRAMACROCHAETAE, A NEGATIVE REGULATOR OF SENSORY ORGAN DEVELOPMENT IN DROSOPHILA, DEFINES A NEW CLASS OF HELIX-LOOP-HELIX PROTEINS	CELL			English	Article									UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	ELLIS, HM (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,B-022,LA JOLLA,CA 92093, USA.							ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; BENEZRA R, 1990, CELL, V61; BOTAS J, 1982, EMBO J, V1, P307, DOI 10.1002/j.1460-2075.1982.tb01165.x; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X; CAMPUZANO S, 1986, CELL, V44, P303, DOI 10.1016/0092-8674(86)90764-6; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CAUDY M, 1988, GENE DEV, V2, P843, DOI 10.1101/gad.2.7.843; CLINE TW, 1989, CELL, V59, P231, DOI 10.1016/0092-8674(89)90280-8; Cramer L., 1980, DROS INFORM SERV, V55, P197; Craymer L, 1984, DROS INFORM SERV, V60, P234; DAMBLYCHAUDIERE C, 1988, ROUX ARCH DEV BIOL, V197, P419, DOI 10.1007/BF00398993; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DEPINHO RA, 1987, GENE DEV, V1, P1311, DOI 10.1101/gad.1.10.1311; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; GARCIAALONSO L, 1986, ROUX ARCH DEV BIOL, V195, P259; GARCIAALONSO L, 1988, ROUX ARCH DEV BIOL, V197, P328; GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9; GARCIABELLIDO A, 1978, GENETICS, V88, P469; GARCIABELLIDO A, 1979, GENETICS, V91, P491; GOLDBERG DA, 1983, CELL, V34, P59, DOI 10.1016/0092-8674(83)90136-8; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; Maniatis T., 1982, MOL CLONING; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; OCONNELL P, 1984, NUCLEIC ACIDS RES, V12, P5495, DOI 10.1093/nar/12.13.5495; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; ROBERTSON HM, 1988, GENETICS, V118, P461; ROMANI S, 1987, EMBO J, V6, P2085, DOI 10.1002/j.1460-2075.1987.tb02474.x; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUBIGER M, 1987, DEV BIOL, V123, P145, DOI 10.1016/0012-1606(87)90436-2; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; SUSSKIND MM, 1983, LAMBDA, V2, P347; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; WIESCHAUS E, 1980, DEV NEUROBIOLOGY DRO, P85; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	58	365	368	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					27	38		10.1016/0092-8674(90)90212-W	http://dx.doi.org/10.1016/0092-8674(90)90212-W			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	1690604				2022-12-28	WOS:A1990CY38200007
J	GARRELL, J; MODOLELL, J				GARRELL, J; MODOLELL, J			THE DROSOPHILA EXTRAMACROCHAETAE LOCUS, AN ANTAGONIST OF PRONEURAL GENES THAT, LIKE THESE GENES, ENCODES A HELIX-LOOP-HELIX PROTEIN	CELL			English	Article									UNIV AUTONOMA MADRID,CSIC,E-28049 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	GARRELL, J (corresponding author), UNIV AUTONOMA MADRID,CTR BIOL MOLEC,CANTO BLANCO,E-28049 MADRID,SPAIN.			Garrell, Joan/0000-0001-7395-9448				ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; BALCELLS L, 1988, EMBO J, V7, P3899, DOI 10.1002/j.1460-2075.1988.tb03276.x; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BOTAS J, 1982, EMBO J, V1, P307, DOI 10.1002/j.1460-2075.1982.tb01165.x; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; CAMPUZANO S, 1986, CELL, V44, P303, DOI 10.1016/0092-8674(86)90764-6; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CAUDY M, 1988, GENE DEV, V2, P843, DOI 10.1101/gad.2.7.843; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CLINE TW, 1989, CELL, V59, P231, DOI 10.1016/0092-8674(89)90280-8; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DAMBLYCHAUDIERE C, 1988, ROUX ARCH DEV BIOL, V197, P419, DOI 10.1007/BF00398993; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P246; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242; DEPINHO RA, 1987, GENE DEV, V1, P1311, DOI 10.1101/gad.1.10.1311; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Finnegan D J, 1986, Oxf Surv Eukaryot Genes, V3, P1; GARCIAALONSO L, 1988, ROUX ARCH DEV BIOL, V197, P328; GARCIABELLIDO A, 1979, GENETICS, V91, P491; GARCIABELLIDO A, 1981, CELLULAR CONTROLS DI, P281; GHYSEN A, 1988, GENE DEV, V2, P495, DOI 10.1101/gad.2.5.495; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; INGHAM PW, 1985, COLD SPRING HARB SYM, V50, P201, DOI 10.1101/SQB.1985.050.01.026; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V627; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; Maniatis T., 1982, MOL CLONING; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MODOLELL J, 1983, P NATL ACAD SCI-BIOL, V80, P1678, DOI 10.1073/pnas.80.6.1678; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; ROMANI S, 1987, EMBO J, V6, P2085, DOI 10.1002/j.1460-2075.1987.tb02474.x; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; TORRES M, 1989, EMBO J, V8, P3079, DOI 10.1002/j.1460-2075.1989.tb08459.x; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; VILLARES R, 1986, THESIS U AUTONOMA MA; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7	66	331	335	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					39	48		10.1016/0092-8674(90)90213-X	http://dx.doi.org/10.1016/0092-8674(90)90213-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	1690605				2022-12-28	WOS:A1990CY38200008
J	ADLER, CH; GALETTA, SL				ADLER, CH; GALETTA, SL			OCULO-FACIAL-SKELETAL MYORHYTHMIA IN WHIPPLE DISEASE - TREATMENT WITH CEFTRIAXONE	ANNALS OF INTERNAL MEDICINE			English	Note											ADLER, CH (corresponding author), HOSP UNIV PENN, DEPT NEUROL, 3400 SPRUCE ST, PHILADELPHIA, PA 19104 USA.							ADAMS M, 1987, ANN NEUROL, V21, P104, DOI 10.1002/ana.410210121; COMER GM, 1983, AM J GASTROENTEROL, V78, P107; GROTTA JC, 1987, ANN NEUROL, V22, P395, DOI 10.1002/ana.410220325; HAUSSERHAUW C, 1988, MOVEMENT DISORD, V3, P179, DOI 10.1002/mds.870030211; KEINATH RD, 1985, GASTROENTEROLOGY, V88, P1867, DOI 10.1016/0016-5085(85)90012-5; KNOX DL, 1976, MEDICINE, V55, P467, DOI 10.1097/00005792-197611000-00003; PALLIS CA, 1980, HDB NEUROLOGY, V39, P449; POLLOCK S, 1981, J NEUROL NEUROSUR PS, V44, P1104, DOI 10.1136/jnnp.44.12.1104; SCHWARTZ MA, 1986, ANN NEUROL, V20, P677, DOI 10.1002/ana.410200605; Van BOGAERT L., 1963, REV NEUROL, V109, P443	10	35	35	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	1990	112	6					467	469		10.7326/0003-4819-76-3-112-6-467	http://dx.doi.org/10.7326/0003-4819-76-3-112-6-467			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT100	1689977				2022-12-28	WOS:A1990CT10000011
J	BONIFACINO, JS; MCCARTHY, SA; MAGUIRE, JE; NAKAYAMA, T; SINGER, DS; KLAUSNER, RD; SINGER, A				BONIFACINO, JS; MCCARTHY, SA; MAGUIRE, JE; NAKAYAMA, T; SINGER, DS; KLAUSNER, RD; SINGER, A			NOVEL POSTTRANSLATIONAL REGULATION OF TCR EXPRESSION IN CD4+ CD8+ THYMOCYTES INFLUENCED BY CD4	NATURE			English	Article									NCI,EXPTL IMMUNOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	BONIFACINO, JS (corresponding author), NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892, USA.		Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007; Bonifacino, Juan S./0000-0002-5673-6370				BANIYASH M, 1988, J BIOL CHEM, V263, P9874; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; BONIFACINO JS, 1988, J BIOL CHEM, V263, P8965; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; COLLINS MKL, 1985, P NATL ACAD SCI USA, V82, P4503, DOI 10.1073/pnas.82.13.4503; CRISPE IN, 1987, J IMMUNOL, V139, P3585; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; FURLEY AJ, 1986, CELL, V46, P75, DOI 10.1016/0092-8674(86)90861-5; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; LANIER LL, 1986, J IMMUNOL, V137, P2501; Maniatis T., 1982, MOL CLONING; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; ORLOFF DG, 1989, J BIOL CHEM, V264, P14812; PETTEY CL, 1987, J BIOL CHEM, V262, P4854; RAULET DH, 1985, NATURE, V314, P103, DOI 10.1038/314103a0; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; ROYER HD, 1985, P NATL ACAD SCI USA, V82, P5510, DOI 10.1073/pnas.82.16.5510; SAMELSON LE, 1985, CELL, V43, P223, DOI 10.1016/0092-8674(85)90027-3; SAMELSON LE, 1986, J IMMUNOL, V137, P3254; SAMELSON LE, 1985, NATURE, V315, P765, DOI 10.1038/315765a0; SNODGRASS HR, 1985, NATURE, V315, P232, DOI 10.1038/315232a0; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDONGEN JJM, 1987, J IMMUNOL, V138, P1260; ZUNIGAPFLUCKER JC, 1989, J EXP MED, V169, P2085, DOI 10.1084/jem.169.6.2085	28	76	76	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 15	1990	344	6263					247	251		10.1038/344247a0	http://dx.doi.org/10.1038/344247a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU138	1690353				2022-12-28	WOS:A1990CU13800060
J	BLACHLYDYSON, E; PENG, SZ; COLOMBINI, M; FORTE, M				BLACHLYDYSON, E; PENG, SZ; COLOMBINI, M; FORTE, M			SELECTIVITY CHANGES IN SITE-DIRECTED MUTANTS OF THE VDAC ION CHANNEL - STRUCTURAL IMPLICATIONS	SCIENCE			English	Article									OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201; UNIV MARYLAND,DEPT ZOOL,CELL BIOL LABS,COLLEGE PK,MD 20742	Oregon Health & Science University; University System of Maryland; University of Maryland College Park			Colombini, Marco/A-1540-2014		NIGMS NIH HHS [GM35759] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELSBERGERMANGAN DM, 1987, J MEMBRANE BIOL, V98, P157, DOI 10.1007/BF01872128; BENZ R, 1989, J BIOENERG BIOMEMBR, V21, P439, DOI 10.1007/BF00762516; BLACHLYDYSON E, 1989, J BIOENERG BIOMEMBR, V21, P471, DOI 10.1007/BF00762519; Colombini M, 1980, Ann N Y Acad Sci, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0; Colombini M., 1986, ION CHANNEL RECONSTI, P533; DAUM G, 1982, J BIOL CHEM, V257, P3028; DIHANICH M, 1987, EMBO J, V6, P723, DOI 10.1002/j.1460-2075.1987.tb04813.x; DORING C, 1985, J MEMBRANE BIOL, V83, P81, DOI 10.1007/BF01868740; FORTE M, 1987, J MEMBRANE BIOL, V99, P65, DOI 10.1007/BF01870622; FORTE M, 1987, J BIOENERG BIOMEMBR, V19, P341, DOI 10.1007/BF00768537; FREITAG H, 1982, EUR J BIOCHEM, V123, P629; FREITAG H, 1983, METHOD ENZYMOL, V97, P286; GUO XJ, 1986, YEAST, V2, pS138; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAN LY, 1989, CELL, V56, P13, DOI 10.1016/0092-8674(89)90979-3; KLEENE R, 1987, EMBO J, V6, P2627, DOI 10.1002/j.1460-2075.1987.tb02553.x; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LINDEN M, 1983, BIOCHIM BIOPHYS ACTA, V736, P125, DOI 10.1016/0005-2736(83)90177-3; LINDEN M, 1982, BIOCHEM J, V208, P77, DOI 10.1042/bj2080077; LUDWIG O, 1988, EUR BIOPHYS J BIOPHY, V15, P269, DOI 10.1007/BF00256477; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; MIHARA K, 1985, EMBO J, V4, P769, DOI 10.1002/j.1460-2075.1985.tb03695.x; MILLER C, 1989, NEURON, V2, P1195, DOI 10.1016/0896-6273(89)90304-8; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; ZALMAN LS, 1980, J BIOL CHEM, V255, P1771	31	254	257	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 9	1990	247	4947					1233	1236		10.1126/science.1690454	http://dx.doi.org/10.1126/science.1690454			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT096	1690454				2022-12-28	WOS:A1990CT09600046
J	DOLLE, P; CASTRILLO, JL; THEILL, LE; DEERINCK, T; ELLISMAN, M; KARIN, M				DOLLE, P; CASTRILLO, JL; THEILL, LE; DEERINCK, T; ELLISMAN, M; KARIN, M			EXPRESSION OF GHF-1 PROTEIN IN MOUSE PITUITARIES CORRELATES BOTH TEMPORALLY AND SPATIALLY WITH THE ONSET OF GROWTH-HORMONE GENE ACTIVITY	CELL			English	Article									FAC MED STRASBOURG, CNRS, GENET MOLEC EUCARYOTES LAB, INSERM, U184, F-67085 STRASBOURG, FRANCE; UNIV CALIF SAN DIEGO, SCH MED, DEPT PHARMACOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, SCH MED, DEPT NEUROSCI, LA JOLLA, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California San Diego; University of California System; University of California San Diego			Dolle, Pascal/A-8037-2010	Dolle, Pascal/0000-0002-9294-9090	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014718] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-38527] Funding Source: Medline; NINDS NIH HHS [NS-14718] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BUGNON C, 1974, CR SOC BIOL, V168, P460; CASTRILLO JL, 1989, SCIENCE, V243, P814, DOI 10.1126/science.2563596; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHATELAIN A, 1979, CELL TISSUE RES, V196, P409; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; COLOSI P, 1988, MOL ENDOCRINOL, V2, P579, DOI 10.1210/mend-2-6-579; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; DOLLE P, 1989, EMBO J, V8, P1507, DOI 10.1002/j.1460-2075.1989.tb03535.x; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; GAUL U, 1987, CELL, V50, P639, DOI 10.1016/0092-8674(87)90037-7; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; KARIN M, 1989, TISSUE SPECIFIC GENE; KEMPF J, 1982, MICROSC ACTA, V86, P215; KESSEL M, 1988, NATURE, V332, P117, DOI 10.1038/332117c0; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; LEDOUARI.N, 1967, CR ACAD SCI D NAT, V264, P3027; LINZER DIH, 1985, J BIOL CHEM, V260, P9574; LOCKE M, 1966, MAJOR PROBLEMS DEV B; LUGO DI, 1989, MOL ENDOCRINOL, V3, P1313, DOI 10.1210/mend-3-8-1313; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MCCORMICK A, 1988, CELL, V55, P379, DOI 10.1016/0092-8674(88)90061-X; MILLER WL, 1983, ENDOCR REV, V4, P97, DOI 10.1210/edrv-4-2-97; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NICOLL CS, 1986, ENDOCR REV, V7, P169, DOI 10.1210/edrv-7-2-169; RUGH R, 1968, MOUSE ITS REPRODUCTI; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SETALO G, 1976, ENDOCRINOL EXP, V10, P155; SLABAUGH MB, 1982, ENDOCRINOLOGY, V110, P1489, DOI 10.1210/endo-110-5-1489; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; WATANABE YG, 1979, DEV BIOL, V68, P557, DOI 10.1016/0012-1606(79)90226-4; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	41	210	213	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	1990	60	5					809	820		10.1016/0092-8674(90)90095-V	http://dx.doi.org/10.1016/0092-8674(90)90095-V			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CV174	1690079				2022-12-28	WOS:A1990CV17400013
J	MAIONE, TE; GRAY, GS; PETRO, J; HUNT, AJ; DONNER, AL; BAUER, SI; CARSON, HF; SHARPE, RJ				MAIONE, TE; GRAY, GS; PETRO, J; HUNT, AJ; DONNER, AL; BAUER, SI; CARSON, HF; SHARPE, RJ			INHIBITION OF ANGIOGENESIS BY RECOMBINANT HUMAN-PLATELET FACTOR-IV AND RELATED PEPTIDES	SCIENCE			English	Article									HARVARD UNIV, SCH MED, DEPT DERMATOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	MAIONE, TE (corresponding author), REPLIGEN CORP, 1 KENDALL SQ, CAMBRIDGE, MA 02139 USA.							BARBER AJ, 1972, BIOCHIM BIOPHYS ACTA, V286, P312, DOI 10.1016/0304-4165(72)90267-X; BARONE AD, 1988, J BIOL CHEM, V263, P8710; DAMORE PA, 1988, SEMIN THROMB HEMOST, V14, P73, DOI 10.1055/s-2007-1002758; DEUEL TF, 1977, P NATL ACAD SCI USA, V74, P2256, DOI 10.1073/pnas.74.6.2256; DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584; EISENSTEIN R, 1979, AM J OPHTHALMOL, V88, P1005, DOI 10.1016/0002-9394(79)90406-9; FILES JC, 1981, BLOOD, V58, P607; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Folkman J, 1985, Important Adv Oncol, P42; FOLKMAN J, 1989, SCIENCE, V243, P1490, DOI 10.1126/science.2467380; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; HANDIN RI, 1976, J BIOL CHEM, V251, P4273; HORTON JE, 1980, BIOCHIM BIOPHYS ACTA, V630, P459, DOI 10.1016/0304-4165(80)90295-0; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; KATZ IR, 1986, P NATL ACAD SCI USA, V83, P3491, DOI 10.1073/pnas.83.10.3491; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; LEVINE SP, 1976, J BIOL CHEM, V251, P324; LUTTY GA, 1983, INVEST OPHTH VIS SCI, V24, P52; MOORE S, 1975, BIOCHIM BIOPHYS ACTA, V379, P370, DOI 10.1016/0005-2795(75)90144-0; MULLER G, 1987, P NATL ACAD SCI USA, V84, P5600, DOI 10.1073/pnas.84.16.5600; PONCZ M, 1987, BLOOD, V69, P219; PRESTA M, 1988, HAEMOSTASIS, V18, P6; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; SENIOR RM, 1983, J CELL BIOL, V96, P382, DOI 10.1083/jcb.96.2.382; SIDKY YA, 1987, CANCER RES, V47, P5155; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0	26	615	691	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 5	1990	247	4938					77	79		10.1126/science.1688470	http://dx.doi.org/10.1126/science.1688470			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG620	1688470				2022-12-28	WOS:A1990CG62000040
J	MACKAY, TW; FITZPATRICK, MF; DOUGLAS, NJ				MACKAY, TW; FITZPATRICK, MF; DOUGLAS, NJ			NONADRENERGIC, NONCHOLINERGIC NERVOUS-SYSTEM AND OVERNIGHT AIRWAY CALIBER IN ASTHMATIC AND NORMAL SUBJECTS	LANCET			English	Article							NOCTURNAL ASTHMA; FLOW-RATE; BRONCHODILATION; MECHANISMS; CAPSAICIN	Increased parasympathetic tone does not fully explain the night-time bronchoconstriction responsible for nocturnal cough and wheezing in asthmatic subjects. The overnight variation in function of the other neural pathway innervating bronchial smooth muscle-the non-adrenergic, non-cholinergic (NANC) system-was thus examined. NANC function was tested after parasympathetic and beta-adrenergic blockade in 12 normal subjects and 12 patients with mild asthma by comparing the bronchodilator effect (measured as oscillatory resistance, Ros) of capsaicin (an NANC stimulant) at 0400 h with that at 1600 h. The order in which capsaicin or diluent was given was randomised, and observers were blind as to which substance had been inhaled. Bronchodilatation was greater at 1600 h than at 0400 h in both the normal subjects (mean decrease in Ros 1-3 min after capsaicin at 1600 h 9% [SEM 1], at 0400 h -2% [1]; p < 0.001) and the asthmatic group (1% [1], -7% [2]; p = 0.001). The results suggest that inhibition of NANC function in the early morning may contribute to overnight bronchoconstriction.	CITY HOSP EDINBURGH, DEPT MED RIE, RESP MED UNIT, EDINBURGH EH10 5SB, MIDLOTHIAN, SCOTLAND				Douglas, Neil/B-1491-2013					BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; CATTERALL JR, 1988, THORAX, V43, P720, DOI 10.1136/thx.43.9.720; COLERIDGE HM, 1965, J PHYSIOL-LONDON, V179, P248, DOI 10.1113/jphysiol.1965.sp007660; EWING DJ, 1980, J APPL PHYSIOL, V49, P809, DOI 10.1152/jappl.1980.49.5.809; FRANETZKI M, 1979, J APPL PHYSIOL, V46, P956, DOI 10.1152/jappl.1979.46.5.956; FULLER RW, 1985, J APPL PHYSIOL, V58, P1080, DOI 10.1152/jappl.1985.58.4.1080; HETZEL MR, 1980, THORAX, V35, P732, DOI 10.1136/thx.35.10.732; ICHINOSE M, 1988, AM REV RESPIR DIS, V138, P31, DOI 10.1164/ajrccm/138.1.31; KERR HD, 1973, ARCH ENVIRON HEALTH, V26, P144, DOI 10.1080/00039896.1973.10666242; LAMMERS JWJ, 1988, J APPL PHYSIOL, V64, P1817, DOI 10.1152/jappl.1988.64.5.1817; LAMMERS JWJ, 1989, J APPL PHYSIOL, V67, P856, DOI 10.1152/jappl.1989.67.2.856; LEWINSOHN HC, 1960, BRIT MED J, V1, P462, DOI 10.1136/bmj.1.5171.462; MORRISON JFJ, 1988, BRIT MED J, V296, P1427, DOI 10.1136/bmj.296.6634.1427; NIELD JE, 1989, RESP MED, V83, P111, DOI 10.1016/S0954-6111(89)80224-0; RICHARDSON PS, 1969, BMJ-BRIT MED J, V3, P143, DOI 10.1136/bmj.3.5663.143; RYAN G, 1982, THORAX, V37, P423, DOI 10.1136/thx.37.6.423; TATTERSFIELD AE, 1973, J APPL PHYSIOL, V35, P613, DOI 10.1152/jappl.1973.35.5.613; TURNERWARWICK M, 1977, BRIT J DIS CHEST, V71, P73, DOI 10.1016/0007-0971(77)90086-9; TURNERWARWICK M, 1989, J ROY COLL GEN PRACT, V39, P239	19	28	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	1991	338	8778					1289	1292		10.1016/0140-6736(91)92591-O	http://dx.doi.org/10.1016/0140-6736(91)92591-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682685				2022-12-28	WOS:A1991GR02300003
J	PELTOLA, H; SIITONEN, A; KYRONSEPPA, H; SIMULA, I; MATTILA, L; OKSANEN, P; KATAJA, MJ; CADOZ, M				PELTOLA, H; SIITONEN, A; KYRONSEPPA, H; SIMULA, I; MATTILA, L; OKSANEN, P; KATAJA, MJ; CADOZ, M			PREVENTION OF TRAVELERS DIARRHEA BY ORAL B-SUBUNIT WHOLE-CELL CHOLERA VACCINE	LANCET			English	Article							GM1-ENZYME-LINKED IMMUNOSORBENT-ASSAY; TOXIGENIC ESCHERICHIA-COLI; TRAVELERS DIARRHEA; SALMONELLA-TYPHIMURIUM; RELATIVE IMPORTANCE; ENTERO-TOXIN; FIELD TRIAL; EPIDEMIOLOGY; INFECTIONS; VOLUNTEERS	B-subunit/whole-cell cholera vaccine (BS-WC) has been shown to give Bangladeshi mothers and children only 3 months' protection against severe diarrhoea due td enterotoxigenic Escherichia coli (ETEC). Since a long-lasting effect is not necessary for protection against travellers' diarrhoea, a prospective double-blind study was conducted among tourists who went to Morocco from Finland. 307 tourists received two oral doses of BS-WC, whereas 308 controls received a placebo before departure. A research team went out with tourists and a laboratory for enteric pathogens was set up on location. A faecal specimen was taken from 100 randomly selected subjects before departure, from all travellers with diarrhoea, and routinely after return. Enteropathogenic bacteria were not isolated from any of the pre-departure specimens but were present during or after the holiday in 47% of tourists with travellers' diarrhoea, and in 14% of those without diarrhoea. BS-WC induced a 52% protection (p = 0.013) against diarrhoea caused by ETEC. The protection was better for mixed infections (65%, p = 0.016). The protective efficacy against a combination of ETEC and any other pathogen was 71% (p = 0.02), and that against ETEC plus Salmonella enterica even better at 82% (p = 0.01). Partial protection against travellers' diarrhoea is thus obtainable by active immunisation with BS-WC.	JORVI HOSP,ESPOO,FINLAND; PASTEUR MERIEUX SERUMS & VACCINS,MARNES COQUETTE,FRANCE; NATL PUBL HLTH INST,SF-00280 HELSINKI 28,FINLAND; UNIV HELSINKI HOSP,DEPT MED 1,HELSINKI,FINLAND; FINNAIR,HELSINKI,FINLAND	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	PELTOLA, H (corresponding author), UNIV HELSINKI,CHILDRENS HOSP,11 STENBACK ST,SF-00290 HELSINKI 29,FINLAND.							BACK E, 1980, J INFECTION, V2, P302, DOI 10.1016/S0163-4453(80)92672-9; BLACK RE, 1990, REV INFECT DIS, V12, pS73; BLACK RE, 1987, INFECT IMMUN, V55, P1116, DOI 10.1128/IAI.55.5.1116-1120.1987; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; Ewing W.H., 1986, EDWARDS EWINGS IDENT; FINKELSTEIN RA, 1983, FEMS MICROBIOL LETT, V17, P239; HOLMGREN J, 1977, J INFECT DIS, V136, pS105, DOI 10.1093/infdis/136.Supplement.S105; JERTBORN M, 1988, J INFECT DIS, V157, P374, DOI 10.1093/infdis/157.2.374; KANTELE A, 1991, VACCINE, V9, P423, DOI 10.1016/0264-410X(91)90129-T; KORPPI M, 1989, PEDIATR INFECT DIS J, V8, P687, DOI 10.1097/00006454-198910000-00005; Lennette E.H, 1985, MANUAL CLIN MICROBIO, V4th ed.; LEVINE MM, 1983, MICROBIOL REV, V47, P510, DOI 10.1128/MMBR.47.4.510-550.1983; MATTILA L, IN PRESS J INFECT DI; MINOR LL, 1987, INT J SYST BACTERIOL, V37, P465; MORGER H, 1983, BRIT MED J, V286, P184, DOI 10.1136/bmj.286.6360.184; PELTOLA H, 1983, SCAND J INFECT DIS, V15, P375, DOI 10.3109/inf.1983.15.issue-4.08; PITKANEN T, 1982, ANN CLIN RES, V14, P111; QI GM, 1989, J MED MICROBIOL, V30, P213, DOI 10.1099/00222615-30-3-213; RISTAINO PA, 1983, J CLIN MICROBIOL, V18, P808, DOI 10.1128/JCM.18.4.808-815.1983; ROWLAND HAK, 1978, T ROY SOC TROP MED H, V72, P289, DOI 10.1016/0035-9203(78)90210-9; SACK RB, 1990, REV INFECT DIS, V12, pS59; SACK RB, 1979, GASTROENTEROLOGY, V76, P1368; SANDEFUR PD, 1976, INFECT IMMUN, V14, P671, DOI 10.1128/IAI.14.3.671-679.1976; SNYDER JD, 1982, JAMA-J AM MED ASSOC, V247, P2268, DOI 10.1001/jama.1982.03320410050031; STEFFEN R, 1986, REV INFECT DIS, V8, pS122; STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176; STEFFEN R, 1987, BAILLIERE CLIN GASTR, V1, P361, DOI 10.1016/0950-3528(87)90009-1; SVENNERHOLM A-M, 1986, P135; SVENNERHOLM AM, 1984, J INFECT DIS, V149, P884, DOI 10.1093/infdis/149.6.884; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; WOODHEAD MA, 1987, LANCET, V1, P671	32	196	211	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1285	1289		10.1016/0140-6736(91)92590-X	http://dx.doi.org/10.1016/0140-6736(91)92590-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682684				2022-12-28	WOS:A1991GR02300002
J	CONWAY, MA; ALLIS, J; OUWERKERK, R; NIIOKA, T; RAJAGOPALAN, B; RADDA, GK				CONWAY, MA; ALLIS, J; OUWERKERK, R; NIIOKA, T; RAJAGOPALAN, B; RADDA, GK			DETECTION OF LOW PHOSPHOCREATINE TO ATP RATIO IN FAILING HYPERTROPHIED HUMAN MYOCARDIUM BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY	LANCET			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CORONARY-ARTERY DISEASE; CREATINE-KINASE SYSTEM; METABOLISM	Phosphorus-31 magnetic resonance spectroscopy can be used to study intracellular biochemistry non-invasively by measuring the relative proportions of high energy phosphates. Study of deteriorating cardiac metabolism might be useful in the management of hypertrophy and heart failure. P-31 magnetic resonance spectroscopy was carried out in fourteen patients with aortic valve disease (six with aortic stenosis, eight with aortic incompetence). Six patients were receiving treatment for symptoms of heart failure. The phosphocreatine (PCr) to ATP ratio in these patients (1.1 [SD 0.32]) was significantly lower than that in thirteen controls (1.5 [0.2], p < 0.001 ) or in the eight patients who did not have symptoms of heart failure (1.56 [0.15], p < 0.0035). These findings indicate that heart failure in aortic valve disease is associated with low PCr, which could be due to loss of intracellular creatine. The measurement could eventually have a role in helping to determine the optimum timing for aortic valve replacement.			CONWAY, MA (corresponding author), JOHN RADCLIFFE HOSP,MRC,BIOCHEM & CLIN MAGNET RESONANCE UNIT,OXFORD OX3 9DU,ENGLAND.							ATTARIAN DE, 1981, J THORAC CARDIOV SUR, V81, P382; AUFFERMAN W, 1990, CARDIOVASC RES, V24, P57, DOI 10.1093/cvr/24.1.57; BLACKLEDGE MJ, 1987, P NATL ACAD SCI USA, V84, P4283, DOI 10.1073/pnas.84.12.4283; BUSER PT, 1989, CIRCULATION, V80, P1837, DOI 10.1161/01.CIR.80.6.1837; FURCHGOTT R, 1961, CIRCULATION, V24, P416; INGWALL JS, 1985, NEW ENGL J MED, V313, P1050, DOI 10.1056/NEJM198510243131704; INGWALL JS, 1990, EUR HEART J, V11, P108, DOI 10.1093/eurheartj/11.suppl_B.108; POOL PE, 1967, CIRC RES, V21, P365, DOI 10.1161/01.RES.21.3.365; SWAIN JL, 1982, P NATL ACAD SCI-BIOL, V79, P655, DOI 10.1073/pnas.79.2.655; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304	10	253	261	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					973	976		10.1016/0140-6736(91)91838-L	http://dx.doi.org/10.1016/0140-6736(91)91838-L			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681342				2022-12-28	WOS:A1991GK97400004
J	MACMAHON, EME; GLASS, JD; HAYWARD, SD; MANN, RB; BECKER, PS; CHARACHE, P; MCARTHUR, JC; AMBINDER, RF				MACMAHON, EME; GLASS, JD; HAYWARD, SD; MANN, RB; BECKER, PS; CHARACHE, P; MCARTHUR, JC; AMBINDER, RF			EPSTEIN-BARR-VIRUS IN AIDS-RELATED PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA	LANCET			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; INSITU HYBRIDIZATION; MEMBRANE-PROTEIN; GENE-EXPRESSION; INFECTED-CELLS; EBV; DISORDERS; THERAPY; DISEASE; GENOME	Primary central nervous system lymphoma occurs more often in patients with AIDS. Epstein-Barr virus (EBV) has been detected in these tumours, but the degree of association has not been defined because of both the highly restricted expression of EBV in malignant tissue and the lack of a technique that is reliable in formalin-fixed paraffin-embedded specimens. EBV-transformed lymphocytes contain short non-protein coding EBV transcripts (EBERs), which are expressed in much higher quantity than other EBV-latency transcripts. We describe a new strategy for detection of latent EBV with these transcripts as targets for in-situ hybridisation. 18 cases of AIDS-related primary CNS lymphoma from a consecutive necropsy series together with specimens from 3 further cases were studied. In each case, a strong positive signal over tumour cells indicated abundant expression of the EBV-EBER1 transcript. This 100% association suggests that the pathogenesis of these AIDS-associated lymphomas may differ from the systemic disease in which only 30-50% of tumours are associated with EBV. A pathogenetic role for EBV was further supported by showing expression of a viral protein (the latent membrane protein) that is implicated as an effector for EBV-associated lymphomagenesis. EBV might have a role as a tumour marker in the diagnosis and management of AIDS-related primary CNS lymphoma.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University					NCI NIH HHS [R01 CA42245, R01 CA55529] Funding Source: Medline; NINDS NIH HHS [NS 07179] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042245, R01CA055529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007179] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASHIR RM, 1989, NEUROLOGY, V39, P813, DOI 10.1212/WNL.39.6.813; BASHIR RM, 1990, MODERN PATHOL, V3, P429; BAUMGARTNER JE, 1990, J NEUROSURG, V73, P206, DOI 10.3171/jns.1990.73.2.0206; BIRX DL, 1986, NEW ENGL J MED, V314, P874, DOI 10.1056/NEJM198604033141403; CARTUN RW, 1989, J HISTOTECHNOL, V12, P273; GILLIGAN K, 1990, P NATL ACAD SCI USA, V87, P8790, DOI 10.1073/pnas.87.22.8790; GLICKMAN JN, 1988, J VIROL, V62, P902, DOI 10.1128/JVI.62.3.902-911.1988; HAMILTONDUTOIT SJ, 1991, AM J PATHOL, V138, P149; HANTO DW, 1981, CANCER RES, V41, P4253; HOCHBERG FH, 1988, J NEUROSURG, V68, P835, DOI 10.3171/jns.1988.68.6.0835; HOWE JG, 1986, P NATL ACAD SCI USA, V83, P9006, DOI 10.1073/pnas.83.23.9006; LAWRENCE JB, 1988, CELL, V52, P51; LERNER MR, 1981, P NATL ACAD SCI USA, V78, P505; NAKHLEH RE, 1991, CANCER, V67, P444, DOI 10.1002/1097-0142(19910115)67:2<444::AID-CNCR2820670221>3.0.CO;2-W; PALLESEN G, 1991, LANCET, V337, P320, DOI 10.1016/0140-6736(91)90943-J; PLUDA JM, 1990, ANN INTERN MED, V113, P276, DOI 10.7326/0003-4819-113-4-276; ROSENBERG NL, 1986, ANN NEUROL, V20, P98, DOI 10.1002/ana.410200118; ROWE M, 1987, J GEN VIROL, V68, P1575, DOI 10.1099/0022-1317-68-6-1575; SHERMAN ME, 1991, AM J CLIN PATHOL, V95, P878, DOI 10.1093/ajcp/95.6.878; SUBAR M, 1988, BLOOD, V72, P667; TOCZYSKI DPW, 1991, EMBO J, V10, P459, DOI 10.1002/j.1460-2075.1991.tb07968.x; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WU TC, 1991, AM J PATHOL, V138, P1461; WU TC, 1990, INT J CANCER, V46, P801, DOI 10.1002/ijc.2910460509; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604; YOUNG LS, 1988, J GEN VIROL, V69, P1051, DOI 10.1099/0022-1317-69-5-1051	26	441	455	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					969	973		10.1016/0140-6736(91)91837-K	http://dx.doi.org/10.1016/0140-6736(91)91837-K			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681341	hybrid			2022-12-28	WOS:A1991GK97400003
J	LUFKIN, T; DIERICH, A; LEMEUR, M; MARK, M; CHAMBON, P				LUFKIN, T; DIERICH, A; LEMEUR, M; MARK, M; CHAMBON, P			DISRUPTION OF THE HOX-1.6 HOMEOBOX GENE RESULTS IN DEFECTS IN A REGION CORRESPONDING TO ITS ROSTRAL DOMAIN OF EXPRESSION	CELL			English	Article							SEGMENT-SPECIFIC EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MOUSE EMBRYOS; NEURAL CREST; FUNCTIONAL-ORGANIZATION; ANTENNAPEDIA-COMPLEX; INT-1 PROTOONCOGENE; HOMEOTIC GENES; RETINOIC ACID; MURINE	The Hox-1.6 gene disrupted in embryonic stem cells by homologous recombination was introduced into the mouse germline. Heterozygous mice were normal, but homozygous mice died at birth from anoxia and had numerous defects that were centered at the level of rhombomeres 4 to 7 and included delayed hindbrain neural tube closure, absence of certain cranial nerves and ganglia, and malformed inner ears and bones of the skull. Thus, Hox-1.6 is involved in regional specification along the rostrocaudal axis, but only in its most rostral domain of expression. Hox-1.6 appears to specify neurogenic neural crest cells prior to specification of mesenchymal neural crest cells by Hox-1.5. Thus, within the same region of the presumptive hindbrain, two HOX-1 genes are involved in the patterning of two different populations of neural crest cells. The implication of these results for the function of the Hox network during mouse embryogenesis is discussed.			LUFKIN, T (corresponding author), FAC MED STRASBOURG, INST CHIM BIOL,INSERM,U184,CNRS, GENET MOLEC LAB, 11 RUE HUMANN, F-67085 STRASBOURG, FRANCE.		Lufkin, Thomas/AAG-7476-2019; Lufkin, Thomas/B-5352-2011	Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771				AKAM M, 1987, DEVELOPMENT, V101, P1; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; AWGULEWITSCH A, 1986, NATURE, V320, P328, DOI 10.1038/320328a0; BARON A, 1987, EMBO J, V6, P2977, DOI 10.1002/j.1460-2075.1987.tb02603.x; BRADLEY A, 1987, TERATOCARCINOMAS EMB; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CHO KWY, 1991, CELL, V65, P55, DOI 10.1016/0092-8674(91)90407-P; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; COULY G, 1990, DEVELOPMENT, V108, P543; DAVSON H, 1962, PRINCIPLES HUMAN PHY, P380; DEOL MS, 1966, NATURE, V209, P219, DOI 10.1038/209219a0; DIEDERICH RJ, 1989, GENE DEV, V3, P399, DOI 10.1101/gad.3.3.399; DO MS, 1988, GENOMICS, V3, P195, DOI 10.1016/0888-7543(88)90079-1; DRESSLER GR, 1989, DIFFERENTIATION, V41, P193, DOI 10.1111/j.1432-0436.1989.tb00747.x; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 1991, CURR OPIN GENET DEV, V1, P211, DOI 10.1016/S0959-437X(05)80072-3; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; FROMENTAL C, 1988, CELL, V54, P943, DOI 10.1016/0092-8674(88)90109-2; GAUNT SJ, 1987, DEVELOPMENT, V101, P51; GAUNT SJ, 1988, DEVELOPMENT, V103, P135; GAUNT SJ, 1986, NATURE, V324, P662, DOI 10.1038/324662a0; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GONZALEZREYES A, 1990, NATURE, V344, P78, DOI 10.1038/344078a0; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Goulding MD, 1989, CURR OPIN CELL BIOL, V1, P1088, DOI 10.1016/S0955-0674(89)80055-9; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HAMILTON WJ, 1946, HUMAN EMBRYOLOGY; HART C P, 1987, Genomics, V1, P182, DOI 10.1016/0888-7543(87)90011-5; HOLLAND PWH, 1988, DEVELOPMENT, V103, P17; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; HOLTFRETER J, 1968, EPITHELIAL MESENCHYM, P1; HUNT P, 1991, DEVELOPMENT, V112, P43; HUNT P, 1991, DEVELOPMENT, P187; JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KEYNES R, 1990, NEURON, V4, P1, DOI 10.1016/0896-6273(90)90438-L; KOCHHAR DM, 1973, TERATOLOGY, V7, P289, DOI 10.1002/tera.1420070310; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; LATHE R, 1987, GENE, V57, P193, DOI 10.1016/0378-1119(87)90122-3; LEDOUARIN NM, 1986, TRENDS NEUROSCI, V9, P175, DOI 10.1016/0166-2236(86)90055-X; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MCKNIGHT SL, 1980, NUCLEIC ACIDS RES, V8, P5949, DOI 10.1093/nar/8.24.5949; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MLODZIK M, 1988, EMBO J, V7, P2569, DOI 10.1002/j.1460-2075.1988.tb03106.x; MOODY SA, 1983, J COMP NEUROL, V213, P344, DOI 10.1002/cne.902130309; MORRISSKAY G, 1987, TRENDS GENET, V3, P257, DOI 10.1016/0168-9525(87)90260-5; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; MURPHY P, 1991, DEVELOPMENT, V111, P61; NICHOLS DH, 1981, J EMBRYOL EXP MORPH, V64, P105; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; NODEN DM, 1988, DEVELOPMENT, V103, P121; REID L, 1990, CELL, V63, P875, DOI 10.1016/0092-8674(90)90491-V; SCHUGHART K, 1989, GENOMICS, V5, P76, DOI 10.1016/0888-7543(89)90089-X; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STUBBS L, 1990, GENOMICS, V7, P422, DOI 10.1016/0888-7543(90)90177-V; SUNDIN OH, 1990, DEVELOPMENT, V108, P47; Theiler K., 1972, HOUSE MOUSE; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; VANDEWATER TR, 1988, DEVELOPMENT, V103, P185; VERWOERD CDA, 1979, ADV ANATOMY EMBRYOLO, V58; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; WRIGHT C, 1991, NATURE, V350, P458, DOI 10.1038/350458a0	67	632	641	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 20	1991	66	6					1105	1119		10.1016/0092-8674(91)90034-V	http://dx.doi.org/10.1016/0092-8674(91)90034-V			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG552	1680563				2022-12-28	WOS:A1991GG55200006
J	BAEKKESKOV, S; AANSTOOT, HJ; CHRISTGAU, S; REETZ, A; SOLIMENA, M; CASCALHO, M; FOLLI, F; RICHTEROLESEN, H; CAMILLI, PD				BAEKKESKOV, S; AANSTOOT, HJ; CHRISTGAU, S; REETZ, A; SOLIMENA, M; CASCALHO, M; FOLLI, F; RICHTEROLESEN, H; CAMILLI, PD			IDENTIFICATION OF THE 64K AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES AS THE GABA-SYNTHESIZING ENZYME GLUTAMIC-ACID DECARBOXYLASE	NATURE			English	Article									UNIV CALIF SAN FRANCISCO, SCH MED, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, SCH MED, HORMONE RES INST, SAN FRANCISCO, CA 94143 USA; YALE UNIV, SCH MED, DEPT CELL BIOL, NEW HAVEN, CT 06510 USA; HAGEDORN RES LAB, DK-2820 GENTOFTE, DENMARK	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; Novo Nordisk; Hagedorn Research Institute	BAEKKESKOV, S (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT MICROBIOL IMMUNOL, SAN FRANCISCO, CA 94143 USA.		Solimena, Michele/E-1275-2011; folli, franco/J-2795-2018; Solimena, Michele/GVS-5990-2022	folli, franco/0000-0001-9824-5222; Baekkeskov, Steinunn/0000-0003-0878-3188; Aanstoot, Henk-Jan/0000-0002-5534-1633; Cascalho, Marilia/0000-0002-2695-3921				ALBERS RW, 1959, J BIOL CHEM, V234, P926; AMES GFL, 1976, BIOCHEMISTRY-US, V15, P616, DOI 10.1021/bi00648a026; ATKINSON MA, 1990, LANCET, V335, P1357, DOI 10.1016/0140-6736(90)91241-2; BAEKKESKOV S, 1989, DIABETES, V38, P1133, DOI 10.2337/diabetes.38.9.1133; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; BAEKKESKOV S, 1987, J CLIN INVEST, V79, P926, DOI 10.1172/JCI112903; BAEKKESKOV S, 1981, P NATL ACAD SCI-BIOL, V78, P6456, DOI 10.1073/pnas.78.10.6456; BAEKKESKOV S, 1986, IMMUNOLOGY ENDOCRINE, P73; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CHANG YC, 1988, J NEUROSCI, V8, P2123; CHRISTIE MR, 1990, J BIOL CHEM, V265, P376; COOKE A, 1990, CURR TOP MICROBIOL, V164, P125; DECAMILLI P, 1990, REV PHYSL, V52, P625; GARRY DJ, 1988, J HISTOCHEM CYTOCHEM, V36, P573, DOI 10.1177/36.6.2896676; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; JULIEN JF, 1990, J NEUROCHEM, V54, P703, DOI 10.1111/j.1471-4159.1990.tb01928.x; LIE WR, 1990, NATURE, V344, P439, DOI 10.1038/344439a0; Mugnaini E, 1985, HDB CHEM NEUROANATOM, P436; OERTEL WH, 1980, BRAIN RES BULL, V5, P713, DOI 10.1016/0361-9230(80)90117-3; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; PASSARIELLO N, 1982, J CLIN ENDOCR METAB, V54, P1145, DOI 10.1210/jcem-54-6-1145; REUSENSBILLEN B, 1984, CELL TISSUE RES, V235, P503, DOI 10.1007/BF00226946; ROBBINS MS, 1981, DIABETES, V30, P168, DOI 10.2337/diabetes.30.2.168; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; SIGURDSSON E, 1990, CURR TOP MICROBIOL, V164, P143; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; WRAITH DC, 1989, CELL, V57, P709, DOI 10.1016/0092-8674(89)90786-1; [No title captured]	35	1467	1529	4	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	1990	347	6289					151	156		10.1038/347151a0	http://dx.doi.org/10.1038/347151a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY352	1697648				2022-12-28	WOS:A1990DY35200051
J	ABELSON, J				ABELSON, J			DIRECTED EVOLUTION OF NUCLEIC-ACIDS BY INDEPENDENT REPLICATION AND SELECTION	SCIENCE			English	Editorial Material											ABELSON, J (corresponding author), CALTECH,DIV BIOL,PASADENA,CA 91125, USA.							BASS B, 1987, BIOCHEMISTRY-US, V25, P4473; ELLINGTON AD, IN PRESS NATURE; HUTCHISON CA, 1986, P NATL ACAD SCI USA, V83, P710, DOI 10.1073/pnas.83.3.710; JOYCE GF, 1977, RNA CATALYSIS SPLICI, P83; KRAMER FR, 1974, J MOL BIOL, V89, P719, DOI 10.1016/0022-2836(74)90047-3; MCNEIL JB, 1985, MOL CELL BIOL, V5, P3545, DOI 10.1128/MCB.5.12.3545; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; OLIPHANT AR, 1988, NUCLEIC ACIDS RES, V16, P7673, DOI 10.1093/nar/16.15.7673; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; SAFFHILL R, 1970, J MOL BIOL, V51, P531, DOI 10.1016/0022-2836(70)90006-9; YARUS M, 1988, SCIENCE, V240, P1751, DOI 10.1126/science.3381099	12	32	45	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 3	1990	249	4968					488	489		10.1126/science.1696394	http://dx.doi.org/10.1126/science.1696394			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR811	1696394				2022-12-28	WOS:A1990DR81100028
J	TUKE, JW				TUKE, JW			SCREENING AND SURVEILLANCE OF SCHOOL AGED CHILDREN	BMJ-BRITISH MEDICAL JOURNAL			English	Article											TUKE, JW (corresponding author), W SUFFOLK HLTH AUTHOR, BURY ST EDMUNDS IP33 1YJ, ENGLAND.							BAX M, 1983, BRIT MED J, V286, P1793, DOI 10.1136/bmj.286.6380.1793; BAX M, 1989, CHILDCARE GENERAL PR; BERGMAN AB, 1977, AM J PUBLIC HEALTH, V67, P601, DOI 10.2105/AJPH.67.7.601; BEWLEY BR, 1984, J ROY COLL GEN PRACT, V34, P543; FELDMAN W, 1980, LANCET, V2, P1014; Francois M, 1988, Ann Otolaryngol Chir Cervicofac, V105, P349; GODBER G, 1978, WORLD MED, V22, P22; HALL DMB, 1989, HLTH CHILDREN PROGRA; JACKSON R, 1988, CHEST, V94, P914, DOI 10.1378/chest.94.5.914; LANDMAN GB, 1986, PEDIATR CLIN N AM, V33, P935; MACFARLANE A, 1986, HLTH SERVICES SCH; MACFARLANE JA, 1984, BRIT MED J, V289, P851, DOI 10.1136/bmj.289.6448.851; MOATTI JP, 1988, REV EPIDEMIOL SANTE, V36, P395; MURRAY M, 1983, J CHILD PSYCHOL PSYC, V24, P223, DOI 10.1111/j.1469-7610.1983.tb00571.x; OCALLAGHAN EM, 1987, ARCH DIS CHILD, V62, P1041, DOI 10.1136/adc.62.10.1041; PALFREY JS, 1987, J PEDIATR-US, V111, P651, DOI 10.1016/S0022-3476(87)80238-X; SKINNER DW, 1988, CLIN OTOLARYNGOL, V13, P341, DOI 10.1111/j.1365-2273.1988.tb00763.x; SPEIGHT ANP, 1983, BRIT MED J, V286, P1253, DOI 10.1136/bmj.286.6373.1253; STEWARTBROWN S, 1985, J EPIDEMIOL COMMUN H, V39, P107, DOI 10.1136/jech.39.2.107; STEWARTBROWN S, 1987, BRIT MED J, V294, P1386, DOI 10.1136/bmj.294.6584.1386; Stott N C, 1979, J R Coll Gen Pract, V29, P201; Vuori H, 1984, Community Med, V6, P221; WALKER WO, 1989, J DEV BEHAV PEDIATR, V10, P134; ZIELHUIS GA, 1989, LANCET, V1, P311; ZUSMAN J, 1973, INT J MENT HEALTH, V2, P111, DOI 10.1080/00207411.1973.11448624; 1980, EURO REP STUD, V30, P15; 1987, INVESTING FUTURE; 1982, SPECIAL ED NEEDS; 1976, CMND6680; 1985, CHILD HEALTH SURVEIL	30	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	1990	300	6733					1180	1182		10.1136/bmj.300.6733.1180	http://dx.doi.org/10.1136/bmj.300.6733.1180			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC150	1693301	Green Published, Bronze			2022-12-28	WOS:A1990DC15000022
J	KEW, MC; HOUGHTON, M; CHOO, QL; KUO, G				KEW, MC; HOUGHTON, M; CHOO, QL; KUO, G			HEPATITIS-C VIRUS-ANTIBODIES IN SOUTHERN AFRICAN BLACKS WITH HEPATOCELLULAR-CARCINOMA	LANCET			English	Article									CHIRON CORP,EMERYVILLE,CA	Novartis	KEW, MC (corresponding author), UNIV WITWATERSRAND,DEPT MED,7 YORK RD,JOHANNESBURG 2193,SOUTH AFRICA.			Houghton, Michael/0000-0003-3762-6771				BRUIX J, 1989, LANCET, V2, P1004; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COLOMBO M, 1989, LANCET, V2, P1006; ESTEBAN JI, 1989, LANCET, V2, P294; KEW MC, 1982, MEDICINE, V61, P98, DOI 10.1097/00005792-198203000-00004; KEW MC, 1989, GASTROENTEROLOGY, V97, P136, DOI 10.1016/0016-5085(89)91426-1; KEW MC, 1984, SEMIN LIVER DIS, V4, P136, DOI 10.1055/s-2008-1040653; KEW MC, 1986, CANCER SURV, V5, P719; KEW MC, 1981, HEPATOLOGY, V1, P366, DOI 10.1002/hep.1840010415; KEW MC, 1984, BRIT MED J, V288, P1727, DOI 10.1136/bmj.288.6432.1727; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; PATERSON AC, 1985, HEPATOLOGY, V5, P72, DOI 10.1002/hep.1840050116	12	252	253	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 14	1990	335	8694					873	874		10.1016/0140-6736(90)90474-J	http://dx.doi.org/10.1016/0140-6736(90)90474-J			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ135	1691422				2022-12-28	WOS:A1990CZ13500002
J	WHITE, MB; AMOS, J; HSU, JMC; GERRARD, B; FINN, P; DEAN, M				WHITE, MB; AMOS, J; HSU, JMC; GERRARD, B; FINN, P; DEAN, M			A FRAME-SHIFT MUTATION IN THE CYSTIC-FIBROSIS GENE	NATURE			English	Article									BOSTON UNIV,MED CTR,BOSTON,MA; WAYNE STATE UNIV,SCH MED,DETROIT,MI 48201	Boston University; Wayne State University	WHITE, MB (corresponding author), NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21701, USA.		Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; 				AMOS JA, 1989, CLIN INVEST MED, V13, P1; BARTELS I, 1986, AM J HUM GENET, V38, P280; BOAT TF, 1987, METABOLIC BASIS INHE, P2649; DEAN M, 1988, Genomics, V3, P93, DOI 10.1016/0888-7543(88)90138-3; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DISANTAGNESE PA, 1962, ANN NY ACAD SCI, V93, P555; ESTIVILL X, 1986, HUM GENET, V74, P320; ESTIVILL X, 1989, AM J HUM GENET, V44, P704; FRIZZELL RA, 1987, TRENDS NEUROSCI, V10, P190, DOI 10.1016/0166-2236(87)90144-5; HWANG TC, 1989, SCIENCE, V244, P1351, DOI 10.1126/science.2472005; IANNUZZI MC, 1989, AM J HUM GENET, V44, P695; JETTEN AM, 1989, SCIENCE, V244, P1472, DOI 10.1126/science.2472008; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LITT M, 1989, AM J HUM GENET, V44, P397; Maniatis T., 1982, MOL CLONING; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENSTEIN BJ, 1984, CYSTIC FIBROSIS, P85; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7	26	99	106	1	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 12	1990	344	6267					665	667		10.1038/344665a0	http://dx.doi.org/10.1038/344665a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY719	1691449				2022-12-28	WOS:A1990CY71900088
J	SCHOLER, HR; RUPPERT, S; SUZUKI, N; CHOWDHURY, K; GRUSS, P				SCHOLER, HR; RUPPERT, S; SUZUKI, N; CHOWDHURY, K; GRUSS, P			NEW TYPE OF POU DOMAIN IN GERM LINE-SPECIFIC PROTEIN OCT-4	NATURE			English	Article									DEUTSCH KREBSFORSCHUNGSZENTRUM, W-6900 HEIDELBERG, GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)	SCHOLER, HR (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MOLEC CELL BIOL, W-3400 GOTTINGEN, GERMANY.			Scholer, Hans/0000-0003-2643-5136				BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; CONNOLLY T, 1989, J CELL BIOL, V108, P299, DOI 10.1083/jcb.108.2.299; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; GARGIABLANCO MA, 1989, GENE DEV, V3, P739, DOI 10.1101/gad.3.6.739; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; PERARA E, 1986, SCIENCE, V232, P348, DOI 10.1126/science.3961485; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RUPPERT S, 1988, EMBO J, V7, P2715, DOI 10.1002/j.1460-2075.1988.tb03125.x; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SIEGEL V, 1988, EMBO J, V7, P1769, DOI 10.1002/j.1460-2075.1988.tb03007.x; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	30	608	648	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	1990	344	6265					435	439		10.1038/344435a0	http://dx.doi.org/10.1038/344435a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW478	1690859	Green Submitted			2022-12-28	WOS:A1990CW47800064
J	BACHMANN, M; PFEIFER, K; SCHRODER, HC; MULLER, WEG				BACHMANN, M; PFEIFER, K; SCHRODER, HC; MULLER, WEG			CHARACTERIZATION OF THE AUTOANTIGEN-LA AS A NUCLEIC-ACID DEPENDENT ATPASE DATPASE WITH MELTING PROPERTIES	CELL			English	Article											BACHMANN, M (corresponding author), UNIV MAINZ,INST PHYSIOL CHEM,DUESBERGWEG 6,W-6500 MAINZ,GERMANY.		Müller, W. E. G./AAR-8651-2020; Bachmann, Michael/AAA-5153-2020; Bachmann, Michael P/E-8850-2010	Müller, W. E. G./0000-0002-8223-3689; Bachmann, Michael/0000-0002-8029-5755; Bachmann, Michael P/0000-0002-8029-5755; Schroder, Heinz C./0000-0003-0992-6427				AKIZUKI M, 1977, J IMMUNOL, V119, P932; BACHMANN M, 1983, EUR J BIOCHEM, V136, P447, DOI 10.1111/j.1432-1033.1983.tb07762.x; BACHMANN M, 1988, CELL BIOL INT REP, V12, P765, DOI 10.1016/0309-1651(88)90088-4; BACHMANN M, 1989, MOL CELL BIOCHEM, V85, P103, DOI 10.1007/BF00577106; BACHMANN M, 1983, J BIOL CHEM, V258, P7033; BACHMANN M, 1989, J GEN VIROL, V70, P881, DOI 10.1099/0022-1317-70-4-881; BACHMANN M, 1986, BIOL CHEM H-S, V367, P671, DOI 10.1515/bchm3.1986.367.2.671; BACHMANN M, 1987, MOL BIOL REP, V12, P239, DOI 10.1007/BF00356918; BACHMANN M, 1986, P NATL ACAD SCI USA, V83, P7770, DOI 10.1073/pnas.83.20.7770; BACHMANN M, 1987, BIOCHEM J, V243, P189, DOI 10.1042/bj2430189; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BLANCHARD KL, 1983, J BIOL CHEM, V258, P4091; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; CARMOFONSECA M, 1989, EXP CELL RES, V185, P73, DOI 10.1016/0014-4827(89)90038-4; CHAMBERS JC, 1983, J BIOL CHEM, V258, P1438; CHAN EK, 1986, J IMMUNOL, V15, P3744; DAHLBERG JE, 1988, STRUCTURE FUNCTION M, P39; GALE A, 1986, ADV RHEUMATOL, V70, P237; GOTTLIEB E, 1987, MOL BIOL REP, V12, P243, DOI 10.1007/BF00356921; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; GOTTLIEB EL, 1989, EMBO J, V8, P841, DOI 10.1002/j.1460-2075.1989.tb03445.x; GRAMZOW M, 1986, J CELL BIOL, V102, P1344, DOI 10.1083/jcb.102.4.1344; GUIMARES RC, 1981, REV BRAS GENET 4, V3, P245; HAMELIN R, 1986, VIROLOGY, V152, P87, DOI 10.1016/0042-6822(86)90374-0; HARADA F, 1979, NUCLEIC ACIDS RES, V7, P909, DOI 10.1093/nar/7.4.909; HARADA F, 1980, NUCLEIC ACIDS RES, V8, P1273, DOI 10.1093/nar/8.6.1273; HARDIN JA, 1985, CLIN RHEUM DIS, V11, P485; HEYWOOD SM, 1986, NUCLEIC ACIDS RES, V14, P6771, DOI 10.1093/nar/14.16.6771; HOCH SO, 1984, J IMMUNOL, V133, P1397; HORI H, 1979, P NATL ACAD SCI USA, V76, P381, DOI 10.1073/pnas.76.1.381; JELINEK W, 1978, CELL, V15, P205, DOI 10.1016/0092-8674(78)90095-8; KATO N, 1982, BIOCHEM BIOPH RES CO, V99, P1477; KURATA N, 1976, ARTHRITIS RHEUM, V19, P574, DOI 10.1002/art.1780190309; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWERYGO.C, 1974, P NATL ACAD SCI USA, V71, P2003, DOI 10.1073/pnas.71.5.2003; MADORE SJ, 1984, J BIOL CHEM, V259, P1929; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTIOLI M, 1974, ARTHRITIS RHEUM-US, V17, P421, DOI 10.1002/art.1780170413; MCNEILAGE LJ, 1984, J IMMUNOL METHODS, V66, P253, DOI 10.1016/0022-1759(84)90336-3; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; RAUH AJG, 1988, EUR J IMMUNOL, V18, P2049, DOI 10.1002/eji.1830181227; Reddy R., 1988, STRUCTURE FUNCTION M, P1, DOI 10.1007/978-3-642-73020-7_1; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; SCHRODER HC, 1986, J BIOL CHEM, V261, P663; STEFANO JE, 1984, CELL, V36, P145, DOI 10.1016/0092-8674(84)90083-7; STUDIER FW, 1965, J MOL BIOL, V11, P373, DOI 10.1016/S0022-2836(65)80064-X; VENABLES PJW, 1983, CLIN EXP IMMUNOL, V54, P731	47	104	106	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 12	1990	60	1					85	93		10.1016/0092-8674(90)90718-T	http://dx.doi.org/10.1016/0092-8674(90)90718-T			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CJ358	1688513				2022-12-28	WOS:A1990CJ35800011
J	RIGAUD, G; ROUX, J; PICTET, R; GRANGE, T				RIGAUD, G; ROUX, J; PICTET, R; GRANGE, T			INVIVO FOOTPRINTING OF RAT TAT GENE - DYNAMIC INTERPLAY BETWEEN THE GLUCOCORTICOID RECEPTOR AND A LIVER-SPECIFIC FACTOR	CELL			English	Article							TYROSINE AMINOTRANSFERASE GENE; STEROID-DEPENDENT INTERACTION; TRANSCRIPTION FACTORS; MMTV PROMOTER; TRYPTOPHAN OXYGENASE; ENHANCER SEQUENCES; NUCLEAR FACTOR; BINDING-SITE; DNA-BINDING; HORMONE	HNF5, a liver-specific DNA-binding protein, interacts with DNA in a manner that allows DNAase I cleavage in the middle of its recognition sequence. Using this property we have identified in vivo HNF5 bound to its sites within two glucocorticoid-responsive units of the rat tyrosine aminotransferase (TAT) gene. One HNF5-binding site is also a glucocorticoid receptor-binding site; glucocorticoid-dependent HNF5 binding could be detected at this site even though it is incompatible with glucocorticoid receptor binding. HNF5 binds within 10 min of hormone addition, indicating that it participates in transcriptional activation. In the TAT gene glucocorticoid-dependent HNF5 binding occurs where there is glucocorticoid-dependent disruption of nucleosomal structure; constitutive binding occurs in constitutively disrupted regions. These results suggest a hit-and-run mechanism of transcriptional activation by glucocorticoid receptor: the activated receptor binds its target sequence, modifies local chromatin structure, then leaves its site accessible to another factor.			RIGAUD, G (corresponding author), UNIV PARIS 07,CNRS,INST JACQUES MONOD,TOUR 43,2 PL JUSSIEU,F-75251 PARIS 05,FRANCE.			Grange, Thierry/0000-0001-8700-3092				ALTSCHMIED J, 1989, NUCLEIC ACIDS RES, V17, P4975, DOI 10.1093/nar/17.13.4975; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; BAKKER O, 1988, MOL CELL BIOL, V8, P4557, DOI 10.1128/MCB.8.10.4557; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKER P, 1984, EMBO J, V3, P2015, DOI 10.1002/j.1460-2075.1984.tb02084.x; BECKER PB, 1986, NATURE, V324, P686, DOI 10.1038/324686a0; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; BURCH JBE, 1983, CELL, V33, P65, DOI 10.1016/0092-8674(83)90335-5; CARR KD, 1990, P NATL ACAD SCI USA, V87, P9300, DOI 10.1073/pnas.87.23.9300; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; CORDINGLEY MG, 1988, NUCLEIC ACIDS RES, V16, P609, DOI 10.1093/nar/16.2.609; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; DANESCH U, 1987, EMBO J, V6, P625, DOI 10.1002/j.1460-2075.1987.tb04800.x; GRANGE T, 1989, EXP CELL RES, V180, P220, DOI 10.1016/0014-4827(89)90226-7; GRANGE T, 1989, NUCLEIC ACIDS RES, V17, P8695, DOI 10.1093/nar/17.21.8695; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; GRANNER DK, 1983, MOL CELL BIOCHEM, V53-4, P113; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JACKSON DA, 1988, J CELL SCI, V90, P365; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEMAIGRE FP, 1990, MOL CELL BIOL, V10, P1811, DOI 10.1128/MCB.10.4.1811; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; ODDOS J, 1989, NUCLEIC ACIDS RES, V17, P8877, DOI 10.1093/nar/17.21.8877; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602; SCHAUER M, 1989, P NATL ACAD SCI USA, V86, P1123, DOI 10.1073/pnas.86.4.1123; SCHAUFELE F, 1990, J BIOL CHEM, V265, P17189; SCHERER G, 1982, P NATL ACAD SCI-BIOL, V79, P7205, DOI 10.1073/pnas.79.23.7205; SCHMID E, 1987, EUR J BIOCHEM, V165, P499, DOI 10.1111/j.1432-1033.1987.tb11467.x; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; TANGUAY RL, 1990, NUCLEIC ACIDS RES, V18, P5902, DOI 10.1093/nar/18.19.5902; TRAVERS AA, 1990, CELL, V60, P177, DOI 10.1016/0092-8674(90)90729-X; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; WIJNHOLDS J, 1991, NUCLEIC ACIDS RES, V19, P33, DOI 10.1093/nar/19.1.33; WIJNHOLDS J, 1988, EMBO J, V7, P2757, DOI 10.1002/j.1460-2075.1988.tb03130.x; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3	47	244	244	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					977	986		10.1016/0092-8674(91)90370-E	http://dx.doi.org/10.1016/0092-8674(91)90370-E			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1683601				2022-12-28	WOS:A1991GT75500016
J	ROUGEMONT, A; BRESLOW, N; BRENNER, E; MORET, AL; DUMBO, O; DOLO, A; SOULA, G; PERRIN, L				ROUGEMONT, A; BRESLOW, N; BRENNER, E; MORET, AL; DUMBO, O; DOLO, A; SOULA, G; PERRIN, L			EPIDEMIOLOGIC BASIS FOR CLINICAL-DIAGNOSIS OF CHILDHOOD MALARIA IN ENDEMIC ZONE IN WEST AFRICA	LANCET			English	Article							POPULATION	It is difficult to distinguish childhood malaria from other common febrile disorders by parasite count alone, because of the wide variation in tolerance of parasitaemia among individuals. We postulated that the proportion of febrile episodes among young children that can be attributed to parasitaemia varies according to simple clinical criteria. We studied 1114 children aged 2-9 years, who attended a dispensary in the Republic of Niger, with a case-control approach; each of 557 febrile children was matched with a non-febrile control by sex, age, ethnic group, and day of presentation. Febrile episodes were classified according to three clinical criteria: the presence of a likely non-malarial cause; the duration (less than 3 or more than 3 days before presentation); and the intensity (below 39-degrees-C or 39-degrees-C and above). There was no evidence for an association between febrile episodes and parasite count during the dry, low-transmission, season. During the rainy, high-transmission, season, by contrast, there was a highly significant relation (p < 0.0001 ) between the likelihood of fever and the parasite count, each clinical criterion strengthened the association. There was no association between parasitaemia and low intensity fevers, with an obvious cause, that started 3 or more days before presentation, even in the rainy season; however, the relative risk of a fever that met all three criteria developing in those with vs those without parasitaemia was 27.5. The proportion of febrile cases attributable to detectable parasitaemia (population attributable risk) ranged from 0 to 0.92. Our results suggest that simple clinical criteria may be valuable in the selection of febrile patients for antimalarial treatment. In this geographic area, high fever of short duration and with no other obvious cause that occurs during the rainy season is most likely to be malaria.	NATL SCH MED & PHARM,EPIDEMIOL & PARASIT INFECT LAB,BAMAKO,MALI; CANTONAL UNIV HOSP,DEPT INTERNAL MED,VIRAL SEROL LAB,GENEVA,SWITZERLAND; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195	University of Geneva; University of Washington; University of Washington Seattle	ROUGEMONT, A (corresponding author), UNIV GENEVA,SCH MED,DEPT SOCIAL & PREVENT MED,DEPT COMMUNITY HLTH & TROP MED,CH-1211 GENEVA 4,SWITZERLAND.							BASSETT MT, 1991, J TROP MED HYG, V94, P65; Baudon D, 1988, Med Trop (Mars), V48, P123; Breslow N, 1980, STAT METHODS CANC RE, P248; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; DABIS F, 1989, B WORLD HEALTH ORGAN, V67, P675; DELFINI LF, 1973, J TROP MED HYG, V76, P111; Ekunwe EO, 1984, WORLD HEALTH FORUM, V5, P19; ESSEX BJ, 1976, DIAGNOSTIC PATHWAYS; FEINBERG SE, 1980, ANAL CROSS CLASSIFIE; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; MORET AL, 1989, THESIS GENEVE; ROUGEMONT A, 1975, BRIT MED J, V2, P684, DOI 10.1136/bmj.2.5972.684-c; ROUGEMONT A, 1988, LANCET, V2, P709; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; 1991, EGRET USERS MANUAL; 1986, TECH REP SER WHO, V735; 1990, T R SOC TROP MED H S, V84, P1	17	81	82	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1292	1295		10.1016/0140-6736(91)92592-P	http://dx.doi.org/10.1016/0140-6736(91)92592-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682686				2022-12-28	WOS:A1991GR02300004
J	DENNISON, AR; MADDERN, GJ				DENNISON, AR; MADDERN, GJ			A TEMPORARY CHEF-DE-CLINIQUE	LANCET			English	Editorial Material									UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT SURG,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND; UNIV ADELAIDE,ROYAL ADELAIDE HOSP,DEPT SURG,ADELAIDE,SA 5000,AUSTRALIA	University of Sheffield; Royal Adelaide Hospital; University of Adelaide				Maddern, Guy/0000-0003-2064-181X; Dennison, Ashley/0000-0003-0090-503X					0	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1255	1256		10.1016/0140-6736(91)92114-H	http://dx.doi.org/10.1016/0140-6736(91)92114-H			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682655				2022-12-28	WOS:A1991GQ16600015
J	KASHLEV, M; LEE, JY; ZALENSKAYA, K; NIKIFOROV, V; GOLDFARB, A				KASHLEV, M; LEE, JY; ZALENSKAYA, K; NIKIFOROV, V; GOLDFARB, A			BLOCKING OF THE INITIATION-TO-ELONGATION TRANSITION BY A TRANSDOMINANT RNA-POLYMERASE MUTATION	SCIENCE			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032; ACAD SCI USSR,INST MOLEC GENET,MOSCOW 123182,USSR	Columbia University; Russian Academy of Sciences					NIGMS NIH HHS [GM30717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BERGHOFER B, 1988, NUCLEIC ACIDS RES, V16, P8113, DOI 10.1093/nar/16.16.8113; BIGGS J, 1985, CELL, V42, P611, DOI 10.1016/0092-8674(85)90118-7; BORODIN AM, 1988, DOKL AKAD NAUK SSSR+, V302, P1261; Buhler J.M., 1987, RNA POLYM REGULATION, P25; Burgess R.R., 1987, RNA POLYM REGULATION, P3; BURGESS RR, 1969, J BIOL CHEM, V244, P6168; CAI H, 1987, J BIOL CHEM, V262, P298; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; FALKENBURG D, 1987, J MOL BIOL, V195, P929, DOI 10.1016/0022-2836(87)90496-7; GLASS RE, 1986, MOL GEN GENET, V203, P487, DOI 10.1007/BF00422074; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; HEUMANN H, 1986, EUR J BIOCHEM, V158, P575, DOI 10.1111/j.1432-1033.1986.tb09793.x; HEUMANN H, 1988, J MOL BIOL, V201, P115, DOI 10.1016/0022-2836(88)90443-3; HUDSON GS, 1988, J MOL BIOL, V200, P639, DOI 10.1016/0022-2836(88)90477-9; HUET J, 1983, EMBO J, V2, P1291, DOI 10.1002/j.1460-2075.1983.tb01583.x; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JOHNSTON DE, 1976, RNA POLYM, P101; KASHLEV MV, 1989, MOL GEN GENET, V216, P469, DOI 10.1007/BF00334392; LEFFERS H, 1989, J MOL BIOL, V206, P1, DOI 10.1016/0022-2836(89)90519-6; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; MALIK S, 1985, J MOL BIOL, V185, P83, DOI 10.1016/0022-2836(85)90184-6; MALIK S, 1984, J BIOL CHEM, V259, P3292; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MCKINNEY JD, 1987, GENE, V58, P13, DOI 10.1016/0378-1119(87)90024-2; NENE V, 1984, MOL GEN GENET, V194, P166, DOI 10.1007/BF00383512; NENE V, 1982, MOL GEN GENET, V88, P399; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; OVCHINNIKOV YA, 1981, EUR J BIOCHEM, V116, P621, DOI 10.1111/j.1432-1033.1981.tb05381.x; PUHLER G, 1989, NUCLEIC ACIDS RES, V17, P4517, DOI 10.1093/nar/17.12.4517; SCHULZ W, 1981, NUCLEIC ACIDS RES, V9, P6889, DOI 10.1093/nar/9.24.6889; SENTENAC A, 1985, CRC CR REV BIOCH MOL, V18, P31, DOI 10.3109/10409238509082539; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; SIMPSON RB, 1979, CELL, V18, P277, DOI 10.1016/0092-8674(79)90047-3; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133; YURA T, 1979, ANNU REV GENET, V13, P59, DOI 10.1146/annurev.ge.13.120179.000423; ZALENSKAYA K, IN PRESS GENE; ZILLIG W, 1987, RNA POLYM REGULATION, P17	44	73	73	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 25	1990	248	4958					1006	1009		10.1126/science.1693014	http://dx.doi.org/10.1126/science.1693014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF144	1693014				2022-12-28	WOS:A1990DF14400034
J	ROBERTSON, DL; JOYCE, GF				ROBERTSON, DL; JOYCE, GF			SELECTION INVITRO OF AN RNA ENZYME THAT SPECIFICALLY CLEAVES SINGLE-STRANDED-DNA	NATURE			English	Article									SCRIPPS CLIN & RES FDN,RES INST,DEPT CHEM,10666 N TORREY PINES RD,LA JOLLA,CA 92037; SCRIPPS CLIN & RES FDN,RES INST,DEPT MOLEC BIOL,LA JOLLA,CA 92037	Scripps Research Institute; Scripps Research Institute								BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; Chamberlin M., 1982, ENZYMES, V15, P87; DAVIES RW, 1982, NATURE, V300, P719, DOI 10.1038/300719a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; INOUE T, 1986, J MOL BIOL, V189, P143, DOI 10.1016/0022-2836(86)90387-6; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; JOYCE GF, 1989, NUCLEIC ACIDS RES, V17, P711, DOI 10.1093/nar/17.12.4885; Joyce GF., 1989, UCLA S MOL CELLULAR, V94, P361; KAY PS, 1987, NATURE, V327, P343, DOI 10.1038/327343a0; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; KWOH DY, 1989, P NATL ACAD SCI USA, V86, P1173, DOI 10.1073/pnas.86.4.1173; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1983, EMBO J, V2, P33, DOI 10.1002/j.1460-2075.1983.tb01376.x; MILMAN G, 1967, P NATL ACAD SCI USA, V57, P1804, DOI 10.1073/pnas.57.6.1804; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WANG AHJ, 1982, NATURE, V299, P601, DOI 10.1038/299601a0; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; WOODSON SA, 1989, CELL, V57, P335, DOI 10.1016/0092-8674(89)90971-9; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0; ZAUG AJ, 1985, SCIENCE, V229, P1060, DOI 10.1126/science.2412290	23	1003	1164	6	143	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 29	1990	344	6265					467	468		10.1038/344467a0	http://dx.doi.org/10.1038/344467a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW478	1690861				2022-12-28	WOS:A1990CW47800075
J	SILVER, RM; HEYES, MP; MAIZE, JC; QUEARRY, B; VIONNETFUASSET, M; STERNBERG, EM				SILVER, RM; HEYES, MP; MAIZE, JC; QUEARRY, B; VIONNETFUASSET, M; STERNBERG, EM			SCLERODERMA, FASCIITIS, AND EOSINOPHILIA ASSOCIATED WITH THE INGESTION OF TRYPTOPHAN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									MED UNIV S CAROLINA,DEPT DERMATOL,CHARLESTON,SC 29425; NIMH,WASHINGTON,DC 20032; NIAMSD,WASHINGTON,DC	Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	SILVER, RM (corresponding author), MED UNIV S CAROLINA,DEPT MED,CHARLESTON,SC 29425, USA.				NCRR NIH HHS [RR01070-13] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001070] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AUFFRANC JC, 1985, ANN DERMATOL VENER, V112, P691; BOUCEK RJ, 1970, SCIENCE, V167, P898, DOI 10.1126/science.167.3919.898; CALOGERO AE, 1988, BRAIN RES, V463, P28, DOI 10.1016/0006-8993(88)90523-9; COHEN ML, 1989, LIFE SCI, V44, P957, DOI 10.1016/0024-3205(89)90495-5; FREESE A, 1988, ANN INTERN MED, V108, P312, DOI 10.7326/0003-4819-108-2-312_2; GRAHAM JR, 1966, NEW ENGL J MED, V274, P359, DOI 10.1056/NEJM196602172740701; HAYES MP, 1989, BR RES, V491, P173; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; HEYES MP, 1988, BIOMED ENVIRON MASS, V15, P291, DOI 10.1002/bms.1200150509; HOLMES EW, 1988, ANAL BIOCHEM, V172, P518, DOI 10.1016/0003-2697(88)90478-2; HORNSTEIN OP, 1989, NERVENHEILKUNDE, V8, P239; KALOGERAS KT, IN PRESS J CLIN ENDO; LAKHANPAL S, 1988, SEMIN ARTHRITIS RHEU, V17, P221, DOI 10.1016/0049-0172(88)90008-X; MACDONALD RA, 1958, P SOC EXP BIOL MED, V97, P334; MARICQ HR, 1981, ARTHRITIS RHEUM, V24, P1159, DOI 10.1002/art.1780240907; MOUTSOPOULOS HM, 1980, AM J MED, V68, P701, DOI 10.1016/0002-9343(80)90257-0; OZAKI Y, 1987, BIOCHEM BIOPH RES CO, V144, P1147, DOI 10.1016/0006-291X(87)91431-8; PFEFFERKORN ER, 1986, J INTERFERON RES, V6, P267, DOI 10.1089/jir.1986.6.267; POMFRET DW, 1987, J PHARMACOL EXP THER, V241, P465; PRICE JM, 1967, ARCH DERMATOL, V95, P462, DOI 10.1001/archderm.95.5.462; SCHNEIDERHELMERT D, 1986, PSYCHOPHARMACOLOGY, V89, P1; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; Shulman L E, 1975, Trans Assoc Am Physicians, V88, P70; STACHOW A, 1979, ACTA DERM-VENEREOL, V59, P1; STACHOW A, 1985, CURRENT TOPICS RHEUM, P130; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P2374, DOI 10.1073/pnas.86.7.2374; STERNBERG EM, 1980, NEW ENGL J MED, V303, P782, DOI 10.1056/NEJM198010023031403; SU WPD, 1981, AM J DERMATOPATH, V3, P251; TAKIKAWA O, 1986, J BIOL CHEM, V261, P3648; WERNERFELMAYER G, 1989, BIOCHIM BIOPHYS ACTA, V1012, P140, DOI 10.1016/0167-4889(89)90087-6; WINKELMANN RK, 1985, SEMIN DERMATOL, P90; ZARAFONETIS CJD, 1958, AM J MED SCI, V236, P1, DOI 10.1097/00000441-195807000-00001; 1989, MMWR, V38, P785; 1989, MMWR, V38, P765; 1982, LANCET, V2, P697	35	276	280	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	1990	322	13					874	881		10.1056/NEJM199003293221302	http://dx.doi.org/10.1056/NEJM199003293221302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV826	1690352				2022-12-28	WOS:A1990CV82600002
J	BUTTERFIELD, J				BUTTERFIELD, J			GILBERT MAGNETISM	LANCET			English	Article																		DEKKER T, WONDERFUL YEAR 1603; GILBERT, MAGNETE; JONSON B, MAGNETIC LADY	3	5	5	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1576	1579						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683984				2022-12-28	WOS:A1991GW03600017
J	NAVA, E; PALMER, RMJ; MONCADA, S				NAVA, E; PALMER, RMJ; MONCADA, S			INHIBITION OF NITRIC-OXIDE SYNTHESIS IN SEPTIC SHOCK - HOW MUCH IS BENEFICIAL	LANCET			English	Note							HYPOTENSION	Hypotension in septic shock is often resistant to treatment with vasoconstrictors and appears to be mediated by production of nitric oxide (NO). Reversal of endotoxin-induced hypotension in rats was achieved by intravenous injection of 30 mg/kg NG-monomethyl-L-arginine (L-NMMA), an inhibitor of endogenous NO synthesis. A lower dose of 3 mg/kg L-NMMA was ineffective, but 300 mg/kg L-NMMA accelerated and enhanced the fall in blood pressure. NO synthase inhibitors may be helpful in the treatment of hypotension associated with sepsis or therapeutic use of cytokines, but complete inhibition of endogenous NO synthesis may be counterproductive.	WELLCOME RES LABS,LANGLEY COURT,BECKENHAM BR3 3BS,KENT,ENGLAND	GlaxoSmithKline; Wellcome Research Laboratories				nava, eduardo/0000-0003-3259-0511				COHEN J, 1991, LANCET, V338, P736, DOI 10.1016/0140-6736(91)91453-2; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; KLABUNDE RE, 1991, BIOCHEM BIOPH RES CO, V178, P1135, DOI 10.1016/0006-291X(91)91010-A; MONCADA S, 1991, PHARMACOL REV, V43, P109; SCOTTBURDEN T, IN PRESS BIOL NITRIC; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; VALLANCE P, 1989, LANCET, V2, P997; WRIGHT CE, IN PRESS CARDIOVASC	9	389	394	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1555	1557		10.1016/0140-6736(91)92375-C	http://dx.doi.org/10.1016/0140-6736(91)92375-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683974				2022-12-28	WOS:A1991GW03600006
J	SANTIBANEZKOREF, MF; BIRCH, JM; HARTLEY, AL; JONES, PHM; CRAFT, AW; EDEN, T; CROWTHER, D; KELSEY, AM; HARRIS, M				SANTIBANEZKOREF, MF; BIRCH, JM; HARTLEY, AL; JONES, PHM; CRAFT, AW; EDEN, T; CROWTHER, D; KELSEY, AM; HARRIS, M			P53 GERMLINE MUTATIONS IN LI-FRAUMENI SYNDROME	LANCET			English	Note							CANCER; FAMILY; GENE	Germline mutations within a defined region of the p53 gene have recently been found in families with the Li-Fraumeni syndrome (LFS). In the present study this region of p53 was sequenced in affected individuals from 8 families with LFS. In only 2 of them were such mutations detected. Our findings suggest that the p53 mutation could be the primary lesion in some but not all families with LFS, and confirm that there is a "hot spot" for these mutations at the CpG dinucleotide moiety of codon 248. Assigning risks and counselling families on the basis of presence of p53 mutations should be approached with caution.	CHRISTIE HOSP & HOLT RADIUM INST,CANC RES CAMPAIGN,PEDIAT & FAMILIAL CANC RES GRP,MANCHESTER M20 9BX,LANCS,ENGLAND; CHRISTIE HOSP & HOLT RADIUM INST,PATERSON INST,CANC RES CAMPAIGN,DEPT CANC GENET,MANCHESTER M20 9BX,LANCS,ENGLAND; CHRISTIE HOSP & HOLT RADIUM INST,CANC RES CAMPAIGN,DEPT MED ONCOL,MANCHESTER M20 9BX,LANCS,ENGLAND; CHRISTIE HOSP & HOLT RADIUM INST,DEPT PATHOL,MANCHESTER M20 9BX,LANCS,ENGLAND; ROYAL MANCHESTER CHILDRENS HOSP,MANCHESTER M27 1HA,LANCS,ENGLAND; ROYAL VICTORIA INFIRM,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND; ROYAL HOSP SICK CHILDREN,EDINBURGH EH9 1LF,MIDLOTHIAN,SCOTLAND	Christie NHS Foundation Trust; Christie Hospital; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; Christie NHS Foundation Trust; Christie Hospital; Christie NHS Foundation Trust; Christie Hospital; Royal Manchester Children's Hospital; Newcastle University - UK	BIRCH, JM (corresponding author), CHRISTIE HOSP & HOLT RADIUM INST,CANC RES CAMPAIGN,PEDIAT & FAMILIAL CANC RES GRP,MANCHESTER M20 9BX,LANCS,ENGLAND.							BIRCH JM, 1990, CANCER-AM CANCER SOC, V66, P2239, DOI 10.1002/1097-0142(19901115)66:10<2239::AID-CNCR2820661034>3.0.CO;2-Q; DEANE M, 1990, EUR J IMMUNOL, V20, P2209, DOI 10.1002/eji.1830201009; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LI FP, 1988, CANCER RES, V48, P5358; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Sambrook J, 1989, MOL CLONING LABORATO; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153	10	136	136	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1490	1491		10.1016/0140-6736(91)92303-J	http://dx.doi.org/10.1016/0140-6736(91)92303-J			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683921				2022-12-28	WOS:A1991GV07700007
J	FANNING, A; EDWARDS, S				FANNING, A; EDWARDS, S			MYCOBACTERIUM-BOVIS INFECTION IN HUMAN-BEINGS IN CONTACT WITH ELK (CERVUS-ELAPHUS) IN ALBERTA, CANADA	LANCET			English	Article								Human infection with Mycobacterium bovis is rare in developed countries because of milk pasteurisation and the slaughter of infected cattle. An epizootic of M bovis infection in domesticated elk (Cervus elaphus) in Alberta, Canada, which started in April, 1990, prompted us to seek human contacts of elk herds. There were 446 identified contacts, in 394 of whom tuberculin skin tests were done. Of 81 contacts who were skin-test positive, 50 had been in contact with culture-positive animals. 6 of 106 subjects tested a second time became tuberculin positive. 1 case of active M bovis infection was diagnosed by sputum culture. The mode of transmission of M bovis from these farm animals to man is likely to be aerosolisation of infected particles. Because of the apparent susceptibility of farmed Cervidae (deer) to M bovis infection, and the evidence of spread to man, control measures to prevent human infection should be developed.			FANNING, A (corresponding author), UNIV ALBERTA,DEPT MED,DIV INFECT DIS,2E4 11 WALTER MACKENZIE HLTH SCI CTR,EDMONTON T6G 2J3,ALBERTA,CANADA.							COLLINS CH, 1957, IRISH VET J, V41, P363; FANNING A, 1991, American Review of Respiratory Disease, V143, pA284; GEORGHIOU P, 1989, AUST NZ J MED, V19, P409, DOI 10.1111/j.1445-5994.1989.tb00289.x; KARLSON AG, 1970, ANN INTERN MED, V73, P979, DOI 10.7326/0003-4819-73-6-979; ROBINSON P, 1988, NZ J MED, V18, P701; Stumpff C. D., 1982, Proceedings of the American Animal Health Association, V86, P524; WIGLE WD, 1973, AM REV RESPIR DIS, V106, P528; YATES MD, 1986, J EPIDEMIOL COMMUN H, V40, P295, DOI 10.1136/jech.40.4.295	8	75	77	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1253	1255		10.1016/0140-6736(91)92113-G	http://dx.doi.org/10.1016/0140-6736(91)92113-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682654				2022-12-28	WOS:A1991GQ16600014
J	PIRZER, U; SCHONHAAR, A; FLEISCHER, B; HERMANN, E; ZUMBUSCHENFELDE, KHM				PIRZER, U; SCHONHAAR, A; FLEISCHER, B; HERMANN, E; ZUMBUSCHENFELDE, KHM			REACTIVITY OF INFILTRATING LYMPHOCYTES-T WITH MICROBIAL ANTIGENS IN CROHNS-DISEASE	LANCET			English	Note							CELL ACTIVATION; RESPONSES; PROTEIN	Intestinal T lymphocytes are normally unresponsive to microbial and recall antigens in vitro, whereas the same antigens induce strong immune responses in peripheral-blood-derived T cells. We obtained T lymphocytes from peripheral blood and from the non-inflamed and inflamed intestinal mucosa of 6 patients (3 male, 3 female; mean age 33 years) with Crohn's disease. The T cells were stimulated in vitro with a range of microbial antigens. Whereas T cells from normal mucosa were unresponsive, those from inflamed mucosa had a proliferative response comparable to that of the peripheral-blood-derived T cells. These findings suggest that physiologic unresponsiveness to luminal antigens is abrogated in the inflammatory lesions of Crohn's disease patients. Infiltrating T lymphocytes may therefore mediate chronic inflammation on encountering the many antigens present in the intestine.	UNIV MAINZ,DEPT MED 1,W-6500 MAINZ,GERMANY	Johannes Gutenberg University of Mainz								DEDOMBAL FT, 1974, GUT, V15, P435, DOI 10.1136/gut.15.6.435; JAMES SP, 1988, GASTROENTEROLOGY, V94, P647; MACDERMOTT RP, 1988, ADV IMMUNOL, V42, P285, DOI 10.1016/S0065-2776(08)60848-2; MEUER SC, 1987, J CLIN INVEST, V80, P743, DOI 10.1172/JCI113129; MUNK ME, 1988, EUR J IMMUNOL, V18, P1835, DOI 10.1002/eji.1830181128; PITZALIS C, 1988, EUR J IMMUNOL, V18, P1397, DOI 10.1002/eji.1830180915; SELBY WS, 1984, GUT, V25, P32, DOI 10.1136/gut.25.1.32; YOUNG DB, 1987, IMMUNOL TODAY, V8, P215, DOI 10.1016/0167-5699(87)90168-X; ZEITZ M, 1988, GASTROENTEROLOGY, V94, P647, DOI 10.1016/0016-5085(88)90235-1	9	125	126	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1238	1239		10.1016/0140-6736(91)92104-A	http://dx.doi.org/10.1016/0140-6736(91)92104-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682646				2022-12-28	WOS:A1991GQ16600006
J	DRISCOLL, PC; CYSTER, JG; CAMPBELL, ID; WILLIAMS, AF				DRISCOLL, PC; CYSTER, JG; CAMPBELL, ID; WILLIAMS, AF			STRUCTURE OF DOMAIN-1 OF RAT LYMPHOCYTE-T CD2 ANTIGEN	NATURE			English	Article							IMMUNOGLOBULIN SUPERFAMILY; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN; FRAGMENT; SPECTROSCOPY; ACTIVATION; RESOLUTION; RECEPTORS; SEQUENCES	THE CD2 antigen is largely restricted to cells of the T-lymphocyte lineage and has been established as an important adhesion molecule in interactions between human T lymphocytes and accessory cells 1. In the adhesion reaction, CD2 on T cells binds to LFA-3 on other cells, with binding through domain 1 of CD2 (ref. 2). CD2 can also be a target for the delivery of mitogenic signals to T lymphocytes cultured with combinations of anti-CD2 antibodies 3,4. Two predictions that are contradictory have been made for the structure of CD2 domain 1. One suggests an immunoglobulin (Ig) fold, on the basis of sequence patterns conserved in the Ig-superfamily (IgSF) 5, whilst the other proposes a pattern of alternating alpha-helices and beta-strands, on the basis of secondary structure predictions 6. Thus CD2 domain 1 is an important test case for the validity of IgSF assignments based on sequence patterns. We report here the expression of domain 1 of rat CD2 in an Escherichia coli expression system and have determined a low-resolution solution structure by NMR spectroscopy.	UNIV OXFORD, SIR WILLIAM DUNN SCH PATHOL, MRC, CELLULAR IMMUNOL RES UNIT, OXFORD OX1 3RE, ENGLAND	University of Oxford	DRISCOLL, PC (corresponding author), UNIV OXFORD, DEPT BIOCHEM, OXFORD OX1 3QU, ENGLAND.		Driscoll, Paul C/B-8007-2010	Driscoll, Paul C/0000-0002-4124-6950				AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; BEYERS AD, 1989, IMMUNOL REV, V111, P59, DOI 10.1111/j.1600-065X.1989.tb00542.x; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1990, X PLOR MANUAL VERSIO; CLAYTON LK, 1987, EUR J IMMUNOL, V17, P1367, DOI 10.1002/eji.1830170922; CLORE GM, 1989, CRIT REV BIOCHEM MOL, V24, P479, DOI 10.3109/10409238909086962; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P3542, DOI 10.1021/bi00466a018; EPP O, 1975, BIOCHEMISTRY-US, V14, P4943, DOI 10.1021/bi00693a025; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; HOLMGREN A, 1989, NATURE, V342, P248, DOI 10.1038/342248a0; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KILLEEN N, 1988, EMBO J, V7, P3087, DOI 10.1002/j.1460-2075.1988.tb03174.x; KRAULIS P, IN PRESS J APPL CRYS; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; PETERSON A, 1987, NATURE, V329, P842, DOI 10.1038/329842a0; RECNY MA, 1990, J BIOL CHEM, V265, P8542; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; SAUL FA, 1978, J BIOL CHEM, V253, P585; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WILLIAMS AF, 1989, COLD SPRING HARB SYM, V54, P637; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, J EXP MED, V165, P368, DOI 10.1084/jem.165.2.368	29	150	161	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	1991	353	6346					762	765		10.1038/353762a0	http://dx.doi.org/10.1038/353762a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL696	1682812				2022-12-28	WOS:A1991GL69600071
J	KHAJOTIA, RR; MOHN, A; POKIESER, L; SCHALLESCHAK, J; VETTER, N				KHAJOTIA, RR; MOHN, A; POKIESER, L; SCHALLESCHAK, J; VETTER, N			INDUCED SPUTUM AND CYTOLOGICAL DIAGNOSIS OF LUNG-CANCER	LANCET			English	Note							FIBEROPTIC BRONCHOSCOPY; BIOPSY	Diagnosis of lung cancer by examination of induced sputum specimens for malignant cells may be a valuable alternative to diagnosis by bronchoscopy. Patients suspected of having lung cancer were recruited and randomly distributed into two groups, one group (n = 34) having sputum induced by use of an ultrasonic nebuliser before bronchoscopy, and the other (n = 33) undergoing ordinary expectoration before bronchoscopy. 25 patients in the induced-sputum group were diagnosed as having primary lung cancer, induced sputum was positive for malignant cells in 21 of these patients (84%), whereas bronchoscopy was positive in 23 (92%) (not significantly different). In comparison, ordinary sputum was positive in 15 of 29 patients (52%) diagnosed as having primary lung cancer, whereas bronchoscopy was positive in 28 (97%) (p < 0.001). Induction of sputum by an ultrasonic nebuliser was an effective procedure for diagnosis of primary lung cancer.	PULMOLOG ZENTRUM, DEPT CYTOL, A-1145 VIENNA, AUSTRIA		KHAJOTIA, RR (corresponding author), PULMOLOG ZENTRUM, DEPT CHEST MED, SANATORIUMSTR 2, A-1145 VIENNA, AUSTRIA.							CREDLE WF, 1974, AM REV RESPIR DIS, V109, P67; PAYNE CR, 1979, THORAX, V34, P294, DOI 10.1136/thx.34.3.294; PEDERSEN B, 1985, ACTA CYTOL, V29, P750; XIAO ML, 1989, J SURG ONCOL, V40, P107, DOI 10.1002/jso.2930400210; ZAVALA DC, 1975, CHEST, V68, P12, DOI 10.1378/chest.68.1.12	5	28	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	1991	338	8773					976	977		10.1016/0140-6736(91)91839-M	http://dx.doi.org/10.1016/0140-6736(91)91839-M			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681343				2022-12-28	WOS:A1991GK97400005
J	MARTINEZ, CK; MONACO, JJ				MARTINEZ, CK; MONACO, JJ			HOMOLOGY OF PROTEASOME SUBUNITS TO A MAJOR HISTOCOMPATIBILITY COMPLEX-LINKED LMP GENE	NATURE			English	Article							RAT HEPATOMA-CELLS; CDNA CLONING; MOLECULAR-CLONING; CROSSING-OVER; PROTEINASE; MHC; ANTIGENS; LIVER	THE ClaSS II region of the major histocompatibility complex (MHC) contains genes encoding at least two subunits of a large, intracellular protein complex (the low molecular mass polypeptide, or LMP, complex) 1-3. This complex is biochemically similar to the proteasome, an abundant and well conserved protein complex having multiple proteolytic activities. Here we report the isolation of a complementary DNA corresponding to one of the subunits of the LMP complex, LMP-2. The protein predicted from this cDNA sequence closely matches the amino-terminal peptide sequence of a rat proteasome subunit, confirming that the proteasome and the LMP complex share polypeptide subunits. The LMP-2 gene is tightly linked to HAM1, a gene thought to be required for translocating peptide fragments of endogenous antigens into the endoplasmic reticulum for association with MHC class I molecules 4. These observations suggest that the LMP complex may be responsible for generating peptides from cytoplasmic antigen during antigen processing.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PATHOL,RICHMOND,VA 23298	Virginia Commonwealth University	MARTINEZ, CK (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298, USA.							BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; CHO SG, 1991, P NATL ACAD SCI USA, V88, P5197, DOI 10.1073/pnas.88.12.5197; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FUJIWARA T, 1989, BIOCHEMISTRY-US, V28, P7332, DOI 10.1021/bi00444a028; KUMATORI A, 1990, FEBS LETT, V264, P279, DOI 10.1016/0014-5793(90)80267-M; LEE LW, 1990, BIOCHIM BIOPHYS ACTA, V1037, P178, DOI 10.1016/0167-4838(90)90165-C; LILLEY KS, 1990, FEBS LETT, V262, P327, DOI 10.1016/0014-5793(90)80220-D; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MONACO JJ, 1982, P NATL ACAD SCI-BIOL, V79, P3001, DOI 10.1073/pnas.79.9.3001; MONACO JJ, 1986, HUM IMMUNOL, V15, P416, DOI 10.1016/0198-8859(86)90019-4; MONACO JJ, 1984, NATURE, V309, P797, DOI 10.1038/309797a0; TAMURA T, 1990, FEBS LETT, V264, P91, DOI 10.1016/0014-5793(90)80773-C; TANAKA K, 1990, BIOCHEM BIOPH RES CO, V171, P676, DOI 10.1016/0006-291X(90)91199-3; TANAKA K, 1990, BIOCHEMISTRY-US, V29, P3777, DOI 10.1021/bi00467a026; UEMATSU Y, 1988, IMMUNOGENETICS, V27, P96, DOI 10.1007/BF00351082; UEMATSU Y, 1986, EMBO J, V5, P2123, DOI 10.1002/j.1460-2075.1986.tb04475.x	16	252	261	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 17	1991	353	6345					664	667		10.1038/353664a0	http://dx.doi.org/10.1038/353664a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK672	1681432				2022-12-28	WOS:A1991GK67200072
J	COHEN, J; GLAUSER, MP				COHEN, J; GLAUSER, MP			SEPTIC SHOCK - TREATMENT	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; GRAM-NEGATIVE BACTEREMIA; ANTIBODIES; METHYLPREDNISOLONE; MORTALITY; CACHECTIN; THERAPY; FEVER; ALPHA		CHU VAUDOIS,DEPT MED,DIV INFECT DIS,CH-1011 LAUSANNE,SWITZERLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London	COHEN, J (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT BACTERIOL,INFECT DIS UNIT,DU CANE RD,LONDON W12 0NN,ENGLAND.							APPELMELK BJ, IN PRESS BACTERIAL L; BAUMGARTNER JD, 1987, REV INFECT DIS, V9, P194; BAUMGARTNER JD, 1991, J INFECT DIS, V163, P769, DOI 10.1093/infdis/163.4.769; BAUMGARTNER JD, 1990, EUR J CLIN MICROBIOL, V9, P711, DOI 10.1007/BF02184682; BAUMGARTNER JD, 1990, J EXP MED, V171, P889, DOI 10.1084/jem.171.3.889; BAUMGARTNER JD, 1985, LANCET, V2, P59; BAYSTON KF, 1990, 1990 INT C ANT AG CH, P136; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BORELICK K, 1990, THERAPEUTIC MONOCLON, P253; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; COHEN J, 1988, J HOSP INFECT, V12, P47, DOI 10.1016/0195-6701(88)90029-1; COHEN J, 1991, UPDATE INTENSIVE CAR, V14, P262; EXLEY AR, 1990, LANCET, V335, P1275, DOI 10.1016/0140-6736(90)91337-A; HEUMANN D, 1991, J INFECT DIS, V163, P762, DOI 10.1093/infdis/163.4.762; Hinshaw LPP, 1987, NEW ENGL J MED, V317, P659; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; KREGER BE, 1980, AM J MED, V68, P344, DOI 10.1016/0002-9343(80)90102-3; MARKS JD, 1990, AM REV RESPIR DIS, V141, P94, DOI 10.1164/ajrccm/141.1.94; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; ROINE I, 1990, 1990 INT C ANT AG CH, P136; SHAUNAK S, 1988, Q J MED, V69, P921; SHEAGREN JN, 1985, SEPTIC SHOCK, P201; SHOEMAKER WC, 1990, CRIT CARE MED, V18, pS19; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; TENG NNH, 1985, P NATL ACAD SCI USA, V82, P1790, DOI 10.1073/pnas.82.6.1790; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	29	67	71	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					736	739		10.1016/0140-6736(91)91453-2	http://dx.doi.org/10.1016/0140-6736(91)91453-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679877				2022-12-28	WOS:A1991GG10400014
J	SUTTER, RW; PATRIARCA, PA; BROGAN, S; MALANKAR, PG; PALLANSCH, MA; KEW, OM; BASS, AG; COCHI, SL; ALEXANDER, JP; HALL, DB; SULEIMAN, AJM; ALGHASSANY, AAK; ELBUALY, MS				SUTTER, RW; PATRIARCA, PA; BROGAN, S; MALANKAR, PG; PALLANSCH, MA; KEW, OM; BASS, AG; COCHI, SL; ALEXANDER, JP; HALL, DB; SULEIMAN, AJM; ALGHASSANY, AAK; ELBUALY, MS			OUTBREAK OF PARALYTIC POLIOMYELITIS IN OMAN - EVIDENCE FOR WIDESPREAD TRANSMISSION AMONG FULLY VACCINATED CHILDREN	LANCET			English	Article								From January, 1988, to March, 1989, a widespread outbreak (118 cases) of poliomyelitis type 1 occurred in Oman. Incidence of paralytic disease was highest in children younger than 2 years (87/100 000) despite an immunisation programme that recently had raised coverage with 3 doses of oral poliovirus vaccine (OPV) among 12-month-old children from 67% to 87%. We did a case-control study (70 case-patients, 692 age-matched controls) to estimate the clinical efficacy of OPV, assessed the immunogenicity of OPV and extent of poliovirus spread by serology, retrospectively evaluated the cold chain and vaccine potency, and sought the origin of the outbreak strain by genomic sequencing. 3 doses of OPV reduced the risk of paralysis by 91%; vaccine failures could not be explained by failures in the cold chain nor on suboptimum vaccine potency. Cases and controls had virtually identical type 1 neutralising antibody profiles, suggesting that poliovirus type 1 circulation was widespread. Genomic sequencing indicated that the outbreak strain had been recently imported from South Asia and was distinguishable from isolates indigenous to the Middle East. Accumulation of enough children to sustain the outbreak seems to have been due to previous success of the immunisation programme in reducing spread of endemic strains, suboptimum efficacy of OPV, and delay in completing the primary immunisation series until 7 months of age. Additionally, the estimated attack rate of infection among children aged 9-23 months exceeded 25% in some regions, suggesting that a substantial proportion of fully vaccinated children had been involved in the chain of transmission.	CTR DIS CONTROL, DIV VIRAL & RICKETTSIAL DIS, ATLANTA, GA 30333 USA; UNICEF, Muscat, OMAN; WHO, EXPANDED PROGRAMME IMMUNISAT, CH-1211 GENEVA 27, SWITZERLAND; MINIST HLTH, Muscat, OMAN	Centers for Disease Control & Prevention - USA; World Health Organization	SUTTER, RW (corresponding author), CTR DIS CONTROL, DIV IMMUNISAT E05, ATLANTA, GA 30333 USA.							BASS AG, 1989, REVIEW VACCINE OLD C; BERNIER RH, 1984, REV INFECT DIS, V6, pS371; De-Xiang D, 1986, B WORLD HEALTH ORGAN, V64, P853; DEMING MS, IN PRESS AM J EPIDEM; GAIL MH, 1981, BIOMETRIKA, V68, P703, DOI 10.1093/biomet/68.3.703; HANLON P, 1987, LANCET, V1, P800; JOHN TJ, 1984, REV INFECT DIS, V6, pS438; KIMFARLEY RJ, 1984, LANCET, V2, P1322; Melnick JL, 1979, DIAGNOSTIC PROCEDURE, V5th, P471; OTTEN MW, IN PRESS AM J EPIDEM; PATRIARCA PA, 1988, LANCET, V1, P429; PATRIARCA PA, IN PRESS REV INFECT; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; SABIN AB, 1960, JAMA-J AM MED ASSOC, V173, P1521, DOI 10.1001/jama.1960.03020320001001; SABIN AB, 1982, YALE J BIOL MED, V55, P383; SLATER PE, 1990, LANCET, V335, P1192, DOI 10.1016/0140-6736(90)92705-M; SUTTER RW, 1989, AM J PUBLIC HEALTH, V79, P495, DOI 10.2105/AJPH.79.4.495; SUTTER RW, 1989, 38TH ANN M AM SOC TR; TULCHINSKY T, 1989, AM J PUBLIC HEALTH, V79, P1648, DOI 10.2105/AJPH.79.12.1648; 1988, WHO TECH REP SER, V771; 1989, WEEKLY EPIDEMIOL REC, V64, P273; 1990, MMWR, V39, P557; 1985, TRAINING COURSE MID; 1988, WEEKLY EPIDEMIOL REC, V63, P161	24	81	81	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	1991	338	8769					715	720		10.1016/0140-6736(91)91442-W	http://dx.doi.org/10.1016/0140-6736(91)91442-W			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679866				2022-12-28	WOS:A1991GG10400003
J	BRAHAMS, D				BRAHAMS, D			GROUP LITIGATION ON THE HORIZON	LANCET			English	Editorial Material							PORCINE INSULIN; HYPOGLYCEMIA											BERGER W, 1989, LANCET, V1, P1041, DOI 10.1016/S0140-6736(89)92444-6; DENISON S, 1991, INDEPENDENT     0807; GALE EAM, 1989, LANCET, V2, P1264; TEUSCHER A, 1987, LANCET, V2, P382	4	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 7	1991	338	8767					625	626		10.1016/0140-6736(91)90624-X	http://dx.doi.org/10.1016/0140-6736(91)90624-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GD809	1679162				2022-12-28	WOS:A1991GD80900015
J	HECKEL, JL; SANDGREN, EP; DEGEN, JL; PALMITER, RD; BRINSTER, RL				HECKEL, JL; SANDGREN, EP; DEGEN, JL; PALMITER, RD; BRINSTER, RL			NEONATAL BLEEDING IN TRANSGENIC MICE EXPRESSING UROKINASE-TYPE PLASMINOGEN-ACTIVATOR	CELL			English	Article									UNIV CINCINNATI,COLL MED,DEPT PEDIAT,CINCINNATI,OH 45229; UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195	University System of Ohio; University of Cincinnati; University of Pennsylvania; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	HECKEL, JL (corresponding author), CHILDRENS HOSP RES FDN,CINCINNATI,OH 45229, USA.			Brinster, Ralph/0000-0003-1408-7656	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009172, R01HD009172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA038635, R29CA044611] Funding Source: NIH RePORTER; NCI NIH HHS [CA38635, CA44611] Funding Source: Medline; NICHD NIH HHS [HD09172] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADDIEGO JE, 1974, J PEDIATR, V85, P807; AOKI N, 1989, BLOOD REV, V3, P11, DOI 10.1016/0268-960X(89)90021-0; AOKI N, 1980, BLOOD, V55, P483; AOKI N, 1979, J CLIN INVEST, V63, P877, DOI 10.1172/JCI109387; AZNAR J, 1984, THROMB HAEMOSTASIS, V52, P196; BAEHNER ROBERT L., 1966, N ENGL J MED, V275, P524, DOI 10.1056/NEJM196609082751003; BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BELL SM, 1990, J BIOL CHEM, V265, P1333; BOOTH NA, 1983, BLOOD, V61, P267; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLEN D, 1987, MOL BASIS BLOOD DISE, P662; CRABTREE GR, 1981, J BIOL CHEM, V256, P9718; DANO K, 1985, ADV CANCER RES, V44, P149; DAS PC, 1969, BRIT J HAEMATOL, V17, P431, DOI 10.1111/j.1365-2141.1969.tb01391.x; DURNAM DM, 1983, ANAL BIOCHEM, V131, P385, DOI 10.1016/0003-2697(83)90188-4; EICHELBERGER MR, 1986, PEDIATR SURG, P145; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCIS RB, 1989, BLUT, V59, P1, DOI 10.1007/BF00320240; FRIEZNERDEGEN S, 1987, BIOCHEMISTRY-US, V26, P8270; GIROLAMI A, 1986, ACTA HAEMATOL-BASEL, V75, P54, DOI 10.1159/000206083; GRALNICK HR, 1973, BRIT J HAEMATOL, V24, P89, DOI 10.1111/j.1365-2141.1973.tb05730.x; IMAOKA S, 1986, CANCER-AM CANCER SOC, V58, P1736, DOI 10.1002/1097-0142(19861015)58:8<1736::AID-CNCR2820580825>3.0.CO;2-8; KAZAMA M, 1981, THROMB RES, V21, P517, DOI 10.1016/0049-3848(81)90154-7; KLUFT C, 1987, J CLIN INVEST, V80, P1391, DOI 10.1172/JCI113217; KORDICH L, 1985, THROMB RES, V40, P645, DOI 10.1016/0049-3848(85)90302-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOTTENBERG R, 1985, AM J HEMATOL, V19, P181, DOI 10.1002/ajh.2830190211; MARDER VJ, 1988, NEW ENGL J MED, V318, P1512, DOI 10.1056/NEJM198806093182306; MILES LA, 1982, BLOOD, V59, P1246; ORNITZ DM, 1985, NATURE, V313, P600, DOI 10.1038/313600a0; OSKI FA, 1982, HEMATOLOGIC PROBLEMS, P137; PELLMAN CM, 1966, J UROLOGY, V96, P375, DOI 10.1016/S0022-5347(17)63273-7; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SANE DC, 1989, AM J HEMATOL, V31, P53, DOI 10.1002/ajh.2830310111; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; TAGNON HJ, 1952, CANCER, V5, P9, DOI 10.1002/1097-0142(195201)5:1<9::AID-CNCR2820050104>3.0.CO;2-S; Van Slyck E J, 1989, Henry Ford Hosp Med J, V37, P33	40	175	197	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 10	1990	62	3					447	456		10.1016/0092-8674(90)90010-C	http://dx.doi.org/10.1016/0092-8674(90)90010-C			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1696178				2022-12-28	WOS:A1990DU44500007
J	WAFFORD, KA; BURNETT, DM; DUNWIDDIE, TV; HARRIS, RA				WAFFORD, KA; BURNETT, DM; DUNWIDDIE, TV; HARRIS, RA			GENETIC-DIFFERENCES IN THE ETHANOL SENSITIVITY OF GABA-A RECEPTORS EXPRESSED IN XENOPUS OOCYTES	SCIENCE			English	Article									VET ADM MED CTR,DENVER,CO 80220	US Department of Veterans Affairs; Veterans Health Administration (VHA)	WAFFORD, KA (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262, USA.			Wafford, Keith/0000-0003-4537-4690	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006399, R37AA006399, P50AA003527] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA06399, AA03527] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Allan A M, 1987, Recent Dev Alcohol, V5, P313; ALLAN AM, 1986, LIFE SCI, V39, P2005, DOI 10.1016/0024-3205(86)90324-3; ALLAN AM, 1987, PHARMACOL BIOCHEM BE, V27, P665, DOI 10.1016/0091-3057(87)90192-4; BELKNAP JK, 1983, BEHAV GENET, V13, P383, DOI 10.1007/BF01065776; CELENTANO JJ, 1989, BRAIN RES, V455, P337; GAGE PW, 1985, BRIT J PHARMACOL, V85, P675, DOI 10.1111/j.1476-5381.1985.tb10563.x; GALLAHER EJ, 1987, PSYCHOPHARMACOLOGY, V93, P25, DOI 10.1007/BF02439582; HARRIS DP, 1984, GEN PHARMACOL, V15, P449, DOI 10.1016/0306-3623(84)90198-8; HARRIS RA, 1989, BRAIN RES, V490, P26; HARRIS RA, 1989, FASEB J, V3, P1689, DOI 10.1096/fasebj.3.6.2467834; HARRIS RA, 1988, J PHARMACOL EXP THER, V247, P1012; HOFFMAN PL, 1989, J NEUROCHEM, V52, P1937, DOI 10.1111/j.1471-4159.1989.tb07280.x; HOUAMED KM, 1984, NATURE, V310, P318, DOI 10.1038/310318a0; HOWERTON TC, 1983, J PHARMACOL EXP THER, V227, P389; KIER WJ, IN PRESS SOC NEUR AB; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; MANCILLAS JR, 1986, SCIENCE, V231, P161, DOI 10.1126/science.2867600; MCCLEARN GE, 1973, BEHAV GENET, V3, P409; MCQUILKIN SJ, 1990, LIFE SCI, V46, P527, DOI 10.1016/0024-3205(90)90009-G; MEHTA AK, 1988, J PHARMACOL EXP THER, V246, P558; NESTOROS JN, 1980, SCIENCE, V209, P708, DOI 10.1126/science.7394531; PALMER MR, 1988, J PHARMACOL EXP THER, V247, P1018; PRITCHETT DB, 1989, NATURE, V338, P582, DOI 10.1038/338582a0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SUZDAK PD, 1986, P NATL ACAD SCI USA, V83, P4071, DOI 10.1073/pnas.83.11.4071; SUZDAK PD, 1988, J PHARMACOL EXP THER, V245, P880; SUZDAK PD, 1986, SCIENCE, V234, P1243, DOI 10.1126/science.3022383; TAKADA R, 1989, ALCOHOL, V6, P115, DOI 10.1016/0741-8329(89)90035-9; TICKU MK, 1988, PHARMACOL BIOCHEM BE, V30, P501, DOI 10.1016/0091-3057(88)90487-X; WAFFORD KA, 1989, BRAIN RES, V505, P215, DOI 10.1016/0006-8993(89)91445-5; WILSON JR, 1986, SOC BIOL, V32, P162	32	146	147	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 20	1990	249	4966					291	293		10.1126/science.1695761	http://dx.doi.org/10.1126/science.1695761			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP599	1695761				2022-12-28	WOS:A1990DP59900038
J	DEARLOVE, J; KEARNEY, D				DEARLOVE, J; KEARNEY, D			HOW GOOD IS GENERAL-PRACTICE DEVELOPMENTAL SCREENING	BRITISH MEDICAL JOURNAL			English	Article											DEARLOVE, J (corresponding author), YEOVIL DIST HOSP,HIGHER KINGSTON,YEOVIL BA21 4AT,SOMERSET,ENGLAND.							BISHOP D, 1988, J CHILD PSYCHOL PSYC, V29, P265; BOWIE D, 1984, BRIT MED J, V299, P1322; CARROLL DJ, 1977, EDINBURGH READING TE, V1; DRILLIEN C, 1983, CLIN DEV MED, V86; FRANKENB.WK, 1971, CHILD DEV, V42, P475, DOI 10.1111/j.1467-8624.1971.tb03653.x; FRANKENBURG WK, 1987, J PEDIATR, V10, P653; FRANKENBURG WK, 1975, PAEDIATRIC SCREENING; GRAY DP, 1989, GUIDELINES TRAINING; INGRAM RM, 1989, BMJ-BRIT MED J, V298, P204, DOI 10.1136/bmj.298.6668.204; JHALL DMB, 1989, HLTH ALL CHILDREN; KNOBLOCH H, 1979, PEDIATRICS, V63, P872; LINDE DB, 1979, PAEDIATRIC NURSING, V1, P33; MAYALL B, 1986, KEEPING CHILDREN HLT; PENDELTON D, 1986, PURSUIT QUALITY; SILVA PA, 1987, DEV MED CHILD NEUROL, V29, P630; SMITH RD, 1978, J PEDIATR-US, V93, P524, DOI 10.1016/S0022-3476(78)81186-X; SONNANDER K, 1987, THESIS U UPPSALA UPP; TIZARD B, 1988, YOUNG CHILDREN LEARN; WILLIAMS PR, 1985, J R COLL GEN PRACT, V35, P77; WILSON JMG, 1968, WHO34 PUBL HLTH PAP; YULE W, 1987, CLIN DEV MED, V101, P189; IN PRESS CHILD HLTH; 1989, CMND555	23	33	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 5	1990	300	6733					1177	1180		10.1136/bmj.300.6733.1177	http://dx.doi.org/10.1136/bmj.300.6733.1177			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC150	1693300	Green Published, Bronze			2022-12-28	WOS:A1990DC15000021
J	[Anonymous]				[Anonymous]			RED MEN SHOULD GO - VANCOMYCIN AND HISTAMINE-RELEASE	LANCET			English	Editorial Material																		Alam M, 1939, J PHYSIOL-LONDON, V95, P148, DOI 10.1113/jphysiol.1939.sp003716; Dale HH, 1910, J PHYSIOL-LONDON, V41, P318; DUCOR P, 1980, PSEUDOALLERGIC REACT, V1; ELLIS HV, 1970, J PHARMACOL EXP THER, V175, P627; FELDBERG W, 1952, J PHYSIOL-LONDON, V118, P124, DOI 10.1113/jphysiol.1952.sp004778; FELDBERG W, 1945, AM REV PHYSL, V3, P671; GARRELTS JC, 1985, NEW ENGL J MED, V312, P245; GELL PGH, 1968, CLIN ASPECTS IMMUNOL; Goetzl E J, 1977, Inflammation, V2, P239, DOI 10.1007/BF00917598; KALLOS P, 1956, LETT INT CORRESP SOC, V19, P70; LEVY JH, 1987, ANESTHESIOLOGY, V67, P122, DOI 10.1097/00000542-198707000-00026; MCHENRY MC, 1983, PEDIATR CLIN N AM, V30, P31; MOSS J, 1981, ANESTHESIOLOGY, V55, P19, DOI 10.1097/00000542-198107000-00006; PATON WDM, 1955, INT ARCH ALLER A IMM, V6, P203, DOI 10.1159/000228178; POLK RE, 1988, J INFECT DIS, V157, P502, DOI 10.1093/infdis/157.3.502; ROSOW CE, 1982, ANESTHESIOLOGY, V56, P93, DOI 10.1097/00000542-198202000-00003; ROTHENBERG HJ, 1959, JAMA-J AM MED ASSOC, V171, P1101, DOI 10.1001/jama.1959.73010260008010b; SAHAI J, 1989, J INFECT DIS, V160, P876, DOI 10.1093/infdis/160.5.876; SCHACHTER M, 1952, J PHYSIOL-LONDON, V118, P258, DOI 10.1113/jphysiol.1952.sp004790; SCHACHTER M, 1952, BRIT J PHARM CHEMOTH, V7, P646, DOI 10.1111/j.1476-5381.1952.tb00733.x; SCHACHTER M, 1956, CIBA F S HISTAMINE, P167; SOUTHORN PA, 1986, MAYO CLIN PROC, V61, P721, DOI 10.1016/S0025-6196(12)62773-6; WANG LS, 1988, CLIN THER, V10, P574; WATKINS J, 1978, BRIT J ANAESTH, V50, P1159, DOI 10.1093/bja/50.11.1159; WATKINS J, 1978, ADVERSE RESPONSE INT	25	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	1990	335	8696					1006	1007						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB072	1691428				2022-12-28	WOS:A1990DB07200008
J	BROWN, F				BROWN, F			FROM JENNER TO GENES - THE NEW VACCINES	LANCET			English	Article											BROWN, F (corresponding author), WELLCOME BIOTECH, DEPT VIROL RES & DEV, LANGLEY COURT, BECKENHAM BR3 3BS, ENGLAND.							BITTLE JL, 1982, NATURE, V298, P30, DOI 10.1038/298030a0; BROWN F, 1984, ANNU REV MICROBIOL, V38, P221; BURKE KL, 1988, NATURE, V332, P81, DOI 10.1038/332081a0; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; DOUGAN G, 1987, PARASITE IMMUNOL, V9, P151, DOI 10.1111/j.1365-3024.1987.tb00496.x; JACOBS WR, 1987, NATURE, V327, P532, DOI 10.1038/327532a0; MACKETT M, 1986, J GEN VIROL, V67, P2067, DOI 10.1099/0022-1317-67-10-2067; MATTHEWS REF, 1985, ANNU REV MICROBIOL, V39, P451, DOI 10.1146/annurev.mi.39.100185.002315; MILICH DR, 1989, ADV IMMUNOL, V45, P195; MURRAY K, 1984, NEW APPROACHES VACCI	10	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 10	1990	335	8689					587	590		10.1016/0140-6736(90)90360-H	http://dx.doi.org/10.1016/0140-6736(90)90360-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1689794				2022-12-28	WOS:A1990CT65300014
J	YU, GL; BRADLEY, JD; ATTARDI, LD; BLACKBURN, EH				YU, GL; BRADLEY, JD; ATTARDI, LD; BLACKBURN, EH			INVIVO ALTERATION OF TELOMERE SEQUENCES AND SENESCENCE CAUSED BY MUTATED TETRAHYMENA-TELOMERASE RNAS	NATURE			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley								AGARD DA, 1983, NATURE, V302, P676, DOI 10.1038/302676a0; BERNARDS A, 1983, NATURE, V303, P592, DOI 10.1038/303592a0; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; BLACKBURN EH, 1981, P NATL ACAD SCI-BIOL, V78, P2263, DOI 10.1073/pnas.78.4.2263; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BLACKBURN EH, 1984, CELL, V37, P7, DOI 10.1016/0092-8674(84)90295-2; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BUDARF ML, 1986, J BIOL CHEM, V261, P363; BUDARF ML, 1986, NUCLEIC ACIDS RES, V15, P6273; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; DIFFLEY JFX, 1989, NATURE, V342, P24, DOI 10.1038/342024a0; FORNEY J, 1987, NUCLEIC ACIDS RES, V15, P9143, DOI 10.1093/nar/15.22.9143; FRANKEL J, 1977, DEV BIOL, V58, P255, DOI 10.1016/0012-1606(77)90091-4; FRANKEL J, 1976, J CELL BIOL, V71, P242, DOI 10.1083/jcb.71.1.242; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; KIMMERLY WJ, 1987, MOL CELL BIOL, V7, P4225, DOI 10.1128/MCB.7.12.4225; KINGSTON RE, 1988, CURRENT PROTOCOLS MO; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LABHART P, 1986, CELL, V45, P431, DOI 10.1016/0092-8674(86)90329-6; LARSON DD, 1987, CELL, V50, P477, DOI 10.1016/0092-8674(87)90501-0; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, IN PRESS CELL; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PERROT M, 1987, MOL CELL BIOL, V7, P1725, DOI 10.1128/MCB.7.5.1725; PLUTA AF, 1989, NATURE, V337, P429, DOI 10.1038/337429a0; PRICE CM, 1987, GENE DEV, V1, P783, DOI 10.1101/gad.1.8.783; PRICE CM, 1989, BIOCHEMISTRY-US, V28, P769, DOI 10.1021/bi00428a053; RAGHURAMAN MK, 1989, CELL, V59, P719, DOI 10.1016/0092-8674(89)90018-4; RAGHURAMAN MK, 1989, NUCLEIC ACIDS RES, V17, P4235, DOI 10.1093/nar/17.11.4235; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SHIPPENLENTZ D, 1989, MOL CELL BIOL, V9, P2761, DOI 10.1128/MCB.9.6.2761; SHOEMAN RL, 1988, J BIOL CHEM, V263, P18744; SHOEMAN RL, IN PRESS J BIOL CHEM; SPANGLER EA, 1988, NUCLEIC ACIDS RES, V16, P5569, DOI 10.1093/nar/16.12.5569; SUGEWARA N, 1986, YEAST S, V2, P373; TONDRAVI MM, 1986, P NATL ACAD SCI USA, V83, P4369, DOI 10.1073/pnas.83.12.4369; YU GL, 1989, P NATL ACAD SCI USA, V86, P8487, DOI 10.1073/pnas.86.21.8487; YU GL, 1988, P NATL ACAD SCI USA, V85, P5151, DOI 10.1073/pnas.85.14.5151; YU GL, IN PRESS MOL CELL BI; ZAHLER AM, 1988, NUCLEIC ACIDS RES, V16, P6953, DOI 10.1093/nar/16.14.6953	48	575	620	0	37	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 8	1990	344	6262					126	132		10.1038/344126a0	http://dx.doi.org/10.1038/344126a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT095	1689810				2022-12-28	WOS:A1990CT09500059
J	COOKE, ED; NICOLAIDES, AN				COOKE, ED; NICOLAIDES, AN			RAYNAUDS SYNDROME	BRITISH MEDICAL JOURNAL			English	Editorial Material									ST MARYS HOSP,SCH MED,IRVINE LAB CARDIOVASC INVEST & RES,ACAD SURG UNIT,LONDON W2 1NY,ENGLAND	Imperial College London	COOKE, ED (corresponding author), ST BARTHOLOMEWS HOSP,DEPT MED ELECTR,THERMOG & BLOOD FLOW UNIT,LONDON EC1A 7BE,ENGLAND.							ALDOORI M, 1986, CARDIOVASC RES, V20, P466, DOI 10.1093/cvr/20.6.466; AYLWARD M, 1982, CURR MED RES OPIN, V8, P158, DOI 10.1185/03007998209112378; BELCH JJF, 1985, LANCET, V1, P1180; BELCH JJF, 1983, LANCET, V1, P313; BENNETT R, 1971, ANN RHEUM DIS, V30, P581, DOI 10.1136/ard.30.6.581; BIRMINGHAM AT, 1965, J PHARM PHARMACOL, V17, P449, DOI 10.1111/j.2042-7158.1965.tb07701.x; BLACK CM, 1979, BRIT J HOSP MED, V22, P28; BLUNT RJ, 1980, BRIT J HAEMATOL, V45, P657; BROWSE NL, 1977, BRIT MED J, V1, P478, DOI 10.1136/bmj.1.6059.478; COOKE ED, 1985, ANGIOLOGY, V36, P867, DOI 10.1177/000331978503601205; COOKE ED, IN PRESS J R SOC MED; COULTER DM, 1988, BRIT MED J, V296, P1086, DOI 10.1136/bmj.296.6629.1086; CUNLIFFE WJ, 1969, BRIT J DERMATOL, V81, P220, DOI 10.1111/j.1365-2133.1969.tb16012.x; DIGIACOMO RA, 1989, AM J MED, V86, P158, DOI 10.1016/0002-9343(89)90261-1; DODDS AJ, 1979, BRIT MED J, V2, P1186, DOI 10.1136/bmj.2.6199.1186; DOWD PM, 1982, BRIT J DERMATOL, V106, P81, DOI 10.1111/j.1365-2133.1982.tb00905.x; DUNGER DB, 1985, LANCET, V2, P50; FISHER S, 1983, BIOCHEM BIOPH RES CO, V116, P1091; FISHER S, 1984, NATURE, V307, P165; Flavahan N., 1988, PHLEBOLOGY, V3, P41; FREEDMAN RR, 1983, BRIT MED J, V287, P1499, DOI 10.1136/bmj.287.6404.1499; FREEDMAN RR, 1989, ARTHRITIS RHEUM, V32, P61, DOI 10.1002/anr.1780320110; GOODFIELD MJD, 1988, BRIT J DERMATOL, V119, P643, DOI 10.1111/j.1365-2133.1988.tb03477.x; GOYLE KB, 1976, LANCET, V1, P1317; Grigg M J, 1989, Eur J Vasc Surg, V3, P309, DOI 10.1016/S0950-821X(89)80066-0; HALPERN ALFRED, 1960, ANGIOLOGY, V11, P151, DOI 10.1177/000331976001100301; HESLOP J, 1983, J ROY COLL GEN PRACT, V33, P85; JARRETT PEM, 1978, BRIT MED J, V2, P523, DOI 10.1136/bmj.2.6136.523; JOBE JB, 1985, J RHEUMATOL, V12, P953; JOBE JB, 1982, ANN INTERN MED, V87, P706; KAHALEH MB, 1982, ANN INTERN MED, V96, P610, DOI 10.7326/0003-4819-96-5-610; KEENAN EJ, 1983, SURGERY, V94, P204; KYLE V, 1985, ANN RHEUM DIS, V44, P73, DOI 10.1136/ard.44.2.73; Lewis T, 1929, HEART-J STUD CIRC, V15, P7; MARTIN MFR, 1981, ANN RHEUM DIS, V40, P350, DOI 10.1136/ard.40.4.350; MCGRATH MA, 1977, ANN RHEUM DIS, V36, P569, DOI 10.1136/ard.36.6.569; MCHUGH NJ, 1988, ANN RHEUM DIS, V47, P43, DOI 10.1136/ard.47.1.43; MYERS KA, 1968, CARDIOVASC RES, V2, P360, DOI 10.1093/cvr/2.4.360; NAKIR AM, 1986, ISRAEL J MED SCI, V22, P139; RADEMAKER M, 1987, POSTGRAD MED J, V63, P617, DOI 10.1136/pgmj.63.742.617; RADEMAKER M, 1989, BRIT MED J, V298, P561, DOI 10.1136/bmj.298.6673.561; RAYNAUD M, 1888, SELECTED MONOGRAPHS, V121; RICE R, 1988, J ROY SOC MED, V81, P499, DOI 10.1177/014107688808100902; ROALD OK, 1984, BRIT MED J, V289, P577, DOI 10.1136/bmj.289.6445.577; RUSTIN MHA, 1987, BRIT J DERMATOL, V117, P751, DOI 10.1111/j.1365-2133.1987.tb07356.x; SIEBOLD JR, 1986, J RHEUMATOL, V13, P337; SINGER HA, 1983, J PHARMACOL EXP THER, V226, P790; SMITH CD, 1982, LANCET, V2, P1299; SORKIN EM, 1985, DRUGS, V30, P182, DOI 10.2165/00003495-198530030-00002; TAN EM, 1988, CLIN IMMUNOL IMMUNOP, V47, P121, DOI 10.1016/0090-1229(88)90066-9; TERREGINO CA, 1985, ANGIOLOGY, V36, P88, DOI 10.1177/000331978503600204; THOMAS RHM, 1987, BRIT J DERMATOL, V117, P237, DOI 10.1111/j.1365-2133.1987.tb04122.x; YARDUMIAN DA, 1988, BRIT J RHEUMATOL, V27, P220; 1989, LANCET, V2, P779	54	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 3	1990	300	6724					553	555		10.1136/bmj.300.6724.553	http://dx.doi.org/10.1136/bmj.300.6724.553			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT313	1691027	Green Published, Bronze			2022-12-28	WOS:A1990CT31300003
J	MORRISON, G; MORRISON, J; REDMOND, A; BYERS, C; MCCRACKEN, K; DODGE, JA				MORRISON, G; MORRISON, J; REDMOND, A; BYERS, C; MCCRACKEN, K; DODGE, JA			PANCREATIC-ENZYME SUPPLEMENTS IN CYSTIC-FIBROSIS	LANCET			English	Letter									DEPT AGR,BELFAST,ANTRIM,NORTH IRELAND; QUEENS UNIV BELFAST,DEPT CHILD HLTH,BELFAST BT12 6BJ,ANTRIM,NORTH IRELAND	Queens University Belfast	MORRISON, G (corresponding author), ROYAL BELFAST HOSP SICK CHILDREN,BELFAST,NORTH IRELAND.							MURPHY JL, 1991, ARCH DIS CHILD, V66, P495, DOI 10.1136/adc.66.4.495; OWEN, 1991, LANCET, V338, P1153	2	11	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1596	1597		10.1016/0140-6736(91)92421-W	http://dx.doi.org/10.1016/0140-6736(91)92421-W			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683999				2022-12-28	WOS:A1991GW03600042
J	DOMINGO, JL; GOMEZ, M; LLOBET, JM; RICHART, C				DOMINGO, JL; GOMEZ, M; LLOBET, JM; RICHART, C			EFFECT OF ASCORBIC-ACID ON GASTROINTESTINAL ALUMINUM ABSORPTION	LANCET			English	Letter											DOMINGO, JL (corresponding author), UNIV BARCELONA,SCH MED,E-43201 REUS,SPAIN.		Domingo, Jose L/E-8327-2014; RICHART, CRISTOBAL C/S-9158-2017; Llobet, Juan M/F-7775-2016	RICHART, CRISTOBAL C/0000-0003-0852-6739; Domingo, Jose L/0000-0001-6647-9470; Gomez, Mercedes/0000-0003-1892-5557				DOMINGO JL, 1991, KIDNEY INT, V39, P598, DOI 10.1038/ki.1991.70; NOLAN CR, 1990, KIDNEY INT, V38, P937, DOI 10.1038/ki.1990.294; PARTRIDGE NA, 1989, KIDNEY INT, V35, P1413, DOI 10.1038/ki.1989.142; SLANINA P, 1986, CLIN CHEM, V32, P539; WALKER JA, 1990, ARCH INTERN MED, V150, P2037, DOI 10.1001/archinte.150.10.2037	5	22	22	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1467	1467		10.1016/0140-6736(91)92776-X	http://dx.doi.org/10.1016/0140-6736(91)92776-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683458				2022-12-28	WOS:A1991GT90400057
J	DAHLOF, B; LINDHOLM, LH; HANSSON, L; SCHERSTEN, B; EKBOM, T; WESTER, PO				DAHLOF, B; LINDHOLM, LH; HANSSON, L; SCHERSTEN, B; EKBOM, T; WESTER, PO			MORBIDITY AND MORTALITY IN THE SWEDISH TRIAL IN OLD PATIENTS WITH HYPERTENSION (STOP-HYPERTENSION)	LANCET			English	Article							BLOOD-PRESSURE; AGE; SEX	Although the benefits of antihypertensive treatment in "young" elderly (under 70 years) hypertensive patients are well established, the value of treatment in older patients (70-84 years) is less clear. The Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) was a prospective, randomised, double-blind, intervention study set up to compare the effects of active antihypertensive therapy (three beta-blockers and one diuretic) and placebo on the frequency of fatal and non-fatal stroke and myocardial infarction and other cardiovascular death in hypertensive Swedish men and women aged 70-84 years. We recruited 1627 patients at 116 health centres throughout Sweden, who were willing to participate, and who met the entry criteria of three separate recordings during a 1-month placebo run-in period of systolic blood pressure between 180 and 230 mm Hg with a diastolic pressure of at least 90 mm Hg, or a diastolic pressure between 105 and 120 mm Hg irrespective of the systolic pressure. The total duration of the study was 65 months and the average time in the study was 25 months. 812 patients were randomly allocated active treatment and 815 placebo. The mean difference in supine blood pressure between the active treatment and placebo groups at the last follow-up before an endpoint, death, or study termination was 19.5/8.1 mm Hg. Compared with placebo, active treatment significantly reduced the number of primary endpoints (94 vs 58; p = 0.0031) and stroke morbidity and mortality (53 vs 29; p = 0.0081). Although we did not set out to study an effect on total mortality, we also noted a significantly reduced number of deaths in the active treatment group (63 vs 36; p = 0.0079). The benefits of treatment were discernible up to age 84 years. We conclude that antihypertensive treatment in hypertensive men and women aged 70-84 confers highly significant and clinically relevant reductions in cardiovascular morbidity and mortality as well as in total mortality.	GOTHENBURG UNIV, OSTRA HOSP, DEPT CHEM, S-41685 GOTHENBURG, SWEDEN; UMEA UNIV HOSP, DEPT MED, S-90185 UMEA, SWEDEN; UNIV LUND, HLTH SCI CTR, DALBY, SWEDEN	Sahlgrenska University Hospital; University of Gothenburg; Umea University; Lund University								AGNER E, 1983, ACTA MED SCAND, V214, P285; AMERY A, 1985, LANCET, V1, P1349; AMERY A, 1986, LANCET, V2, P589; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1970, JAMA, V213, P1143; Breslow NE., 1987, IARC SCI PUBL, VII, P131; COOPE J, 1986, BRIT MED J, V293, P1145, DOI 10.1136/bmj.293.6555.1145; Dahlof B, 1987, J Hypertens Suppl, V5, pS607; DAHLOF B, 1986, J HYPERTENS, V4, P511, DOI 10.1097/00004872-198608000-00019; FRIEDMAN LM, 1985, FUNDAMENTALS CLIN TR, P213; FRY J, 1974, LANCET, V2, P431; HANSSON L, 1987, CURR OPIN CARDIOL S1, V2, pS15; Hansson L, 1990, CARDIOVASC DRUG THER, V4, P1253; HOLME I, 1976, ACTA MED SCAND, V200, P229; Hypertension Detection Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.1979.03300230018021; KANNEL WB, 1978, B NEW YORK ACAD MED, V54, P573; LANDAHL S, 1987, J HYPERTENS, V5, P745, DOI 10.1097/00004872-198712000-00019; LEHMANN EL, 1959, TESTING STATISTICAL, P140; MATTILA K, 1988, BRIT MED J, V296, P887, DOI 10.1136/bmj.296.6626.887; Sorensen K H, 1988, Scand J Prim Health Care, V6, P105, DOI 10.3109/02813438809009299; 1981, MED J AUSTRALIA, V2, P398	22	1529	1569	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	1991	338	8778					1281	1285		10.1016/0140-6736(91)92589-T	http://dx.doi.org/10.1016/0140-6736(91)92589-T			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682683				2022-12-28	WOS:A1991GR02300001
J	GRANSTROM, M; OLINDERNIELSEN, AM; HOLMBLAD, P; MARK, A; HANNGREN, K				GRANSTROM, M; OLINDERNIELSEN, AM; HOLMBLAD, P; MARK, A; HANNGREN, K			SPECIFIC IMMUNOGLOBULIN FOR TREATMENT OF WHOOPING-COUGH	LANCET			English	Article							BORDETELLA-PERTUSSIS; DIAGNOSIS; GLOBULIN	Immunoglobulin treatment for whooping cough (pertussis) is widely believed to be ineffective although there are sound reasons for regarding the condition as a toxin-induced disease. We wondered whether the lack of success with pertussis immunoglobulins might be attributable to inadequate dose, so we designed a randomised, double-blind, placebo-controlled trial of two immunoglobulin preparations. The study was conducted at three Swedish hospitals. We enrolled 73 children aged less than 36 months who were admitted with a clinical diagnosis of whooping cough. On admission they were assigned to one of three groups: (a) monocomponent pertussis toxoid vaccine; (b) two-component acellular vaccine also containing filamentous haemagglutinin; or (c) 20% albumin solution (placebo). The immunoglobulins had a high antitoxin content and had been raised with acellular pertussis vaccines. Diagnosis of pertussis was confirmed by laboratory tests and the follow-up was completed in 67 children. The main study group consisted of 47 children with less-than-or-equal-to 14 days of disease before therapy. Duration of whoops post-treatment was 8.7 days (95% CI 4.8, 12.6) in the 33 children receiving immunoglobulin vs 20.6 (95% CI 11.9, 29.3) in the 14 receiving placebo (p = 0.0041). Mean number of whoops during the first week of follow-up was also significantly reduced (p = 0.0196). We found that early treatment was important, since the effect on duration of whoops was most pronounced when disease duration before treatment was less-than-or-equal-to 7 days. There were no significant differences between the two immunoglobulin preparations. High-dose specific pertussis immunoglobulin with a high antitoxin concentration has a beneficial effect in the treatment of whooping cough.	RYHOV HOSP,DEPT INFECT DIS,JONKOPING,SWEDEN; VASTERAS HOSP,DEPT INFECT DIS,VASTERAS,SWEDEN; NATL BACTERIOL LAB,DEPT VACCINE PROD,S-10521 STOCKHOLM,SWEDEN; GOTHENBURG UNIV,OSTRA HOSP,DEPT PAEDIAT 1,S-41124 GOTHENBURG,SWEDEN	Vasteras Central Hospital; Sahlgrenska University Hospital; University of Gothenburg	GRANSTROM, M (corresponding author), KAROLINSKA HOSP,DEPT CLIN MICROBIOL,BOX 60500,S-10401 STOCKHOLM 60,SWEDEN.							AMES RG, 1953, PEDIATRICS, V11, P323; BALAGTAS RC, 1971, J PEDIATR-US, V79, P203, DOI 10.1016/S0022-3476(71)80102-6; BASS JW, 1969, J PEDIATR-US, V75, P768, DOI 10.1016/S0022-3476(69)80299-4; FERNGREN H, 1986, J BIOL STAND, V14, P297, DOI 10.1016/0092-1157(86)90017-X; GRANSTROM G, 1991, J INFECTION, V22, P17, DOI 10.1016/0163-4453(91)90842-G; GRANSTROM G, 1988, J CLIN MICROBIOL, V26, P1818; GRANSTROM G, 1990, SERODIAG IMMUN INF D, V4, P151, DOI 10.1016/0888-0786(90)90040-U; IMAIZUMI A, 1985, VOX SANG, V48, P18, DOI 10.1111/j.1423-0410.1985.tb00140.x; KOHN JL, 1947, AM J DIS CHILD, V74, P321, DOI 10.1001/archpedi.1947.02030010332005; LAPIN JH, 1945, J PEDIATR-US, V26, P555, DOI 10.1016/S0022-3476(45)80082-3; PITTMAN M, 1984, PEDIATR INFECT DIS J, V3, P467, DOI 10.1097/00006454-198409000-00019	11	59	65	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1230	1233		10.1016/0140-6736(91)92101-7	http://dx.doi.org/10.1016/0140-6736(91)92101-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682643				2022-12-28	WOS:A1991GQ16600003
J	SIMANJUNTAK, CH; PALEOLOGO, FP; PUNJABI, NH; DARMOWIGOTO, R; TOTOSUDIRJO, SH; HARYANTO, P; SUPRIJANTO, E; WITHAM, ND; HOFFMAN, SL				SIMANJUNTAK, CH; PALEOLOGO, FP; PUNJABI, NH; DARMOWIGOTO, R; TOTOSUDIRJO, SH; HARYANTO, P; SUPRIJANTO, E; WITHAM, ND; HOFFMAN, SL			ORAL IMMUNIZATION AGAINST TYPHOID-FEVER IN INDONESIA WITH TY21A VACCINE	LANCET			English	Article							CONTROLLED FIELD TRIAL; VI-CAPSULAR POLYSACCHARIDE; ENTERIC-COATED CAPSULES; SALMONELLA-TYPHI; TY 21A; LIVE; FORMULATION; IMMUNITY; STRAIN	When tested under conditions of moderate transmission of typhoid fever, a liquid formulation of the oral typhoid fever vaccine Ty21 a had a protective efficacy of 96% in Egypt, and an enteric coated capsule formulation had an efficacy of 67% in Chile. We compared the two formulations under conditions of intense transmission of typhoid fever in Indonesia in a randomised, double-blind trial. 20 543 subjects (age range 3-44 years) received either three doses of enteric coated capsules containing placebo or live Ty21 a, or three doses of lyophilised placebo or live Ty21 a reconstituted with phosphate buffer. During 30 months of follow-up, the rate of blood-culture-positive typhoid fever among controls was 810/100 000 per year. Rates of typhoid fever were 379/100 00 per year for subjects who received the liquid formulation of vaccine and 468/100000 per year for subjects who received enteric coated capsules. The protective efficacies of the liquid and enteric coated formulations were 53% and 42%, respectively. Neither formulation protected against infection with Salmonella paratyphi A. No major side-effects were noted, but the overall incidence of side-effects was greater in the vaccine groups. Under conditions of intense transmission, Ty21 a protected against typhoid fever; however, because Ty21 a will not protect all individuals, there is a need for additional approaches to prevent the disease.	PERTAMINA OIL CO,DEPT PUBL HLTH,JAKARTA,INDONESIA; USN,MED RES UNIT 2,JAKARTA DETACHMENT,JAKARTA,INDONESIA; PERTAMINA OIL CO,DEPT PUBL HLTH,PLAJU,INDONESIA; USN,MED RES INST,MALARIA PROGRAM,BETHESDA,MD 20814	University of 19 November Kolaka; Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy	SIMANJUNTAK, CH (corresponding author), MINIST HLTH,NATL INST HLTH RES & DEV,CTR INFECT DIS RES,JALAN PERCETAKAN NEGARA 29,JAKARTA 10560,INDONESIA.							ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; ASCROFT MT, 1967, LANCET, V2, P1050; BUDIARSO R, 1986, MUCHTARUDDIN HOUSEHO; DARMOWIGOTO R, 1984, 11TH INT C TROP MED, P193; Edwards P. R., 1972, IDENTIFICATION ENTER; FERRECCIO C, 1989, J INFECT DIS, V159, P766, DOI 10.1093/infdis/159.4.766; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; HEJFEC LB, 1966, B WORLD HEALTH ORGAN, V34, P321; HOFFMAN SL, 1984, J INFECT DIS, V149, P157, DOI 10.1093/infdis/149.2.157; HOFFMAN SL, 1984, HUNTERS TROPICAL MED, P282; Hornick R B, 1976, Dev Biol Stand, V33, P89; HORNICK RB, 1970, NEW ENGL J MED, V283, P686, DOI 10.1056/NEJM197009242831306; KLUGMAN KP, 1987, LANCET, V2, P1165; LEVINE MM, 1987, LANCET, V1, P1049; LEVINE MM, 1990, LANCET, V336, P891; SIMANJUNTAK CH, 1987, CERMIN DUNIA KEDOKTE, V45, P16; TAGLIABUE A, 1985, CLIN EXP IMMUNOL, V62, P242; TAGLIABUE A, 1986, J IMMUNOL, V137, P1504; TAPA S, 1975, B WORLD HEALTH ORGAN, V52, P75; WAHDAN MH, 1982, J INFECT DIS, V145, P292, DOI 10.1093/infdis/145.3.292; 1964, B WORLD HEALTH ORGAN, V30, P623; 1962, B WORLD HEALTH ORGAN, V26, P357; 1966, B WORLD HEALTH ORGAN, V34, P221; 1986, NEW VACCINE DEV ESTA, V2	24	181	184	0	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1055	1059		10.1016/0140-6736(91)91910-M	http://dx.doi.org/10.1016/0140-6736(91)91910-M			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681365				2022-12-28	WOS:A1991GM25300013
J	ULLMAN, KS; FLANAGAN, WM; EDWARDS, CA; CRABTREE, GR				ULLMAN, KS; FLANAGAN, WM; EDWARDS, CA; CRABTREE, GR			ACTIVATION OF EARLY GENE-EXPRESSION IN LYMPHOCYTES-T BY OCT-1 AND AN INDUCIBLE PROTEIN, OAP40	SCIENCE			English	Article							RNA POLYMERASE-II; HISTONE H2B GENE; TRANSCRIPTION FACTOR; BINDING-PROTEIN; POU DOMAIN; CONTAINS; PURIFICATION; INTERACTS; COMPLEX; PROMOTERS	After antigenic stimulation of T lymphocytes, genes essential for proliferation and immune function, such as the interleukin-2 (IL-2) gene, are transcriptionally activated. In both transient transfections and T lymphocyte-specific in vitro transcription, the homeodomain-containing protein Oct-1 participated in the inducible regulation of transcription of the IL-2 gene. Oct-1 functioned in this context with a 40-kilodalton protein called Oct-1-associated protein (OAP40). In addition to interacting specifically with DNA, OAP40 reduced the rate of dissociation of Oct-I from its cognate DNA-binding site, suggesting that a direct interaction exists between Oct-1 and OAP40.	STANFORD UNIV,BECKMAN CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; GENELABS INC,REDWOOD CITY,CA 94063; STANFORD UNIV,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University; Stanford University				Ullman, Katharine/0000-0003-3693-2830	NATIONAL CANCER INSTITUTE [R01CA039612, R37CA039612] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033942] Funding Source: NIH RePORTER; NCI NIH HHS [CA39612] Funding Source: Medline; NHLBI NIH HHS [HL33942] Funding Source: Medline; NIAID NIH HHS [AI07290] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; EDWARDS CM, UNPUB; FLANAGAN WM, IN PRESS J BIOL CHEM; FLANAGAN WP, UNPUB; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACKSON SP, 1989, P NATL ACAD SCI USA, V86, P1781, DOI 10.1073/pnas.86.6.1781; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KAMPS MP, 1990, MOL CELL BIOL, V10, P5464, DOI 10.1128/MCB.10.10.5464; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KEMP LM, 1988, EMBO J, V7, P4239, DOI 10.1002/j.1460-2075.1988.tb03321.x; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; OHARE P, 1988, EMBO J, V7, P4231, DOI 10.1002/j.1460-2075.1988.tb03320.x; OHARE P, 1988, CELL, V52, P435, DOI 10.1016/S0092-8674(88)80036-9; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; PRESTON CM, 1988, CELL, V52, P425, DOI 10.1016/S0092-8674(88)80035-7; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; STURM R, 1987, GENE DEV, V1, P1147, DOI 10.1101/gad.1.10.1147; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; SUZUKI N, 1990, EMBO J, V9, P3723, DOI 10.1002/j.1460-2075.1990.tb07585.x; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Ullman K.S., UNPUB; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113	37	153	155	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 25	1991	254	5031					558	562		10.1126/science.1683003	http://dx.doi.org/10.1126/science.1683003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL799	1683003				2022-12-28	WOS:A1991GL79900045
J	SHAW, LR; MILLER, JD; SLUTSKY, AS; MAURER, JR; PUSKAS, JD; PATTERSON, GA; SINGER, PA				SHAW, LR; MILLER, JD; SLUTSKY, AS; MAURER, JR; PUSKAS, JD; PATTERSON, GA; SINGER, PA			ETHICS OF LUNG TRANSPLANTATION WITH LIVE DONORS	LANCET			English	Editorial Material							LIVING DONORS		UNIV TORONTO,CTR BIOETH,TANZ BLDG,ROOM 303,6 QUEENS PK CRESCENT W,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT SURG,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto; University of Toronto; University of Toronto			Slutsky, Arthur S/A-6013-2008; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; 				DESLAURIERS J, 1989, CAN J SURG, V5, P335; Fellner C. H., 1970, AM J PSYCHIAT, V126, P79; GINSBERG RJ, 1983, J THORAC CARDIOV SUR, V86, P654; GOLDSMITH MF, 1990, JAMA-J AM MED ASSOC, V264, P2724, DOI 10.1001/jama.1990.03450210014003; Kolata Gina, 1991, N Y Times Web, pA11; LEVINE ROBERT J., 1986, ETHICS REGULATION CL, P63; MILLER JD, 1991, IN PRESS CAN J SURG; MOORE FD, 1989, JAMA-J AM MED ASSOC, V261, P1483, DOI 10.1001/jama.261.10.1483; MOORE FD, 1988, TRANSPLANT P, V20, P1061; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1982, MAKING HLTH CARE DEC, V1; RIEHLE RA, 1990, J UROLOGY, V144, P845, DOI 10.1016/S0022-5347(17)39606-4; SINGER PA, 1990, THEOR MED, V11, P87, DOI 10.1007/BF00489452; SINGER PA, 1988, CLIN RES, V36, P539; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; STILLER CR, 1985, TRANSPLAN P S3, V12, P85; 1987, GUIDELINES RES INVOL, P12	16	34	34	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					678	681		10.1016/0140-6736(91)91244-O	http://dx.doi.org/10.1016/0140-6736(91)91244-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679484				2022-12-28	WOS:A1991GF10500015
J	BAILLEUL, B; SURANI, MA; WHITE, S; BARTON, SC; BROWN, K; BLESSING, M; JORCANO, J; BALMAIN, A				BAILLEUL, B; SURANI, MA; WHITE, S; BARTON, SC; BROWN, K; BLESSING, M; JORCANO, J; BALMAIN, A			SKIN HYPERKERATOSIS AND PAPILLOMA FORMATION IN TRANSGENIC MICE EXPRESSING A RAS ONCOGENE FROM A SUPRABASAL KERATIN PROMOTER	CELL			English	Article									BEATSON INST CANC RES,GLASGOW G61 1BD,SCOTLAND; AFRC,INST ANIM PHYSIOL & GENET RES,DEPT MOLEC EMBRYOL,CAMBRIDGE CB2 4AT,ENGLAND; UNIV GLASGOW,DEPT DERMATOL,GLASGOW G12 8QQ,SCOTLAND; GERMAN CANC RES CTR,DEPT CELL & TUMOR BIOL,W-6900 HEIDELBERG,GERMANY; CIUDAD UNIV MADRID,INST PRYMA,CTR INVEST ENERGET MEDIOAMBIENTALES & TECHNOL,E-29040 MADRID,SPAIN	Beatson Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas				Surani, Azim/0000-0002-8640-4318				ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALLEN N D, 1987, P217; ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; Argyris T S, 1982, Carcinog Compr Surv, V7, P43; BAILLEUL B, 1988, NUCLEIC ACIDS RES, V16, P359, DOI 10.1093/nar/16.1.359; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; BLESSING M, 1989, EMBO J, V8, P117, DOI 10.1002/j.1460-2075.1989.tb03355.x; BLESSING M, 1987, EMBO J, V6, P567, DOI 10.1002/j.1460-2075.1987.tb04792.x; Boutwell R K, 1974, CRC Crit Rev Toxicol, V2, P419; BROWN K, 1988, MOL CARCINOGEN, V1, P161, DOI 10.1002/mc.2940010304; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; BROWN K, 1990, P NATL ACAD SCI USA, V87, P538, DOI 10.1073/pnas.87.2.538; BURNS FJ, 1976, CANCER RES, V36, P1422; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COHEN S, 1962, J BIOL CHEM, V237, P1555; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DOTTO GP, 1985, NATURE, V318, P472; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1988, TRENDS GENET, V4, P277, DOI 10.1016/0168-9525(88)90169-2; Fuchs E., 1988, ADV CELL CULT, V6; GIUDICE GJ, 1987, CELL, V48, P453, DOI 10.1016/0092-8674(87)90196-6; GREGORY H, 1988, REGUL PEPTIDES, V22, P217, DOI 10.1016/0167-0115(88)90034-1; GRONER B, 1987, TRENDS GENET, V3, P306, DOI 10.1016/0168-9525(87)90276-9; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HANKINS WD, 1981, CELL, V26, P91, DOI 10.1016/0092-8674(81)90036-2; HECKER E, 1982, CARCINOGENESIS COMPR, V7; HOWELEVANS W, 1958, Q J MED, V27, P413; HSIAO WLW, 1984, SCIENCE, V226, P552, DOI 10.1126/science.6436974; Klein-Szanto A J, 1989, Carcinog Compr Surv, V11, P19; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LEHNERT ME, 1984, EMBO J, V3, P3279, DOI 10.1002/j.1460-2075.1984.tb02290.x; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; MARQUARDT H, 1983, P NATL ACAD SCI-BIOL, V80, P4684; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MORGAN JR, 1987, SCIENCE, V237, P1476; MORRIS RJ, 1986, CANCER RES, V46, P3061; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEWBOLD RF, 1981, CARCINOGENESIS, V2, P243, DOI 10.1093/carcin/2.3.243; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RHODES JA, 1986, P NATL ACAD SCI USA, V83, P3844, DOI 10.1073/pnas.83.11.3844; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; SCHWEIZER J, 1984, CELL, V37, P159, DOI 10.1016/0092-8674(84)90311-8; SCHWEIZER J, 1988, CELL TISSUE RES, V253, P221; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEWART TA, 1984, CELL, V38, P6227; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WISEMAN RW, 1986, P NATL ACAD SCI USA, V83, P5825, DOI 10.1073/pnas.83.16.5825; YESUDIAN P, 1980, BRIT J DERMATOL, V102, P597, DOI 10.1111/j.1365-2133.1980.tb07662.x; YOTTI LP, 1979, SCIENCE, V206, P1089, DOI 10.1126/science.493994; YUSPA SH, 1985, NATURE, V314, P459, DOI 10.1038/314459a0; YUSPA SH, 1988, ADV CANCER RES, V50, P25, DOI 10.1016/S0065-230X(08)60434-0; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	66	249	257	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 24	1990	62	4					697	708		10.1016/0092-8674(90)90115-U	http://dx.doi.org/10.1016/0092-8674(90)90115-U			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DW306	1696852				2022-12-28	WOS:A1990DW30600010
J	CONTENTE, S; KENYON, K; RIMOLDI, D; FRIEDMAN, RM				CONTENTE, S; KENYON, K; RIMOLDI, D; FRIEDMAN, RM			EXPRESSION OF GENE-RRG IS ASSOCIATED WITH REVERSION OF NIH 3T3 TRANSFORMED BY LTR-C-H-RAS	SCIENCE			English	Article											CONTENTE, S (corresponding author), UNIFORMED SERV UNIV HLTH SCI,DEPT PATHOL,BETHESDA,MD 20814, USA.			Contente, Sara/0000-0002-8099-2817	NCI NIH HHS [R01 CA 37351-04A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037351] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; Blair D G, 1981, Haematol Blood Transfus, V26, P460; BOS JL, 1989, CANCER RES, V49, P4682; CHANG EH, 1982, NATURE, V297, P479, DOI 10.1038/297479a0; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CONTENTE S, UNPUB; GREEN PJ, 1986, ANNU REV BIOCHEM, V55, P569, DOI 10.1146/annurev.bi.55.070186.003033; GREEN PL, 1987, P NATL ACAD SCI USA, V84, P5932, DOI 10.1073/pnas.84.16.5932; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HANAFUSA T, 1980, P NATL ACAD SCI-BIOL, V77, P3009, DOI 10.1073/pnas.77.5.3009; HAND PH, 1987, J NATL CANCER I, V79, P59; IZANT JG, 1985, SCIENCE, V229, P345, DOI 10.1126/science.2990048; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; JANSEN HW, 1984, NATURE, V307, P281, DOI 10.1038/307281a0; KASID U, 1989, SCIENCE, V243, P1354, DOI 10.1126/science.2466340; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; ROBBINS KC, 1982, SCIENCE, V218, P1131, DOI 10.1126/science.6293053; SAMID D, 1985, BIOCHEM BIOPH RES CO, V126, P509, DOI 10.1016/0006-291X(85)90635-7; SAMID D, 1987, MOL CELL BIOL, V7, P2196, DOI 10.1128/MCB.7.6.2196; SAMID D, 1984, BIOCHEM BIOPH RES CO, V119, P21, DOI 10.1016/0006-291X(84)91612-7; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SPANDIDOS DA, 1984, BRIT J CANCER, V49, P681, DOI 10.1038/bjc.1984.108; TANAKA T, 1986, CANCER RES, V46, P1465; WEINTRAUB H, 1985, TRENDS GENET, V1, P22, DOI 10.1016/0168-9525(85)90010-1	27	234	243	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 17	1990	249	4970					796	798		10.1126/science.1697103	http://dx.doi.org/10.1126/science.1697103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV088	1697103				2022-12-28	WOS:A1990DV08800037
J	LIN, AY; DEVAUX, B; GREEN, A; SAGERSTROM, C; ELLIOTT, JF; DAVIS, MM				LIN, AY; DEVAUX, B; GREEN, A; SAGERSTROM, C; ELLIOTT, JF; DAVIS, MM			EXPRESSION OF T-CELL ANTIGEN RECEPTOR HETERODIMERS IN A LIPID-LINKED FORM	SCIENCE			English	Article									STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University; Stanford University				Davis, Mark/0000-0001-6868-657X				ACUTO O, 1983, CELL, V34, P717, DOI 10.1016/0092-8674(83)90528-7; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BECKER DM, 1985, NATURE, V317, P430, DOI 10.1038/317430a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; GASCOIGNE NRJ, 1987, P NATL ACAD SCI USA, V84, P2936, DOI 10.1073/pnas.84.9.2936; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; KAM W, 1985, P NATL ACAD SCI USA, V82, P8715, DOI 10.1073/pnas.82.24.8715; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LIN AL, UNPUB; LOW MG, 1988, J IMMUNOL METHODS, V113, P101, DOI 10.1016/0022-1759(88)90386-9; MEUER SC, 1983, NATURE, V303, P808, DOI 10.1038/303808a0; MICANOVIC R, 1988, P NATL ACAD SCI USA, V85, P1398, DOI 10.1073/pnas.85.5.1398; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P742, DOI 10.1073/pnas.83.3.742; PATTEN P, 1984, NATURE, V312, P40, DOI 10.1038/312040a0; PATTEN PA, UNPUB; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; REINHERZ E, COMMUNICATION; SAITO T, 1987, NATURE, V329, P256, DOI 10.1038/329256a0; SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972; SPRINGER TA, 1977, J BIOL CHEM, V252, P6201; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TRAUNECKER A, 1989, IMMUNOL TODAY, V10, P29, DOI 10.1016/0167-5699(89)90062-5; TYKOCINSKI ML, 1988, P NATL ACAD SCI USA, V85, P3555, DOI 10.1073/pnas.85.10.3555; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; WETTSTEIN DA, UNPUB	34	240	274	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 10	1990	249	4969					677	679		10.1126/science.1696397	http://dx.doi.org/10.1126/science.1696397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT796	1696397				2022-12-28	WOS:A1990DT79600046
J	BLUM, B; SIMPSON, L				BLUM, B; SIMPSON, L			GUIDE RNAS IN KINETOPLASTID MITOCHONDRIA HAVE A NONENCODED 3' OLIGO(U) TAIL INVOLVED IN RECOGNITION OF THE PREEDITED REGION	CELL			English	Article									UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles	BLUM, B (corresponding author), UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009102, R01AI009102] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAKALARA N, 1989, J BIOL CHEM, V264, P18679; BENNE R, 1989, BIOCHIM BIOPHYS ACTA, V1007, P131, DOI 10.1016/0167-4781(89)90031-6; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; CHRISTIANSON T, 1983, J BIOL CHEM, V258, P4025; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; LABBE D, 1990, J BIOL CHEM, V265, P2988; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; MULLIGAN RM, 1988, P NATL ACAD SCI USA, V85, P7998, DOI 10.1073/pnas.85.21.7998; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; Silberklang M, 1979, Methods Enzymol, V59, P58; SIMPSON AM, 1985, NUCLEIC ACIDS RES, V13, P5977, DOI 10.1093/nar/13.16.5977; SIMPSON L, 1970, J PROTOZOOL, V17, P511, DOI 10.1111/j.1550-7408.1970.tb04719.x; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SIMPSON L, 1978, CELL, V14, P169, DOI 10.1016/0092-8674(78)90311-2; STUART K, 1989, PARASITOL TODAY, V5, P5, DOI 10.1016/0169-4758(89)90211-1; STUART K, 1989, GENE, V82, P155, DOI 10.1016/0378-1119(89)90040-1; STURM NR, 1990, CELL, V61, P879, DOI 10.1016/0092-8674(90)90198-N; VANDERSPEK H, 1990, EMBO J, V9, P257, DOI 10.1002/j.1460-2075.1990.tb08103.x; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	26	203	207	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 27	1990	62	2					391	397		10.1016/0092-8674(90)90375-O	http://dx.doi.org/10.1016/0092-8674(90)90375-O			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR202	1695552				2022-12-28	WOS:A1990DR20200018
J	LIGHTMAN, S				LIGHTMAN, S			UVEITIS - MANAGEMENT	LANCET			English	Article							EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; LOW-DOSE CYCLOSPORINE; BEHCETS-DISEASE; S-ANTIGEN; T-CELLS; INHIBITION; INFLAMMATION; ANTIBODY; THERAPY; RATS				LIGHTMAN, S (corresponding author), MOORFIELDS EYE HOSP,CITY RD,LONDON EC1V 2PD,ENGLAND.							AKTULGA E, 1980, HAEMATOLOGICA, V65, P399; ATALLA L, 1990, INVEST OPHTH VIS SCI, V31, P1264; BERAUD E, 1990, Investigative Ophthalmology and Visual Science, V31, P213; BINDER AI, 1987, BRIT J RHEUMATOL, V26, P285; BOREL JJV, 1986, CYCLOSPORIN AUTOIMMU, P24; CASPI RR, 1988, J IMMUNOL, V140, P2579; CASPI RR, 1986, J IMMUNOL, V136, P928; DEKOZAK Y, 1981, CURR EYE RES, V1, P327, DOI 10.3109/02713688108998359; DEKOZAK Y, 1987, EUR J IMMUNOL, V17, P541, DOI 10.1002/eji.1830170417; DUMONT FJ, 1990, J IMMUNOL, V144, P1418; KAWASHIMA H, 1988, INVEST OPHTH VIS SCI, V29, P1265; MATSUMURA N, 1975, LANCET, V2, P813; NUSSENBLATT RB, 1983, AM J OPHTHALMOL, V96, P275, DOI 10.1016/S0002-9394(14)77814-6; NUSSENBLATT RB, 1990, J IMMUNOL, V144, P1689; NUSSENBLATT RB, 1985, ARTHRITIS RHEUM, V28, P671, DOI 10.1002/art.1780280611; PALESTINE AG, 1986, NEW ENGL J MED, V314, P1293, DOI 10.1056/NEJM198605153142005; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; ROBERGE FG, 1989, J IMMUNOL, V143, P3498; RUSSIN MM, 1988, JPN J OPHTHALMOL, V34, P385; SHAW L, 1987, CLIN CHEM, V33, P1629; TABBARA KF, 1983, OPHTHALMOLOGY, V90, P906; TOWLER HMA, 1990, EYE, V4, P514, DOI 10.1038/eye.1990.68; TOWLER HMA, 1989, EYE, V3, P282, DOI 10.1038/eye.1989.39; WETZIG R, 1988, CURR EYE RES, V7, P809, DOI 10.3109/02713688809033212; YAZICI H, 1990, NEW ENGL J MED, V322, P281, DOI 10.1056/NEJM199002013220501	25	24	25	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1501	1504		10.1016/0140-6736(91)92310-X	http://dx.doi.org/10.1016/0140-6736(91)92310-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683928				2022-12-28	WOS:A1991GV07700014
J	MALONE, S; LIU, PP; HOLLOWAY, R; RUTHERFORD, R; XIE, A; BRADLEY, TD				MALONE, S; LIU, PP; HOLLOWAY, R; RUTHERFORD, R; XIE, A; BRADLEY, TD			OBSTRUCTIVE SLEEP-APNEA IN PATIENTS WITH DILATED CARDIOMYOPATHY - EFFECTS OF CONTINUOUS POSITIVE AIRWAY PRESSURE	LANCET			English	Article							CONGESTIVE HEART-FAILURE; INTRA-THORACIC PRESSURE; APNEA SYNDROME; ANGINA-PECTORIS; RISK FACTOR; DISEASE; HYPERTENSION; PATHOGENESIS; STROKE; MEN	The combined effects of negative intrathoracic pressure swings during obstructive sleep apnoeas (OSAs) and increased sympathetic nervous system tone associated with hypoxia and sleep arousal may lead to pulmonary oedema or left-ventricular hypertrophy. Therefore, we have done a study of patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy to see whether OSA could contribute to impaired left-ventricular function and to assess nasal continuous positive airway pressure (NCPAP) for treatment. Eight men (aged 29-69 years) took part in the study, all were obese. Left-ventricular ejection fraction (LVEF) was measured while on stable medication and then 4 weeks after the start of nocturnal NCPAP. NCPAP was associated with abolition of OSA (mean [SE] number of apnoeas and hypopnoeas per hour of sleep 54.1 [7.2] and 1.0 [0.4] for pretreatment and NCPAP nights, respectively, p < 0.0001). Mean (SE) LVEF increased from 37 (4)% pretreatment to 49 (5)% after four weeks' NCPAP therapy (p < 0.0001). Withdrawal of NCPAP for 1 week in four patients was associated with a reduction in LVEF from 53 (6)% to 45 (5)% (p < 0.001). OSA may contribute to impaired left-ventricular function in some patients with dilated cardiomyopathy of otherwise unknown origin, and reversal of OSA by NCPAP can lead to significant improvement in LVEF.	TORONTO GEN HOSP,DEPT MED,200 ELIZABETH ST,TORONTO M5G 2C4,ONTARIO,CANADA; QUEEN ELIZABETH HOSP,SLEEP RES LAB,TORONTO,ONTARIO,CANADA; MT SINAI HOSP,DEPT MED,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	BRADLEY, TD (corresponding author), TORONTO GEN HOSP,DEPT MED,200 ELIZABETH ST,TORONTO M5G 2C4,ONTARIO,CANADA.							ABT K, 1981, CONTROL CLIN TRIALS, V1, P377, DOI 10.1016/0197-2456(81)90042-8; ALLEN DG, 1987, CIRC RES, V60, P153, DOI 10.1161/01.RES.60.2.153; BARRUZZI A, 1991, SLEEP, V14, P83; BRADLEY TD, 1985, MED CLIN N AM, V69, P1169; BRADLEY TD, 1985, AM REV RESPIR DIS, V131, P835; BRADLEY TD, IN PRESS AM REV RESP; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; BUDA AJ, 1981, INT J CARDIOL, V1, P67, DOI 10.1016/0167-5273(81)90050-4; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; CHADHA TS, 1982, AM REV RESPIR DIS, V125, P644; CHAN HS, 1991, CHEST, V99, P1023, DOI 10.1378/chest.99.4.1023; CHAUDHARY BA, 1982, CHEST, V82, P122, DOI 10.1378/chest.82.1.122; GOULD GA, 1988, AM REV RESPIR DIS, V137, P895, DOI 10.1164/ajrccm/137.4.895; HEDNER J, 1990, J HYPERTENS, V8, P941, DOI 10.1097/00004872-199010000-00009; HEDNER J, 1988, HYPERTENSION DALL S4, V6, pS529; HUNG J, 1990, LANCET, V336, P261, DOI 10.1016/0140-6736(90)91799-G; KATZ AM, 1990, NEW ENGL J MED, V322, P100; KOSKENVUO M, 1987, BRIT MED J, V294, P16, DOI 10.1136/bmj.294.6563.16; KOSKENVUO M, 1985, LANCET, V1, P893; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; RINGLER J, 1990, J APPL PHYSIOL, V69, P2143, DOI 10.1152/jappl.1990.69.6.2143; SCHARF SM, 1981, CIRCULATION, V63, P871, DOI 10.1161/01.CIR.63.4.871; Schroeder JS, 1978, SLEEP APNEA SYNDROME, P177; SULLIVAN CE, 1981, LANCET, V1, P862; TAKASAKI Y, 1989, AM REV RESPIR DIS, V140, P1578, DOI 10.1164/ajrccm/140.6.1578; TOLLE FA, 1983, J APPL PHYSIOL, V55, P1718, DOI 10.1152/jappl.1983.55.6.1718; WALLER PC, 1989, LANCET, V1, P143; WEBER KT, 1984, CLIN CHEST MED, V5, P173	29	276	292	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1480	1484						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683918				2022-12-28	WOS:A1991GV07700003
J	BROWNER, WS; MALINOW, MR				BROWNER, WS; MALINOW, MR			HOMOCYST(E)INAEMIA AND BONE-DENSITY IN ELDERLY WOMEN	LANCET			English	Letter									OREGON REG PRIMATE RES CTR,BEAVERTON,OR 97006	Oregon Health & Science University; Oregon National Primate Research Center	BROWNER, WS (corresponding author), UNIV CALIF SAN FRANCISCO,DIV CLIN EPIDEMIOL,SAN FRANCISCO,CA 94105, USA.							BRATTSTROM L, IN PRESS EUR J CLIN; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; COULL BM, 1990, STROKE, V21, P572, DOI 10.1161/01.STR.21.4.572; MALINOW MR, 1989, CIRCULATION, V79, P1180, DOI 10.1161/01.CIR.79.6.1180; MUDD SH, 1983, METABOLIC BASIS INHE, P522; 1991, LANCET, V337, P355	6	20	21	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1470	1470		10.1016/0140-6736(91)92782-W	http://dx.doi.org/10.1016/0140-6736(91)92782-W			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683464				2022-12-28	WOS:A1991GT90400064
J	KITTUR, DS; HOGAN, MM; THUKRAL, VK; MCGAW, LJ; ALEXANDER, JW				KITTUR, DS; HOGAN, MM; THUKRAL, VK; MCGAW, LJ; ALEXANDER, JW			INCENTIVES FOR ORGAN DONATION	LANCET			English	Editorial Material							LAW		UNITED NETWORK ORGAN SHARING,1100 BOULDERS PKWY,SUITE 500,POB 13770,RICHMOND,VA 23225; TULANE UNIV,MED CTR,SCH PUBL HLTH & TROP MED,NEW ORLEANS,LA 70118; UNIV CINCINNATI,COLL MED,CINCINNATI,OH 45221; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205; NIAID,BETHESDA,MD 20892	United Network for Organ Sharing; Tulane University; University of Cincinnati; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								CAPLAN AL, 1986, TRANSPLANT P, V28, P49; CAPLAN AL, 1987, HUM ORGAN TRANSPL, V272, P275; Chengappa, 1990, INDIA TODAY     0731, P60; COHEN LR, 1989, GW LAW REV, V1, P1; FRANKEL T, 1987, J LEGAL STUD, V7, P323; IYER TKK, 1987, FORENSIC SCI INT, V35, P131, DOI 10.1016/0379-0738(87)90048-X; LANDES EM, 1987, J LEGAL STUD, V7, P323; NATHAN HM, 1991, TRANSPLANTATION, V51, P142, DOI 10.1097/00007890-199101000-00022; PETERS TG, 1991, JAMA-J AM MED ASSOC, V265, P1302, DOI 10.1001/jama.265.10.1302; ROELS L, 1990, TRANSPLANT P, V22, P2078; Sipes Daphne D., 1990, BYU J PUBLIC LAW, V4, P395; ZIMMERMAN D, 1981, SAN FRANCISCO E 0726, P16; 1985, US PUBLICS ATTITUDE; 1987, US PUBLICS ATTITUDE; 1986, US PUBLICS ATTITUDE; 1991, CONTROVERSIES ORGAN, P52	16	81	81	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1441	1443		10.1016/0140-6736(91)92735-K	http://dx.doi.org/10.1016/0140-6736(91)92735-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683431				2022-12-28	WOS:A1991GT90400015
J	ROONEY, JF; BRYSON, Y; MANNIX, ML; DILLON, M; WOHLENBERG, CR; BANKS, S; WALLINGTON, CJ; NOTKINS, AL; STRAUS, SE				ROONEY, JF; BRYSON, Y; MANNIX, ML; DILLON, M; WOHLENBERG, CR; BANKS, S; WALLINGTON, CJ; NOTKINS, AL; STRAUS, SE			PREVENTION OF ULTRAVIOLET-LIGHT-INDUCED HERPES LABIALIS BY SUNSCREEN	LANCET			English	Article							SIMPLEX VIRUS-INFECTION; B IRRADIATION; HUMAN-SKIN; RADIATION; HYPERSENSITIVITY; REACTIVATION; CULTURE; GANGLIA; LATENCY; CELLS	Sunlight exposure is reported by some patients to precede onset of recurrent herpes labialis. Ultraviolet (UV) B light is known to be a stimulus for the reactivation of herpes simplex virus (HSV) infections. We assessed the effect of a sunblocking agent on UV-light-induced reactivation of recurrent herpes labialis in a double-blind, placebo-controlled crossover trial. 38 patients were exposed on two separate occasions to four minimum erythema doses of UV light at an area of previous labial herpes recurrence. A solution containing sunscreen was applied to the lips before one exposure and a matched placebo before the other. After placebo and UV exposure, herpes labialis developed in 27 (71%) of the 38 patients, with a mean time to recurrence of 2.9 (SEM 0.2) days. In contrast, when sunscreen was applied before UV exposure, no lesions developed, but 1 of the 35 patients shed virus at the exposure site. We conclude that UV light is a potent stimulus for inducing reactivation of herpes labialis, and that application of sunscreen may be effective in the prevention of sunlight-induced recurrent infection.	NIAID,CLIN INVEST LAB,BETHESDA,MD 20892; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	ROONEY, JF (corresponding author), NIDR,ORAL MED LAB,BLDG 30,ROOM 121,BETHESDA,MD 20892, USA.							ABERER W, 1981, J INVEST DERMATOL, V76, P202, DOI 10.1111/1523-1747.ep12525745; BLACK AK, 1982, BRIT J CLIN PHARMACO, V13, P351, DOI 10.1111/j.1365-2125.1982.tb01385.x; BLANK H, 1973, J INVEST DERMATOL, V61, P223, DOI 10.1111/1523-1747.ep12676442; CLEMENTS GB, 1988, J GEN VIROL, V69, P375, DOI 10.1099/0022-1317-69-2-375; COREY L, 1985, ANTIVIRAL CHEMOTHERA, P167; EDWARDS EK, 1986, INT J DERMATOL, V25, P327, DOI 10.1111/j.1365-4362.1986.tb02259.x; EFRON B, 1971, BIOMETRIKA, V58, P403, DOI 10.2307/2334377; FISHER MS, 1989, J INVEST DERMATOL, V92, P337, DOI 10.1111/1523-1747.ep12277156; HILL TJ, 1976, LANCET, V1, P397; HOWIE S, 1986, J INVEST DERMATOL, V86, P125, DOI 10.1111/1523-1747.ep12284128; KRIPKE ML, 1984, IMMUNOL REV, V80, P87, DOI 10.1111/j.1600-065X.1984.tb00496.x; LYCKE E, 1984, J GEN VIROL, V65, P55, DOI 10.1099/0022-1317-65-1-55; MAHMIAS AJ, 1989, VIRAL INFECTIONS HUM, P393; MILLS J, 1987, AM J SPORT MED, V15, P76, DOI 10.1177/036354658701500111; OPENSHAW H, 1979, FED PROC, V38, P2660; OVERALL JC, 1982, VIRAL INFECTIONS ORA, P53; PATHAK MA, 1987, DERMATOLOGY GENERAL, P1507; PERNA JJ, 1987, J AM ACAD DERMATOL, V17, P473, DOI 10.1016/S0190-9622(87)70232-1; PUNNONEN K, 1987, J INVEST DERMATOL, V88, P611, DOI 10.1111/1523-1747.ep12470217; ROONEY JF, 1986, NEW ENGL J MED, V314, P1561, DOI 10.1056/NEJM198606123142407; SPRUANCE SL, 1991, J INFECT DIS, V163, P728, DOI 10.1093/infdis/163.4.728; YOUNG SK, 1976, ORAL SURG ORAL MED O, V41, P498, DOI 10.1016/0030-4220(76)90277-2	22	105	111	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1419	1422		10.1016/0140-6736(91)92723-F	http://dx.doi.org/10.1016/0140-6736(91)92723-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683420				2022-12-28	WOS:A1991GT90400004
J	BRIGGS, DC; VAUGHAN, RW; WELSH, KI; MYERS, A; DUBOIS, RM; BLACK, CM				BRIGGS, DC; VAUGHAN, RW; WELSH, KI; MYERS, A; DUBOIS, RM; BLACK, CM			IMMUNOGENETIC PREDICTION OF PULMONARY FIBROSIS IN SYSTEMIC-SCLEROSIS	LANCET			English	Note							CLINICAL CORRELATIONS; ANTIGENS	75 systemic sclerosis patients were independently tested for pulmonary fibrosis, autoantibodies, and MHC class II genes. 24 of 42 (57%) patients with pulmonary fibrosis had either HLA DR3/DRw52a or anti-Scl-70 vs 2 of 33 (6%) patients without pulmonary fibrosis. The presence of DR3/DRw52a or anti-Scl-70 gives a relative risk of 16.7 for the development of pulmonary fibrosis in a patient with scleroderma-a risk substantial enough to require careful monitoring of these patients and treatment at an early stage of disease.	TEMPLE UNIV,HLTH SCI CTR,PHILADELPHIA,PA 19140; ROYAL BROMPTON HOSP,DEPT THORAC MED,LONDON,ENGLAND; ROYAL FREE HOSP,DEPT RHEUMATOL,LONDON,ENGLAND	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Royal Brompton Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	BRIGGS, DC (corresponding author), GUYS HOSP,DEPT IMMUNOGENET,TISSUE TYPING LAB,ST THOMAS ST,LONDON SE1 9RT,ENGLAND.			Briggs, David/0000-0002-6796-7086				BIDWELL J, 1988, IMMUNOL TODAY, V9, P18, DOI 10.1016/0167-5699(88)91351-5; CATOGGIO LJ, 1983, ANN RHEUM DIS, V42, P23, DOI 10.1136/ard.42.1.23; HARRISON NK, 1989, RESPIR MED, V83, P404; LEROY EC, 1988, J RHEUMATOL, V15, P202; LYNCH CJ, 1982, J CLIN IMMUNOL, V2, P314, DOI 10.1007/BF00915073; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; TURNERWARWICK M, 1980, THORAX, V35, P171, DOI 10.1136/thx.35.3.171; WEINER ES, 1990, ARTHRITIS RHEUM, V34, P68	8	112	114	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					661	662		10.1016/0140-6736(91)91235-M	http://dx.doi.org/10.1016/0140-6736(91)91235-M			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679476				2022-12-28	WOS:A1991GF10500006
J	MELBYE, M; SPROGEL, P				MELBYE, M; SPROGEL, P			ETIOLOGIC PARALLEL BETWEEN ANAL CANCER AND CERVICAL-CANCER	LANCET			English	Article							INTRAEPITHELIAL NEOPLASIA; PAPILLOMAVIRUS INFECTION; MARITAL-STATUS; RISK; IMMUNODEFICIENCY; ASSOCIATION; MEN	It has been postulated that an infectious agent and/or specific sexual behaviour is involved in the aetiology of anal cancer, in analogy with the aetiology established for cancer of the cervix. A case-control study of 29 648 women with cancers registered in the Danish Cancer Registry during 1968-87 tested the hypothesis that anal cancer patients were more likely than patients with colon, stomach, or vulva cancer to have had a previous diagnosis of cervical intraepithelial neoplasia (CIN) or invasive cervical cancer. The odds ratio of CIN, adjusted for age and year of diagnosis, for anal vs colon cancer was 5.2 (95% confidence interval [CI] 3.3-8.3), that for anal vs stomach cancer 3.6 (2.1-6.0), and that for anal vs vulva cancer 1.6 (0.9-2.9). The median time from diagnosis of CIN to diagnosis of the registered cancer was 151 months for anal, 112 months for vulva, 114 months for colon, and 126 months for stomach cancer. The association with previous invasive cervical cancer was also investigated; no patient with cervical cancer in this second analysis had been included in the CIN analysis. The odds ratios were similar. In addition, anal cancer patients were significantly more likely to have had cervical cancer than were patients with vulva cancer (odds ratio 1.8 [1.0-3.9]). The strong association between anal cancer and CIN/invasive cervical cancer suggests that these cancers share common risk factors. The association is at least as strong as that between cervical and vulva cancer.	DANISH CANC REGISTRY,INST CANC EPIDEMIOL,DANISH CANC SOC,COPENHAGEN,DENMARK	Danish Cancer Society	MELBYE, M (corresponding author), STATE SERUM INST,DEPT EPIDEMIOL,ARTILLERIVEJ 5,DK-2300 COPENHAGEN 5,DENMARK.			melbye, mads/0000-0001-8264-6785				Austin D F, 1982, Natl Cancer Inst Monogr, V62, P89; BIGGAR RJ, 1989, INT J CANCER, V43, P979, DOI 10.1002/ijc.2910430605; BOSCH FX, 1989, IARC SCI PUBL, V94, P135; BRINTON LA, 1986, INT J CANCER, V38, P339, DOI 10.1002/ijc.2910380307; CABRERA A, 1966, CANCER, V19, P470, DOI 10.1002/1097-0142(196604)19:4<470::AID-CNCR2820190403>3.0.CO;2-W; CAUSSY D, 1990, INT J CANCER, V46, P214, DOI 10.1002/ijc.2910460212; DALING JR, 1982, JAMA-J AM MED ASSOC, V247, P1988; DALING JR, 1987, NEW ENGL J MED, V317, P973, DOI 10.1056/NEJM198710153171601; FRANKLIN EW, 1972, J OBSTET GYNECOL, V90, P15; HAUSEN HZ, 1982, LANCET, V2, P1370; HOLLY EA, 1989, J NATL CANCER I, V81, P26; HOLMES F, 1988, GASTROENTEROLOGY, V95, P107, DOI 10.1016/0016-5085(88)90297-1; Kondlapoodi P, 1982, JAMA, V248, P2114; MELBYE M, 1990, INT J CANCER, V46, P203, DOI 10.1002/ijc.2910460210; MUNOZ N, 1989, IARC SCI PUBL, V94, P9; PALEFSKY J, 1990, 6 INT C AIDS SAN FRA, P85; PALEFSKY JM, 1990, JAMA-J AM MED ASSOC, V263, P2911, DOI 10.1001/jama.263.21.2911; PETERS RK, 1983, BRIT J CANCER, V48, P629, DOI 10.1038/bjc.1983.244; PETERSEN O, 1955, PRECANCEROUS CHANGES; REEVES WC, 1989, NEW ENGL J MED, V320, P1437, DOI 10.1056/NEJM198906013202201; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P177; SCHOLEFIELD JH, 1989, LANCET, V2, P765; SCHOLEFIELD JH, 1990, BRIT J CANCER, V62, P286, DOI 10.1038/bjc.1990.279; SCHOTTENFELD D, 1982, CANCER EPIDEMIOL, P703; STORM HH, IN PRESS CANCER REGI; THOMAS DG, 1975, COMPUT BIOMED RES, V8, P423, DOI 10.1016/0010-4809(75)90048-8; WEXNER SD, 1987, DIS COLON RECTUM, V30, P942, DOI 10.1007/BF02554281; 1987, IARC PUBLICATION, V88, P808	28	123	133	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					657	659		10.1016/0140-6736(91)91233-K	http://dx.doi.org/10.1016/0140-6736(91)91233-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679474				2022-12-28	WOS:A1991GF10500004
J	GAMBLE, JR; SKINNER, MP; BERNDT, MC; VADAS, MA				GAMBLE, JR; SKINNER, MP; BERNDT, MC; VADAS, MA			PREVENTION OF ACTIVATED NEUTROPHIL ADHESION TO ENDOTHELIUM BY SOLUBLE ADHESION PROTEIN-GMP140	SCIENCE			English	Article									INST MED & VET SCI,DIV HUMAN IMMUNOL,FROME RD,ADELAIDE,SA 5000,AUSTRALIA; WESTMEAD HOSP,THROMBOSIS & CARDIOVASC DIS RES CTR,DEPT MED,WESTMEAD,NSW 2006,AUSTRALIA	Institute Medical & Veterinary Science Australia; University of Sydney			Vadas, Mathew/R-1378-2019; Berndt, Michael C/D-5580-2012					ANDERSON DC, 1986, J IMMUNOL, V137, P15; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BONFANTI R, 1989, BLOOD, V73, P1109; BUYON JP, 1988, J IMMUNOL, V140, P3156; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GAMBLE JR, 1989, P NATL ACAD SCI USA, V86, P7169, DOI 10.1073/pnas.86.18.7169; GAMBLE JR, 1988, J IMMUNOL METHODS, V109, P175, DOI 10.1016/0022-1759(88)90240-2; GAMBLE JR, 1985, P NATL ACAD SCI USA, V82, P8667, DOI 10.1073/pnas.82.24.8667; GAMBLE JR, UNPUB; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; HATTORI R, 1989, J BIOL CHEM, V264, P7768; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; LO SK, 1989, J IMMUNOL, V143, P3325; LO SK, 1989, J EXP MED, V169, P1779, DOI 10.1084/jem.169.5.1779; LUSCINSKAS FW, 1989, J IMMUNOL, V142, P2257; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; MOSER R, 1989, J CLIN INVEST, V83, P444, DOI 10.1172/JCI113903; PHILIPS MR, 1988, J CLIN INVEST, V82, P495, DOI 10.1172/JCI113623; SAEGUSA Y, 1988, J IMMUNOL, V141, P4140; SCHLEIFFENBAUM B, 1989, J IMMUNOL, V142, P3537; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SKINNER MP, 1989, BIOCHEM BIOPH RES CO, V164, P1373, DOI 10.1016/0006-291X(89)91821-4; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SMITH WW, UNPUB; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; TONNESEN MG, 1989, J CLIN INVEST, V83, P637, DOI 10.1172/JCI113928; VEDDER NB, 1988, J CLIN INVEST, V81, P676, DOI 10.1172/JCI113372; WALL RT, 1978, J CELL PHYSIOL, V96, P203, DOI 10.1002/jcp.1040960209; ZIMMERMAN GA, 1988, J CLIN INVEST, V81, P531, DOI 10.1172/JCI113351; ZIMMERMAN GA, 1985, J CLIN INVEST, V76, P2235, DOI 10.1172/JCI112232	37	258	278	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 27	1990	249	4967					414	417						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ702	1696029				2022-12-28	WOS:A1990DQ70200042
J	LIN, A; FELLER, ER				LIN, A; FELLER, ER			PANCREATIC-CARCINOMA AS A CAUSE OF UNEXPLAINED PANCREATITIS - REPORT OF 10 CASES	ANNALS OF INTERNAL MEDICINE			English	Note									MEM HOSP, PAWTUCKET, RI 02860 USA; MIRIAM HOSP, PROVIDENCE, RI 02906 USA; BROWN UNIV, PROVIDENCE, RI 02912 USA	Lifespan Health Rhode Island; Miriam Hospital; Brown University								ALLAN BJ, 1973, GASTROENTEROLOGY, V65, P412; FELLER ER, 1988, GASTROINTEST ENDOSC, V34, P131, DOI 10.1016/S0016-5107(88)71279-1; GAMBILL EE, 1971, MAYO CLIN PROC, V46, P174; HOWARD JM, 1989, ANN SURG, V209, P31, DOI 10.1097/00000658-198901000-00004; KOHLER H, 1987, PANCREAS, V2, P676, DOI 10.1097/00006676-198701000-00018; LAUGIER R, 1983, AM J SURG, V146, P551, DOI 10.1016/0002-9610(83)90287-8; MCLATCHIE GR, 1981, DIGESTION, V21, P13, DOI 10.1159/000198513; RALLS PW, 1980, RADIOLOGY, V134, P347, DOI 10.1148/radiology.134.2.7352212; ROHRMANN CA, 1976, RADIOLOGY, V121, P311, DOI 10.1148/121.2.311; WILSON C, 1986, POSTGRAD MED J, V62, P765, DOI 10.1136/pgmj.62.730.765	10	65	66	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 15	1990	113	2					166	167		10.7326/0003-4819-113-2-166	http://dx.doi.org/10.7326/0003-4819-113-2-166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN083	1694415				2022-12-28	WOS:A1990DN08300013
J	[Anonymous]				[Anonymous]			ANOTHER REASON FOR IODINE PROPHYLAXIS	LANCET			English	Editorial Material																		BACHRACH LK, 1985, PEDIATRIC THYROIDOLO, P1; BOYAGES SC, 1988, J CLIN ENDOCR METAB, V67, P1262, DOI 10.1210/jcem-67-6-1262; BOYAGES SC, 1990, J CLIN ENDOCR METAB, V70, P336, DOI 10.1210/jcem-70-2-336; DELANGE F, 1989, B WORLD HEALTH ORGAN, V67, P317; EASTMAN CJ, 1988, BAILLIERE CLIN ENDOC, V2, P719, DOI 10.1016/S0950-351X(88)80062-4; FERREIRO B, 1988, J CLIN ENDOCR METAB, V67, P853, DOI 10.1210/jcem-67-4-853; HETZEL BS, 1988, LANCET, V1, P1386; OBREGON MJ, 1984, ENDOCRINOLOGY, V114, P305, DOI 10.1210/endo-114-1-305; PHAROAH POD, 1971, LANCET, V1, P308; STUDER H, 1985, CLIN ENDOCRINOL META, V14, P351, DOI 10.1016/S0300-595X(85)80038-4; THILLY CH, 1978, J CLIN ENDOCR METAB, V47, P354, DOI 10.1210/jcem-47-2-354; VANDERPAS JB, 1986, NEW ENGL J MED, V315, P791, DOI 10.1056/NEJM198609253151302; VULSMA T, 1989, NEW ENGL J MED, V321, P13, DOI 10.1056/NEJM198907063210103	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	1990	335	8703					1433	1434						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ234	1693742				2022-12-28	WOS:A1990DJ23400008
J	MARSDEN, CD				MARSDEN, CD			PARKINSONS-DISEASE	LANCET			English	Review											MARSDEN, CD (corresponding author), UNIV LONDON,NATL HOSP NERVOUS DIS,DEPT CLIN NEUROL,QUEEN SQ,LONDON WC1N 3BG,ENGLAND.							Agid Y, 1987, MOVEMENT DISORD, V1, P166; BALLARD PA, 1985, NEUROLOGY, V35, P949, DOI 10.1212/WNL.35.7.949; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BROOKS DJ, 1989, J NEUROL NEUROSURG S, V52, P68; CALNE DB, 1983, LANCET, V2, P1457, DOI 10.1016/S0140-6736(83)90802-4; CHEN G, 1989, ANN NEUROL, V26, P689; CHIBA K, 1984, BIOCHEM BIOPH RES CO, V120, P574, DOI 10.1016/0006-291X(84)91293-2; COLEMAN RJ, 1989, MOVEMENT DISORD, V4, P129, DOI 10.1002/mds.870040204; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; DAMATO RJ, 1987, J NEUROCHEM, V48, P653, DOI 10.1111/j.1471-4159.1987.tb04142.x; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; FRANKEL JP, 1990, J NEUROL NEUROSUR PS, V53, P96, DOI 10.1136/jnnp.53.2.96; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jenner P, 1989, J NEUROL NEUROSURG S, V52, P22, DOI [10.1136/jnnp.52.Suppl.22, DOI 10.1136/JNNP.52.SUPPL.22]; LEES AJ, 1986, Q J MED, V59, P535; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LINDVALL O, 1989, J NEUROL NEUROSURG S, V52, P39; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; MARSDEN CD, 1977, LANCET, V1, P345; MARSDEN CD, 1976, LANCET, V1, P292, DOI 10.1016/S0140-6736(76)91416-1; NUTT JG, 1986, NEUROLOGY, V36, P739, DOI 10.1212/WNL.36.6.739; NUTT JG, 1984, NEW ENGL J MED, V310, P483, DOI 10.1056/NEJM198402233100802; OBESO JA, 1986, LANCET, V1, P467; QUINN N, 1984, NEUROLOGY, V34, P1131, DOI 10.1212/WNL.34.9.1131; RINNE UK, 1987, NEUROLOGY, V37, P826, DOI 10.1212/WNL.37.5.826; RINNE UK, 1989, NEUROLOGY, V39, P336, DOI 10.1212/WNL.39.3.336; ROSSETTI ZL, 1988, BIOCHEM PHARMACOL, V37, P4573, DOI 10.1016/0006-2952(88)90674-0; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; TANNER CM, 1989, TRENDS NEUROSCI, V12, P49, DOI 10.1016/0166-2236(89)90135-5; VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x; WARD CD, 1983, NEUROLOGY, V33, P815, DOI 10.1212/WNL.33.7.815; 1989, NEW ENGL J MED, V321, P1364	38	330	336	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 21	1990	335	8695					948	952		10.1016/0140-6736(90)91006-V	http://dx.doi.org/10.1016/0140-6736(90)91006-V			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA350	1691427				2022-12-28	WOS:A1990DA35000010
J	LIGHT, DB; CORBIN, JD; STANTON, BA				LIGHT, DB; CORBIN, JD; STANTON, BA			DUAL ION-CHANNEL REGULATION BY CYCLIC-GMP AND CYCLIC GMP-DEPENDENT PROTEIN-KINASE	NATURE			English	Article									DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT PHYSIOL,HANOVER,NH 03756; VANDERBILT UNIV,MED CTR,SCH MED,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37232	Dartmouth College; Vanderbilt University								BEEBE SJ, 1986, ENZYMES, V17, P43; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; DEBOLD AJ, 1986, FED PROC, V45, P2081; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FESENKO EE, 1986, BIOCHIM BIOPHYS ACTA, V856, P661, DOI 10.1016/0005-2736(86)90162-8; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; HAYNES L, 1985, NATURE, V317, P61, DOI 10.1038/317061a0; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x; LEVITAN IB, 1988, ANNU REV NEUROSCI, V11, P119, DOI 10.1146/annurev.neuro.11.1.119; LIGHT DB, 1988, AM J PHYSIOL, V255, pF278, DOI 10.1152/ajprenal.1988.255.2.F278; LIGHT DB, 1989, J CLIN INVEST, V84, P352, DOI 10.1172/JCI114162; LIGHT DB, 1989, SCIENCE, V243, P383, DOI 10.1126/science.2463673; MAACK T, 1986, BIOCHEM PHARMACOL, V35, P2057, DOI 10.1016/0006-2952(86)90570-8; NAGATA K, 1989, BIOCHEM BIOPH RES CO, V160, P235, DOI 10.1016/0006-291X(89)91646-X; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; PAUPARDINTRITSCH D, 1986, NATURE, V323, P812, DOI 10.1038/323812a0; STANTON BA, 1989, AM J PHYSIOL, V256, pF862, DOI 10.1152/ajprenal.1989.256.5.F862; TANAKA JC, 1987, P NATL ACAD SCI USA, V84, P724, DOI 10.1073/pnas.84.3.724; WALTER U, 1981, EUR J BIOCHEM, V118, P339; WOLFE L, 1987, J BIOL CHEM, V262, P16906; WOODY CD, 1986, BRAIN RES, V386, P379, DOI 10.1016/0006-8993(86)90175-7; YADA Y, 1989, FEBS LETT, V242, P368, DOI 10.1016/0014-5793(89)80503-4; ZEIDEL ML, 1988, J CLIN INVEST, V82, P1067, DOI 10.1172/JCI113663; ZICK Y, 1986, P NATL ACAD SCI USA, V83, P9294, DOI 10.1073/pnas.83.24.9294	28	175	176	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 22	1990	344	6264					336	339		10.1038/344336a0	http://dx.doi.org/10.1038/344336a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV289	1690355				2022-12-28	WOS:A1990CV28900066
J	FIESSINGER, JN; SCHAFER, M				FIESSINGER, JN; SCHAFER, M			TRIAL OF ILOPROST VERSUS ASPIRIN TREATMENT FOR CRITICAL LIMB ISCHEMIA OF THROMBOANGIITIS-OBLITERANS	LANCET			English	Article									HOP BROUSSAIS,CTR CLAUDE BERNARD RECH MALAD VASC PERIPHER,F-75674 PARIS 14,FRANCE; SCHERING AG,CLIN RES DEPT INTERNAL MED 1,BERLIN,GERMANY	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Schering AG	FIESSINGER, JN (corresponding author), HOP BROUSSAIS,SERV PATHOL VASC,F-75674 PARIS 14,FRANCE.							BELCH JJF, 1983, LANCET, V1, P315; BOLLINGER A, 1979, SCHWEIZ MED WSCHR, V109, P537; CARLSON LA, 1976, LANCET, V2, P810; CRONENWETT JL, 1986, SURGERY, V100, P369; CRONENWETT JL, 1986, J VASC SURG, V2, P370; HILL GL, 1974, BRIT J SURG, V61, P476, DOI 10.1002/bjs.1800610615; MCPHERSON JR, 1963, ANN INTERN MED, V59, P288, DOI 10.7326/0003-4819-59-3-288; MILLS JL, 1987, AM J SURG, V154, P123, DOI 10.1016/0002-9610(87)90301-1; NIELUBOWICZ J, 1980, J CARDIOVASC SURG, V21, P529; NIZANKOWSKI R, 1985, THROMB RES, V37, P21, DOI 10.1016/0049-3848(85)90029-5; OLSSON AG, 1978, ACTA DERM-VENEREOL, V58, P467; SAKAGUCHI S, 1978, VASA-J VASCULAR DIS, V7, P263; SPITTELL JA, 1983, NEW ENGL J MED, V308, P1157, DOI 10.1056/NEJM198305123081910; SZCZEKLIK A, 1979, LANCET, V1, P1114	14	210	218	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					555	557		10.1016/0140-6736(90)90346-7	http://dx.doi.org/10.1016/0140-6736(90)90346-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1689791				2022-12-28	WOS:A1990CT65300001
J	LO, SC; HAYES, MM; WANG, RYH; PIERCE, PF; KOTANI, H; SHIH, JWK				LO, SC; HAYES, MM; WANG, RYH; PIERCE, PF; KOTANI, H; SHIH, JWK			NEWLY DISCOVERED MYCOPLASMA ISOLATED FROM PATIENTS INFECTED WITH HIV	LANCET			English	Article							AIDS; INCOGNITUS; STRAINS; AGENT	Mycoplasmas have been isolated from patients with acquired immunodeficiency syndrome (AIDS) and they may contribute to the pathogenesis of this disease. We have isolated repeatedly a previously unknown mycoplasma from the urine of an HIV-positive male homosexual and, subsequently, from the urine of 5 HIV-positive patients with AIDS. The mycoplasma was not found in the urine of 98 healthy control subjects. The organism has an unusual tip-like structure with densely packed fine granules and metabolises both glucose and arginine for growth. Antigenic and DNA analyses show the organism to be distinct from other known mycoplasmas. The mycoplasma displays in-vitro activities associated with virulence in vivo. In addition, electronmicroscopy shows that the mycoplasma can invade and attach to various human and animal cells. We are investigating whether the new mycoplasma has a role in human disease.	NIH,WARREN GRANT MAGUNSON CLINICAL CTR,DEPT TRANSFUS MED,BETHESDA,MD 20892; GEORGETOWN UNIV HOSP,HIV CLIN PROGRAM,WASHINGTON,DC 20007	National Institutes of Health (NIH) - USA; Georgetown University	LO, SC (corresponding author), ARMED FORCES INST PATHOL,DEPT INFECT & PARASIT DIS PATHOL,AMER REGISTRY PATHOL,WASHINGTON,DC 20306, USA.							ALUOTTO B B, 1970, International Journal of Systematic Bacteriology, V20, P35; BARILE MF, 1988, INFECT IMMUN, V56, P2443, DOI 10.1128/IAI.56.9.2443-2449.1988; BARILE MF, 1983, METHODS MYCOPLASMOLO, V1, P345; BAUER FA, 1991, HUM PATHOL, V22, P63, DOI 10.1016/0046-8177(91)90063-U; BIBERFELD G, 1983, MYCOPLASMAS, V4, P293; CHANDLER DKF, 1982, INFECT IMMUN, V38, P604, DOI 10.1128/IAI.38.2.604-609.1982; CHOWDHURY MIH, 1990, LANCET, V336, P247; DAWSON MS, 1991, 91ST GEN M AM SOC MI; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOBLE UB, 1984, SCIENCE, V226, P1211; HOWARD CJ, 1983, MYCOPLASMAS, V4, P259; LO SC, 1989, AM J TROP MED HYG, V40, P213, DOI 10.4269/ajtmh.1989.40.213; LO SC, 1989, AM J TROP MED HYG, V41, P586, DOI 10.4269/ajtmh.1989.41.586; LO SC, 1989, AM J TROP MED HYG, V41, P601, DOI 10.4269/ajtmh.1989.41.601; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; MIRSALIMI SM, 1989, AVIAN DIS, V33, P310, DOI 10.2307/1590849; TAYLORROBINSON D, 1980, NEW ENGL J MED, V302, P1003, DOI 10.1056/NEJM198005013021805; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; TULLY JG, 1981, LANCET, V1, P1288; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; 1991, LANCET, V337, P20	21	104	127	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1415	1418		10.1016/0140-6736(91)92721-D	http://dx.doi.org/10.1016/0140-6736(91)92721-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683419				2022-12-28	WOS:A1991GT90400003
J	WYATT, J				WYATT, J			COMPUTER-BASED KNOWLEDGE SYSTEMS	LANCET			English	Article							EXPERT SYSTEMS; DECISION AIDS; INFORMATION; MANAGEMENT; DIAGNOSIS; NEEDS				WYATT, J (corresponding author), STANFORD UNIV, MED CTR, SCH MED, MED INFORMAT SECT, MSOB X-215, STANFORD, CA 94305 USA.		Wyatt, Jeremy/F-8160-2010	Wyatt, Jeremy/0000-0001-7008-1473				ADAMS ID, 1986, BRIT MED J, V293, P800, DOI 10.1136/bmj.293.6550.800; ANDREASSEN S, 1991, 3RD P EUR C ART INT, P239; BANKOWITZ RA, 1989, ANN INTERN MED, V110, P824, DOI 10.7326/0003-4819-110-10-824; BARNETT GO, 1987, JAMA-J AM MED ASSOC, V258, P67, DOI 10.1001/jama.258.1.67; Beinlinch I., 1989, 2ND P EUR C ART INT, P247; BLOIS M, 1984, 8TH P S COMP APPL ME, P86; BLOIS MS, 1990, MED INFORMATICS COMP, P3; BRAHAMS D, 1989, LANCET, V2, P632; CARR RM, 1991, BYTE MAGAZINE    FEB, P211; Conklin J., 1989, IEEE COMPUT, V20, P17, DOI DOI 10.1109/MC.1987.1663693; COVELL DG, 1985, ANN INTERN MED, V103, P596, DOI 10.7326/0003-4819-103-4-596; DEBLIEK R, 1988, 12TH P ANN S COMP AP, P225; EVANS D, 1989, COGNITIVE SCI MED; FEINSTEIN AR, 1977, CLIN PHARMACOL THER, V21, P482; Fox J., 1990, Artificial Intelligence in Medicine, V2, P323, DOI 10.1016/0933-3657(90)90007-E; GREENES R A, 1990, Journal of the American Medical Association, V263, P1114, DOI 10.1001/jama.263.8.1114; GREENES RA, 1989, COMPUT BIOMED RES, V22, P113, DOI 10.1016/0010-4809(89)90021-9; HART A, 1990, MED INFORM, V15, P229, DOI 10.3109/14639239009025270; HART A, 1989, 2ND P EUR C ART INT, P115; HOLLINGSWORTH TH, 1959, J R STAT SOC SER A-G, V122, P221, DOI 10.2307/2342604; HUMPHREYS BL, 1989, 13TH P S COMP APPL M, P475; HUTH EJ, 1989, ANN INTERN MED, V110, P99, DOI 10.7326/0003-4819-110-2-99; INGRAM D, 1990, COMPUTERS OBSTETRICS, P313; KENT DL, 1985, J CLIN ONCOL, V3, P1409, DOI 10.1200/JCO.1985.3.10.1409; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; MAHY I, 1988, LANCET, V1, P444; MILLER RA, 1990, METHOD INFORM MED, V29, P1; MILLER RA, 1986, WESTERN J MED, V145, P816; MILLIKEN JA, 1983, J ELECTROCARDIOL, V16, P141, DOI 10.1016/S0022-0736(83)80018-1; NATHWANI BN, 1990, HUM PATHOL, V21, P11, DOI 10.1016/0046-8177(90)90071-C; POZEN MW, 1980, ANN INTERN MED, V92, P238, DOI 10.7326/0003-4819-92-2-238; PROUDFOOT AT, 1984, BRIT MED J, V289, P1420, DOI 10.1136/bmj.289.6456.1420-a; Pryor T A, 1983, J Med Syst, V7, P87, DOI 10.1007/BF00995116; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SHIFFMAN S, 1991, IEEE EXPERT      FEB, P41; SHORTLIFFE EH, 1990, MED INFORMATICS COMP, P466; SHORTLIFFE EH, 1990, MED INFORMATICS; Sox HC, 1988, MED DECISION MAKING; SPIEGELHALTER DJ, 1984, J R STAT SOC A STAT, V147, P35, DOI 10.2307/2981737; STINSON ER, 1980, JAMA-J AM MED ASSOC, V243, P140, DOI 10.1001/jama.243.2.140; SZOLOVITS P, 1988, ANN INTERN MED, V108, P80, DOI 10.7326/0003-4819-108-1-80; Timpka T., 1990, Artificial Intelligence in Medicine, V2, P179, DOI 10.1016/0933-3657(90)90057-X; VANDERLEI J, 1991, COMPUT BIOMED RES, V24, P344, DOI 10.1016/0010-4809(91)90034-T; WEED LL, 1985, MT SINAI J MED, V52, P94; WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94; WILLIAMSON JW, 1989, ANN INTERN MED, V110, P151, DOI 10.7326/0003-4819-110-2-151; WINTER RM, 1991, LONDON DYSMORPHOLOGY; WYATT J, 1990, LANCET, V335, P1223; WYATT J, 1990, MED INFORM, V15, P205, DOI 10.3109/14639239009025268; WYATT J, 1989, THORAX, V44, P327; WYATT J, 1991, THESIS OXFORD U; WYATT J, 1989, 6TH P WORLD C MED IN, P111; XAKELLIS GC, 1990, ACAD MED, V65, P23, DOI 10.1097/00001888-199001000-00006	53	44	45	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	1991	338	8780					1431	1436		10.1016/0140-6736(91)92731-G	http://dx.doi.org/10.1016/0140-6736(91)92731-G			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683428				2022-12-28	WOS:A1991GT90400012
J	KROEMER, G; MARTINEZA, C				KROEMER, G; MARTINEZA, C			THE FAIL-SAFE PARADIGM OF IMMUNOLOGICAL SELF-TOLERANCE	LANCET			English	Note							T-CELL RECEPTOR; AUTOIMMUNE ENCEPHALOMYELITIS; CLONAL ANERGY; INTERLEUKIN-2 RECEPTOR; LIMITED HETEROGENEITY; LYMPHOCYTES-T; VACCINATION; EXPANSION; ARTHRITIS; ANTIBODY	Immunological self-tolerance is guaranteed by several complementary mechanisms arranged in a fail-safe hierarchy-namely, clonal deletion, inactivation, and suppression. Only failure of all these self-tolerance-preserving systems allows autoimmune disease to develop. The notion of such a fail-safe organisation of the immune system is compatible with several features of autoimmune disease: its multicausal nature, its slowly progressive and relapsing course, and the diverse range of interventions available to restore autotolerance. This hypothesis has practical implications for the understanding of both the pathogenesis of iatrogenic autoimmune disease and the design of strategies to re-establish self-tolerance.			KROEMER, G (corresponding author), UNIV AUTOMOMA MADRID, CSIC, CTR BIOL MOLEC, CAMPUS CANTOBLANCO, E-28049 MADRID, SPAIN.		KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020	KROEMER, Guido/0000-0002-9334-4405; 				ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; AHARONI R, 1991, NATURE, V351, P147, DOI 10.1038/351147a0; ANDREUSANCHEZ JL, 1991, J EXP MED, V173, P1323, DOI 10.1084/jem.173.6.1323; [Anonymous], 1991, LANCET, V338, P789; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; HASHIM GA, 1990, J IMMUNOL, V144, P4621; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; HOWLETT TA, 1984, LANCET, V2, P1101; ISHIDA Y, 1989, J EXP MED, V170, P1103, DOI 10.1084/jem.170.4.1103; JONES RJ, 1989, LANCET, V1, P754; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KROEMER G, 1991, IMMUNOL REV, V122, P173, DOI 10.1111/j.1600-065X.1991.tb00602.x; KROEMER G, 1991, ADV IMMUNOL, V150, P147; KYLE V, 1989, ANN RHEUM DIS, V48, P428, DOI 10.1136/ard.48.5.428; LIDER O, 1987, P NATL ACAD SCI USA, V84, P4577, DOI 10.1073/pnas.84.13.4577; LORBERBOUMGALSKI H, 1990, J BIOL CHEM, V265, P16311; MILTENBURG AMM, 1990, SCAND J IMMUNOL, V31, P121, DOI 10.1111/j.1365-3083.1990.tb02750.x; OKSENBERG JR, 1990, NATURE, V345, P344, DOI 10.1038/345344a0; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; REMUZZI G, 1991, LANCET, V337, P750, DOI 10.1016/0140-6736(91)91368-5; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; TORIBIO ML, 1989, NATURE, V342, P82, DOI 10.1038/342082a0; VANLIESSUM PA, 1989, LANCET, V1, P224; WILLIAMS ME, 1990, J IMMUNOL, V144, P1208; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0	28	25	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	1991	338	8777					1246	1249		10.1016/0140-6736(91)92110-N	http://dx.doi.org/10.1016/0140-6736(91)92110-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682652				2022-12-28	WOS:A1991GQ16600012
J	EPSTEIN, DJ; VEKEMANS, M; GROS, P				EPSTEIN, DJ; VEKEMANS, M; GROS, P			SPLOTCH (SP2H), A MUTATION AFFECTING DEVELOPMENT OF THE MOUSE NEURAL-TUBE, SHOWS A DELETION WITHIN THE PAIRED HOMEODOMAIN OF PAX-3	CELL			English	Article							DEVELOPING EXCRETORY SYSTEM; CONSERVED LINKAGE; GENES; BOX; EXPRESSION; DROSOPHILA; DOMAIN; MUTANT	The molecular basis of the mouse mutation splotch (Sp), which is associated with spina bifida and exencephaly, was analyzed at three of its alleles, Sp, Sp2H, and Sp(r). We mapped the paired box gene Pax-3 within the Inha to Akp3 interval, near or at the Sp locus on chromosome 1, and found Pax-3 to be deleted in heterozygous Sp(r)/+ mice. Analysis of genomic DNA and cDNA clones constructed from Sp2H/Sp2H embryos identified a deletion of 32 nucleotides in the Pax-3 mRNA transcript and gene. This deletion maps within the paired homeodomain of PAX-3 and is predicted to create a truncated protein as a result of a newly created termination codon at the deletion breakpoint. Our study provides evidence for a causal link between deletion of the paired homeodomain of Pax-3 and the Sp2H mutation, and infers that Pax-3 plays a key role in normal neural development.	MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,QUEBEC,CANADA	McGill University	EPSTEIN, DJ (corresponding author), MCGILL UNIV,DEPT BIOL,MONTREAL H3G 1Y6,QUEBEC,CANADA.							ARIAS S, 1978, CYTOGENET CELL GENET, V22, P291, DOI 10.1159/000130956; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; ASHER JH, 1991, AM J HUM GENET, V48, P43; AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; Beechey CV, 1986, MOUSE NEWS LETT, V75, P28; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DICKIE MM, 1964, J HERED, V55, P97, DOI 10.1093/oxfordjournals.jhered.a107317; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; EDELMAN GM, 1986, ANNU REV CELL BIOL, V2, P81, DOI 10.1146/annurev.cb.02.110186.000501; Edmonds L D, 1990, MMWR CDC Surveill Summ, V39, P19; EPSTEIN DJ, 1991, GENOMICS, V10, P89, DOI 10.1016/0888-7543(91)90488-Z; EVANS EP, 1988, MOUSE NEWS LETT, V81, P66; FRANZ T, 1990, ACTA ANAT, V138, P246; FRANZ T, 1989, ANAT EMBRYOL, V1806, P4577; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HIRSCH MR, 1990, MOL CELL BIOL, V10, P1959, DOI 10.1128/MCB.10.5.1959; ISHIKIRIYAMA S, 1989, AM J MED GENET, V33, P505, DOI 10.1002/ajmg.1320330419; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Le Douarin N, 1980, Curr Top Dev Biol, V16, P31; MALO D, 1991, GENOMICS, V10, P356, DOI 10.1016/0888-7543(91)90320-E; MALO D, 1990, GENOMICS, V6, P697, DOI 10.1016/0888-7543(90)90507-Q; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P976; MOASE CE, 1990, TERATOLOGY, V42, P171, DOI 10.1002/tera.1420420208; MOASE CE, 1989, TERATOLOGY, V40, P67, DOI 10.1002/tera.1420400109; MOASE CE, 1991, IN PRESS DEVELOPMENT; MORRISSEY D, 1991, GENE DEV, V5, P1684, DOI 10.1101/gad.5.9.1684; NORNES HO, 1990, DEVELOPMENT, V109, P797; OLSON E, 1990, GENOMICS, V8, P427, DOI 10.1016/0888-7543(90)90028-S; PLACHOV D, 1990, DEVELOPMENT, V110, P643; RUSSELL WL, 1947, GENETICS, V32, P107; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SCHURR E, 1990, GENOMICS, V8, P477, DOI 10.1016/0888-7543(90)90034-R; SKOW LC, 1988, BIOCHEM GENET, V26, P557, DOI 10.1007/BF02399601; SNELL GD, 1954, HEREDITY, V8, P271, DOI 10.1038/hdy.1954.23; STEEL KP, 1989, DEVELOPMENT, V107, P453; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594	46	620	628	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 15	1991	67	4					767	774		10.1016/0092-8674(91)90071-6	http://dx.doi.org/10.1016/0092-8674(91)90071-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GQ407	1682057				2022-12-28	WOS:A1991GQ40700013
J	BJUNE, G; HOIBY, EA; GRONNESBY, JK; ARNESEN, O; HOLSTFREDRIKSEN, J; HALSTENSEN, A; HOLTEN, E; LINDBAK, AK; NOKLEBY, H; ROSENQVIST, E; SOLBERG, LK; CLOSS, O; ENG, J; FROHOLM, LO; LYSTAD, A; BAKKETEIG, LS; HAREIDE, B				BJUNE, G; HOIBY, EA; GRONNESBY, JK; ARNESEN, O; HOLSTFREDRIKSEN, J; HALSTENSEN, A; HOLTEN, E; LINDBAK, AK; NOKLEBY, H; ROSENQVIST, E; SOLBERG, LK; CLOSS, O; ENG, J; FROHOLM, LO; LYSTAD, A; BAKKETEIG, LS; HAREIDE, B			EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY	LANCET			English	Article								For more than 15 years, Norway has had the highest incidence of meningococcal disease in northern Europe, with 80% of cases being due to serogroup B meningococci. The case-fatality has remained high, at about 10%. In this study, an outer membrane vaccine, which had previously been shown to induce an increase in bactericidal antibodies to the parent strain, was assessed in a large-scale, randomised, double-blind trial. From October, 1988, 171800 students in secondary schools volunteered to take part in a double-blind, placebo-controlled, efficacy trial with school as the randomisation unit. Hospitals and clinics that routinely receive patients with infectious disease were asked to report urgently all cases of suspected meningitis and/or septicaemia in 13-21-year-old students in Norway. These cases were registered and further investigated according to a detailed protocol. 89 out of the 221 cases investigated by June 3, 1991, were shown to be severe systemic disease due to group B meningococci. 36 cases in 35 schools took part in the trial (11 schools with vaccinated students and 24 with students given placebo). The calculated rate of protection was thus 57.2% (p = 0.012, one-sided test). The findings suggest that, although the vaccine conferred protection against group B meningococcal disease, the effect was insufficient to justify a public vaccination programme.	AKERSHUS CENT HOSP,DEPT MICROBIOL,N-1474 NORDBYHAGEN,NORWAY; HAUKELAND HOSP,DEPT MED,N-5021 BERGEN,NORWAY	University of Oslo; University of Bergen; Haukeland University Hospital	BJUNE, G (corresponding author), NATL INST PUBL HLTH,GEITMYRSVEIEN 75,N-0462 OSLO,NORWAY.							BOSLEGO J, 1990, 7TH INT PATH NEISS C; BOVRE K, 1980, NIPH (National Institute of Public Health) Annals (Oslo), V3, P9; BOVRE K, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P75; BOVRE K, 1986, A VAN LEEUW J MICROB, V52, P208, DOI 10.1007/BF00555233; CAUGANT DA, 1986, J GEN MICROBIOL, V132, P641; Cox D. R., 1984, ANAL SURVIVAL DATA; FINNE J, 1983, LANCET, V2, P355; Fleiss JL, 1981, STAT METHODS RATES P; FRASCH CE, 1989, CLIN MICROBIOL REV, V2, pS134, DOI 10.1128/CMR.2.Suppl.S134-S138.1989; FROHOLM LO, 1991, NEISSERIAE 1990, P57; GEDDE-DAHL T W, 1978, NIPH (National Institute of Public Health) Annals (Oslo), V1, P43; GEDDEDAHL TW, 1979, NIPH ANN, V2, P79; HOIBY EA, 1986, A VAN LEEUW J MICROB, V52, P255, DOI 10.1007/BF00555251; HOIBY EA, 1991, NEISSERIAE 1990, P241; SIERRA GVG, 1991, NEISSERIAE 1990, P129; ZOLLINGER WD, 1979, J CLIN INVEST, V63, P836, DOI 10.1172/JCI109383	16	538	620	0	19	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1093	1096		10.1016/0140-6736(91)91961-S	http://dx.doi.org/10.1016/0140-6736(91)91961-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682541				2022-12-28	WOS:A1991GM78400001
J	SATOW, YI; HASHIDO, M; ISHIKAWA, KI; HONDA, H; MIZUNO, M; KAWANA, T; HAYAMI, M				SATOW, YI; HASHIDO, M; ISHIKAWA, KI; HONDA, H; MIZUNO, M; KAWANA, T; HAYAMI, M			DETECTION OF HTLV-I ANTIGEN IN PERIPHERAL AND CORD BLOOD-LYMPHOCYTES FROM CARRIER MOTHERS	LANCET			English	Note							T-CELL LEUKEMIA; TRANSMISSION; ANTIBODY; VIRUS	Vertical transmission of human T-cell lymphotropic virus type-I (HTLV-I) from an antibody-positive carrier mother to her infant has been reported, but it is not clear when and by what route such transmission occurs. Peripheral blood and cord blood lymphocytes from 40 antibody-positive carrier mothers were cultured for 2 months and HTLV-I antigen was sought by indirect immunofluorescence. Viral antigen was detected in 28 (70%) samples of peripheral blood lymphocytes and in 2 of cord blood lymphocytes, both from mothers positive for antigen in peripheral blood. From these data it is estimated that transplacental infection occurs at a rate of about 7%.	UNIV TOKYO,DEPT OBSTET & GYNAECOL,MEJIRODAI,JAPAN; MITSUI MEM HOSP,DEPT OBSTET & GYNAECOL,TOKYO 101,JAPAN; UNIV TOKYO,DEPT OBSTET & GYNAECOL,TOKYO 113,JAPAN; UNIV TOKYO,INST MED SCI,DEPT ANIM PATHOL,SHIROGANEDAI,JAPAN; KYOTO UNIV,INST VIRUS RES,IMMUNODEFICIENCY VIRUS RES CTR,KYOTO 606,JAPAN	University of Tokyo; Mitsui Memorial Hospital; University of Tokyo; University of Tokyo; Kyoto University								HINO S, 1987, LANCET, V2, P158; HINO S, 1985, JPN J CANCER RES, V76, P474; HINUMA Y, 1982, GANN, V73, P341; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; ICHIJO M, 1988, OBSTET GYNECOL PRACT, V37, P45; KOMURO A, 1983, LANCET, V1, P240; MAEDA Y, 1989, JPN J CANCER RES, V80, P915, DOI 10.1111/j.1349-7006.1989.tb01625.x; SAITO S, 1990, JPN J CANCER RES, V81, P890, DOI 10.1111/j.1349-7006.1990.tb02663.x	8	28	29	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					915	916		10.1016/0140-6736(91)91775-P	http://dx.doi.org/10.1016/0140-6736(91)91775-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681269				2022-12-28	WOS:A1991GJ89900006
J	WILSON, P; LEESE, T; MORGAN, WP; KELLY, JF; BRIGG, JK				WILSON, P; LEESE, T; MORGAN, WP; KELLY, JF; BRIGG, JK			ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY FOR ALL-COMERS	LANCET			English	Article								Laparoscopic cholecystectomy is a safe and effective procedure in specialist centres, but its wider application will depend on the ability of general surgeons to become skilled in this technique. 180 patients underwent elective laparoscopic cholecystectomy during a nine-month period at a single district general hospital. All patients who would have been eligible for elective open cholecystectomy were offered the laparoscopic alternative. Laparoscopic cholecystectomy was abandoned in favour of an open procedure in 10 (6%) patients. Median operating time was 55 min. 2 patients had serious morbidity (right hepatic duct injury and a duodenal fistula) and there were no deaths. 3 patients required subsequent treatment for retained common duct stones. 90% of patients were discharged within 48 h of the operation and the median time to resume full activity after discharge was 12 days. Laparoscopic cholecystectomy is a safe and cost-effective technique in a district general hospital.	ROYAL LANCASTER INFIRM,DEPT SURG,LANCASTER LA1 4RP,ENGLAND									CUSCHIERI A, 1991, AM J SURG, V161, P385, DOI 10.1016/0002-9610(91)90603-B; DENT TL, 1991, AM J SURG, V161, P399, DOI 10.1016/0002-9610(91)90607-F; GRACE PA, 1991, BRIT J SURG, V78, P160, DOI 10.1002/bjs.1800780209; PATERSONBROWN S, 1991, BRIT J SURG, V78, P131, DOI 10.1002/bjs.1800780203; REDDICK E J, 1989, Surgical Endoscopy, V3, P131, DOI 10.1007/BF00591357; SULLIVAN DM, 1982, AM J SURG, V143, P218, DOI 10.1016/0002-9610(82)90072-1; TODD GJ, 1978, AM J SURG, V135, P622, DOI 10.1016/0002-9610(78)90121-6; 1991, AM J SURG, V161, P324	8	78	79	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					795	797		10.1016/0140-6736(91)90674-E	http://dx.doi.org/10.1016/0140-6736(91)90674-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681169				2022-12-28	WOS:A1991GG97900013
J	HOWARD, NJ; LAING, RO				HOWARD, NJ; LAING, RO			CHANGES IN THE WORLD-HEALTH-ORGANIZATION ESSENTIAL DRUG LIST	LANCET			English	Review								The World Health Organisation Model List of Essential Drugs is an attempt to provide guidelines for selection of essential pharmaceuticals. Analysis of the six lists produced between 1977 and 1990 shows an increase in the number of items from 205 to 268. 120 drugs have been added and 57 deleted; however, only 16 of the additional drugs can be considered new clinical entities or to have new indications. The original purpose of the essential drug list was to itemise the minimum number of essential drugs. Many additions were due to a change in perception about the usefulness of a particular drug, not scientific advances. Nevertheless, the list remains a useful guide for countries selecting their own national lists.	MANAGEMENT SCI HLTH,165 ALLANDALE RD,BOSTON,MA 02130									[Anonymous], 1989, WHO MODEL PRESCRIBIN; 1985, TECHNIAL REPORT SERI, V722; 1990, LANCET, V335, P1003; 1988, TECHNICAL REPORT SER, V770; 1990, WHO MODEL PRESCRIBIN; 1987, 1986 INT WORKSH NORD, P3; 1990, TECHNICAL REPORT SER, V796; 1983, TECHNICAL REPORT SER, V685; 1979, TECHNICAL REPORT SER, V641; 1977, TECHICAL REPORT SERI, V615	10	13	13	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					743	745		10.1016/0140-6736(91)91455-4	http://dx.doi.org/10.1016/0140-6736(91)91455-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679879				2022-12-28	WOS:A1991GG10400016
J	ALVAREZBUYLLA, A; KIRN, JR; NOTTEBOHM, F				ALVAREZBUYLLA, A; KIRN, JR; NOTTEBOHM, F			BIRTH OF PROJECTION NEURONS IN ADULT AVIAN BRAIN MAY BE RELATED TO PERCEPTUAL OR MOTOR LEARNING	SCIENCE			English	Article											ALVAREZBUYLLA, A (corresponding author), ROCKEFELLER UNIV,FIELD RES CTR,TYRREL RD,RR2,BOX 38B,MILLBROOK,NY 12545, USA.			Alvarez-Buylla, Arturo/0000-0003-4426-8925	NIMH NIH HHS [MH18343] Funding Source: Medline; NINDS NIH HHS [NS28478, NS08340] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH018343, R37MH018343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028478, R01NS028478, F32NS008340, R37NS028478] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; ALVAREZBUYLLA A, 1988, P NATL ACAD SCI USA, V85, P8722, DOI 10.1073/pnas.85.22.8722; BAYER SA, 1987, PROG NEUROBIOL, V29, P57, DOI 10.1016/0301-0082(87)90015-3; BOTTJER SW, 1986, NEUROSCI LETT, V67, P263, DOI 10.1016/0304-3940(86)90319-8; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; HINDE RA, 1969, BIRD VOCALIZATIONS, P61; Jacobson M., 2013, DEV NEUROBIOL; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; KIRN JR, 1989, J NEUROSCI, V9, P3176; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; KORDOWER JH, 1990, J COMP NEUROL, V291, P637, DOI 10.1002/cne.902910410; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MCCONNELL SK, 1988, BRAIN RES REV, V13, P1, DOI 10.1016/0165-0173(88)90002-1; NORDEEN EJ, 1990, TRENDS NEUROSCI, V13, P31, DOI 10.1016/0166-2236(90)90060-N; NORDEEN KW, 1988, NATURE, V334, P149, DOI 10.1038/334149a0; NORDEEN KW, 1989, J NEUROBIOL, V20, P651, DOI 10.1002/neu.480200705; NOTTEBOHM F, 1984, CONDOR, V86, P227, DOI 10.2307/1366988; NOTTEBOHM F, 1985, ANN NY ACAD SCI, V457, P143, DOI 10.1111/j.1749-6632.1985.tb20803.x; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1981, BRAIN RES, V213, P99, DOI 10.1016/0006-8993(81)91250-6; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Nottebohm F., 1980, PROGR PSYCHOBIOLOGY, V9, P85; NOTTEBOHM F, IN PRESS PHILOS T B; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; PATON JA, 1985, J NEUROSCI, V5, P3088; REH TA, 1989, J NEUROSCI, V9, P4179; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321	34	223	229	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 21	1990	249	4975					1444	1446		10.1126/science.1698312	http://dx.doi.org/10.1126/science.1698312			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ451	1698312				2022-12-28	WOS:A1990DZ45100049
J	ALBIN, RL; YOUNG, AB; PENNEY, JB; HANDELIN, B; BALFOUR, R; ANDERSON, KD; MARKEL, DS; TOURTELLOTTE, WW; REINER, A				ALBIN, RL; YOUNG, AB; PENNEY, JB; HANDELIN, B; BALFOUR, R; ANDERSON, KD; MARKEL, DS; TOURTELLOTTE, WW; REINER, A			ABNORMALITIES OF STRIATAL PROJECTION NEURONS AND N-METHYL-D-ASPARTATE RECEPTORS IN PRESYMPTOMATIC HUNTINGTONS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									UNIV TENNESSEE,CTR HLTH SCI,DEPT ANAT,MEMPHIS,TN 38163; INTEGRATED GENET INC,FRAMINGHAM,MA; UNIV MICHIGAN,DEPT NEUROL,ANN ARBOR,MI 48109; VET AFFAIRS WADSWORTH MED CTR,NEUROL SERV,LOS ANGELES,CA	University of Tennessee System; University of Tennessee Health Science Center; University of Michigan System; University of Michigan			Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232; Markel, Dorene/0000-0002-3382-6779	NINDS NIH HHS [NS19620, NS17978, NS15655, R01 NS019620] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017978, R01NS019620, P50NS015655, P01NS015655] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALBINRL, IN PRESS ANN NEUROL; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BEAL MF, 1985, BRAIN RES, V361, P135; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BECKSTEAD RM, 1986, NEUROSCIENCE, V19, P147, DOI 10.1016/0306-4522(86)90012-6; BOEGMAN RJ, 1987, BRAIN RES, V415, P178, DOI 10.1016/0006-8993(87)90284-8; Church G M, 1985, Prog Clin Biol Res, V177, P17; COYLE JT, 1976, NATURE, V263, P244, DOI 10.1038/263244a0; DAVIES SW, 1988, NEUROSCIENCE, V26, P387, DOI 10.1016/0306-4522(88)90156-X; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; ELLISON DW, 1987, BRAIN, V110, P1657, DOI 10.1093/brain/110.6.1657; FEGER J, 1984, NEUROSCI LETT, V49, P7, DOI 10.1016/0304-3940(84)90127-7; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1983, PSYCHOL MED, V13, P537, DOI 10.1017/S0033291700047966; FOLSTEIN SE, 1986, NEUROLOGY, V36, P1279, DOI 10.1212/WNL.36.10.1279; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; GRAYBIEL AM, 1979, EXP BRAIN RES, V34, P189; GRAYBIEL AM, 1986, NEUROPEPTIDES NEUROL, P135; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HABER SN, 1983, NEUROSCIENCE, V9, P245, DOI 10.1016/0306-4522(83)90291-9; HEFTER H, 1987, BRAIN, V110, P585, DOI 10.1093/brain/110.3.585; HIRSCH EC, 1989, NEUROSCI LETT, V96, P145, DOI 10.1016/0304-3940(89)90048-7; LAMS BE, 1988, BRAIN RES, V475, P401, DOI 10.1016/0006-8993(88)90635-X; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; McKeever PE, 1987, HISTOCHEMISTRY PATHO, P871; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P535, DOI 10.1056/NEJM198803033180903; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P4186, DOI 10.1093/nar/16.9.4186; OLNEY JW, 1987, BRAIN RES BULL, V19, P597, DOI 10.1016/0361-9230(87)90077-3; OLNEY JW, 1983, EXCITOTOXINS, P82; PARENT A, 1984, BRAIN RES, V303, P385, DOI 10.1016/0006-8993(84)91224-1; PENNEY JB, IN PRESS MOV DISORD; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; ROBERTS RC, 1988, J COMP NEUROL, V274, P406, DOI 10.1002/cne.902740309; Roos RAC, 1986, HDB CLIN NEUROLOGY, V49, P315; SCHOENFELD M, 1984, J NEUROL NEUROSUR PS, V47, P1283, DOI 10.1136/jnnp.47.12.1283; Schwarcz R., 1987, P19; Shoulson I, 1986, DIS NERVOUS SYSTEM, P1258; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WALKER FO, 1984, NEUROLOGY, V34, P1237, DOI 10.1212/WNL.34.9.1237; WASMUTH JJ, 1988, NATURE, P332; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762	46	202	213	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	1990	322	18					1293	1298		10.1056/NEJM199005033221807	http://dx.doi.org/10.1056/NEJM199005033221807			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB069	1691447				2022-12-28	WOS:A1990DB06900007
J	GORANSSON, M; SONDEN, B; NILSSON, P; DAGBERG, B; FORSMAN, K; EMANUELSSON, K; UHLIN, BE				GORANSSON, M; SONDEN, B; NILSSON, P; DAGBERG, B; FORSMAN, K; EMANUELSSON, K; UHLIN, BE			TRANSCRIPTIONAL SILENCING AND THERMOREGULATION OF GENE-EXPRESSION IN ESCHERICHIA-COLI	NATURE			English	Article									UMEA UNIV,DEPT MICROBIOL,S-90187 UMEA,SWEDEN	Umea University			Uhlin, Bernt Eric/AAO-6292-2021	Uhlin, Bernt Eric/0000-0002-2991-8072				BAGA M, 1985, EMBO J, V4, P3887, DOI 10.1002/j.1460-2075.1985.tb04162.x; BAGA M, 1988, CELL, V52, P197, DOI 10.1016/0092-8674(88)90508-9; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CUKIERKA.R, 1972, P NATL ACAD SCI USA, V69, P3643, DOI 10.1073/pnas.69.12.3643; DEFEZ R, 1981, GENETICS, V97, P11; DIDERICHSEN B, 1980, MOL GEN GENET, V180, P425, DOI 10.1007/BF00425858; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; ECHOLS H, 1986, SCIENCE, V233, P1050, DOI 10.1126/science.2943018; FALCONI M, 1988, MOL MICROBIOL, V2, P323, DOI 10.1111/j.1365-2958.1988.tb00035.x; FORSMAN K, 1989, EMBO J, V8, P1271, DOI 10.1002/j.1460-2075.1989.tb03501.x; GORANSSON M, 1984, EMBO J, V3, P2885, DOI 10.1002/j.1460-2075.1984.tb02225.x; GORANSSON M, 1989, MOL MICROBIOL, V3, P1557, DOI 10.1111/j.1365-2958.1989.tb00141.x; GORANSSON M, 1989, GENE DEV, V3, P123, DOI 10.1101/gad.3.1.123; HIGGINS CF, 1988, CELL, V52, P569, DOI 10.1016/0092-8674(88)90470-9; HROMOCKYJ AE, 1989, J BACTERIOL, V171, P2879, DOI 10.1128/jb.171.5.2879-2881.1989; HUISMAN O, 1989, J BACTERIOL, V171, P3704, DOI 10.1128/jb.171.7.3704-3712.1989; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; LAINE B, 1984, BIOCHEM BIOPH RES CO, V119, P1147, DOI 10.1016/0006-291X(84)90895-7; LUPSKI JR, 1984, MOL GEN GENET, V195, P391, DOI 10.1007/BF00341439; Maniatis T., 1982, MOL CLONING; PON CL, 1988, MOL GEN GENET, V212, P199, DOI 10.1007/BF00334684; PRUSS GJ, 1989, CELL, V56, P521, DOI 10.1016/0092-8674(89)90574-6; RAIBAUD O, 1989, MOL MICROBIOL, V3, P455; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; SPEARS PA, 1986, J BACTERIOL, V168, P179, DOI 10.1128/jb.168.1.179-185.1986; STOKER NG, 1982, GENE, V18, P335, DOI 10.1016/0378-1119(82)90172-X; TRAVERS A, 1974, FEBS LETT, V43, P86, DOI 10.1016/0014-5793(74)81111-7; TRAVERS A, 1989, NATURE, V341, P184, DOI 10.1038/341184a0; VARSHAVSKY AJ, 1977, NUCLEIC ACIDS RES, V4, P2725, DOI 10.1093/nar/4.8.2725; WADA M, 1988, J MOL BIOL, V204, P581, DOI 10.1016/0022-2836(88)90357-9	30	268	269	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 12	1990	344	6267					682	685		10.1038/344682a0	http://dx.doi.org/10.1038/344682a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY719	1691451				2022-12-28	WOS:A1990CY71900094
J	HERSCHLAG, D; CECH, TR				HERSCHLAG, D; CECH, TR			DNA CLEAVAGE CATALYZED BY THE RIBOZYME FROM TETRAHYMENA	NATURE			English	Article									UNIV COLORADO,HOWARD HUGHES MED INST,DEPT CHEM & BIOCHEM,BOULDER,CO 80309	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder								ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; ARNOTT S, 1986, J MOL BIOL, V188, P631, DOI 10.1016/S0022-2836(86)80011-0; BARFOD ET, 1989, MOL CELL BIOL, V9, P3657, DOI 10.1128/MCB.9.9.3657; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; CHOU SH, 1989, BIOCHEMISTRY-US, V28, P2435, DOI 10.1021/bi00432a014; CRAIG ME, 1971, J MOL BIOL, V62, P383, DOI 10.1016/0022-2836(71)90434-7; DAVIES RW, 1982, NATURE, V300, P719, DOI 10.1038/300719a0; DOUDNA JA, 1989, P NATL ACAD SCI USA, V86, P7402, DOI 10.1073/pnas.86.19.7402; DUJON B, 1989, GENE, V82, P91, DOI 10.1016/0378-1119(89)90034-6; Fersht A, 1985, ENZYME STRUCTURE MEC, P104; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HAAKE PC, 1961, J AM CHEM SOC, V83, P1102, DOI 10.1021/ja01466a025; JENCKS WP, 1987, COLD SPRING HARB SYM, V52, P65, DOI 10.1101/SQB.1987.052.01.010; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; KIRBY AJ, 1970, J CHEM SOC B, P1165, DOI 10.1039/j29700001165; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; KUMAMOTO J, 1956, J AM CHEM SOC, V78, P4858, DOI 10.1021/ja01600a012; LOWARY P, 1986, NATO ASI SER A, V110, P69; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MURPHY FL, 1989, P NATL ACAD SCI USA, V86, P9218, DOI 10.1073/pnas.86.23.9218; NELSON JW, 1982, BIOCHEMISTRY-US, V21, P5289, DOI 10.1021/bi00264a026; PARDI A, 1981, BIOCHEMISTRY-US, V20, P3986, DOI 10.1021/bi00517a007; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; RAY WJ, 1976, BIOCHEMISTRY-US, V15, P3993, DOI 10.1021/bi00663a014; SAENGER W, 1984, PRINCIPLES NUCLEIC A, P277; SUGIMOTO N, 1989, NUCLEIC ACIDS RES, V17, P355, DOI 10.1093/nar/17.1.355; Uchida T., 1971, ENZYMES, V4, P205; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; WALKER GT, 1988, NUCLEIC ACIDS RES, V16, P3091, DOI 10.1093/nar/16.7.3091; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; WOODSON SA, 1989, CELL, V57, P335, DOI 10.1016/0092-8674(89)90971-9; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; ZAUG AJ, 1983, NATURE, V301, P578, DOI 10.1038/301578a0; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008	39	122	132	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 29	1990	344	6265					405	409		10.1038/344405a0	http://dx.doi.org/10.1038/344405a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW478	1690858				2022-12-28	WOS:A1990CW47800054
J	WINDLE, JJ; ALBERT, DM; OBRIEN, JM; MARCUS, DM; DISTECHE, CM; BERNARDS, R; MELLON, PL				WINDLE, JJ; ALBERT, DM; OBRIEN, JM; MARCUS, DM; DISTECHE, CM; BERNARDS, R; MELLON, PL			RETINOBLASTOMA IN TRANSGENIC MICE	NATURE			English	Article									SALK INST BIOL STUDIES,REGULATORY BIOL LAB,10010 N TORREY PINES RD,LA JOLLA,CA 92037; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,HOWE LAB OPHTHALMOL,BOSTON,MA 02114; UNIV WASHINGTON,SCH MED,DEPT PATHOL,SEATTLE,WA 98195; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,CTR CANC,BOSTON,MA 02129	Salk Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Massachusetts General Hospital				Bernards, Rene/0000-0001-8677-3423; Windle, Jolene/0000-0001-6690-385X	NICHD NIH HHS [R01 HD020377] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020377] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERT DM, 1978, JPN J OPHTHALMOL, V22, P358; BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; BOTTERI FM, 1987, MOL CELL BIOL, V7, P3178, DOI 10.1128/MCB.7.9.3178; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EFRAT S, 1987, EMBO J, V6, P2699, DOI 10.1002/j.1460-2075.1987.tb02562.x; Flexner S, 1891, B J HOPKINS HOSP, V15, P115; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HOGAN B, 1986, MANIPULATING MOUSE E; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P461, DOI 10.1007/BF01534896; Jenkins N A, 1989, Important Adv Oncol, P61; KIVELA T, 1987, ANTIGENIC PROPERTIES, P51; KYRITSIS AP, 1984, NATURE, V307, P471, DOI 10.1038/307471a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; Maniatis T., 1982, MOL CLONING; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; STONE JC, 1989, GENOMICS, V5, P70, DOI 10.1016/0888-7543(89)90088-8; TALMADGE K, 1984, NATURE, V307, P37, DOI 10.1038/307037a0; TEDDER TF, 1988, J IMMUNOL, V141, P4388; TOOZE J, 1981, MOL BIOL TUMOR VIR 2; Ts'o M O, 1970, Am J Ophthalmol, V69, P339; Ts'o M O, 1970, Am J Ophthalmol, V69, P350; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WINTERSTEINER H, 1887, NEUROEPITHELIOMA RET; Wright JH, 1910, J EXP MED, V12, P556, DOI 10.1084/jem.12.4.556	35	203	213	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 15	1990	343	6259					665	669		10.1038/343665a0	http://dx.doi.org/10.1038/343665a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN989	1689463	Green Submitted			2022-12-28	WOS:A1990CN98900072
J	ROBERTS, GW; GENTLEMAN, SM; LYNCH, A; GRAHAM, DI				ROBERTS, GW; GENTLEMAN, SM; LYNCH, A; GRAHAM, DI			BETA-A4 AMYLOID PROTEIN DEPOSITION IN BRAIN AFTER HEAD TRAUMA	LANCET			English	Note								Previous reports have suggested that both repetitive head trauma and a single injury can be associated with the presence of diffuse beta-A4 amyloid protein plaques in long-term survivors. We have studied sixteen patients (aged 10-63 years) who sustained head injury and survived for only 6-18 days. Immunostaining with an antibody to beta-A4 amyloid showed extensive deposits of the protein in the cortex in six of the sixteen patients (38%). Thus, severe head injury can trigger beta-A4 deposition in the brain within days.	SO GEN HOSP,INST NEUROL SCI,DEPT NEUROPATHOL,GLASGOW G51 4TF,SCOTLAND	University of Glasgow	ROBERTS, GW (corresponding author), IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT ANAT,LONDON,ENGLAND.							ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; GENTLEMAN SM, 1989, HISTOCHEMISTRY, V92, P355, DOI 10.1007/BF00500553; GRAHAM DI, 1990, SYSTEMIC PATHOLOGY, V4, P125; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; VANDUIJN CM, 1991, INT J EPIDEMIOL, V20, pS4, DOI 10.1093/ije/20.Supplement_2.S4; 1990, LANCET, V335, P886; 1990, ALZHEIMERS DISEASE Y	10	409	419	1	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1422	1423		10.1016/0140-6736(91)92724-G	http://dx.doi.org/10.1016/0140-6736(91)92724-G			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683421				2022-12-28	WOS:A1991GT90400005
J	VITA, A; GARBARINI, M; GIOBBIO, GM; MORGANTI, C; DIECI, M				VITA, A; GARBARINI, M; GIOBBIO, GM; MORGANTI, C; DIECI, M			PROGNOSTIC VALUE OF VENTRICULAR ENLARGEMENT IN ACUTE SCHIZOPHRENIFORM DISORDER	LANCET			English	Letter											VITA, A (corresponding author), UNIV MILAN,POLICLIN PAD GUARDIA 2,INST PSYCHIAT,I-20122 MILAN,ITALY.		Vita, Antonio/K-4345-2018	Vita, Antonio/0000-0002-3621-6394; Dieci, Massimiliano/0000-0002-9605-0162				ANDREASEN NC, 1988, SCIENCE, V239, P1381, DOI 10.1126/science.3279509; JOHNSTONE EC, 1976, LANCET, V2, P924; SYNEK V, 1976, BRIT J RADIOL, V49, P233, DOI 10.1259/0007-1285-49-579-233; WEINBERGER DR, 1982, ARCH GEN PSYCHIAT, V39, P778	4	8	8	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1458	1458		10.1016/0140-6736(91)92758-T	http://dx.doi.org/10.1016/0140-6736(91)92758-T			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT904	1683441				2022-12-28	WOS:A1991GT90400036
J	HEDMAN, K; VAHERI, A; BRUMMERKORVENKONTIO, M				HEDMAN, K; VAHERI, A; BRUMMERKORVENKONTIO, M			RAPID DIAGNOSIS OF HANTAVIRUS DISEASE WITH AN IGG-AVIDITY ASSAY	LANCET			English	Article							NEPHROPATHIA EPIDEMICA; HEMORRHAGIC-FEVER; IMMUNOGLOBULIN-M; RENAL SYNDROME; INFECTION; ANTIBODY	Nephropathia epidemica (NE), due to Puumala virus, is endemic in eastern Europe and Scandinavia. Serodiagnosis of NE relies on conventional indirect immunofluorescence to detect IgG against Puumala virus. However, in conventional serology, most patients with acute NE have raised but stable non-diagnostic antibody titres. For better serodiagnosis of NE, we have developed a test that measures the avidity (functional affinity) of IgG antibodies against Puumala virus. This new assay was highly specific and sensitive; a diagnosis of NE could be confirmed or excluded rapidly from an early single serum sample. With this test we have now verified the diagnosis of NE in more than 1300 Finnish patients during 22 months in 1989-91. Our findings point to an incidence of confirmed hantavirus disease much higher than previously shown.			HEDMAN, K (corresponding author), UNIV HELSINKI, DEPT VIROL, HAARTMANINKATU 3, SF-00290 HELSINKI 29, FINLAND.		Vaheri, Antti/AAV-1523-2020; Hedman, Klaus/D-5379-2009					[Anonymous], 1990, LANCET, V336, P407; ANTONIADIS A, 1989, REV INFECT DIS, V11, pS891; AVSICZUPANC T, 1989, ACTA VIROL, V33, P327; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; BRUMMERKORVENKONTIO M, 1982, SCAND J INFECT DIS, P88; DESTRIHOU CV, 1989, Q J MED, V73, P941; HEDMAN K, 1989, J INFECT DIS, V159, P736, DOI 10.1093/infdis/159.4.736; KANGRO HO, 1991, J MED VIROL, V33, P100, DOI 10.1002/jmv.1890330207; LEE HW, 1989, PROG MED VIROL, V36, P62; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LEE HW, 1989, REV INFECT DIS, V11, pS864; LEE PW, 1985, J CLIN MICROBIOL, V22, P940, DOI 10.1128/JCM.22.6.940-944.1985; NIKLASSON B, 1988, J CLIN MICROBIOL, V26, P1519, DOI 10.1128/JCM.26.8.1519-1523.1988; OSTERHAUS ADME, 1989, LANCET, V2, P338; PILASKI J, 1991, LANCET, V337, P111, DOI 10.1016/0140-6736(91)90765-H; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; SETTERGREN B, 1987, J CLIN MICROBIOL, V25, P1134, DOI 10.1128/JCM.25.6.1134-1136.1987; SETTERGREN B, 1989, REV INFECT DIS, V11, P921; THOMAS HIJ, 1991, MED VIROL, V1, P41; YANAGIHARA R, 1990, REV INFECT DIS, V12, P449; ZOLLER L, 1991, LANCET, V338, P183, DOI 10.1016/0140-6736(91)90169-P	22	145	149	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	1991	338	8779					1353	1356		10.1016/0140-6736(91)92235-T	http://dx.doi.org/10.1016/0140-6736(91)92235-T			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682736				2022-12-28	WOS:A1991GR77300003
J	BRADY, AJB; CRAKE, T; OAKLEY, CM				BRADY, AJB; CRAKE, T; OAKLEY, CM			PERCUTANEOUS CATHETER FRAGMENTATION AND DISTAL DISPERSION OF PROXIMAL PULMONARY EMBOLUS	LANCET			English	Article								Rapid restoration of pulmonary blood flow is important in preventing death due to a massive pulmonary embolus. Devices developed specifically for percutaneous transvenous removal of pulmonary emboli are bulky and their insertion through a cut down or by the use of a large venous sheath Gan lead to bleeding at the entry site. ln 3 patients with acute massive pulmonary embolism, conventional cardiac catheters were used to break up the embolus and disperse the fragments distally. Cardiac output was rapidly restored in all patients. There were no serious complications. This technique requires no more specialist equipment or skill than those needed for temporary cardiac pacing and could be important for the emergency management of patients with acute severe pulmonary embolism.	HAMMERSMITH HOSP,DEPT MED,DIV CARDIOL,LONDON W12 0HS,ENGLAND	Imperial College London								ALLISON DJ, 1986, DIAGNOSTIC RADIOLOGY, P2121; COON WW, 1959, SURG GYNECOL OBSTET, V109, P259; COPE C, 1986, RADIOLOGY, V161, P553, DOI 10.1148/radiology.161.2.3763933; DALEN JE, 1990, HEART, P1205; DONALDSON GA, 1963, NEW ENGL J MED, V268, P171, DOI 10.1056/NEJM196301242680402; DOTTER CT, 1981, SEMIN ROENTGENOL, V16, P7, DOI 10.1016/0037-198X(81)90015-8; Feltrin G, 1980, Radiol Med, V66, P793; GOLDHABER SZ, 1988, HEART DISEASE, P1577; GREENFIELD LJ, 1974, ANN SURG, V180, P461, DOI 10.1097/00000658-197410000-00011; HALL RJC, 1989, DISEASES HEART, P1293; 1980, ANN INTERN MED, V93, P141	11	105	108	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1186	1189		10.1016/0140-6736(91)92042-Z	http://dx.doi.org/10.1016/0140-6736(91)92042-Z			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682601				2022-12-28	WOS:A1991GP03400014
J	SALTZ, BL; WOERNER, MG; KANE, JM; LIEBERMAN, JA; ALVIR, JMJ; BERGMANN, KJ; BLANK, K; KOBLENZER, J; KAHANER, K				SALTZ, BL; WOERNER, MG; KANE, JM; LIEBERMAN, JA; ALVIR, JMJ; BERGMANN, KJ; BLANK, K; KOBLENZER, J; KAHANER, K			PROSPECTIVE-STUDY OF TARDIVE-DYSKINESIA INCIDENCE IN THE ELDERLY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE; MOVEMENTS; AGE	Objectives. - To investigate the incidence of tardive dyskinesia in elderly individuals beginning treatment with antipsychotic drugs and to identify risk factors for the development of tardive dyskinesia in the elderly. Design. - A cohort of previously neuroleptic-naive patients was identified at the time of initiation of antipsychotic drug treatment. Patients were evaluated at baseline and followed up at 3-month intervals for periods ranging from 3 to 119 weeks. Setting. - Subjects were recruited from the psychiatric and geriatric medical services of two medical centers, a geriatric institute, and three nursing homes in the metropolitan area of New York City, NY. Patients. - Two hundred fifteen individuals older than 55 years have entered the study thus far. Preliminary data are presented for 160 patients who were followed up for at least 1 month. Their age range was 57 to 99 years (mean, 77 years). Seventy-two percent were women and 87% were white. Sixty-seven percent of patients had a diagnosis of organic mental syndrome and 42% had a psychiatric diagnosis. Interventions. - A naturalistic, longitudinal, repeated assessment paradigm was employed. Assessments included abnormal involuntary movements, extrapyramidal signs, psychiatric symptoms, and medical and drug treatment histories. Main Outcome Measure. - The incidence of tardive dyskinesia was determined using a standardized rating instrument and survival analysis. Results. - The incidence of neuroleptic-induced dyskinesia was 31% (95% confidence interval, 20%, 42%) after 43 weeks of cumulative neuroleptic treatment. Psychiatric (as opposed to organic) diagnosis and presence of extrapyramidal signs early in treatment were associated with increased tardive dyskinesia vulnerability.	LONG ISL JEWISH MED CTR,DEPT NEUROL,NEW HYDE PK,NY 11042; PARKER JEWISH GERIATR CTR,NEW HYDE PK,NY; YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461; BETH ISRAEL MED CTR,DEPT PSYCHIAT,NEW YORK,NY 10003	Northwell Health; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center	SALTZ, BL (corresponding author), LONG ISL JEWISH MED CTR,HILLSIDE HOSP,DEPT PSYCHIAT,BOX 38,GLEN OAKS,NY 11004, USA.		Lieberman, Jeffrey/AAY-8239-2020		NIMH NIH HHS [MH-41960, MH-40015, MH-32369] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH032369, P50MH041960, P30MH041960, R01MH040015, R01MH032369] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARNES TRE, 1983, J NEUROL NEUROSUR PS, V46, P540, DOI 10.1136/jnnp.46.6.540; BENEDETTI J, 1985, BMDP STATISTICAL SOF, P557; BOURGEOIS M, 1980, J NERV MENT DIS, V168, P177, DOI 10.1097/00005053-198003000-00009; BRANDON S, 1971, BRIT J PSYCHIAT, V118, P171, DOI 10.1192/bjp.118.543.171; CASEY DE, 1985, J CLIN PSYCHIAT, V46, P42; CHACKO RC, 1985, J CLIN PSYCHIAT, V46, P55; CRANE GE, 1974, ARCH GEN PSYCHIAT, V30, P314; DEGKWITZ R, 1969, PSYCHOTROPIC SIGNS D; DELWAIDE PJ, 1977, ACTA NEUROL SCAND, V56, P256; FINCH CE, 1973, BRAIN RES, V52, P261, DOI 10.1016/0006-8993(73)90663-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GARDOS G, 1983, TARDIVE DYSKINESIA A; GUY W, 1976, ADM76338 NAT I MENT; HOPKINS A, 1985, BMDP STATISTICAL SOF, P576; JESTE DV, 1982, UNDERSTANDING TREATI; JONES M, 1969, PSYCHOTROPIC DRUGS D, P53; KANE JM, 1982, ARCH GEN PSYCHIAT, V39, P473; KANE JM, 1982, PSYCHOPHARMACOLOGY, V77, P105, DOI 10.1007/BF00431929; KANE JM, 1986, DRUG DEVELOP RES, P41; KARSON CN, 1990, AM J PSYCHIAT, V147, P1646; LIEBERMAN J, 1984, PSYCHOPHARMACOL BULL, V20, P382; PRIEN RF, 1973, J AM GERIATR SOC, V21, P546; RABINS P, 1984, COMPR PSYCHIAT, V25, P290, DOI 10.1016/0010-440X(84)90060-9; RASKIND M, 1979, J AM GERIATR SOC, V27, P459, DOI 10.1111/j.1532-5415.1979.tb01727.x; SALZMAN C, 1987, PSYCHOPHARMACOLOGY 3, P1167; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11; SIMPSON GM, 1979, PSYCHOPHARMACOLOGY, V64, P171, DOI 10.1007/BF00496058; SIRIS SG, 1982, ELECTROCONVULSIVE TH; SMITH JM, 1980, ARCH GEN PSYCHIAT, V37, P1368; SPIKER DG, 1985, AM J PSYCHIAT, V142, P430; TOENNIESSEN LM, 1985, ARCH GEN PSYCHIAT, V42, P278; UHRBRAND I, 1960, PSYCHOPHARMACOLOGIA, V1, P408; WOERNER MG, 1988, PSYCHOPHARMACOL BULL, V24, P112; WOERNER MG, 1991, J CLIN PSYCHOPHARM, V11, P34; YASSA R, 1985, PSYCHOSOMATICS, V26, P305, DOI 10.1016/S0033-3182(85)72863-0; 1987, DIAGNOSTIC STATISTIC	37	150	150	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	1991	266	17					2402	2406						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM790	1681122				2022-12-28	WOS:A1991GM79000027
J	FOWLER, MS; MASON, AJS; RICHARDSON, A; STEIN, JF				FOWLER, MS; MASON, AJS; RICHARDSON, A; STEIN, JF			YELLOW SPECTACLES TO IMPROVE VISION IN CHILDREN WITH BINOCULAR AMBLYOPIA	LANCET			English	Note							DYSLEXIC-CHILDREN	Yellow spectacles were given to 20 children who had binocular amblyopia. Immediately, their vision improved. Furthermore, in the younger children, after they had worn the yellow lenses for up to nine months, this improvement persisted even when they were not wearing the spectacles. Yellow filters may help these children with binocular amblyopia because they remove the blue fringes that are due to chromatic aberration of the eye.	UNIV OXFORD,PHYSIOL LAB,PARKS RD,OXFORD OX1 3PT,ENGLAND; ROYAL BERKSHIRE HOSP,READING RG1 5AN,BERKS,ENGLAND	University of Oxford; Royal Berkshire Hospital								CAMPBELL FW, 1967, J PHYSIOL-LONDON, V192, P345, DOI 10.1113/jphysiol.1967.sp008304; Fitzgerald A, 1989, AUST ORTHOPTIC J, V25, P10; KELLY SA, 1990, J OPT SOC AM A, V7, P1905, DOI 10.1364/JOSAA.7.001905; KINNEY JAS, 1983, AM J OPTOM PHYS OPT, V60, P132; MOLLON JD, 1982, ANNU REV PSYCHOL, V33, P41, DOI 10.1146/annurev.ps.33.020182.000353; STEIN J, 1985, LANCET, V2, P69; STEIN JF, 1988, BRIT J OPHTHALMOL, V72, P162, DOI 10.1136/bjo.72.3.162; WILLIAMS DR, 1981, VISION RES, V21, P1341, DOI 10.1016/0042-6989(81)90241-8; YAP M, 1984, OPHTHAL PHYSL OPT, V4, P227, DOI 10.1111/j.1475-1313.1984.tb00360.x	9	11	11	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1109	1110		10.1016/0140-6736(91)91966-X	http://dx.doi.org/10.1016/0140-6736(91)91966-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682545				2022-12-28	WOS:A1991GM78400006
J	WOLBERGER, C; VERSHON, AK; LIU, BS; JOHNSON, AD; PABO, CO				WOLBERGER, C; VERSHON, AK; LIU, BS; JOHNSON, AD; PABO, CO			CRYSTAL-STRUCTURE OF A MAT ALPHA-2 HOMEODOMAIN-OPERATOR COMPLEX SUGGESTS A GENERAL-MODEL FOR HOMEODOMAIN-DNA INTERACTIONS	CELL			English	Article							BINDING SPECIFICITY; REPRESSOR; RESOLUTION; YEAST; PROTEINS; SPECTROSCOPY; RECOGNITION; DIFFRACTION; DODECAMER; SEQUENCE	The MAT-alpha-2 homeodomain regulates the expression of cell type-specific genes in yeast. We have determined the 2.7 angstrom resolution crystal structure of the alpha-2 homeodomain bound to a biologically relevant DNA sequence. The DNA in this complex is contacted primarily by the third of three alpha-helices, with additional contacts coming from an N-terminal arm. Comparison of the yeast alpha-2 and the Drosophila engrailed homeodomain-DNA complexes shows that the protein fold is highly conserved, despite a 3-residue insertion in alpha-2 and only 27% sequence identity between the two homeodomains. Moreover, the orientation of the recognition helix on the DNA is also conserved. This docking arrangement is maintained by side chain contacts with the DNA-primarily the sugar-phosphate backbone- that are identical in alpha-2 and engrailed. Since these residues are conserved among all homeodomains, we propose that the contacts with the DNA are also conserved and suggest a general model for homeodomain-DNA interactions.	JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco				Wolberger, Cynthia/0000-0001-8578-2969	NIGMS NIH HHS [GM31471, GM37049-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM031471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, X PLOR V2 1 MANUAL; DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0; DIGABRIELE AD, 1989, P NATL ACAD SCI USA, V86, P1816, DOI 10.1073/pnas.86.6.1816; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; HANES SD, 1991, SCIENCE, V251, P426, DOI 10.1126/science.1671176; HARRISON SC, 1990, ANNU REV BIOCHEM, V59, P933, DOI 10.1146/annurev.bi.59.070190.004441; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; MONDRAGON A, 1991, J MOL BIOL, V219, P321, DOI 10.1016/0022-2836(91)90568-Q; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; PABO CO, 1990, SCIENCE, V247, P1210, DOI 10.1126/science.2315694; PERCIVALSMITH A, 1990, EMBO J, V9, P3967, DOI 10.1002/j.1460-2075.1990.tb07617.x; PHILLIPS CL, 1991, GENE DEV, V5, P764, DOI 10.1101/gad.5.5.764; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; SHERIFF S, 1987, ACTA CRYSTALLOGR A, V43, P118, DOI 10.1107/S010876738709977X; STRATHERN J, 1988, GENETICS, V120, P75; TREACY MN, 1991, NATURE, V350, P577, DOI 10.1038/350577a0; TREISMAN J, 1989, CELL, V59, P553; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WOLBERGER C, 1991, J MOL BIOL, V217, P11, DOI 10.1016/0022-2836(91)90605-6	31	482	493	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 1	1991	67	3					517	528		10.1016/0092-8674(91)90526-5	http://dx.doi.org/10.1016/0092-8674(91)90526-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GN664	1682054	hybrid			2022-12-28	WOS:A1991GN66400008
J	NUDESHIMA, J				NUDESHIMA, J			OBSTACLES TO BRAIN-DEATH AND ORGAN-TRANSPLANTATION IN JAPAN	LANCET			English	Editorial Material											NUDESHIMA, J (corresponding author), MITSUBISHI KASEI INST LIFE SCI,LIFE SCI & SOC PROGRAMME,11 MINAMIOOYA,MACHIDA,TOKYO 194,JAPAN.							LOCK M, 1990, SOCIAL SCI PERSPECTI, P99; MANNINEN DL, 1985, JAMA-J AM MED ASSOC, V253, P3111, DOI 10.1001/jama.253.21.3111; PETERS TG, 1991, JAMA-J AM MED ASSOC, V265, P1302, DOI 10.1001/jama.265.10.1302; Yanagita Kunio, 1970, OUR ANCESTORS JAPANE; 1981, DEFINING DEATH	5	29	29	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1063	1064		10.1016/0140-6736(91)91912-E	http://dx.doi.org/10.1016/0140-6736(91)91912-E			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681367				2022-12-28	WOS:A1991GM25300015
J	DAMIAN, D; TATTERSALL, MHN				DAMIAN, D; TATTERSALL, MHN			LETTERS TO PATIENTS - IMPROVING COMMUNICATION IN CANCER CARE	LANCET			English	Article							INFORMATION	Numerous studies have shown that patients are usually dissatisfied with the information they receive during clinical consultations with medical specialists. Therefore, a randomised study design has been used to assess the role of personal letters to patients outlining their cancer consultation. Compared with the control group, patients receiving letters were more satisfied with the amount of information given, and tended to have greater and more accurate recall of the consultation. A survey of referring doctors revealed general support for the idea of sending to cancer patients letters that outline the substance of their consultations. The study shows that letters to patients are a useful method of improving patient satisfaction and recall in clinical consultations. They also provide a permanent record of the consultation, which can be kept for future reference, and encourage greater patient involvement in their care.	UNIV SYDNEY, DEPT CANC MED, BLACKBURN BLDG, SYDNEY, NSW 2006, AUSTRALIA; ROYAL PRINCE ALFRED HOSP, DEPT MED ONCOL, CAMPERDOWN, NSW 2050, AUSTRALIA	University of Sydney; University of Sydney								CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; ELLIS DA, 1979, BRIT MED J, V1, P456, DOI 10.1136/bmj.1.6161.456; GEORGE CF, 1983, BRIT MED J, V287, P1193, DOI 10.1136/bmj.287.6400.1193; HOGBIN B, 1989, BRIT J HOSP MED, V41, P330; Ley P., 1988, COMMUNICATING PATIEN; LUNN D, 1988, SPIDA USERS MANUAL; REYNOLDS PM, 1981, BRIT MED J, V282, P1449, DOI 10.1136/bmj.282.6274.1449; TATTERSALL R, 1990, DIABETIC MED, V7, P917, DOI 10.1111/j.1464-5491.1990.tb01330.x; TATTERSALL RB, 1989, LANCET, V2, P280; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269	10	100	101	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	1991	338	8772					923	925		10.1016/0140-6736(91)91782-P	http://dx.doi.org/10.1016/0140-6736(91)91782-P			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681275				2022-12-28	WOS:A1991GJ89900013
J	YOKOUCHI, Y; SASAKI, H; KUROIWA, A				YOKOUCHI, Y; SASAKI, H; KUROIWA, A			HOMEOBOX GENE-EXPRESSION CORRELATED WITH THE BIFURCATION PROCESS OF LIMB CARTILAGE DEVELOPMENT	NATURE			English	Article							RETINOIC ACID; MORPHOGENESIS; CELLS	THE complex architecture of the limb cartilage pattern probably develops by the sequential segmentation and branching process of precartilaginous cell condensation under the control of positional signalling 1,2 provided by the zone of polarizing activity (anteroposterior) 3,4 and the apical ectodermal ridge (proximodistal) 5. This signalling is monitored and interpreted in the mesenchymal cells and induces the position-specific response of subsets of genes. Homeobox genes may be responsible for the interpretation of signalling 6-11. A correlation between limb pattern and expression domains of the homeobox genes in the upstream region of Hox/Chox-4 has been proposed 10-12. We have analysed the spatial expression pattern of the Chox-1 genes during development of chick limb buds. In contrast to genes in Hox/Chox-4 expressed coordinately along the anteroposterior axis 10,11, homeobox genes in Chox-1 have unique and mutually exclusive expression domains along the proximodistal axis. We report here that the expression domains of the Chox-1 genes are closely related to the segmental structure of cartilage along the proximodistal axis, whereas the expression domains of the Chox-4 genes are related to the cartilage branching pattern.	TOHOKU UNIV,TB & CANC RES INST,DEPT CELL BIOL,4-1 SEIRYOMACHI,AOBA KU,SENDAI,MIYAGI 980,JAPAN; TOHOKU UNIV,FAC SCI,INST BIOL,AOBA KU,SENDAI,MIYAGI 980,JAPAN	Tohoku University; Tohoku University				Sasaki, Hiroshi/0000-0001-8752-6846; Kuroiwa, Atsushi/0000-0001-7710-4041				ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; AULTHOUSE AL, 1987, DEV BIOL, V120, P377, DOI 10.1016/0012-1606(87)90240-5; CRAWFORD K, 1988, DEVELOPMENT, V104, P703; DOLLE P, 1989, EMBO J, V8, P1507, DOI 10.1002/j.1460-2075.1989.tb03535.x; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; NARDI JB, 1983, DIFFERENTIATION, V25, P27; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; OLIVER G, 1989, GENE DEV, V3, P641, DOI 10.1101/gad.3.5.641; OLIVER G, 1990, EMBO J, V9, P3093, DOI 10.1002/j.1460-2075.1990.tb07506.x; OSTER GF, 1988, EVOLUTION, V42, P862, DOI 10.1111/j.1558-5646.1988.tb02508.x; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SHUBIN NH, 1986, EVOL BIOL, V20, P319; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; YOKOUCHI Y, IN PRESS DEVELOPMENT, V113	20	295	298	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 3	1991	353	6343					443	445		10.1038/353443a0	http://dx.doi.org/10.1038/353443a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH606	1680221				2022-12-28	WOS:A1991GH60600061
J	TWYCROSS, RG				TWYCROSS, RG			ASSISTED DEATH - A REPLY	LANCET			English	Editorial Material											TWYCROSS, RG (corresponding author), SIR MICHAEL SOBELL HOUSE, CHURCHILL HOUSE, OXFORD OX3 7LJ, ENGLAND.							ANGELL M, 1988, NEW ENGL J MED, V319, P1348, DOI 10.1056/NEJM198811173192010; DRAIN G, 1990, LANCET, V2, P610; FENIGSEN R, 1989, HASTINGS CENT REP, V19, pS22; GAYLIN W, 1988, JAMA-J AM MED ASSOC, V259, P2139; RAGLAN, 1972, CONTACT, V39, P9; Roy D J, 1990, J Palliat Care, V6, P3	6	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	1990	336	8718					796	798		10.1016/0140-6736(90)93253-L	http://dx.doi.org/10.1016/0140-6736(90)93253-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1698235				2022-12-28	WOS:A1990EB07700016
J	HOPWOOD, ND; GURDON, JB				HOPWOOD, ND; GURDON, JB			ACTIVATION OF MUSCLE GENES WITHOUT MYOGENESIS BY ECTOPIC EXPRESSION OF MYOD IN FROG EMBRYO CELLS	NATURE			English	Article											HOPWOOD, ND (corresponding author), DEPT ZOOL,CANC RES CAMPAIGN,MOLEC EMBRYOL GRP,DOWNING ST,CAMBRIDGE CB2 3EJ,ENGLAND.			GURDON, JOHN/0000-0002-5621-3799; Hopwood, Nick/0000-0001-7069-7497				ALTABA AR, 1989, CELL, V57, P317, DOI 10.1016/0092-8674(89)90969-0; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Gurdon J.B., 1977, Methods Cell Biol, V16, P125; HARVEY RP, 1988, CELL, V53, P687, DOI 10.1016/0092-8674(88)90087-6; HOPWOOD ND, 1989, EMBO J, V8, P3409, DOI 10.1002/j.1460-2075.1989.tb08505.x; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; KINTNER C, 1988, NEURON, V1, P545, DOI 10.1016/0896-6273(88)90104-3; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LIN ZY, 1989, GENE DEV, V3, P986, DOI 10.1101/gad.3.7.986; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; MOHUN TJ, 1989, EMBO J, V8, P1153, DOI 10.1002/j.1460-2075.1989.tb03486.x; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NIEUWKOOP P D, 1969, Wilhelm Roux' Archiv fuer Entwicklungsmechanik der Organismen, V162, P341, DOI 10.1007/BF00578701; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SUDARWAT.S, 1971, ROUX ARCH DEV BIOL, V166, P189, DOI 10.1007/BF00650029; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434	27	114	114	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 13	1990	347	6289					197	200		10.1038/347197a0	http://dx.doi.org/10.1038/347197a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY352	1697650				2022-12-28	WOS:A1990DY35200068
J	YATANI, A; OKABE, K; CODINA, J; BIRNBAUMER, L; BROWN, AM				YATANI, A; OKABE, K; CODINA, J; BIRNBAUMER, L; BROWN, AM			HEART-RATE REGULATION BY G-PROTEINS ACTING ON THE CARDIAC-PACEMAKER CHANNEL	SCIENCE			English	Article									BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor University	YATANI, A (corresponding author), BAYLOR UNIV,DEPT MOLEC PHYSIOL & BIOPHYS,HOUSTON,TX 77030, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019318, R37DK019318] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36930, HL39262] Funding Source: Medline; NIDDK NIH HHS [DK19318] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKAIKE N, 1986, J PHYSIOL-LONDON, V379, P7; BERNE RM, 1988, PHYSIOLOGY, P451; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; BUXTON ILO, 1985, J BIOL CHEM, V260, P6733; CARRIER GO, 1972, J PHARMACOL EXP THER, V180, P31; CODINA J, 1983, P NATL ACAD SCI-BIOL, V80, P4276, DOI 10.1073/pnas.80.14.4276; CODINA J, 1984, J BIOL CHEM, V259, P5871; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1987, PFLUG ARCH EUR J PHY, V410, P139, DOI 10.1007/BF00581906; DIFRANCESCO D, 1988, J PHYSIOL-LONDON, V405, P493, DOI 10.1113/jphysiol.1988.sp017344; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; GILES W, 1986, CARDIAC MUSCLE REGUL, P1; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOHL CM, 1987, BIOCHIM BIOPHYS ACTA, V921, P356, DOI 10.1016/0005-2760(87)90037-3; KARDON MB, 1975, CIRC RES, V37, P41, DOI 10.1161/01.RES.37.1.41; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; KURACHI Y, 1989, NATURE, V337, P555, DOI 10.1038/337555a0; Levy M., 1979, HDB PHYSL SECT 2 CAR, P581; MATTERA R, 1989, J BIOL CHEM, V264, P465; NAKAYAMA T, 1984, PFLUG ARCH EUR J PHY, V402, P248, DOI 10.1007/BF00585507; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; NIEDERGERKE R, 1977, PROC R SOC SER B-BIO, V197, P333, DOI 10.1098/rspb.1977.0074; NOMA A, 1980, PFLUG ARCH EUR J PHY, V388, P1, DOI 10.1007/BF00582621; OKABE K, IN PRESS J BIOL CHEM; POWELL T, 1976, BIOCHEM BIOPH RES CO, V72, P1218, DOI 10.1016/S0006-291X(76)80260-4; SCHERER NM, 1987, ARCH BIOCHEM BIOPHYS, V259, P431, DOI 10.1016/0003-9861(87)90509-1; VANDONGEN AMJ, 1988, SCIENCE, V242, P1433, DOI 10.1126/science.3144040; YATANI A, 1990, AM J PHYSIOL, V258, pH1947, DOI 10.1152/ajpheart.1990.258.6.H1947; YATANI A, 1990, AM J PHYSIOL, V258, pH1507, DOI 10.1152/ajpheart.1990.258.5.H1507; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YATANI A, 1989, SCIENCE, V245, P71, DOI 10.1126/science.2544999	33	101	101	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 7	1990	249	4973					1163	1166		10.1126/science.1697697	http://dx.doi.org/10.1126/science.1697697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX399	1697697				2022-12-28	WOS:A1990DX39900035
J	OTA, K; MATSUI, M; MILFORD, EL; MACKIN, GA; WEINER, HL; HAFLER, DA				OTA, K; MATSUI, M; MILFORD, EL; MACKIN, GA; WEINER, HL; HAFLER, DA			T-CELL RECOGNITION OF AN IMMUNODOMINANT MYELIN BASIC-PROTEIN EPITOPE IN MULTIPLE-SCLEROSIS	NATURE			English	Article									BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,DIV NEUROL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,TISSUE TYPING LAB,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School								ALLEGRETTA M, 1990, SCIENCE, V247, P718, DOI 10.1126/science.1689076; Alvord EC, 1984, EXPT ALLERGIC ENCEPH; ANTEL JP, 1979, ANN NEUROL, V5, P338, DOI 10.1002/ana.410050406; BACEVANIS CN, 1989, J NEUROIMMUN, V22, P23; BRINKMAN CJJ, 1981, ANN NEUROL, V11, P450; BROD SA, 1990, CELL IMMUNOL, V125, P426, DOI 10.1016/0008-8749(90)90096-A; CHOFFLON M, 1988, ANN NEUROL, V24, P185, DOI 10.1002/ana.410240203; CHOU FCH, 1976, J BIOL CHEM, V251, P2671; Dupont B, 1989, IMMUNOBIOLOGY HLA, V1st; ELIAN M, 1987, DIS MARKERS, V5, P89; FRANCIS DA, 1986, LANCET, V1, P211; HAFLER DA, 1987, J IMMUNOL, V139, P68; HAFLER DA, 1989, IMMUNOL TODAY, V10, P104, DOI 10.1016/0167-5699(89)90236-3; HAPP MP, 1988, J IMMUNOL, V141, P1489; HO HZ, 1981, IMMUNOGENETICS, V15, P509; JOHNSON D, 1986, J NEUROIMMUNOL, V13, P99, DOI 10.1016/0165-5728(86)90053-6; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; OFFNER H, 1989, J EXP MED, V170, P355, DOI 10.1084/jem.170.2.355; SAKAI K, 1988, J NEUROIMMUNOL, V19, P21, DOI 10.1016/0165-5728(88)90032-X; SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128; SPIELMAN RS, 1982, EPIDEMIOL REV, V4, P45, DOI 10.1093/oxfordjournals.epirev.a036251; VANDENBARK AA, 1985, J IMMUNOL, V135, P229; WAKSMAN BH, 1954, J EXP MED, V100, P451, DOI 10.1084/jem.100.5.451; YOSHIMURA T, 1985, J NEUROL SCI, V69, P47, DOI 10.1016/0022-510X(85)90006-1; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	25	782	826	2	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 12	1990	346	6280					183	187		10.1038/346183a0	http://dx.doi.org/10.1038/346183a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN424	1694970				2022-12-28	WOS:A1990DN42400064
J	STARZL, TE; FUNG, J; JORDAN, M; SHAPIRO, R; TZAKIS, A; MCCAULEY, J; JOHNSTON, J; IWAKI, Y; JAIN, A; ALESSIANI, M; TODO, S				STARZL, TE; FUNG, J; JORDAN, M; SHAPIRO, R; TZAKIS, A; MCCAULEY, J; JOHNSTON, J; IWAKI, Y; JAIN, A; ALESSIANI, M; TODO, S			KIDNEY-TRANSPLANTATION UNDER FK-506	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV PITTSBURGH,CTR HLTH,DEPT MED,PITTSBURGH,PA 15213; UNIV PITTSBURGH,CTR HLTH,DEPT PATHOL,PITTSBURGH,PA 15213; UNIV PITTSBURGH,VET ADM MED CTR,PITTSBURGH,PA 15260	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	STARZL, TE (corresponding author), UNIV PITTSBURGH,CTR HLTH,DEPT SURG,FALK CLIN,3601 5TH AVE,PITTSBURGH,PA 15213, USA.		Alessiani, Mario/AAC-3281-2019; FUNG, John Julian/A-2679-2012	Alessiani, Mario/0000-0003-2660-5780; FUNG, John Julian/0000-0002-3038-0441	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK029961, R01DK029961] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 29961, R01 DK029961-19] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALEJANDRO R, 1989, DIABETES, V38, P698, DOI 10.2337/diabetes.38.6.698; BALLANTYNE CM, 1989, JAMA-J AM MED ASSOC, V262, P53, DOI 10.1001/jama.262.1.53; CARROLL PB, IN PRESS TRANSPLANTA; ENGFELDT P, 1986, TRANSPLANT P, V18, P65; FALK JA, 1985, TRANSPLANT P, V17, P1530; FARID NR, 1979, DIABETES, V28, P552, DOI 10.2337/diabetes.28.6.552; FUNG J, 1987, TRANSPLANT P, V19, P767; FUNG JJ, 1987, NEPHRON, V46, P19, DOI 10.1159/000184431; FUNG JJ, 1990, TRANSPLANT P, V22, P6; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; IWAKI Y, 1987, TRANSPLANT P, V19, P764; IWAKI Y, 1988, CLIN TRANSPLANT, V2, P81; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; KERMAN RH, 1990, TRANSPLANTATION, V49, P52, DOI 10.1097/00007890-199001000-00011; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; KINO T, 1987, J ANTIBIOT, V40, P1249, DOI 10.7164/antibiotics.40.1249; LIN HY, 1989, NEW ENGL J MED, V321, P287, DOI 10.1056/NEJM198908033210504; MCCAULEY J, 1989, LANCET, V2, P1516; MCCAULEY J, 1990, LANCET, V335, P674, DOI 10.1016/0140-6736(90)90471-G; MCCAULEY J, 1990, TRANSPLANT P, V22, P17; MIELES L, 1990, TRANSPLANT P, V22, P41; NALESNIK MA, 1987, TRANSPLANT P, V19, P89; NALESNIK MA, 1990, TRANSPLANT P, V22, P87; RUIZ JO, 1973, SURGERY, V73, P759; SAWADA S, 1987, J IMMUNOL, V139, P1797; SHAPIRO R, 1990, TRANSPLANT P, V22, P35; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SOLOW H, 1979, DIABETES, V28, P1, DOI 10.2337/diabetes.28.1.1; STARZL TE, 1989, LANCET, V2, P1000; STARZL TE, IN PRESS TRANSPLANTA; STARZL TE, 1964, EXPERIENCE RENAL TRA, P177; STEGALL MD, 1989, TRANSPLANTATION, V48, P944, DOI 10.1097/00007890-198912000-00009; TAMURA K, 1987, TRANSPLANT P, V19, P23; TAYLOR CJ, 1989, TRANSPLANTATION, V48, P953, DOI 10.1097/00007890-198912000-00011; TODO S, 1987, TRANSPLANT P, V19, P57; TODO S, 1990, TRANSPLANT P, V22, P13; TODO S, 1988, SURGERY, V104, P239; TZAKIS A, 1988, TRANSPLANT P, V20, P92; TZE WJ, IN PRESS TRANSPLANTA; VANTHIEL DH, 1990, TRANSPLANT P, V22, P37; YAGISAWA T, 1986, TRANSPLANT P, V18, P1543; ZEEVI A, 1987, TRANSPLANT P, V19, P40	42	234	243	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	1990	264	1					63	67		10.1001/jama.264.1.63	http://dx.doi.org/10.1001/jama.264.1.63			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL320	1693970	Green Accepted			2022-12-28	WOS:A1990DL32000026
J	PEDERSEN, C; SANDSTROM, E; PETERSEN, CS; NORKRANS, G; GERSTOFT, J; KARLSSON, A; CHRISTENSEN, KC; HAKANSSON, C; PEHRSON, P; NIELSEN, JO; JURGENSEN, HJ				PEDERSEN, C; SANDSTROM, E; PETERSEN, CS; NORKRANS, G; GERSTOFT, J; KARLSSON, A; CHRISTENSEN, KC; HAKANSSON, C; PEHRSON, P; NIELSEN, JO; JURGENSEN, HJ			THE EFFICACY OF INOSINE PRANOBEX IN PREVENTING THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									ROSAGSTULLS HOSP,DEPT INFECT DIS,STOCKHOLM,SWEDEN; LEO PHARMACEUT PROD,BALLERUP,DENMARK; SODER SJUKHUSET,DEPT DERMATOVENEREOL,S-10064 STOCKHOLM,SWEDEN; BISPEBJERG HOSP,DEPT DERMATOVENEREOL,DK-2400 COPENHAGEN,DENMARK; OSTRA HOSP,DEPT INFECT DIS,S-41685 GOTHENBURG,SWEDEN; RIGSHOSP,DEPT INFECT DIS,DK-2100 COPENHAGEN,DENMARK; SAHLGRENS UNIV HOSP,DEPT DERMATOVENEREOL,S-41345 GOTHENBURG,SWEDEN	Sodersjukhuset Hospital; University of Copenhagen; Bispebjerg Hospital; Sahlgrenska University Hospital; Rigshospitalet; University of Copenhagen; Sahlgrenska University Hospital	PEDERSEN, C (corresponding author), UNIV COPENHAGEN,HVIDOVRE HOSP,DEPT INFECT DIS,144,DK-2650 HVIDOVRE,DENMARK.							BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BATISTA J, 1977, APPL STAT, V26, P214; BEKESI JG, 1987, J CLIN LAB IMMUNOL, V24, P155; BINDERUP L, 1985, INT J IMMUNOPHARMACO, V7, P93, DOI 10.1016/0192-0561(85)90014-1; CHAN K, 1988, J CHROMATOGR-BIOMED, V426, P103, DOI 10.1016/S0378-4347(00)81931-3; CHESON BD, 1987, JAMA-J AM MED ASSOC, V258, P1347, DOI 10.1001/jama.258.10.1347; CRUMPACKER C, 1987, ANN INTERN MED, V107, P664, DOI 10.7326/0003-4819-107-5-664; EXON JH, 1986, INT J IMMUNOPHARMACO, V8, P53, DOI 10.1016/0192-0561(86)90073-1; FISCHBACH M, 1985, CLIN EXP IMMUNOL, V61, P242; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GLASKY AJ, 1986, METHOD FIND EXP CLIN, V8, P35; GOEDERT JJ, 1987, JAMA-J AM MED ASSOC, V257, P331, DOI 10.1001/jama.257.3.331; HESSOL NA, 1988, 4TH P INT C AIDS STO; JONES CE, 1982, LANCET, V1, P1034; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KROON S, 1990, 2ND EUR C CLIN ASP H; MANN JM, 1988, J ACQ IMMUN DEF SYND, V1, P209; MEHTA CR, 1983, J AM STAT ASSOC, V78, P427, DOI 10.2307/2288652; MOSS AR, 1989, AIDS, V3, P55, DOI 10.1097/00002030-198902000-00001; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; POMPIDOU A, 1985, LANCET, V2, P1423; POMPIDOU A, 1985, CANCER RES, V45, P4671; REDFIELD RR, 1986, NEW ENGL J MED, V314, P131, DOI 10.1056/NEJM198601093140232; SCHINAZI RF, 1988, ANTIMICROB AGENTS CH, V32, P1784, DOI 10.1128/AAC.32.12.1784; TAYLOR J, 1986, BLOOD, V67, P666; TAYLOR JMG, 1986, J INFECT DIS, V154, P694, DOI 10.1093/infdis/154.4.694; TSANG PH, 1987, CLIN IMMUNOL IMMUNOP, V45, P166, DOI 10.1016/0090-1229(87)90031-6; TSANG PH, 1986, J CLIN LAB IMMUNOL, V20, P159; WALLACE JI, 1986, CLIN IMMUNOL IMMUNOP, V39, P179, DOI 10.1016/0090-1229(86)90218-7; WIRANOWSKASTEWART M, 1986, INT J IMMUNOPHARMACO, V8, P63, DOI 10.1016/0192-0561(86)90074-3; 1987, MMWR S1S, V36, pS1; 1986, ANN INTERN MED, V205, P234; 1989, LANCET, V1, P415; 1988, J ACQUIR IMMUNE DEFI, V1, P111; 1985, MMWR, V34, P373	36	69	71	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	1990	322	25					1757	1763		10.1056/NEJM199006213222501	http://dx.doi.org/10.1056/NEJM199006213222501			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ232	1693173				2022-12-28	WOS:A1990DJ23200001
J	GARSTIN, IWH; COOPER, GG; HOOD, JM				GARSTIN, IWH; COOPER, GG; HOOD, JM			ARTERIAL THROMBOSIS AFTER TREATMENT WITH BLEOMYCIN AND CISPLATIN	BRITISH MEDICAL JOURNAL			English	Letter											GARSTIN, IWH (corresponding author), ROYAL VICTORIA HOSP,VASC SURG UNIT,BELFAST BT12 6BA,NORTH IRELAND.							BODENSTEINER DC, 1981, SOUTHERN MED J, V74, P898, DOI 10.1097/00007611-198107000-00036; DOLL DC, 1986, J CLIN ONCOL, V4, P1405, DOI 10.1200/JCO.1986.4.9.1405; DOLL DC, 1986, ANN INTERN MED, V105, P48, DOI 10.7326/0003-4819-105-1-48; NICOLSON GL, 1985, CANCER RES, V45, P331; VOGELZANG NJ, 1981, ANN INTERN MED, V95, P288, DOI 10.7326/0003-4819-95-3-288; VOGELZANG NJ, 1985, CANCER, V56, P2765, DOI 10.1002/1097-0142(19851215)56:12<2765::AID-CNCR2820561208>3.0.CO;2-2	6	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 14	1990	300	6730					1018	1018		10.1136/bmj.300.6730.1018-a	http://dx.doi.org/10.1136/bmj.300.6730.1018-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ489	1693094	Bronze, Green Published			2022-12-28	WOS:A1990CZ48900051
J	MYSLINSKI, E; SEGAULT, V; BRANLANT, C				MYSLINSKI, E; SEGAULT, V; BRANLANT, C			AN INTRON IN THE GENES FOR U3 SMALL NUCLEOLAR RNAS OF THE YEAST SACCHAROMYCES-CEREVISIAE	SCIENCE			English	Article									UNIV NANCY 1,CNRS,URA 457,ENZYMOL & GENIE GENET LAB,BP 239,F-54506 VANDOEUVRE NANCY,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine				Branlant, Christiane/0000-0003-4728-5499				BRANLANT C, 1982, EMBO J, V1, P1259, DOI 10.1002/j.1460-2075.1982.tb00022.x; BRINGMANN P, 1983, EMBO J, V2, P1129, DOI 10.1002/j.1460-2075.1983.tb01557.x; BROW DA, 1989, NATURE, V337, P14, DOI 10.1038/337014a0; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; CALVET JP, 1981, CELL, V26, P363, DOI 10.1016/0092-8674(81)90205-1; CARBON P, 1987, CELL, V51, P71, DOI 10.1016/0092-8674(87)90011-0; CHEVALLIER MR, 1980, GENE, V11, P11, DOI 10.1016/0378-1119(80)90082-7; CHOI TSR, 1976, BIOCHEMISTRY-US, V15, P3823; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERBI SA, 1987, COLD SPRING HARB SYM, V52, P709, DOI 10.1101/SQB.1987.052.01.080; HUGHES JMX, 1987, EMBO J, V6, P2145, DOI 10.1002/j.1460-2075.1987.tb02482.x; KROL A, 1983, NUCLEIC ACIDS RES, V11, P8583, DOI 10.1093/nar/11.24.8583; LACROUTE F, 1968, J BACTERIOL, V95, P824, DOI 10.1128/JB.95.3.824-832.1968; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; MYSLINSKI E, UNPUB; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; Parker R, 1987, MOL BIOL RNA NEW PER, P133; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; PORTER GL, 1988, NUCLEIC ACIDS RES, V16, P10131, DOI 10.1093/nar/16.21.10131; QU LH, 1983, NUCLEIC ACIDS RES, V11, P5903, DOI 10.1093/nar/11.17.5903; RIEDEL N, 1986, P NATL ACAD SCI USA, V83, P8097, DOI 10.1073/pnas.83.21.8097; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEGAULT V, UNPUB; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; STROKE IL, 1985, J MOL BIOL, V184, P183, DOI 10.1016/0022-2836(85)90372-9; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; SUH D, 1986, BIOCHEM BIOPH RES CO, V137, P1133, DOI 10.1016/0006-291X(86)90343-8; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; TEEM JL, 1984, NUCLEIC ACIDS RES, V12, P8295, DOI 10.1093/nar/12.22.8295; WATTS FZ, 1983, EMBO J, V2, P2085, DOI 10.1002/j.1460-2075.1983.tb01704.x; WISE JA, 1980, CELL, V22, P109, DOI 10.1016/0092-8674(80)90159-2	31	83	85	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 9	1990	247	4947					1213	1216		10.1126/science.1690452	http://dx.doi.org/10.1126/science.1690452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT096	1690452				2022-12-28	WOS:A1990CT09600040
J	ELLIS, C; MORAN, M; MCCORMICK, F; PAWSON, T				ELLIS, C; MORAN, M; MCCORMICK, F; PAWSON, T			PHOSPHORYLATION OF GAP AND GAP-ASSOCIATED PROTEINS BY TRANSFORMING AND MITOGENIC TYROSINE KINASES	NATURE			English	Article									MT SINAI HOSP, RES INST, DIV MOLEC & DEV BIOL, 600 UNIV AVE, TORONTO M5G 1X5, ONTARIO, CANADA; CETUS CORP, DEPT MOLEC BIOL, EMERYVILLE, CA 94608 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute			Pawson, Tony J/E-4578-2013					COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; DEGUNZBURG J, 1989, P NATL ACAD SCI USA, V86, P4007; JOHNSON RM, 1989, SCIENCE, V246, P121, DOI 10.1126/science.2506643; KAMPS MP, 1988, ONCOGENE, V2, P305; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KOCH CA, 1989, MOL CELL BIOL, V9, P4131, DOI 10.1128/MCB.9.10.4131; LETWIN K, 1988, ONCOGENE, V3, P621; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; PAWSON T, 1988, ONCOGENE, V3, P491; RAYMOND VW, 1987, VIROLOGY, V160, P400, DOI 10.1016/0042-6822(87)90011-0; SADOWSKI I, 1987, ONCOGENE, V1, P181; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VERDERAME MF, 1989, J VIROL, V63, P338, DOI 10.1128/JVI.63.1.338-348.1989; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WANG HCR, 1989, J VIROL, V63, P291, DOI 10.1128/JVI.63.1.291-302.1989	25	744	762	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	1990	343	6256					377	381		10.1038/343377a0	http://dx.doi.org/10.1038/343377a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK918	1689011	Green Submitted			2022-12-28	WOS:A1990CK91800065
J	RIA, F; CHAN, BMC; SCHERER, MT; SMITH, JA; GEFTER, ML				RIA, F; CHAN, BMC; SCHERER, MT; SMITH, JA; GEFTER, ML			IMMUNOLOGICAL ACTIVITY OF COVALENTLY LINKED T-CELL EPITOPES	NATURE			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,DEPT PATHOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			Di Sante, Gabriele/N-5280-2018; Ria, Francesco/AAD-1174-2022	Di Sante, Gabriele/0000-0001-6608-3388; Ria, Francesco/0000-0001-7455-4290				ADORINI L, 1988, NATURE, V334, P623, DOI 10.1038/334623a0; ALLEN PM, 1985, J IMMUNOL, V135, P368; GAMMON G, 1986, NATURE, V319, P413, DOI 10.1038/319413a0; GUILLET JG, 1986, NATURE, V324, P260, DOI 10.1038/324260a0; GUILLET JG, 1987, SCIENCE, V235, P865, DOI 10.1126/science.2433769; KUISAKI J, 1986, EUR J IMMUNOL, V16, P236; LAI MZ, 1987, J IMMUNOL, V139, P3973; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; MARKMANN J, 1988, NATURE, V336, P476, DOI 10.1038/336476a0; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; QUILL H, 1987, J IMMUNOL, V138, P3704; ROY S, 1989, SCIENCE, V244, P572, DOI 10.1126/science.2470147; SAUER RT, 1978, BIOCHEMISTRY-US, V17, P1092, DOI 10.1021/bi00599a024; SCHAEFFER EB, 1989, P NATL ACAD SCI USA, V86, P4649, DOI 10.1073/pnas.86.12.4649; SETTE A, 1987, NATURE, V328, P395, DOI 10.1038/328395a0; SHASTRI N, 1986, J IMMUNOL, V136, P371; SHIMONKEWITZ R, 1974, J IMMUNOL, V133, P2067; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5	18	105	109	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 25	1990	343	6256					381	383		10.1038/343381a0	http://dx.doi.org/10.1038/343381a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK918	1689012				2022-12-28	WOS:A1990CK91800066
J	MITCHELL, MJ; WOODS, DR; TUCKER, PK; OPP, JS; BISHOP, CE				MITCHELL, MJ; WOODS, DR; TUCKER, PK; OPP, JS; BISHOP, CE			HOMOLOGY OF A CANDIDATE SPERMATOGENIC GENE FROM THE MOUSE Y-CHROMOSOME TO THE UBIQUITIN-ACTIVATING ENZYME-E1	NATURE			English	Article							SEX-DETERMINING REGION; L-CELL DEFECT; INSITU HYBRIDIZATION; DNA-REPLICATION; MICE; LOCALIZATION; EXPRESSION; ANTIGEN; DIFFERENTIATION; SEQUENCES	THE Sxr (sex-reversed) region, a fragment of the Y chromosome short arm, can cause chromosomally female XXSxr or XSxrO mice to develop as sterile males 1-3. The original Sxr region, termed Sxr(a), encodes: Tdy, the primary sex-determining gene; Hya, the controlling or structural locus for the minor transplantation antigen H-Y (ref. 4); gene(s) controlling the expression of the serologically detected male antigen (SDMA) 5; Spy, a gene(s) required for the survival and proliferation of A spermatogonia during spermatogenesis 6,7; Zfy-1/Zfy-2, zinc-finger-containing genes of unknown function 8; and Sry, which is probably identical to Tdy (ref. 9). A deletion variant 10 of Sxr(a), termed Sxr(b), which lacks Hya, SDMA expression, Spy and some Zfy-2 sequences, makes positional cloning of these genes possible. We report here the isolation of a new testis-specific gene, Sby, mapping to the DNA deleted from the Sxr(b) region (the DELTA-Sxr(b) interval). Sby has extensive homology to the X-linked human ubiquitin-activating enzyme E1 (ref. 11). The critical role of this enzyme in nuclear DNA replication 12 together with the testis-specific expression of Sby suggests Sby as a candidate for the spermatogenic gene Spy.	INST PASTEUR,INSERM,U276,UNITE IMMUNOGENET HUMAINE,PARIS 15,FRANCE; UNIV MICHIGAN,MUSEUM ZOOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL,ANN ARBOR,MI 48109	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	MITCHELL, MJ (corresponding author), UNIV TENNESSEE,DEPT OBSTET GYNECOL,DIV REPROD GENET,MOLEC GENET RES LAB,MEMPHIS,TN 38105, USA.		Mitchell, Michael/I-3987-2016	Mitchell, Michael/0000-0003-2052-7347				AMAR L C, 1988, Genomics, V2, P220, DOI 10.1016/0888-7543(88)90006-7; AVNER P, 1987, P NATL ACAD SCI USA, V84, P5330, DOI 10.1073/pnas.84.15.5330; BISHOP CE, 1987, DEVELOPMENT, V101, P167; BURGOYNE PS, 1986, NATURE, V320, P170, DOI 10.1038/320170a0; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROHMAN MA, 1990, PCR PROTOCOLS; GOLDBERG EH, IN PRESS J REPROD IM; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HANDLEY PM, 1991, P NATL ACAD SCI USA, V88, P258, DOI 10.1073/pnas.88.1.258; HANDLEY PM, 1991, P NATL ACAD SCI USA, V88, P7456; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HATFIELD PM, 1990, J BIOL CHEM, V265, P15813; MARDON G, 1989, SCIENCE, V243, P78, DOI 10.1126/science.2563173; MAYER A, 1989, J BIOL CHEM, V264, P2060; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; MCLAREN A, 1988, P NATL ACAD SCI USA, V85, P6442, DOI 10.1073/pnas.85.17.6442; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; MITCHELL M, 1989, GENETICS, V121, P803; MITCHELL MJ, IN PRESS GENOMICS; ROBERTS C, 1988, P NATL ACAD SCI USA, V85, P6446, DOI 10.1073/pnas.85.17.6446; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMPSON E, 1984, TRANSPLANTATION, V37, P17, DOI 10.1097/00007890-198401000-00007; SIMPSON EM, 1991, GENOMICS, V11, P601, DOI 10.1016/0888-7543(91)90067-O; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; TUCKER PK, IN PRESS MAMMALIAN G; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932; ZACKSENHAUS E, 1990, CYTOGENET CELL GENET, V53, P20, DOI 10.1159/000132887; ZACKSENHAUS E, 1990, EMBO J, V9, P2923, DOI 10.1002/j.1460-2075.1990.tb07483.x	33	150	156	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 12	1991	354	6353					483	486		10.1038/354483a0	http://dx.doi.org/10.1038/354483a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV078	1684224	Green Published			2022-12-28	WOS:A1991GV07800062
J	SKEGG, K; COX, B				SKEGG, K; COX, B			IMPACT OF PSYCHIATRIC-SERVICES ON PRISON SUICIDE	LANCET			English	Article								Severe restrictions on the transfer of mentally disturbed prisoners to psychiatric hospital were introduced in Auckland in 1983, while policy in other parts of New Zealand was unchanged. Among male prisoners, the suicide rate (per 100 000 man-years) increased from 27.3 in 1973-82 to 178.0 in 1983-87-an increase in relative risk, compared with unconfined men, from 1.6 to 8.2. Auckland accounted for most of this increase, from 37/100 000 man-years in 1973-82 to 549/100 000 in 1983-87. This striking increase in prison suicide rate in Auckland underlines the importance of ready access to psychiatric care for prisoners.	UNIV OTAGO, SCH MED, DEPT PREVENT & SOCIAL MED, DUNEDIN, NEW ZEALAND	University of Otago	SKEGG, K (corresponding author), UNIV OTAGO, SCH MED, DEPT PSYCHOL MED, DUNEDIN, NEW ZEALAND.							BACKETT SA, 1987, BRIT J PSYCHIAT, V151, P218, DOI 10.1192/bjp.151.2.218; BLAND RC, 1990, CAN J PSYCHIAT, V35, P407, DOI 10.1177/070674379003500508; BURTCH BE, 1979, BRIT J PSYCHIAT, V135, P90, DOI 10.1192/bjp.135.1.90a; COX JF, 1988, INT J LAW PSYCHIAT, V11, P391, DOI 10.1016/0160-2527(88)90009-X; DOOLEY E, 1990, BRIT J PSYCHIAT, V156, P40, DOI 10.1192/bjp.156.1.40; HURLEY W, 1989, MED J AUSTRALIA, V151, P188, DOI 10.5694/j.1326-5377.1989.tb115987.x; NIEMI T, 1975, PSYCHIATRIA FENNICA, P267; SALIVE M E, 1989, Journal of the American Medical Association, V262, P365, DOI 10.1001/jama.262.3.365; SKEGG K, 1991, AUST NZ J PSYCHIAT, V25, P181, DOI 10.3109/00048679109077733; 1988, REPORT COMMITTEE INQ; 1990, SUICIDE SELF HARM PR	11	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	1991	338	8780					1436	1438		10.1016/0140-6736(91)92732-H	http://dx.doi.org/10.1016/0140-6736(91)92732-H			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683429				2022-12-28	WOS:A1991GT90400013
J	FAUVEAU, V; STEWART, K; KHAN, SA; CHAKRABORTY, J				FAUVEAU, V; STEWART, K; KHAN, SA; CHAKRABORTY, J			EFFECT ON MORTALITY OF COMMUNITY-BASED MATERNITY-CARE PROGRAM IN RURAL BANGLADESH	LANCET			English	Article							HEALTH-SERVICES PROJECT; MATLAB; IMPACT; MCH	Various community-based interventions have been proposed to improve maternity care, but hardly any studies have reported the effect of these measures on maternal mortality. In this study, the efficacy of a maternity-care programme to reduce maternal mortality has been evaluated in the context of a primary health-care project in rural Bangladesh. Trained midwives were posted in villages, and asked to attend as many home-deliveries as possible, detect and manage obstetric complications at onset, and accompany patients requiring referral for higher-level care to the project central maternity clinic. The effect of the programme was evaluated by comparison of direct obstetric maternal mortality ratios between the programme area and a neighbouring control area without midwives. Random assignment of the intervention was not possible but potentially confounding characteristics, including coverage and use of other health and family planning services, were similar in both areas. Maternal mortality ratios due to obstetric complications were similar in both areas during the 3 years preceding the start of the programme. By contrast, during the following 3 years, the ratio was significantly lower in the programme than in the control area (1.4 vs 3.8 per 1000 live births, p = 0.02). The findings suggest that maternal survival can be improved by the posting of midwives at village level, if they are given proper training, means, supervision, and back-up. The inputs for such a programme to succeed and the constraints of its replication on a large scale should not be underestimated.	LONDON SCH HYG & TROP MED,CTR POPULAT STUDIES,LONDON WC1E 6AZ,ENGLAND; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT INT HLTH,BALTIMORE,MD 21218; INT CTR DIARRHOEAL DIS,MATLAB MCH FP PROJECT,DHAKA 1000,BANGLADESH	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; International Centre for Diarrhoeal Disease Research (ICDDR)								ARMITAGE P, 1971, STATISTICAL METHODS; BHATIA S, 1980, STUD FAMILY PLANN, V11, P202, DOI 10.2307/1966377; CHEN LC, 1983, STUD FAMILY PLANN, V14, P199, DOI 10.2307/1966412; FAUVEAU V, 1988, B WORLD HEALTH ORGAN, V66, P643; FAUVEAU V, 1988, HEALTH POLICY PLANN, V3, P271; FAUVEAU V, 1988, SPECIAL PUBLICATION, V26; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; LAMB WH, 1984, LANCET, V2, P912; MAHLER H, 1987, LANCET, V1, P668; PHILLIPS JF, 1982, STUD FAMILY PLANN, V13, P131, DOI 10.2307/1966283; ROSENFIELD A, 1985, LANCET, V2, P83; RUZICKA LT, 1978, 9 INT CTR DIARRH DIS, V1; [No title captured]	13	99	99	1	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1183	1186		10.1016/0140-6736(91)92041-Y	http://dx.doi.org/10.1016/0140-6736(91)92041-Y			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GP034	1682600				2022-12-28	WOS:A1991GP03400013
J	WILLIAMS, NS; PATEL, J; GEORGE, BD; HALLAN, RI; WATKINS, ES				WILLIAMS, NS; PATEL, J; GEORGE, BD; HALLAN, RI; WATKINS, ES			DEVELOPMENT OF AN ELECTRICALLY STIMULATED NEOANAL SPHINCTER	LANCET			English	Article							FECAL INCONTINENCE; GRACILIS MUSCLE; SKELETAL-MUSCLE; CONSTRUCTION; CONTINENCE	In early surgical attempts to create a neoanal sphincter for patients who are faecally incontinent, skeletal muscle (usually the gracilis) has been transposed around the anal canal. Despite modifications, such as intermittent electrical stimulation, this procedure is likely to fail because the fast-twitch gracilis muscle is incapable of prolonged contraction without fatigue. Long-term electrical stimulation to convert such a muscle to a slow-twitch, fatigue-resistant muscle, though practicable, has yielded inconsistent results. We describe further modifications of this technique. A neoanal sphincter was constructed with an electrically stimulated transposed gracilis muscle in 20 incontinent patients with a deficient anal sphincter, and as part of a reconstruction in 12 patients in whom the anorectum had been excised or was congenitally absent. A totally implanted stimulator was used to convert the muscle from a fast-twitch to a slow-twitch muscle. Other modifications included vascular delay 4-6 weeks before transposition of the muscle, stimulation of the main nerve to the gracilis rather than its peripheral branches, and intermittent higher frequency stimulation. 2-4 of these modifications gave significantly fewer failures than did 0-1. With the new technique, continence has been restored in patients whose only other treatment option was a permanent stoma.	ROYAL LONDON HOSP,NEUROSURG UNIT,LONDON E1 1BB,ENGLAND	Barts Health NHS Trust; Royal London Hospital	WILLIAMS, NS (corresponding author), ROYAL LONDON HOSP,SURG UNIT,LONDON E1 1BB,ENGLAND.							BAETEN C, 1988, DIS COLON RECTUM, V31, P134, DOI 10.1007/BF02562646; CAVINA E, 1987, Italian Journal of Surgical Sciences, V17, P305; HALLAN RI, 1990, BRIT J SURG, V77, P208, DOI 10.1002/bjs.1800770226; PATEL J, 1991, CLIN ANAT, V4, P385; PATEL J, 1991, J ANAT, V176, P270; PICKRELL KL, 1952, ANN SURG, V135, P853, DOI 10.1097/00000658-195206000-00010; SALMONS S, 1981, MUSCLE NERVE, V4, P94, DOI 10.1002/mus.880040204; SIMONSEN SO, 1976, BRIT J SURG, V63, P389; WILLIAMS NS, 1990, DIS COLON RECTUM, V33, P561, DOI 10.1007/BF02052207; WILLIAMS NS, 1989, BRIT J SURG, V76, P1191, DOI 10.1002/bjs.1800761124; WILLIAMS NS, 1990, ANN ROY COLL SURG, V72, P108; WILLIAMS NS, 1991, CLIN MEASUREMENT COL, P109; WOMACK NR, 1988, BRIT J SURG, V75, P48, DOI 10.1002/bjs.1800750118; WONG SKC, 1984, AUST NZ J SURG, V54, P575, DOI 10.1111/j.1445-2197.1984.tb05450.x; YOSHIOKA K, 1988, DIS COLON RECTUM, V31, P767, DOI 10.1007/BF02560102	15	228	243	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1166	1169						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682591				2022-12-28	WOS:A1991GP03400003
J	AKHRAS, F; JACKSON, G				AKHRAS, F; JACKSON, G			EFFICACY OF NIFEDIPINE AND ISOSORBIDE MONONITRATE IN COMBINATION WITH ATENOLOL IN STABLE ANGINA	LANCET			English	Article							ISOSORBIDE-5-MONONITRATE; PECTORIS; THERAPY	Many patients with angina pectoris whose symptoms are not completely controlled by beta-blockers are treated with several types of drugs, but it is not clear whether addition of a calcium-channel antagonist and/or a nitrate confers any advantage over beta-blockade alone. 18 patients receiving atenolol for stable angina pectoris completed a double-blind, randomised, crossover trial of atenolol treatment plus placebo, isosorbide mononitrate, nifedipine, and mononitrate and nifedipine (triple therapy). The patients were assessed subjectively and by treadmill exercise testing and 24 h ambulatory electrocardiographic recordings at the end of each 4-week treatment period. There were no significant differences among the treatment periods in angina attack rates, glyceryl trinitrate consumption, exercise duration to onset of angina or 1 mm ST depression, or duration of symptomless ischaemia. Total exercise duration was longer on atenolol plus mononitrate than on atenolol alone (mean difference 46 [95% confidence interval 18-88] s; p = 0.005), atenolol plus nifedipine (36 [2-71] s; p = 0.04), or triple therapy (28 [6-61] s, not significant). In 12 patients the exercise time was shorter on triple therapy than on atenolol plus mononitrate alone. Although "maximum" antianginal treatment with two or three drugs is commonly accepted, this approach confers no substantial advantage over optimum beta-blockades monotherapy. If a second drug is needed,there is as light advantage in favour of isosorbide mononitrate, but if this is not effective, treatment should be changed rather than added. Many patients with angina pectoris seem to be pharmacologically overtreated.	GUYS HOSP,DEPT CARDIAC,ST THOMAS ST,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust								ABSHAGEN U, 1981, EUR J CLIN PHARMACOL, V19, P423, DOI 10.1007/BF00548586; AKHRAS F, 1985, Z KARDIOL, V74, P16; AKHRAS F, 1989, INT J CARDIOL, V24, P191, DOI 10.1016/0167-5273(89)90304-5; AKHRAS F, 1987, MONONITRATE, V2, P184; DEBUITLEIR M, 1985, AM J CARDIOL, V55, pE15, DOI 10.1016/0002-9149(85)91206-8; GIANELLY RE, 1967, ANN INTERN MED, V67, P1216, DOI 10.7326/0003-4819-67-6-1216; JACKSON G, 1978, BRIT HEART J, V40, P998; NESTO RW, 1985, AM J CARDIOL, V55, pE3, DOI 10.1016/0002-9149(85)91204-4; RUSSEK HI, 1968, AM J CARDIOL, V21, P44, DOI 10.1016/0002-9149(68)90012-X; STEIN G, 1980, 4TH P INT A S AMST, P233; STONE PH, 1980, ANN INTERN MED, V93, P886, DOI 10.7326/0003-4819-93-6-886; TOLINS M, 1984, J AM COLL CARDIOL, V3, P1051, DOI 10.1016/S0735-1097(84)80366-6; TWEDDEL AC, 1980, 4TH P INT AD S AMST, P143; WOLFSON S, 1966, AM J CARDIOL, V18, P345, DOI 10.1016/0002-9149(66)90052-X	14	64	67	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1036	1039		10.1016/0140-6736(91)91900-F	http://dx.doi.org/10.1016/0140-6736(91)91900-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681355				2022-12-28	WOS:A1991GM25300003
J	CLARKE, A				CLARKE, A			IS NONDIRECTIVE GENETIC-COUNSELING POSSIBLE	LANCET			English	Editorial Material											CLARKE, A (corresponding author), UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES.							CLARKE A, 1990, LANCET, V335, P1145, DOI 10.1016/0140-6736(90)91139-2; GAVRILOV DK, 1991, STUDY FREQUENCIES AL; LIPPMAN A, 1991, AM J LAW MED, V17, P15; 1989, REPORT PRENATAL DIAG; 1991, NATURE, V351, P591	5	151	153	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					998	1001		10.1016/0140-6736(91)91849-P	http://dx.doi.org/10.1016/0140-6736(91)91849-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GK974	1681352				2022-12-28	WOS:A1991GK97400014
J	TOMA, E; FOURNIER, S				TOMA, E; FOURNIER, S			ADVERSE REACTIONS TO COTRIMOXAZOLE IN HIV-INFECTION	LANCET			English	Letter							PNEUMOCYSTIS-CARINII PNEUMONIA		HOP HOTEL DIEU,DEPT PHARM,MONTREAL H2W 1T8,QUEBEC,CANADA	Universite de Montreal	TOMA, E (corresponding author), HOP HOTEL DIEU,DIV MICROBIOL & INFECT DIS,MONTREAL H2W 1T8,QUEBEC,CANADA.							BLACK JR, 1991, EUR J CLIN MICROBIOL, V10, P204, DOI 10.1007/BF01964465; MEDINA I, 1990, NEW ENGL J MED, V323, P776, DOI 10.1056/NEJM199009203231202; PERREAULT S, 1986, JUN INT C AIDS PAR; RUF B, 1991, EUR J CLIN MICROBIOL, V10, P207, DOI 10.1007/BF01964466; TOMA E, 1991, EUR J CLIN MICROBIOL, V10, P210, DOI 10.1007/BF01964467; TOMA E, 1989, LANCET, V1, P1046, DOI 10.1016/S0140-6736(89)92446-X; VANDERVEN, 1991, LANCET, V338, P431	7	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					954	954		10.1016/0140-6736(91)91827-H	http://dx.doi.org/10.1016/0140-6736(91)91827-H			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681303				2022-12-28	WOS:A1991GJ89900055
J	PECOUL, B; VARAINE, F; KEITA, M; SOGA, G; DJIBO, A; SOULA, G; ABDOU, A; ETIENNE, J; REY, M				PECOUL, B; VARAINE, F; KEITA, M; SOGA, G; DJIBO, A; SOULA, G; ABDOU, A; ETIENNE, J; REY, M			LONG-ACTING CHLORAMPHENICOL VERSUS INTRAVENOUS AMPICILLIN FOR TREATMENT OF BACTERIAL-MENINGITIS	LANCET			English	Article							DISEASE; AFRICA	In most developing countries, bacterial meningitis (BM) is associated with a high case-fatality rate. The search for a simple, convenient, and inexpensive antibiotic treatment remains a priority. In this study, a non-blinded, multicentre, randomised clinical trial of 528 cases of BM was done in two hospitals in Mali and Niger, between March, 1989, and May, 1990, to see whether a double injection of long-acting chloramphenicol (on admission to hospital and 48 h later) is as effective as a course of intravenous ampicillin (8 days, 4 times a day). The cumulative case-fatality rate on day 4 (principal end-point) among the chloramphenicol (254 patients) and ampicillin (274) groups were, respectively, 28% and 24.5% (relative risk 1.14, 95% confidence interval 0.86-1.52). No outbreak occurred during the study period. The hospital case-fatality rate was 33.1%. Main risk factors for death were associated with clinical condition on admission-ie, altered consciousness, convulsions, or dehydration. The case-fatality rates were 13% (21/161) for Neisseria meningitidis, 36.1% (48/133) for Haemophilus influenzae, and 67% (77/115) for Streptococcus pneumoniae. In a multiple logistic regression model, controlling for the differential distribution of potential risk factors (including bacterial species), there was no difference between treatment groups. Our findings suggest that long-acting chloramphenicol is a useful first-line presumptive treatment for BM in high-incidence countries.	GABRIEL TOURE HOSP,BAMAKO,MALI; NATL HOSP,NIAMEY,NIGER; POINT G HOSP,BAMAKO,MALI		PECOUL, B (corresponding author), EPICTR,8 RUE ST SABIN,F-75011 PARIS,FRANCE.							BLANCKWELDER WC, 1982, CONTROLLED CLIN TRIA, V3, P345; Cisse M F, 1989, Med Trop (Mars), V49, P265; ESSAN GJF, 1973, W AFRICAN J S, V22, P534; GEDDEDAHL TW, 1990, REV INFECT DIS, V12, P359; GLESKMAN RA, 1975, ARCH INTERN MED, V135, P1125; GREENWOOD BM, 1984, REV INFECT DIS, V6, P374; MAR ID, 1979, MED AFR NOIRE, V26, P599; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PELTOLA H, 1989, LANCET, V1, P1282; REY M, 1972, LYON MED, V228, P503; Rey M, 1976, MED MALADIES INFECT, V6, P120; REY M, 1972, LYON MED, V228, P18; SALIOU P., 1977, Medecine Tropicale, V37, P189; SHANN F, 1985, LANCET, V2, P681; WALI SS, 1979, T ROY SOC TROP MED H, V73, P698, DOI 10.1016/0035-9203(79)90024-5; WHITTLE HC, 1973, BMJ-BRIT MED J, V3, P379, DOI 10.1136/bmj.3.5876.379; 1990, WKLY EPIDEMIOL REC, V16, P120	17	54	56	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					862	866		10.1016/0140-6736(91)91511-R	http://dx.doi.org/10.1016/0140-6736(91)91511-R			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681224				2022-12-28	WOS:A1991GH94500013
J	MEISEL, SR; KUTZ, I; DAYAN, KI; PAUZNER, H; CHETBOUN, I; ARBEL, Y; DAVID, D				MEISEL, SR; KUTZ, I; DAYAN, KI; PAUZNER, H; CHETBOUN, I; ARBEL, Y; DAVID, D			EFFECT OF IRAQI MISSILE WAR ON INCIDENCE OF ACUTE MYOCARDIAL-INFARCTION AND SUDDEN-DEATH IN ISRAELI CIVILIANS	LANCET			English	Note							ISCHEMIA	The Iraqi missile attack on Israel provided a unique opportunity to study the effects of fright due to a perceived threat of annihilation on the incidence of acute myocardial infarction (MI) and sudden death among the civilian population. During the first days of the Gulf war we noted a sharp rise in the incidence of acute MI and sudden death in our area compared with five control periods. Patient population in the various study periods did not differ significantly in age, sex ratio, hospital mortality, or proportion of patients in whom the acute event was the first presentation of coronary disease. However, during the first period of the war there were more cases of anterior wall MI and more patients received thrombolytic therapy than during control periods. Despite the continuing missile threat, the incidence of acute MI reverted to normal after the initial phase of the Gulf war.	MEIR HOSP,SAPIR MED CTR,DEPT CARDIOL,IL-44281 KEFAR SAVA,ISRAEL; SAPIR MED CTR,PSYCHIAT SERV,KEFAR SAVA,ISRAEL; SHALVATAH PSYCHIAT HOSP,KEFAR SAVA,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine			Meisel, Simcha/AAH-8985-2021	Meisel, Simcha/0000-0002-2041-2833				DIMSDALE JE, 1980, JAMA-J AM MED ASSOC, V243, P340, DOI 10.1001/jama.243.4.340; Frankenhaeuser M, 1975, EMOTIONS THEIR PARAM; GORDON JB, 1986, CIRCULATION S2, V73, P481; REBECCA G, 1986, CLIN RES, V34, pA338; ROZANSKI A, 1987, AM HEART J, V114, P615, DOI 10.1016/0002-8703(87)90760-5	6	312	319	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					660	661		10.1016/0140-6736(91)91234-L	http://dx.doi.org/10.1016/0140-6736(91)91234-L			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679475				2022-12-28	WOS:A1991GF10500005
J	KYPTA, RM; GOLDBERG, Y; ULUG, ET; COURTNEIDGE, SA				KYPTA, RM; GOLDBERG, Y; ULUG, ET; COURTNEIDGE, SA			ASSOCIATION BETWEEN THE PDGF RECEPTOR AND MEMBERS OF THE SRC FAMILY OF TYROSINE KINASES	CELL			English	Article											KYPTA, RM (corresponding author), EUROPEAN MOLEC BIOL LAB,DIFFERENTIAT PROGRAMME,MEYERHOFSTR 1,W-6900 HEIDELBERG,GERMANY.		Kypta, Robert/F-7699-2011	Kypta, Robert/0000-0002-2389-310X; Goldberg, Yves/0000-0001-7446-8595				BISHAYEE S, 1988, MOL CELL BIOL, V8, P3696, DOI 10.1128/MCB.8.9.3696; BOLEN JB, 1989, TRENDS BIOCHEM SCI, V14, P404, DOI 10.1016/0968-0004(89)90288-0; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; CLAESSONWELSH L, 1989, J BIOL CHEM, V264, P1742; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COOPER JA, 1989, PEPTIDES PROTEIN PHO; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ESCOBEDO JA, 1988, NATURE, V335, P85, DOI 10.1038/335085a0; FANTL WJ, 1989, MOL CELL BIOL, V9, P4473, DOI 10.1128/MCB.9.10.4473; FUKUI Y, 1989, ONCOGENE RES, V4, P283; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1989, TRENDS GENET, V5, P108, DOI 10.1016/0168-9525(89)90040-1; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KEATING MT, 1988, J BIOL CHEM, V263, P12805; KORNBLUTH S, 1987, NATURE, V325, P171, DOI 10.1038/325171a0; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; KYPTA RM, 1988, EMBO J, V7, P3837, DOI 10.1002/j.1460-2075.1988.tb03269.x; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; PARSONS SJ, 1986, J VIROL, V59, P755, DOI 10.1128/JVI.59.3.755-758.1986; PAWSON T, 1988, ONCOGENE, V3, P491; RALSTON R, 1985, P NATL ACAD SCI USA, V82, P7845, DOI 10.1073/pnas.82.23.7845; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922	40	636	655	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 10	1990	62	3					481	492		10.1016/0092-8674(90)90013-5	http://dx.doi.org/10.1016/0092-8674(90)90013-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1696179				2022-12-28	WOS:A1990DU44500010
J	WEINER, AM; MAIZELS, N				WEINER, AM; MAIZELS, N			RNA EDITING - GUIDED BUT NOT TEMPLATED	CELL			English	Review											WEINER, AM (corresponding author), YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06510, USA.							ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BORST P, 1979, PLASMID, V2, P20, DOI 10.1016/0147-619X(79)90003-9; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; DARNELL JE, 1986, P NATL ACAD SCI USA, V83, P1271, DOI 10.1073/pnas.83.5.1271; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4; LAKE JA, 1988, P NATL ACAD SCI USA, V85, P4779, DOI 10.1073/pnas.85.13.4779; MAHEDRAN R, 1990, IN PRESS CELL, V62; MAIZELS N, 1988, NATURE, V334, P469, DOI 10.1038/334469a0; RAY DS, 1989, MOL CELL BIOL, V9, P1365, DOI 10.1128/MCB.9.3.1365; RYAN KA, 1989, MOL CELL BIOL, V9, P3212, DOI 10.1128/MCB.9.8.3212; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; SILVER LE, 1986, CELL, V47, P537, DOI 10.1016/0092-8674(86)90618-5; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; STURM NR, 1990, CELL, V61, P879, DOI 10.1016/0092-8674(90)90198-N; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M; UNROE D, 1990, IN PRESS MOL CELL BI, V10; WEISSMANN C, 1990, NATURE, V343, P697, DOI 10.1038/343697a0; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; ZWIERZYNSKI TA, 1989, NUCLEIC ACIDS RES, V17, P4647, DOI 10.1093/nar/17.12.4647	29	25	25	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 15	1990	61	6					917	920		10.1016/0092-8674(90)90053-H	http://dx.doi.org/10.1016/0092-8674(90)90053-H			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK145	1693547	hybrid			2022-12-28	WOS:A1990DK14500001
J	BELL, GB; MARINO, AA; CHESSON, AL; STRUVE, FA				BELL, GB; MARINO, AA; CHESSON, AL; STRUVE, FA			HUMAN SENSITIVITY TO WEAK MAGNETIC-FIELDS	LANCET			English	Letter									LOUISIANA STATE UNIV,MED CTR,DEPT MED,SHREVEPORT,LA 71130; LOUISIANA STATE UNIV,MED CTR,DEPT PSYCHIAT,SHREVEPORT,LA 71130	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	BELL, GB (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT ORTHOPAED SURG,SHREVEPORT,LA 71130, USA.							Becker R.O., 1982, ELECTROMAGNETISM LIF; BELL GA, IN PRESS BRAIN RES; BELL GB, 1989, J BIOELECTRICITY, V8, P147, DOI 10.3109/15368378909020953; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; COLEMAN M, 1983, LANCET, V1, P982; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; WRIGHT WE, 1982, LANCET, V2, P160	8	45	47	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1521	1522		10.1016/0140-6736(91)92336-Z	http://dx.doi.org/10.1016/0140-6736(91)92336-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683938				2022-12-28	WOS:A1991GV07700029
J	KOLARS, JC; AWNI, WM; MERION, RM; WATKINS, PB				KOLARS, JC; AWNI, WM; MERION, RM; WATKINS, PB			1ST-PASS METABOLISM OF CYCLOSPORINE BY THE GUT	LANCET			English	Note							HUMAN-LIVER; IDENTIFICATION	Cyclosporin is thought to be exclusively metabolised in the liver. We instilled cyclosporin into the small bowel of 2 patients during the anhepatic phase of liver transplantation; cyclosporin metabolites were readily detected in portal venous blood. Our findings indicate that the small intestine is a major site of cyclosporin breakdown: such intestinal metabolism might help to explain the poor oral bioavailability and drug interactions of cyclosporin.	UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MED CTR, DEPT SURG, ANN ARBOR, MI 48109 USA; HENNEPIN CTY MED CTR, DRUG EVALUAT UNIT, MINNEAPOLIS, MN 55415 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hennepin County Medical Center	WATKINS, PB (corresponding author), UNIV MICHIGAN HOSP, KUGHN CLIN RES CTR, A7119 UNIV HOSP, ANN ARBOR, MI 48109 USA.			Kolars, Joseph/0000-0002-2603-188X				AOYAMA T, 1989, J BIOL CHEM, V264, P10388; AWNI WM, 1988, J CHROMATOGR-BIOMED, V425, P233, DOI 10.1016/0378-4347(88)80027-6; GUPTA SK, 1989, BRIT J CLIN PHARMACO, V27, P475, DOI 10.1111/j.1365-2125.1989.tb05396.x; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; KOLARS JC, IN PRESS TRANSPLANTA; KRONBACH T, 1988, CLIN PHARMACOL THER, V43, P630, DOI 10.1038/clpt.1988.87; LUCEY MR, 1990, LANCET, V335, P11, DOI 10.1016/0140-6736(90)90137-T; PTACHCINSKI RJ, 1986, CLIN PHARMACOKINET, V11, P107, DOI 10.2165/00003088-198611020-00002; WATKINS PB, 1990, SEMIN LIVER DIS, V10, P235, DOI 10.1055/s-2008-1040480; WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156	10	387	404	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	1991	338	8781					1488	1490		10.1016/0140-6736(91)92302-I	http://dx.doi.org/10.1016/0140-6736(91)92302-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683920	Green Submitted			2022-12-28	WOS:A1991GV07700006
J	VANDERLEI, J; MUSEN, MA; VANDERDOES, E; INTVELD, AJM; VANBEMMEL, JH				VANDERLEI, J; MUSEN, MA; VANDERDOES, E; INTVELD, AJM; VANBEMMEL, JH			COMPARISON OF COMPUTER-AIDED AND HUMAN REVIEW OF GENERAL-PRACTITIONERS MANAGEMENT OF HYPERTENSION	LANCET			English	Article							PHYSICIANS; REMINDERS	Computer programs that automatically review decisions can help physicians provide better patient care. In the Netherlands, the ELIAS computer information system has replaced paper medical records in some general practices. We have written a computer program called 'HyperCritic' that audits general practitioners' management of patients with essential hypertension by taking patient-specific data from the ELIAS system. We investigated whether the computer-based medical records contain sufficient information to generate critiques, and compared the limitations of audit by hypercritic with those of review by a panel of eight physicians. Hypercritic and the physicians independently reviewed the medical records of 20 randomly selected patients with hypertension and commented on the decisions made at each of 243 patient visits. Of 468 comments on patient management 260 were judged correct by six or more of the physicians, hypercritic also made 118 of these 260 comments. The main reasons why the program did not produce the other 142 comments were: insufficient data in the computer-based medical record; absence of sufficient medical consensus; and omissions in the database of hypercritic. Calculation of an "index of merit" ([sensitivity + specificity]-1) for individual reviewers showed that hypercritic performed better (index of merit 0.62) in its limited domain than did physician reviewers (0.3-0.56). At least in hypertension management, automated review of computer-based medical records compares favourably with review by physicians. Further development of computer-aided clinical audit requires the introduction of computer-based medical records that capture the reasoning of physicians, and of widely accepted practice guidelines.	ERASMUS UNIV,FAC MED & HLTH SCI,INST PRIMARY CARE,3000 DR ROTTERDAM,NETHERLANDS; ERASMUS UNIV,FAC MED & HLTH SCI,DEPT INTERNAL MED 1,3000 DR ROTTERDAM,NETHERLANDS; STANFORD UNIV,MED CTR,SCH MED,MED INFORMAT SECT,STANFORD,CA 94305	Erasmus University Rotterdam; Erasmus University Rotterdam; Stanford University	VANDERLEI, J (corresponding author), ERASMUS UNIV,FAC MED & HLTH SCI,DEPT MED INFORMAT,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.			Musen, Mark/0000-0003-3325-793X	NATIONAL LIBRARY OF MEDICINE [R29LM005157] Funding Source: NIH RePORTER; NLM NIH HHS [LM05157] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BLOIS MS, 1980, NEW ENGL J MED, V303, P192, DOI 10.1056/NEJM198007243030405; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COOPER G, 1990, ARTIF INTELL MED, V2, P293; DALKEY N, 1969, FUTURES          SEP, P408; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P287, DOI 10.1001/jama.263.2.287; EVANS RS, 1986, JAMA-J AM MED ASSOC, V256, P1007, DOI 10.1001/jama.256.8.1007; Lamberts H., 1987, ICPC INT CLASSIFICAT; MCDONALD CJ, 1988, JAMA-J AM MED ASSOC, V259, P3433, DOI 10.1001/jama.259.23.3433; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MCDONALD CJ, 1984, ANN INTERN MED, V100, P130, DOI 10.7326/0003-4819-100-1-130; MILLER RA, 1990, METHOD INFORM MED, V29, P1; MILLER RA, 1982, NEW ENGL J MED, V307, P468, DOI 10.1056/NEJM198208193070803; SHORTLIFFE EH, 1987, JAMA-J AM MED ASSOC, V258, P61, DOI 10.1001/jama.258.1.61; SHORTLIFFE EH, 1989, METHOD INFORM MED, V28, P1; VANDERLEI J, 1991, COMPUT BIOMED RES, V24, P344, DOI 10.1016/0010-4809(91)90034-T; Weed, 1971, MED RECORDS MED ED P; WESTERHOF HP, 1987, PRESENT STATUS COMPU, P1; YU VL, 1979, JAMA-J AM MED ASSOC, V242, P1279, DOI 10.1001/jama.242.12.1279; [No title captured]; 1984, 26 ROYAL COLL GEN PR	20	40	40	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1504	1508		10.1016/0140-6736(91)92311-O	http://dx.doi.org/10.1016/0140-6736(91)92311-O			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683929				2022-12-28	WOS:A1991GV07700015
J	HUGHES, RAC				HUGHES, RAC			INEFFECTIVENESS OF HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE IN GUILLAIN-BARRE-SYNDROME	LANCET			English	Letter											HUGHES, RAC (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT NEUROL,LONDON SE1 9RT,ENGLAND.							[Anonymous], 1978, Ann Neurol, V3, P565; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; 1986, JAMA-J AM MED ASSOC, V256, P1333	3	39	45	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1142	1142		10.1016/0140-6736(91)91995-7	http://dx.doi.org/10.1016/0140-6736(91)91995-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682558				2022-12-28	WOS:A1991GM78400032
J	HUNT, P; GULISANO, M; COOK, M; SHAM, MH; FAIELLA, A; WILKINSON, D; BONCINELLI, E; KRUMLAUF, R				HUNT, P; GULISANO, M; COOK, M; SHAM, MH; FAIELLA, A; WILKINSON, D; BONCINELLI, E; KRUMLAUF, R			A DISTINCT HOX CODE FOR THE BRANCHIAL REGION OF THE VERTEBRATE HEAD	NATURE			English	Article							HOMEOBOX-CONTAINING GENE; MOUSE HINDBRAIN; EXPRESSION; MURINE; SEGMENTATION; ORGANIZATION; HOX-5.1; HOX-2.6; DOMAINS; HOX-1.5	THE branchial region of the vertebrate head forms through complex interactions involving rhombomeric segments, neural crest and branchial arches 1. It is thought that aspects of their patterning mechanisms are linked 2 and involve Hox-2 genes, whose overlapping and spatially restricted expression domains represent a combinatorial code for generating regional diversity 3-5. Vertebrates possess four Hox clusters of Antennapedia class homeobox genes, related to each other by duplication and divergence from a common ancestral complex 3,6-8. In consequence, at equivalent positions in different clusters there are highly related genes known as subfamilies or paralogous groups. As Hox-2 genes cannot fully account for patterning individual rhombomeres, we investigated whether offsets in expression limits of paralogous genes could account for the generation of regional diversity. We report here that, with the exception of the labial subfamily, paralogues show identical expression limits in rhombomeres, cranial ganglia and branchial arches, providing a combinatorial Hox code for the branchial region that seems to be different in organization to that of the trunk.	NATL INST MED RES, MRC, EUKARYOT MOLEC GENET LAB, RIDGEWAY, LONDON NW7 1AA, ENGLAND; CNR, INT INST GENET & BIOPHYS, NAPLES, ITALY	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)			Krumlauf, Robb/AAH-5012-2019; Gulisano, Massimo/F-6609-2012; Sham, Mai Har/AAX-3781-2020	Krumlauf, Robb/0000-0001-9102-7927; Gulisano, Massimo/0000-0001-8654-1745; Sham, Mai Har/0000-0003-1179-7839				BONCINELLI E, 1991, TRENDS GENET, V7, P329, DOI 10.1016/0168-9525(91)90423-N; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0; DOLLE P, 1990, DEVELOPMENT, V110, P1133; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1986, EMBO J, V5, P1973, DOI 10.1002/j.1460-2075.1986.tb04452.x; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FEATHERSTONE MS, 1988, P NATL ACAD SCI USA, V85, P4760, DOI 10.1073/pnas.85.13.4760; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; FROHMAN MA, 1989, TECHNIQUE, V1, P165; GAUNT SJ, 1987, DEVELOPMENT, V101, P51; GAUNT SJ, 1988, DEVELOPMENT, V103, P135; GAUNT SJ, 1989, DEVELOPMENT, V107, P131; GRAHAM A, 1991, DEVELOPMENT, V112, P255; GRAHAM A, 1988, GENE DEV, V2, P1424, DOI 10.1101/gad.2.11.1424; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HOLLAND P, 1990, EVOLUTION SEGMENTAL, V1, P135; HUNT P, 1991, DEVELOPMENT, V112, P43; HUNT P, 1991, DEVELOPMENT, P187; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, IN PRESS DEVELOPMENT; Lumsden A.G.S., 1990, Seminars in Developmental Biology, V1, P117; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; MURPHY P, 1991, DEVELOPMENT, V111, P61; NODEN DM, 1988, DEVELOPMENT, V103, P121; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; SIMEONE A, 1991, MECH DEVELOP, V33, P215, DOI 10.1016/0925-4773(91)90029-6; SUNDIN OH, 1990, GENE DEV, V4, P1267, DOI 10.1101/gad.4.8.1267; THOROGOOD P, 1988, DEVELOPMENT, V103, P141; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0	39	456	463	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 31	1991	353	6347					861	864		10.1038/353861a0	http://dx.doi.org/10.1038/353861a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM732	1682814				2022-12-28	WOS:A1991GM73200065
J	SALAS, R; DEMANZIONE, N; TESH, RB; RICOHESSE, R; SHOPE, RE; BETANCOURT, A; GODOY, O; BRUZUAL, R; PACHECO, ME; RAMOS, B; TAIBO, ME; TAMAYO, JG; JAIMES, E; VASQUEZ, C; ARAOZ, F; QUERALES, J				SALAS, R; DEMANZIONE, N; TESH, RB; RICOHESSE, R; SHOPE, RE; BETANCOURT, A; GODOY, O; BRUZUAL, R; PACHECO, ME; RAMOS, B; TAIBO, ME; TAMAYO, JG; JAIMES, E; VASQUEZ, C; ARAOZ, F; QUERALES, J			VENEZUELAN HEMORRHAGIC-FEVER	LANCET			English	Article							LASSA FEVER; EPIDEMIOLOGY	An outbreak of severe haemorrhagic illness began in the municipality of Guanarito, Portuguesa State, Venezuela, in September, 1989. Subsequent detailed study of 15 cases confirmed the presence of a new viral disease, designated Venezuelan haemorrhagic fever. Characteristic features are fever, toxicity, headache, arthralgia, diarrhoea, conjunctivitis, pharyngitis, leucopenia, thrombocytopenia, and haemorrhagic manifestations. Other features include facial oedema, cervical lymphadenopathy, nausea/vomiting, cough, chest or abdominal pain, and convulsions. The patients ranged in age from 6 to 54 years; all were residents of rural areas in central Venezuela, and 9 died. Infection with Guanarito virus, a newly recognised arenavirus, was shown by direct culture or by serological confirmation in all cases. Epidemiological studies suggest that the disease is endemic in some rural areas of central Venezuela and that it is rodent-borne. Venezuelan haemorrhagic fever has many similarities to Lassa fever and to the arenavirus haemorrhagic fevers that occur in Argentina and Bolivia.	YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,YALE ARBOVIRUS RES UNIT,POB 3333,NEW HAVEN,CT 06510; NATL INST HYG RAFAEL RANGEL,CARACAS,VENEZUELA; MINIST HLTH & SOCIAL ASSISTANCE,DIV TRANSMISSIBLE DIS,CARACAS,VENEZUELA; MIGUEL ORAA HOSP,GUANARE,VENEZUELA; CENT UNIV VENEZUELA,INST ANAT PATHOL,CARACAS,VENEZUELA	Yale University; University of Central Venezuela			Rico-Hesse, Rebeca/C-5294-2011; Rico-Hesse, Rebecca/AAW-9501-2021	Rico-Hesse, Rebeca/0000-0001-6216-1000; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI010984, R01AI010984, R37AI010984] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-10984] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; CHILD PL, 1967, ARCH PATHOL, V83, P434; HERNANDEZ T, 1991, NACIONAL CARACA 0407; Johnson KM, 1973, LYMPHOCYTIC CHORIOME, P241; MACKENZIE RB, 1964, AM J TROP MED HYG, V13, P620, DOI 10.4269/ajtmh.1964.13.620; MAIZTEGUI JI, 1975, B WORLD HEALTH ORGAN, V50, P567; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MCCORMICK JB, 1987, J INFECT DIS, V155, P549; MERTENS PE, 1973, AM J TROP MED HYG, V22, P780, DOI 10.4269/ajtmh.1973.22.780; MONATH TP, 1987, J INFECT DIS, V155, P433, DOI 10.1093/infdis/155.3.433; MONATH TP, 1974, AM J TROP MED HYG, V23, P1140, DOI 10.4269/ajtmh.1974.23.1140; MONATH TP, 1975, B WORLD HEALTH ORGAN, V52, P577; PETERS CJ, 1974, AM J EPIDEMIOL, V9, P425; RUGIERO H. R., 1962, REV ASOC MED ARGENTINA, V76, P413; STINEBAUGH BJ, 1966, AM J MED, V40, P217, DOI 10.1016/0002-9343(66)90103-3; TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053; WALKER DH, 1982, AM J PATHOL, V107, P349; WHITE HA, 1972, T ROY SOC TROP MED H, V66, P390, DOI 10.1016/0035-9203(72)90269-6; 1990, PAHO EPIDEMIOL B, V11, P1	19	121	123	0	9	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1033	1036		10.1016/0140-6736(91)91899-6	http://dx.doi.org/10.1016/0140-6736(91)91899-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM253	1681354	hybrid			2022-12-28	WOS:A1991GM25300002
J	HIGGINS, GD; DAVY, M; RODER, D; UZELIN, DM; PHILLIPS, GE; BURRELL, CJ				HIGGINS, GD; DAVY, M; RODER, D; UZELIN, DM; PHILLIPS, GE; BURRELL, CJ			INCREASED AGE AND MORTALITY ASSOCIATED WITH CERVICAL CARCINOMAS NEGATIVE FOR HUMAN PAPILLOMAVIRUS RNA	LANCET			English	Article							PROGNOSTIC-SIGNIFICANCE; INVASIVE-CARCINOMA; DNA; MAINTENANCE; NEOPLASIA; CANCER	Attempts to relate presence and type of human papillomavirus in cervical carcinoma with prognosis have yielded conflicting results. To further investigate this relation, the association between survival of cervical cancer patients after diagnosis and the presence of human papillomavirus (HPV) RNA within the tumour was assessed retrospectively. Formalin-fixed biopsy specimens from 212 patients with cervical carcinoma who had been followed for up to 6 years were tested by in-situ hybridisation with I-125-labelled riboprobes. HPV-RNA-positive women were 11.9 years younger than HPV-negative women at diagnosis (p < 0.001). Case-fatality rates from cervical cancer rose with absence of HPV RNA, age at diagnosis, or FIGO stage. Multivariate analysis confirmed that absence of detectable HPV RNA and advanced FIGO stage were independent risk factors. No differences in survival between HPV types 16, 18, 31, or 33 were seen. These observations suggest that cervical carcinoma patients fall into two groups-a younger, HPV-RNA-positive group, with a better prognosis, and an older, HPV-RNA-negative group with poorer prognosis. Treatment regimens for the two groups may need to differ.	ROYAL ADELAIDE HOSP,INST MED & VET SCI,DIV TISSUE PATHOL,ADELAIDE,SA 5000,AUSTRALIA; ROYAL ADELAIDE HOSP,INST MED & VET SCI,DEPT GYNAECOL ONCOL,ADELAIDE,SA 5000,AUSTRALIA; UNIV ADELAIDE,S AUSTRALIAN HLTH COMM,EPIDEMIOL BRANCH,ADELAIDE,SA 5001,AUSTRALIA; UNIV ADELAIDE,DEPT MICROBIOL & IMMUNOL,ADELAIDE,SA 5001,AUSTRALIA	Institute Medical & Veterinary Science Australia; Royal Adelaide Hospital; Institute Medical & Veterinary Science Australia; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	HIGGINS, GD (corresponding author), ROYAL ADELAIDE HOSP,INST MED & VET SCI,DIV MED VIROL,FROME RD,ADELAIDE,SA 5000,AUSTRALIA.		Roder, David/B-7038-2013; Phillips, Gael E/H-6321-2012	Roder, David/0000-0001-6442-4409; 				BARNES W, 1988, GYNECOL ONCOL, V29, P267, DOI 10.1016/0090-8258(88)90225-9; BONETT A, 1989, AUST NZ J OBSTET GYN, V29, P193, DOI 10.1111/j.1479-828X.1989.tb01717.x; BONETT P, 1988, MED J AUSTRALIA, V148, P556; CAMPO MS, 1985, EMBO J, V4, P1819, DOI 10.1002/j.1460-2075.1985.tb03856.x; COLLINS JE, 1988, J CLIN PATHOL, V41, P289, DOI 10.1136/jcp.41.3.289; CROOK T, 1991, ONCOGENE, V6, P873; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; HIGGINS GD, 1991, J GEN VIROL, V72, P885, DOI 10.1099/0022-1317-72-4-885; HIGGINS GD, 1991, CANCER-AM CANCER SOC, V68, P561, DOI 10.1002/1097-0142(19910801)68:3<561::AID-CNCR2820680320>3.0.CO;2-R; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KING LA, 1989, CANCER, V63, P897, DOI 10.1002/1097-0142(19890301)63:5<897::AID-CNCR2820630517>3.0.CO;2-W; LORINCZ AT, 1987, J NATL CANCER I, V79, P671; MORGAN D, 1990, J VIROL, V64, P969, DOI 10.1128/JVI.64.3.969-976.1990; RIOU G, 1990, LANCET, V335, P1171; ROSE BR, 1991, LANCET, V337, P489, DOI 10.1016/0140-6736(91)93422-6; WALKER J, 1989, OBSTET GYNECOL, V74, P781; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; [No title captured]	19	152	154	2	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					910	913		10.1016/0140-6736(91)91773-N	http://dx.doi.org/10.1016/0140-6736(91)91773-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681267				2022-12-28	WOS:A1991GJ89900004
J	GANGAR, KF; VYAS, S; WHITEHEAD, M; CROOK, D; MEIRE, H; CAMPBELL, S				GANGAR, KF; VYAS, S; WHITEHEAD, M; CROOK, D; MEIRE, H; CAMPBELL, S			PULSATILITY INDEX IN INTERNAL CAROTID-ARTERY IN RELATION TO TRANSDERMAL ESTRADIOL AND TIME SINCE MENOPAUSE	LANCET			English	Article							CORONARY HEART-DISEASE; BLOOD-FLOW; ESTROGEN; WOMEN; MORTALITY; THERAPY; DOPPLER; FETAL; RISK	The protection afforded by postmenopausal oestrogen replacement against cardiovascular disease is not fully explained by changes in plasma lipoproteins. To investigate the effect of oestrogen on arterial tone, doppler ultrasound was used to assess blood flow characteristics in the internal carotid arteries of 12 postmenopausal women. Patients were studied pretreatment and at weeks 4, 6, 9, and 22 of therapy with transdermal oestradiol 50-mu-g/day. The pulsatility index (PI), which is thought to represent impedance to blood flow distal to the point of sampling, was measured from the flow velocity waveform. 11 of the 12 patients were within 5 years of menopause; 1 was 8 years postmenopausal but had experienced bleeding 4 years after menopause. In the 11 women there was a highly significant correlation (r = 0.77) between time since menopause and baseline PI. A similar correlation (r = 0.74) was observed when the episode of postmenopausal bleeding was redefined as time of menopause in the twelfth patient. For all 12 patients, there was a significant negative correlation (r = -0.70) between change in PI during transdermal oestradiol therapy and mean of baseline plus week 22 PI value. For all correlations between changes in PI and time since menopause, the longer the time the greater the fall in PI. These results, and previous observations of a reduction in uterine artery PI with oestradiol treatment, suggest that oestrogen has a generalised effect on the arterial system.	UNIV LONDON KINGS COLL, SCH MED & DENT, MENOPAUSE CLIN, ACAD DEPT OBSTET & GYNAECOL, LONDON WC2R 2LS, ENGLAND; WYNN INST METAB RES, LONDON, ENGLAND; UNIV LONDON KINGS COLL HOSP, DEPT RADIOL, LONDON SE5 8RX, ENGLAND	University of London; King's College London; Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London				Crook, David/0000-0002-9587-3730				ANDERSON SG, 1977, AM J OBSTET GYNECOL, V127, P138, DOI 10.1016/S0002-9378(16)33239-2; BOURNE T, 1990, LANCET, V335, P1470, DOI 10.1016/0140-6736(90)91505-5; BUSH TL, 1983, JAMA-J AM MED ASSOC, V249, P903, DOI 10.1001/jama.249.7.903; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CLARKSON TB, 1990, OBSTET GYNECOL, V75, P217; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; DOWSETT M, 1987, CANCER RES, V47, P1957; FARISH E, 1990, BRIT J OBSTET GYNAEC, V97, P78, DOI 10.1111/j.1471-0528.1990.tb01721.x; GILL JS, 1985, LANCET, V1, P567; GINSBURG J, 1989, BRIT MED J, V298, P1488, DOI 10.1136/bmj.298.6686.1488; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; Gosling RG., 1975, ARTERIES VEINS, P61; GRIFFIN D, 1983, CLIN OBSTET GYNAECOL, V10, P565; HENDERSON BE, 1988, AM J OBSTET GYNECOL, V159, P312, DOI 10.1016/S0002-9378(88)80074-7; MATTA WHM, 1988, FERTIL STERIL, V49, P1083; MATTHEWS KA, 1989, NEW ENGL J MED, V321, P641, DOI 10.1056/NEJM198909073211004; MEIRE HB, 1990, CLIN RADIOL, V41, P223, DOI 10.1016/S0009-9260(05)81651-4; MEIRE HB, 1983, RECENT ADV RADIOLOGY, P63; OLDHAM PD, 1968, MEASUREMENT MED INTE, P148; PADWICK ML, 1988, MENOPAUSE, P227; PAGANINIHILL A, 1988, BMJ-BRIT MED J, V297, P519, DOI 10.1136/bmj.297.6647.519; SARREL P, 1989, CIRCULATION FEMALE C, P117; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; VYAS S, 1990, BRIT J OBSTET GYNAEC, V97, P797, DOI 10.1111/j.1471-0528.1990.tb02573.x; VYAS S, 1989, AM J OBSTET GYNECOL, V161, P168, DOI 10.1016/0002-9378(89)90257-3; WAHL P, 1983, NEW ENGL J MED, V308, P862, DOI 10.1056/NEJM198304143081502; WOLINSKY H, 1972, CIRC RES, V30, P341, DOI 10.1161/01.RES.30.3.341; 1979, DHEW PHS7955071 PUBL	28	374	375	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	1991	338	8771					839	842						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681213				2022-12-28	WOS:A1991GH94500002
J	ABDELMAEBOUD, KH; ELNAGGAR, T; ELHAWI, EMM; MAHMOUD, SAR; ABDELHAY, S				ABDELMAEBOUD, KH; ELNAGGAR, T; ELHAWI, EMM; MAHMOUD, SAR; ABDELHAY, S			RECTAL SUPPOSITORY - COMMONSENSE AND MODE OF INSERTION	LANCET			English	Article								Rectal suppository is a well-known form of medication and its use is increasing. The commonest shape is one with an apex (pointed end) tapering to a base (blunt end). Because of a general lack of information about mode of insertion, we asked 360 lay subjects (Egyptians and non-Egyptians) and 260 medical personnel (physicians, pharmacists, and nurses) by questionnaire which end they inserted foremost. Apart from 2 individuals, all subjects suggested insertion with the apex foremost. Commonsense was the most frequent basis for this practice (86.9% of lay subjects and 84.6% of medical personnel) followed by information from a relative, a friend, or medical personnel, or from study at medical school. Suppository insertion with the base or apex foremost was compared in 100 subjects (60 adults, 40 infants and children). Retention with the former method was more easily achieved in 98% of the cases, with no need to introduce a finger in the anal canal (1% vs 83%), and lower expulsion rate (0% vs 3%). The designer of the "torpedo-shaped" suppository suggested its insertion with apex foremost. Our data suggest that a suppository is better inserted with the base foremost. Reversed vermicular contractions or pressure gradient of the anal canal might press it inwards.	AIN SHAMS UNIV HOSP,CAIRO,EGYPT	Egyptian Knowledge Bank (EKB); Ain Shams University								ANSET HC, 1981, INTRO PHARMACEUTICAL, P328; Avouac B, 1988, J Clin Pharmacol, V28, pS2; BENNETT RC, 1964, BRIT J SURG, V51, P355, DOI 10.1002/bjs.1800510514; BENTLEY AO, 1936, TXB PHARMACEUTICS, P565; BERGSTROM BKV, 1988, J INT MED RES, V16, P376, DOI 10.1177/030006058801600507; CARTER SJ, 1975, DISPENSING PHARM STU, P232; COLLINS CD, 1967, GUT, V8, P354, DOI 10.1136/gut.8.4.354; DUTHIE HL, 1963, GUT, V4, P179, DOI 10.1136/gut.4.2.179; DUTHIE LH, 1965, GUT, V6, P64; GOLIGHER JC, 1980, SURGERY ANUS RECTUM, P1; HANCOCK BD, 1976, GUT, V17, P645, DOI 10.1136/gut.17.8.645; HILL J R, 1960, Dis Colon Rectum, V3, P203, DOI 10.1007/BF02616555; KAPOOR DA, 1989, J UROLOGY, V142, P1428, DOI 10.1016/S0022-5347(17)39117-6; KUROSAWA S, 1987, J INT MED RES, V15, P121, DOI 10.1177/030006058701500301; NEWRICK PG, 1990, LANCET, V335, P212, DOI 10.1016/0140-6736(90)90289-H; NISHIHATA T, 1989, J PHARM PHARMACOL, V41, P799, DOI 10.1111/j.2042-7158.1989.tb06372.x; ODIGIE EA, 1988, INT J GYNECOL OBSTET, V26, P57, DOI 10.1016/0020-7292(88)90196-8; SENIOR N, 1969, PHARM J, V203, P703; SHAFIK A, 1975, INVEST UROL, V12, P412; SONANDER H, 1985, BRIT J ANAESTH, V57, P578, DOI 10.1093/bja/57.6.578; WELLCOME HS, 1893, 41ST P ANN M AM PHAR, P103; 1979, PHARMACEUTICAL CODEX, P890	22	17	17	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					798	800		10.1016/0140-6736(91)90676-G	http://dx.doi.org/10.1016/0140-6736(91)90676-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681170				2022-12-28	WOS:A1991GG97900014
J	WILLIAMS, DE; EISENMAN, J; BAIRD, A; RAUCH, C; VANNESS, K; MARCH, CJ; PARK, LS; MARTIN, U; MOCHIZUKI, DY; BOSWELL, HS; BURGESS, GS; COSMAN, D; LYMAN, SD				WILLIAMS, DE; EISENMAN, J; BAIRD, A; RAUCH, C; VANNESS, K; MARCH, CJ; PARK, LS; MARTIN, U; MOCHIZUKI, DY; BOSWELL, HS; BURGESS, GS; COSMAN, D; LYMAN, SD			IDENTIFICATION OF A LIGAND FOR THE C-KIT PROTOONCOGENE	CELL			English	Article									IMMUNEX CORP,DEPT PROT CHEM,SEATTLE,WA 98101; IMMUNEX CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101; IMMUNEX CORP,DEPT BIOCHEM,SEATTLE,WA 98101; INDIANA UNIV,VET ADM HOSP,SCH MED,DEPT MED HEMATOL ONCOL,INDIANAPOLIS,IN 46223	Immunex Corporation; Immunex Corporation; Immunex Corporation; Indiana University System; Indiana University-Purdue University Indianapolis	WILLIAMS, DE (corresponding author), IMMUNEX CORP,DEPT EXPTL HEMATOL,51 UNIV ST,SEATTLE,WA 98101, USA.							BERNSTEIN SE, 1968, ANN NY ACAD SCI, V149, P475, DOI 10.1111/j.1749-6632.1968.tb15186.x; BERNSTEIN SE, 1970, AM J SURG, V119, P448, DOI 10.1016/0002-9610(70)90148-0; BOSWELL HS, 1990, EXP HEMATOL, V18, P794; BOSWELL HS, 1987, EXP HEMATOL, V15, P46; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; COCHET C, 1988, J BIOL CHEM, V263, P3290; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DEXTER TM, 1977, NATURE, V269, P412, DOI 10.1038/269412a0; ELIASON JF, 1988, EXP HEMATOL, V16, P307; FRIED W, 1973, BRIT J HAEMATOL, V24, P643, DOI 10.1111/j.1365-2141.1973.tb01690.x; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GUALTIERI RJ, 1987, EXP HEMATOL, V15, P883; HARRISON DE, 1972, BRIT J HAEMATOL, V22, P155, DOI 10.1111/j.1365-2141.1972.tb08797.x; HUEBNER K, 1985, SCIENCE, V230, P1282, DOI 10.1126/science.2999978; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, BLOOD, V53, P492; LEBEAU MM, 1987, P NATL ACAD SCI USA, V84, P5913; LI CL, 1985, NATURE, V316, P633, DOI 10.1038/316633a0; LYMAN SD, 1989, ONCOGENE RES, V4, P149; Maniatis T., 1982, MOL CLONING; MAYER TC, 1968, DEV BIOL, V18, P62, DOI 10.1016/0012-1606(68)90023-7; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MURPHY ED, 1973, TRANSPLANTATION, V15, P526; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NAMEN AE, 1988, J EXP MED, V167, P988, DOI 10.1084/jem.167.3.988; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; PARK LS, 1986, J BIOL CHEM, V261, P4177; PARK LS, 1986, J BIOL CHEM, V261, P205; PARK LS, 1989, J BIOL CHEM, V264, P5420; PRESTIDGE RL, 1984, J IMMUNOL, V133, P293; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ES, 1956, SCIENCE, V124, P1076, DOI 10.1126/science.124.3231.1076; RUSSELL ES, 1968, ARCH BIOCHEM BIOPHYS, V125, P594, DOI 10.1016/0003-9861(68)90617-6; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; WILLIAMS DE, 1990, IN PRESS BLOOD; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	44	995	1032	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 5	1990	63	1					167	174		10.1016/0092-8674(90)90297-R	http://dx.doi.org/10.1016/0092-8674(90)90297-R			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EB461	1698553				2022-12-28	WOS:A1990EB46100017
J	PIRCHER, H; MOSKOPHIDIS, D; ROHRER, U; BURKI, K; HENGARTNER, H; ZINKERNAGEL, RM				PIRCHER, H; MOSKOPHIDIS, D; ROHRER, U; BURKI, K; HENGARTNER, H; ZINKERNAGEL, RM			VIRAL ESCAPE BY SELECTION OF CYTOTOXIC T-CELL-RESISTANT VIRUS VARIANTS INVIVO	NATURE			English	Article									SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND	Novartis; Sandoz	PIRCHER, H (corresponding author), UNIV HOSP ZURICH, INST PATHOL, CH-8091 ZURICH, SWITZERLAND.							AEBISCHER T, 1990, EUR J IMMUNOL, V20, P523, DOI 10.1002/eji.1830200310; ARALACHAVES MP, 1988, AM J VET RES, V49, P1955; BAENZIGER J, 1986, EUR J IMMUNOL, V16, P387, DOI 10.1002/eji.1830160413; BERNARDS R, 1983, NATURE, V305, P776, DOI 10.1038/305776a0; BOON T, 1989, IMMUNOGENETICS, V29, P75, DOI 10.1007/BF00395854; BYRNE JA, 1984, J VIROL, V51, P682, DOI 10.1128/JVI.51.3.682-686.1984; CATTANEO R, 1988, J VIROL, V62, P1388, DOI 10.1128/JVI.62.4.1388-1397.1988; COLE GA, 1972, NATURE, V238, P335, DOI 10.1038/238335a0; DENT PB, 1972, PROG MED VIROL, V14, P1; DESTGROTH SF, 1981, IMMUNE SYSTEM, V1, P155; DIAMOND DC, 1988, J IMMUNOL, V141, P3715; DOHERTY PC, 1990, IMMUNOL TODAY, V11, P55; FENYO EM, 1988, J VIROL, V62, P4414; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GLASGOW LA, 1971, FED PROC, V30, P1846; Gresser I, 1966, Prog Med Virol, V8, P62; HANY M, 1989, EUR J IMMUNOL, V19, P417, DOI 10.1002/eji.1830190302; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HOTCHIN J, 1962, COLD SPRING HARB SYM, V27, P479, DOI 10.1101/SQB.1962.027.001.046; JOSEPH BS, 1975, J EXP MED, V142, P864, DOI 10.1084/jem.142.4.864; KVIST S, 1978, P NATL ACAD SCI USA, V75, P5674, DOI 10.1073/pnas.75.11.5674; LAVER WG, 1973, VIROLOGY, V51, P383, DOI 10.1016/0042-6822(73)90437-6; LAVER WG, 1979, VIROLOGY, V98, P226, DOI 10.1016/0042-6822(79)90540-3; LEHMANNGRUBE F, 1977, J GEN VIROL, V37, P85, DOI 10.1099/0022-1317-37-1-85; LEHMANNGRUBE F, 1971, VIROL MONOGR, V10, P1; LEVY JA, 1988, NATURE, V333, P519, DOI 10.1038/333519a0; MCCLURE HM, 1989, VET IMMUNOL IMMUNOP, V21, P13, DOI 10.1016/0165-2427(89)90126-8; MCINTYRE KW, 1985, ANTIVIR RES, V5, P299, DOI 10.1016/0166-3542(85)90044-0; MIMS CA, 1982, PATHOGENESIS INFECTI; MOSKOPHIDIS D, 1987, J VIROL, V61, P1867, DOI 10.1128/JVI.61.6.1867-1874.1987; MURRAY RJ, 1989, PROG IMMUN, V7, P939; NARAYAN O, 1977, SCIENCE, V197, P376, DOI 10.1126/science.195339; NOTKINS AL, 1984, CONCEPTS VIRAL PATHO; OLDSTONE MBA, 1987, CURR TOP MICROBIOL, V133, P1; OLDSTONE MBA, 1988, J EXP MED, V168, P559, DOI 10.1084/jem.168.2.559; PALESE P, 1982, SCIENCE, V215, P1468, DOI 10.1126/science.7038875; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PIRCHER H, 1987, EUR J IMMUNOL, V17, P159, DOI 10.1002/eji.1830170202; POPESCU M, 1976, J GEN VIROL, V30, P113, DOI 10.1099/0022-1317-30-1-113; POZSGAY JM, 1989, VIROLOGY, V173, P330, DOI 10.1016/0042-6822(89)90251-1; RIVIERE Y, 1987, CURR TOP MICROBIOL, V133, P59; RIVIERE Y, 1986, J VIROL, V59, P363, DOI 10.1128/JVI.59.2.363-368.1986; ROMANOWSKI V, 1985, VIRUS RES, V3, P101, DOI 10.1016/0168-1702(85)90001-2; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; ROSENBERG ZF, 1989, ADV IMMUNOL, V47, P377, DOI 10.1016/S0065-2776(08)60665-3; SAKAI K, 1988, J VIROL, V62, P4078, DOI 10.1128/JVI.62.11.4078-4085.1988; SOUTHERN PJ, 1987, VIROLOGY, V157, P145, DOI 10.1016/0042-6822(87)90323-0; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; TOMONARI K, 1988, IMMUNOGENETICS, V28, P455, DOI 10.1007/BF00355379; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WHITE HD, 1990, J VIROL, V64, P2608, DOI 10.1128/JVI.64.6.2608-2619.1990; YEWDELL JW, 1979, NATURE, V279, P246, DOI 10.1038/279246a0; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X; ZINKERNAGEL RM, 1976, J IMMUNOL, V117, P1495	59	511	518	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 16	1990	346	6285					629	633		10.1038/346629a0	http://dx.doi.org/10.1038/346629a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU728	1696684				2022-12-28	WOS:A1990DU72800051
J	BOLZ, J; NOVAK, N; GOTZ, M; BONHOEFFER, T				BOLZ, J; NOVAK, N; GOTZ, M; BONHOEFFER, T			FORMATION OF TARGET-SPECIFIC NEURONAL PROJECTIONS IN ORGANOTYPIC SLICE CULTURES FROM RAT VISUAL-CORTEX	NATURE			English	Article									MAX PLANCK INST BIOL CYBERNET,W-7400 TUBINGEN,GERMANY	Max Planck Society	BOLZ, J (corresponding author), MAX PLANCK GESELL,FRIEDRICH MIESCHER LAB,SPEMANNSTR 37-39,W-7400 TUBINGEN,GERMANY.		Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634; Gotz, Magdalena/0000-0003-1551-9203				ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BERRY M, 1963, NATURE, V197, P984, DOI 10.1038/197984a0; BULLIER J, 1984, J COMP NEUROL, V228, P329, DOI 10.1002/cne.902280304; CAESER M, 1989, EXPL BRAIN RES, V77, P24; Cajal S. R., 1911, HISTOLOGIE SYSTEME N; CHUN JJM, 1987, NATURE, V325, P617, DOI 10.1038/325617a0; CHUN JJM, 1989, J COMP NEUROL, V282, P555, DOI 10.1002/cne.902820407; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; GODEMENT P, 1987, DEVELOPMENT, V101, P697; GOTZ M, 1989, NEUROSCI LETT, V107, P6, DOI 10.1016/0304-3940(89)90782-9; HARRIS WA, 1986, NATURE, V320, P266, DOI 10.1038/320266a0; HARRIS WA, 1989, NATURE, V339, P218, DOI 10.1038/339218a0; HUBENER M, 1988, NEUROSCI LETT, V94, P76, DOI 10.1016/0304-3940(88)90273-X; KATZ LC, 1987, J NEUROSCI, V7, P1223; KLEIN BG, 1986, NEUROSCIENCE, V17, P57, DOI 10.1016/0306-4522(86)90225-3; LUMSDEN AGS, 1986, NATURE, V323, P538, DOI 10.1038/323538a0; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; OLAVARRIA J, 1983, BRAIN RES, V279, P233, DOI 10.1016/0006-8993(83)90182-8; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; SCHOFIELD BR, 1987, J COMP NEUROL, V261, P85, DOI 10.1002/cne.902610107; SEFTON AJ, 1981, BRAIN RES, V215, P1, DOI 10.1016/0006-8993(81)90487-X; SINGER M, 1979, J COMP NEUROL, V185, P1, DOI 10.1002/cne.901850102; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SWADLOW HA, 1983, BRAIN RES REV, V6, P1, DOI 10.1016/0165-0173(83)90002-4; SYMONDS LL, 1984, J COMP NEUROL, V229, P1, DOI 10.1002/cne.902290103; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; THONG IG, 1986, DEV BRAIN RES, V25, P227, DOI 10.1016/0165-3806(86)90212-9; VALVERDE F, 1989, J COMP NEUROL, V290, P118, DOI 10.1002/cne.902900108; WAHLE P, 1989, J COMP NEUROL, V282, P215, DOI 10.1002/cne.902820206; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258	36	179	180	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 26	1990	346	6282					359	362		10.1038/346359a0	http://dx.doi.org/10.1038/346359a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ567	1695716				2022-12-28	WOS:A1990DQ56700060
J	SINCLAIR, AH; BERTA, P; PALMER, MS; HAWKINS, JR; GRIFFITHS, BL; SMITH, MJ; FOSTER, JW; FRISCHAUF, AM; LOVELLBADGE, R; GOODFELLOW, PN				SINCLAIR, AH; BERTA, P; PALMER, MS; HAWKINS, JR; GRIFFITHS, BL; SMITH, MJ; FOSTER, JW; FRISCHAUF, AM; LOVELLBADGE, R; GOODFELLOW, PN			A GENE FROM THE HUMAN SEX-DETERMINING REGION ENCODES A PROTEIN WITH HOMOLOGY TO A CONSERVED DNA-BINDING MOTIF	NATURE			English	Article									NATL INST MED RES,EUKARYOT MOLEC GENET LAB,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research	SINCLAIR, AH (corresponding author), IMPERIAL CANC RES FUND,HUMAN MOLEC GENET LAB,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Sinclair, Andrew H/A-3598-2010; Hawkins, Ross/M-7702-2014	Sinclair, Andrew H/0000-0003-2741-7992; Lovell-Badge, Robin/0000-0001-9364-4179	Medical Research Council [MC_U117562207] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BISHOP CE, 1983, NATURE, V303, P831, DOI 10.1038/303831a0; BURK RD, 1985, MOL CELL BIOL, V5, P576, DOI 10.1128/MCB.5.3.576; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS JF, 1988, COMPUT APPL BIOSCI, V4, P67; DEKRETSER TA, 1982, EUR J IMMUNOL, V12, P600, DOI 10.1002/eji.1830120713; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FERGUSONSMITH MA, 1966, LANCET, V2, P475; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; GOODFELLOW PN, 1988, DEVELOPMENT, V102, P251; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; Jost A., 1973, Recent Progress Hormone Res, V29, P1; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PALMER MS, 1990, P NATL ACAD SCI USA, V87, P1681, DOI 10.1073/pnas.87.5.1681; PALMER MS, 1989, NATURE, V342, P937, DOI 10.1038/342937a0; PETIT C, 1987, CELL, V49, P595, DOI 10.1016/0092-8674(87)90535-6; PRITCHARD CA, 1987, NATURE, V328, P273, DOI 10.1038/328273a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SINCLAIR AH, 1988, NATURE, V336, P780, DOI 10.1038/336780a0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; WEISSENBACH J, 1987, DEVELOPMENT, V101, P67; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0; WRIGHT JM, 1988, BIOCHEMISTRY-US, V27, P576, DOI 10.1021/bi00402a012	35	2482	2682	10	153	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 19	1990	346	6281					240	244		10.1038/346240a0	http://dx.doi.org/10.1038/346240a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP456	1695712				2022-12-28	WOS:A1990DP45600054
J	FAHRAEUS, R; RYMO, L; RHIM, JS; KLEIN, G				FAHRAEUS, R; RYMO, L; RHIM, JS; KLEIN, G			MORPHOLOGICAL TRANSFORMATION OF HUMAN KERATINOCYTES EXPRESSING THE LMP GENE OF EPSTEIN-BARR-VIRUS	NATURE			English	Article									GOTHENBURG UNIV,DEPT MED CHEM,S-40033 GOTHENBURG,SWEDEN; NCI,CELLULAR & MOLEC BIOL LAB,BETHESDA,MD 20892	University of Gothenburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	FAHRAEUS, R (corresponding author), KAROLINSKA INST,DEPT TUMOR BIOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN.		fahraeus, robin/K-8726-2014	, robin/0000-0003-0402-8492				ANDERSSONANVRET M, 1977, INT J CANCER, V20, P486, DOI 10.1002/ijc.2910200403; ARRAND JR, 1981, NUCLEIC ACIDS RES, V9, P2999, DOI 10.1093/nar/9.13.2999; BAICHWAL VR, 1988, ONCOGENE, V2, P461; DILLNER J, 1988, ADV CANCER RES, V50, P95, DOI 10.1016/S0065-230X(08)60436-4; FAHRAEUS R, 1988, INT J CANCER, V42, P329, DOI 10.1002/ijc.2910420305; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1654; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P4737, DOI 10.1073/pnas.71.12.4737; KLEIN G, 1979, EPSTEINBARR VIRUS, P339; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANN KP, 1987, J VIROL, V61, P2100, DOI 10.1128/JVI.61.7.2100-2108.1987; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MURRAY RJ, 1988, J VIROL, V62, P3747, DOI 10.1128/JVI.62.10.3747-3755.1988; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; RICKSTEN A, 1987, J GEN VIROL, V68, P2407, DOI 10.1099/0022-1317-68-9-2407; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; RYMO L, 1985, P NATL ACAD SCI USA, V82, P3435, DOI 10.1073/pnas.82.10.3435; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; SKARE J, 1985, J VIROL, V55, P268; Sun TT, 1984, CANCER CELLS, V1, P169; WANG D, 1988, J VIROL, V62, P2337, DOI 10.1128/JVI.62.7.2337-2346.1988; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806	22	276	281	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 31	1990	345	6274					447	449		10.1038/345447a0	http://dx.doi.org/10.1038/345447a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG082	1692971				2022-12-28	WOS:A1990DG08200066
J	COLVER, AF				COLVER, AF			HEALTH SURVEILLANCE OF PRESCHOOL-CHILDREN - 4 YEARS EXPERIENCE	BRITISH MEDICAL JOURNAL			English	Article											COLVER, AF (corresponding author), BEACONHILL CHILDRENS CTR,CRAMLINGTON NE23 8EH,NORTHD,ENGLAND.							COLVER AF, 1986, BRIT MED J, V293, P258, DOI 10.1136/bmj.293.6541.258; HALL DMB, 1989, HLTH ALL CHILDREN PR; 1989, NATIONAL HLTH SERVIC	3	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 12	1990	300	6734					1246	1248		10.1136/bmj.300.6734.1246	http://dx.doi.org/10.1136/bmj.300.6734.1246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD181	1693864	Bronze, Green Published			2022-12-28	WOS:A1990DD18100022
J	LICHTER, P; WARD, DC				LICHTER, P; WARD, DC			IS NONISOTOPIC INSITU HYBRIDIZATION FINALLY COMING OF AGE	NATURE			English	Review									YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06510	Yale University	LICHTER, P (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,NEW HAVEN,CT 06510, USA.							ALBERTSON DG, 1988, EMBO J, V7, P2801, DOI 10.1002/j.1460-2075.1988.tb03135.x; ANASTASI J, 1990, AM J PATHOL, V136, P131; ARNOLDUS EPJ, 1989, HUM GENET, V83, P231, DOI 10.1007/BF00285162; BHATT B, 1988, NUCLEIC ACIDS RES, V16, P3951, DOI 10.1093/nar/16.9.3951; CHERIF D, 1989, HUM GENET, V81, P358, DOI 10.1007/BF00283691; CREMER T, 1988, EXP CELL RES, V176, P199, DOI 10.1016/0014-4827(88)90325-4; CREMER T, 1986, HUM GENET, V74, P346, DOI 10.1007/BF00280484; CREMER T, 1988, HUM GENET, V80, P235, DOI 10.1007/BF01790091; DEVILEE P, 1988, CANCER RES, V48, P5825; EMMERICH P, 1989, EXP CELL RES, V181, P126, DOI 10.1016/0014-4827(89)90188-2; GARSON JA, 1987, NUCLEIC ACIDS RES, V15, P4761, DOI 10.1093/nar/15.12.4761; GRAY JW, 1990, CYTOMETRY, V11; HAASE AT, 1989, IN SITU HYBRIDIZATIO, P143; HOPMAN AHN, 1988, HISTOCHEMISTRY, V89, P307, DOI 10.1007/BF00500631; LANDEGENT JE, 1987, HUM GENET, V77, P366, DOI 10.1007/BF00291428; LAWRENCE JB, 1988, CELL, V52, P51; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LICHTER P, 1989, CYTOGENET CELL GENET, V51, P1033; LICHTER P, 1988, P NATL ACAD SCI USA, V85, P9664, DOI 10.1073/pnas.85.24.9664; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LICHTER P, IN PRESS MOL GENETIC; LUX SE, IN PRESS NATURE; MANUELIDIS L, 1988, CHROMOSOMA, V96, P397, DOI 10.1007/BF00303033; NEDERLOF PM, 1989, CANCER GENET CYTOGEN, V42, P87, DOI 10.1016/0165-4608(89)90011-3; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; POPP S, IN PRESS EXP CELL RE; SHAW J, IN PRESS CYTOGENET C; TRASK B, 1988, HUM GENET, V78, P251, DOI 10.1007/BF00291672; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; VIEGASPEQUIGNOT E, 1989, P NATL ACAD SCI USA, V86, P582, DOI 10.1073/pnas.86.2.582	31	110	142	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 3	1990	345	6270					93	95		10.1038/345093a0	http://dx.doi.org/10.1038/345093a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB957	1691830				2022-12-28	WOS:A1990DB95700067
J	RAJAVASHISTH, TB; ANDALIBI, A; TERRITO, MC; BERLINER, JA; NAVAB, M; FOGELMAN, AM; LUSIS, AJ				RAJAVASHISTH, TB; ANDALIBI, A; TERRITO, MC; BERLINER, JA; NAVAB, M; FOGELMAN, AM; LUSIS, AJ			INDUCTION OF ENDOTHELIAL-CELL EXPRESSION OF GRANULOCYTE AND MACROPHAGE COLONY-STIMULATING FACTORS BY MODIFIED LOW-DENSITY LIPOPROTEINS	NATURE			English	Article									UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT MICROBIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT PATHOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles			Rajavashisth, Tripathi/ABB-6379-2020					AVERILL LE, 1989, AM J PATHOL, V135, P369; AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; BAKER DP, 1984, ARTERIOSCLEROSIS, V4, P248, DOI 10.1161/01.ATV.4.3.248; BARRETT TB, 1987, P NATL ACAD SCI USA, V84, P1099, DOI 10.1073/pnas.84.4.1099; BERLINER JA, 1986, ARTERIOSCLEROSIS, V6, P254, DOI 10.1161/01.ATV.6.3.254; BERLINER JA, IN PRESS J CLIN INVE; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERRITY RG, 1979, AM J PATHOL, V95, P775; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; GOLDE DW, 1972, J CLIN INVEST, V52, P2981; HABERLAND ME, 1988, SCIENCE, V241, P215, DOI 10.1126/science.2455346; HOFF HF, 1982, ATHEROSCLEROSIS, V42, P273, DOI 10.1016/0021-9150(82)90157-5; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; KOSUGI K, 1987, J CELL PHYSIOL, V130, P311, DOI 10.1002/jcp.1041300302; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; LIBBY P, 1986, AM J PATHOL, V124, P179; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MORTON RE, 1986, J LIPID RES, V27, P1124; NAGATA S, 1986, NATURE, V324, P73; NAVAB M, 1988, J CLIN INVEST, V82, P1853, DOI 10.1172/JCI113802; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; RAJAVASHISTH TB, 1987, P NATL ACAD SCI USA, V84, P1157, DOI 10.1073/pnas.84.5.1157; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SALSER WA, 1985, LEUKEMIA RECENT ADV, P349; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; TSUKADA T, 1986, ARTERIOSCLEROSIS, V6, P601, DOI 10.1161/01.ATV.6.6.601; WANG JM, 1988, J IMMUNOL, V141, P575; WONG GG, 1987, SCIENCE, V235, P1504, DOI 10.1126/science.3493529; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623	34	631	652	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 15	1990	344	6263					254	257		10.1038/344254a0	http://dx.doi.org/10.1038/344254a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CU138	1690354				2022-12-28	WOS:A1990CU13800062
J	VOLLOCH, V; SCHWEITZER, B; RITS, S				VOLLOCH, V; SCHWEITZER, B; RITS, S			UNCOUPLING OF THE SYNTHESIS OF EDITED AND UNEDITED COIII RNA IN TRYPANOSOMA-BRUCEI	NATURE			English	Article									HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	VOLLOCH, V (corresponding author), BOSTON BIOMED RES INST,DEPT METAB REGULAT,BOSTON,MA 02114, USA.							ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; BENNE R, 1989, BIOCHIM BIOPHYS ACTA, V1007, P131, DOI 10.1016/0167-4781(89)90031-6; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BENNE R, 1983, NUCLEIC ACIDS RES, V11, P6925, DOI 10.1093/nar/11.20.6925; EISEN H, 1988, CELL, V53, P331, DOI 10.1016/0092-8674(88)90150-X; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1985, NUCLEIC ACIDS RES, V13, P4577, DOI 10.1093/nar/13.12.4577; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; HENSGENS LAM, 1984, NUCLEIC ACIDS RES, V12, P7327, DOI 10.1093/nar/12.19.7327; LAMOND AI, 1988, TRENDS BIOCHEM SCI, V13, P283, DOI 10.1016/0968-0004(88)90117-X; MAIZELS N, 1988, NATURE, V334, P469, DOI 10.1038/334469a0; Maniatis T., 1982, MOL CLONING; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; STUART K, 1989, PARASITOL TODAY, V5, P5, DOI 10.1016/0169-4758(89)90211-1; VANDERSPEK H, 1988, EMBO J, V7, P2509, DOI 10.1002/j.1460-2075.1988.tb03098.x; VOLCKAERT G, 1977, ANAL BIOCHEM, V83, P222, DOI 10.1016/0003-2697(77)90530-9; VOLLOCH V, 1987, EXP CELL RES, V173, P38, DOI 10.1016/0014-4827(87)90329-6	20	14	14	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 1	1990	343	6257					482	484		10.1038/343482a0	http://dx.doi.org/10.1038/343482a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	1689017				2022-12-28	WOS:A1990CL81800067
J	PICCIRILLI, JA; KRAUCH, T; MORONEY, SE; BENNER, SA				PICCIRILLI, JA; KRAUCH, T; MORONEY, SE; BENNER, SA			ENZYMATIC INCORPORATION OF A NEW BASE PAIR INTO DNA AND RNA EXTENDS THE GENETIC ALPHABET	NATURE			English	Article											PICCIRILLI, JA (corresponding author), SWISS FED INST TECHNOL,ORGAN CHEM LAB,CH-8092 ZURICH,SWITZERLAND.							BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; BENNER SA, 1987, COLD SPRING HARB SYM, V52, P53, DOI 10.1101/SQB.1987.052.01.009; CECH TR, 1981, CELL, V27, P487, DOI 10.1016/0092-8674(81)90390-1; CHEN JH, 1988, BIOCHEMISTRY-US, V27, P6032, DOI 10.1021/bi00416a031; COBIANCHI F, 1987, METHOD ENZYMOL, V152, P94; COLEMAN JE, 1988, BIOCHEMISTRY-US, V27, P3966; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; GILBERT W, 1986, NATURE, V319, P818; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; JOYCE GF, 1987, P NATL ACAD SCI USA, V84, P4398, DOI 10.1073/pnas.84.13.4398; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; PICCIRILLI JA, 1989, THESIS HARVARD U; RICH A, 1962, HORIZONS BIOCH, V103, P103; ROY KB, 1983, NUCLEOS NUCLEOT, V2, P231, DOI 10.1080/07328318308078857; SCHRAMM G, 1961, ANGEW CHEM INT EDIT, V73, P619, DOI 10.1002/ange.19610731707; SWITZER C, 1989, J AM CHEM SOC, V111, P8322, DOI 10.1021/ja00203a067; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; USHER DA, 1976, P NATL ACAD SCI USA, V73, P1149, DOI 10.1073/pnas.73.4.1149; VISSER CM, 1978, J MOL EVOL, V11, P171, DOI 10.1007/BF01733892; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; WHITE HB, 1976, J MOL EVOL, V7, P101, DOI 10.1007/BF01732468	24	532	622	13	92	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					33	37		10.1038/343033a0	http://dx.doi.org/10.1038/343033a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1688644				2022-12-28	WOS:A1990CG61400043
J	DREXLER, H; ZEIHER, AM; MEINZER, K; JUST, H				DREXLER, H; ZEIHER, AM; MEINZER, K; JUST, H			CORRECTION OF ENDOTHELIAL DYSFUNCTION IN CORONARY MICROCIRCULATION OF HYPERCHOLESTEROLEMIC PATIENTS BY L-ARGININE	LANCET			English	Article							CHOLESTEROL-FED RABBITS; DEPENDENT RELAXATION; NITRIC-OXIDE; ARTERIES	Hypercholesterolaemia impairs endothelial function, possibly by interference with the intracellular formation of endothelium-derived relaxing factor from its precursor L-arginine. Whether L-arginine reverses hypercholesterolaemia-induced endothelial dysfunction in the coronary circulation was thus investigated. Epicardial artery cross-sectional area and coronary blood flow velocity were measured in 8 hypercholesterolaemic patients (mean serum cholesterol 7.8 [SE 0.3] mmol/l) and 7 age-matched controls before and after graded intracoronary infusions of the endothelium-dependent agent acetylcholine (0.036, 0.36, 3.6-mu-g/min). The effect of intracoronary infusion of L-arginine (160-mu-mol/min via the guiding catheter) on these measurements was then examined. In controls, acetylcholine induced a moderate dose-dependent constriction of the epicardial artery segment of the left anterior descending artery and increased coronary blood flow (by 239% [SE 57] at the highest dose). In patients with hypercholesterolaemia, the vasoconstrictive effect of acetylcholine on epicardial segments was similar to that in controls, but the increase in coronary blood flow with acetylcholine was significantly attenuated (highest dose: 61% [19), p < 0.02 vs controls). L-arginine restored the acetylcholine-induced increase in blood flow in patients with hypercholesterolaemia (198% [61] vs baseline) but did not affect coronary blood flow in controls. The findings suggest that hypercholesterolaemia impairs endothelium-dependent dilatation of the coronary microcirculation and that this impairment can be restored by short-term administration of L-arginine. The possibility that L-arginine might form the basis of treatment for coronary endothelial abnormalities induced by hypercholesterolaemia could be worth investigating.			DREXLER, H (corresponding author), UNIV FREIBURG, MED KLIN 3, W-7800 FREIBURG, GERMANY.							CALVER A, 1990, LANCET, V336, P1016; COHEN RA, 1988, CIRC RES, V63, P903, DOI 10.1161/01.RES.63.5.903; COOKE JP, 1991, CIRCULATION, V83, P1057, DOI 10.1161/01.CIR.83.3.1057; DREXLER H, 1991, HYPERTENSION, V18, P90, DOI 10.1161/01.HYP.18.4_Suppl.II90; DREXLER H, 1989, CIRCULATION, V80, P466, DOI 10.1161/01.CIR.80.3.466; DREXLER H, IN PRESS CIRCULATION; GALLE J, 1991, ARTERIOSCLER THROMB, V11, P198, DOI 10.1161/01.ATV.11.1.198; GIRERD XJ, 1990, CIRC RES, V67, P1301, DOI 10.1161/01.RES.67.6.1301; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; HENDERSON AH, 1991, BRIT HEART J, V65, P116; HOGAN JC, 1988, BRIT J PHARMACOL, V94, P1020, DOI 10.1111/j.1476-5381.1988.tb11616.x; LUDMER PL, 1986, NEW ENGL J MED, V315, P1046, DOI 10.1056/NEJM198610233151702; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; OSBORNE JA, 1989, AM J PHYSIOL, V256, pC591, DOI 10.1152/ajpcell.1989.256.3.C591; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; ROSSITCH E, 1991, J CLIN INVEST, V87, P1295, DOI 10.1172/JCI115132; RUBANYI GM, 1991, CIRCULATION, V83, P1118, DOI 10.1161/01.CIR.83.3.1118; SCHMIDT HHHW, 1988, EUR J PHARMACOL, V148, P293, DOI 10.1016/0014-2999(88)90578-X; SCHMIDT HHHW, 1990, BRIT J PHARMACOL, V101, P145, DOI 10.1111/j.1476-5381.1990.tb12104.x; SELLKE FW, 1990, CIRCULATION, V81, P1586, DOI 10.1161/01.CIR.81.5.1586; SHIMOKAWA H, 1989, CIRC RES, V64, P900, DOI 10.1161/01.RES.64.5.900; TAGAWA H, 1991, CIRC RES, V68, P330, DOI 10.1161/01.RES.68.2.330; TANNER FC, 1991, CIRCULATION, V83, P2012, DOI 10.1161/01.CIR.83.6.2012; VERBEUREN TJ, 1986, CIRC RES, V58, P552, DOI 10.1161/01.RES.58.4.552; WERNS SW, 1989, CIRCULATION, V79, P287, DOI 10.1161/01.CIR.79.2.287; WOLLSCHLAGER H, 1986, COMPUT CARDIOL, P483; YLAHERTTUALA S, 1991, J CLIN INVEST, V87, P1146, DOI 10.1172/JCI115111; ZEIHER AM, 1991, CIRCULATION, V84, P1984, DOI 10.1161/01.CIR.84.5.1984; ZEIHER AM, 1991, CIRCULATION, V83, P391, DOI 10.1161/01.CIR.83.2.391; ZEIHER AM, 1991, CIRCULATION S, V84, P652	31	719	791	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	1991	338	8782-3					1546	1550		10.1016/0140-6736(91)92372-9	http://dx.doi.org/10.1016/0140-6736(91)92372-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683971				2022-12-28	WOS:A1991GW03600003
J	SRIVASTAVA, RN; VASUDEV, AS; BAGGA, A				SRIVASTAVA, RN; VASUDEV, AS; BAGGA, A			LEVAMISOLE IN NEPHROTIC SYNDROME	LANCET			English	Letter											SRIVASTAVA, RN (corresponding author), ALL INDIA INST MED SCI,DEPT PAEDIAT,NEW DELHI 110029,INDIA.							MANNA AL, 1988, CHILD NEPHROL UROL, V9, P200; MONGEAU JG, 1988, PEDIATR NEPHROL, V2, P398, DOI 10.1007/BF00853429; SYMOENS J, 1978, CANCER TREAT REP, V62, P1721; 1991, LANCET, V337, P1555	4	7	7	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1275	1275		10.1016/0140-6736(91)92143-P	http://dx.doi.org/10.1016/0140-6736(91)92143-P			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682671				2022-12-28	WOS:A1991GQ16600046
J	HERROELEN, L; DEKEYSER, J; EBINGER, G				HERROELEN, L; DEKEYSER, J; EBINGER, G			CENTRAL-NERVOUS-SYSTEM DEMYELINATION AFTER IMMUNIZATION WITH RECOMBINANT HEPATITIS-B VACCINE	LANCET			English	Note								2 patients had neurological symptoms and signs, with evidence of central-nervous-system demyelination, 6 weeks after administration of recombinant hepatitis B vaccine. 1 had known multiple sclerosis but the other had no history of neurological disease; both had H LA haplotypes DR2 and B7, which are associated with multiple sclerosis. A causal link between vaccination and demyelination cannot be established from these 2 case-reports, but the time interval would fit a proposed immunological mechanism.			HERROELEN, L (corresponding author), FREE UNIV BRUSSELS HOSP,DEPT NEUROL,LAARBEEKLAAN 101,B-1090 BRUSSELS,BELGIUM.		De Keyser, Jacques/D-3725-2013	De Keyser, Jacques/0000-0002-3394-7757				Ebers G C, 1983, Neurol Clin, V1, P645; SHAW FE, 1988, AM J EPIDEMIOL, V127, P337, DOI 10.1093/oxfordjournals.aje.a114808; SRIRAM S, 1984, NEUROL CLIN, V2, P341, DOI 10.1016/S0733-8619(18)31107-1; 1990, WHO DRUG INFORMATION, V4, P129	4	137	140	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1174	1175		10.1016/0140-6736(91)92034-Y	http://dx.doi.org/10.1016/0140-6736(91)92034-Y			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682594				2022-12-28	WOS:A1991GP03400006
J	WHITEHEAD, M; DAHLGREN, G				WHITEHEAD, M; DAHLGREN, G			WHAT CAN BE DONE ABOUT INEQUALITIES IN HEALTH	LANCET			English	Article									INST FUTURE STUDIES,STOCKHOLM,SWEDEN	Institute for Futures Studies	WHITEHEAD, M (corresponding author), OLD SCH,ASH MAGNA,WHITCHURCH SY13 4DR,SHROPS,ENGLAND.							ACHESON ED, 1990, LANCET, V336, P1482; [Anonymous], 1980, INEQUALITIES HLTH RE; Carmichael C L, 1984, Community Dent Health, V1, P47; DAHLGREN G, IN PRESS WHO REGIONA; Enkin M, 1990, GUIDE EFFECTIVE CARE; GRAHAM H, 1989, HLTH PROMOTION, V3, P371; GUNNINGSCHEPERS L, 1991, MAY M EUR COMM PROJ; GUNNINGSCHEPERS LJ, 1989, SOCIOECONOMIC INEQUA; GUNNINGSCHEPERS LJ, 1989, HLTH PROMOTION, V4, P149; Illsley R., 1986, HLTH BURDEN SOCIAL I; JAMROZIK K, 1984, BRIT MED J, V288, P1499, DOI 10.1136/bmj.288.6429.1499; KOGEVINAS M, 1991, J EPIDEMIOL COMMUN H, V45, P216, DOI 10.1136/jech.45.3.216; KOHLER L, 1985, INEQUALITIES HLTH HL; LUNDBERG B, 1991, APR EUR C HLTH PROM; LUNDBERG B, 1990, 1 CTR PUBL HLTH RES; Lundberg O., 1990, OJAMLIKA OHALSAN KLA; MORRIS JN, 1990, LANCET, V336, P491, DOI 10.1016/0140-6736(90)92026-E; OAKLEY A, 1990, BRIT J OBSTET GYNAEC, V97, P155, DOI 10.1111/j.1471-0528.1990.tb01741.x; POUND A, 1991, CHILD ABUSE REV, V5, P7; REICH MR, 1984, AM J PUBLIC HEALTH, V74, P1031, DOI 10.2105/AJPH.74.9.1031; RODERICK P, 1991, BRIT MED J, V302, P157, DOI 10.1136/bmj.302.6769.157; SMITH R, 1987, UNEMPLOYMENT HLTH; TOWNSEND JL, 1987, APPL ECON, V19, P355, DOI 10.1080/00036848700000007; VOGEL J, 1988, INEQUALITY SWEDEN; WALD NJ, 1984, ANTENATAL NEONATAL S; Whitehead, 1988, HLTH DIVIDE; Whitehead M, 1990, CONCEPTS PRINCIPLES; WHITEHEAD M, 1988, GUARDIAN        1207; WNUKLIPINSKI E, 1990, SOC SCI MED, V31, P833, DOI 10.1016/0277-9536(90)90019-O; 1987, HLTH YEAR 2000 FINNI; 1991, HLTH NATION CONSULTA; [No title captured]; 1989, OCCUPATIONAL HLTH WO	33	180	194	1	88	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 26	1991	338	8774					1059	1063		10.1016/0140-6736(91)91911-D	http://dx.doi.org/10.1016/0140-6736(91)91911-D			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM253	1681366				2022-12-28	WOS:A1991GM25300014
J	ZAGURY, D				ZAGURY, D			ANTI-HIV CELLULAR IMMUNOTHERAPY IN AIDS	LANCET			English	Letter											ZAGURY, D (corresponding author), UNIV PARIS 06,F-75230 PARIS 05,FRANCE.							GUILLAUME JC, 1991, LANCET, V337, P1034, DOI 10.1016/0140-6736(91)92689-Y; PICARD O, 1991, J ACQ IMMUN DEF SYND, V4, P641; PICARD O, 1990, LANCET, V336, P179, DOI 10.1016/0140-6736(90)91699-B	3	13	14	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					694	695		10.1016/0140-6736(91)91269-Z	http://dx.doi.org/10.1016/0140-6736(91)91269-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679492				2022-12-28	WOS:A1991GF10500031
J	FREEDMAN, AS; MUNRO, JM; RICE, GE; BEVILACQUA, MP; MORIMOTO, C; MCINTYRE, BW; RHYNHART, K; POBER, JS; NADLER, LM				FREEDMAN, AS; MUNRO, JM; RICE, GE; BEVILACQUA, MP; MORIMOTO, C; MCINTYRE, BW; RHYNHART, K; POBER, JS; NADLER, LM			ADHESION OF HUMAN B-CELLS TO GERMINAL-CENTERS INVITRO INVOLVES VLA-4 AND INCAM-110	SCIENCE			English	Article									HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT IMMUNOL,HOUSTON,TX 77030	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center	FREEDMAN, AS (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115, USA.				NCI NIH HHS [CA40216] Funding Source: Medline; NHLBI NIH HHS [5T32HL07627-03] Funding Source: Medline; NIAMS NIH HHS [AR33713] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033713] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON AO, 1976, IMMUNOLOGY, V31, P731; BOYD AW, 1985, J IMMUNOL, V134, P1516; BOYD AW, 4TH INT WORKSH LEUK; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; BUTCHER EC, 1979, J IMMUNOL, V123, P1996; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; COSSMAN J, 1984, AM J PATHOL, V115, P117; DAVIGNON D, 1981, P NATL ACAD SCI-BIOL, V78, P4535, DOI 10.1073/pnas.78.7.4535; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FOSSUM S, 1985, HISTOPATHOLOGY, V9, P469, DOI 10.1111/j.1365-2559.1985.tb02830.x; FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224; FREEDMAN AM, UNPUB; FREEDMAN AS, 1987, LEUKEMIA, V1, P9; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; GUTMAN GA, 1972, IMMUNOLOGY, V23, P465; HARRIS NL, 1984, AM J PATHOL, V117, P262; HART DNJ, 1988, J EXP MED, V168, P157, DOI 10.1084/jem.168.1.157; HEINEN E, 1984, EUR J IMMUNOL, V14, P267, DOI 10.1002/eji.1830140312; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; INABA K, 1984, J EXP MED, V160, P858, DOI 10.1084/jem.160.3.858; JAFFE ES, 1974, NEW ENGL J MED, V290, P814; JALKANEN ST, 1986, EUR J IMMUNOL, V16, P1195, DOI 10.1002/eji.1830161003; KRAAL G, 1986, EUR J IMMUNOL, V16, P829, DOI 10.1002/eji.1830160718; KRAAL G, 1982, NATURE, V298, P377, DOI 10.1038/298377a0; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MANN RB, 1976, NEW ENGL J MED, V295, P685, DOI 10.1056/NEJM197609232951301; MINOWADA J, 1978, J NATL CANCER I, V60, P1269, DOI 10.1093/jnci/60.6.1269; MORIMOTO C, 1985, J IMMUNOL, V134, P3762; MUNRO M, UNPUB; NIEUWENHUIS P, 1974, IMMUNOLOGY, V26, P509; NIEUWENHUIS P, 1976, CELL IMMUNOL, V23, P254, DOI 10.1016/0008-8749(76)90191-X; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PICKER LJ, 1989, J IMMUNOL, V142, P2046; PISCHEL KD, 1987, J IMMUNOL, V138, P226; RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROUSE RV, 1982, J IMMUNOL, V128, P2243; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SANCHEZMADRID F, 1986, EUR J IMMUNOL, V16, P1344; SCHNIZLEIN CT, 1985, J IMMUNOL, V134, P1360; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STEIN H, 1982, CLIN HAEMATOL, V11, P531; STOOLMAN LM, 1983, J CELL BIOL, V96, P722, DOI 10.1083/jcb.96.3.722; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; SZAKAL AK, 1988, J IMMUNOL, V140, P341; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1990, J IMMUNOL, V144, P532; THORBECKE GJ, 1962, J EXP MED, V116, P295, DOI 10.1084/jem.116.3.295; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; [No title captured]	65	288	295	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 31	1990	249	4972					1030	1033		10.1126/science.1697696	http://dx.doi.org/10.1126/science.1697696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX004	1697696				2022-12-28	WOS:A1990DX00400043
J	DURRANT, I				DURRANT, I			LIGHT-BASED DETECTION OF BIOMOLECULES	NATURE			English	Article											DURRANT, I (corresponding author), AMERSHAM INT PLC,DNA LABELLING & DETECT PROGRAMME,WHITE LION RD,AMERSHAM HP7 9LL,BUCKS,ENGLAND.							BONISZEWSKI ZAM, 1990, IN PRESS ELECTROPHOR; DURRANT I, 1990, BIOTECHNIQUES, V8, P564; EVANS MR, 1990, IN PRESS 6TH P INT C; HASHIDA S, 1984, Journal of Applied Biochemistry, V6, P56; HODGSON M, 1989, J BIOLUM CHEMILUM, V3, P21, DOI 10.1002/bio.1170030105; POLLARDKNIGHT D, 1990, ANAL BIOCHEM, V185, P84, DOI 10.1016/0003-2697(90)90259-C; POLLARDKNIGHT D, 1990, TECHNIQUES, V2, P1; RENZ M, 1984, NUCLEIC ACIDS RES, V12, P3435, DOI 10.1093/nar/12.8.3435; SORG R, 1990, IN PRESS LIFE SCI, V2; THORPE GHG, 1987, BIOLUMINESCENCE CHEM; WHITEHEAD TP, 1983, NATURE, V305, P158, DOI 10.1038/305158a0; 1990, ECL TECHNICAL MANUAL	12	71	74	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 19	1990	346	6281					297	298		10.1038/346297a0	http://dx.doi.org/10.1038/346297a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP456	1695714				2022-12-28	WOS:A1990DP45600075
J	OKABE, S; HIROKAWA, N				OKABE, S; HIROKAWA, N			TURNOVER OF FLUORESCENTLY LABELED TUBULIN AND ACTIN IN THE AXON	NATURE			English	Article											OKABE, S (corresponding author), UNIV TOKYO, SCH MED, DEPT ANAT & CELL BIOL, TOKYO 113, JAPAN.			Okabe, Shigeo/0000-0003-1216-8890				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BAMBURG JR, 1986, NATURE, V321, P788, DOI 10.1038/321788a0; BLACK MM, 1980, J CELL BIOL, V86, P616, DOI 10.1083/jcb.86.2.616; GOLDENBERG SSS, 1983, J NEUROBIOL, V14, P195, DOI 10.1002/neu.480140304; HAMAGUCHI Y, 1987, CELL STRUCT FUNCT, V12, P43, DOI 10.1247/csf.12.43; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HIROKAWA N, 1985, J CELL BIOL, V101, P227, DOI 10.1083/jcb.101.1.227; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P223, DOI 10.1083/jcb.108.2.223; KEITH CH, 1987, SCIENCE, V235, P337, DOI 10.1126/science.2432662; KELLOGG DR, 1988, DEVELOPMENT, V103, P675; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KREIS TE, 1982, CELL, V29, P835, DOI 10.1016/0092-8674(82)90445-7; LIM SS, 1989, J CELL BIOL, V109, P253, DOI 10.1083/jcb.109.1.253; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; NIXON RA, 1986, J CELL BIOL, V102, P647, DOI 10.1083/jcb.102.2.647; OBLINGER MM, 1987, J NEUROSCI, V7, P453; OKABE S, 1989, J CELL BIOL, V109, P1581, DOI 10.1083/jcb.109.4.1581; OKABE S, 1988, J CELL BIOL, V107, P651, DOI 10.1083/jcb.107.2.651; OKABE S, 1989, P NATL ACAD SCI USA, V86, P4127, DOI 10.1073/pnas.86.11.4127; SALMON ED, 1984, J CELL BIOL, V99, P2157, DOI 10.1083/jcb.99.6.2157; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; TASHIRO T, 1989, J NEUROSCI, V9, P760; VIGERS GPA, 1988, J CELL BIOL, V107, P1011, DOI 10.1083/jcb.107.3.1011; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEISENBERG RC, 1987, SCIENCE, V238, P1119, DOI 10.1126/science.2446388; WILLARD M, 1974, P NATL ACAD SCI USA, V71, P2183, DOI 10.1073/pnas.71.6.2183; WOLF DE, 1989, METHOD CELL BIOL, V30, P271	30	152	152	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	1990	343	6257					479	482		10.1038/343479a0	http://dx.doi.org/10.1038/343479a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	1689016				2022-12-28	WOS:A1990CL81800066
J	KAJIWARA, K; HAHN, LB; MUKAI, S; TRAVIS, GH; BERSON, EL; DRYJA, TP				KAJIWARA, K; HAHN, LB; MUKAI, S; TRAVIS, GH; BERSON, EL; DRYJA, TP			MUTATIONS IN THE HUMAN RETINAL DEGENERATION SLOW GENE IN AUTOSOMAL DOMINANT RETINITIS-PIGMENTOSA	NATURE			English	Article							RHODOPSIN GENE; RDS; MICE	THE murine retinal degeneration slow (rds) gene is a semidominant mutation with a phenotype having rod and cone photoreceptors that develop abnormally and then slowly degenerate 1-3. The phenotype is a possible model for retinitis pigmentosa, one of the scores of hereditary human retinal degenerations, which is also characterized by photoreceptor degeneration. We report here three mutations of the human homologue of the rds gene (RDS) that cosegregate with autosomal dominant retinitis pigmentosa in separate families. Our results indicate that some cases of autosomal dominant retinitis pigmentosa are due to mutations at the RDS locus.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,HOWE LAB OPHTHALMOL,243 CHARLES ST,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA 02114; UNIV TEXAS,SW MED CTR,DEPT PSYCHIAT,DALLAS,TX 75237	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	DRYJA, TP (corresponding author), HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,HOWE LAB OPHTHALMOL,243 CHARLES ST,BOSTON,MA 02114, USA.		Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493				BEGY C, 1990, NUCLEIC ACIDS RES, V18, P3058, DOI 10.1093/nar/18.10.3058; BERSON EL, 1976, T AM ACAD OPHTHALMOL, V81, P659; COHEN AI, 1983, INVEST OPHTH VIS SCI, V24, P832; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; KEEN TJ, 1991, GENOMICS, V11, P199, DOI 10.1016/0888-7543(91)90119-Y; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; REICHEL E, 1989, AM J OPHTHALMOL, V108, P540, DOI 10.1016/0002-9394(89)90431-5; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; VANNIE R, 1978, TISSUE ANTIGENS, V12, P106, DOI 10.1111/j.1399-0039.1978.tb01305.x; YANDELL DW, 1989, CANCER CEL, V7, P223	19	376	388	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 12	1991	354	6353					480	483		10.1038/354480a0	http://dx.doi.org/10.1038/354480a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GV078	1684223				2022-12-28	WOS:A1991GV07800061
J	MURRAY, CJL; DEJONGHE, E; CHUM, HJ; NYANGULU, DS; SALOMAO, A; STYBLO, K				MURRAY, CJL; DEJONGHE, E; CHUM, HJ; NYANGULU, DS; SALOMAO, A; STYBLO, K			COST-EFFECTIVENESS OF CHEMOTHERAPY FOR PULMONARY TUBERCULOSIS IN 3 SUB-SAHARAN AFRICAN COUNTRIES	LANCET			English	Article							ONCHOCERCIASIS CONTROL PROGRAM; BLINDNESS PREVENTION; HIV	The value of programmes to control pulmonary tuberculosis in developing countries remains the subject of debate. We have examined the cost-effectiveness of chemotherapy programmes for the control of pulmonary sputum-smear-positive tuberculosis in Malawi, Mozambique, and Tanzania. Effective cure rates of 86-90% were achieved with short-course chemotherapy and of 60-66% with standard chemotherapy. The average incremental costs per year of life saved were US $1.7-2.1 for short-course chemotherapy with hospital admission $2.4-3.4 for standard chemotherapy with hospital admission, $0.9-1.1 for ambulatory short-course chemotherapy, and $0.9-1.3 for ambulatory standard chemotherapy. Chemotherapy for smear-positive tuberculosis is thus cheaper than other cost-effective health interventions such as immunisation against measles and oral rehydration therapy. Because the greatest benefit of chemotherapy is reduced transmission of the bacillus, treating HIV-seropositive, tuberculosis smear-positive patients would be only slightly less cost-effective than treating HIV-seronegative, tuberculosis-smear-positive patients.	MINIST HLTH,BRUSSELS,BELGIUM; MINIST HLTH,DAR ES SALAAM,TANZANIA; MINIST HLTH,LILONGWE,MALAWI; MINIST SAUDE,MAPUTO,MOZAMBIQUE; CTR SURVEILLANCE RES UNIT,THE HAGUE,NETHERLANDS		MURRAY, CJL (corresponding author), HARVARD UNIV,CTR POPULAT STUDIES,9 BOW ST,CAMBRIDGE,MA 02138, USA.							ANDREWS R H, 1960, Bull World Health Organ, V23, P463; BARNUM H, 1987, SOC SCI MED, V24, P833, DOI 10.1016/0277-9536(87)90184-5; BARNUM HN, 1986, SOC SCI MED, V23, P847, DOI 10.1016/0277-9536(86)90212-1; CAUTHEN GM, 1988, ANN RISK TUBERCULOSI, P154; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; Chorba R W, 1971, Health Serv Res, V6, P144; COLEBUNDERS RL, 1989, AM REV RESPIR DIS, V139, P1082, DOI 10.1164/ajrccm/139.5.1082; ELLIOTT AM, 1990, BRIT MED J, V301, P412, DOI 10.1136/bmj.301.6749.412; EVANS TG, 1987, SOC SCI MED, V25, P241, DOI 10.1016/0277-9536(87)90227-9; FELDSTEIN MS, 1973, B WORLD HEALTH ORGAN, V50, P1; GRZYBOWSKI S, 1976, Tubercle, V57, P1; Jamison Dean T., 1991, EVOLVING HLTH SECTOR; JOESOEF MR, 1989, INT J EPIDEMIOL, V18, P174, DOI 10.1093/ije/18.1.174; KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; OLAKOWSKI T, 1975, ASSIGNMENT REPORT TU; PROST A, 1984, B WORLD HEALTH ORGAN, V62, P795; REVELLE C, 1970, AM REV RESPIR DIS, V102, P403; Styblo K, 1980, Adv Tuberc Res, V20, P1; YANEZ A, 1982, Boletin de la Oficina Sanitaria Panamericana, V92, P127; 1974, B WORLD HEALTH ORGAN, V51, P473; 1959, B WORLD HEALTH ORGAN, V21, P44	22	150	152	0	9	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1305	1308		10.1016/0140-6736(91)92600-7	http://dx.doi.org/10.1016/0140-6736(91)92600-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682693				2022-12-28	WOS:A1991GR02300012
J	WEINTRAUB, M; SINGH, S; BYRNE, L; MAHARAJ, K; GUTTMACHER, L				WEINTRAUB, M; SINGH, S; BYRNE, L; MAHARAJ, K; GUTTMACHER, L			CONSEQUENCES OF THE 1989 NEW-YORK-STATE TRIPLICATE BENZODIAZEPINE PRESCRIPTION REGULATIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ABUSE	Objective. - Comparison of psychoactive medication prescribing and Medicaid expenditures before (1987 through 1988) and after (1989 through 1990) institution of the New York State triplicate benzodiazepine regulations. Data Sources. - The National Prescription Audit (IMS America, Plymouth Meeting, Pa), New York State Medicaid, and Blue Cross/Blue Shield of the Rochester (NY) Area. Results. - From 1988 to 1989, New York State benzodiazepine prescribing decreased by 44%, 60%, and 30% as assessed by IMS America, Medicaid, and Blue Cross/Blue Shield, respectively. Prescribing of the following alternative sedative-hypnotics increased in New York State compared with decreases nationally (IMS America data): meprobamate, + 125% vs - 9%; methyprylon, + 84% vs - 15%; ethchlorvynol, + 29% vs - 18%; butabarbital, + 31 % vs - 15%; hydroxyzine, + 15% vs - 1.1 %; and chloral hydrate, + 136% vs - 0.4%. increased prescribing of alternatives was also seen in the Medicaid and Blue Cross/Blue Shield data. Medicaid benzodiazepine expenditures decreased 52% from 1988 to 1989 ($21.7 million to $10.4 million). Alternative sedative expenditures increased 115% ($3.9 million to $8.4 million). Total Medicaid psychoactive medication expenditures remained nearly constant ($46.7 million to $45.6 million). Conclusion. - Although the triplicate regulations have decreased benzodiazepine prescribing, an undesirable increase has occurred in the prescribing of less acceptable medications. The wider public health, patient care, and financial implications of triplicate benzodiazepine regulations are of concern and require further study before other jurisdictions undertake similar programs.	UNIV ROCHESTER,SCH MED & DENT,DEPT PSYCHIAT,ROCHESTER,NY 14642	University of Rochester	WEINTRAUB, M (corresponding author), UNIV ROCHESTER,SCH MED & DENT,DEPT COMMUNITY & PREVENT MED,BOX 644,601 ELMWOOD AVE,ROCHESTER,NY 14642, USA.							BLACKWELL B, 1973, JAMA-J AM MED ASSOC, V223, P798, DOI 10.1001/jama.1973.03220070052017; BRAHAMS D, 1990, LANCET, V336, P1372, DOI 10.1016/0140-6736(90)92914-4; EADIE JL, 1988, DEC AM MED ASS NAT S; FINKLE BS, 1979, JAMA-J AM MED ASSOC, V242, P429, DOI 10.1001/jama.242.5.429; KAUFMAN A, 1972, J AMER MED ASSOC, V221, P1504, DOI 10.1001/jama.221.13.1504; KUNIN CM, 1973, ANN INTERN MED, V79, P555, DOI 10.7326/0003-4819-79-4-555; MADDALONI M A, 1990, Veterinary and Human Toxicology, V32, P355; MARKS J, 1985, BENZODIAZEPINES USE; PRESCOTT LP, 1983, BENZODIAZEPINES MOL, P252; RALL T W, 1990, P345; ROACHE JD, 1987, J PHARMACOL EXP THER, V243, P978; RODOS JJ, 1990, J AM OSTEOPATH ASSOC, V90, P26; SHENFIELD GM, 1980, BRIT MED J, V281, P651, DOI 10.1136/bmj.281.6241.651; WOODS JH, 1988, JAMA-J AM MED ASSOC, V260, P3476, DOI 10.1001/jama.260.23.3476; 1987, NEW YORK STAT R 0831; 1990, NEW YORK STATES REGU; 1989, EPIDEMIOL NOTES, P4; 1982, WHO6TH REP; 1990, EPIDEMIOL NOTES, P5; 1990, BENZODIAZEPINE DEPEN	20	123	127	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 6	1991	266	17					2392	2397		10.1001/jama.266.17.2392	http://dx.doi.org/10.1001/jama.266.17.2392			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM790	1681121				2022-12-28	WOS:A1991GM79000025
J	SAUERBRUCH, T; PAUMGARTNER, G				SAUERBRUCH, T; PAUMGARTNER, G			GALLBLADDER STONES - MANAGEMENT	LANCET			English	Article							SHOCK-WAVE LITHOTRIPSY; TERT-BUTYL ETHER; URSODEOXYCHOLIC ACID; CHENODEOXYCHOLIC ACID; GALLSTONE RECURRENCE; CHOLESTEROL GALLSTONES; DISSOLUTION; EFFICACY; SAFETY; CATHETER				SAUERBRUCH, T (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,MARCHIONINISTR 15,W-8000 MUNICH 70,GERMANY.							ALLEN MJ, 1985, GASTROENTEROLOGY, V88, P122, DOI 10.1016/S0016-5085(85)80143-8; ALLEN MJ, 1985, NEW ENGL J MED, V312, P217, DOI 10.1056/NEJM198501243120406; BATESON MC, 1990, LANCET, P1196; CHIVERTON SG, 1990, BRIT MED J, V300, P1310, DOI 10.1136/bmj.300.6735.1310; CUSCHIERI A, 1991, AM J SURG, V161, P385, DOI 10.1016/0002-9610(91)90603-B; DANZINGE.RG, 1973, J CLIN INVEST, V52, P2809, DOI 10.1172/JCI107477; DANZINGER RG, 1972, NEW ENGL J MED, V286, P1, DOI 10.1056/NEJM197201062860101; DUBOIS F, 1990, ANN SURG, V211, P60, DOI 10.1097/00000658-199001000-00010; ELL C, 1990, GASTROENTEROLOGY, V99, P1439, DOI 10.1016/0016-5085(90)91173-4; FACHE JS, 1990, RADIOLOGY, V177, P719, DOI 10.1148/radiology.177.3.2243975; FOERSTER EC, 1988, ENDOSCOPY, V20, P30, DOI 10.1055/s-2007-1018121; Fromm H, 1988, Adv Intern Med, V33, P409; GLEESON D, 1990, Q J MED, V76, P711; GREINER L, 1990, GASTROENTEROLOGY, V98, P1620, DOI 10.1016/0016-5085(90)91099-R; HOLL J, 1991, DIGEST DIS SCI, V36, P1097, DOI 10.1007/BF01297453; HOOD K, 1988, LANCET, V2, P1223; Langenbuch, 1882, BERL KLIN WOCHENSCHR, V19, P725; LEUSCHNER U, 1991, DIGEST DIS SCI, V36, P193, DOI 10.1007/BF01300756; LOGAN GM, 1990, GASTROENTEROLOGY, V98, P1572, DOI 10.1016/0016-5085(90)91092-K; MCCULLOUGH J E, 1990, Gastroenterology, V98, pA255; MILLER FJ, 1991, RADIOLOGY, V178, P781, DOI 10.1148/radiology.178.3.1994418; NAKAGAWA S, 1977, LANCET, V2, P367; NORTHFIELD TC, 1990, STRATEGIES TREATMENT, P163; PODDA M, 1989, GASTROENTEROLOGY, V96, P222, DOI 10.1016/0016-5085(89)90784-1; PONCHON T, 1988, LANCET, V2, P276; REWBRIDGE AG, 1936, SURGERY, V33, P395; SACKMANN M, 1991, ANN INTERN MED, V114, P290, DOI 10.7326/0003-4819-114-4-290; SACKMANN M, 1990, GASTROENTEROLOGY, V98, P392, DOI 10.1016/0016-5085(90)90830-T; SACKMANN M, 1990, HEPATOLOGY, V12, pA869; SAUERBRUCH T, 1986, NEW ENGL J MED, V314, P818, DOI 10.1056/NEJM198603273141304; SCHOENFIELD LJ, 1990, NEW ENGL J MED, V323, P1239, DOI 10.1056/NEJM199011013231804; SCHOENFIELD LJ, 1981, ANN INTERN MED, V95, P257, DOI 10.7326/0003-4819-95-3-257; SOEHENDRA N, 1990, ENDOSCOPY, V22, P176, DOI 10.1055/s-2007-1012834; THISTLE JL, 1989, NEW ENGL J MED, V320, P633, DOI 10.1056/NEJM198903093201004; VILLANOVA N, 1989, GASTROENTEROLOGY, V97, P726, DOI 10.1016/0016-5085(89)90644-6; WENZEL H, 1990, DEUT MED WOCHENSCHR, V115, P77; 1991, NEW ENGL J MED, V324, P1073	37	26	26	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1121	1124		10.1016/0140-6736(91)91973-X	http://dx.doi.org/10.1016/0140-6736(91)91973-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682551				2022-12-28	WOS:A1991GM78400013
J	THOMPSON, SG; POCOCK, SJ				THOMPSON, SG; POCOCK, SJ			CAN META-ANALYSES BE TRUSTED	LANCET			English	Editorial Material							CLINICAL-TRIALS; RANDOMIZED TRIALS; PUBLICATION BIAS	The enthusiasm for meta-analyses (or overviews) expressed by their proponents is not always shared by the broader medical community. To encourage constructive debate, we adopt a critical perspective on the conduct and interpretation of meta-analysis. We focus particularly on some of the statistical issues, especially heterogeneity between studies, and also on the extrapolation of meta-analysis findings to clinical practice. We conclude that meta-analysis is not an exact statistical science that provides definitive simple answers to complex clinical problems. It is more appropriately viewed as a valuable objective descriptive technique, which often furnishes clear qualitative conclusions about broad treatment policies, but whose quantitative results have to be interpreted cautiously.			THOMPSON, SG (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED, MED STAT UNIT, KEPPEL ST, LONDON WC1E 7HT, ENGLAND.							ARMITAGE P, 1987, STATISTICAL METHODS, P194; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; CHALMERS I, 1989, EFFECTIVE CARE PREGN, V1; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; COLLINS R, 1985, BMJ-BRIT MED J, V290, P17, DOI 10.1136/bmj.290.6461.17; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; DICKERSIN K, 1985, CONTROL CLIN TRIALS, V6, P306, DOI 10.1016/0197-2456(85)90106-0; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GREENLAND S, 1990, STAT MED, V9, P247, DOI 10.1002/sim.4780090307; LAW MR, 1991, CANCER CAUSE CONTROL, V2, P253, DOI 10.1007/BF00052142; LONGNECKER M P, 1988, Journal of the American Medical Association, V260, P652, DOI 10.1001/jama.260.5.652; MANTEL N, 1959, J NATL CANCER I, V22, P719; PETO R, 1987, STAT MED, V6, P233, DOI 10.1002/sim.4780060306; POCOCK SJ, 1991, CORONARY HEART DISEA; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; SPECTOR TD, 1991, J EPIDEMIOL COMMUN H, V45, P89, DOI 10.1136/jech.45.2.89; WHITEHEAD A, IN PRESS STAT MED; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; 1988, BRIT MED J, V296, P320; 1990, TREATMENT EARLY BREA	23	401	404	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 2	1991	338	8775					1127	1130		10.1016/0140-6736(91)91975-Z	http://dx.doi.org/10.1016/0140-6736(91)91975-Z			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682553				2022-12-28	WOS:A1991GM78400015
J	WHITWORTH, JAG; GILBERT, CE; MABEY, DM; MAUDE, GH; MORGAN, D; TAYLOR, DW				WHITWORTH, JAG; GILBERT, CE; MABEY, DM; MAUDE, GH; MORGAN, D; TAYLOR, DW			EFFECTS OF REPEATED DOSES OF IVERMECTIN ON OCULAR ONCHOCERCIASIS - COMMUNITY-BASED TRIAL IN SIERRA-LEONE	LANCET			English	Article							WEST-AFRICAN SAVANNA; DIETHYLCARBAMAZINE; CHEMOTHERAPY; INVOLVEMENT; INFECTION; INTENSITY; SURAMIN; PLACEBO; LESIONS	Ivermectin seems to be a safe and effective treatment for onchocerciasis when given in a single dose, but less is known about the effects of repeated doses. Also, there seem to be differences in its effectiveness in anterior and posterior segment ocular disease. The ocular effects of ivermectin were studied in 586 villagers who were taking part in a double-blind, placebo-controlled, randomised trial in Sierra Leone. Only those who had received four doses, with 6-month intervals, of ivermectin or placebo were eligible. The 296 ivermectin-treated subjects and the 272 who received placebo were comparable with respect to age, sex, Onchocerca infection, blindness, and visual impairment before treatment. After treatment, the ivermectin group had less anterior segment disease than the placebo group, with significantly lower prevalences of microfilariae in the anterior chamber and cornea, and punctate keratitis (all p < 0.001), and iritis (p < 0.05). There was no significant difference in the prevalence of sclerosing keratitis, optic atrophy, or chorioretinitis between the groups. Visual acuities tended to be better in the ivermectin group, but the difference was not significant. There was a small but significant (p < 0.01) excess of vascular sheathing in the ivermectin group. These differences persisted when subjects who were blind or visually impaired at baseline were excluded from analysis. The long-term effects of ivermectin, particularly on posterior segment disease, need further evaluation. in the mean time, the mass distribution of ivermectin should be promoted for all communities with hyperendemic onchocerciasis at risk of anterior segment disease.	MRC LABS,BO,SIERRA LEONE; UNIV LONDON LONDON SCH HYG & TROP MED,DEPT TROP MED & INFECT DIS,LONDON WC1E 7HT,ENGLAND; INST OPHTHALMOL,DEPT PREVENT OPHTHALMOL,LONDON WC1H 9QS,ENGLAND; WESTERN OPHTHALM HOSP,LONDON,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Cambridge	WHITWORTH, JAG (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,KEPPEL ST,LONDON WC1E 7HT,ENGLAND.			Mabey, David/0000-0002-0031-8276				ANDERSON J, 1976, TROPENMED PARASITOL, V27, P263; Anderson J, 1977, Trop Dis Bull, V74, P257; ANDERSON J, 1974, T ROY SOC TROP MED H, V68, P190, DOI 10.1016/0035-9203(74)90116-3; ANDERSON J, 1976, TROPENMED PARASITOL, V27, P279; AWADZI K, 1985, ANN TROP MED PARASIT, V79, P63, DOI 10.1080/00034983.1985.11811889; AWADZI K, 1986, ANN TROP MED PARASIT, V80, P433, DOI 10.1080/00034983.1986.11812044; BIRD AC, 1979, LANCET, V2, P46; BROWN KR, 1990, ACTA LEIDENSIA, V59, P443; BUCK AA, 1974, ONCHOCERCIASIS; CHAN CC, 1987, OPHTHALMOLOGY, V94, P439; DADZIE KY, 1986, TROP MED PARASITOL, V37, P263; DADZIE KY, 1989, TROP MED PARASITOL, V40, P355; DADZIE KY, 1990, T ROY SOC TROP MED H, V84, P103, DOI 10.1016/0035-9203(90)90395-U; GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301; MCMAHON JE, 1988, T ROY SOC TROP MED H, V82, P601, DOI 10.1016/0035-9203(88)90525-1; MURPHY RP, 1984, AM J OPHTHALMOL, V98, P519, DOI 10.1016/0002-9394(84)90147-8; NEWLAND HS, 1988, BRIT J OPHTHALMOL, V72, P561, DOI 10.1136/bjo.72.8.561; ODAY J, 1985, TROP DOCT, V15, P87, DOI 10.1177/004947558501500213; REMME J, 1989, TROP MED PARASITOL, V40, P340; ROTHOVA A, 1989, LANCET, V1, P1439; ROTHOVA A, 1990, AM J OPHTHALMOL, V110, P6, DOI 10.1016/S0002-9394(14)76930-2; SEMBA RD, 1990, OPHTHALMOLOGY, V97, P1334; TAYLOR HR, 1989, AM J TROP MED HYG, V40, P494, DOI 10.4269/ajtmh.1989.40.494; TAYLOR HR, 1986, ARCH OPHTHALMOL-CHIC, V104, P863, DOI 10.1001/archopht.1986.01050180097039; THYLEFORS B, 1979, B WORLD HEALTH ORGAN, V57, P479; THYLEFORS B, 1989, COMMUNITY EYE HLTH, V3, P5; WALSH JF, 1979, TROPENMED PARASITOL, V30, P328; WHITWORTH JAG, 1988, LANCET, V2, P97; WHITWORTHJAG, 1991, T R SOC TROP MED HYG, V85, P92; 1987, TECHNICAL REPORT SER, V752	30	34	35	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1100	1103		10.1016/0140-6736(91)91963-U	http://dx.doi.org/10.1016/0140-6736(91)91963-U			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682543				2022-12-28	WOS:A1991GM78400003
J	BRAHAMS, D				BRAHAMS, D			TRIAZOLAM SUSPENDED	LANCET			English	Editorial Material																		BRAHAMS D, 1991, LANCET, V338, P502, DOI 10.1016/0140-6736(91)90565-7; BRAHAMS D, 1991, LANCET, V338, P243, DOI 10.1016/0140-6736(91)90367-X; OSWALD I, 1991, LANCET, V338, P516, DOI 10.1016/0140-6736(91)90592-D	3	13	13	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					938	938		10.1016/0140-6736(91)91792-S	http://dx.doi.org/10.1016/0140-6736(91)91792-S			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681280				2022-12-28	WOS:A1991GJ89900018
J	FARGIER, JJ; LOUIS, FJ; COT, M; MAUBERT, B; HOUNSINOU, C; LOUIS, JP; LEBRAS, J; TOUZE, JE				FARGIER, JJ; LOUIS, FJ; COT, M; MAUBERT, B; HOUNSINOU, C; LOUIS, JP; LEBRAS, J; TOUZE, JE			REDUCTION OF COMA BY QUININE LOADING DOSE IN FALCIPARUM CEREBRAL MALARIA	LANCET			English	Letter									ORSTOM, OCEAC, MED ENTOMOL UNIT, YAOUNDE, CAMEROON; ORSTOM, OCEAC, EPIDEMOL UNIT, YAOUNDE, CAMEROON; CTR NATL REFERENCE CHIMIOSENSIBIL PALUDISME, IMET, PARIS, FRANCE; SERV SANTE ARMEES, INST MED TROP, MARSEILLE, FRANCE	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD)	FARGIER, JJ (corresponding author), HOP CENT YAOUNDE, INTENS CARE UNIT, YAOUNDE, CAMEROON.		Cot, Michel/E-7633-2011	Cot, Michel/0000-0003-3014-4294				DAVIS TME, 1990, J INFECT DIS, V161, P1305, DOI 10.1093/infdis/161.6.1305; HENGY C, 1990, B SOC FR PARASITO S1, V8, P430; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; WHITE NJ, 1982, AM J MED, V73, P564, DOI 10.1016/0002-9343(82)90337-0; [No title captured]	5	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	1991	338	8771					896	897		10.1016/0140-6736(91)91563-A	http://dx.doi.org/10.1016/0140-6736(91)91563-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681260				2022-12-28	WOS:A1991GH94500063
J	DOHERTY, P; ASHTON, SV; MOORE, SE; WALSH, FS				DOHERTY, P; ASHTON, SV; MOORE, SE; WALSH, FS			MORPHOREGULATORY ACTIVITIES OF NCAM AND N-CADHERIN CAN BE ACCOUNTED FOR BY G PROTEIN-DEPENDENT ACTIVATION OF L-TYPE AND N-TYPE NEURONAL CA2+ CHANNELS	CELL			English	Article							NERVE GROWTH-FACTOR; CELL-ADHESION MOLECULES; NEURITE OUTGROWTH; PC12 CELLS; KINASE-C; EXTRACELLULAR-MATRIX; EXPRESSION; CALCIUM; CAM; MUSCLE	We present evidence that the morphoregulatory activities of neural cell adhesion molecule (NCAM) and N-cadherin involve activation of intracellular second messenger pathways. PC12 cells were cultured on monolayers of control 3T3 cells or 3T3 cells expressing transfected N-cadherin or NCAM. NCAM and N-cadherin directly induced a transcription-independent change in the morphology of PC12 cells from an adrenal to neuronal phenotype and also specifically increased Thy-1, but not L1/NILE or low affinity NGF receptor, immunoreactivity. The morphological response was more rapid and, in the case of N-cadherin, more substantial than that induced by NGF. It could be fully inhibited by pertussis toxin and a combination of L- and N-type Ca2+ channel antagonists, but not by broad-specificity kinase inhibitors. It was blocked, however, by the kinase inhibitor K-252b. These studies suggest that cell adhesion molecules directly alter cell phenotype and provide direct evidence for transmembrane signaling mediating both the morphological and biochemical responses induced by NCAM and N-cadherin.			DOHERTY, P (corresponding author), UNIV MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT EXPTL PATHOL,LONDON BRIDGE,LONDON SE1 9RT,ENGLAND.		Doherty, Patrick/A-8752-2008		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; BIXBY JL, 1990, J CELL BIOL, V111, P2725, DOI 10.1083/jcb.111.6.2725; BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555; BOTELHO LHP, 1988, METHOD ENZYMOL, V159, P159; CAMPENOT RB, 1989, NEURON, V3, P733, DOI 10.1016/0896-6273(89)90242-0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; DICKSON G, 1990, NATURE, V344, P348, DOI 10.1038/344348a0; DOHERTY P, 1987, DEVELOPMENT, V101, P605; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; DOHERTY P, 1987, J NEUROCHEM, V49, P610, DOI 10.1111/j.1471-4159.1987.tb02907.x; DOHERTY P, 1988, EXP CELL RES, V179, P233, DOI 10.1016/0014-4827(88)90362-X; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOHERTY P, 1989, J CELL BIOL, V109, P789, DOI 10.1083/jcb.109.2.789; DOHERTY P, 1991, NEURON, V6, P247, DOI 10.1016/0896-6273(91)90360-C; DOHERTY P, 1988, J CELL BIOL, V107, P333, DOI 10.1083/jcb.107.1.333; DOHERTY P, 1988, NEUROSCI LETT, V92, P222, DOI 10.1016/0304-3940(88)90065-1; Doherty P, 1989, CURR OPIN CELL BIOL, V1, P1102, DOI 10.1016/S0955-0674(89)80057-2; DOLPHIN AC, 1990, ANNU REV PHYSIOL, V52, P243; EDELMAN GM, 1987, P NATL ACAD SCI USA, V84, P8502, DOI 10.1073/pnas.84.23.8502; ERNSBERGER U, 1989, DEV BIOL, V135, P250, DOI 10.1016/0012-1606(89)90177-2; FUJIMOTO M, 1991, NEUROSCI LETT, V122, P9, DOI 10.1016/0304-3940(91)90180-2; GREENE LA, 1984, TRENDS NEUROSCI, V7, P91, DOI 10.1016/S0166-2236(84)80164-2; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P424; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; GUNNING PW, 1981, J NEUROSCI, V1, P1085; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; INOUE K, 1988, J BIOL CHEM, V263, P8157; KATER SB, 1991, J NEUROSCI, V11, P891; KINTNER CR, 1987, DEVELOPMENT, V99, P311; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; KOIZUMI S, 1988, J NEUROSCI, V8, P715; LENDAHL U, 1990, TRENDS NEUROSCI, V13, P132, DOI 10.1016/0166-2236(90)90004-T; MANN DA, 1989, J NEUROCHEM, V53, P1581, DOI 10.1111/j.1471-4159.1989.tb08555.x; MATSUNAGA M, 1988, NATURE, V334, P62, DOI 10.1038/334062a0; MATTHIES HJG, 1987, J NEUROSCI, V7, P1198; MOORE SE, 1987, J CELL BIOL, V105, P1377, DOI 10.1083/jcb.105.3.1377; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; PIZZEY JA, 1989, J CELL BIOL, V109, P3465, DOI 10.1083/jcb.109.6.3465; PLUMMER MR, 1989, NEURON, V2, P1453, DOI 10.1016/0896-6273(89)90191-8; PRENTICE HM, 1987, EMBO J, V6, P1859, DOI 10.1002/j.1460-2075.1987.tb02444.x; REBER BFX, 1991, J PHYSIOL-LONDON, V435, P145, DOI 10.1113/jphysiol.1991.sp018502; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SCOTT RH, 1990, MOL PHARMACOL, V38, P711; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SILVER RA, 1990, NATURE, V343, P751, DOI 10.1038/343751a0; STRITTMATTER SM, 1991, BIOESSAYS, V13, P127, DOI 10.1002/bies.950130306; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TAKEICHI M, 1991, DEVELOPMENT, V251, P1451; TOGARI A, 1985, J NEUROSCI, V5, P307; WALSH FS, 1990, J NEUROCHEM, V55, P805, DOI 10.1111/j.1471-4159.1990.tb04563.x; WALSH FS, 1991, IN PRESS SEMIN NEURO, V3	57	388	395	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 4	1991	67	1					21	33		10.1016/0092-8674(91)90569-K	http://dx.doi.org/10.1016/0092-8674(91)90569-K			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GJ320	1680564				2022-12-28	WOS:A1991GJ32000004
J	HUNT, P; KRUMLAUF, R				HUNT, P; KRUMLAUF, R			DECIPHERING THE HOX CODE - CLUES TO PATTERNING BRANCHIAL REGIONS OF THE HEAD	CELL			English	Review							CONTAINING GENES; NEURAL CREST; EXPRESSION; DROSOPHILA; HINDBRAIN; MURINE; ORGANIZATION; SEGMENTATION; EMBRYO; MESENCHYME				HUNT, P (corresponding author), NATL INST MED RES,MRC,LONDON NW7 1AA,ENGLAND.		Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927				AKAM M, 1987, DEVELOPMENT, V101, P1; BONCINELLI E, 1989, GENOME, V31, P745, DOI 10.1139/g89-133; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DRESSLER GR, 1989, DIFFERENTIATION, V41, P193, DOI 10.1111/j.1432-0436.1989.tb00747.x; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; HUNT P, 1991, DEVELOPMENT, V112, P43; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KESSEL M, 1991, IN PRESS CELL, V67; Le Douarin N., 1999, DEV CELL BIOL SERIES, V2nd, DOI [10.1017/CBO9780511897948, DOI 10.1017/CBO9780511897948, 10.1017/cbo9780511897948]; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LIM T, 1991, IN PRESS DEVELOPMENT, V113; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LUMSDEN A, 1990, TRENDS NEUROSCI, V13, P329, DOI 10.1016/0166-2236(90)90144-Y; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; MURPHY P, 1991, DEVELOPMENT, V111, P61; NICHOLS DH, 1986, AM J ANAT, V176, P221, DOI 10.1002/aja.1001760210; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; NODEN DM, 1988, DEVELOPMENT, V103, P121; PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0; STERN C, 1991, IN PRESS DEVELOPMENT, V113; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0	27	139	143	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 20	1991	66	6					1075	1078		10.1016/0092-8674(91)90029-X	http://dx.doi.org/10.1016/0092-8674(91)90029-X			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GG552	1680562				2022-12-28	WOS:A1991GG55200003
J	COPELAND, NG; GILBERT, DJ; CHO, BC; DONOVAN, PJ; JENKINS, NA; COSMAN, D; ANDERSON, D; LYMAN, SD; WILLIAMS, DE				COPELAND, NG; GILBERT, DJ; CHO, BC; DONOVAN, PJ; JENKINS, NA; COSMAN, D; ANDERSON, D; LYMAN, SD; WILLIAMS, DE			MAST-CELL GROWTH-FACTOR MAPS NEAR THE STEEL LOCUS ON MOUSE CHROMOSOME-10 AND IS DELETED IN A NUMBER OF STEEL ALLELES	CELL			English	Article									IMMUNEX CORP,DEPT EXPTL HEMATOL,SEATTLE,WA 98101; IMMUNEX CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101	Immunex Corporation; Immunex Corporation	COPELAND, NG (corresponding author), FREDERICK CANC RES & DEV CTR,NCI,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK,MD 21702, USA.				OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; Beechey C.V., 1986, MOUSE NEWS LETT, V74, P92; BEECHEY CV, 1985, MOUSE NEWS LETT, V73, P17; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; BERNSTEIN SE, 1968, ANN NY ACAD SCI, V149, P475, DOI 10.1111/j.1749-6632.1968.tb15186.x; BERNSTEIN SE, 1960, MOUSE NEWS LETT, V23, P33; BUCHBERG AM, 1988, ONCOGENE RES, V2, P149; CACHEIRO NLA, 1975, GENET RES, V25, P193, DOI 10.1017/S0016672300015597; CATTANACH BM, 1988, MOUSE NEWS LETT, V80, P157; CATTANACH BM, 1980, MOUSE NEWS LETT, V80, P156; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; FALCONER DS, 1965, MOUSE NEWS LETT, V32, P30; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1981, GENETICS, V97, P337; GREEN EL, 1981, MOUSE BIOMEDICAL RES, V1, P91; HAYASHI C, 1985, DEV BIOL, V109, P234, DOI 10.1016/0012-1606(85)90363-X; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JUSTICE MJ, 1990, GENOMICS, V6, P341, DOI 10.1016/0888-7543(90)90575-F; JUSTICE MJ, 1990, GENETICS, V125, P855; KITAMURA Y, 1979, BLOOD, V53, P492; LEDLEY FD, 1988, CYTOGENET CELL GENET, V47, P125, DOI 10.1159/000132528; MAJUMDER S, 1988, MOL CELL BIOL, V8, P4896, DOI 10.1128/MCB.8.11.4896; MAYER TC, 1970, DEV BIOL, V23, P297, DOI 10.1016/0012-1606(70)90100-4; MAYER TC, 1968, DEV BIOL, V18, P62, DOI 10.1016/0012-1606(68)90023-7; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MCCUSKEY RS, 1973, AM J ANAT, V137, P187, DOI 10.1002/aja.1001370205; MITCHELL M, 1989, GENETICS, V121, P803; MORRISONGRAHAM K, 1990, DEV BIOL, V139, P308, DOI 10.1016/0012-1606(90)90300-8; MORRISONGRAHAM K, 1989, TRENDS GENET, V5, P116, DOI 10.1016/0168-9525(89)90042-5; MORRISONGRAHAM K, 1990, DEV BIOL, V139, P299, DOI 10.1016/0012-1606(90)90299-X; NAKAYAMA H, 1988, DEVELOPMENT, V102, P117; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; PETERS J, 1985, GENETICS, V110, P709; PETERS J, 1987, MOUSE NEWS LETT, V77, P125; POPP RA, 1983, GENETICS, V105, P157; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL LB, 1971, MUTAT RES, V11, P107, DOI 10.1016/0027-5107(71)90036-4; RUSSELL LB, 1989, MUTAT RES, V212, P23, DOI 10.1016/0027-5107(89)90019-5; RUSSELL WL, 1981, ENV MUTAGENS CARCINO, P59; SARVELLA PATRICIA A., 1956, JOUR HEREDITY, V47, P123; SCHAIBLE RH, 1961, MOUSE NEWS LETT, V24, P38; SCHAIBLE RH, 1963, MOUSE NEWS LETT, V29, P48; Silver W. K., 1979, COAT COLORS MICE MOD, P243; STEVENS LC, 1961, J NATL CANCER I, V27, P443; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; WILLIAMS DE, 1990, CELL, V62, P167; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	53	603	622	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 5	1990	63	1					175	183		10.1016/0092-8674(90)90298-S	http://dx.doi.org/10.1016/0092-8674(90)90298-S			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EB461	1698554				2022-12-28	WOS:A1990EB46100018
J	ELLINGTON, AD; SZOSTAK, JW				ELLINGTON, AD; SZOSTAK, JW			INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS	NATURE			English	Article									MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital								ARNOLD FH, 1986, J CHROMATOGR, V355, P1, DOI 10.1016/S0021-9673(01)97299-1; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; COUTURE S, IN PRESS J MOL BIOL; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669	9	7103	8002	76	1259	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 30	1990	346	6287					818	822		10.1038/346818a0	http://dx.doi.org/10.1038/346818a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW488	1697402				2022-12-28	WOS:A1990DW48800045
J	ETLINGER, HM; GILLESSEN, D; LAHM, HW; MATILE, H; SCHONFELD, HJ; TRZECIAK, A				ETLINGER, HM; GILLESSEN, D; LAHM, HW; MATILE, H; SCHONFELD, HJ; TRZECIAK, A			USE OF PRIOR VACCINATIONS FOR THE DEVELOPMENT OF NEW VACCINES	SCIENCE			English	Article											ETLINGER, HM (corresponding author), F HOFFMANN LA ROCHE & CO LTD,CENT RES UNIT,CH-4002 BASEL,SWITZERLAND.							ADORINI L, 1979, J EXP MED, V150, P293, DOI 10.1084/jem.150.2.293; ALLISON AC, 1986, J IMMUNOL METHODS, V95, P157, DOI 10.1016/0022-1759(86)90402-3; ANDERSON P, 1985, J CLIN INVEST, V76, P52, DOI 10.1172/JCI111976; Atherton E., 1987, PEPTIDES ANAL SYNTHE, V9, P1; BORRASCUESTA F, 1987, EUR J IMMUNOL, V17, P1213, DOI 10.1002/eji.1830170820; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; DELGIUDICE G, 1986, J IMMUNOL, V137, P2952; DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048; ETLINGER HM, 1988, IMMUNOLOGY, V64, P551; ETLINGER HM, 1988, J IMMUNOL, V140, P626; ETLINGER HM, UNPUB; FRANCIS MJ, 1987, NATURE, V330, P168, DOI 10.1038/330168a0; GEERLIGS HJ, 1989, J IMMUNOL METHODS, V124, P95, DOI 10.1016/0022-1759(89)90190-7; GOOD MF, 1986, J EXP MED, V164, P655, DOI 10.1084/jem.164.2.655; HERRINGTON DA, 1987, NATURE, V328, P257, DOI 10.1038/328257a0; HERZENBERG LA, 1982, J EXP MED, V155, P1741, DOI 10.1084/jem.155.6.1741; HERZENBERG LA, 1982, J EXP MED, V155, P1730, DOI 10.1084/jem.155.6.1730; JACOB CO, 1985, MOL IMMUNOL, V22, P1333, DOI 10.1016/0161-5890(85)90054-9; LEWIS GK, 1978, J EXP MED, V148, P915, DOI 10.1084/jem.148.4.915; LISE LD, 1987, INFECT IMMUN, V55, P2658, DOI 10.1128/IAI.55.11.2658-2661.1987; MITCHISON N A, 1971, European Journal of Immunology, V1, P10, DOI 10.1002/eji.1830010103; MOREIN B, 1984, NATURE, V308, P457, DOI 10.1038/308457a0; PANINABORDIGNON P, 1989, EUR J IMMUNOL, V19, P2237, DOI 10.1002/eji.1830191209; RAJEWSKY K, 1969, J EXP MED, V129, P1131, DOI 10.1084/jem.129.6.1131; ROTHBARD JB, 1988, EMBO J, V7, P93, DOI 10.1002/j.1460-2075.1988.tb02787.x; SCHUTZE MP, 1987, CELL IMMUNOL, V104, P79, DOI 10.1016/0008-8749(87)90008-6; SCHUTZE MP, 1985, J IMMUNOL, V135, P2319; SERCARZ EE, 1978, IMMUNOL REV, V39, P108, DOI 10.1111/j.1600-065X.1978.tb00398.x; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; STUCHLER D, 1989, VACCINE, V7, P457; ZAVALA F, 1987, J EXP MED, V166, P1591, DOI 10.1084/jem.166.5.1591; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	33	92	99	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUL 27	1990	249	4967					423	425		10.1126/science.1696030	http://dx.doi.org/10.1126/science.1696030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ702	1696030				2022-12-28	WOS:A1990DQ70200045
J	CUTTING, GR; KASCH, LM; ROSENSTEIN, BJ; ZIELENSKI, J; TSUI, LC; ANTONARAKIS, SE; KAZAZIAN, HH				CUTTING, GR; KASCH, LM; ROSENSTEIN, BJ; ZIELENSKI, J; TSUI, LC; ANTONARAKIS, SE; KAZAZIAN, HH			A CLUSTER OF CYSTIC-FIBROSIS MUTATIONS IN THE 1ST NUCLEOTIDE-BINDING FOLD OF THE CYSTIC-FIBROSIS CONDUCTANCE REGULATOR PROTEIN	NATURE			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	CUTTING, GR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205, USA.		Tsui, Lap-chee/A-1081-2010; Antonarakis, Stylianos/N-8866-2014	Antonarakis, Stylianos/0000-0001-8907-5823				ADAMS JG, IN PRESS SEM HEMATOL; CUTTING GR, 1989, AM J HUM GENET, V44, P307; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; ESTIVILL X, 1989, AM J HUM GENET, V44, P704; HIGGINS C, 1989, NATURE, V341, P103, DOI 10.1038/341103a0; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEITERSDORF E, 1989, AM J HUM GENET, V44, P409; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RAMSAY M, 1990, GENOMICS, V6, P39, DOI 10.1016/0888-7543(90)90446-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; WOO SLC, 1988, AM J HUM GENET, V43, P781	18	393	415	1	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 26	1990	346	6282					366	369		10.1038/346366a0	http://dx.doi.org/10.1038/346366a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ567	1695717				2022-12-28	WOS:A1990DQ56700062
J	DEBATIN, KM; GOLDMANN, CK; BAMFORD, R; WALDMANN, TA; KRAMMER, PH				DEBATIN, KM; GOLDMANN, CK; BAMFORD, R; WALDMANN, TA; KRAMMER, PH			MONOCLONAL-ANTIBODY-MEDIATED APOPTOSIS IN ADULT T-CELL LEUKEMIA	LANCET			English	Article									GERMAN CANC RES CTR,DIV IMMUNOGENET,W-6900 HEIDELBERG 1,GERMANY; NCI,METAB BRANCH,BETHESDA,MD 20205	Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	DEBATIN, KM (corresponding author), UNIV HEIDELBERG,CHILDRENS HOSP,ONCOL IMMUNOL SECT,NEUENHEIMER FELD 150,W-6900 HEIDELBERG,GERMANY.		Debatin, Klaus-Michael/J-9704-2014; Waldmann, Thomas/AAT-5972-2021	Debatin, Klaus-Michael/0000-0002-8397-1886; Waldmann, Thomas/0000-0003-4500-6660				ARIMA N, 1986, BLOOD, V68, P779; BRODER S, 1984, ANN INTERN MED, V100, P543, DOI 10.7326/0003-4819-100-4-543; DEPPER JM, 1984, J IMMUNOL, V133, P1691; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; GREENE WC, 1986, ANN INTERN MED, V105, P560, DOI 10.7326/0003-4819-105-4-560; MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5; POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; UCHIYAMA T, 1988, BLOOD, V72, P1182; WALDMANN TA, 1988, BLOOD, V72, P1805; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534	14	156	158	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					497	500		10.1016/0140-6736(90)90735-N	http://dx.doi.org/10.1016/0140-6736(90)90735-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1689786				2022-12-28	WOS:A1990CT01500003
J	ALEXANDERWILLIAMS, J				ALEXANDERWILLIAMS, J			ADVANCED RECTAL-CANCER	BRITISH MEDICAL JOURNAL			English	Editorial Material											ALEXANDERWILLIAMS, J (corresponding author), GEN HOSP,GASTROINTESTINAL SURG,BIRMINGHAM B4 6NH,W MIDLANDS,ENGLAND.							BERRY AR, IN PRESS BR J SURG; CRILE G, 1972, SURG GYNECOL OBSTETR, V135, P391; EISENBERG HW, 1984, SURG GYNECOL OBSTET, V159, P471; GUNDERSON LL, 1988, ANN SURG, V207, P52; Mason A Y, 1972, Ann R Coll Surg Engl, V51, P320; MELLOW MH, 1989, GASTROINTEST ENDOSC, V35, P283, DOI 10.1016/S0016-5107(89)72792-9; PAPILLON J, 1982, RECTAL ANAL CANCERS; PARKS AG, 1973, BRIT J SURG, V60, P688, DOI 10.1002/bjs.1800600908; ZINKIN LD, 1979, SURG GYNECOL OBSTET, V148, P427	9	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 3	1990	300	6720					276	277		10.1136/bmj.300.6720.276	http://dx.doi.org/10.1136/bmj.300.6720.276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM195	1690034	Bronze, Green Published			2022-12-28	WOS:A1990CM19500002
J	BANCEWICZ, J				BANCEWICZ, J			CANCER OF THE ESOPHAGUS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											BANCEWICZ, J (corresponding author), HOPE HOSP, SURG, SALFORD M6 8HD, LANCS, ENGLAND.							AKIYAMA H, 1984, AM J SURG, V147, P9, DOI 10.1016/0002-9610(84)90027-8; BOWN SG, 1987, GUT, V28, P799, DOI 10.1136/gut.28.7.799; EARLAM R, 1980, BRIT J SURG, V67, P381, DOI 10.1002/bjs.1800670602; IIZUKA T, 1988, CHEST, V93, P1054, DOI 10.1378/chest.93.5.1054; JENSEN DM, 1988, GASTROENTEROLOGY, V94, P1263, DOI 10.1016/0016-5085(88)90662-2; KELSEN D, 1983, AM J MED, V75, P645, DOI 10.1016/0002-9343(83)90451-5; KING RM, 1987, ANN THORAC SURG, V44, P119, DOI 10.1016/S0003-4975(10)62019-X; LAUNOIS B, 1987, BAILLIERE CLIN GASTR, V1, P893, DOI 10.1016/0950-3528(87)90025-X; MATHISEN DJ, 1988, ANN THORAC SURG, V45, P137, DOI 10.1016/S0003-4975(10)62424-1; MATTHEWS HR, 1987, BRIT J SURG, V74, P1115, DOI 10.1002/bjs.1800741214; MATTHEWS HR, 1986, BRIT J SURG, V73, P621, DOI 10.1002/bjs.1800730811; MORSTYN G, 1986, J CLIN ONCOL, V4, P1062, DOI 10.1200/JCO.1986.4.7.1062; OGILVIE AL, 1982, GUT, V23, P1060, DOI 10.1136/gut.23.12.1060; PEARSON JG, 1977, CANCER, V39, P882, DOI 10.1002/1097-0142(197702)39:2+<882::AID-CNCR2820390726>3.0.CO;2-X; PRADHAN GN, 1989, SURG GYNECOL OBSTET, V168, P49; ROWLAND CG, 1985, LANCET, V2, P981; SAEGER HD, 1987, LANGENBECK ARCH CHIR, V372, P161, DOI 10.1007/BF01297808; Salama F D, 1989, J R Coll Surg Edinb, V34, P97; SLEVIN NJ, 1989, CLIN RADIOL, V40, P200, DOI 10.1016/S0009-9260(89)80097-2; WANG M, 1989, INT J RADIAT ONCOL, V16, P325	20	17	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	1990	300	6716					3	4		10.1136/bmj.300.6716.3	http://dx.doi.org/10.1136/bmj.300.6716.3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG773	1688726	Green Published, Bronze			2022-12-28	WOS:A1990CG77300003
J	YAQOOB, M; MCCLELLAND, P; BELL, GM; AHMAD, R; BAKRAN, A				YAQOOB, M; MCCLELLAND, P; BELL, GM; AHMAD, R; BAKRAN, A			BLADDER-TUMORS IN PARAPLEGIC PATIENTS ON RENAL REPLACEMENT THERAPY	LANCET			English	Note							SPINAL-CORD INJURY; CANCER	Fourteen adult patients with end-stage renal disease due to spina bifida or spinal-cord injury underwent regular haemodialysis for 3-120 (mean 20) months. Seven of these patients received renal transplants. Urinary bladder tumours developed in four of the fourteen patients (three squamous-cell carcinoma in patients still on dialysis, one poorly differentiated transitional-cell carcinoma in a patient after successful transplantation). All four had widespread metastatic disease and died within 8 weeks of the diagnosis of cancer. We recommend regular urological evaluation for patients with neurogenic bladder even after initiation of dialysis treatment. Total cystectomy before transplantation might greatly reduce the risk of these rare tumours.			YAQOOB, M (corresponding author), ROYAL LIVERPOOL UNIV HOSP,RENAL UNIT,PRESCOT ST,LIVERPOOL L7 8XP,ENGLAND.							BROECKER BH, 1981, J UROLOGY, V125, P196, DOI 10.1016/S0022-5347(17)54963-0; ELMASRI WS, 1981, PARAPLEGIA, V19, P265, DOI 10.1038/sc.1981.52; FELDMAN AR, 1986, NEW ENGL J MED, V315, P1394, DOI 10.1056/NEJM198611273152206; GRUBER SA, 1991, TRANSPLANT P, V23, P1104; KAUFMAN JM, 1977, J UROLOGY, V118, P967, DOI 10.1016/S0022-5347(17)58266-X; Melzak J, 1966, Paraplegia, V4, P85; MIRAHMADI MK, 1982, PARAPLEGIA, V20, P43, DOI 10.1038/sc.1982.5; MURALIKRISHNA GS, 1989, BRIT MED J, V299, P1506, DOI 10.1136/bmj.299.6714.1506; PENN I, 1991, TRANSPLANT P, V23, P1101; RAGHAVAN D, 1990, NEW ENGL J MED, V322, P1129, DOI 10.1056/NEJM199004193221607	10	14	14	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1554	1555		10.1016/0140-6736(91)92374-B	http://dx.doi.org/10.1016/0140-6736(91)92374-B			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683973				2022-12-28	WOS:A1991GW03600005
J	LOGAN, RPH; GUMMETT, PA; MISIEWICZ, JJ; KARIM, QN; WALKER, MM; BARON, JH				LOGAN, RPH; GUMMETT, PA; MISIEWICZ, JJ; KARIM, QN; WALKER, MM; BARON, JH			ONE WEEK ERADICATION REGIMEN FOR HELICOBACTER-PYLORI	LANCET			English	Article								Although Helicobacter pylori is both a frequent cause of gastritis and an important factor in duodenal ulcer recurrence, no treatment regimen exists that is completely safe and effective. We have studied a short eradication regimen of tripotassium dicitrato bismuthate 120 mg four times daily and amoxycillin 500 mg four times daily for seven days with metronidazole 400 mg five times daily for three days (days 5-7). 106 patients with peptic ulceration and non-ulcer dyspepsia, who were also infected with H pylori, were entered into the study. H pylori was successfully eradicated in 76/106 (72%) patients (median follow-up 9.3 months). The rate of eradication was higher among patients with metronidazole-sensitive H pylori (40/43, 93%). In 17/30 patients in whom eradication failed, pretreatment metronidazole-resistant strains were subsequently isolated. Side-effects were mild, the commonest (24/106, 24%) being taste disturbance with metronidazole. A one-week eradication regimen is a safe, effective, cheap, and well-tolerated treatment for metronidazole-sensitive H pylori.	ST MARYS HOSP,LONDON,ENGLAND	Imperial College London	LOGAN, RPH (corresponding author), CENT MIDDLESEX HOSP,DEPT GASTROENTEROL & NUTR,PARKSIDE HELICOBACTER STUDY GRP,LONDON NW10 7NS,ENGLAND.		Walker, Marjorie Mary/F-6504-2013					AXON AR, 1991, BRIT MED J, V302, P919, DOI 10.1136/bmj.302.6782.919; BORODY TJ, 1989, GASTROENTEROLOGY, V94, pA43; FORMAN D, 1990, INT J CANCER, V46, P608, DOI 10.1002/ijc.2910460410; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; GLUPCZYNSKI Y, 1990, LANCET, V335, P976, DOI 10.1016/0140-6736(90)91043-A; GLUPCZYNSKI Y, 1990, Gastroenterology, V98, pA48; GLUPCZYNSKI Y, 1990, HELICOBACTER PYLORI, P49; LOGAN RPH, 1990, GUT, V31, pA1178; LOGAN RPH, 1991, LANCET, P562; LOGAN RPH, 1990, GUT, V30, pA1177; LOGAN RPH, IN PRESS HELICOBACTE; MARSHALL B J, 1991, Gastroenterology, V100, pA117; MOSHAL MG, 1975, POSTGRAD MED J, V51, P36; RAUWS EA, 1988, GASTROENTEROLOGY, V94, P33, DOI 10.1016/0016-5085(88)90606-3; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; TYTGAT GNJ, 1990, HELICOBACTER PYLORI, P36; WEIL J, 1990, ALIMENT PHARM THERAP, V4, P651; WEIL J, 1990, LANCET, P1445; WELLER IVD, 1988, GUT, V29, P1134, DOI 10.1136/gut.29.8.1134	19	175	176	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1249	1252		10.1016/0140-6736(91)92111-E	http://dx.doi.org/10.1016/0140-6736(91)92111-E			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682653				2022-12-28	WOS:A1991GQ16600013
J	PAUMGARTNER, G; SAUERBRUCH, T				PAUMGARTNER, G; SAUERBRUCH, T			GALLSTONES - PATHOGENESIS	LANCET			English	Article							NUCLEATION TIME; BILIARY LIPIDS; GALL-STONES; BILE-ACIDS; CHOLESTEROL; SECRETION; DISEASE; SLUDGE				PAUMGARTNER, G (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,MARCHIONINISTR 15,W-8000 MUNICH 70,GERMANY.							BAZZOLI F, 1991, Gastroenterology, V100, pA309; BEEN JM, 1979, GASTROENTEROLOGY, V76, P548; BOUCHIER IA, 1965, GASTROENTEROLOGY, V49, P343; BUSCH N, 1991, J LIPID RES, V32, P695; CAREY MC, 1987, BILE ACIDS LIVER, P287; CARULLI N, 1984, J CLIN INVEST, V74, P614, DOI 10.1172/JCI111459; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; EVERSON GT, 1991, J CLIN INVEST, V87, P237, DOI 10.1172/JCI114977; FESTI D, 1990, GASTROENTEROLOGY, V99, P1779, DOI 10.1016/0016-5085(90)90487-L; GALLINGER S, 1985, GASTROENTEROLOGY, V89, P648, DOI 10.1016/0016-5085(85)90464-0; GROEN AK, 1990, HEPATOLOGY, V11, P525, DOI 10.1002/hep.1840110402; HALPERN Z, 1986, GASTROENTEROLOGY, V90, P875, DOI 10.1016/0016-5085(86)90863-2; HENRIKSSON P, 1989, J CLIN INVEST, V84, P811, DOI 10.1172/JCI114240; HOLAN KR, 1979, GASTROENTEROLOGY, V77, P611; HOLZBACH RT, 1983, GASTROENTEROLOGY, V84, P1055; KERN F, 1981, J CLIN INVEST, V68, P1229, DOI 10.1172/JCI110369; KERN F JR, 1991, Gastroenterology, V100, pA760; KIBE A, 1984, SCIENCE, V225, P514, DOI 10.1126/science.6429856; LEE SP, 1981, SCIENCE, V211, P1429, DOI 10.1126/science.7466399; LEE SP, 1986, GASTROENTEROLOGY, V90, P677, DOI 10.1016/0016-5085(86)91123-6; LIPSETT P A, 1991, Gastroenterology, V100, pA767; MARCUS SN, 1988, GUT, V29, P522, DOI 10.1136/gut.29.4.522; OLEARY DP, 1991, HEPATOLOGY, V13, P957, DOI 10.1016/0270-9139(91)90270-6; PIXLEY F, 1985, BRIT MED J, V291, P11, DOI 10.1136/bmj.291.6487.11; SITZMANN JV, 1990, SURG GYNECOL OBSTET, V170, P25; SMITH BF, 1985, J CLIN INVEST, V76, P439, DOI 10.1172/JCI111991; SPENGLER U, 1989, GASTROENTEROLOGY, V96, P860; STRASBERG SM, 1990, GASTROENTEROLOGY, V98, P739, DOI 10.1016/0016-5085(90)90297-E; TERA H, 1960, ACTA CHIR SCAND    S, V256, P4; VILLANOVA N, 1989, GASTROENTEROLOGY, V97, P726, DOI 10.1016/0016-5085(89)90644-6; VONHOHENHEIM T, 1989, ANDER THEIL BUCHER S, P246	31	139	145	1	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1117	1121		10.1016/0140-6736(91)91972-W	http://dx.doi.org/10.1016/0140-6736(91)91972-W			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682550				2022-12-28	WOS:A1991GM78400012
J	RUTGEERTS, P; GOBOES, K; PEETERS, M; HIELE, M; PENNINCKX, F; AERTS, R; KERREMANS, R; VANTRAPPEN, G				RUTGEERTS, P; GOBOES, K; PEETERS, M; HIELE, M; PENNINCKX, F; AERTS, R; KERREMANS, R; VANTRAPPEN, G			EFFECT OF FECAL STREAM DIVERSION ON RECURRENCE OF CROHNS-DISEASE IN THE NEOTERMINAL ILEUM	LANCET			English	Article							FECAL STREAM; COLITIS; ILEOSTOMY; COLON; MANAGEMENT; RESECTION; SURGERY	Aphthous lesions recur in the neoterminal ileum within the first few months after curative resection of the distal ileum in patients with Crohn's disease. These lesions do not originate from microscopic disease that is already present at the time of surgery. To investigate the importance of faecal stream in the pathogenesis of recurrent Crohn's lesions, we have studied 5 patients with Crohn's disease who had ileal resection. After curative resection and ileocolonic anastomosis, a diverting terminal ileostomy was constructed 25-35 cm proximal to the anastomosis thereby excluding the neoterminal ileum, the anastomosis, and the colon from intestinal transit. After six months of exclusion, endoscopy of the ileocolon was undertaken and biopsy specimens were taken. Transit was then restored. Six months after reanastomosis further biopsy specimens were taken. These patients were compared with a control group of 75 patients with Crohn's disease who underwent a one-step ileal resection and ileocolonic anastomosis. None of the 5 patients had endoscopic lesions in the neoterminal ileum after six months of exclusion and biopsies did not show inflammatory changes characteristic of Crohn's disease. By contrast, 53 of 75 patients with one-step surgery had endoscopic recurrence in the neoterminal ileum within six months of surgery. All 5 patients had an important recurrence of disease, both endoscopically and histologically, at ileocolonoscopy six months after reanastomosis. Our findings strongly support the view that recurrence of Crohn's disease in the neoterminal ileum after curative ileal resection is dependent on faecal stream.	UNIV HOSP LEUVEN,DEPT MED,LOUVAIN,BELGIUM; UNIV HOSP LEUVEN,DEPT SURG,LOUVAIN,BELGIUM; UNIV HOSP LEUVEN,DEPT PATHOL,LOUVAIN,BELGIUM	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven			Peeters, Marc/C-5525-2013	Peeters, Marc/0000-0003-4969-2303				AUFSES AH, 1971, ANN SURG, V73, P91; BURMAN JH, 1971, GUT, V12, P11, DOI 10.1136/gut.12.1.11; GLOTZER DJ, 1981, GASTROENTEROLOGY, V80, P438; GREENSTEIN AJ, 1988, GUT, V29, P588, DOI 10.1136/gut.29.5.588; HARPER PH, 1985, GUT, V26, P279, DOI 10.1136/gut.26.3.279; HARPER PH, 1983, GUT, V24, P106, DOI 10.1136/gut.24.2.106; JONES JH, 1966, GUT, V7, P448, DOI 10.1136/gut.7.5.448; LESCUT D, 1990, GASTROENTEROL CLIN B, V4, pA20; MALCHOW H, 1987, GASTROINTEST ENDOSC, V33, P163; MCILRATH DC, 1971, ARCH SURG-CHICAGO, V103, P308; NUGENT FW, 1973, GASTROENTEROLOGY, V65, P398; OLAISON G, IN PRESS GUT; RUTGEERTS P, 1984, GUT, V25, P665, DOI 10.1136/gut.25.6.665; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P950; TYTGAT GNJ, 1988, ENDOSCOPY, V20, P260, DOI 10.1055/s-2007-1018188; WILLIAMS JG, 1991, BRIT J SURG, V78, P10, DOI 10.1002/bjs.1800780106; WINSLET MC, 1988, GUT, V29, pA1475; ZELAS P, 1980, ANN SURG, V191, P164, DOI 10.1097/00000658-198002000-00006	18	582	588	0	26	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					771	774		10.1016/0140-6736(91)90663-A	http://dx.doi.org/10.1016/0140-6736(91)90663-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681159				2022-12-28	WOS:A1991GG97900002
J	RADANOV, BP; DISTEFANO, G; SCHNIDRIG, A; BALLINARI, P				RADANOV, BP; DISTEFANO, G; SCHNIDRIG, A; BALLINARI, P			ROLE OF PSYCHOSOCIAL STRESS IN RECOVERY FROM COMMON WHIPLASH	LANCET			English	Article							SOMATIZATION; INJURIES; NECK	It is widely accepted that psychosocial factors are related to illness behaviour and there is some evidence that they may influence the rate of recovery from post-traumatic disorders. The abilities of psychosocial stress, somatic symptoms, and subjectively assessed cognitive impairment to predict delayed recovery from common whiplash were investigated in a follow-up study. 78 consecutive patients referred 7.2 (SD 4.5) days after they had sustained common whiplash in car accidents were assessed for psychosocial stress, negative affectivity, personality traits, somatic complaints, and cognitive impairment by semistructured interview and by several standardised tests. On examination 6 months later 57 patients were fully recovered and 21 had persisting symptoms. The groups' scores for the independent variables assessed at the baseline examination were compared. Stepwise regression analysis showed that psychosocial factors, negative affectivity, and personality traits were not significant in predicting the outcome. However, initial neck pain intensity, injury-related cognitive impairment, and age were significant factors predicting illness behaviour. This study, which was based on a random sample and which considered many other possible predictive factors as well as psychosocial status, does not support previous findings that psychosocial factors predict illness behaviour in post-trauma patients.	UNIV BERN,DEPT PSYCHOL,CH-3010 BERN,SWITZERLAND	University of Bern	RADANOV, BP (corresponding author), UNIV BERN,DEPT PSYCHIAT,MURTENSTR 21,CH-3010 BERN,SWITZERLAND.							BALLA JI, 1982, CULT MED PSYCHIAT, V6, P191, DOI 10.1007/BF00051428; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; COSTA PJ, 1988, J PERS, V55, P299; Fahrenberg J, 1984, FREIBURGER PERSONLIC; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; GOLDBERG DP, 1988, J PSYCHOSOM RES, V32, P137, DOI 10.1016/0022-3999(88)90048-7; HIRSCH SA, 1988, ORTHOP CLIN N AM, V19, P791; HODGE JR, 1971, PSYCHOSOMATICS, V12, P245; LEAVITT F, 1990, J PSYCHOSOM RES, V34, P447, DOI 10.1016/0022-3999(90)90068-F; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; MAIMARIS C, 1988, INJURY, V19, P393, DOI 10.1016/0020-1383(88)90131-3; MERSKEY H, 1984, CAN MED ASSOC J, V130, P1119; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLS H, 1986, NEW ZEAL MED J, V99, P373; MURPHY M, 1989, BRIT MED J, V298, P1331, DOI 10.1136/bmj.298.6684.1331; NORRIS SH, 1983, J BONE JOINT SURG BR, V65, P608, DOI 10.1302/0301-620X.65B5.6643566; PEARCE JMS, 1989, J NEUROL NEUROSUR PS, V52, P1329, DOI 10.1136/jnnp.52.12.1329; REINHERZ HZ, 1989, J AM ACAD CHILD PSY, V28, P942, DOI 10.1097/00004583-198911000-00021; RODGERS B, 1990, J CHILD PSYCHOL PSYC, V31, P393, DOI 10.1111/j.1469-7610.1990.tb01577.x; Von Zerssen D., 1976, BEFINDLICHKEITSSKALA; VONZERSSEN D, 1983, METHODOLOGY EVALUATI, P183; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; 1986, SPSS X	23	161	164	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					712	715		10.1016/0140-6736(91)91441-V	http://dx.doi.org/10.1016/0140-6736(91)91441-V			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG104	1679865				2022-12-28	WOS:A1991GG10400002
J	KRAUSS, S; JOHANSEN, T; KORZH, V; FJOSE, A				KRAUSS, S; JOHANSEN, T; KORZH, V; FJOSE, A			EXPRESSION PATTERN OF ZEBRAFISH PAX GENES SUGGESTS A ROLE IN EARLY BRAIN REGIONALIZATION	NATURE			English	Article							DEVELOPING EXCRETORY SYSTEM; PROTO-ONCOGENE INT-1; DROSOPHILA; CONSERVATION; HINDBRAIN; EMBRYOS	IN vertebrates the developing hindbrain is organized in segmental units 1. These units provide the primary grid for differentiation and axonal outgrowth 1,2. In the more anterior regions of the brain, however, the subdivisions remain more controversial. Cellular and molecular studies of the embryonic brain in lower vertebrates such as the zebrafish, Brachydanio rerio, may reveal remnants of such subdivisions. We have isolated complementary DNA clones for two zebrafish pax genes related to Drosophila and mouse paired-box-containing segmentation genes 3-10. The expression of these two genes is confined to specific regions in the embryonic forebrain and midbrain. Strikingly, the borders of expression of the two pax genes coincide with morphological landmarks corresponding to the primary axon tracts that are generated in the embryonic brain a few hours after the initiation of expression of these genes 11,12.	UNIV TROMSO,INST MED BIOL,DEPT MICROBIOL,BIOTECHNOL GRP,N-9000 TROMSO,NORWAY	UiT The Arctic University of Tromso	KRAUSS, S (corresponding author), UNIV TROMSO,INST MED BIOL,DEPT MICROBIOL,MOLEC GENET GRP,N-9000 TROMSO,NORWAY.		Johansen, Terje/N-2971-2015; Korzh, Vladimir P/H-1596-2011; Johansen, Terje/AAY-1753-2021	Johansen, Terje/0000-0003-1451-9578; Korzh, Vladimir P/0000-0002-6580-7986; Johansen, Terje/0000-0003-1451-9578; Krauss, Stefan/0000-0001-6992-8091				BERGQUIST HARRY, 1952, ACTA ZOOL [STOCKHOLM], V33, P117; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BOPP D, 1989, EMBO J, V8, P1183; CHITNIS AB, 1990, J NEUROSCI, V10, P1892; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; HATTA K, 1991, DEVELOPMENT, V112, P821; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; KEYNES R, 1990, NEURON, V2, P1; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; METCALFE WK, 1990, DEVELOPMENT, V110, P491; MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x; NORNES HO, 1990, DEVELOPMENT, V109, P797; PLACHOV D, 1990, DEVELOPMENT, V110, P643; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILSON SW, 1990, DEVELOPMENT, V108, P121; WILSON SW, 1991, P NATL ACAD SCI USA, V88, P2293, DOI 10.1073/pnas.88.6.2293	23	235	241	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 19	1991	353	6341					267	270		10.1038/353267a0	http://dx.doi.org/10.1038/353267a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF674	1680220				2022-12-28	WOS:A1991GF67400063
J	TROPSCHUG, M; WACHTER, E; MAYER, S; SCHONBRUNNER, ER; SCHMID, FX				TROPSCHUG, M; WACHTER, E; MAYER, S; SCHONBRUNNER, ER; SCHMID, FX			ISOLATION AND SEQUENCE OF AN FK506-BINDING PROTEIN FROM NEUROSPORA-CRASSA WHICH CATALYZES PROTEIN FOLDING	NATURE			English	Article									UNIV BAYREUTH,BIOCHEM LAB,W-8580 BAYREUTH,GERMANY	University of Bayreuth	TROPSCHUG, M (corresponding author), UNIV MUNICH,INST PHYSIOL CHEM,GOETHESTR 33,W-8000 MUNICH 2,GERMANY.							BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989; ENGLEBERG NC, 1989, INFECT IMMUN, V57, P1263, DOI 10.1128/IAI.57.4.1263-1270.1989; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P244; HARDING MW, 1986, J BIOL CHEM, V261, P8547; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; KLEENE R, 1987, EMBO J, V6, P2627, DOI 10.1002/j.1460-2075.1987.tb02553.x; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LIN LN, 1988, BIOCHIM BIOPHYS ACTA, V956, P256, DOI 10.1016/0167-4838(88)90142-2; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; QUESNIAUX VFJ, 1987, EUR J IMMUNOL, V17, P1359, DOI 10.1002/eji.1830170921; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWADA S, 1987, J IMMUNOL, V139, P1797; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIEKIERKA JJ, 1990, ADV GENE TECHNOLOGY, P140; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; TROPSCHUG M, 1990, NUCLEIC ACIDS RES, V18, P190, DOI 10.1093/nar/18.1.190; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433	31	159	161	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 16	1990	346	6285					674	677		10.1038/346674a0	http://dx.doi.org/10.1038/346674a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU728	1696687				2022-12-28	WOS:A1990DU72800068
J	CARMAN, WF; ZANETTI, AR; KARAYIANNIS, P; WATERS, J; MANZILLO, G; TANZI, E; ZUCKERMAN, AJ; THOMAS, HC				CARMAN, WF; ZANETTI, AR; KARAYIANNIS, P; WATERS, J; MANZILLO, G; TANZI, E; ZUCKERMAN, AJ; THOMAS, HC			VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS	LANCET			English	Article									HOSP COTUGNO, DEPT INFECT DIS, NAPLES, ITALY; ROYAL FREE HOSP, SCH MED, DEPT MED MICROBIOL, LONDON, ENGLAND; UNIV MILAN, IST VIROL, I-20122 MILAN, ITALY	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Milan	CARMAN, WF (corresponding author), ST MARYS HOSP, SCH MED, DEPT MED, LONDON W2 1NY, ENGLAND.		Thomas, Howard C/A-3152-2009	Karayiannis, Peter/0000-0001-5195-7863	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ASHTONRICKARDT PG, 1989, J MED VIROL, V29, P196, DOI 10.1002/jmv.1890290310; BRECHOT C, 1985, NEW ENGL J MED, V312, P270, DOI 10.1056/NEJM198501313120503; BROWN SE, 1984, LANCET, V2, P184; BRUNETTO MR, 1989, VIRAL GASTROENTEROLO, V21, P151; CARMAN WF, 1989, LANCET, V2, P588; COURSAGET P, 1987, LANCET, V2, P1354; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; KANEKO S, 1989, J INFECT DIS, V160, P903, DOI 10.1093/infdis/160.5.903; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEMON SM, 1990, J INFECT DIS, V161, P7, DOI 10.1093/infdis/161.1.7; MCMAHON G, 1990, INT S VIRAL HEPATITI; MINOR PD, 1988, J GEN VIROL, V69, P1091, DOI 10.1099/0022-1317-69-5-1091; MINOR PD, 1986, J GEN VIROL, V67, P693, DOI 10.1099/0022-1317-67-4-693; PORATH EB, 1985, TRANSFUSION, V25, P10, DOI 10.1046/j.1537-2995.1985.25185116491.x; STROFFOLINI T, 1988, PUBLIC HEALTH, V102, P329, DOI 10.1016/S0033-3506(88)80102-1; THIERS V, 1988, LANCET, V2, P1273; VYAS GN, 1972, SCIENCE, V178, P1300, DOI 10.1126/science.178.4067.1300; WANDS JR, 1986, P NATL ACAD SCI USA, V83, P6608, DOI 10.1073/pnas.83.17.6608; WU CTB, 1990, J VIROL, V64, P856, DOI 10.1128/JVI.64.2.856-863.1990	20	903	975	0	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	1990	336	8711					325	329		10.1016/0140-6736(90)91874-A	http://dx.doi.org/10.1016/0140-6736(90)91874-A			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU075	1697396				2022-12-28	WOS:A1990DU07500001
J	BIDART, JM; TROALEN, F; GHILLANI, P; ROUAS, N; RAZAFINDRATSITA, A; BOHUON, C; BELLET, D				BIDART, JM; TROALEN, F; GHILLANI, P; ROUAS, N; RAZAFINDRATSITA, A; BOHUON, C; BELLET, D			PEPTIDE IMMUNOGEN MIMICRY OF A PROTEIN-SPECIFIC STRUCTURAL EPITOPE ON HUMAN CHORIOGONADOTROPIN	SCIENCE			English	Article									INST GUSTAVE ROUSSY,DEPT BIOL CLIN,F-94805 VILLEJUIF,FRANCE; UNIV PARIS 05,FAC SCI PHARMACEUT & BIOL,IMMUNOL LAB,F-75270 PARIS 06,FRANCE	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite								AVRAMEAS S, 1969, IMMUNOCHEMISTRY, V6, P67, DOI 10.1016/0019-2791(69)90179-7; BERGER P, 1987, NATURE, V326, P648, DOI 10.1038/326648a0; BIDART JM, 1987, J BIOL CHEM, V262, P15483; BIDART JM, 1987, MOL IMMUNOL, V24, P339, DOI 10.1016/0161-5890(87)90175-1; BIDART JM, 1987, J BIOL CHEM, V262, P8551; BIDART JM, UNPUB; BIRKEN S, 1977, J BIOL CHEM, V252, P5386; GOODFRIEND TL, 1964, SCIENCE, V144, P1344, DOI 10.1126/science.144.3624.1344; HOGREFE HH, 1989, J BIOL CHEM, V264, P10513; JONES WR, 1988, LANCET, V1, P1295; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; MILLAR SE, 1989, SCIENCE, V246, P497; MOTTE P, 1987, J IMMUNOL, V138, P3332; OZTURK M, 1987, ENDOCRINOLOGY, V120, P549, DOI 10.1210/endo-120-2-549; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; STEVENS VC, 1986, IMMUNOL TODAY, V7, P369, DOI 10.1016/0167-5699(86)90029-0; TALWAR GP, 1988, CONTRACEPTION RES TO, P183; VANREGENMORTEL MHV, 1989, IMMUNOL TODAY, V10, P266, DOI 10.1016/0167-5699(89)90140-0; VANREGENMORTEL MHV, 1987, TRENDS BIOCHEM SCI, V12, P237, DOI 10.1016/0968-0004(87)90117-4; WALTER G, 1980, P NATL ACAD SCI-BIOL, V77, P5197, DOI 10.1073/pnas.77.9.5197; WEARE JA, 1979, J BIOL CHEM, V254, P6972; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	23	41	44	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 11	1990	248	4956					736	739		10.1126/science.1692160	http://dx.doi.org/10.1126/science.1692160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC926	1692160				2022-12-28	WOS:A1990DC92600035
J	PETERSON, M; MILLER, J				PETERSON, M; MILLER, J			INVARIANT CHAIN INFLUENCES THE IMMUNOLOGICAL RECOGNITION OF MHC CLASS-II MOLECULES	NATURE			English	Article											PETERSON, M (corresponding author), UNIV CHICAGO,DEPT MOLEC GENET & CELL BIOL,CHICAGO,IL 60637, USA.							BHATTACHARYA A, 1981, J IMMUNOL, V127, P2488; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; CRESSWELL P, 1985, P NATL ACAD SCI USA, V82, P8188, DOI 10.1073/pnas.82.23.8188; GERMAIN RN, 1986, ANNU REV IMMUNOL, V4, P281, DOI 10.1146/annurev.iy.04.040186.001433; GLIMCHER LH, 1983, J IMMUNOL, V131, P2868; HARDING CV, 1989, J IMMUNOL, V142, P12; HOLT GD, 1985, J IMMUNOL, V135, P399; JENSEN PE, 1988, J IMMUNOL, V141, P2545; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KOCH N, 1982, EUR J IMMUNOL, V12, P909, DOI 10.1002/eji.1830121103; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; MILLER J, 1988, P NATL ACAD SCI USA, V85, P1359, DOI 10.1073/pnas.85.5.1359; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PIERRES M, 1981, IMMUNOGENETICS, V14, P481, DOI 10.1007/BF00350120; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; SIMONIS S, 1989, J IMMUNOL, V143, P3619; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143	24	150	154	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 10	1990	345	6271					172	174		10.1038/345172a0	http://dx.doi.org/10.1038/345172a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC833	1692393				2022-12-28	WOS:A1990DC83300071
J	LENDAHL, U; ZIMMERMAN, LB; MCKAY, RDG				LENDAHL, U; ZIMMERMAN, LB; MCKAY, RDG			CNS STEM-CELLS EXPRESS A NEW CLASS OF INTERMEDIATE FILAMENT PROTEIN	CELL			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139; KAROLINSKA INST,MED NOBEL INST,DEPT MOLEC GENET,S-10401 STOCKHOLM 60,SWEDEN	Massachusetts Institute of Technology (MIT); Karolinska Institutet	LENDAHL, U (corresponding author), MIT,DEPT BRAIN & COGNIT SCI,CAMBRIDGE,MA 02139, USA.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BIGNAMI A, 1982, DEV BIOL, V91, P286, DOI 10.1016/0012-1606(82)90035-5; BRECKLER J, 1982, J CELL BIOL, V92, P795, DOI 10.1083/jcb.92.3.795; CEPKO CL, 1989, ANNU REV NEUROSCI, V12, P47, DOI 10.1146/annurev.ne.12.030189.000403; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FEDEROFF S, 1985, MOL BASES NEURAL DEV, P91; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FREDERIKSEN K, 1988, NEURON, V1, P439, DOI 10.1016/0896-6273(88)90175-4; GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HYNES RO, 1978, CELL, V13, P151, DOI 10.1016/0092-8674(78)90146-0; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; JULIEN JP, 1988, GENE, V68, P307, DOI 10.1016/0378-1119(88)90033-9; KNAPP B, 1986, NUCLEIC ACIDS RES, V14, P751, DOI 10.1093/nar/14.2.751; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LEVINE JM, 1984, J NEUROSCI, V4, P820; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Maniatis T., 1982, MOL CLONING; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MIYATANI S, 1986, J CELL BIOL, V103, P1957, DOI 10.1083/jcb.103.5.1957; MONTEIRO MJ, 1989, J CELL BIOL, V108, P579, DOI 10.1083/jcb.108.2.579; PRICE J, 1988, DEVELOPMENT, V104, P473; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RUBINSTEIN LJ, 1985, J NEUROSURG, V62, P795, DOI 10.3171/jns.1985.62.6.0795; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Spemann H., 1938, EMBRYONIC DEV INDUCT; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; [No title captured]	48	2677	2972	1	70	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 23	1990	60	4					585	595		10.1016/0092-8674(90)90662-X	http://dx.doi.org/10.1016/0092-8674(90)90662-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	1689217				2022-12-28	WOS:A1990CQ72300009
J	GENG, JG; BEVILACQUA, MP; MOORE, KL; MCINTYRE, TM; PRESCOTT, SM; KIM, JM; BLISS, GA; ZIMMERMAN, GA; MCEVER, RP				GENG, JG; BEVILACQUA, MP; MOORE, KL; MCINTYRE, TM; PRESCOTT, SM; KIM, JM; BLISS, GA; ZIMMERMAN, GA; MCEVER, RP			RAPID NEUTROPHIL ADHESION TO ACTIVATED ENDOTHELIUM MEDIATED BY GMP-140	NATURE			English	Article									UNIV OKLAHOMA, HLTH SCI CTR, ST FRANCIS MED RES INST, OKLAHOMA CITY, OK 73104 USA; UNIV OKLAHOMA, HLTH SCI CTR, DEPT MED, OKLAHOMA CITY, OK 73104 USA; OKLAHOMA MED RES FDN, OKLAHOMA CITY, OK 73104 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, DIV VASC RES, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; UNIV UTAH, DEPT MED, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, DEPT BIOCHEM, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, SCH MED, NORA ECCLES HARRISON CARDIOVASC RES & TRAINING INS, SALT LAKE CITY, UT 84112 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah								BERMAN CL, 1986, J CLIN INVEST, V78, P130, DOI 10.1172/JCI112542; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BONFANTI R, 1989, BLOOD, V73, P1109; BRASS LF, 1989, METHOD ENZYMOL, V169, P355; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; HAMBURGER SA, 1990, BLOOD, V75, P550; HATTORI R, 1989, J BIOL CHEM, V264, P7768; HSULIN SC, 1984, J BIOL CHEM, V259, P9121; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LEY K, 1989, BLOOD, V73, P1324; MARCHESI VT, 1985, ANDERSONS PATHOLOGY, P22; MCEVER RP, 1983, J BIOL CHEM, V258, P5269; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MCINTYRE TM, 1985, J CLIN INVEST, V76, P271, DOI 10.1172/JCI111957; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; WHATLEY RE, 1989, J BIOL CHEM, V264, P6325; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; YEDNOCK TA, 1989, ADV IMMUNOL, V44, P313, DOI 10.1016/S0065-2776(08)60645-8; ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529; ZIMMERMAN GA, 1988, J CLIN INVEST, V81, P531, DOI 10.1172/JCI113351; ZIMMERMAN GA, 1985, J CLIN INVEST, V76, P2235, DOI 10.1172/JCI112232	28	936	987	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	1990	343	6260					757	760		10.1038/343757a0	http://dx.doi.org/10.1038/343757a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	1689464				2022-12-28	WOS:A1990CP80700061
J	SHIPPENLENTZ, D; BLACKBURN, EH				SHIPPENLENTZ, D; BLACKBURN, EH			FUNCTIONAL EVIDENCE FOR AN RNA TEMPLATE IN TELOMERASE	SCIENCE			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley								ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; BEEN MD, 1987, CELL, V50, P951, DOI 10.1016/0092-8674(87)90522-8; BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BLACKBURN EH, 1984, CELL, V37, P7, DOI 10.1016/0092-8674(84)90295-2; BLACKBURN EH, 1983, COLD SPRING HARB SYM, V47, P1195; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; FORNEY J, 1987, NUCLEIC ACIDS RES, V15, P9143, DOI 10.1093/nar/15.22.9143; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; KINGSTON RE, 1988, CURRENT PROTOCOLS MO; Klobutcher L.A., 1986, P111; KLOBUTCHER LA, 1981, P NATL ACAD SCI-BIOL, V78, P3015, DOI 10.1073/pnas.78.5.3015; KUMAZAKI T, 1983, J MOL EVOL, V19, P411, DOI 10.1007/BF02102316; LIM D, 1989, MOL MICROBIOL, V3, P1141, DOI 10.1111/j.1365-2958.1989.tb00264.x; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; PLUTA AF, 1982, NUCLEIC ACIDS RES, V10, P8145, DOI 10.1093/nar/10.24.8145; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; RINEHART FP, 1981, BIOCHEMISTRY-US, V20, P3003, DOI 10.1021/bi00514a003; ROMERO D, UNPUB; SHIPPENLENTZ D, 1989, MOL CELL BIOL, V9, P2761, DOI 10.1128/MCB.9.6.2761; SHIPPENLENTZ D, UNPUB; VARMUS H, 1989, MOBILE DNA, P53; VARMUS HE, 1989, CELL, V56, P721, DOI 10.1016/0092-8674(89)90673-9; WAUGH DS, 1989, SCIENCE, V244, P569; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; YU GS, UNPUB; ZAHLER AM, 1988, NUCLEIC ACIDS RES, V16, P6953, DOI 10.1093/nar/16.14.6953	39	340	357	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 2	1990	247	4942					546	552		10.1126/science.1689074	http://dx.doi.org/10.1126/science.1689074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM419	1689074				2022-12-28	WOS:A1990CM41900025
J	PAUWELS, R; ANDRIES, K; DESMYTER, J; SCHOLS, D; KUKLA, MJ; BRESLIN, HJ; RAEYMAECKERS, A; VANGELDER, J; WOESTENBORGHS, R; HEYKANTS, J; SCHELLEKENS, K; JANSSEN, MAC; DECLERCQ, E; JANSSEN, PAJ				PAUWELS, R; ANDRIES, K; DESMYTER, J; SCHOLS, D; KUKLA, MJ; BRESLIN, HJ; RAEYMAECKERS, A; VANGELDER, J; WOESTENBORGHS, R; HEYKANTS, J; SCHELLEKENS, K; JANSSEN, MAC; DECLERCQ, E; JANSSEN, PAJ			POTENT AND SELECTIVE-INHIBITION OF HIV-1 REPLICATION INVITRO BY A NOVEL SERIES OF TIBO DERIVATIVES	NATURE			English	Article									JANSSEN RES FDN,B-2340 BEERSE,BELGIUM; JANSSEN RES FDN,SPRING HOUSE,PA 19477	Johnson & Johnson; Johnson & Johnson; Johnson & Johnson USA	PAUWELS, R (corresponding author), CATHOLIC UNIV LEUVEN,REGA INST MED RES,MINDERBROEDERSSTR 10,B-3000 LOUVAIN,BELGIUM.		Schols, Dominique/S-9057-2017; Schols, Dominique/AAC-1309-2021	Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; De Clercq, Erik/0000-0002-2985-8890				BABA M, 1988, ANTIVIR RES, V9, P335, DOI 10.1016/0166-3542(88)90035-6; BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; BALZARINI J, 1987, BIOCHEM BIOPH RES CO, V145, P269, DOI 10.1016/0006-291X(87)91316-7; Balzarini J., 1988, CLIN USE ANTIVIRAL D, P361; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; CHU CK, 1988, BIOCHEM PHARMACOL, V37, P3543, DOI 10.1016/0006-2952(88)90383-8; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; CLAVEL F, 1986, NATURE, V324, P691, DOI 10.1038/324691a0; CLAVEL F, 1987, AIDS, V1, P135; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DECLERCQ E, 1989, ANTIVIR RES, V12, P1, DOI 10.1016/0166-3542(89)90064-8; FRANCHINI G, 1987, NATURE, V328, P539, DOI 10.1038/328539a0; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; JANSSEN PAJ, 1988, J PHARMACOL EXP THER, V244, P685; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; NAKASHIMA H, 1989, J VIROL METHODS, V26, P319, DOI 10.1016/0166-0934(89)90114-6; PAUWELS R, 1987, J VIROL METHODS, V16, P171, DOI 10.1016/0166-0934(87)90002-4; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; REY MA, 1989, VIROLOGY, V173, P258, DOI 10.1016/0042-6822(89)90242-0; SCHOLS D, 1989, J GEN VIROL, V70, P2397, DOI 10.1099/0022-1317-70-9-2397; SCHOLS D, 1989, J ACQ IMMUN DEF SYND, V2, P10; SCHOLS D, 1989, P NATL ACAD SCI USA, V86, P3322, DOI 10.1073/pnas.86.9.3322; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6	25	824	889	1	29	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 1	1990	343	6257					470	474		10.1038/343470a0	http://dx.doi.org/10.1038/343470a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	1689015				2022-12-28	WOS:A1990CL81800063
J	SCHMALE, H; HOLTGREVEGREZ, H; CHRISTIANSEN, H				SCHMALE, H; HOLTGREVEGREZ, H; CHRISTIANSEN, H			POSSIBLE ROLE FOR SALIVARY-GLAND PROTEIN IN TASTE RECEPTION INDICATED BY HOMOLOGY TO LIPOPHILIC-LIGAND CARRIER PROTEINS	NATURE			English	Article											SCHMALE, H (corresponding author), UNIV HAMBURG, INST ZELLBIOCHEM & KLIN NEUROBIOL, MARTINISTR 52, W-2000 HAMBURG 20, GERMANY.							Baumgartner EA, 1917, AM J ANAT, V22, P365, DOI 10.1002/aja.1000220303; BIGNETTI E, 1985, EUR J BIOCHEM, V149, P227, DOI 10.1111/j.1432-1033.1985.tb08916.x; CAVAGGIONI A, 1987, FEBS LETT, V212, P225, DOI 10.1016/0014-5793(87)81349-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDNER RJ, 1979, CHEM SENS FLAV, V4, P275, DOI 10.1093/chemse/4.4.275; GODOVAC-ZIMMERMANN J, 1988, TRENDS BIOCHEM SCI, V13, P64, DOI 10.1016/0968-0004(88)90031-X; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAND AR, 1970, J CELL BIOL, V44, P340, DOI 10.1083/jcb.44.2.340; HIGGINS GA, 1989, P NATL ACAD SCI USA, V86, P2074, DOI 10.1073/pnas.86.6.2074; Kinnamon J.C., 1987, P277; KINNAMON SC, 1988, TRENDS NEUROSCI, V11, P491, DOI 10.1016/0166-2236(88)90010-0; LANCET D, 1987, TRENDS BIOCHEM SCI, V12, P63, DOI 10.1016/0968-0004(87)90032-6; Lawless H. T, 1987, NEUROBIOLOGY TASTE S, P401; LEE KH, 1987, SCIENCE, V235, P1053, DOI 10.1126/science.3493528; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0; PEVSNER J, 1985, P NATL ACAD SCI USA, V82, P3050, DOI 10.1073/pnas.82.9.3050; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; PEVSNER J, 1988, P NATL ACAD SCI USA, V85, P2383, DOI 10.1073/pnas.85.7.2383; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMALE H, 1989, EUR J BIOCHEM, V182, P621, DOI 10.1111/j.1432-1033.1989.tb14871.x; SCHOFIELD PR, 1988, TRENDS NEUROSCI, V11, P471, DOI 10.1016/0166-2236(88)90001-X; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561	23	136	141	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	1990	343	6256					366	369		10.1038/343366a0	http://dx.doi.org/10.1038/343366a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK918	1689010				2022-12-28	WOS:A1990CK91800061
J	NARCHI, P; BENHAMOU, D; FERNANDEZ, H				NARCHI, P; BENHAMOU, D; FERNANDEZ, H			INTRAPERITONEAL LOCAL-ANESTHETIC FOR SHOULDER PAIN AFTER DAY-CASE LAPAROSCOPY	LANCET			English	Article							STERILIZATION; BUPIVACAINE; ANALGESIA; RING	Laparoscopy is frequently associated with Postoperative shoulder Pain that may last several days. We have assessed the analgesic effect of intraperitoneal local anaesthetics during day-case diagnostic laparoscopy. 80 young women were randomly assigned to one of four groups of 20 patients each: group 1, no peritoneal administration; group 2, 80 ml saline injected under direct vision in the right subdiaphragmatic area at the start of the procedure; group 3, 80 ml 0.5% lignocaine with adrenaline (320 000 dilution); group 4, 0.125% bupivacaine with adrenaline (800 000 dilution). Scapular pain was assessed with a visual analogue pain scale, and information about nausea, vomiting, abdominal Pain, and analgesic requirements during the first 48 h was sought. Both local anaesthetics were more effective in reducing postoperative shoulder pain than either control or saline. Analgesic requirements were greater in the non-treatment groups than in the local anaesthetic groups. Intraperitoneal local anaesthetic administration during laparoscopy is both a non-invasive and an efficient method of reducing the intensity of scapular pain.	HOP ANTOINE BECLERE,DEPT OBSTET & GYNAECOL,F-92141 CLAMART,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	NARCHI, P (corresponding author), HOP ANTOINE BECLERE,DEPT ANAESTHESIA,157 RUE PORTE TRIVAUX,F-92141 CLAMART,FRANCE.		Benhamou, Dan/ABG-7935-2021					ALEXANDER CD, 1987, CAN J ANAESTH, V34, P362, DOI 10.1007/BF03010134; DOBBS FF, 1987, BRIT J OBSTET GYNAEC, V94, P262, DOI 10.1111/j.1471-0528.1987.tb02365.x; FRASER RA, 1989, PAIN, V30, P189; KOETSAWANG S, 1984, AM J OBSTET GYNECOL, V150, P931, DOI 10.1016/0002-9378(84)90384-3; MCKENZIE R, 1989, CAN J ANAESTH, V36, P510, DOI 10.1007/BF03005376; NARCHI P, IN PRESS EUR J CLIN; SPIELMAN FJ, 1983, AM J OBSTET GYNECOL, V146, P821, DOI 10.1016/0002-9378(83)91085-2; WALL PD, 1988, PAIN, V33, P289, DOI 10.1016/0304-3959(88)90286-2	8	164	169	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1569	1570		10.1016/0140-6736(91)92384-E	http://dx.doi.org/10.1016/0140-6736(91)92384-E			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683981				2022-12-28	WOS:A1991GW03600014
J	TON, CCT; HIRVONEN, H; MIWA, H; WEIL, MM; MONAGHAN, P; JORDAN, T; VANHEYNINGEN, V; HASTIE, ND; MEIJERSHEIJBOER, H; DRECHSLER, M; ROYERPOKORA, B; COLLINS, F; SWAROOP, A; STRONG, LC; SAUNDERS, GF				TON, CCT; HIRVONEN, H; MIWA, H; WEIL, MM; MONAGHAN, P; JORDAN, T; VANHEYNINGEN, V; HASTIE, ND; MEIJERSHEIJBOER, H; DRECHSLER, M; ROYERPOKORA, B; COLLINS, F; SWAROOP, A; STRONG, LC; SAUNDERS, GF			POSITIONAL CLONING AND CHARACTERIZATION OF A PAIRED BOX-CONTAINING AND HOMEOBOX-CONTAINING GENE FROM THE ANIRIDIA REGION	CELL			English	Article							WILMS TUMOR ASSOCIATION; AUTOSOMAL DOMINANT ANIRIDIA; DEVELOPING EXCRETORY SYSTEM; MOLECULAR ANALYSIS; PHYSICAL MAP; ANTENNAPEDIA HOMEODOMAIN; HUMAN CHROMOSOME-11; SPATIAL EXPRESSION; SMALL EYE; DROSOPHILA	Based on the map location of the aniridia (AN) locus in human chromosomal band 11p13, we have cloned a candidate AN cDNA (D11S812E) that is completely or partially deleted in two patients with AN. The < 70 kb smallest region of overlap between the two deletions encompasses the 3' coding region of the cDNA. This cDNA, which spans over 50 kb of genomic DNA, detects a 2.7 kb message specifically within all tissues affected in AN. The predicted polypeptide product possesses a paired domain, a homeodomain, and a serine/threonine-rich carboxy-terminal domain, structural motifs characteristic of certain transcription factors. The concordance between expression and pathology, map location, structure, and predicted function argues that the cDNA corresponds to the AN gene.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EXPTL PEDIAT,HOUSTON,TX 77030; UNIV TURKU,DEPT MED BIOCHEM,SF-20520 TURKU 52,FINLAND; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV HEIDELBERG,INST HUMANGENET & ANTHROPOL,W-6900 HEIDELBERG 1,GERMANY; HOWARD HUGHES MED INST,DEPT INTERNAL MED,ANN ARBOR,MI; HOWARD HUGHES MED INST,DEPT HUMAN GENET,ANN ARBOR,MI; UNIV MICHIGAN,DEPT OPHTHALMOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Texas System; UTMD Anderson Cancer Center; University of Turku; University of Edinburgh; Ruprecht Karls University Heidelberg; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	TON, CCT (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030, USA.		van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; Swaroop, Anand/0000-0002-1975-1141	NCI NIH HHS [CA 46720, CA 16672, CA 34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA034936, R01CA046720] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apple, 1986, PATHOLOGY EYE, P1, DOI 10.1007/978-1-4613-8525-7; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; COMPTON DA, 1988, CELL, V55, P827, DOI 10.1016/0092-8674(88)90138-9; COTE S, 1987, EMBO J, V6, P2793, DOI 10.1002/j.1460-2075.1987.tb02575.x; DAVIS LG, 1986, BASIC METHODS MOL BI, P129; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; DAVIS LM, 1989, SOMAT CELL MOLEC GEN, V15, P605, DOI 10.1007/BF01534921; DEROBERTIS EM, 1991, DEVELOPMENT, V112, P669; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DORSSERS L, 1987, NUCLEIC ACIDS RES, V15, P3629, DOI 10.1093/nar/15.8.3629; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; DUBOULE D, 1989, NATO ASI SERIES H, V26, P97; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRELL RE, 1980, P NATL ACAD SCI-BIOL, V77, P1580, DOI 10.1073/pnas.77.3.1580; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FRAUMENI JF, 1968, J AMER MED ASSOC, V206, P825, DOI 10.1001/jama.206.4.825; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GESSLER M, 1989, SCIENCE, V244, P1575, DOI 10.1126/science.2544995; GESSLER M, 1989, GENOMICS, V5, P43, DOI 10.1016/0888-7543(89)90084-0; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; HODGSON SV, 1980, J MED GENET, V6, P478; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JONES C, 1978, HUM GENET, V44, P1; JOSTES B, 1991, MECH DEVELOP, V33, P27; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KILCHHERR F, 1986, NATURE, V321, P493, DOI 10.1038/321493a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; LAST RJ, 1968, E WOLFS ANATOMY EYE, P419; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; MANIATIS T, 1982, MOL CLONING LABORATO, P309; MANNENS M, 1989, CYTOGENET CELL GENET, V52, P32, DOI 10.1159/000132834; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MICHALOPOULOS EE, 1985, HUM GENET, V70, P157, DOI 10.1007/BF00273074; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; MONAGHAN P, 1991, DEVELOPMENT, V112, P1053; MOORE JW, 1986, HUM GENET, V72, P297, DOI 10.1007/BF00290952; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; OTTING G, 1988, EMBO J, V7, P4305, DOI 10.1002/j.1460-2075.1988.tb03329.x; PLACHOV D, 1990, DEVELOPMENT, V110, P643; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; RICCARDI VM, 1978, PEDIATRICS, V61, P604; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SHAW MW, 1960, AM J HUM GENET, V12, P389; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; SWAROOP A, 1988, NUCLEIC ACIDS RES, V16, P8739, DOI 10.1093/nar/16.17.8739; THEILER K, 1978, ANAT EMBRYOL, V155, P81, DOI 10.1007/BF00315732; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; WEISSMAN BE, 1987, SCIENCE, V236, P175, DOI 10.1126/science.3031816; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880	77	721	748	0	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	DEC 20	1991	67	6					1059	1074		10.1016/0092-8674(91)90284-6	http://dx.doi.org/10.1016/0092-8674(91)90284-6			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX164	1684738	Green Published			2022-12-28	WOS:A1991GX16400006
J	OZTURK, M				OZTURK, M			P53 MUTATION IN HEPATOCELLULAR-CARCINOMA AFTER AFLATOXIN EXPOSURE	LANCET			English	Article							HEPATITIS-B VIRUS; EPIDEMIOLOGY; PREVALENCE; CANCER; JAPAN	Mutations of the p53 gene are found in hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Specific mutations might reflect exposure to specific carcinogens and we have screened HCC samples from patients in 14 different countries to determine the frequency of a hotspot mutation at codon 249 of the tumour suppressor p53 gene. We detected mutations in 17% of tumours (12/72) from four countries in south Africa and the southeast coast of Asia. There was no codon 249 mutation in 95 specimens of HCC from other geographical locations including North America, Europe, Middle East, and Japan. Worldwide, the presence of the codon 249 mutation in HCCs correlated with high risk of exposure to aflatoxins and the hepatitis B virus (HBV). Further studies were completed in two groups of HBV-infected patients at different risks of exposure to aflatoxins. 53% of patients (8/15) from Mozambique at high risk of aflatoxin exposure had a tumour with a codon 249 mutation, in contrast with 8% of patients from Transkei (1/12) who were at low risk. HCC is an endemic disease in Mozambique and accounts for up to two thirds of all tumours in men. A codon 249 mutation of the p53 gene identifies an endemic form of HCC strongly associated with dietary aflatoxin intake.			OZTURK, M (corresponding author), MASSACHUSETTS GEN HOSP,CTR CANC,MOLEC HEPATOL LAB,BOSTON,MA 02129, USA.		OZTURK, MEHMET/AAS-7241-2021; ozturk, mehmet/G-3330-2014	OZTURK, MEHMET/0000-0002-6092-9706; Vyas, Girish/0000-0003-1090-4911; Kar, Siddhartha/0000-0001-9293-9274; Carr, Brian/0000-0002-6111-5077; PUISIEUX, Alain/0000-0002-9938-3798	NCI NIH HHS [CA35711, CA49832] Funding Source: Medline; NIAAA NIH HHS [AA00048] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA035711, R01CA035711, R29CA049832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA000048] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BEASLEY RP, 1982, HEPATOLOGY, V2, pS21; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; DUSHEIKO GM, 1989, AM J EPIDEMIOL, V129, P138, DOI 10.1093/oxfordjournals.aje.a115102; GROOPMAN JD, 1988, CRC CR REV TOXICOL, V19, P113, DOI 10.3109/10408448809014902; HANN HWL, 1982, INT J CANCER, V30, P47, DOI 10.1002/ijc.2910300109; HAYWARD NK, 1991, NATURE, V352, P764, DOI 10.1038/352764a0; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; Kew MC, 1984, ADV HEPATITIS RES, P203; LANGE W, 1987, POSTGRAD MED J, V63, P21; MAYANS MV, 1990, INT J CANCER, V46, P378, DOI 10.1002/ijc.2910460307; MIVECHI NF, 1990, CANCER RES, V50, P2877; MUIR CS, 1990, CANCER RES, V50, P6441; OKUDA K, 1987, CANCER RES, V47, P4967; PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205; PUISIEUX A, IN PRESS CANCER RES; TANAKA T, 1986, AM J EPIDEMIOL, V124, P368, DOI 10.1093/oxfordjournals.aje.a114407; TOWNSEND TR, 1990, JAMA-J AM MED ASSOC, V263, P290; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153; YEH FS, 1989, CANCER RES, V49, P2506; YU SZ, 1985, SUBCLINICAL HEPATOCE, P189	22	415	424	0	24	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 30	1991	338	8779					1356	1359						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682737				2022-12-28	WOS:A1991GR77300004
J	NOKES, DJ; ANDERSON, RM				NOKES, DJ; ANDERSON, RM			VACCINE SAFETY VERSUS VACCINE EFFICACY IN MASS IMMUNIZATION PROGRAMS	LANCET			English	Article							MUMPS-MEASLES-VACCINES; JERYL-LYNN-MORATEN; RUBELLA VACCINE; YOUNG-CHILDREN; VIRUS-VACCINES; AGE; INFECTION; IMMUNOGENICITY; EPIDEMIOLOGY; IMMUNIZATION	In community-wide immunisation programmes against childhood infections there is a conflict between the interests of the individual (vaccine safety and efficacy) and the interests of the community (vaccine uptake and level of herd immunity). Studies suggesting that the complication rate is greater with the high efficacy Urabe Am 9 mumps vaccine than with the lower efficacy Jeryl Lynn vaccine, have led to concern about whether the higher efficacy mumps vaccine should be introduced or retained in nationwide mass immunisation programmes. We describe the use of a mathematical model to assess benefits and risks to both individual and community, and illustrate this method by reference to immunisation programmes based on these vaccines. On the basis of current epidemiological data on viral transmission and vaccine coverage in England and Wales, data on vaccine-associated and infection-associated complication rates, and vaccine efficacies estimated from clinical trials, our analyses suggest there is little to choose between the two vaccines, but that overall performance depends on the level of vaccine coverage in a defined population. In community-based programmes, the greater apparent safety of the Jeryl Lynn vaccine (fewer vaccine-induced complications) is offset by the greater apparent efficacy of the Urabe Am 9 vaccine (fewer complications due to natural infection). The findings suggest that it may not always be in the interests of the community to use the vaccine with the lowest complication rate.			NOKES, DJ (corresponding author), IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOL, PARASITE EPIDEMIOL RES GRP, LONDON SW7 2BB, ENGLAND.			Anderson, Roy/0000-0002-9528-3175	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; ANDERSON RM, 1987, EPIDEMIOL INFECT, V99, P65, DOI 10.1017/S0950268800066875; ANDERSON RM, 1991, OXFORD TXB PUBLIC HL, V2, P225; BERGER R, 1988, J BIOL STAND, V16, P269, DOI 10.1016/0092-1157(88)90014-5; CAMPBELL AGM, 1990, IMMUNISATION INFECTI, P51; CHRISTENSON B, 1983, J BIOL STAND, V11, P323, DOI 10.1016/S0092-1157(83)80021-3; CHRISTENSON B, 1991, VACCINE, V9, P326, DOI 10.1016/0264-410X(91)90058-E; FARRINGTON CP, 1990, STAT MED, V9, P953, DOI 10.1002/sim.4780090811; FESCHAREK R, 1990, VACCINE, V8, P446, DOI 10.1016/0264-410X(90)90245-H; Furesz J, 1990, Can Dis Wkly Rep, V16, P253; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; JUST M, 1987, MUNCHEN MED WOCHEN, V129, P446; JUST M, 1987, MUNCHEN MED WOCHEN, V129, P188; KAKAKIOS AM, 1990, MED J AUSTRALIA, V152, P472, DOI 10.5694/j.1326-5377.1990.tb125306.x; KIMFARLEY R, 1985, AM J EPIDEMIOL, V121, P593, DOI 10.1093/oxfordjournals.aje.a114037; LAVERGNE B, 1986, CAN DIS WEEKLY REP, V12, P85; MORGANCAPNER P, 1988, BRIT MED J, V297, P770, DOI 10.1136/bmj.297.6651.770; NALIN DR, 1989, LANCET, V2, P1396; NALIN DR, 1989, BRIT MED J, V299, P1219, DOI 10.1136/bmj.299.6709.1219-b; NOKES DJ, 1988, EPIDEMIOL INFECT, V101, P1, DOI 10.1017/S0950268800029186; NOKES DJ, 1990, EPIDEMIOL INFECT, V105, P175, DOI 10.1017/S0950268800047762; POPOWKRAUPP T, 1986, J MED VIROL, V18, P69, DOI 10.1002/jmv.1890180109; Quast U, 1979, Dev Biol Stand, V43, P269; VESIKARI T, 1983, ACTA PAEDIATR SCAND, V72, P41, DOI 10.1111/j.1651-2227.1983.tb09661.x; VESIKARI T, 1984, AM J DIS CHILD, V138, P843, DOI 10.1001/archpedi.1984.02140470043013; VESIKARI T, 1983, ACTA PAEDIATR SCAND, V72, P37, DOI 10.1111/j.1651-2227.1983.tb09660.x; 1974, J R COLL GEN PRACT, V24, P552; 1958, REGISTRAR GENERALS S; 1958, REPORTS HOSPITAL INP	29	23	23	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1309	1312		10.1016/0140-6736(91)92601-W	http://dx.doi.org/10.1016/0140-6736(91)92601-W			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682694				2022-12-28	WOS:A1991GR02300013
J	SCHAAD, UB; LANG, AB; WEDGWOOD, J; RUEDEBERG, A; QUE, JU; FURER, E; CRYZ, SJ				SCHAAD, UB; LANG, AB; WEDGWOOD, J; RUEDEBERG, A; QUE, JU; FURER, E; CRYZ, SJ			SAFETY AND IMMUNOGENICITY OF PSEUDOMONAS-AERUGINOSA CONJUGATE-A VACCINE IN CYSTIC-FIBROSIS	LANCET			English	Note							PULMONARY	To assess the safety and immunogenicity of a Pseudomonas aeruginosa octavalent O-polysaccharide-toxin A conjugate vaccine, 22 patients (mean age 7 years) with cystic fibrosis who had no history of colonisation with P aeruginosa were immunised with the vaccine. Adverse reactions were mild and self-limiting. IgG antibody concentrations to all vaccine antigens were significantly raised after vaccination and remained so for 12 months. Immunisation produced opsonic and toxin A neutralising antibodies. A booster dose given at 12 months led to an anamnestic response. There was no significant change in clinical status after vaccination. Further work to assess efficacy in patients with cystic fibrosis can now be considered since our findings support the safety and immunogenicity of the vaccine.	SWISS SERUM & VACCINE INST,BERN,SWITZERLAND		SCHAAD, UB (corresponding author), UNIV BERN,INSELSPITAL,CHILDRENS HOSP,DEPT PEDIAT,CH-3010 BERN,SWITZERLAND.							CHRISPIN AR, 1974, PEDIATR RADIOL, V2, P101, DOI 10.1007/BF01314939; Cryz S J Jr, 1989, Antibiot Chemother (1971), V42, P177; CRYZ SJ, 1987, J CLIN INVEST, V80, P51, DOI 10.1172/JCI113062; CRYZ SJ, 1991, INFECT IMMUN, V59, P45, DOI 10.1128/IAI.59.1.45-50.1991; KRAEMER R, 1979, HELV PAEDIATR ACTA, V34, P417; LANGFORD DT, 1984, ARCH DIS CHILD, V59, P1131, DOI 10.1136/adc.59.12.1131; MARKS MI, 1981, J PEDIATR-US, V98, P173, DOI 10.1016/S0022-3476(81)80631-2	7	74	82	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1236	1237		10.1016/0140-6736(91)92103-9	http://dx.doi.org/10.1016/0140-6736(91)92103-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682645				2022-12-28	WOS:A1991GQ16600005
J	MULLER, W; CONNOR, JA				MULLER, W; CONNOR, JA			DENDRITIC SPINES AS INDIVIDUAL NEURONAL COMPARTMENTS FOR SYNAPTIC CA2+ RESPONSES	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL PYRAMIDAL CELLS; EXCITATORY AMINO-ACIDS; SYNAPSES; BLOCK	THE possibility that postsynaptic spines on neuronal dendrites are discrete biochemical compartments for Ca2+-activated processes involved in synaptic plasticity 1-6 is a widely proposed concept that has eluded experimental demonstration. Using microfluorometry on CA3 neurons in hippocampal slices, we show here that with weak presynaptic stimulation of associative/commissural fibres, Ca2+ accumulates in single postsynaptic spines but not in the parent dendrite. Stronger stimulation also promotes changes in dendrites. The NMDA-receptor antagonist AP-5 blocks changes in Ca2+ in spines. Sustained steep Ca2+ gradients between single spines and the parent dendrite, often lasting several minutes, develop with repeated stimulation. The observed compartmentalization allows for the specificity 7,8, cooperativity 9 and associativity 10-14 displayed by memory models such as long-term potentiation.			MULLER, W (corresponding author), ROCHE INST MOLEC BIOL,ROCHE RES CTR,DEPT NEUROSCI,340 KINGSLAND ST,NUTLEY,NJ 07110, USA.							BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; DINGLEDINE R, 1983, J PHYSIOL-LONDON, V343, P385, DOI 10.1113/jphysiol.1983.sp014899; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HARRIS KM, 1989, J NEUROSCI, V9, P2982; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MULLER W, 1991, NEURON, V6, P901, DOI 10.1016/0896-6273(91)90230-W; MULLER W, 1988, EXP BRAIN RES, V72, P287; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	23	413	418	1	9	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 7	1991	354	6348					73	76		10.1038/354073a0	http://dx.doi.org/10.1038/354073a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN829	1682815				2022-12-28	WOS:A1991GN82900061
J	SERAFINI, T; ORCI, L; AMHERDT, M; BRUNNER, M; KAHN, RA; ROTHMAN, JE				SERAFINI, T; ORCI, L; AMHERDT, M; BRUNNER, M; KAHN, RA; ROTHMAN, JE			ADP-RIBOSYLATION FACTOR IS A SUBUNIT OF THE COAT OF GOLGI-DERIVED COP-COATED VESICLES - A NOVEL ROLE FOR A GTP-BINDING PROTEIN	CELL			English	Article							YPT1 GENE-PRODUCT; ADENYLATE-CYCLASE; ENDOPLASMIC-RETICULUM; CHOLERA-TOXIN; REGULATORY COMPONENT; SUCCESSIVE COMPARTMENTS; VESICULAR TRANSPORT; NUCLEOTIDE-BINDING; SECRETORY VESICLES; MOLECULAR-CLONING	ADP-ribosylation factor (ARF) is an abundant and highly conserved low molecular weight GTP-binding protein that was originally identified as a key element required for the action of cholera toxin in mammalian cells, but whose physiological role is unknown. We report that ARF family proteins are highly concentrated in non-clathrin-coated transport vesicles and are coat proteins. About three copies of ARF are present on the outside of coated vesicles per alpha-COP (and thus per coatomer). ARF is highly enriched in coated vesicles as compared with parental Golgi cisternae, as shown both by biochemical and morphological methods, and ARF is removed from transport vesicles through uncoating during transport. Furthermore, ARF binds to Golgi cisternae in a GTP-dependent manner independently of coated vesicle budding. These observations strongly suggest a new role for GTP-binding proteins: ARF proteins may modulate vesicle budding and uncoating through controlled GTP hydrolysis.	PRINCETON UNIV, DEPT MOLEC BIOL, LEWIS THOMAS LABS, PRINCETON, NJ 08544 USA; UNIV GENEVA, INST HISTOL & EMBRYOL, DEPT MORPHOL, CH-1211 GENEVA 4, SWITZERLAND; NCI, DIV CANC TREATMENT, BIOL CHEM LAB, BETHESDA, MD 20892 USA	Princeton University; University of Geneva; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	SERAFINI, T (corresponding author), STANFORD UNIV, BECKMAN CTR, DEPT BIOCHEM, STANFORD, CA 94305 USA.		Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601; Brunner, Michael/0000-0001-9798-3047	NCI NIH HHS [CA47767-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047767] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMBRUSTER BL, 1982, J MICROSC-OXFORD, V126, P77, DOI 10.1111/j.1365-2818.1982.tb00358.x; BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; BOMSEL M, 1990, CELL, V62, P719, DOI 10.1016/0092-8674(90)90117-W; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; BUCCI C, 1988, NUCLEIC ACIDS RES, V16, P9979, DOI 10.1093/nar/16.21.9979; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GODA Y, 1991, J CELL BIOL, V112, P823, DOI 10.1083/jcb.112.5.823; GOUD B, 1990, NATURE, V345, P553, DOI 10.1038/345553a0; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; HARLOW E, 1988, ANTIBODIES LABORATOR; HAUBRUCK H, 1989, EMBO J, V8, P1427, DOI 10.1002/j.1460-2075.1989.tb03524.x; HAUBRUCK H, 1987, EMBO J, V6, P4049, DOI 10.1002/j.1460-2075.1987.tb02750.x; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1988, J BIOL CHEM, V263, P8282; KAHN RA, 1991, J BIOL CHEM, V266, P2606; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; LAPETINA EG, 1987, P NATL ACAD SCI USA, V84, P2261, DOI 10.1073/pnas.84.8.2261; LITTLE SP, 1977, VIROLOGY, V81, P37, DOI 10.1016/0042-6822(77)90056-3; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MAYORGA LS, 1989, SCIENCE, V244, P1475, DOI 10.1126/science.2499930; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; MIZOGUCHI A, 1990, J BIOL CHEM, V265, P11872; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; ORCI L, 1985, P NATL ACAD SCI USA, V82, P5385, DOI 10.1073/pnas.82.16.5385; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; ORCI L, 1991, CELL, V64, P1183; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; ROTHMAN JE, 1990, FASEB J, V4, P1460, DOI 10.1096/fasebj.4.5.2407590; RUOHOLA H, 1988, J CELL BIOL, V107, P1465, DOI 10.1083/jcb.107.4.1465; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHLEIFER LS, 1982, J BIOL CHEM, V257, P20; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SCHMITT HD, 1986, CELL, V47, P401, DOI 10.1016/0092-8674(86)90597-0; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SEWELL JL, 1988, P NATL ACAD SCI USA, V85, P4620, DOI 10.1073/pnas.85.13.4620; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; TOOZE SA, 1990, NATURE, V347, P207, DOI 10.1038/347207a0; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TSAI SC, 1988, J BIOL CHEM, V263, P1768; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; WALWORTH NC, 1989, EMBO J, V8, P1685, DOI 10.1002/j.1460-2075.1989.tb03560.x; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; WEISS O, 1989, J BIOL CHEM, V264, P21066; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	69	519	529	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 18	1991	67	2					239	253		10.1016/0092-8674(91)90176-Y	http://dx.doi.org/10.1016/0092-8674(91)90176-Y			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL470	1680566				2022-12-28	WOS:A1991GL47000004
J	KJELDSENKRAGH, J; HAUGEN, M; BORCHGREVINK, CF; LAERUM, E; EEK, M; MOWINKEL, P; HOVI, K; FORRE, O				KJELDSENKRAGH, J; HAUGEN, M; BORCHGREVINK, CF; LAERUM, E; EEK, M; MOWINKEL, P; HOVI, K; FORRE, O			CONTROLLED TRIAL OF FASTING AND ONE-YEAR VEGETARIAN DIET IN RHEUMATOID-ARTHRITIS	LANCET			English	Article							INDUCED ALLERGIC ARTHRITIS; DISEASE-ACTIVITY; FOOD; THERAPY	Fasting is an effective treatment for rheumatoid arthritis, but most patients relapse on reintroduction of food. The effect of fasting followed by one year of a vegetarian diet was assessed in a randomised, single-blind controlled trial. 27 patients were allocated to a four-week stay at a health farm. After an initial 7-10 day subtotal fast, they were put on an individually adjusted gluten-free vegan diet for 3.5 months. The food was then gradually changed to a lactovegetarian diet for the remainder of the study. A control group of 26 patients stayed for four weeks at a convalescent home, but ate an ordinary diet throughout the whole study period. After four weeks at the health farm the diet group showed a significant improvement in number of tender joints, Ritchie's articular index, number of swollen joints, pain score, duration of morning stiffness, grip strength, erythrocyte sedimentation rate, C-reactive protein, white blood cell count, and a health assessment questionnaire score. In the control group, only pain score improved significantly. The benefits in the diet group were still present after one year, and evaluation of the whole course showed significant advantages for the diet group in all measured indices. This dietary regimen seems to be a useful supplement to conventional medical treatment of rheumatoid arthritis.	UNIV OSLO,DEPT GEN PRACTICE,N-0264 OSLO,NORWAY; OSLO SANITETSFORENING REUMATISM HOSP,N-0172 OSLO,NORWAY; MEDSTAT RES,N-2011 STROMMEN,NORWAY; TONSASEN REKREASJONSHEIM,N-2890 ETNEDAL,NORWAY	University of Oslo	KJELDSENKRAGH, J (corresponding author), NATL HOSP,INST IMMUNOL & RHEUMATOL,FREDRIKKE QVAMS GATE 1,N-0172 OSLO,NORWAY.		Kjeldsen-Kragh, Jens/A-4472-2008; Haugen, Margaretha/H-7007-2016	Haugen, Margaretha/0000-0001-5924-5000				[Anonymous], FEAST TOOLBOX; BERI D, 1988, ANN RHEUM DIS, V47, P69, DOI 10.1136/ard.47.1.69; DARLINGTON LG, 1986, LANCET, V1, P236; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; GOOD RA, 1981, J CLIN IMMUNOL, V1, P3, DOI 10.1007/BF00915471; HAFSTROM I, 1988, ARTHRITIS RHEUM, V31, P585, DOI 10.1002/art.1780310502; HAUGEN M, IN PRESS CLIN RHEUMA; KLEINBAUM DG, 1988, APPLIED REGRESSION A, P96; KREMER JM, 1990, ARTHRITIS RHEUM, V33, P810, DOI 10.1002/art.1780330607; LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481, DOI 10.1177/028418517701800415; MONTGOMERY DC, 1984, DESIGN ANAL EXPT, P117; PANUSH RS, 1983, ARTHRITIS RHEUM, V26, P462, DOI 10.1002/art.1780260403; PANUSH RS, 1986, ARTHRITIS RHEUM, V29, P220, DOI 10.1002/art.1780290210; PANUSH RS, 1990, J RHEUMATOL, V17, P291; PARKE AL, 1981, BRIT MED J, V282, P2027, DOI 10.1136/bmj.282.6281.2027; PHINNEY SD, 1990, AM J CLIN NUTR, V51, P385, DOI 10.1093/ajcn/51.3.385; RITCHIE DM, 1968, Q J MED, V37, P393; ROPES M W, 1958, Bull Rheum Dis, V9, P175; SKOLDSTAM L, 1979, SCAND J RHEUMATOL, V8, P249, DOI 10.3109/03009747909114631; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; UDEN AM, 1983, ANN RHEUM DIS, V42, P45, DOI 10.1136/ard.42.1.45; 1984, MATVARETABELL	22	267	272	2	52	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					899	902		10.1016/0140-6736(91)91770-U	http://dx.doi.org/10.1016/0140-6736(91)91770-U			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681264				2022-12-28	WOS:A1991GJ89900001
J	SCHUSTER, CM; ULTSCH, A; SCHLOSS, P; COX, JA; SCHMITT, B; BETZ, H				SCHUSTER, CM; ULTSCH, A; SCHLOSS, P; COX, JA; SCHMITT, B; BETZ, H			MOLECULAR-CLONING OF AN INVERTEBRATE GLUTAMATE RECEPTOR SUBUNIT EXPRESSED IN DROSOPHILA MUSCLE	SCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL NERVOUS-SYSTEM; ACTIVE RIBONUCLEIC-ACID; FUNCTIONAL EXPRESSION; XENOPUS OOCYTES; INSECT MUSCLE; MESSENGER-RNA; CHANNELS; FAMILY; DNA	Insects and other invertebrates use glutamate as a neurotransmitter in the central nervous system and at the neuromuscular junction. A complementary DNA from Drosophila melanogaster, designated DGluR-II, has been isolated that encodes a distant homolog of the cloned mammalian ionotropic glutamate receptor family and is expressed in somatic muscle tissue of Drosophila embryos. Electrophysiological recordings made in Xenopus oocytes that express DGluR-II revealed depolarizing responses to L-glutamate and L-aspartate but low sensitivity to quisqualate, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), and kainate. The DGluR-II protein may represent a distinct glutamate receptor subtype, which shares its structural design with other members of the ionotropic glutamate receptor family.	UNIV HEIDELBERG, ZENTRUM MOLEK BIOL, NEUENHEIMER FELD 282, W-6900 HEIDELBERG, GERMANY; MAX PLANCK INST HIRNFORSCH, NEUROCHEM ABT, W-6000 FRANKFURT 71, GERMANY; MAX PLANCK INST MED RES, ZELLPHYSIOL ABT, W-6900 HEIDELBERG 1, GERMANY	Ruprecht Karls University Heidelberg; Max Planck Society; Max Planck Society								ABE T, 1983, J PHYSIOL-LONDON, V339, P243, DOI 10.1113/jphysiol.1983.sp014714; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BETTLER B, 1990, NEURON, V5, P583, DOI 10.1016/0896-6273(90)90213-Y; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BICKER G, 1988, J NEUROSCI, V8, P2108; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHENPS, 1968, REV SUISSE ZOOL, V75, P509; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; CULLCANDY SG, 1981, J PHYSIOL-LONDON, V321, P195, DOI 10.1113/jphysiol.1981.sp013979; CULLCANDY SG, 1978, J PHYSIOL-LONDON, V276, P165, DOI 10.1113/jphysiol.1978.sp012226; DELGADO R, 1989, FEBS LETT, V243, P337, DOI 10.1016/0014-5793(89)80157-7; DUCE IR, 1983, BRAIN RES, V263, P77, DOI 10.1016/0006-8993(83)91202-7; DUDEL J, 1989, BRAIN RES, V481, P215, DOI 10.1016/0006-8993(89)90796-8; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOSTER AC, 1984, BRAIN RES REV, V7, P103, DOI 10.1016/0165-0173(84)90020-1; FRASER SP, 1990, MOL BRAIN RES, V8, P331, DOI 10.1016/0169-328X(90)90047-H; GORMAN CM, 1989, VIROLOGY, V171, P377, DOI 10.1016/0042-6822(89)90605-3; GRATION KAF, 1981, NATURE, V291, P423, DOI 10.1038/291423a0; GRATION KAF, 1979, BRAIN RES, V171, P360, DOI 10.1016/0006-8993(79)90343-3; GREGOR P, 1989, NATURE, V342, P689, DOI 10.1038/342689a0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HORSEMAN BG, 1988, NEUROSCI LETT, V85, P65, DOI 10.1016/0304-3940(88)90430-2; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; IRVING SN, 1980, J COMP PHYSIOL, V135, P299, DOI 10.1007/BF00657646; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; KAWAI N, 1988, NEUROSCI LETT, V95, P203, DOI 10.1016/0304-3940(88)90657-X; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KERRY CJ, 1987, BIOPHYS J, V51, P137, DOI 10.1016/S0006-3495(87)83318-0; KORNFELD K, 1989, GENE DEV, V3, P243, DOI 10.1101/gad.3.2.243; KOTARSKI MA, 1985, GENETICS, V105, P374; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LEISS D, 1988, DEVELOPMENT, V104, P525; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATHERS DA, 1976, NATURE, V259, P409, DOI 10.1038/259409a0; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; NAKANISHI N, 1990, NEURON, V5, P569, DOI 10.1016/0896-6273(90)90212-X; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWRUK E, 1990, EMBO J, V9, P2671, DOI 10.1002/j.1460-2075.1990.tb07452.x; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHUSTER C, UNPUB; SHERBY SM, 1987, COMP BIOCHEM PHYS C, V87, P99, DOI 10.1016/0742-8413(87)90189-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; ULTSCH A, UNPUB; Usherwood P N, 1978, Adv Comp Physiol Biochem, V7, P227; USHERWOOD PN, 1969, NATURE, V223, P411, DOI 10.1038/223411a0; WADA K, 1989, NATURE, V342, P684, DOI 10.1038/342684a0; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0	60	158	162	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	1991	254	5028					112	114		10.1126/science.1681587	http://dx.doi.org/10.1126/science.1681587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH605	1681587				2022-12-28	WOS:A1991GH60500041
J	PETERS, F; FLICKFILLIES, D				PETERS, F; FLICKFILLIES, D			HAND DISINFECTION TO PREVENT PUERPERAL MASTITIS	LANCET			English	Letter											PETERS, F (corresponding author), UNIV MAINZ,ST HILDEGARDIS HOSP,W-6500 MAINZ,GERMANY.							BICKENBACH W, 1964, Munch Med Wochenschr, V106, P1825; Duncan JT, 1942, J HYG-CAMBRIDGE, V42, P474, DOI 10.1017/S0022172400035683; FULTON AA, 1945, BRIT MED J, V1, P693, DOI 10.1136/bmj.1.4402.693; Lawrence RA., BREASTFEEDING GUIDE, V8th; SOLTAU DHK, 1960, BRIT MED J, V1, P1603, DOI 10.1136/bmj.1.5186.1603; 1976, BRIT MED J, V1, P920	6	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					831	831		10.1016/0140-6736(91)90728-8	http://dx.doi.org/10.1016/0140-6736(91)90728-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681208				2022-12-28	WOS:A1991GG97900062
J	MAKI, M; HALLSTROM, O; MARTTINEN, A				MAKI, M; HALLSTROM, O; MARTTINEN, A			REACTION OF HUMAN NONCOLLAGENOUS POLYPEPTIDES WITH CELIAC-DISEASE AUTOANTIBODIES	LANCET			English	Note							IGA-CLASS RETICULIN; CELIAC-DISEASE; DERMATITIS-HERPETIFORMIS; ANTIBODY; RECOGNITION	We identified and purified six human noncollagenous protein molecules that specifically bind to serum IgA from patients with coeliac disease, and which as a combination can act as true antigen to reticulin antibodies. In affinity chromatography, the purified human protein molecules removed antibodies against reticulin and endomysium from serum samples of coeliac disease patients. We postulate that an autoimmune mechanism operates in generating the jejunal damage in gluten-sensitive enteropathy and that the human protein molecules described here act as self-antigens in the disease.			MAKI, M (corresponding author), UNIV TAMPERE,DEPT CLIN SCI,TEISKONTIE 35,POB 607,SF-33101 TAMPERE,FINLAND.							BORN W, 1990, SCIENCE, V249, P67, DOI 10.1126/science.1695022; CHORZELSKI TP, 1984, BRIT J DERMATOL, V111, P395, DOI 10.1111/j.1365-2133.1984.tb06601.x; HALLSTROM O, 1989, GUT, V30, P1225, DOI 10.1136/gut.30.9.1225; KARPATI S, 1990, LANCET, V336, P1335, DOI 10.1016/0140-6736(90)92893-M; KARPATI S, 1991, J INVEST DERMATOL, V96, P228, DOI 10.1111/1523-1747.ep12462097; LAMB JR, 1990, MOL BIOL MED, V7, P311; MAKI M, 1984, J PEDIATR-US, V105, P901, DOI 10.1016/S0022-3476(84)80074-8; MAKI M, IN PRESS GUT; SEAH PP, 1971, LANCET, V1, P834	9	72	72	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					724	725		10.1016/0140-6736(91)91445-Z	http://dx.doi.org/10.1016/0140-6736(91)91445-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679869				2022-12-28	WOS:A1991GG10400006
J	BRAHAMS, D				BRAHAMS, D			AUSTRALIAN MOTHER SUED BY CHILD INJURED INUTERO	LANCET			English	Editorial Material																		BRAHAMS D, 1990, LANCET, V336, P1572, DOI 10.1016/0140-6736(90)93335-M; MASON JK, 1991, LAW MED ETHICS, P139; MILLIKEN R, 1991, INDEPENDENT     0807, P8	3	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					687	688		10.1016/0140-6736(91)91252-P	http://dx.doi.org/10.1016/0140-6736(91)91252-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679486				2022-12-28	WOS:A1991GF10500018
J	ROTZSCHKE, O; FALK, K; WALLNY, HJ; FAATH, S; RAMMENSEE, HG				ROTZSCHKE, O; FALK, K; WALLNY, HJ; FAATH, S; RAMMENSEE, HG			CHARACTERIZATION OF NATURALLY-OCCURRING MINOR HISTOCOMPATIBILITY PEPTIDES INCLUDING H-4 AND H-Y	SCIENCE			English	Article									MAX PLANCK INST BIOL, IMMUNGENET ABT, W-7400 TUBINGEN, GERMANY	Max Planck Society			Roetzschke, Olaf/GXH-0012-2022					BEVAN MJ, 1975, NATURE, V256, P419, DOI 10.1038/256419a0; BILLINGHAM RE, 1981, HUM GENET, V58, P9, DOI 10.1007/BF00284141; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BODMER HC, 1988, CELL, V52, P253, DOI 10.1016/0092-8674(88)90514-4; DAVIS AP, 1990, IMMUNOGENETICS, V31, P7, DOI 10.1007/BF00702483; DEMOTZ S, 1989, NATURE, V342, P682, DOI 10.1038/342682a0; DEPLAEN E, 1988, P NATL ACAD SCI USA, V85, P2274; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; EICHWALD EJ, 1955, TRANSPLAN B, V2, P121; FALK K, UNPUB; GORDON RD, 1975, J EXP MED, V142, P1108, DOI 10.1084/jem.142.5.1108; GOULMY E, 1977, NATURE, V266, P544, DOI 10.1038/266544a0; GRAFF RJ, 1987, IMMUNOGENETICS, V26, P111, DOI 10.1007/BF00345464; KAUFMANN SHE, 1986, J EXP MED, V164, P363, DOI 10.1084/jem.164.1.363; LINDAHL KF, 1989, COLD SH Q B, V54, P563; LOVELAND B, 1986, IMMUNOL TODAY, V7, P223, DOI 10.1016/0167-5699(86)90109-X; MCMICHAEL AJ, COMMUNICATION; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; RAMMENSEE HG, 1983, IMMUNOGENETICS, V17, P637, DOI 10.1007/BF00366131; RAMMENSEE HG, 1989, IMMUNOGENETICS, V30, P296, DOI 10.1007/BF02421334; RAMMENSEE HG, 1986, NATURE, V319, P502, DOI 10.1038/319502a0; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; SCHILD H, 1990, SCIENCE, V247, P1587, DOI 10.1126/science.2321019; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SNELL GD, 1961, IMMUNOLOGY, V4, P366; SPEISER DE, 1990, P NATL ACAD SCI USA, V87, P2021, DOI 10.1073/pnas.87.5.2021; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; WALLNY HJ, 1990, NATURE, V343, P275, DOI 10.1038/343275a0; WETTSTEIN PJ, 1982, J IMMUNOL, V128, P2629; WETTSTEIN PJ, 1986, J IMMUNOL, V137, P2073; WETTSTEIN PJ, 1989, HUMAN IMMUNOGENETICS, P339; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	38	206	211	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	1990	249	4966					283	287		10.1126/science.1695760	http://dx.doi.org/10.1126/science.1695760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP599	1695760				2022-12-28	WOS:A1990DP59900036
J	RHYMES, J				RHYMES, J			HOSPICE CARE IN AMERICA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											RHYMES, J (corresponding author), UNIV CHICAGO,MED CTR,DEPT MED,GEN INTERNAL MED SECT,5841 S MARYLAND AVE,BOX 72,CHICAGO,IL 60637, USA.							BAYER R, 1983, NEW ENGL J MED, V309, P1490, DOI 10.1056/NEJM198312153092405; BRODY H, 1984, NEW ENGL J MED, V310, P920; CHARAP AD, 1978, MT SINAI J MED, V45, P561; CLEELAND CS, 1986, CANCER, V58, P796, DOI 10.1002/1097-0142(19860801)58:3<796::AID-CNCR2820580331>3.0.CO;2-#; DAHL JL, 1989, AM J HOSPICE CARE, V6, P39; FOLEY KM, 1985, NEW ENGL J MED, V313, P84, DOI 10.1056/NEJM198507113130205; FORSTER LE, 1988, ARCH INTERN MED, V148, P2540, DOI 10.1001/archinte.148.12.2540; FRASER I, 1986, INQUIRY-J HEALTH CAR, V23, P141; HANNAN EL, 1984, INQUIRY-J HEALTH CAR, V21, P338; KANE RL, 1984, LANCET, V1, P890; LONG SH, 1984, INQUIRY-J HEALTH CAR, V21, P315; MacDonald D, 1989, Am J Hosp Care, V6, P17, DOI 10.1177/104990918900600215; MacDonald D., 1989, AM J HOSPICE CARE, V6, P40; MARKS RM, 1973, ANN INTERN MED, V78, P173, DOI 10.7326/0003-4819-78-2-173; MOR V, 1985, MED CARE, V23, P1115, DOI 10.1097/00005650-198509000-00008; MOR V, 1985, HEALTH SERV RES, V20, P407; MOR V, 1987, HOSPICE CARE SYSTEMS, P38; MORRIS JN, 1986, J CHRON DIS, V39, P27, DOI 10.1016/0021-9681(86)90104-9; SAGER MA, 1989, NEW ENGL J MED, V320, P433, DOI 10.1056/NEJM198902163200705; SPECTOR WD, 1984, INQUIRY-J HEALTH CAR, V21, P328; VOLICER L, 1986, J AM GERIATR SOC, V34, P655, DOI 10.1111/j.1532-5415.1986.tb04907.x; WALLSTON KA, 1988, MED CARE, V26, P177, DOI 10.1097/00005650-198802000-00008; 1989, HRD89111 GEN ACC OFF	23	62	63	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	1990	264	3					369	372		10.1001/jama.264.3.369	http://dx.doi.org/10.1001/jama.264.3.369			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN164	1694548				2022-12-28	WOS:A1990DN16400034
J	SIEGELMAN, MH; CHENG, IC; WEISSMAN, IL; WAKELAND, EK				SIEGELMAN, MH; CHENG, IC; WEISSMAN, IL; WAKELAND, EK			THE MOUSE LYMPH-NODE HOMING RECEPTOR IS IDENTICAL WITH THE LYMPHOCYTE CELL-SURFACE MARKER LY-22 - ROLE OF THE EGF DOMAIN IN ENDOTHELIAL BINDING	CELL			English	Article									UNIV FLORIDA, MED CTR, DEPT PATHOL, GAINESVILLE, FL 32610 USA	State University System of Florida; University of Florida	SIEGELMAN, MH (corresponding author), STANFORD UNIV, MED CTR,SCH MED,HOWARD HUGHES MED INST, DEPT PATHOL, EXPTL ONCOL LAB, STANFORD, CA 94305 USA.			CHENG, IVAN-CHEN/0000-0002-0168-3902	NCI NIH HHS [CA42551] Funding Source: Medline; NIAID NIH HHS [AI09072, AI17966] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017966] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; ALTMAN PL, 1979, INBRED GENETICALLY 1, P16; APPELLA E, 1987, J BIOL CHEM, V262, P4437; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BAILEY D, 1981, MOUSE BIOMEDICAL RES; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOCK SC, 1985, CYTOGENET CELL GENET, V39, P67, DOI 10.1159/000132105; BOWEN BR, 1990, J CELL BIOL, V110, P147, DOI 10.1083/jcb.110.1.147; BOWEN BR, 1989, J CELL BIOL, V109, P421, DOI 10.1083/jcb.109.1.421; BUTCHER EC, 1979, J IMMUNOL, V123, P1996; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; CHAN MM, 1983, J IMMUNOL, V130, P2075; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN S, 1982, J BIOL CHEM, V257, P1523; DAILEY MO, 1985, J MOL CELL IMMUNOL, V2, P27; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; FINK PJ, 1985, NATURE, V313, P233, DOI 10.1038/313233a0; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KANSAS GS, 1985, J IMMUNOL, V134, P2995; KANSAS GS, 1985, J IMMUNOL, V134, P3003; KOMORIYA A, 1984, P NATL ACAD SCI-BIOL, V81, P1351, DOI 10.1073/pnas.81.5.1351; KREITMAN ME, 1986, GENETICS, V114, P93; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LIEBERMAN M, 1979, INT J CANCER, V24, P168, DOI 10.1002/ijc.2910240208; MARCHESI VT, 1964, PROC R SOC SER B-BIO, V159, P283, DOI 10.1098/rspb.1964.0002; MCCONNELL TJ, 1986, J IMMUNOL, V136, P3076; MCINTYRE BW, 1984, CELL, V38, P659, DOI 10.1016/0092-8674(84)90260-5; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PINK J, 1979, RES METHODS IMMUNOLO, V1, P169; REICHERT RA, 1983, J EXP MED, V157, P813, DOI 10.1084/jem.157.3.813; REICHERT RA, 1986, J IMMUNOL, V136, P3535; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; RUDIKOFF S, 1976, P NATL ACAD SCI USA, V73, P2109, DOI 10.1073/pnas.73.6.2109; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; Seldin MF, 1988, GENOMICS, V2, P48, DOI 10.1016/0888-7543(88)90108-5; SIEGELMAN M, 1986, SCIENCE, V231, P823, DOI 10.1126/science.3003913; SIEGELMAN M, 1988, UBIQUITIN, P239; SIEGELMAN MH, 1989, P NATL ACAD SCI USA, V86, P5562, DOI 10.1073/pnas.86.14.5562; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SINGER PA, 1988, P NATL ACAD SCI USA, V85, P7729, DOI 10.1073/pnas.85.20.7729; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STJOHN T, 1986, SCIENCE, V231, P845, DOI 10.1126/science.3003914; STOOLMAN LM, 1983, J CELL BIOL, V96, P722, DOI 10.1083/jcb.96.3.722; STOOLMAN LM, 1987, BLOOD, V70, P1842; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; TADA N, 1983, HYBRIDOMA, V2, P29, DOI 10.1089/hyb.1983.2.29; TAKADA S, 1989, J IMMUNOL, V142, P3038; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YEDNOCK TA, 1987, J CELL BIOL, V104, P713, DOI 10.1083/jcb.104.3.713; YEDNOCK TA, 1984, J CELL BIOL, V99, pA68; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725	68	112	121	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	1990	61	4					611	622		10.1016/0092-8674(90)90473-R	http://dx.doi.org/10.1016/0092-8674(90)90473-R			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DE904	1693096				2022-12-28	WOS:A1990DE90400007
J	MORIYAMA, T; GUILHOT, S; KLOPCHIN, K; MOSS, B; PINKERT, CA; PALMITER, RD; BRINSTER, RL; KANAGAWA, O; CHISARI, FV				MORIYAMA, T; GUILHOT, S; KLOPCHIN, K; MOSS, B; PINKERT, CA; PALMITER, RD; BRINSTER, RL; KANAGAWA, O; CHISARI, FV			IMMUNOBIOLOGY AND PATHOGENESIS OF HEPATOCELLULAR INJURY IN HEPATITIS-B VIRUS TRANSGENIC MICE	SCIENCE			English	Article									SCRIPPS CLIN & RES FDN,RES INST,LA JOLLA,CA 92037; NIAID,BETHESDA,MD 20205; LILLY RES LABS,LA JOLLA,CA 92037; UNIV PENN,PHILADELPHIA,PA 19104; UNIV WASHINGTON,SEATTLE,WA 98195	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Eli Lilly; University of Pennsylvania; University of Washington; University of Washington Seattle			Chisari, Francis V/A-3086-2008	Brinster, Ralph/0000-0003-1408-7656; Pinkert, Carl/0000-0001-7460-3881; Moss, Bernard/0000-0002-2154-8564; Chisari, Francis/0000-0002-4832-1044	NATIONAL CANCER INSTITUTE [R01CA034635, R01CA038635, R01CA040489, R37CA040489] Funding Source: NIH RePORTER; NCI NIH HHS [CA40489, CA38635, CA34635] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNABA V, 1989, J IMMUNOL, V143, P2650; CELIS E, 1988, J IMMUNOL, V140, P1808; CHENG KC, 1986, J VIROL, V60, P337, DOI 10.1128/JVI.60.2.337-344.1986; CHENG KC, 1987, J VIROL, V61, P1286, DOI 10.1128/JVI.61.4.1286-1290.1987; CHISARI FV, 1985, SCIENCE, V230, P1157, DOI 10.1126/science.3865369; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; CHISARI FV, 1986, J VIROL, V60, P880, DOI 10.1128/JVI.60.3.880-887.1986; CHISARI FV, 1989, MICROB PATHOGENESIS, V6, P311, DOI 10.1016/0882-4010(89)90073-9; CHISARI FV, UNPUB; FERRARI C, 1987, J IMMUNOL, V139, P2050; FRANCO A, 1988, HEPATOLOGY, V8, P449, DOI 10.1002/hep.1840080302; HORDER M, 1981, SCAND J CLIN LAB INV, V41, P107, DOI 10.3109/00365518109092022; JIN Y, 1988, J EXP MED, V168, P293, DOI 10.1084/jem.168.1.293; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; LEE F, 1981, NATURE, V294, P228, DOI 10.1038/294228a0; LEVY GA, 1981, SPRINGER SEMIN IMMUN, V3, P439, DOI 10.1007/BF01951492; MONDELLI M, 1982, J IMMUNOL, V129, P2773; MORIYAMA T, 1988, CELL IMMUNOL, V111, P482, DOI 10.1016/0008-8749(88)90111-6; MORIYAMA T, UNPUB, P37001; SI L, 1983, J CLIN IMMUNOL, V3, P408, DOI 10.1007/BF00915803; SKOSKIEWICZ MJ, 1985, J EXP MED, V162, P1645, DOI 10.1084/jem.162.5.1645; SMITH GL, 1983, NATURE, V302, P490, DOI 10.1038/302490a0; SPRENT J, 1986, NATURE, V322, P541, DOI 10.1038/322541a0; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TOWNSEND ARM, 1983, IMMUNOGENETICS, V17, P283, DOI 10.1007/BF00364412	25	322	341	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 20	1990	248	4953					361	364		10.1126/science.1691527	http://dx.doi.org/10.1126/science.1691527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ837	1691527				2022-12-28	WOS:A1990CZ83700037
J	LEWIS, SH; REYNOLDSKOHLER, C; FOX, HE; NELSON, JA				LEWIS, SH; REYNOLDSKOHLER, C; FOX, HE; NELSON, JA			HIV-1 IN TROPHOBLASTIC AND VILLOUS HOFBAUER CELLS, AND HEMATOLOGICAL PRECURSORS IN 8-WEEK FETUSES	LANCET			English	Article									SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,LA JOLLA,CA 92037; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR COMPREHENS CANC,NEW YORK,NY 10032	Scripps Research Institute; Columbia University; Columbia University	LEWIS, SH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT OBSTET & GYNECOL,NEW YORK,NY 10032, USA.							BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; DEMIR R, 1984, ACTA ANAT, V119, P18; DRAKE BL, 1987, PLACENTA, V8, P129, DOI 10.1016/0143-4004(87)90016-6; GABUZDA DH, 1986, ANN NEUROL, V20, P289, DOI 10.1002/ana.410200304; GOLDSTEIN J, 1988, AM J PATHOL, V133, P648; HUSTIN J, 1987, AM J OBSTET GYNECOL, V157, P162, DOI 10.1016/S0002-9378(87)80371-X; JOVAISAS E, 1985, LANCET, V2, P1129; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; LAPOINTE N, 1985, NEW ENGL J MED, V312, P1325, DOI 10.1056/NEJM198505163122012; MAURY W, 1989, J INFECT DIS, V160, P583, DOI 10.1093/infdis/160.4.583; NELSON JA, 1988, LANCET, V1, P259; PUMAROLEJUNE T, 1986, ANN NEUROL, V20, P289; SAMRA JS, 1989, OBSTET GYNECOL, V73, P832; SPRECHER S, 1986, LANCET, V2, P288; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; YOUNG N, 1984, J CLIN INVEST, V74, P2024, DOI 10.1172/JCI111625; 1987, AIDS WEEKLY SURVEILL; 1988, LANCET, V2, P1057	18	228	229	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					565	568		10.1016/0140-6736(90)90349-A	http://dx.doi.org/10.1016/0140-6736(90)90349-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1689792	hybrid			2022-12-28	WOS:A1990CT65300004
J	MERRIL, CR				MERRIL, CR			SILVER STAINING OF PROTEINS AND DNA	NATURE			English	Article											MERRIL, CR (corresponding author), NIMH,BLDG 10,BETHESDA,MD 20892, USA.							GOLDMAN D, 1980, CLIN CHEM, V26, P1317; HARRINGTON MG, 1986, NEW ENGL J MED, V315, P279, DOI 10.1056/NEJM198607313150502; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; MERRIL CR, 1986, ACTA HISTOCHEM CYTOC, V19, P655, DOI 10.1267/ahc.19.655; MERRIL CR, 1986, ANAL BIOCHEM, V156, P96, DOI 10.1016/0003-2697(86)90160-0; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; MERRIL CR, 1988, P NATL ACAD SCI USA, V85, P453, DOI 10.1073/pnas.85.2.453; MERRIL CR, 1984, 2 DIMENSIONAL GEL EL, P93; MERRIL CR, 1987, ADV ELECTROPHORESIS, V1, P111; NIELSEN BL, 1984, ANAL BIOCHEM, V141, P311, DOI 10.1016/0003-2697(84)90047-2; OCHS D, 1983, ANAL BIOCHEM, V135, P470, DOI 10.1016/0003-2697(83)90714-5; SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303	12	70	74	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 22	1990	343	6260					779	780		10.1038/343779a0	http://dx.doi.org/10.1038/343779a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	1689465				2022-12-28	WOS:A1990CP80700068
J	SAVILL, J; DRANSFIELD, I; HOGG, N; HASLETT, C				SAVILL, J; DRANSFIELD, I; HOGG, N; HASLETT, C			VITRONECTIN RECEPTOR-MEDIATED PHAGOCYTOSIS OF CELLS UNDERGOING APOPTOSIS	NATURE			English	Article									IMPERIAL CANC RES FUND,MACROPHAGE LAB,LONDON WC2A 3PX,ENGLAND	Cancer Research UK	SAVILL, J (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND.			Dransfield, Ian/0000-0001-5848-7059				BROWN DL, 1989, J CLIN INVEST, V84, P366, DOI 10.1172/JCI114166; BROWN EJ, 1988, J EXP MED, V167, P777, DOI 10.1084/jem.167.3.777; BURNS GF, 1986, CELL, V45, P269, DOI 10.1016/0092-8674(86)90391-0; CHARO IF, 1986, P NATL ACAD SCI USA, V83, P8351, DOI 10.1073/pnas.83.21.8351; CHARO IF, 1987, J BIOL CHEM, V262, P9935; CHERESH DA, 1987, J BIOL CHEM, V262, P1434; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; GRESHAM HD, 1989, J CELL BIOL, V108, P1935, DOI 10.1083/jcb.108.5.1935; HUBBARD AL, 1975, J CELL BIOL, V64, P438, DOI 10.1083/jcb.64.2.438; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; MORGANELLI PM, 1988, J IMMUNOL, V140, P2296; MYONES BL, 1988, J CLIN INVEST, V82, P640, DOI 10.1172/JCI113643; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; PHILLIPS DR, 1988, BLOOD, V71, P831; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328; SAVILL JS, 1989, THESIS U LONDON; Wright S D, 1986, Methods Enzymol, V132, P204; WRIGHT SD, 1988, J CELL SCI S, V9, P251; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; WYLLIE AH, 1984, J PATHOL, V142, P62	30	732	742	1	16	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 11	1990	343	6254					170	173		10.1038/343170a0	http://dx.doi.org/10.1038/343170a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH527	1688647				2022-12-28	WOS:A1990CH52700060
J	GOEDERT, JJ; DULIEGE, AM; AMOS, CI; FELTON, S; BIGGAR, RJ				GOEDERT, JJ; DULIEGE, AM; AMOS, CI; FELTON, S; BIGGAR, RJ			HIGH-RISK OF HIV-1 INFECTION FOR 1ST-BORN TWINS	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ONE DIZYGOTIC TWIN; CARRIER MOTHERS; INFANTS BORN; TRANSMISSION; TYPE-1	To examine the epidemiology and natural history of mother-to-infant transmission of human immunodeficiency virus type 1 (HIV-1), especially genetic and intrapartum exposure factors, we obtained data on twins and triplets born to women infected with the virus. 40 investigators in nine countries contributed demographic, clinical, and epidemiological data on 100 sets of twins and 1 set of triplets. Among the 66 evaluable sets, HIV-1 infection was more common in first-born than in second- born twins (p = 0.004). In 22 sets, only one twin was infected (18 first-born, 4 second-born). 50% of first-born twins delivered vaginally and 38% of first-born twins delivered by caesarean were infected, compared with 19% of second-born twins delivered by either route. HIV-1 infection status tended to be concordant in more monozygotic (14 of 17 sets) than dizygotic (26 of 43) sets, but the frequency and clinical signs of HIV-1-related disease were similar in only 3 of the 10 sets with both children infected. These findings suggest that some infants may be infected in utero before labour but that a substantial proportion of HIV-1 transmission occurs as the first twin encounters the cervix and birth canal. Such measures as cleansing of the birth canal and caesarean delivery before membrane rupture might reduce the risk of transmission for infants born to HIV-1-infected women and should be the subjects of controlled clinical trials. Caesarean section should not be regarded as a wholly preventive measure, however, since substantial proportions of both first-born and second-born twins delivered in this way were infected.	GENENTECH INC,DIV CLIN RES,SAN FRANCISCO,CA 94080; RES TRIANGLE INST,RES TRIANGLE PK,NC 27709; NCI,VIRAL EPIDEMIOL SECT,ROCKVILLE,MD; NCI,FAMILY STUDIES SECT,ROCKVILLE,MD	Roche Holding; Genentech; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	GOEDERT, JJ (corresponding author), 6130 EXECUT BLVD,SUITE 434,ROCKVILLE,MD 20852, USA.		Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP095612] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-95612] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMSTEY MS, 1974, OBSTET GYNECOL, V44, P394; ANDIMAN WA, 1990, AM J DIS CHILD, V144, P758, DOI 10.1001/archpedi.1990.02150310026020; BENIRSCHKE K, 1990, CLIN OBSTET GYNECOL, V33, P18, DOI 10.1097/00003081-199003000-00006; BISHOP YMM, 1976, DISCRETE MULTIVARIAT; BLANCHE S, 1989, NEW ENGL J MED, V320, P1643, DOI 10.1056/NEJM198906223202502; Chiodo F, 1986, Lancet, V1, P739; COURGNAUD V, 1991, AIDS RES HUM RETROV, V7, P83; EHRNST, 1991, LANCET, V338, P203; FRANCIOSI RA, 1973, J PEDIATR-US, V82, P707, DOI 10.1016/S0022-3476(73)80604-3; GABIANO C, 1991, 7TH INT C AIDS SAN F, P356; GOEDERT JJ, 1989, LANCET, V2, P1351; GROWDON WA, 1987, JAMA-J AM MED ASSOC, V257, P508; HINO S, 1987, LANCET, V2, P158; JOHNSON FD, 1991, 7TH INT C AIDS, P355; LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A; LINDGREN S, 1991, AIDS, V5, P1111, DOI 10.1097/00002030-199109000-00009; MENEZBAUTISTA R, 1986, AM J DIS CHILD, V140, P678, DOI 10.1001/archpedi.1986.02140210076029; MINKOFF HL, 1987, JAMA-J AM MED ASSOC, V258, P2714, DOI 10.1001/jama.258.19.2714; MOK JQ, 1987, LANCET, V1, P1164; PARK CL, 1987, J CLIN MICROBIOL, V25, P1119, DOI 10.1128/JCM.25.6.1119-1121.1987; PATTERSON RM, 1990, AM J PERINAT, V7, P217, DOI 10.1055/s-2007-999485; PLAEGERMARSHALL S, 1989, PEDIATR INFECT DIS J, V8, P171; SHEARER WT, 1972, J PEDIATR-US, V81, P1161, DOI 10.1016/S0022-3476(72)80254-3; STRANDSKOV HH, 1946, GENETICS, V31, P438; WONG VCW, 1980, BRIT J OBSTET GYNAEC, V87, P958, DOI 10.1111/j.1471-0528.1980.tb04458.x; 1988, LANCET, V2, P1043; 1988, LANCET, V2, P1039; 1991, LANCET, V337, P253; 1987, MMWR, V36, P225; 1987, MMWR, V36, P235	30	275	277	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1471	1475		10.1016/0140-6736(91)92297-F	http://dx.doi.org/10.1016/0140-6736(91)92297-F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683916				2022-12-28	WOS:A1991GV07700001
J	GRANOWITZ, EV; SANTOS, AA; POUTSIAKA, DD; CANNON, JG; WILMORE, DW; WOLFF, SM; DINARELLO, CA				GRANOWITZ, EV; SANTOS, AA; POUTSIAKA, DD; CANNON, JG; WILMORE, DW; WOLFF, SM; DINARELLO, CA			PRODUCTION OF INTERLEUKIN-1-RECEPTOR ANTAGONIST DURING EXPERIMENTAL ENDOTOXEMIA	LANCET			English	Note							TUMOR NECROSIS FACTOR; INHIBITOR; SHOCK; URINE	Interleukin-1 (IL-1) has been implicated in the pathogenesis of sepsis. IL-1-receptor antagonist (IL-1ra) is a naturally occurring inhibitor of IL-1 activity that competes with IL-1 for occupancy of cell-surface receptors but possesses no agonist activity. We induced endotoxaemia in 9 healthy human volunteers by injection of Escherichia coli endotoxin, and measured plasma concentrations of IL-1 and IL-1ra by radioimmunoassay during the next 24 h. Peak plasma concentrations of IL-1ra were about a hundred-fold greater than those of IL-1-beta. No IL-1 or IL-1ra were detectable in the plasma of 4 volunteers injected with saline. Our results suggest that the predominant natural response to endotoxin in man is the production of antagonist rather than agonist.	TUFTS UNIV,NEW ENGLAND MED CTR,SCH MED,DEPT MED,750 WASHINGTON ST,BOSTON,MA 02111; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT SURG,BOSTON,MA 02115	Tufts Medical Center; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School					NIAID NIH HHS [AI-15614] Funding Source: Medline; NIAMS NIH HHS [AR-39595] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R56AI015614, R37AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039595] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CANNON JG, 1990, J INFECT DIS, V161, P79, DOI 10.1093/infdis/161.1.79; COMINELLI F, 1990, J CLIN INVEST, V86, P972, DOI 10.1172/JCI114799; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; DINARELLO CA, 1991, BLOOD, V77, P1627; GRANOWITZ EV, 1991, J BIOL CHEM, V266, P14147; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; POUTSIAKA DD, 1991, BLOOD, V78, P1275; PRIEUR AM, 1987, LANCET, V2, P1240; SECKINGER P, 1987, J IMMUNOL, V139, P1546; SMITH J, 1990, AM SOC CLIN ONCOL, V9, P717; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816	11	308	314	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1423	1424		10.1016/0140-6736(91)92725-H	http://dx.doi.org/10.1016/0140-6736(91)92725-H			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683422				2022-12-28	WOS:A1991GT90400006
J	PATTERSON, DLH; TREASURE, T				PATTERSON, DLH; TREASURE, T			THE CULPRIT CORONARY-ARTERY LESION	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; DISEASE		ST GEORGE HOSP,DEPT CARDIOTHORAC,LONDON,ENGLAND	St Georges University London	PATTERSON, DLH (corresponding author), WHITTINGTON HOSP,DEPT CARDIAC,HIGHGATE HILL,LONDON N19 5NF,ENGLAND.							BROWN G, 1990, NEW ENGL J MED, V323, P1989; DETRE K, 1981, CIRCULATION, V63, P1329, DOI 10.1161/01.CIR.63.6.1329; HACKETT D, 1988, EUR HEART J, V9, P1317, DOI 10.1093/oxfordjournals.eurheartj.a062449; HAFT JI, 1988, CHEST, V94, P731, DOI 10.1378/chest.94.4.731; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; MCHENRY PL, 1984, CIRCULATION, V70, P547, DOI 10.1161/01.CIR.70.4.547; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; RENTROP KP, 1988, AM J CARDIOL, V61, P677, DOI 10.1016/0002-9149(88)91048-X; 1980, LANCET, V2, P1173; 1983, CIRCULATION, V68, P939	10	7	7	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 30	1991	338	8779					1379	1380		10.1016/0140-6736(91)92248-Z	http://dx.doi.org/10.1016/0140-6736(91)92248-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682748				2022-12-28	WOS:A1991GR77300015
J	VANGRIENSVEN, GJP; BOUCHER, EC; ROOS, M; COUTINHO, RA				VANGRIENSVEN, GJP; BOUCHER, EC; ROOS, M; COUTINHO, RA			EXPANSION OF AIDS CASE DEFINITION	LANCET			English	Letter									BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS		VANGRIENSVEN, GJP (corresponding author), MUNICIPAL HLTH SERV,DEPT PUBL HLTH,1000 HE AMSTERDAM,NETHERLANDS.		van Griensven, Frits/G-4719-2013	van Griensven, Frits/0000-0002-0971-2843					0	15	15	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					1012	1013		10.1016/0140-6736(91)91872-R	http://dx.doi.org/10.1016/0140-6736(91)91872-R			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681315				2022-12-28	WOS:A1991GK97400029
J	NIMMANNIT, S; MALASIT, P; CHAOVAKUL, V; SUSAENGRAT, W; VASUVATTAKUL, S; NILWARANGKUR, S				NIMMANNIT, S; MALASIT, P; CHAOVAKUL, V; SUSAENGRAT, W; VASUVATTAKUL, S; NILWARANGKUR, S			PATHOGENESIS OF SUDDEN UNEXPLAINED NOCTURNAL DEATH (LAI TAI) AND ENDEMIC DISTAL RENAL TUBULAR-ACIDOSIS	LANCET			English	Editorial Material							ASIAN REFUGEES; SLEEP; THAILAND	Sudden unexplained nocturnal death (SUND), a disorder of unknown cause that occurs in otherwise healthy young adults, mostly male, during their sleep, is prevalent in the north-east region of Thailand, where it has been known for generations as lai tai. It occurs in the same population and area where hypokalaemic periodic paralysis (HPP), endemic distal renal tubular acidosis (EdRTA), and renal stones are also endemic. SUND has occurred in families of patients with EdRTA, and HPP can present as sudden onset of muscle paralysis with potentially lethal cardiac arrhythmias and respiratory failure from severe hypokalaemia occurring in the middle of the night. Surveys in which serum and urinary potassium have been measured indicate a deficiency of the electrolyte in the population. Potassium deficiency is probably the prime factor responsible for SUND and HPP. Low urinary citrate concentrations and the high prevalence of acidification defects in the population indicate that potassium deficiency is also responsible for the prevalence of EdRTA and for renal stones.	UBOLRAJATHANI HOSP,BANGKOK,THAILAND; KHONKAEN HOSP,BANGKOK,THAILAND		NIMMANNIT, S (corresponding author), MAHIDOL UNIV,SIRIRAJ HOSP,DEPT MED,RENAL UNIT,BANGKOK 10700,THAILAND.							ANDRES R, 1957, J CLIN INVEST, V36, P723, DOI 10.1172/JCI103475; APONTE GE, 1960, ANN INTERN MED, V52, P1258, DOI 10.7326/0003-4819-52-6-1258; CHAMBUMRUNG S, 1985, AM J CLIN NUTR, V41, P770; DEFONZO R, 1981, KIDNEY INT, V20, P83; GOH KT, 1990, LANCET, V335, P1154, DOI 10.1016/0140-6736(90)91153-2; HALPERIN M, 1991, CLIN DISORDER FLUID; HALPERIN ML, 1989, KIDNEY INT, V35, P1277, DOI 10.1038/ki.1989.122; HELFANT RH, 1986, AM J MED, V80, P13, DOI 10.1016/0002-9343(86)90336-0; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; KNOCHEL JP, 1972, J CLIN INVEST, V51, P1750, DOI 10.1172/JCI106976; MOORE FJ, 1974, THAILAND ITS PEOPLE; MUNGER RG, 1986, LANCET, V2, P1093; MUNGER RG, 1987, AM J PUBLIC HEALTH, V77, P1187, DOI 10.2105/AJPH.77.9.1187; MUNGER RG, 1990, LANCET, V335, P1154, DOI 10.1016/0140-6736(90)91154-3; NATH KA, 1985, J CLIN INVEST, V76, P667, DOI 10.1172/JCI112020; NATH KA, 1989, KIDNEY INT, V36, pS52; NILWARANGKUR S, 1990, Q J MED, V74, P289; NILWARANGKUR S, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P437; NIMMANNIT S, 1990, LANCET, V336, P116, DOI 10.1016/0140-6736(90)91631-J; NIMMANNIT S, 1989, 6TH P INT S UR NEW Y, P681; OTTO CM, 1984, ANN INTERN MED, V100, P45; TATSANAVIVAT A, 1991, 7TH ANN M ROYAL COLL, P101; WILLIAMS ME, 1985, NEW ENGL J MED, V312, P923; ZIERLER KL, 1957, J CLIN INVEST, V36, P730, DOI 10.1172/JCI103476; 1981, MMWR, V30, P581; 1948, J PHILIPP MED ASSOC, V24, P627	26	50	52	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					930	932		10.1016/0140-6736(91)91786-T	http://dx.doi.org/10.1016/0140-6736(91)91786-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681278				2022-12-28	WOS:A1991GJ89900016
J	TANG, CM; SHI, QY; KATCHMAN, A; LYNCH, G				TANG, CM; SHI, QY; KATCHMAN, A; LYNCH, G			MODULATION OF THE TIME COURSE OF FAST EPSCS AND GLUTAMATE CHANNEL KINETICS BY ANIRACETAM	SCIENCE			English	Article							MOUSE CENTRAL NEURONS; QUISQUALATE RECEPTORS; DESENSITIZATION; CURRENTS; POTENTIATION	It is generally accepted that glutamate serves as the neurotransmitter at most excitatory synapses in the mammalian central nervous system (CNS). Synaptic release of glutamate may trigger a fast and a slow excitatory postsynaptic current (EPSC). The slow EPSC is mediated by N-methyl-D-aspartate (NMDA) receptor channels, whereas the fast EPSC is mediated by non-NMDA receptor channels. The nootropic agent aniracetam selectively and reversibly slows the desensitization kinetics of non-NMDA channels and lengthens their single-channel open times. Aniracetam also modulates the kinetics of the fast EPSC in a manner that mirrors its action on the kinetics of the non-NMDA channels. These results support the hypothesis that the properties of the non-NMDA glutamate channels rather than the rate of neurotransmitter clearance are the primary determinants of the kinetics of the fast EPSC in the mammalian CNS.	UNIV CALIF IRVINE,BONNEY CTR LEARNING & MEMORY,IRVINE,CA 92717; GRAD HOSP PHILADELPHIA,PHILADELPHIA,PA 19146	University of California System; University of California Irvine; University of Pennsylvania; Pennsylvania Medicine	TANG, CM (corresponding author), UNIV PENN,DEPT NEUROL,PHILADELPHIA,PA 19104, USA.				NINDS NIH HHS [NS28158] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS028158] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FROSTL W, 1989, PHARMACOPSYCHIATRY, V22, P54, DOI 10.1055/s-2007-1014626; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; ITO I, 1990, J PHYSIOL-LONDON, V424, P533, DOI 10.1113/jphysiol.1990.sp018081; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P173, DOI 10.1113/jphysiol.1972.sp009840; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; STAUBLI U, IN PRESS HIPPOCAMPUS; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WESTBROOK GL, 1989, SEMINARS NEUROSCIENC, V1, P103; XIAO P, IN PRESS HIPPOCAMPUS; ZORUMSKI CF, 1989, CELL MOL NEUROBIOL, V9, P95, DOI 10.1007/BF00711446; ZORUMSKI CF, 1990, SOC NEUR ABSTR, V16, P547	16	183	185	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 11	1991	254	5029					288	290		10.1126/science.1681589	http://dx.doi.org/10.1126/science.1681589			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ642	1681589				2022-12-28	WOS:A1991GJ64200040
J	DOCKRELL, HM; EASTCOTT, H; YOUNG, S; MACFARLANE, A; HUSSAIN, R; WATERS, MFR				DOCKRELL, HM; EASTCOTT, H; YOUNG, S; MACFARLANE, A; HUSSAIN, R; WATERS, MFR			POSSIBLE TRANSMISSION OF MYCOBACTERIUM-LEPRAE IN A GROUP OF UK LEPROSY CONTACTS	LANCET			English	Article							HOUSEHOLD CONTACTS; ANTIGEN; ANTIBODIES; SERODIAGNOSIS; TUBERCULOSIS; AGE	A case of infectious leprosy in residential accommodation in the UK prompted a study of the cellular and humoral response to Mycobacterium leprae in two groups of individuals who were in contact with the index case for almost a year. In the younger staff group (mean age 44 years) 23 of 30 individuals had positive Mitsuda skin tests, 25 showed lymphocyte transformation to a soluble sonicate of M leprae and 2 had slightly raised IgM antibody concentrations to the terminal disaccharide of M leprae phenolic glycolipid-1. In the older group of residents (mean age 83 years) 7 of 36 individuals were skin-test-positive, 25 of 33 were positive by lymphocyte transformation, but none had raised antibody levels. When retested on two further occasions, the same 2 individuals in the younger group still had raised antibody concentrations, 1 of whom had a persistent lepromin skin-test response for over 8 months and showed a pronounced increase in lymphocyte transformation to mycobacterial antigens. The findings suggest that transmission of M leprae may have occurred in these 2 contacts, who were therefore given 6 months' chemoprophylaxis with rifampicin.	MID DOWNS HLTH AUTHOR, HAYWARDS HEATH, W SUSSEX, ENGLAND; AGA KHAN UNIV, FAC HLTH SCI, DEPT MICROBIOL, KARACHI, PAKISTAN; HOSP TROP DIS, LONDON NW1 0PE, ENGLAND	Aga Khan University; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine	DOCKRELL, HM (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED, DEPT CLIN SCI, KEPPEL ST, LONDON WC1E 7HT, ENGLAND.		Hussain, Rabia/E-9982-2015	Dockrell, Hazel/0000-0003-1869-9107				ADLER WH, 1990, PRINCIPLES GERIATRIC, P60; BAGSHAWE AF, 1990, INT J LEPROSY, V58, P25; BUCHANAN TM, 1983, INT J LEPROSY, V51, P638; CHANTEAU S, 1987, INT J LEPROSY, V55, P626; CHO SN, 1984, J INFECT DIS, V150, P311, DOI 10.1093/infdis/150.3.311; DESFORGES S, 1989, INT J LEPROSY, V57, P794; DOCKRELL HM, 1989, INFECT IMMUN, V57, P1979, DOI 10.1128/IAI.57.7.1979-1983.1989; DOUGLAS JT, 1987, INT J LEPROSY, V55, P718; GODAL T, 1973, BRIT MED J, V3, P557, DOI 10.1136/bmj.3.5880.557; GONZALEZABREU E, 1990, LEPROSY REV, V61, P145; HASAN R, 1989, INT J LEPROSY, V57, P766; HUNTER SW, 1982, J BIOL CHEM, V257, P5072; HUSSAIN R, 1990, INT J LEPROSY, V58, P491; JOPLING WH, 1991, LEPROSY REV, V62, P1; MacLeod JMH, 1925, BMJ-BRIT MED J, V1925, P107, DOI 10.1136/bmj.1.3342.107; Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4; STEAD WW, 1981, ANN INTERN MED, V94, P606, DOI 10.7326/0003-4819-94-5-606; STEAD WW, 1983, J INFECT DIS, V147, P951, DOI 10.1093/infdis/147.5.951; WATERS MFR, 1973, INT J LEPROSY, V41, P563; WILLIAMS DL, 1990, J INFECT DIS, V162, P193, DOI 10.1093/infdis/162.1.193; YOUNG DB, 1983, SCIENCE, V221, P1057, DOI 10.1126/science.6348948; 1980, BRIT MED J, V281, P895	22	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	1991	338	8769					739	743		10.1016/0140-6736(91)91454-3	http://dx.doi.org/10.1016/0140-6736(91)91454-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679878				2022-12-28	WOS:A1991GG10400015
J	ANDERSON, DM; LYMAN, SD; BAIRD, A; WIGNALL, JM; EISENMAN, J; RAUCH, C; MARCH, CJ; BOSWELL, HS; GIMPEL, SD; COSMAN, D; WILLIAMS, DE				ANDERSON, DM; LYMAN, SD; BAIRD, A; WIGNALL, JM; EISENMAN, J; RAUCH, C; MARCH, CJ; BOSWELL, HS; GIMPEL, SD; COSMAN, D; WILLIAMS, DE			MOLECULAR-CLONING OF MAST-CELL GROWTH-FACTOR, A HEMATOPOIETIN THAT IS ACTIVE IN BOTH MEMBRANE-BOUND AND SOLUBLE FORMS	CELL			English	Article									VET ADM MED CTR,INDIANAPOLIS,IN 46223; IMMUNEX CORP,DEPT EXPTL HEMATOL,SEATTLE,WA 98101; IMMUNEX CORP,DEPT PROT CHEM,SEATTLE,WA 98101	US Department of Veterans Affairs; Veterans Health Administration (VHA); Immunex Corporation; Immunex Corporation	ANDERSON, DM (corresponding author), IMMUNEX CORP,DEPT MOLEC BIOL,51 UNIV ST,SEATTLE,WA 98101, USA.							ALTUS MS, 1971, P SOC EXP BIOL MED, V138, P985; BERNSTEIN SE, 1970, AM J SURG, V119, P448, DOI 10.1016/0002-9610(70)90148-0; BOSWELL HS, 1990, EXP HEMATOL, V18, P794; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; CERRETTI DP, 1988, MOL IMMUNOL, V25, P761, DOI 10.1016/0161-5890(88)90112-5; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CONLON PJ, 1987, J IMMUNOL, V139, P98; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DOWER SK, 1989, J IMMUNOL, V142, P4314; FRIED W, 1973, BRIT J HAEMATOL, V24, P643, DOI 10.1111/j.1365-2141.1973.tb01690.x; FUJITA J, 1988, J CELL PHYSIOL, V134, P78, DOI 10.1002/jcp.1041340109; FUJITA J, 1989, P NATL ACAD SCI USA, V86, P2888, DOI 10.1073/pnas.86.8.2888; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GENTRY LE, 1987, MOL CELL BIOL, V7, P1585, DOI 10.1128/MCB.7.5.1585; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; HARRISON DE, 1972, BRIT J HAEMATOL, V22, P155, DOI 10.1111/j.1365-2141.1972.tb08797.x; HEARD JM, 1987, ONCOGENE RES, V1, P423; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1979, BLOOD, V53, P492; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LADNER MB, 1987, EMBO J, V6, P2693, DOI 10.1002/j.1460-2075.1987.tb02561.x; LARSEN A, 1990, IN PRESS J EXP MED; LU L, 1985, EXP HEMATOL, V13, P989; Maniatis T., 1982, MOL CLONING; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MAYER TC, 1968, DEV BIOL, V18, P62, DOI 10.1016/0012-1606(68)90023-7; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MORRISONGRAHAM K, 1989, TRENDS GENET, V5, P116, DOI 10.1016/0168-9525(89)90042-5; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MURPHY ED, 1973, TRANSPLANTATION, V15, P526; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; PIETRANGELI CE, 1988, EUR J IMMUNOL, V18, P863, DOI 10.1002/eji.1830180606; PRICE V, 1987, GENE, V55, P287, DOI 10.1016/0378-1119(87)90288-5; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; RETTENMIER CW, 1988, MOL CELL BIOL, V8, P5026, DOI 10.1128/MCB.8.11.5026; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ES, 1956, SCIENCE, V124, P1076, DOI 10.1126/science.124.3231.1076; RUSSELL ES, 1968, ARCH BIOCHEM BIOPHYS, V125, P594, DOI 10.1016/0003-9861(68)90617-6; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; WILLIAMS DE, 1990, IN PRESS BLOOD; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	52	900	932	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 5	1990	63	1					235	243		10.1016/0092-8674(90)90304-W	http://dx.doi.org/10.1016/0092-8674(90)90304-W			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EB461	1698558				2022-12-28	WOS:A1990EB46100024
J	CITRON, M; SCHUSTER, H				CITRON, M; SCHUSTER, H			THE C4 REPRESSORS OF BACTERIOPHAGE-P1 AND BACTERIOPHAGE-P7 ARE ANTISENSE RNAS	CELL			English	Article											CITRON, M (corresponding author), MAX PLANCK INST MOLEC GENET, IHNESTR 73, W-1000 BERLIN 33, GERMANY.							APPLEYARD RK, 1954, GENETICS, V39, P440; BAGDASARIAN M, 1981, CURR TOP MICROBIOL, V96, P47; BAUMSTARK BR, 1987, VIROLOGY, V156, P197, DOI 10.1016/0042-6822(87)90398-9; CHESNEY RH, 1975, VIROLOGY, V67, P375, DOI 10.1016/0042-6822(75)90439-0; DEVLIN BH, 1982, VIROLOGY, V120, P360, DOI 10.1016/0042-6822(82)90037-X; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; HANSEN EB, 1989, J MOL BIOL, V207, P135, DOI 10.1016/0022-2836(89)90445-2; HEISIG A, 1989, J MOL BIOL, V209, P525, DOI 10.1016/0022-2836(89)90591-3; HEISIG A, 1989, THESIS FREIE U BERLI; IIDA S, 1979, MOL GEN GENET, V173, P249, DOI 10.1007/BF00268635; INOUYE M, 1988, GENE, V72, P25, DOI 10.1016/0378-1119(88)90124-2; KRINKE L, 1987, GENE DEV, V1, P1005, DOI 10.1101/gad.1.9.1005; LIAO SM, 1987, GENE DEV, V1, P197, DOI 10.1101/gad.1.2.197; MA C, 1990, EMBO J, V9, P1267, DOI 10.1002/j.1460-2075.1990.tb08235.x; MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT JR, 1977, VIROLOGY, V76, P39, DOI 10.1016/0042-6822(77)90279-3; SCOTT JR, 1968, VIROLOGY, V36, P564, DOI 10.1016/0042-6822(68)90188-8; SIMONS RW, 1988, ANNU REV GENET, V22, P567, DOI 10.1146/annurev.ge.22.120188.003031; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WALKER DH, 1975, J VIROL, V16, P525, DOI 10.1128/JVI.16.3.525-534.1975; WANDERSMAN C, 1977, VIROLOGY, V77, P386, DOI 10.1016/0042-6822(77)90435-4; WU TH, 1987, GENE DEV, V1, P204, DOI 10.1101/gad.1.2.204; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YARMOLINSKY MB, 1988, BACTERIOPHAGES, V1, P291; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	28	41	43	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	1990	62	3					591	598		10.1016/0092-8674(90)90023-8	http://dx.doi.org/10.1016/0092-8674(90)90023-8			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1696181				2022-12-28	WOS:A1990DU44500020
J	WEIHER, H; NODA, T; GRAY, DA; SHARPE, AH; JAENISCH, R				WEIHER, H; NODA, T; GRAY, DA; SHARPE, AH; JAENISCH, R			TRANSGENIC MOUSE MODEL OF KIDNEY-DISEASE - INSERTIONAL INACTIVATION OF UBIQUITOUSLY EXPRESSED GENE LEADS TO NEPHROTIC SYNDROME	CELL			English	Article									MIT,WHITEHEAD INST,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			/U-3554-2018	/0000-0002-8634-4984	NCI NIH HHS [R35CA44339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; COVARRUBIAS L, 1986, P NATL ACAD SCI USA, V83, P6020, DOI 10.1073/pnas.83.16.6020; FRIES JWU, 1989, LAB INVEST, V60, P205; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GRIDLEY T, 1987, TRENDS GENET, V3, P162, DOI 10.1016/0168-9525(87)90218-6; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JAENISCH R, 1983, CELL, V32, P209, DOI 10.1016/0092-8674(83)90511-1; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAHNER D, 1980, NATURE, V287, P456, DOI 10.1038/287456a0; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRATOCHWIL K, 1989, CELL, V57, P807, DOI 10.1016/0092-8674(89)90795-2; KRAYEV AS, 1980, NUCLEIC ACIDS RES, V8, P1201, DOI 10.1093/nar/8.6.1201; KRAYEV AS, 1982, NUCLEIC ACIDS RES, V10, P7461, DOI 10.1093/nar/10.23.7461; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; MACKAY K, 1987, KIDNEY INT, V32, P827, DOI 10.1038/ki.1987.283; MAHON KA, 1988, P NATL ACAD SCI USA, V85, P1165, DOI 10.1073/pnas.85.4.1165; Maniatis T., 1982, MOL CLONING; MARK W, 1985, COLD SPRING HARB SYM, V50, P447; MCNEISH JD, 1988, SCIENCE, V241, P837, DOI 10.1126/science.3406741; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; RENNKE HG, 1989, AM J KIDNEY DIS, V13, P443, DOI 10.1016/S0272-6386(89)80001-0; ROBBINS SL, 1989, PATHOLOGIC BASIS DIS, P991; ROHDEWOHLD H, 1987, J VIROL, V61, P336, DOI 10.1128/JVI.61.2.336-343.1987; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; SELIGER B, 1986, MOL CELL BIOL, V6, P286, DOI 10.1128/MCB.6.1.286; Sheehan D.C., 1980, THEORY PRACTICE HIST; SORIANO P, 1987, GENE DEV, V1, P366, DOI 10.1101/gad.1.4.366; SPENCE SE, 1989, MOL CELL BIOL, V9, P177, DOI 10.1128/MCB.9.1.177; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; WEIHER H, 1987, J VIROL, V61, P2742, DOI 10.1128/JVI.61.9.2742-2746.1987; WILKIE TM, 1987, MOL CELL BIOL, V7, P1646, DOI 10.1128/MCB.7.5.1646; WOYCHIK RP, 1985, NATURE, V318, P36, DOI 10.1038/318036a0	34	150	153	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 10	1990	62	3					425	434		10.1016/0092-8674(90)90008-3	http://dx.doi.org/10.1016/0092-8674(90)90008-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1696177				2022-12-28	WOS:A1990DU44500005
J	SANDGREN, EP; LUETTEKE, NC; PALMITER, RD; BRINSTER, RL; LEE, DC				SANDGREN, EP; LUETTEKE, NC; PALMITER, RD; BRINSTER, RL; LEE, DC			OVEREXPRESSION OF TGF-ALPHA IN TRANSGENIC MICE - INDUCTION OF EPITHELIAL HYPERPLASIA, PANCREATIC METAPLASIA, AND CARCINOMA OF THE BREAST	CELL			English	Article									UNIV N CAROLINA,SCH MED,LINEBERGER CANC RES CTR,CHAPEL HILL,NC 27514; UNIV N CAROLINA,SCH MED,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27514; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	SANDGREN, EP (corresponding author), UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104, USA.			Brinster, Ralph/0000-0003-1408-7656	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009172, R01HD009172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA038635, R01CA043793] Funding Source: NIH RePORTER; NCI NIH HHS [CA43793, CA38635] Funding Source: Medline; NICHD NIH HHS [HD09172] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; BLASBAND AJ, 1990, MOL CELL BIOL, V10, P2111, DOI 10.1128/MCB.10.5.2111; BLASBAND AJ, 1990, IN PRESS ONCOGENE; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; CATTERTON WZ, 1979, PEDIATR RES, V13, P104, DOI 10.1203/00006450-197902000-00004; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; COHEN S, 1962, J BIOL CHEM, V237, P1555; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DEMBINSKI AB, 1985, ENDOCRINOLOGY, V116, P90, DOI 10.1210/endo-116-1-90; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DERYNCK R, 1987, CANCER RES, V47, P707; DICKSON RB, 1986, CANCER RES, V46, P1707; DIMARCO E, 1989, ONCOGENE, V4, P831; DOLLING M, 1983, J ANAT, V136, P656; DURNAM DM, 1983, ANAL BIOCHEM, V131, P385, DOI 10.1016/0003-2697(83)90188-4; ELDER JT, 1989, SCIENCE, V243, P811, DOI 10.1126/science.2916128; GENTRY LE, 1987, MOL CELL BIOL, V7, P1585, DOI 10.1128/MCB.7.5.1585; GOODLAD RA, 1987, GUT, V28, P37, DOI 10.1136/gut.28.Suppl.37; HAMMER RE, 1985, COLD SPRING HARB SYM, V50, P379, DOI 10.1101/SQB.1985.050.01.048; HAN VKM, 1987, MOL CELL BIOL, V7, P2335, DOI 10.1128/MCB.7.7.2335; IBBOTSON KJ, 1986, P NATL ACAD SCI USA, V83, P2228, DOI 10.1073/pnas.83.7.2228; KOBRIN MS, 1986, J BIOL CHEM, V261, P4414; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; LEE DC, 1990, HDB EXPT PHARM, P611; LIU C, 1988, CANCER RES, V48, P850; LIU SC, 1987, MOL ENDOCRINOL, V1, P683, DOI 10.1210/mend-1-10-683; LONGNECKER DS, 1984, ENVIRON HEALTH PERSP, V56, P245, DOI 10.2307/3429850; LUETTEKE NC, 1988, BIOCHEMISTRY-US, V27, P6487, DOI 10.1021/bi00417a043; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MATHEWS LS, 1988, ENDOCRINOLOGY, V123, P2827, DOI 10.1210/endo-123-6-2827; MCGEADY ML, 1989, ONCOGENE, V4, P1375; MEAD JE, 1989, P NATL ACAD SCI USA, V86, P1558, DOI 10.1073/pnas.86.5.1558; Medina D., 1982, MOUSE BIOMEDICAL RES, VIV, P373; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; MYDLO JH, 1989, CANCER RES, V49, P3407; ORNITZ DM, 1985, NATURE, V313, P600, DOI 10.1038/313600a0; PALMITER RD, 1982, CELL, V29, P701, DOI 10.1016/0092-8674(82)90186-6; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; PRICE DOROTHY, 1963, NATL CANCER INST MONOGR, V12, P1; QUAIFE C, 1986, DEV BIOL, V118, P549, DOI 10.1016/0012-1606(86)90025-4; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; RAPPOLEE DA, 1988, SCIENCE, V241, P1823, DOI 10.1126/science.3175624; RAYMOND VW, 1989, CANCER RES, V49, P3608; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; SALOMON DS, 1984, CANCER RES, V44, P4069; SALOMON DS, 1987, J CELL PHYSIOL, V130, P397, DOI 10.1002/jcp.1041300313; SAMSOONDAR J, 1986, J BIOL CHEM, V261, P4408; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; SCHULTZ GS, 1987, SCIENCE, V235, P350, DOI 10.1126/science.3492044; SHANKAR V, 1989, MOL CARCINOGEN, V2, P1, DOI 10.1002/mc.2940020102; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SMITH JJ, 1987, P NATL ACAD SCI USA, V84, P7567, DOI 10.1073/pnas.84.21.7567; SMITH JM, 1985, NATURE, V315, P515, DOI 10.1038/315515a0; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; STERN PH, 1985, J CLIN INVEST, V76, P2016, DOI 10.1172/JCI112202; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; SUNDELL HW, 1980, AM J PATHOL, V100, P707; TAM JP, 1985, SCIENCE, V229, P673, DOI 10.1126/science.3860952; TEIXIDO J, 1988, J BIOL CHEM, V263, P3924; TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; VALVERIUS EM, 1989, MOL ENDOCRINOL, V3, P203, DOI 10.1210/mend-3-1-203; WATANABE S, 1987, P NATL ACAD SCI USA, V84, P1258, DOI 10.1073/pnas.84.5.1258; WILCOX JN, 1988, MOL CELL BIOL, V8, P3415, DOI 10.1128/MCB.8.8.3415; WILCOX JN, 1988, J NEUROSCI, V8, P1901; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; WRIGHT NA, 1990, NATURE, V343, P82, DOI 10.1038/343082a0; YEH YC, 1987, CANCER RES, V47, P896	77	678	687	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 15	1990	61	6					1121	1135		10.1016/0092-8674(90)90075-P	http://dx.doi.org/10.1016/0092-8674(90)90075-P			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK145	1693546	hybrid			2022-12-28	WOS:A1990DK14500020
J	BOEKE, JD				BOEKE, JD			REVERSE-TRANSCRIPTASE, THE END OF THE CHROMOSOME, AND THE END OF LIFE	CELL			English	Review											BOEKE, JD (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.							ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; BALTIMORE D, 1985, CELL, V40, P481, DOI 10.1016/0092-8674(85)90190-4; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; HARLEY CB, 1990, IN PRESS NATURE; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HENDERSON ER, 1990, BIOCHEMISTRY-US, V29, P732, DOI 10.1021/bi00455a020; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1990, CELL, V60, P529; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; XU H, 1987, P NATL ACAD SCI USA, V84, P8553, DOI 10.1073/pnas.84.23.8553; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	16	16	16	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 20	1990	61	2					193	195		10.1016/0092-8674(90)90797-I	http://dx.doi.org/10.1016/0092-8674(90)90797-I			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DA752	1691957	hybrid			2022-12-28	WOS:A1990DA75200001
J	LAZOVICH, D; WHITE, E; THOMAS, DB; MOE, RE				LAZOVICH, D; WHITE, E; THOMAS, DB; MOE, RE			UNDERUTILIZATION OF BREAST-CONSERVING SURGERY AND RADIATION-THERAPY AMONG WOMEN WITH STAGE-I OR STAGE-II BREAST-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPARING RADICAL-MASTECTOMY; CONSERVATIVE TREATMENT; AXILLARY DISSECTION; CHOICE; QUADRANTECTOMY; RADIOTHERAPY; LUMPECTOMY; PATIENT; AGE	Objective. - To identify time trends and factors associated with breast-conserving surgery (BCS) and delivery of postoperative radiation therapy among women with stage I or II breast cancer. Design. - Survey. Setting. - Population-based cancer registry in the Seattle-Puget Sound (Wash) region. Participants. - The study included 8095 women diagnosed with stage I or II breast cancer (American Joint Committee on Cancer staging criteria) from 1983 through 1989. Main Outcome Measures. - Breast-conserving surgery with or without radiation therapy vs mastectomy, and, among women with BCS, a comparison of radiation therapy vs no therapy. Results. - In 1985 when results from a US randomized clinical trial of BCS were published, the frequency of BCS peaked (46.3% of stage I; 30.1 % of stage II) followed by a return to levels before 1985 for women with stage II breast cancer and a more moderate decline for stage I breast cancer. The likelihood of BCS decreased with increasing age (P < .001), with stage II disease, and with residence outside the region's major urban center, and it increased with education (P < .001) or median income (P < .001) by census tract. The proportion of women who received radiation therapy after BCS decreased with age (P < .001), was lower for women with stage II than stage I disease, and was lowest in counties without radiation therapy facilities. Conclusions. - Despite scientific evidence of the equivalent efficacy of BCS with radiation therapy and mastectomy, BCS is not performed on the majority of women with stage I or II breast cancer as recommended by the National Institutes of Health, and factors are associated with its use that differ from selection criteria outlined by the National Institutes of Health.	UNIV WASHINGTON,DEPT OCEANOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT SURG,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	LAZOVICH, D (corresponding author), FRED HUTCHINSON CANC RES CTR,DIV PUBL HLTH SCI,1124 COLUMBIA ST,MAILSTOP MP-702,SEATTLE,WA 98104, USA.				NCI NIH HHS [5-P01-CA34847] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034847] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASHCROFT JJ, 1985, J ROY SOC MED, V78, P43; BRESLOW NE, 1980, STATISTICAL METHODS, V2; CAWLEY M, 1990, CANCER NURS, V13, P90; CHU J, 1987, J GERONTOL, V42, P185, DOI 10.1093/geronj/42.2.185; DEBER RB, 1987, ARCH INTERN MED, V147, P1543, DOI 10.1001/archinte.147.9.1543; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; FISHER B, 1985, NEW ENGL J MED, V312, P674, DOI 10.1056/NEJM198503143121102; FISHER B, 1985, WORLD J SURG, V9, P655, DOI 10.1007/BF01655177; FISHER B, 1989, NEW ENGL J MED, V320, P822, DOI 10.1056/NEJM198903303201302; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P1766; HELLMAN S, 1987, CANCER RES, V47, P339; KLEINMAN JC, 1983, MED CARE, V21, P1232, DOI 10.1097/00005650-198312000-00010; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; LIBERATI A, 1987, TUMORI J, V73, P601, DOI 10.1177/030089168707300609; LIBERATI A, 1990, AM J PUBLIC HEALTH, V81, P38; MANN BA, 1988, JAMA-J AM MED ASSOC, V259, P3413; MARGOLIS GJ, 1989, PSYCHOSOMATICS, V30, P192, DOI 10.1016/S0033-3182(89)72300-8; MCKINLAY JB, 1981, MILBANK FUND Q, V59, P374, DOI 10.2307/3349685; MORRIS J, 1989, J ROY SOC MED, V82, P12, DOI 10.1177/014107688908200105; MUNOZ E, 1986, ARCH SURG-CHICAGO, V121, P1297, DOI 10.1001/archsurg.121.11.1297; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; SARRAZIN D, 1984, CANCER, V53, P1209, DOI 10.1002/1097-0142(19840301)53:5<1209::AID-CNCR2820530531>3.0.CO;2-Y; SARRAZIN D, 1989, RADIOTHER ONCOL, V14, P177, DOI 10.1016/0167-8140(89)90165-5; SILLIMAN RA, 1989, J GERONTOL, V44, pM46, DOI 10.1093/geronj/44.2.M46; Tinker M A, 1987, Surg Annu, V19, P279; Valanis B G, 1985, Cancer Nurs, V8, P167; VERONESI U, 1986, EUR J CANCER CLIN ON, V22, P1085, DOI 10.1016/0277-5379(86)90011-8; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; WARD S, 1989, CANCER NURS, V12, P344; WILSON RE, 1984, SURG GYNECOL OBSTET, V159, P309; WOLBERG WH, 1987, J CLIN ONCOL, V5, P68, DOI 10.1200/JCO.1987.5.1.68; YANCIK R, 1989, CANCER, V63, P976, DOI 10.1002/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A; 1991, JAMA-J AM MED ASSOC, V265, P391; 1983, PHC802329 US DEP COM; 1988, MANUAL STAGING CANCE; 1986, 872789 US DEP HLTH H; 1991, CANCER FACTS FIGURES; 1988, BRIT J CANCER, V57, P630; 1990, MEMBERSHIP DIRECTORY; 1983, PHC802347 US DEP COM	40	315	315	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 25	1991	266	24					3433	3438		10.1001/jama.266.24.3433	http://dx.doi.org/10.1001/jama.266.24.3433			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV878	1688350				2022-12-28	WOS:A1991GV87800027
J	KEAN, WF; LOCK, CJL; HOWARDLOCK, HE				KEAN, WF; LOCK, CJL; HOWARDLOCK, HE			CHIRALITY IN ANTIRHEUMATIC DRUGS	LANCET			English	Review							OPTICAL ISOMERS; ENANTIOMERS; IBUPROFEN; HUMANS; PHARMACOKINETICS; METABOLISM; INVERSION; NAPROXEN; ACIDS	Use of chiral molecules in clinical practice may cause problems because different chiral forms of a drug (enantiomers) may have different biological activities clinicians have little awareness of these risks. After discussion of the chemical conventions used to describe chirality, examples of the influence of chirality on the efficacy and toxicity of antirheumatic drugs are given. It is recommended that single enantiomers should be used in biological experiments and clinical trials.	MCMASTER UNIV,DEPT MED,INORGAN MED LABS,HAMILTON L8S 4L8,ONTARIO,CANADA; MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L8,ONTARIO,CANADA; MCMASTER UNIV,DEPT CHEM,HAMILTON L8S 4L8,ONTARIO,CANADA	McMaster University; McMaster University; McMaster University								ADAMS SS, 1976, J PHARM PHARMACOL, V28, P256, DOI 10.1111/j.2042-7158.1976.tb04144.x; Ariens E. J., 1983, STEREOCHEMISTRY BIOL; BLASCHKE G, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1640; CALDWELL J, 1983, BIOCHEM PHARMACOL, V32, P1667, DOI 10.1016/0006-2952(83)90107-7; CRAYFORD JV, 1980, ENDOBIOTICS, V10, P349; FEARS R, 1978, J LIPID RES, V19, P3; FRANKLIN KJ, 1982, INORG CHEM, V21, P1941, DOI 10.1021/ic00135a046; HARRISON IT, 1970, J MED CHEM, V13, P203, DOI 10.1021/jm00296a008; HILL J M, 1977, Journal of Clinical Hematology and Oncology, V7, P681; HOWARDLOCK HE, 1986, SEMIN ARTHRITIS RHEU, V15, P261, DOI 10.1016/0049-0172(86)90022-3; HUTT AJ, 1983, J PHARM PHARMACOL, V35, P693, DOI 10.1111/j.2042-7158.1983.tb02874.x; ISAB AA, 1976, J CHEM SOC CHEM COMM, P1051; KEAN WF, 1989, J PHARM SCI, V78, P324, DOI 10.1002/jps.2600780413; KEAN WF, 1987, JPN J RHEUMATOL, V1, P159; KIDANI Y, 1977, Journal of Clinical Hematology and Oncology, V7, P197; LEE EJD, 1984, J PHARM SCI, V73, P1542, DOI 10.1002/jps.2600731112; LEE EJD, 1985, BRIT J CLIN PHARMACO, V19, P669, DOI 10.1111/j.1365-2125.1985.tb02694.x; NISHIZAWA E E, 1973, Thrombosis Research, V3, P577, DOI 10.1016/0049-3848(73)90118-7; OREILLY RA, 1980, J CLIN INVEST, V65, P746, DOI 10.1172/JCI109722; PASTEUR L, 1905, ALEMBIC CLUB REPRINT, V14; ROSZKOWSKI AP, 1971, J PHARMACOL EXP THER, V179, P114; RUBIN A, 1985, J PHARM SCI, V74, P82, DOI 10.1002/jps.2600740122; SHEN TY, 1974, PROSTAGLANDIN SYNTHE, P19; SIMMONDS R G, 1980, European Journal of Drug Metabolism and Pharmacokinetics, V5, P169; SINGH NN, 1986, J PHARM SCI, V75, P439, DOI 10.1002/jps.2600750503; TAMASSIA V, 1984, INT J CLIN PHARM RES, V4, P223; VERBEECK RK, 1984, BRIT J CLIN PHARMACO, V17, P783, DOI 10.1111/j.1365-2125.1984.tb02421.x	27	88	94	2	30	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1565	1568		10.1016/0140-6736(91)92382-C	http://dx.doi.org/10.1016/0140-6736(91)92382-C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683980				2022-12-28	WOS:A1991GW03600013
J	MARTINEZ, E				MARTINEZ, E			PREVENTION OF GASTROINTESTINAL-BLEEDING IN CIRRHOSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter											MARTINEZ, E (corresponding author), HOSP SANTA CRUZ & SAN PABLO,E-08025 BARCELONA,SPAIN.							POYNARD T, 1991, NEW ENGL J MED, V324, P1532, DOI 10.1056/NEJM199105303242202	1	0	0	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 21	1991	325	21					1517	1517						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ406	1682808				2022-12-28	WOS:A1991GQ40600028
J	HANNINGTONKIFF, JG				HANNINGTONKIFF, JG			DOES FAILED NATURAL OPIOID MODULATION IN REGIONAL SYMPATHETIC-GANGLIA CAUSE REFLEX SYMPATHETIC DYSTROPHY	LANCET			English	Article							ENKEPHALIN	Early features of reflex sympathetic dystrophy in a limb resemble the general effects of autonomic arousal associated with opioid withdrawal. It is suggested that natural opioid peptide modulation in regional sympathetic ganglia normally rises to prevent excessive autonomic activity in an injured limb. After an injury (especially a trivial one) to a susceptible subject, this localised increase in opioid modulation may fail or may rapidly wane so that autonomic features of opioid withdrawal appear in the affected limb. Florid dystrophic changes may then occur because of passive complications of disuse associated with pain, or as a result of more active processes. Preservation of an appropriate opioid bias in the regional sympathetic ganglia might be an important factor in the successful management and prevention of reflex sympathetic dystrophy.			HANNINGTONKIFF, JG (corresponding author), FRIMLEY PK HOSP,CTR PAIN RELIEF,PORTSMOUTH RD,CAMBERLEY GU16 5UJ,SURREY,ENGLAND.							AN HS, 1988, J HAND SURG-AM, V13A, P458, DOI 10.1016/S0363-5023(88)80032-7; ARIAS LM, 1989, REGION ANESTH, V14, P90; Crile GW, 1913, LANCET, V2, P7; DIGIULIO AM, 1978, NEUROPHARMACOLOGY, V17, P989, DOI 10.1016/0028-3908(78)90144-2; HANNINGTONKIFF JG, 1990, J ROY SOC MED, V83, P373, DOI 10.1177/014107689008300612; HANNINGTONKIFF JG, 1988, LANCET, V1, P1404; HELEN P, 1984, NEUROSCIENCE, V12, P907, DOI 10.1016/0306-4522(84)90178-7; Janig W, 1990, PAIN SYMPATHETIC NER, P17; KONISHI S, 1981, NATURE, V294, P80, DOI 10.1038/294080a0; MAYS KS, 1981, J NEUROL NEUROSUR PS, V44, P189, DOI 10.1136/jnnp.44.2.189; NEELY J C, 1956, Br J Ophthalmol, V40, P636, DOI 10.1136/bjo.40.10.636; RIOS L, 1983, EUR J PHARMACOL, V86, P277; ROBERTS WJ, 1986, PAIN, V24, P297, DOI 10.1016/0304-3959(86)90116-8; SCHULTZBERG M, 1979, NEUROSCIENCE, V4, P249, DOI 10.1016/0306-4522(79)90087-3; THOREN P, 1990, MED SCI SPORT EXER, V22, P417; WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2	16	27	27	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 2	1991	338	8775					1125	1127		10.1016/0140-6736(91)91974-Y	http://dx.doi.org/10.1016/0140-6736(91)91974-Y			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM784	1682552				2022-12-28	WOS:A1991GM78400014
J	MEADE, CJ; METCALFE, S; SVVENNSEN, R; JAMIESON, N; WATSON, C; CALNE, RY; KLEBER, G; NEILD, G				MEADE, CJ; METCALFE, S; SVVENNSEN, R; JAMIESON, N; WATSON, C; CALNE, RY; KLEBER, G; NEILD, G			SERUM PAF ACETYLHYDROLASE AND CHRONIC CHOLESTASIS	LANCET			English	Letter							PLATELET-ACTIVATING FACTOR; PLASMA		ADDENBROOKES HOSP,DEPT SURG,CAMBRIDGE CB2 2QQ,ENGLAND; UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT MED 2,W-8000 MUNICH 70,GERMANY; ST PHILLIPS HOSP,LONDON WC2,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Munich	MEADE, CJ (corresponding author), BOEHRINGER INGELHEIM KG,W-6507 INGELHEIM,GERMANY.		Neild, Guy/K-2513-2013					CARAMELO C, 1987, EUR J CLIN INVEST, V17, P7, DOI 10.1111/j.1365-2362.1987.tb01218.x; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; SATOH K, 1988, PROSTAGLANDINS, V35, P685, DOI 10.1016/0090-6980(88)90142-6; SATOH K, 1991, J CLIN INVEST, V87, P476, DOI 10.1172/JCI115020; SATOH K, 1989, PROSTAGLANDINS, V37, P673; SMILEY PL, IN PRESS J BIOL CHEM; STAFFORINI DM, 1989, P NATL ACAD SCI USA, V86, P2393, DOI 10.1073/pnas.86.7.2393; STEINBRECHER UP, 1989, J LIPID RES, V30, P305; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282	10	10	10	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					1016	1017		10.1016/0140-6736(91)91876-V	http://dx.doi.org/10.1016/0140-6736(91)91876-V			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681319				2022-12-28	WOS:A1991GK97400035
J	GARENNE, M; LEROY, O; BEAU, JP; SENE, I				GARENNE, M; LEROY, O; BEAU, JP; SENE, I			CHILD-MORTALITY AFTER HIGH-TITER MEASLES-VACCINES - PROSPECTIVE-STUDY IN SENEGAL	LANCET			English	Article							EDMONSTON-ZAGREB; SUCCESSFUL IMMUNIZATION; MATERNAL ANTIBODY; INFANTS; PROGRESS; SCHWARZ; STRAINS	The use of Edmonston-Zagreb high-titre (EZ-HT) vaccine at age 6 months has been recommended for countries in which measles before the age of 9 months is a substantial cause of death, but little is known about the long-term effects of high-titre live measles vaccines given early in life. In a randomised vaccine trial in a rural area of Senegal, children were randomly assigned at birth to three vaccine groups: EZ-HT at 5 months (n = 336); Schwarz high-titre (SW-HT) at 5 months (n = 321); and placebo at 5 months followed by standard low-titre Schwarz vaccine at 10 months (standard: n = 358). All children were prospectively followed for 24-39 months in a well-established demographic surveillance system. Child mortality after immunisation was significantly higher in the two groups which received high-titre vaccines than in the group given the standard vaccine. The relative risk of death was 1.80 (95% confidence interval [Cl] 1.18-2.74; p = 0.007) in the EZ-HT group and 1.51 (0.97-2.34; p = 0.07) in the SW-HT group compared with the standard group. The three vaccine groups were comparable as regards various social, family, and health characteristics, and there was no difference in mortality between children who received the standard vaccine and those who were eligible for the trial but did not take part for various reasons. The higher risk of death in the two high-titre vaccine groups remained significant in multivariate analyses. These findings suggest a need to reconsider the use of high-titre measles vaccines early in life in less developed countries.	ORSTOM, UR POPULAT & SANTE, DAKAR, SOUTH AFRICA	Institut de Recherche pour le Developpement (IRD)			GARENNE, Michel/A-7712-2013	GARENNE, Michel/0000-0001-6073-7803				AABY P, 1988, LANCET, V2, P809; AABY P, 1988, LANCET, V1, P811; Ajjan N, 1975, Pediatrie, V30, P29; BAER C, 1981, CLIN IMMUNOL IMMUNOP, V19, P452, DOI 10.1016/0090-1229(81)90088-X; BLACK FL, 1986, AM J EPIDEMIOL, V124, P442, DOI 10.1093/oxfordjournals.aje.a114415; CANTRELLE P, 1971, POP STUD-J DEMOG, V25, P505, DOI 10.1080/00324728.1971.10405821; CHOPPIN PW, 1981, ANN NEUROL, V9, P17, DOI 10.1002/ana.410090104; GANDRA YR, 1961, AM J CLIN NUTR, V9, P159, DOI 10.1093/ajcn/9.2.159; GARENNE M, 1990, J INFECT DIS, V161, P1088, DOI 10.1093/infdis/161.6.1088; GARENNE M, 1991, EFFICACY IMMUNOGENIC; GARENNE M, 1987, RISQUES DECES ASSOCI; GARENNE M, 1986, SEMIN INSERM, V145, P515; HAYDEN GF, 1989, J PEDIATR-US, V114, P520, DOI 10.1016/S0022-3476(89)80687-0; HENDERSON RH, 1988, B WORLD HEALTH ORGAN, V66, P535; HIRSCH RL, 1981, CLIN IMMUNOL IMMUNOP, V21, P341, DOI 10.1016/0090-1229(81)90223-3; KHANUM S, 1987, LANCET, V1, P150; KIELMANN AA, 1977, AM J CLIN NUTR, V30, P592, DOI 10.1093/ajcn/30.4.592; MARKOWITZ LE, 1990, NEW ENGL J MED, V322, P580, DOI 10.1056/NEJM199003013220903; Muller AS, 1984, MATERNAL CHILD HLTH; OOMEN APC, 1958, FED PROC, V17, P111; PREBLUD SR, 1988, VACCINES, P182; SABIN A B, 1984, Journal of the American Medical Association, V251, P2363, DOI 10.1001/jama.251.18.2363; SABIN AB, 1983, JAMA-J AM MED ASSOC, V249, P2651, DOI 10.1001/jama.249.19.2651; TIDJANI O, 1989, LANCET, V2, P1357; WHITTLE HC, 1988, LANCET, V1, P963; WHITTLE HC, 1984, LANCET, V2, P834; WILSON D, 1961, AM J CLIN NUTR, V9, P154, DOI 10.1093/ajcn/9.2.154; [No title captured]; 1988, LANCET, V2, P1356; 1982, WEEKLY EPIDEMIOL REC, V57, P89	30	139	139	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	1991	338	8772					903	907		10.1016/0140-6736(91)91771-L	http://dx.doi.org/10.1016/0140-6736(91)91771-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681265				2022-12-28	WOS:A1991GJ89900002
J	RAY, R; AGGARWAL, R; SALUNKE, PN; MEHROTRA, NN; TALWAR, GP; NAIK, SR				RAY, R; AGGARWAL, R; SALUNKE, PN; MEHROTRA, NN; TALWAR, GP; NAIK, SR			HEPATITIS-E VIRUS GENOME IN STOOLS OF HEPATITIS PATIENTS DURING LARGE EPIDEMIC IN NORTH-INDIA	LANCET			English	Note							NON-B HEPATITIS; TRANSMITTED NON-A	Stool samples from patients affected during a large epidemic of hepatitis in north India were examined for the presence of hepatitis E virus (HEV) genome by means of reverse transcription-polymerase chain reaction. 6 to 10 samples studied were positive for the HEV genome, which suggests that HEV caused this large epidemic.	SANJAY GANDHI POSTGRAD INST MED SCI,DEPT GASTROENTEROL,PB 375,RAEBARELI RD,LUCKNOW 226001,INDIA; NATL INST IMMUNOL,NEW DELHI,INDIA; CENT DRUG RES INST,LUCKNOW 226001,UTTAR PRADESH,INDIA	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)			Aggarwal, Rakesh/D-1583-2009	Aggarwal, Rakesh/0000-0001-9689-494X				ARANKALLE VA, 1988, LANCET, V2, P550; BRADLEY DW, 1990, BRIT MED BULL, V46, P442, DOI 10.1093/oxfordjournals.bmb.a072409; BRADLEY DW, 1987, P NATL ACAD SCI USA, V84, P6277, DOI 10.1073/pnas.84.17.6277; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Khuroo M S, 1991, Indian J Gastroenterol, V10, P96; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; RAMALINGASWAMI V, 1988, LANCET, V1, P571; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Viswanathan R., 1957, INDIAN J MED RES S, V45, P1; ZUCKERMAN AJ, 1990, BRIT MED J, V300, P1475, DOI 10.1136/bmj.300.6738.1475	10	70	71	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					783	784		10.1016/0140-6736(91)90667-E	http://dx.doi.org/10.1016/0140-6736(91)90667-E			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681163				2022-12-28	WOS:A1991GG97900006
J	LANDAY, AL; JESSOP, C; LENNETTE, ET; LEVY, JA				LANDAY, AL; JESSOP, C; LENNETTE, ET; LEVY, JA			CHRONIC FATIGUE SYNDROME - CLINICAL CONDITION ASSOCIATED WITH IMMUNE ACTIVATION	LANCET			English	Article							BARR VIRUS-INFECTION; LYMPHOCYTE-T SUBSETS; IMMUNOLOGICAL ABNORMALITIES; EARLY ANTIGEN; MONONUCLEOSIS; PERSISTENT; DYSFUNCTION; ANTIBODIES	There is much conflicting immunological and viral data about the causes of chronic fatigue syndrome (CFS); some findings support the notion that CFS may be due to one or more immune disorders that have resulted from exposure to an infectious agent. In the present study, flow cytometry and several different monoclonal antibodies recognising T, B, and natural killer (NK) cell populations as well as activation and cell adhesion antigens were used to study 147 individuals with CFS. Compared with healthy controls, a reduced CD8 suppressor cell population and increased activation markers (CD38, HLA-DR) on CD8 cells were found. The differences were significant (p = 0.01) in patients with major symptoms of the disease. These immunological indices were not observed in 80 healthy individuals, in 22 contacts of CFS patients, or in 43 patients with other diseases. No correlation of these findings in CFS patients with any known human viruses could be detected by serology. The findings suggest that immune activation is associated with many cases of CFS.	UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,ROOM S1280,3RD & PARNASSUS,SAN FRANCISCO,CA 94143; VIROLAB,BERKELEY,CA; UNIV CALIF SAN FRANCISCO,SCH MED,CANC RES INST,SAN FRANCISCO,CA 94143; RUSH PRESBYTERIAN ST LUKES MED CTR,DEPT IMMUNOL MICROBIOL,CHICAGO,IL 60612	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rush University								ALTAY HT, 1990, INT J PSYCHIAT MED, V20, P141, DOI 10.2190/T6GX-JJ2L-VCVV-T81B; AOKI T, 1987, NAT IMMUN CELL GROW, V6, P116; ARCHARD LC, 1988, J ROY SOC MED, V81, P326, DOI 10.1177/014107688808100608; BEHAN PO, 1985, J INFECTION, V10, P211, DOI 10.1016/S0163-4453(85)92488-0; BORYSIEWICZ LK, 1986, Q J MED, V58, P111; BUCHWALD D, 1991, REV INFECT DIS, V13, P512; CALIGIURI M, 1987, J IMMUNOL, V139, P3306; CARNEY WP, 1981, J IMMUNOL, V126, P2114; CASALI P, 1987, SCIENCE, V236, P77, DOI 10.1126/science.3105056; COON J, 1987, LAB INVEST, V15, P453; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; GRATAMA JW, 1987, BLOOD, V70, P516; HELLINGER WC, 1988, JAMA-J AM MED ASSOC, V260, P971; HENLE W, 1981, CANCER RES, V41, P4222; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; JONES JF, 1985, ANN INTERN MED, V102, P1, DOI 10.7326/0003-4819-102-1; KIBLER R, 1985, J CLIN IMMUNOL, V5, P46, DOI 10.1007/BF00915168; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; KOMAROFF AL, 1991, REV INFECT DIS, V13, pS8; LANDAY AL, 1990, 6TH INT C AIDS SAN F, P141; LENNETTE ET, 1982, J CLIN MICROBIOL, V15, P69, DOI 10.1128/JCM.15.1.69-73.1982; LEVY JA, 1990, LANCET, V335, P1047, DOI 10.1016/0140-6736(90)92628-U; LLOYD AR, 1989, MED J AUSTRALIA, V151, P122, DOI 10.5694/j.1326-5377.1989.tb139594.x; MILLER NA, 1991, BMJ-BRIT MED J, V302, P140, DOI 10.1136/bmj.302.6769.140; NOTKINS AL, 1970, ANNU REV MICROBIOL, V24, P525, DOI 10.1146/annurev.mi.24.100170.002521; PRIETO J, 1989, SCAND J IMMUNOL, V30, P13, DOI 10.1111/j.1365-3083.1989.tb01183.x; ROUSE BT, 1986, REV INFECT DIS, V8, P850; Siegel S., 1956, NONPARAMETRIC STAT B; STRAUS SE, 1989, J INFECT DIS, V160, P1085, DOI 10.1093/infdis/160.6.1085; STRAUS SE, 1991, REV INFECT DIS, V13, pS2; TOBI M, 1982, LANCET, V1, P61; TOMKINSON BE, 1987, J IMMUNOL, V139, P3802; TOSATO G, 1985, J IMMUNOL, V134, P3082	33	263	271	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 21	1991	338	8769					707	712		10.1016/0140-6736(91)91440-6	http://dx.doi.org/10.1016/0140-6736(91)91440-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG104	1679864				2022-12-28	WOS:A1991GG10400001
J	ARULKUMARAN, S; TALBERT, DG; NYMAN, M; WESTGREN, M; HSU, TS; RATNAM, SS				ARULKUMARAN, S; TALBERT, DG; NYMAN, M; WESTGREN, M; HSU, TS; RATNAM, SS			AUDIBLE INUTERO SOUND FROM ULTRASOUND SCANNER	LANCET			English	Letter									INST OBSTET & GYNECOL,LONDON W6,ENGLAND; KAROLINSKA INST,HUDDINGE HOSP,S-14186 HUDDINGE,SWEDEN; NATL UNIV SINGAPORE,DEPT PHYS,SINGAPORE 0511,SINGAPORE	Karolinska Institutet; National University of Singapore	ARULKUMARAN, S (corresponding author), NATL UNIV SINGAPORE,DEPT OBSTET & GYNAECOL,SINGAPORE 0511,SINGAPORE.							NYMEN M, IN PRESS OBSTET GYNE	1	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					704	705		10.1016/0140-6736(91)91287-5	http://dx.doi.org/10.1016/0140-6736(91)91287-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679509				2022-12-28	WOS:A1991GF10500054
J	[Anonymous]				[Anonymous]			HOMOSEXUALITY AND THE HYPOTHALAMUS	LANCET			English	Editorial Material							BRAIN											ALLEN LS, 1989, J NEUROSCI, V9, P497; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	1991	338	8768					688	689						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679487				2022-12-28	WOS:A1991GF10500020
J	YOUNG, LHY; JOAG, SV; ZHENG, LM; LEE, CP; LEE, YS; YOUNG, JDE				YOUNG, LHY; JOAG, SV; ZHENG, LM; LEE, CP; LEE, YS; YOUNG, JDE			PERFORIN-MEDIATED MYOCARDIAL DAMAGE IN ACUTE MYOCARDITIS	LANCET			English	Article									ROCKEFELLER UNIV,NEW YORK,NY 10021; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,BOSTON,MA 02114; CHANG GUNG MEM HOSP,TAIPEI,TAIWAN	Rockefeller University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Chang Gung Memorial Hospital				Young, Lucy/0000-0001-8634-7512	NATIONAL CANCER INSTITUTE [R01CA047307] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47307] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aretz T., 1986, AM J CARDIOVASC PATH, V1, P3; BOWLES NE, 1986, LANCET, V1, P1120; GODENY EK, 1987, AM J PATHOL, V129, P267; GRAVANIS MB, 1987, ARCH PATHOL LAB MED, V111, P915; JOAG S, 1989, J CELL BIOCHEM, V39, P239, DOI 10.1002/jcb.240390304; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LIU CC, 1989, J EXP MED, V170, P2105, DOI 10.1084/jem.170.6.2105; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P2641, DOI 10.1021/bi00408a001; WOODRUFF JF, 1980, AM J PATHOL, V101, P426; YOUNG JDE, 1987, ADV IMMUNOL, V41, P269, DOI 10.1016/S0065-2776(08)60033-4; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429	13	75	76	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1019	1021		10.1016/0140-6736(90)92486-2	http://dx.doi.org/10.1016/0140-6736(90)92486-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1699101				2022-12-28	WOS:A1990EF07600001
J	HOUMAN, F; DIAZTORRES, MR; WRIGHT, A				HOUMAN, F; DIAZTORRES, MR; WRIGHT, A			TRANSCRIPTIONAL ANTITERMINATION IN THE BGL OPERON OF ESCHERICHIA-COLI IS MODULATED BY A SPECIFIC RNA-BINDING PROTEIN	CELL			English	Article											HOUMAN, F (corresponding author), TUFTS UNIV,DEPT MOLEC BIOL & BIOCHEM,HLTH SCI CAMPUS,BOSTON,MA 02111, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038035] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38035] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMSTERCHODER O, 1989, CELL, V58, P847, DOI 10.1016/0092-8674(89)90937-9; BACKMAN K, 1976, P NATL ACAD SCI USA, V73, P4174, DOI 10.1073/pnas.73.11.4174; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BOWEN B, 1980, NUCLEIC ACIDS RES, V8, P1, DOI 10.1093/nar/8.1.1; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; DEBARBOUILLE M, 1990, J BACTERIOL, V172, P3966, DOI 10.1128/jb.172.7.3966-3973.1990; DECKMAN IC, 1987, J MOL BIOL, V196, P323, DOI 10.1016/0022-2836(87)90693-0; EGUCHI Y, 1990, CELL, V60, P199, DOI 10.1016/0092-8674(90)90736-X; FOX CF, 1968, P NATL ACAD SCI USA, V59, P988, DOI 10.1073/pnas.59.3.988; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; HANNA MM, 1983, P NATL ACAD SCI-BIOL, V80, P4238, DOI 10.1073/pnas.80.14.4238; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HENKIN TM, 1987, MOL GEN GENET, V209, P467, DOI 10.1007/BF00331151; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HSARLOW E, 1988, ANTIBODIES LABORATOR; INOUYE S, 1987, DNA RNA SYNTHESIS, P181; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; JAURIN B, 1981, NATURE, V290, P221, DOI 10.1038/290221a0; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KOZAK M, 1988, J CELL BIOL, V107, P1, DOI 10.1083/jcb.107.1.1; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; KURODA MI, 1988, J BACTERIOL, V170, P3080, DOI 10.1128/jb.170.7.3080-3088.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDICK R, 1987, J MOL BIOL, V196, P363, DOI 10.1016/0022-2836(87)90697-8; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; LOPILATO J, 1990, BACTERIAL CHROMOSOME, P435; LOWERY C, 1977, J BIOL CHEM, V252, P1381; MAHADEVAN S, 1987, J BACTERIOL, V169, P2570, DOI 10.1128/jb.169.6.2570-2578.1987; MAHADEVAN S, 1987, CELL, V50, P485, DOI 10.1016/0092-8674(87)90502-2; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; Miller J.H., 1972, EXPT MOL GENETICS; REYNOLDS AE, 1981, NATURE, V293, P625, DOI 10.1038/293625a0; REYNOLDS AE, 1986, J MOL BIOL, V191, P85, DOI 10.1016/0022-2836(86)90424-9; ROBERTS JW, 1988, CELL, V52, P5, DOI 10.1016/0092-8674(88)90523-5; ROLAND KL, 1988, P NATL ACAD SCI USA, V85, P7149, DOI 10.1073/pnas.85.19.7149; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; RYAN T, 1983, J BIOL CHEM, V258, P4690; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNETZ K, 1988, EMBO J, V7, P3271, DOI 10.1002/j.1460-2075.1988.tb03194.x; SCHNETZ K, 1987, J BACTERIOL, V169, P2579, DOI 10.1128/jb.169.6.2579-2590.1987; SHAEFLER S, 1967, J BACTERIOL, V93, P254; SHIMOTSU H, 1986, J BACTERIOL, V168, P380, DOI 10.1128/jb.168.1.380-388.1986; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; Silhavy T. J., 1984, EXPT GENE FUSIONS; STEINMETZ M, 1988, GENETICS BIOTECHNOLO, V2, P11; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TANG CK, 1989, CELL, V57, P531, DOI 10.1016/0092-8674(89)90123-2; TAZI J, 1986, CELL, V47, P755, DOI 10.1016/0092-8674(86)90518-0; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIOQUE A, 1988, J MOL BIOL, V202, P835, DOI 10.1016/0022-2836(88)90562-1; WILLIAMS MG, 1987, J BACTERIOL, V169, P1644, DOI 10.1128/jb.169.4.1644-1650.1987; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; YANOFSKY C, 1988, J BIOL CHEM, V263, P609; ZUKOWSKI M, 1988, GENETICS BIOTECHNOLO, V2, P17	57	166	169	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 21	1990	62	6					1153	1163		10.1016/0092-8674(90)90392-R	http://dx.doi.org/10.1016/0092-8674(90)90392-R			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EA117	1698125				2022-12-28	WOS:A1990EA11700013
J	SCHMID, A; DEHLINGERKREMER, M; SCHULZ, I; GOGELEIN, H				SCHMID, A; DEHLINGERKREMER, M; SCHULZ, I; GOGELEIN, H			VOLTAGE-DEPENDENT INSP3- INSENSITIVE CALCIUM CHANNELS IN MEMBRANES OF PANCREATIC ENDOPLASMIC-RETICULUM VESICLES	NATURE			English	Article											SCHMID, A (corresponding author), MAX PLANCK INST BIOPHYS,KENNEDY ALLEE 70,W-6000 FRANKFURT 70,GERMANY.							BAYERDORFFER E, 1984, J MEMBRANE BIOL, V81, P69, DOI 10.1007/BF01868811; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; EHRLICH BE, 1988, NATURE, V336, P583, DOI 10.1038/336583a0; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GILL DL, 1989, CELL CALCIUM, V10, P363, DOI 10.1016/0143-4160(89)90062-6; GOGELEIN H, 1987, PFLUG ARCH EUR J PHY, V410, P288, DOI 10.1007/BF00580279; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; KEMMER TP, 1987, J BIOL CHEM, V262, P13758; KOSTYUK PG, 1989, J MEMBRANE BIOL, V110, P11, DOI 10.1007/BF01870988; LEE KS, 1984, J PHYSIOL-LONDON, V354, P253, DOI 10.1113/jphysiol.1984.sp015374; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; MARTY A, 1989, J PHYSIOL-LONDON, V419, P665, DOI 10.1113/jphysiol.1989.sp017892; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; ROUSSEAU E, 1989, AM J PHYSIOL, V256, pH328, DOI 10.1152/ajpheart.1989.256.2.H328; SCHMID A, 1988, J MEMBRANE BIOL, V104, P275, DOI 10.1007/BF01872329; SCHMID A, 1989, J MEMBRANE BIOL, V111, P264; SCHULZ I, 1980, AM J PHYSIOL, V239, pG335, DOI 10.1152/ajpgi.1980.239.5.G335; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STREB H, 1984, J MEMBRANE BIOL, V81, P241, DOI 10.1007/BF01868717; THEVENOD F, 1989, J MEMBRANE BIOL, V109, P173, DOI 10.1007/BF01870856	25	83	83	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 26	1990	346	6282					374	376		10.1038/346374a0	http://dx.doi.org/10.1038/346374a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ567	1695718				2022-12-28	WOS:A1990DQ56700065
J	CHUI, DHK; PATTERSON, M; DOWLING, CE; KAZAZIAN, HH; KENDALL, AG				CHUI, DHK; PATTERSON, M; DOWLING, CE; KAZAZIAN, HH; KENDALL, AG			HEMOGLOBIN BARTS DISEASE IN AN ITALIAN BOY - INTERACTION BETWEEN ALPHA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; MCGILL UNIV,SCH MED,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA	Johns Hopkins University; McGill University	CHUI, DHK (corresponding author), MCMASTER UNIV,SCH MED,DEPT PATHOL,HAMILTON L8N 3Z5,ONTARIO,CANADA.			Chui, David/0000-0002-1475-7309	NHLBI NIH HHS [HL-37652] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037652] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS JG, 1985, NEW ENGL J MED, V313, P1402, DOI 10.1056/NEJM198511283132207; ALTER BP, 1980, BRIT J HAEMATOL, V44, P527, DOI 10.1111/j.1365-2141.1980.tb08706.x; BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; BUNN HF, 1987, BLOOD, V69, P1; CAMASCHELLA C, 1989, BLOOD, V73, P1999; CHOREMIS C, 1959, BRIT MED J, V2, P348, DOI 10.1136/bmj.2.5148.348; CHUI DHK, 1986, NEW ENGL J MED, V314, P76, DOI 10.1056/NEJM198601093140203; COLLINS FS, 1985, NATURE, V313, P325, DOI 10.1038/313325a0; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; GALANELLO R, 1984, BRIT J HAEMATOL, V58, P361, DOI 10.1111/j.1365-2141.1984.tb06095.x; GELINAS R, 1985, NATURE, V313, P323, DOI 10.1038/313323a0; GELINAS R, 1986, BLOOD, V67, P1777; HIGGS DR, 1989, BLOOD, V73, P1081; KARLSSON S, 1985, ANNU REV BIOCHEM, V54, P1071; MRABET NT, 1986, J BIOL CHEM, V261, P1111; OTTOLENGHI S, 1988, HUM GENET, V79, P13, DOI 10.1007/BF00291702; PRESSLEY L, 1980, P NATL ACAD SCI-BIOL, V77, P3586, DOI 10.1073/pnas.77.6.3586; QUI CC, 1988, AM J HEMATOL, V29, P58; RAMOT B, 1959, BRIT MED J, V2, P1228, DOI 10.1136/bmj.2.5161.1228; SOPHOCLEOUS T, 1981, BRIT J HAEMATOL, V47, P153, DOI 10.1111/j.1365-2141.1981.tb02770.x; Stallings M, 1983, BLOOD, V62, p75a; STAMATOYANNOPOU.G, 1987, MOL BASIS BLOOD DISE, P66; WABER PG, 1986, BLOOD, V67, P551; WILSON JB, 1983, J LAB CLIN MED, V102, P174	24	8	8	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	1990	323	3					179	182		10.1056/NEJM199007193230307	http://dx.doi.org/10.1056/NEJM199007193230307			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN537	1694572	Bronze			2022-12-28	WOS:A1990DN53700007
J	FINEGOLD, AA; SCHAFER, WR; RINE, J; WHITEWAY, M; TAMANOI, F				FINEGOLD, AA; SCHAFER, WR; RINE, J; WHITEWAY, M; TAMANOI, F			COMMON MODIFICATIONS OF TRIMERIC-G PROTEINS AND RAS PROTEIN - INVOLVEMENT OF POLYISOPRENYLATION	SCIENCE			English	Article									UNIV CHICAGO, DEPT BIOCHEM & MOLEC BIOL, CHICAGO, IL 60637 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELLULAR BIOL, BERKELEY, CA 94720 USA; NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, GENET ENGN SECT, MONTREAL H4P 2R2, QUEBEC, CANADA	University of Chicago; University of California System; University of California Berkeley; National Research Council Canada				Schafer, William/0000-0002-6676-8034	NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM035827] Funding Source: NIH RePORTER; NCI NIH HHS [CA 41996] Funding Source: Medline; NIGMS NIH HHS [GM 35827, GM 07183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BASSON ME, 1988, MOL CELL BIOL, V8, P3797, DOI 10.1128/MCB.8.9.3797; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; DESCHENES RJ, 1989, J BIOL CHEM, V264, P11865; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; DIETZEL C, 1987, CELL, V50, P1001, DOI 10.1016/0092-8674(87)90166-8; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FINEGOLD AA, UNPUB; FUJIYAMA A, 1986, P NATL ACAD SCI USA, V83, P1266, DOI 10.1073/pnas.83.5.1266; FUJIYAMA A, 1987, EMBO J, V6, P223, DOI 10.1002/j.1460-2075.1987.tb04742.x; FUJIYAMA A, 1990, J BIOL CHEM, V265, P3362; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOODMAN LE, 1988, YEAST, V4, P271, DOI 10.1002/yea.320040405; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HERSKOWITZ I, 1987, CELL, V50, P995, DOI 10.1016/0092-8674(87)90162-0; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; MIYAJIMA I, 1987, CELL, V50, P11; NAKAYAMA N, 1988, MOL CELL BIOL, V8, P5410, DOI 10.1128/MCB.8.12.5410; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; ROBISHAW JD, 1989, J BIOL CHEM, V264, P15758; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SEFTON BM, 1982, CELL, V31, P465, DOI 10.1016/0092-8674(82)90139-8; SERRANO R, 1978, MOL CELL BIOCHEM, V22, P51; SHERMAN F, 1986, LABORATORY COURSE MA, P117; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TAMANOI F, 1988, J CELL BIOCHEM, V36, P261, DOI 10.1002/jcb.240360307; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WHITEWAY M, UNPUB; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WILSON KL, 1987, GENETICS, V155, P441; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P1936, DOI 10.1073/pnas.82.7.1936	39	111	114	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	1990	249	4965					165	169		10.1126/science.1695391	http://dx.doi.org/10.1126/science.1695391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN539	1695391				2022-12-28	WOS:A1990DN53900035
J	MATSUDA, M; MAYER, BJ; FUKUI, Y; HANAFUSA, H				MATSUDA, M; MAYER, BJ; FUKUI, Y; HANAFUSA, H			BINDING OF TRANSFORMING PROTEIN, P47GAG-CRK, TO A BROAD RANGE OF PHOSPHOTYROSINE-CONTAINING PROTEINS	SCIENCE			English	Article									ROCKEFELLER UNIV,NEW YORK,NY 10021	Rockefeller University			Fukui, Yasuhisa/E-8806-2010	Matsuda, Michiyuki/0000-0002-5876-9969	NATIONAL CANCER INSTITUTE [R35CA044356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007233] Funding Source: NIH RePORTER; NCI NIH HHS [CA44356] Funding Source: Medline; NIAID NIH HHS [AI 07233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; EMORI Y, 1989, J BIOL CHEM, V264, P21885; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; HAMAGUCHI M, 1988, MOL CELL BIOL, V8, P3035, DOI 10.1128/MCB.8.8.3035; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KAWAI S, 1980, J VIROL, V34, P772, DOI 10.1128/JVI.34.3.772-776.1980; KAWAI S, 1980, P NATL ACAD SCI-BIOL, V77, P6199, DOI 10.1073/pnas.77.10.6199; KIMURA G, 1975, INT J CANCER, V15, P694, DOI 10.1002/ijc.2910150419; KOCH CA, 1989, MOL CELL BIOL, V9, P4131, DOI 10.1128/MCB.9.10.4131; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; Marshall C., UNPUB; MATSUDA M, IN PRESS J BIOL CHEM; MAYER BJ, 1988, COLD SPRING HARB SYM, V53, P907, DOI 10.1101/SQB.1988.053.01.104; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; MAYER BJ, IN PRESS J VIROL; MCCARLEY DJ, 1987, J VIROL, V61, P1927, DOI 10.1128/JVI.61.6.1927-1937.1987; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; PAWSON T, 1988, ONCOGENE, V3, P491; POTTS WM, 1987, J GEN VIROL, V68, P3177, DOI 10.1099/0022-1317-68-12-3177; REICHMAN C, UNPUB; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SEFTON BM, 1982, J VIROL, V41, P813, DOI 10.1128/JVI.41.3.813-820.1982; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934	34	385	399	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 22	1990	248	4962					1537	1539		10.1126/science.1694307	http://dx.doi.org/10.1126/science.1694307			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK408	1694307				2022-12-28	WOS:A1990DK40800035
J	KWEDER, SL; SCHNUR, RA; COOPER, EC				KWEDER, SL; SCHNUR, RA; COOPER, EC			INOSINE PRANOBEX - IS A SINGLE POSITIVE TRIAL ENOUGH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											KWEDER, SL (corresponding author), US FDA,ROCKVILLE,MD 20857, USA.							CAMPOLIRICHARDS DM, 1986, DRUGS, V32, P383, DOI 10.2165/00003495-198632050-00001; DESIMONE C, 1989, MED ONCOL TUMOR PHAR, V6, P63, DOI 10.1007/BF02985225; GRIECO MH, 1984, ANN INTERN MED, V101, P206, DOI 10.7326/0003-4819-101-2-206; LANDAY A, 1989, CLIN RES, V37, pA434; PEDERSEN C, 1990, NEW ENGL J MED, V322, P1757, DOI 10.1056/NEJM199006213222501; SCHINAZI RF, 1988, ANTIMICROB AGENTS CH, V32, P1784, DOI 10.1128/AAC.32.12.1784; WALLACE JI, 1986, CLIN IMMUNOL IMMUNOP, V39, P179, DOI 10.1016/0090-1229(86)90218-7; 1989, MMWR S5, V38, P1; 1987, MMWR S1S, V36, pS3; 1988, PRESS RELEASE N 1115	10	13	13	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	1990	322	25					1807	1809		10.1056/NEJM199006213222509	http://dx.doi.org/10.1056/NEJM199006213222509			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ232	1693175				2022-12-28	WOS:A1990DJ23200009
J	READ, RC; GREEN, M				READ, RC; GREEN, M			INTERNAL-COMBUSTION AND HEALTH	BRITISH MEDICAL JOURNAL			English	Editorial Material									BRITISH LUNG FDN,LONDON SW3 5UE,ENGLAND		READ, RC (corresponding author), NATL HEART & LUNG INST,LONDON SW3 6LY,ENGLAND.			Read, Robert/0000-0002-4297-6728				ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102; COLE PV, 1975, NATURE, V225, P699; EVANS RG, 1988, AM J IND MED, V14, P25, DOI 10.1002/ajim.4700140105; FOLINSBEE LJ, 1985, J APPL PHYSIOL, V58, P1783, DOI 10.1152/jappl.1985.58.6.1783; FOLINSBEE LJ, 1984, J APPL PHYSIOL, V57, P984, DOI 10.1152/jappl.1984.57.4.984; GARSHICK E, 1987, AM REV RESPIR DIS, V135, P1242; HOLMAN C, 1989, AIR POLLUTION HLTH F; INFANTE PF, 1985, AM J IND MED, V7, P403, DOI 10.1002/ajim.4700070507; KOENIG J Q, 1989, American Review of Respiratory Disease, V139, pA281; MCDONNELL WF, 1985, AM REV RESPIR DIS, V131, P36; OREHEK J, 1976, J CLIN INVEST, V57, P301, DOI 10.1172/JCI108281; REID DD, 1964, P ROY SOC MED, V57, P965, DOI 10.1177/003591576405710P201; STEENLAND K, 1986, AM J IND MED, V10, P177; STERN FB, 1988, AM J EPIDEMIOL, V128, P1276, DOI 10.1093/oxfordjournals.aje.a115081; WILLIAMS ML, 1988, ATMOS ENVIRON, V22, P2819, DOI 10.1016/0004-6981(88)90449-0; WILLIAMS ML, 1987, ASSESSMENT UK POSITI; 1987, WHO EUROPEAN SERIES, V23; 1984, REPORT SCI REV PANEL	18	10	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 24	1990	300	6727					761	762		10.1136/bmj.300.6727.761	http://dx.doi.org/10.1136/bmj.300.6727.761			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW227	1691030	Bronze, Green Published			2022-12-28	WOS:A1990CW22700001
J	CUBEDDU, LX; HOFFMANN, IS; FUENMAYOR, NT; FINN, AL				CUBEDDU, LX; HOFFMANN, IS; FUENMAYOR, NT; FINN, AL			EFFICACY OF ONDANSETRON (GR-38032F) AND THE ROLE OF SEROTONIN IN CISPLATIN-INDUCED NAUSEA AND VOMITING	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV N CAROLINA,DEPT PHARMACOL,DIV CLIN PHARMACOL,CHAPEL HILL,NC 27514; PEREZ CARRENO HOSP,CARACAS,VENEZUELA; GLAXO INC,RES TRIANGLE PK,NC	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline	CUBEDDU, LX (corresponding author), CENT UNIV VENEZUELA,DEPT PHARMACOL,APARTADO NUEVA GRANADA,CARACAS,VENEZUELA.							AAPRO MS, 1984, J CLIN ONCOL, V2, P466, DOI 10.1200/JCO.1984.2.5.466; ANDREWS PLR, 1988, TRENDS PHARMACOL SCI, V9, P334, DOI 10.1016/0165-6147(88)90106-X; BARNES N M, 1987, British Journal of Pharmacology, V92, p649P; BERNARD S, 1988, P AM SOC CLIN ONCOL, V7, P291; BERTACCINI G, 1960, J PHYSIOL-LONDON, V153, P239, DOI 10.1113/jphysiol.1960.sp006532; BERTACCINI G, 1960, LANCET, V1, P881; BERTACCINI G, 1958, NATURWISSENSCHAFTEN, V45, P548, DOI 10.1007/BF00632070; BORISON HL, 1983, DRUGS, V25, P8, DOI 10.2165/00003495-198300251-00003; BRITTAIN R T, 1987, British Journal of Pharmacology, V90, p87P; CARL PL, 1989, DRUG METAB REV, V21, P187; COSTALL B, 1986, NEUROPHARMACOLOGY, V25, P1293, DOI 10.1016/0028-3908(86)90151-6; COSTALL B, 1987, British Journal of Pharmacology, V90, p90P; COSTALL B, 1986, NEUROPHARMACOLOGY, V25, P959, DOI 10.1016/0028-3908(86)90030-4; ERSPAMER V, 1959, J PHARM PHARMACOL, V11, P618, DOI 10.1111/j.2042-7158.1959.tb12603.x; ERSPAMER V, 1954, REND SCIENT FARMITAL, V1, P1; FELDBERG W, 1953, J PHYSIOL-LONDON, V119, P352, DOI 10.1113/jphysiol.1953.sp004850; FOZARD JR, 1987, TRENDS PHARMACOL SCI, V8, P44, DOI 10.1016/0165-6147(87)90002-2; GADDUM JH, 1957, BRIT J PHARM CHEMOTH, V12, P323, DOI 10.1111/j.1476-5381.1957.tb00142.x; GAGEN M, 1984, J CLIN ONCOL, V2, P696, DOI 10.1200/JCO.1984.2.6.696; GERSHON MD, 1971, J PHARMACOL EXP THER, V179, P29; GRALLA RJ, 1981, NEW ENGL J MED, V305, P905, DOI 10.1056/NEJM198110153051601; GRALLA RJ, 1983, DRUGS, V25, P63, DOI 10.2165/00003495-198300251-00007; GREEN JA, 1987, BRIT J CANCER, V56, P899; HAWTHORN J, 1988, Q J EXP PHYSIOL CMS, V73, P7, DOI 10.1113/expphysiol.1988.sp003124; HESKETH PJ, 1989, J CLIN ONCOL, V7, P700, DOI 10.1200/JCO.1989.7.6.700; KILPATRICK GJ, 1987, NATURE, V330, P746, DOI 10.1038/330746a0; KRIS MG, 1985, J CLIN ONCOL, V3, P1379, DOI 10.1200/JCO.1985.3.10.1379; KRIS MG, 1988, J CLIN ONCOL, V6, P659, DOI 10.1200/JCO.1988.6.4.659; KRIS MG, 1989, J NATL CANCER I, V81, P42, DOI 10.1093/jnci/81.1.42; KRIS MG, 1985, CANCER, V55, P527, DOI 10.1002/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO;2-2; KRIS MG, 1983, NEW ENGL J MED, V309, P433; LASZLO J, 1983, DRUGS, V25, P1, DOI 10.2165/00003495-198300251-00002; LASZLO J, 1981, NEW ENGL J MED, V305, P948, DOI 10.1056/NEJM198110153051609; LEIBUNDGUT U, 1987, LANCET, V1, P1198; LOEFFLER TM, 1988, P AM SOC CLIN ONCOL, V7, P293; LOUVET C, 1988, P AM SOC CLIN ONCOL, V7, P288; MINER WD, 1986, BRIT J PHARMACOL, V88, P497, DOI 10.1111/j.1476-5381.1986.tb10228.x; PASSALACQUA R, 1988, P AM SOC CLIN ONCOL, V7, P284; PLEZIA PM, 1984, CANCER TREAT REP, V68, P1493; PLEZIA PM, 1988, P AM SOC CLIN ONCOL, V7, P294; RESNICK RH, 1961, GASTROENTEROLOGY, V41, P119; RICHARDSON BP, 1986, TRENDS NEUROSCI, V9, P424, DOI 10.1016/0166-2236(86)90137-2; RICHARDSON BP, 1985, NATURE, V316, P126, DOI 10.1038/316126a0; ROBINSON RG, 1971, J PHARMACOL EXP THER, V178, P311; ROSENBERG JC, 1959, FED PROC, V18, P503; SRIDHAR KS, 1988, CANCER, V61, P1508, DOI 10.1002/1097-0142(19880415)61:8<1508::AID-CNCR2820610806>3.0.CO;2-H; STABLES R, 1987, ANTI-CANCER DRUG DES, V2, P97; SUPRENANT A, 1988, NEUROSCIENCE, V24, P283; UDENFRIEND S, 1958, P SOC EXP BIOL MED, V97, P748; VINCENT BJ, 1983, DRUGS, V25, P52, DOI 10.2165/00003495-198300251-00006; VONHOFF DD, 1979, CANCER TREAT REP, V63, P1527; WAMPLER G, 1983, DRUGS, V25, P35, DOI 10.2165/00003495-198300251-00005	52	416	423	1	13	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 22	1990	322	12					810	816		10.1056/NEJM199003223221204	http://dx.doi.org/10.1056/NEJM199003223221204			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU630	1689807				2022-12-28	WOS:A1990CU63000004
J	HILL, RE; FAVOR, J; HOGAN, BLM; TON, CCT; SAUNDERS, GF; HANSON, IM; PROSSER, J; JORDAN, T; HASTIE, ND; VANHEYNINGEN, V				HILL, RE; FAVOR, J; HOGAN, BLM; TON, CCT; SAUNDERS, GF; HANSON, IM; PROSSER, J; JORDAN, T; HASTIE, ND; VANHEYNINGEN, V			MOUSE SMALL EYE RESULTS FROM MUTATIONS IN A PAIRED-LIKE HOMEOBOX-CONTAINING GENE	NATURE			English	Article							DEVELOPING EXCRETORY SYSTEM; BOX; DROSOPHILA; DELETION; DOMAIN; PAX-1; OCT-1; DNA	SMALL eye (Sey) in mouse is a semidominant mutation which in the homozygous condition results in the complete lack of eyes and nasal primordia. On the basis of comparative mapping studies and on phenotypic similarities, Sey bas been suggested to be homologous to congenital aniridia (lack of iris) in human 1,2. A candidate gene for the aniridia (AN) locus at 11p13 bas been isolated by positional cloning 3 and its sequence and that of the mouse homologue has been established (C.T., manuscript in preparation). This gene belongs to the paired-like class of developmental genes first described in Drosophila which contain two highly conserved motifs, the paired box and the homeobox 4,5. In vertebrates, genes which encode the single paired domain as well as those which express both motifs have been described as the Pax multigene family 6-10. A Pax gene recently described as Pax-6 11,12 is identical to the mouse homologue of the candidate aniridia gene. Here we report the analysis of three independent Sey alleles and show that indeed this gene is mutated and that the mutations would predictably interrupt gene function.	GESELL STRAHLEN & UMWELTFORSCH MBH,INST SAUGETIERGENET,W-8042 NEUHERBERG,GERMANY; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center	HILL, RE (corresponding author), WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530				BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BARTH RK, 1982, P NATL ACAD SCI-BIOL, V79, P500, DOI 10.1073/pnas.79.2.500; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; COTE S, 1987, EMBO J, V6, P2793, DOI 10.1002/j.1460-2075.1987.tb02575.x; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESUMI H, 1983, P NATL ACAD SCI-BIOL, V80, P95, DOI 10.1073/pnas.80.1.95; FAVOR J, 1988, MUTAT RES, V198, P269, DOI 10.1016/0027-5107(88)90003-6; FAVOR J, 1982, MUTAT RES, V92, P181; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; Green MC., 1989, GENETIC VARIANTS STR, P12; HASTIE ND, IN PRESS CURR BIOL; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JOSTES B, 1991, MECH DEVELOP, V33, P27; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; MEYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955; MONAGHAN AP, 1991, DEVELOPMENT, V112, P1053; PLACHOV D, 1990, DEVELOPMENT, V110, P643; PROSSER J, 1990, ONCOGENE, V5, P1573; RESS DJG, 1985, NATURE, V316, P643; ROBERTS RC, 1967, GENET RES, V9, P121, DOI 10.1017/S0016672300010387; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TON CCT, IN PRESS CELL, V67; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, IN PRESS DEVELOPMENT; [No title captured]	37	1157	1175	2	45	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	DEC 19	1991	354	6354					522	525		10.1038/354522a0	http://dx.doi.org/10.1038/354522a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW751	1684639				2022-12-28	WOS:A1991GW75100014
J	AABY, P; SAMB, B; SIMONDON, F; WHITTLE, H; SECK, AMC; KNUDSEN, K; BENNETT, J; MARKOWITZ, L; RHODES, P				AABY, P; SAMB, B; SIMONDON, F; WHITTLE, H; SECK, AMC; KNUDSEN, K; BENNETT, J; MARKOWITZ, L; RHODES, P			CHILD-MORTALITY AFTER HIGH-TITER MEASLES-VACCINES IN SENEGAL - THE COMPLETE DATA SET	LANCET			English	Letter									CHEIKH ANTA DIOP UNIV,INFECT DIS SERV,DAKAR,SOUTH AFRICA; STAT RES UNIT,COPENHAGEN,DENMARK; TASK FORCE CHILD SURVIVAL,ATLANTA,GA; CTR DIS CONTROL,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	AABY, P (corresponding author), ORSTOM,BP 1386,DAKAR,SOUTH AFRICA.			Aaby, Peter/0000-0001-8331-1389; Simondon, Francois/0000-0003-0395-1314				1991, WKLY EPIDEMIOL REC, V66, P249	1	30	30	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1518	1518		10.1016/0140-6736(91)92330-5	http://dx.doi.org/10.1016/0140-6736(91)92330-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683932				2022-12-28	WOS:A1991GV07700022
J	CORTELLARO, M				CORTELLARO, M			ANTITHROMBIN-III AND ARTERIAL-DISEASE	LANCET			English	Letter											CORTELLARO, M (corresponding author), UNIV MILAN,INST MED INTERNA,I-20122 MILAN,ITALY.							CORTELLARO M, IN PRESS ATHEROSCLER; MEADE, 1991, LANCET, V338, P850	2	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1525	1526		10.1016/0140-6736(91)92343-Z	http://dx.doi.org/10.1016/0140-6736(91)92343-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683944				2022-12-28	WOS:A1991GV07700037
J	MARTIN, JF; BATH, PMW; BURR, ML				MARTIN, JF; BATH, PMW; BURR, ML			INFLUENCE OF PLATELET SIZE ON OUTCOME AFTER MYOCARDIAL-INFARCTION	LANCET			English	Article							BLEEDING-TIME; VOLUME; PROGNOSIS; DENSITY; DISEASE; COUNT; DEATH	Although platelet characteristics have an important influence on ischaemic heart disease, the nature of the association of platelet size and platelet count with death and reinfarction after an index heart attack is unknown. Mean platelet volume (MPV), a determinant of platelet reactivity, was measured in 1716 men six months after myocardial infarction (MI). Deaths and recurrent ischaemic heart disease events were then assessed at two years. MPV was greater in 126 men who had a further ischaemic event (fatal or non-fatal) than in the 1590 men who had no further MI (p < 0.001). In addition, the MPV was larger in men who died than in those who did not (p < 0.001). There was no difference in platelet count between these groups. When analysed by quartiles, consistent trends of increasing age-adjusted relative odds of death and recurrent ischaemic events were noted for MPV. MPV did not correlate with known ischaemic heart disease risk factors such as blood pressure, blood lipids, fibrinogen, white cell count, or plasma viscosity. We believe that MPV is a further independent risk factor for recurrent MI.	LLANDOUGH HOSP, MRC, EPIDEMIOL UNIT, PENARTH GP6 1XX, S GLAM, WALES		MARTIN, JF (corresponding author), KINGS COLL, SCH MED & DENT, DEPT MED, BESSEMER RD, LONDON SE5 9PJ, ENGLAND.		Bath, Philip/F-9020-2011	Bath, Philip/0000-0003-2734-5132				[Anonymous], 1988, LANCET, V2, P349; BURR ML, 1989, LANCET, V2, P757; BURR ML, IN PRESS EUR HEART J; DERASMO E, 1990, J INTERN MED, V227, P11, DOI 10.1111/j.1365-2796.1990.tb00111.x; GLADWIN AM, 1990, AM J HEMATOL, V35, P225, DOI 10.1002/ajh.2830350402; HAVER VM, 1981, J LAB CLIN MED, V97, P187; HEPTINSTALL S, 1980, BRIT MED J, V280, P80, DOI 10.1136/bmj.280.6207.80; JAKUBOWSKI JA, 1983, BRIT J HAEMATOL, V53, P503, DOI 10.1111/j.1365-2141.1983.tb02052.x; KRISTENSEN SD, 1990, CARDIOVASC RES, V24, P19, DOI 10.1093/cvr/24.1.19; KRISTENSEN SD, 1988, THROMB HAEMOSTASIS, V59, P167; MARTIN J, 1989, BLOOD CELLS, V15, P108; MARTIN JF, 1983, BRIT J HAEMATOL, V54, P337, DOI 10.1111/j.1365-2141.1983.tb02109.x; MARTIN JF, 1983, BRIT MED J, V287, P456, DOI 10.1136/bmj.287.6390.456; MARTIN JF, 1983, THROMB RES, V32, P443, DOI 10.1016/0049-3848(83)90255-4; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MILNER PC, 1985, BRIT MED J, V290, P1767, DOI 10.1136/bmj.290.6484.1767; STUART J, 1981, J CLIN PATHOL, V34, P464, DOI 10.1136/jcp.34.5.464; THOMPSON CB, 1983, BLOOD, V62, P487; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; TROWBRIDGE EA, 1984, THROMB HAEMOSTASIS, V52, P167; TROWBRIDGE EA, 1985, CLIN PHYS PHYSIOL M, V6, P221, DOI 10.1088/0143-0815/6/3/003; WALKER JJ, 1989, AM J OBSTET GYNECOL, V161, P676, DOI 10.1016/0002-9378(89)90378-5; YARNELL JWG, IN PRESS CIRCULATION; 1988, NEW ENGL J MED, V321, P129	24	464	481	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	1991	338	8780					1409	1411		10.1016/0140-6736(91)92719-I	http://dx.doi.org/10.1016/0140-6736(91)92719-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683417				2022-12-28	WOS:A1991GT90400001
J	STONEBRIDGE, PA; BROPHY, CM				STONEBRIDGE, PA; BROPHY, CM			SPIRAL LAMINAR-FLOW IN ARTERIES	LANCET			English	Note							AORTA	Spiral blood-flow patterns in infrainguinal blood-vessels were observed at angioscopy in 54 patients who underwent peripheral vascular reconstruction; the endoluminal surface had spiral folds in 51 of 75 arteries examined. Spiral flow patterns, congruous with inherent endoluminal anatomical features, might more accurately represent blood-flow in infrainguinal arteries than current models of laminar flow.	YALE UNIV,SCH MED,DIV VASC SURG,NEW HAVEN,CT 06510	Yale University	STONEBRIDGE, PA (corresponding author), ROYAL INFIRM,VASC SURG UNIT,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND.							FRAZIN L, 1990, CLIN RES, V38, pA331; Fung YC, 1984, BIODYNAMICS CIRCULAT, P77; HUNT TH, 1989, CARDIOVASCULAR SCI T, P124; KARINO T, 1987, ANN NY ACAD SCI, V516, P422; LOGERFO FW, 1985, J VASC SURG, V2, P263, DOI 10.1067/mva.1985.avs0020263; MILLER A, 1991, SURGERY, V109, P286; SEGADAL L, 1987, CIRCULATION, V76, P90, DOI 10.1161/01.CIR.76.1.90; UCHIDA Y, 1987, AM HEART J, V114, P1216, DOI 10.1016/0002-8703(87)90199-2	8	102	114	0	19	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 30	1991	338	8779					1360	1361		10.1016/0140-6736(91)92238-W	http://dx.doi.org/10.1016/0140-6736(91)92238-W			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682738				2022-12-28	WOS:A1991GR77300005
J	WYATT, J				WYATT, J			USE AND SOURCES OF MEDICAL KNOWLEDGE	LANCET			English	Article							PRIMARY CARE PRACTITIONERS; CONTINUING-EDUCATION; INFORMATION; JOURNALS; PHYSICIANS; COMPUTER; MANAGEMENT; ARTICLES; TRIALS; ACCESS				WYATT, J (corresponding author), STANFORD UNIV, MED CTR, SCH MED, MED INFORMAT SECT, MSOB X-215, STANFORD, CA 94305 USA.		Wyatt, Jeremy/F-8160-2010	Wyatt, Jeremy/0000-0001-7008-1473				ABBE KA, 1987, ANN INTERN MED, V107, P224; Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109; BARONDESS JA, 1985, ANN INTERN MED, V103, P286, DOI 10.7326/0003-4819-103-2-286; BERNSTEIN LM, 1980, ANN INTERN MED, V93, P169, DOI 10.7326/0003-4819-93-1-169; BUCKNALL CA, 1986, BRIT MED J, V293, P739, DOI 10.1136/bmj.293.6549.739; CAMPBELL EJM, 1987, LANCET, V1, P849; CHALMERS I, 1986, CONTROL CLIN TRIALS, V7, P306, DOI 10.1016/0197-2456(86)90038-3; COVELL DG, 1985, ANN INTERN MED, V103, P596, DOI 10.7326/0003-4819-103-4-596; DELACEY G, 1985, BRIT MED J, V291, P884, DOI 10.1136/bmj.291.6499.884; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; ESSEX B, 1989, BRIT MED J; EVANS CE, 1986, JAMA-J AM MED ASSOC, V255, P501; GARDNER MJ, 1990, JAMA-J AM MED ASSOC, V263, P1355, DOI 10.1001/jama.263.10.1355; HAYNES RB, 1990, ANN INTERN MED, V113, P724, DOI 10.7326/0003-4819-113-9-724; HAYNES RB, 1990, ANN INTERN MED, V112, P78, DOI 10.7326/0003-4819-112-1-78; HAYNES RB, 1986, ANN INTERN MED, V105, P810, DOI 10.7326/0003-4819-105-5-810; HAYNES RB, 1986, ANN INTERN MED, V105, P636, DOI 10.7326/0003-4819-105-4-636; HAYNES RB, 1986, ANN INTERN MED, V105, P978, DOI 10.7326/0003-4819-105-6-978; HAYNES RB, 1986, ANN INTERN MED, V105, P309, DOI 10.7326/0003-4819-105-2-309; HAYNES RB, 1986, ANN INTERN MED, V105, P474, DOI 10.7326/0003-4819-105-3-474; HAYNES RB, 1986, ANN INTERN MED, V105, P149, DOI 10.7326/0003-4819-105-1-149; HAYNES RB, 1987, ANN INTERN MED, V106, P598; HUMPHREY SM, 1989, IEEE EXPERT, V4, P25, DOI 10.1109/64.43268; HUTCHISON SJ, 1987, BRIT MED J, V294, P1261, DOI 10.1136/bmj.294.6582.1261; KAY JDS, 1989, LANCET, V2, P1456; KORS JA, 1989, P MED INFO 89 SINGAP, P156; KREISBERG RA, 1989, MED KNOWLEDGE SELF A, V8; LARGAESPADA MJ, 1988, LANCET, V1, P538; LOCK S, 1988, BRIT MED J, V296, P376, DOI 10.1136/bmj.296.6619.376; LOCK S, 1982, BRIT MED J, V284, P1289, DOI 10.1136/bmj.284.6325.1289; LOCK S, 1991, BRIT MED J, V302, P338; MULROW CD, 1988, ANN INTERN MED, V108, P613, DOI 10.7326/0003-4819-108-4-613; ONEIL M, 1989, 2ND P EUR C ART INT, P62; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; PARSONS DF, 1989, LANCET, V2, P1087; PAUKER SG, 1976, AM J MED, V60, P981, DOI 10.1016/0002-9343(76)90570-2; PENTELOW G, 1989, BRIT MED J, V298, P907, DOI 10.1136/bmj.298.6678.907; SCHMIDT HG, 1990, ACAD MED, V65, P611, DOI 10.1097/00001888-199010000-00001; SHORTLIFFE EH, 1990, MED INFORMATICS; SOHN N, 1985, NEW ENGL J MED, V312, P924; STINSON ER, 1980, JAMA-J AM MED ASSOC, V243, P140, DOI 10.1001/jama.243.2.140; STROSS JK, 1979, JAMA-J AM MED ASSOC, V241, P2622, DOI 10.1001/jama.241.24.2622; STROSS JK, 1989, JAMA-J AM MED ASSOC, V262, P2721, DOI 10.1001/jama.262.19.2721; WEINBERG AD, 1981, J MED EDUC, V56, P174; WILLIAMSON JW, 1989, ANN INTERN MED, V110, P151, DOI 10.7326/0003-4819-110-2-151; WYATT J, 1990, MED INFORM, V15, P205, DOI 10.3109/14639239009025268; ZIMAN JM, 1980, SCIENCE, V208, P369, DOI 10.1126/science.7367863	47	149	152	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	1991	338	8779					1368	1372		10.1016/0140-6736(91)92245-W	http://dx.doi.org/10.1016/0140-6736(91)92245-W			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682745				2022-12-28	WOS:A1991GR77300012
J	WALD, NJ				WALD, NJ			COUPLE SCREENING FOR CYSTIC-FIBROSIS	LANCET			English	Article											WALD, NJ (corresponding author), ST BARTHOLOMEWS HOSP,COLL MED,WOLFSON INST PREVENT MED,DEPT ENVIRONM & PREVENT MED,LONDON EC1M 6BQ,ENGLAND.		Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021					BROCK DJH, 1991, ANTENATAL DIAGNOSIS, P59; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; WALD NJ, 1989, OBSTETRICS, P269; 1988, BRIT MED J, V297, P1599	6	80	80	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1318	1320		10.1016/0140-6736(91)92605-2	http://dx.doi.org/10.1016/0140-6736(91)92605-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682697				2022-12-28	WOS:A1991GR02300016
J	HEALY, JMS; HEFFRON, JJA; LEHANE, M; BRADLEY, DG; JOHNSON, K; MCCARTHY, TV				HEALY, JMS; HEFFRON, JJA; LEHANE, M; BRADLEY, DG; JOHNSON, K; MCCARTHY, TV			DIAGNOSIS OF SUSCEPTIBILITY TO MALIGNANT HYPERTHERMIA WITH FLANKING DNA MARKERS	BRITISH MEDICAL JOURNAL			English	Article							RYANODINE RECEPTOR GENE; MYOTONIC-DYSTROPHY GENE; SARCOPLASMIC-RETICULUM; LINKAGE GROUP; CHROMOSOME-19; CALCIUM; PIGS; LOCALIZATION; CANDIDATE; RELEASE	Objective - To define the region on human chromosome 19 carrying the gene for malignant hyperthermia susceptibility and to evaluate the use of flanking DNA markers in diagnosing susceptibility. Design - Prospective molecular genetic linkage studies in a large malignant hyperthermia pedigree. Setting - Irish malignant hyperthermia testing centre. Subjects - A large Irish malignant hyperthermia pedigree. Main outcome measures - Routine diagnosis of susceptibility to malignant hyperthermia with in vitro contracture test on muscle biopsy specimens and genetic linkage between susceptibility and polymorphic DNA markers in a malignant hyperthermia family. Results - Genetic typing of polymorphic DNA markers in a large Irish malignant hyperthermia pedigree generated a lod score of > 3 for the marker D19S9 and showed that the gene for susceptibility is flanked by the markers D19S9 and D19S16. These tightly linked flanking markers allowed non-invasive presymptomatic diagnosis of susceptibility in five untested subjects in the large pedigree with an accuracy of > 99.7%. Conclusions - DNA markers flanking the gene for susceptibility to malignant hyperthermia can be used with high accuracy to diagnose susceptibility in subjects in large known malignant hyperthermia pedigrees and may replace the previous in vitro contracture test for diagnosing this inherited disorder in large families with malignant hyperthermia.	NATL UNIV IRELAND UNIV COLL CORK,DEPT BIOCHEM,CORK,IRELAND; UNIV DUBLIN TRINITY COLL,DEPT GENET,DUBLIN 2,IRELAND; CHARING CROSS & WESTMINSTER MED SCH,DEPT ANAT,LONDON W6 8RF,ENGLAND	University College Cork; Trinity College Dublin; Imperial College London			Bradley, Daniel G/A-3240-2012; Healy, Sandra J/D-5256-2013	McCarthy, Tommie/0000-0003-4884-6972; Bradley, Daniel G/0000-0001-7335-7092				BRITT BA, 1969, CAN ANAESTH SOC J, V16, P89, DOI 10.1007/BF03005788; BRITT BA, 1970, CAN ANAESTH SOC J, V17, P293, DOI 10.1007/BF03004694; BRITT BA, 1987, MALIGNANT HYPERTHERM, P325; BROOK JD, 1984, HUM GENET, V68, P282, DOI 10.1007/BF00292584; BRUNNER HG, 1989, GENOMICS, V5, P589, DOI 10.1016/0888-7543(89)90027-X; DAVIES KE, 1988, MOL BASIS INHERITED; ELLIS FR, 1985, RECENT ADV ANAESTHES, P173; ENGEL AG, 1986, MYOLOGY, V2, pR4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRONERT GA, 1986, MYOLOGY, V2, P1763; HARLEY HG, 1989, CYTOGENET CELL GENET, V51, P1011; HEFFRON JJA, 1988, BRIT J ANAESTH, V60, P274, DOI 10.1093/bja/60.3.274; Humphries S E, 1983, Mol Biol Med, V1, P463; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEVITT RC, 1990, NATURE, V345, P297, DOI 10.1038/345297b0; LEVITT RC, 1990, J NEUROL SCI S, P513; LOPEZ JR, 1985, MUSCLE NERVE, V8, P355, DOI 10.1002/mus.880080502; MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; McCarthy T V, 1990, Acta Anaesthesiol Belg, V41, P107; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MICKELSON JR, 1988, J BIOL CHEM, V263, P9310; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; OHNISHI ST, 1983, FEBS LETT, V161, P103; ORDING H, 1987, MALIGNANT HYPERTHERM, P267; OTT J, 1985, ANAL HUMAN GENETIC L; ROPERS HH, 1990, CYTOGENET CELL GENET, V55, P218, DOI 10.1159/000133015; Sambrook J, 1989, MOL CLONING LABORATO; SCHEPENS J, 1987, NUCLEIC ACIDS RES, V15, P3192, DOI 10.1093/nar/15.7.3192; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SCHONK D, 1990, HUMAN CYTOGENET CELL, V55, P1075; WAINWRIGHT BJ, 1985, NUCLEIC ACIDS RES, V13, P4610, DOI 10.1093/nar/13.12.4610; 1984, BRIT J ANAESTH, V56, P1267	36	21	21	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	NOV 16	1991	303	6812					1225	1228		10.1136/bmj.303.6812.1225	http://dx.doi.org/10.1136/bmj.303.6812.1225			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ342	1684123	Bronze, Green Published			2022-12-28	WOS:A1991GQ34200019
J	MANZ, A; BERGER, J; DWYER, JH; FLESCHJANYS, D; NAGEL, S; WALTSGOTT, H				MANZ, A; BERGER, J; DWYER, JH; FLESCHJANYS, D; NAGEL, S; WALTSGOTT, H			CANCER MORTALITY AMONG WORKERS IN CHEMICAL-PLANT CONTAMINATED WITH DIOXIN	LANCET			English	Article							HIGHER CHLORINATED DIOXINS; NON-HODGKINS LYMPHOMA; SOFT-TISSUE SARCOMA; PHENOXY HERBICIDES; POTENTIAL EXPOSURE; MALIGNANT-LYMPHOMAS; FOLLOW-UP; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN; 2,3,7,8-TCDD; COHORT	Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin or TCDD) can arise as a contaminant in the production of herbicides. It causes chloracne in those exposed to it but its human carcinogenicity has been a matter of dispute. We report here a mortality follow-up of 1583 workers (1184 men, 399 women) employed in a chemical plant in Germany that produced herbicides, including processes contaminated with TCDD. Production of TCDD was reduced from 1954 after an outbreak of chloracne. Vital status up to 1989 was determined for 97.1% of workers hired between 1952 and 1984, and 367 deaths (313 men, 54 women) were recorded. A malignant neoplasm was the underlying cause of death in 93 men and 20 women. Standardised mortality ratios (SMR) were calculated with, as references, national mortality statistics for West Germany and deaths in a cohort of male gas workers; for total cancer mortality they were 1.24 (95% confidence interval 1.00-1.52) and 1.39 (1.10-1.75), respectively, among men. Cancer mortality was increased among men with 20 or more years of employment (SMR = 1.87 [Germany) and 1.82 [gas workers]) and among men who began employment before 1955 (SMR = 1.61 and 1.87). The group with suspected highest exposure to TCDD had SMRs of 1.42 and 1.78. Only 7% of cohort women worked in the high exposure locations in the plant, compared with 39.6% of men, and no increased risk of cancer mortality was observed among women; but breast cancer mortality was raised (SRM = 2.15). These results, together with a US occupational study and a German investigation of accidental exposure, support the hypothesis that TCDD is a human carcinogen.	INST PREVENT RES, DEPT PREVENT MED, ALHAMBRA, CA USA; UNIV HAMBURG, KRANKENHAUS EPPENDORF, INST MATH & COMP SCI MED, W-2000 HAMBURG 20, GERMANY	University of Hamburg	MANZ, A (corresponding author), HAMBURG DEPT HLTH, CTR CHEM WORKERS HLTH, FUHLSBUTTLER STR 401, W-2000 HAMBURG 60, GERMANY.							BECK H, 1989, CHEMOSPHERE, V18, P507, DOI 10.1016/0045-6535(89)90161-6; BOND GG, 1989, FUND APPL TOXICOL, V12, P172, DOI 10.1016/0272-0590(89)90073-0; BOND GG, 1989, J OCCUP ENVIRON MED, V31, P121; BOYLE CA, 1989, EPIDEMIOL REV, V11, P1; Breslow N E, 1987, IARC Sci Publ, P1; BRESLOW NE, 1984, IARC SCI PUBL, V68, P431; ERIKSSON M, 1990, J NATL CANCER I, V82, P486, DOI 10.1093/jnci/82.6.486; FINGERHUT MA, 1991, NEW ENGL J MED, V324, P212, DOI 10.1056/NEJM199101243240402; FITZGERALD EF, 1989, ARCH ENVIRON HEALTH, V44, P214, DOI 10.1080/00039896.1989.9935886; HARDELL L, 1982, American Journal of Industrial Medicine, V3, P247, DOI 10.1002/ajim.4700030304; HOPKER WW, 1984, VERH D GES PATHOL, V68, P43; JOHNSON ES, 1990, FUND APPL TOXICOL, V14, P219, DOI 10.1016/0272-0590(90)90203-V; KAUNE A, 1990, DIOXINE FURANE QUELL; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; LILIENFELD DE, 1989, EPIDEMIOL REV, V11, P28, DOI 10.1093/oxfordjournals.epirev.a036044; LYNGE E, 1985, BRIT J CANCER, V52, P259, DOI 10.1038/bjc.1985.186; MANZ A, 1983, 352 BUND ANST ARB SC; OTT MG, 1987, J OCCUP ENVIRON MED, V29, P422; PEARCE NE, 1987, INT J CANCER, V39, P155, DOI 10.1002/ijc.2910390206; PERSSON B, 1989, BRIT J IND MED, V46, P516; PITOT HC, 1980, CANCER RES, V40, P3616; POLAND A, 1982, NATURE, V300, P271, DOI 10.1038/300271a0; RAO MS, 1988, CARCINOGENESIS, V9, P1677, DOI 10.1093/carcin/9.9.1677; THIESS A M, 1982, American Journal of Industrial Medicine, V3, P179, DOI 10.1002/ajim.4700030209; WIKLUND K, 1987, BRIT J CANCER, V56, P505, DOI 10.1038/bjc.1987.234; WOODS JS, 1987, J NATL CANCER I, V78, P899; Zack Judith A., 1983, HUMAN ENV RISKS CHLO, P575; Zahm S H, 1990, Epidemiology, V1, P349, DOI 10.1097/00001648-199009000-00004; ZOBER A, 1990, INT ARCH OCC ENV HEA, V62, P139, DOI 10.1007/BF00383591; 1982, DHHS NIH821765 PUBL	31	240	242	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	1991	338	8773					959	964		10.1016/0140-6736(91)91835-I	http://dx.doi.org/10.1016/0140-6736(91)91835-I			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681339				2022-12-28	WOS:A1991GK97400001
J	ULBRICHT, TLV; SOUTHGATE, DAT				ULBRICHT, TLV; SOUTHGATE, DAT			CORONARY HEART-DISEASE - 7 DIETARY FACTORS	LANCET			English	Review							UNSATURATED FATTY-ACIDS; DENSITY-LIPOPROTEIN CHOLESTEROL; PLATELET-FUNCTION; CARDIOVASCULAR-DISEASE; ARTERIAL THROMBOSIS; PLASMA-CHOLESTEROL; OLEIC-ACID; FISH OIL; LIPIDS; RATS	The dietary factors believed to be linked with the incidence of coronary heart disease are reviewed in the light of evidence with regard to their functional role, either in protection or in promotion. Detailed analysis of the evidence shows that the relations are more complex than the current lipid hypothesis suggests. It is proposed that, in particular, the polyunsaturated/saturated ratio as a measure of the propensity of the diet to influence the incidence of coronary heart disease should be replaced by indices of atherogenicity and thrombogenicity.	INST FOOD RES, NORWICH LAB, NORWICH NR4 7UA, NORFOLK, ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia								ANDERSON JW, 1990, AM J CLIN NUTR, V52, P495, DOI 10.1093/ajcn/52.3.495; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BONANOME A, 1988, NEW ENGL J MED, V318, P1244, DOI 10.1056/NEJM198805123181905; BULL NL, 1983, HUM NUTR-APPL NUTR, V37, P373; BURR ML, 1989, LANCET, V2, P757; CRAWFORD MA, 1987, SHORT COURSE POLYUNS; CROUSE JR, 1989, LANCET, V1, P318, DOI 10.1016/S0140-6736(89)91320-2; DARGIE HJ, 1989, BRIT MED J, V299, P1475, DOI 10.1136/bmj.299.6714.1475; Duthie G G, 1989, Nutr Res Rev, V2, P51, DOI 10.1079/NRR19890007; GEY KF, 1990, BIOCHEM SOC T, V18, P1041, DOI 10.1042/bst0181041; GRUNDY SM, 1986, NEW ENGL J MED, V314, P745, DOI 10.1056/NEJM198603203141204; HEGSTED DM, 1965, AM J CLIN NUTR, V17, P281; HEROLD PM, 1986, AM J CLIN NUTR, V43, P566, DOI 10.1093/ajcn/43.4.566; HORLICK L, 1959, LAB INVEST, V8, P723; HORNSTRA G, 1989, WIEN KLIN WOCHENSCHR, V101, P272; HORNSTRA G, 1975, ATHEROSCLEROSIS, V22, P499, DOI 10.1016/0021-9150(75)90029-5; KANNEL WB, 1987, JAMA-J AM MED ASSOC, V258, P1183, DOI 10.1001/jama.258.9.1183; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; KEYS A, 1965, METABOLIS, V14, P776, DOI 10.1016/0026-0495(65)90004-1; KEYS A, 1987, LANCET, V1, P983; KINSELLA JE, 1990, AM J CLIN NUTR, V52, P1; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; LAGARDE M, 1990, BIOCHEM SOC T, V18, P770, DOI 10.1042/bst0180770; LAGARDE M, 1981, Progress in Lipid Research, V20, P439, DOI 10.1016/0163-7827(81)90078-3; LUND EK, 1989, BRIT J NUTR, V62, P91, DOI 10.1079/BJN19890010; LUND EK, 1990, ROY SOC CH, V83, P296, DOI 10.1533/9781845698195.6.296; MACINTYRE DE, 1984, BLOOD, V63, P848; MALMROS H, 1957, LANCET, V2, P1; MATTSON FH, 1985, J LIPID RES, V26, P194; MCGREGOR L, 1978, THROMB RES, V12, P921, DOI 10.1016/0049-3848(78)90287-6; MCGREGOR L, 1980, LAB INVEST, V43, P438; MENSINK RP, 1990, NEW ENGL J MED, V323, P439, DOI 10.1056/NEJM199008163230703; MENSINK RP, 1989, NEW ENGL J MED, V321, P436, DOI 10.1056/NEJM198908173210705; MORRIS JN, 1977, BMJ-BRIT MED J, V2, P1307, DOI 10.1136/bmj.2.6098.1307; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; NELSON AM, 1972, GERIATRICS, V27, P103; ODEA K, 1988, LIPIDS, V23, P234, DOI 10.1007/BF02535464; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; PARTHASARATHY S, 1990, P NATL ACAD SCI USA, V87, P3894, DOI 10.1073/pnas.87.10.3894; Paul A.A., 1980, 1 SUPPLEMENT MCCANCE; RAO GHR, 1983, BIOCHEM BIOPH RES CO, V117, P549, DOI 10.1016/0006-291X(83)91235-4; RAPER NR, 1986, PROG CLIN BIOL RES, V222; REISER R, 1985, AM J CLIN NUTR, V42, P190, DOI 10.1093/ajcn/42.2.190; RENAUD S, 1986, ATHEROSCLEROSIS, V60, P37, DOI 10.1016/0021-9150(86)90085-7; Renaud S, 1969, Angiology, V20, P657, DOI 10.1177/000331976902001104; RENAUD S, 1989, J INTERN MED, V225, P39, DOI 10.1111/j.1365-2796.1989.tb01434.x; RIEMERSMA RA, 1986, BMJ-BRIT MED J, V292, P1423, DOI 10.1136/bmj.292.6533.1423; SALONEN JT, 1989, ANN MED, V21, P59, DOI 10.3109/07853898909149183; SAYNOR R, 1988, BRIT MED J, V297, P1196, DOI 10.1136/bmj.297.6657.1196; SHEPHERD J, 1978, J CLIN INVEST, V61, P1582, DOI 10.1172/JCI109078; SILMAN A, 1985, DIETARY FIBRE FIBRE; SIMONS LA, 1986, AM J CARDIOL, V57, pG5, DOI 10.1016/0002-9149(86)90659-4; SINCLAIR H, 1980, LANCET, V1, P414; SINCLAIR HM, 1956, LANCET, V270, P381; SINCLAIR HM, 1984, HUM NUTR-CLIN NUTR, V38C, P245; STROM A, 1951, LANCET, V260, P126, DOI 10.1016/S0140-6736(51)91210-X; THOROGOOD M, 1990, BRIT MED J, V300, P1297, DOI 10.1136/bmj.300.6735.1297; TUNSTALLPEDOE H, 1989, BRIT MED J, V298, P751, DOI 10.1136/bmj.298.6675.751-c; ULBRICHT TLV, 1989, DIETARY FAT CORONARY; WAHLE KWL, 1989, P PORIM INT PALM OIL, P66; WARDLAW GM, 1990, AM J CLIN NUTR, V51, P815, DOI 10.1093/ajcn/51.5.815; WATTS GF, 1988, BMJ-BRIT MED J, V296, P235, DOI 10.1136/bmj.296.6617.235; 1988, LANCET, V1, P1081; 1991, LANCET, V337, P397	64	2277	2368	5	127	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	1991	338	8773					985	992		10.1016/0140-6736(91)91846-M	http://dx.doi.org/10.1016/0140-6736(91)91846-M			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681350				2022-12-28	WOS:A1991GK97400012
J	TOMASZEWSKI, PJ; SPYT, TJ				TOMASZEWSKI, PJ; SPYT, TJ			AUTOTRANSFUSION IN OPEN-HEART-SURGERY	LANCET			English	Letter							ARTERY				TOMASZEWSKI, PJ (corresponding author), GROBY RD HOSP,CARDIOTHORAC UNIT,LEICESTER LE3 9QE,ENGLAND.							BLAUHUT B, 1991, J THORAC CARDIOV SUR, V101, P958; COSGROVE DM, 1988, J THORAC CARDIOV SUR, V95, P850; COSGROVE DM, 1985, ANN THORAC SURG, V40, P519, DOI 10.1016/S0003-4975(10)60113-0; FOX M A, 1990, Perfusion (London), V5, P21; JOYCE MH, 1990, J CARDIAC SURG, V4, P315; KOUCHOUKOS NT, 1990, ANN THORAC SURG, V49, P210, DOI 10.1016/0003-4975(90)90140-2; SETHI GK, 1990, J AM COLL CARDIOL, V15, P15, DOI 10.1016/0735-1097(90)90168-O; TAGGART DP, 1990, ANN THORAC SURG, V50, P924	8	0	0	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					820	820		10.1016/0140-6736(91)90704-S	http://dx.doi.org/10.1016/0140-6736(91)90704-S			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681185				2022-12-28	WOS:A1991GG97900036
J	DART, JKG; STAPLETON, F; MINASSIAN, D				DART, JKG; STAPLETON, F; MINASSIAN, D			CONTACT-LENSES AND OTHER RISK-FACTORS IN MICROBIAL KERATITIS	LANCET			English	Article							ULCERATIVE KERATITIS; PREDISPOSING FACTORS; CORNEAL ULCERS; DAILY-WEAR; USERS	Microbial keratitis is a potentially blinding disease that is rare in normal eyes unless associated with contact lens (CL) wear. To assess the risks of CL use, and other major causes, for keratitis, a case-control study of 91 cases of keratitis including 60 CL users was done. Relative risks (RR) and population attributable risk percentages (PAR%) for keratitis were estimated for different causes and for the different types of CL. The RR (95% confidence intervals) for CL wear was 80 (38-166) and for trauma cases 14 (6-32) compared with cases of keratitis without a predisposing condition. The PAR% for microbial keratitis attributed to CL wear was 65%. The RR for overnight wear soft lenses was 21 (7-60), for daily-wear soft lenses 3.6 (1-14), and for polymethylmethacrylate hard lenses 1.3 (0-9) compared with gas-permeable hard lenses. Continuous periods of CL wear for more than 6 days was associated with increased risk. CL wear is now the commonest cause, and has the highest risk, for new cases of microbial keratitis at Moorfields Eye Hospital. Soft CLs, especially extended-wear lenses, carry a significantly higher risk than do hard lenses for this disease.	CITY UNIV LONDON,DEPT OPTOMETRY & VISUAL SCI,LONDON EC1V 0HB,ENGLAND; INST OPHTHALMOL,DEPT PREVENT OPHTHALMOL,LONDON WC1H 9QS,ENGLAND	City University London; University of London; University College London	DART, JKG (corresponding author), MOORFIELDS EYE HOSP,DEPT CLIN OPHTHALMOL,CITY RD,LONDON EC1V 2PD,ENGLAND.		Dart, John Kenneth/GZM-7807-2022					ALFONSO E, 1986, AM J OPHTHALMOL, V101, P429, DOI 10.1016/0002-9394(86)90641-0; [Anonymous], 1980, CLASSIFICATION OCCUP; BATES A K, 1989, Eye (London), V3, P803; CHUN MW, 1987, AM J OPTOM PHYS OPT, V64, P274; DART JKG, 1988, BRIT J OPHTHALMOL, V72, P926, DOI 10.1136/bjo.72.12.926; DART JKG, 1988, T BR CONTACT LENS AS, V10, P95; FRANKS WA, 1988, BRIT MED J, V297, P524, DOI 10.1136/bmj.297.6647.524; GALENTINE PG, 1984, ARCH OPHTHALMOL-CHIC, V102, P891; HOLDEN BA, 1985, INVEST OPHTH VIS SCI, V26, P1489; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; MAYO MS, 1986, J CLIN MICROBIOL, V24, P372, DOI 10.1128/JCM.24.3.372-376.1986; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MIETTINEN OS, 1974, AM J EPIDEMIOL, V100, P515; MUSCH DC, 1983, ARCH OPHTHALMOL-CHIC, V101, P1545; ORMEROD LD, 1987, OPHTHALMOLOGY, V94, P1323; POGGIO EC, 1989, NEW ENGL J MED, V321, P779, DOI 10.1056/NEJM198909213211202; SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201; SLUSHER MM, 1987, ARCH OPHTHALMOL-CHIC, V105, P110; 1979, WHO CHRON, V33, P275; 1988, LANCET, V1, P1437	20	267	273	0	17	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					650	653		10.1016/0140-6736(91)91231-I	http://dx.doi.org/10.1016/0140-6736(91)91231-I			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679472				2022-12-28	WOS:A1991GF10500002
J	CAMPBELL, JL; KLECKNER, N				CAMPBELL, JL; KLECKNER, N			ESCHERICHIA-COLI ORIC AND THE DNAA GENE PROMOTER ARE SEQUESTERED FROM DAM METHYLTRANSFERASE FOLLOWING THE PASSAGE OF THE CHROMOSOMAL REPLICATION FORK	CELL			English	Article											CAMPBELL, JL (corresponding author), HARVARD UNIV, DEPT BIOCHEM & MOLEC BIOL, 7 DIVIN AVE, CAMBRIDGE, MA 02138 USA.				NIGMS NIH HHS [5 R01 GM25326-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATLUNG T, 1987, MOL GEN GENET, V206, P51, DOI 10.1007/BF00326535; BAKKER A, 1989, J BACTERIOL, V171, P5738, DOI 10.1128/jb.171.10.5738-5742.1989; BOYE E, 1990, CELL, V62, P981, DOI 10.1016/0092-8674(90)90272-G; BRAUN RE, 1986, MOL GEN GENET, V202, P246, DOI 10.1007/BF00331644; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; CASE CC, 1988, GENE, V72, P219, DOI 10.1016/0378-1119(88)90147-3; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; EBERLE H, 1968, J MOL BIOL, V31, P149, DOI 10.1016/0022-2836(68)90065-X; EBERLE H, 1982, MOL GEN GENET, V186, P57, DOI 10.1007/BF00422912; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; GEIER GE, 1979, J BIOL CHEM, V254, P1408; GEORGOPOULOS C, 1989, TRENDS GENET, V5, P319, DOI 10.1016/0168-9525(89)90118-2; HANSEN FG, 1982, EMBO J, V1, P1043, DOI 10.1002/j.1460-2075.1982.tb01294.x; HELMSTETTER CE, 1987, J BACTERIOL, V169, P3489, DOI 10.1128/jb.169.8.3489-3494.1987; HENDRICKSON WG, 1982, CELL, V30, P915, DOI 10.1016/0092-8674(82)90296-3; HERMAN GE, 1981, J BACTERIOL, V145, P644, DOI 10.1128/JB.145.1.644-646.1981; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; KOPPES LJH, 1987, J BACTERIOL, V169, P430, DOI 10.1128/jb.169.1.430-433.1987; KUCHERER C, 1986, MOL GEN GENET, V205, P115, DOI 10.1007/BF02428040; LANDOULSI A, 1989, MOL GEN GENET, V216, P217, DOI 10.1007/BF00334359; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LOCKSHON D, 1983, NUCLEIC ACIDS RES, V11, P2999, DOI 10.1093/nar/11.10.2999; LYONS SM, 1984, J BACTERIOL, V159, P421, DOI 10.1128/JB.159.1.421-423.1984; MAHAFFY JM, 1989, J THEOR BIOL, V140, P453, DOI 10.1016/S0022-5193(89)80109-2; MARINUS MG, 1987, ANNU REV GENET, V21, P113, DOI 10.1146/annurev.genet.21.1.113; MARINUS MG, 1984, GENE, V28, P123, DOI 10.1016/0378-1119(84)90095-7; MESSER W, 1985, EMBO J, V4, P1327, DOI 10.1002/j.1460-2075.1985.tb03780.x; MESSER W, 1988, CELL, V54, P735, DOI 10.1016/S0092-8674(88)90911-7; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; NAGATA T, 1968, COLD SPRING HARB SYM, V33, P553, DOI 10.1101/SQB.1968.033.01.062; NELSON M, 1984, NUCLEIC ACIDS RES, V12, P5165, DOI 10.1093/nar/12.13.5165; OGDEN GB, 1988, CELL, V54, P127, DOI 10.1016/0092-8674(88)90186-9; OKA A, 1980, MOL GEN GENET, V178, P9, DOI 10.1007/BF00267207; PIERUCCI O, 1989, J BACTERIOL, V171, P3760, DOI 10.1128/jb.171.7.3760-3766.1989; PUKKILA PJ, 1983, GENETICS, V104, P571; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; ROBERTS JM, 1988, CELL, V52, P397, DOI 10.1016/S0092-8674(88)80032-1; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; SCHAEFER C, 1989, EMBO J, V8, P1609, DOI 10.1002/j.1460-2075.1989.tb03545.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; SMITH DW, 1985, EMBO J, V4, P1319, DOI 10.1002/j.1460-2075.1985.tb03779.x; SUEOKA N, 1965, GENETICS, V52, P747; SZYF M, 1982, NUCLEIC ACIDS RES, V10, P7247, DOI 10.1093/nar/10.22.7247; YAMAKI H, 1988, NUCLEIC ACIDS RES, V16, P5067, DOI 10.1093/nar/16.11.5067; YIN JCP, 1988, J MOL BIOL, V199, P35, DOI 10.1016/0022-2836(88)90377-4; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	48	384	391	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	1990	62	5					967	979		10.1016/0092-8674(90)90271-F	http://dx.doi.org/10.1016/0092-8674(90)90271-F			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DY100	1697508				2022-12-28	WOS:A1990DY10000015
J	YOSHIDA, A; KAN, YW				YOSHIDA, A; KAN, YW			ORIGIN OF FUSED GLUCOSE-6-PHOSPHATE-DEHYDROGENASE	CELL			English	Note									UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT LAB MED,SAN FRANCISCO,CA 94145	Howard Hughes Medical Institute; University of California System; University of California San Francisco	YOSHIDA, A (corresponding author), CITY HOPE NATL MED CTR,BECKMAN RES INT,DEPT BIOCHEM GENET,DUARTE,CA 91010, USA.							HENIKOFF S, 1989, CELL, V58, P1021, DOI 10.1016/0092-8674(89)90498-4; KANNO H, 1989, CELL, V58, P595, DOI 10.1016/0092-8674(89)90440-6; YOSHIDA A, 1966, J BIOL CHEM, V241, P4966; YOSHIDA A, 1986, GLUCOSE 6 PHOSPHATE, P473	4	14	15	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 13	1990	62	1					11	12		10.1016/0092-8674(90)90233-5	http://dx.doi.org/10.1016/0092-8674(90)90233-5			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN533	1694726				2022-12-28	WOS:A1990DN53300005
J	TSCHUDI, C; ULLU, E				TSCHUDI, C; ULLU, E			DESTRUCTION OF U2, U4, OR U6 SMALL NUCLEAR-RNA BLOCKS TRANS SPLICING IN TRYPANOSOME CELLS	CELL			English	Article									YALE UNIV,SCH MED,YALE MACARTHUR CTR MOLEC PARASITOL,DEPT CELL BIOL,NEW HAVEN,CT 06510	Yale University	TSCHUDI, C (corresponding author), YALE UNIV,SCH MED,YALE MACARTHUR CTR MOLEC PARASITOL,DEPT INTERNAL MED,NEW HAVEN,CT 06510, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008614] Funding Source: NIH RePORTER; NIAID NIH HHS [AI08614] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; BENAMAR MF, 1988, MOL CELL BIOL, V8, P2166, DOI 10.1128/MCB.8.5.2166; BERGET SM, 1986, CELL, V46, P691, DOI 10.1016/0092-8674(86)90344-2; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; BLACK DL, 1986, CELL, V46, P697, DOI 10.1016/0092-8674(86)90345-4; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; BOOTHROYD JC, 1985, ANNU REV MICROBIOL, V39, P475, DOI 10.1146/annurev.mi.39.100185.002355; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BOZZONI I, 1984, J MOL BIOL, V180, P1173, DOI 10.1016/0022-2836(84)90276-6; BRUZIK JP, 1988, NATURE, V335, P559, DOI 10.1038/335559a0; CAMPBELL DA, 1984, NATURE, V311, P350, DOI 10.1038/311350a0; FILIPOWICZ W, 1978, FEBS LETT, V96, P1, DOI 10.1016/0014-5793(78)81049-7; FRADIN A, 1984, CELL, V37, P927, DOI 10.1016/0092-8674(84)90427-6; FREISTADT MS, 1987, NUCLEIC ACIDS RES, V15, P9861, DOI 10.1093/nar/15.23.9861; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; KOOTER JM, 1984, EMBO J, V3, P2387, DOI 10.1002/j.1460-2075.1984.tb02144.x; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; KRAMER A, 1984, CELL, V38, P299, DOI 10.1016/0092-8674(84)90551-8; LAIRD PW, 1987, EMBO J, V6, P1055, DOI 10.1002/j.1460-2075.1987.tb04858.x; LAIRD PW, 1985, NUCLEIC ACIDS RES, V13, P4253, DOI 10.1093/nar/13.12.4253; MILHAUSEN M, 1984, CELL, V38, P721, DOI 10.1016/0092-8674(84)90267-8; MOTTRAM J, 1989, MOL CELL BIOL, V9, P1212, DOI 10.1128/MCB.9.3.1212; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PERRY KL, 1987, P NATL ACAD SCI USA, V84, P8190, DOI 10.1073/pnas.84.23.8190; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; SATHER S, 1985, P NATL ACAD SCI USA, V82, P5695, DOI 10.1073/pnas.82.17.5695; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734; SUTTON RE, 1988, EMBO J, V7, P1431, DOI 10.1002/j.1460-2075.1988.tb02960.x; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; SUTTON RE, 1988, MOL CELL BIOL, V8, P494, DOI 10.1128/MCB.8.1.494; TSCHUDI C, 1986, NUCLEIC ACIDS RES, V14, P8893, DOI 10.1093/nar/14.22.8893; TSCHUDI C, 1985, P NATL ACAD SCI USA, V82, P3998, DOI 10.1073/pnas.82.12.3998; TSCHUDI C, 1988, NUCLEIC ACIDS RES, V16, P11375, DOI 10.1093/nar/16.23.11375; TSCHUDI C, 1988, EMBO J, V7, P455, DOI 10.1002/j.1460-2075.1988.tb02833.x; TSCHUDI C, 1990, IN PRESS GENE; VANDERPLOEG LHT, 1982, NUCLEIC ACIDS RES, V10, P3591, DOI 10.1093/nar/10.12.3591	40	116	118	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 4	1990	61	3					459	466		10.1016/0092-8674(90)90527-L	http://dx.doi.org/10.1016/0092-8674(90)90527-L			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC934	1692263	hybrid			2022-12-28	WOS:A1990DC93400009
J	EGUCHI, Y; TOMIZAWA, J				EGUCHI, Y; TOMIZAWA, J			COMPLEX FORMED BY COMPLEMENTARY RNA STEM-LOOPS AND ITS STABILIZATION BY A PROTEIN - FUNCTION OF COLE1 ROM PROTEIN	CELL			English	Article											EGUCHI, Y (corresponding author), NIDDKD,MOLEC BIOL LAB,BETHESDA,MD 20892, USA.							BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; CASTAGNOLI L, 1989, EMBO J, V8, P621, DOI 10.1002/j.1460-2075.1989.tb03417.x; CESARENI G, 1985, TRENDS BIOCHEM SCI, V10, P303, DOI 10.1016/0968-0004(85)90168-9; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; DOOLEY TP, 1987, PLASMID, V18, P24, DOI 10.1016/0147-619X(87)90075-8; GROSJEAN H, 1976, J MOL BIOL, V103, P499, DOI 10.1016/0022-2836(76)90214-X; HELMERCITTERICH M, 1988, EMBO J, V7, P557, DOI 10.1002/j.1460-2075.1988.tb02845.x; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; LACATENA RM, 1981, NATURE, V294, P623, DOI 10.1038/294623a0; LACATENA RM, 1983, J MOL BIOL, V170, P635, DOI 10.1016/S0022-2836(83)80125-9; LACATENA RM, 1984, CELL, V37, P4009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASUKATA H, 1987, CELL, V51, P1123, DOI 10.1016/0092-8674(87)90598-8; MASUKATA H, 1986, CELL, V44, P125, DOI 10.1016/0092-8674(86)90491-5; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MORITA M, 1979, EUR J BIOCHEM, V97, P435, DOI 10.1111/j.1432-1033.1979.tb13131.x; PEATTIE DA, 1980, P NATL ACAD SCI-BIOL, V77, P4679, DOI 10.1073/pnas.77.8.4679; SOM T, 1983, P NATL ACAD SCI-BIOL, V80, P3232, DOI 10.1073/pnas.80.11.3232; TOMIZAWA J, 1981, P NATL ACAD SCI-BIOL, V78, P1421, DOI 10.1073/pnas.78.3.1421; TOMIZAWA J, 1984, CELL, V38, P861, DOI 10.1016/0092-8674(84)90281-2; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; TOMIZAWA J, 1987, CELL, V51, P623, DOI 10.1016/0092-8674(87)90131-0; TOMIZAWA J, 1985, CELL, V40, P527, DOI 10.1016/0092-8674(85)90201-6; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; TOMIZAWA JI, 1981, P NATL ACAD SCI-BIOL, V78, P6096, DOI 10.1073/pnas.78.10.6096; TOMIZAWA JI, 1990, IN PRESS J MOL BIOL; VLASSOV VV, 1981, EUR J BIOCHEM, V119, P51, DOI 10.1111/j.1432-1033.1981.tb05575.x; WONG EM, 1985, CELL, V42, P959, DOI 10.1016/0092-8674(85)90292-2	29	116	117	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 26	1990	60	2					199	209		10.1016/0092-8674(90)90736-X	http://dx.doi.org/10.1016/0092-8674(90)90736-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CL816	1688738				2022-12-28	WOS:A1990CL81600005
J	CHO, KWY; BLUMBERG, B; STEINBEISSER, H; DEROBERTIS, EM				CHO, KWY; BLUMBERG, B; STEINBEISSER, H; DEROBERTIS, EM			MOLECULAR NATURE OF SPEMANNS ORGANIZER - THE ROLE OF THE XENOPUS HOMEOBOX GENE GOOSECOID	CELL			English	Article							RETINOIC ACID; POSITIONAL INFORMATION; INSITU HYBRIDIZATION; MESODERMAL PATTERN; DORSAL DEVELOPMENT; PROSPECTIVE AREAS; MESSENGER-RNAS; GROWTH-FACTORS; AXIS FORMATION; FROG EMBRYOS	This study analyzes the function of the homeobox gene goosecoid in Xenopus development. First, we find that goosecoid mRNA distribution closely mimics the expected localization of organizer tissue in normal embryos as well as in those treated with LiCl and UV light. Second, goosecoid mRNA accumulation is induced by activin, even in the absence of protein synthesis. it is not affected by bFGF and is repressed by retinoic acid. Lastly, microinjection of goosecoid mRNA into the ventral side of Xenopus embryos, where goosecoid is normally absent, leads to the formation of an additional complete body axis, including head structures and abundant notochordal tissue. The results suggest that the goosecoid homeodomain protein plays a central role in executing Spemann's organizer phenomenon.	UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles				De Robertis, Edward/0000-0002-7843-1869	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502, R01HD021502, F32HD007273] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD021502-13, R37 HD021502, R01 HD021502, HD 21502-06, HD 07273] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTABA AR, 1989, NATURE, V341, P33; ALTABA ARI, 1991, GENE DEV, V5, P175, DOI 10.1101/gad.5.2.175; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BLUMBERG B, 1991, SCIENCE, V253, P194, DOI 10.1126/science.1677215; BUSA WB, 1989, DEV BIOL, V132, P315, DOI 10.1016/0012-1606(89)90228-5; CHO KWY, 1988, EMBO J, V7, P2139, DOI 10.1002/j.1460-2075.1988.tb03053.x; CHO KWY, 1990, GENE DEV, V4, P1910, DOI 10.1101/gad.4.11.1910; CHO KWY, 1991, CELL, V65, P55, DOI 10.1016/0092-8674(91)90407-P; COOKE J, 1989, DEVELOPMENT, V107, P229; COOKE J, 1987, DEVELOPMENT, V101, P893; COOKE J, 1972, J EMBRYOL EXP MORPH, V28, P27; DENT JA, 1989, DEVELOPMENT, V105, P61; DEROBERTIS EM, 1991, DEVELOPMENT, V112, P669; DEROBERTIS EM, 1990, SCI AM, V263, P46, DOI 10.1038/scientificamerican0790-46; DIXON JE, 1989, DEVELOPMENT, V106, P749; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; ELINSON RP, 1989, DEV GROWTH DIFFER, V31, P423; FRITZ AF, 1989, DEV BIOL, V131, P584, DOI 10.1016/S0012-1606(89)80029-6; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GERHART J, 1989, DEVELOPMENT, V107, P37; GIMLICH RL, 1986, DEV BIOL, V115, P340, DOI 10.1016/0012-1606(86)90254-X; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Hamburger V, 1988, HERITAGE EXPT EMBRYO; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KLEIN SL, 1987, DEV BIOL, V120, P299, DOI 10.1016/0012-1606(87)90127-8; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; MELTON DA, 1991, SCIENCE, V252, P234, DOI 10.1126/science.1672778; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NIEHRS C, 1991, IN PRESS EMBO J; Nieuwkoop P D, 1973, Adv Morphog, V10, P1; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NUSSLEINVOLHARD C, 1991, DEVELOPMENT, P1; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; SAVAGE R, 1989, DEV BIOL, V133, P157, DOI 10.1016/0012-1606(89)90307-2; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIVE HL, 1991, GENE DEV, V5, P1321, DOI 10.1101/gad.5.8.1321; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; Slack J. M. W, 1991, EGG EMBRYON REGIONAL; SLACK JMW, 1989, DEVELOPMENT, V107, P141; SMITH JC, 1985, J EMBRYOL EXP MORPH, V89, P317; SMITH JC, 1989, DEVELOPMENT, V107, P149; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; SPEMANN H, 1931, ROUX ARCH ENTW MECH, V123, P389; Spemann H., 1938, EMBRYONIC DEV INDUCT; STEWART RM, 1990, DEVELOPMENT, V109, P363; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMSEN G, 1990, CELL, V63, P485, DOI 10.1016/0092-8674(90)90445-K; WOLPERT L, 1989, DEVELOPMENT, V107, P3; YUGE M, 1990, DEVELOPMENT, V110, P1051	56	740	749	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 20	1991	67	6					1111	1120		10.1016/0092-8674(91)90288-A	http://dx.doi.org/10.1016/0092-8674(91)90288-A			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GX164	1684739	Green Accepted			2022-12-28	WOS:A1991GX16400010
J	STANOJEVIC, D; SMALL, S; LEVINE, M				STANOJEVIC, D; SMALL, S; LEVINE, M			REGULATION OF A SEGMENTATION STRIPE BY OVERLAPPING ACTIVATORS AND REPRESSORS IN THE DROSOPHILA EMBRYO	SCIENCE			English	Article							GENE-EXPRESSION; GAP PROTEINS; HUNCHBACK; MORPHOGEN; PATTERNS; ELEMENTS; PROMOTER; KRUPPEL	Gene expression stripes in Drosophila melanogaster embryos provide a model for how eukaryotic promoters are turned on and off in response to combinations of transcriptional regulators. Genetic studies suggested that even-skipped (eve) stripe 2 is controlled by three gap genes, hunchback (hb), Kruppel (Kr), and giant (gt), and by the maternal morphogen bicoid (bcd). A direct link is established between binding sites for these regulatory proteins in the stripe 2 promoter element and the expression of the stripe during early embryogenesis. The bcd and hb protein binding sites mediate activation, whereas neighboring gt and Kr protein sites repress expression and establish the stripe borders. The stripe 2 clement has the properties of a genetic on-off switch.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,DEPT BIOL,BONNER HALL,LA JOLLA,CA 92093; COLUMBIA UNIV,FAIRCHILD CTR,DEPT BIOL SCI,NEW YORK,NY 10027	University of California System; University of California San Diego; Columbia University				Levine, Michael/0000-0001-7629-0081	NIGMS NIH HHS [GM 34431] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; GAUL U, 1989, DEVELOPMENT, V107, P651; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MISMER D, 1987, GENETICS, V116, P565; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STANOJEVIC D, UNPUB; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WARRIOR R, 1990, DEVELOPMENT, V110, P759	17	266	270	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1385	1387		10.1126/science.1683715	http://dx.doi.org/10.1126/science.1683715			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1683715				2022-12-28	WOS:A1991GR77700059
J	GALE, RP; BUTTURINI, A				GALE, RP; BUTTURINI, A			MAINTENANCE CHEMOTHERAPY AND CURE OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA	LANCET			English	Article							LYMPHOCYTIC-LEUKEMIA; PROGNOSTIC FACTOR; DRUG-RESISTANCE; THERAPY; CHILDREN; 6-MERCAPTOPURINE; METHOTREXATE; LYMPHOMA; CELLS	Maintenance chemotherapy with 6-mercapto-purine and methotrexate, widely believed an essential contribution to the high cure rates achieved in children with acute lymphoblastic leukaemia (ALL), is thought to work by killing the leukaemia cells that remain after intensive chemotherapy. We suggest instead that ALL commonly arises in precursor B cells normally programmed to die, and that maintenance chemotherapy does not kill these cells but controls growth of the leukaemia clone so that programmed death can occur. A similar approach may apply to other cancers in which programmed death is intrinsic to the normal counterparts of the neoplastic cells.	UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV HEMATOL & ONCOL, LOS ANGELES, CA 90024 USA; UNIV PARMA, DEPT PAEDIAT, DIV HEMATOL & ONCOL, I-43100 PARMA, ITALY	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Parma					NCI NIH HHS [CA 23175] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023175] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARLOGIE B, 1989, BLOOD, V73, P865; BEISHUIZEN A, 1991, NEW ENGL J MED, V324, P772; BORZY MS, 1989, BLOOD, V73, P1608; CHESSELLS JM, 1986, J CLIN ONCOL, V4, P1758, DOI 10.1200/JCO.1986.4.12.1758; CLAVELL LA, 1986, NEW ENGL J MED, V315, P657, DOI 10.1056/NEJM198609113151101; FREI E, 1961, BLOOD, V18, P431, DOI 10.1182/blood.V18.4.431.431; GALLAGHER RB, 1991, IMMUNOL TODAY, V12, P1, DOI 10.1016/0167-5699(91)90102-Y; GAYNON PS, 1988, LANCET, V2, P921; GOLDIE JH, 1984, CANCER RES, V44, P3643; GREAVES MF, 1988, LEUKEMIA, V2, P120; HANN IM, 1990, BRIT J HAEMATOL, V76, P359, DOI 10.1111/j.1365-2141.1990.tb06368.x; HOROWITZ MM, 1990, BLOOD, V75, P555; JERMY A, 1987, EUR J CANCER CLIN ON, V23, P1365, DOI 10.1016/0277-5379(87)90121-0; KOIZUMI S, 1988, CANCER, V61, P1292, DOI 10.1002/1097-0142(19880401)61:7<1292::AID-CNCR2820610703>3.0.CO;2-O; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; LAYWARD L, 1981, BRIT J HAEMATOL, V49, P251, DOI 10.1111/j.1365-2141.1981.tb07221.x; LENNARD L, 1990, LANCET, V336, P225, DOI 10.1016/0140-6736(90)91745-V; LONSDALE D, 1975, CANCER, V36, P341, DOI 10.1002/1097-0142(197508)36:2<341::AID-CNCR2820360208>3.0.CO;2-3; MAUER AM, 1980, BLOOD, V56, P1; MOKYR MB, 1987, CANCER INVEST, V5, P31, DOI 10.3109/07357908709020304; Osmond D G, 1990, Semin Immunol, V2, P173; PATTE C, 1986, J CLIN ONCOL, V4, P1219, DOI 10.1200/JCO.1986.4.8.1219; PETO J, 1986, LANCET, V1, P408; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; PINKEL D, 1987, CANCER, V59, P1683, DOI 10.1002/1097-0142(19870515)59:10<1683::AID-CNCR2820591002>3.0.CO;2-G; PINKEL D, 1971, CANCER-AM CANCER SOC, V27, P247, DOI 10.1002/1097-0142(197102)27:2<247::AID-CNCR2820270202>3.0.CO;2-C; POCHEDLY C, 1990, HEMATOL ONCOL CLIN N, V4, P871; RAPSON NT, 1980, BRIT J HAEMATOL, V45, P41, DOI 10.1111/j.1365-2141.1980.tb03809.x; Riehm H, 1987, Haematol Blood Transfus, V30, P139; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; SCHIMKE RT, 1978, SCIENCE, V202, P1051, DOI 10.1126/science.715457; STRYCKMANS PA, 1983, BLOOD, V62, P606; TERRY WD, 1982, IMMUNOTHERAPY HUMAN; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WHITEHEAD VM, 1990, BLOOD, V76, P44; YAMADA M, 1990, NEW ENGL J MED, V323, P448, DOI 10.1056/NEJM199008163230705	36	58	59	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	1991	338	8778					1315	1318		10.1016/0140-6736(91)92604-Z	http://dx.doi.org/10.1016/0140-6736(91)92604-Z			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682696				2022-12-28	WOS:A1991GR02300015
J	PERETZ, A; BOURDOUX, PP				PERETZ, A; BOURDOUX, PP			INHALED CORTICOSTEROIDS, BONE-FORMATION, AND OSTEOCALCIN	LANCET			English	Letter									FREE UNIV BRUSSELS,HOP ST PIERRE,DEPT NUCL MED,B-100 BRUSSELS,BELGIUM	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel	PERETZ, A (corresponding author), FREE UNIV BRUSSELS,HOP ST PIERRE,DEPT RHEUMATOL,B-100 BRUSSELS,BELGIUM.							ALI N, 1991, BRIT MED J, V302, P1080, DOI 10.1136/bmj.302.6784.1080; DELMAS PD, 1990, J BONE MINER RES, V5, P5, DOI 10.1002/jbmr.5650050104; HODSMAN AB, 1991, J CLIN ENDOCR METAB, V72, P530, DOI 10.1210/jcem-72-3-530; JENNINGS BH, 1991, EUR J CLIN PHARMACOL, V40, P77, DOI 10.1007/BF00315143; PERETZ A, 1989, J RHEUMATOL, V16, P363; POUW EM, 1991, BRIT MED J, V302, P627, DOI 10.1136/bmj.302.6777.627; TEELUCKSINGH, 1991, LANCET, V338, P60	7	9	9	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 23	1991	338	8778					1340	1340		10.1016/0140-6736(91)92648-L	http://dx.doi.org/10.1016/0140-6736(91)92648-L			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR023	1682726				2022-12-28	WOS:A1991GR02300053
J	PASTAN, I; FITZGERALD, D				PASTAN, I; FITZGERALD, D			RECOMBINANT TOXINS FOR CANCER-TREATMENT	SCIENCE			English	Article							EPIDERMAL GROWTH-FACTOR; RICIN-A-CHAIN; EXOTOXIN FUSION PROTEIN; HUMAN OVARIAN-CANCER; NUDE-MOUSE MODEL; T-CELL LEUKEMIA; PSEUDOMONAS EXOTOXIN; DIPHTHERIA-TOXIN; ESCHERICHIA-COLI; MONOCLONAL-ANTIBODIES	Recombinant toxins target cell surface receptors and antigens on tumor cells. They kill by mechanisms different from conventional chemotherapy, so that cross resistance to conventional chemotherapeutic agents should not be a problem. Furthermore, they are not mutagens and should not induce secondary malignancies or accelerate progression of benign malignancies. They can be mass-produced cheaply in bacteria as homogeneous proteins. Either growth factor-toxin fusions or antibody-toxin fusions can be chosen, depending on the cellular target.			PASTAN, I (corresponding author), NCI, DIV CANC BIOL DIAGNOSIS & CTR, MOLEC BIOL LAB, BETHESDA, MD 20892 USA.		pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270				ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; BATRA JK, 1989, P NATL ACAD SCI USA, V86, P8545, DOI 10.1073/pnas.86.21.8545; BATRA JK, 1991, MOL CELL BIOL, V11, P2200, DOI 10.1128/MCB.11.4.2200; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BLYTHMAN HE, 1981, NATURE, V290, P145, DOI 10.1038/290145a0; BRINKMANN U, 1991, P NATL ACAD SCI USA, V88, P8616, DOI 10.1073/pnas.88.19.8616; BYERS VS, 1989, CANCER RES, V49, P6153; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P1066, DOI 10.1073/pnas.87.3.1066; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P9491, DOI 10.1073/pnas.87.23.9491; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; COLOMBATTI M, 1986, J BIOL CHEM, V261, P3030; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; DURRANT LG, 1989, CLIN EXP IMMUNOL, V75, P258; FITZGERALD D, 1980, CELL, V21, P867, DOI 10.1016/0092-8674(80)90450-X; FITZGERALD D, 1989, J NATL CANCER I, V81, P1455, DOI 10.1093/jnci/81.19.1455; FitzGerald D J, 1988, Cancer Treat Res, V37, P161; FITZGERALD DJ, 1987, CANCER RES, V47, P1407; FITZGERALD DJP, 1984, J CLIN INVEST, V74, P966, DOI 10.1172/JCI111516; FRANKEL AE, 1985, J BIOL RESP MODIF, V4, P273; GHETIE MA, 1988, CANCER RES, V48, P2610; GOULD BJ, 1989, J NATL CANCER I, V81, P775, DOI 10.1093/jnci/81.10.775; GREENFIELD L, 1987, SCIENCE, V238, P536, DOI 10.1126/science.3498987; GRIFFIN TW, 1987, CANCER RES, V47, P4266; HARLEY SM, 1985, PLANT SCI, V41, P111, DOI 10.1016/0168-9452(85)90111-6; HEIMBROOK DC, 1990, P NATL ACAD SCI USA, V87, P4697, DOI 10.1073/pnas.87.12.4697; HELLSTROM KE, 1989, FASEB J, V3, P1715, DOI 10.1096/fasebj.3.6.2649402; HENDLER FJ, 1984, J CLIN INVEST, V74, P647, DOI 10.1172/JCI111463; HERTLER AA, 1988, J BIOL RESP MODIF, V7, P97; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; JINNO Y, 1988, J BIOL CHEM, V263, P13203; JONES NR, 1990, CANCER, V66, P152, DOI 10.1002/1097-0142(19900701)66:1<152::AID-CNCR2820660127>3.0.CO;2-5; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KIYOKAWA T, 1989, CANCER RES, V49, P4042; KONDO T, 1988, J BIOL CHEM, V263, P9470; KOZAK RW, 1990, J IMMUNOL, V145, P2766; KREITMAN RJ, 1990, P NATL ACAD SCI USA, V87, P8291, DOI 10.1073/pnas.87.21.8291; KROLICK KA, 1982, J EXP MED, V155, P1797, DOI 10.1084/jem.155.6.1797; LAMBERT JM, 1991, BIOCHEMISTRY-US, V30, P3234, DOI 10.1021/bi00227a011; LAU JLT, 1988, J UROLOGY, V139, P170, DOI 10.1016/S0022-5347(17)42347-0; Laurent G, 1988, Cancer Treat Res, V37, P483; LORBERBOUMGALSKI H, 1988, P NATL ACAD SCI USA, V85, P1922, DOI 10.1073/pnas.85.6.1922; MASUI H, 1989, CANCER RES, V49, P3482; MAY RD, 1991, CELL IMMUNOL, V135, P490, DOI 10.1016/0008-8749(91)90292-J; MORRIS RE, 1985, SURV SYN PATHOL RES, V4, P34; MURARO R, 1985, CANCER RES, V45, P5769; Murphy J R, 1988, Cancer Treat Res, V37, P123; NADLER LM, 1983, J IMMUNOL, V131, P244; NEVILLE D M JR, 1986, Critical Reviews in Therapeutic Drug Carrier Systems, V2, P329; NEVILLE DM, 1986, ANNU REV BIOCHEM, V55, P195, DOI 10.1146/annurev.biochem.55.1.195; OGATA M, 1988, J IMMUNOL, V141, P4224; OGATA M, 1989, P NATL ACAD SCI USA, V86, P4215, DOI 10.1073/pnas.86.11.4215; OGATA M, 1990, J BIOL CHEM, V265, P20678; OHARE M, 1990, FEBS LETT, V273, P200, DOI 10.1016/0014-5793(90)81084-2; Olsnes S, 1988, Cancer Treat Res, V37, P39; PAI LH, 1991, P NATL ACAD SCI USA, V88, P3358, DOI 10.1073/pnas.88.8.3358; PAI LH, 1991, CANCER RES; PAI LH, IN PRESS J CLIN ONCO; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PASTAN I, 1986, CELL, V47, P641, DOI 10.1016/0092-8674(86)90506-4; PASTAN I, 1991, CANCER RES, V51, P3781; PASTAN I, 1989, J BIOL CHEM, V264, P15157; PASTAN I, UNPUB; PIATAK M, 1988, J BIOL CHEM, V263, P4837; PRESS OW, 1988, J IMMUNOL, V141, P4410; PRIOR TI, 1991, CANCER RES, V51, P174; SIEGALL CB, 1990, J BIOL CHEM, V265, P16318; SIEGALL CB, 1988, P NATL ACAD SCI USA, V85, P9738, DOI 10.1073/pnas.85.24.9738; SIEGALL CB, 1991, CANCER RES, V51, P2831; SIEGALL CB, 1989, J BIOL CHEM, V264, P14256; SIEGALL CB, 1991, FASEB J, V5, P2843, DOI 10.1096/fasebj.5.13.1717336; SIEGALL CB, IN PRESS FASEB J; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; SPITLER LE, 1987, CANCER RES, V47, P1717; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; THOMPSON MR, 1991, J BIOL CHEM, V266, P2390; THORPE PE, 1984, EUR J BIOCHEM, V140, P63, DOI 10.1111/j.1432-1033.1984.tb08067.x; UCKUN FM, 1990, BLOOD, V76, P1723; VARKI NM, 1984, CANCER RES, V44, P681; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VITETTA ES, 1987, SCIENCE, V238, P1098, DOI 10.1126/science.3317828; VITETTA ES, 1991, CANCER RES, V51, P4052; WALDMANN TA, 1986, CELL IMMUNOL, V99, P53, DOI 10.1016/0008-8749(86)90215-7; WALZ G, 1989, P NATL ACAD SCI USA, V86, P9485, DOI 10.1073/pnas.86.23.9485; WEINER LM, 1989, CANCER RES, V49, P4062; WEN ZL, 1991, J BIOL CHEM, V266, P12289; WILLIAMS DP, 1987, PROTEIN ENG, V1, P493, DOI 10.1093/protein/1.6.493; WILLIAMS DP, 1990, J BIOL CHEM, V265, P20673; WILLINGHAM MC, 1987, P NATL ACAD SCI USA, V84, P2474, DOI 10.1073/pnas.84.8.2474; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5	90	293	346	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	1991	254	5035					1173	1177		10.1126/science.1683495	http://dx.doi.org/10.1126/science.1683495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1683495				2022-12-28	WOS:A1991GQ83400037
J	NOWAK, MA; ANDERSON, RM; MCLEAN, AR; WOLFS, TFW; GOUDSMIT, J; MAY, RM				NOWAK, MA; ANDERSON, RM; MCLEAN, AR; WOLFS, TFW; GOUDSMIT, J; MAY, RM			ANTIGENIC DIVERSITY THRESHOLDS AND THE DEVELOPMENT OF AIDS	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; ZIDOVUDINE; DISEASE; TYPE-1; INFECTION; EVOLUTION; MUTATIONS; NEUTRALIZATION; REPLICATION	Longitudinal studies of patients infected with HIV-1 reveal a long and variable incubation period between infection and the development of AIDS. Data from a small number of infected patients show temporal changes in the number of genetically distinct strains of the virus throughout the incubation period, with a slow but steady rise in diversity during the progression to disease. A mathematical model of the dynamic interaction between viral diversity and the human immune system suggests the existence of an antigen diversity threshold, below which the immune system is able to regulate viral population growth but above which the virus population induces the collapse of the CD4+ lymphocyte population. The model suggests that antigenic diversity is the cause, not a consequence, of immunodeficiency disease. The model is compared with available data, and is used to assess how the timing of the application of chemotherapy or immunotherapy influences the rate of progress to disease.	DEPT VIROL, HUMAN RETROVIRUS LAB, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, DEPT BIOL, LONDON SW7 2AZ, ENGLAND	Imperial College London	NOWAK, MA (corresponding author), UNIV OXFORD, DEPT ZOOL, S PARKS RD, OXFORD OX1 3PS, ENGLAND.		Nowak, Martin A/A-6977-2008	Anderson, Roy/0000-0002-9528-3175				ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; ANDERSON RM, 1989, CELL TO CELL SIGNALLING : FROM EXPERIMENTS TO THEORETICAL MODELS, P335; ASJO B, 1986, LANCET, V2, P660; BALFE P, 1990, J VIROL, V64, P6221, DOI 10.1128/JVI.64.12.6221-6233.1990; BIGGAR RJ, 1990, AIDS, V4, P1059, DOI 10.1097/00002030-199011000-00002; CASTRO BA, 1988, AIDS, V2, pS17, DOI 10.1097/00002030-198800001-00004; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; DEWOLF F, IN PRESS VIROLOGY; DEWOLF F, 1991, LANCET, V337, P389; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; DOURNON E, 1988, LANCET, V2, P1297; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; FENYO EM, 1989, AIDS, V3, pS5, DOI 10.1097/00002030-198901001-00002; FENYO EM, 1988, J VIROL, V62, P4414; FISCHL MA, 1989, JAMA-J AM MED ASSOC, V262, P2405; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; GAINES H, 1990, AIDS, V4, P995, DOI 10.1097/00002030-199010000-00008; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; GORY RF, 1989, LANCET S1, V3, P683; HAASE AT, 1986, NATURE, V322, P130, DOI 10.1038/322130a0; HAMMING RW, 1986, CODING INFORMATION T; HAVERKOS HW, 1987, J INFECT DIS, V156, P251, DOI 10.1093/infdis/156.1.251; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; LEIDER JM, 1988, J VIROL, V62, P3084, DOI 10.1128/JVI.62.9.3084-3091.1988; LEVY JA, 1990, AIDS, V4, P1051, DOI 10.1097/00002030-199011000-00001; LO SC, 1989, AM J TROP MED HYG, V41, P364, DOI 10.4269/ajtmh.1989.41.364; LOONEY DJ, 1988, SCIENCE, V241, P357, DOI 10.1126/science.3388046; LULLEY R, 1983, J GEN VIROL, V64, P1433; MAY RM, 1981, THEORETICAL ECOLOGY, pCH11; MCKEETING JA, 1989, AIDS, V4, P535; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; NOWAK M, 1989, J THEOR BIOL, V137, P375, DOI 10.1016/S0022-5193(89)80036-0; NOWAK M, 1990, NATURE, V347, P522, DOI 10.1038/347522a0; NOWAK MA, 1990, AIDS, V4, P1095, DOI 10.1097/00002030-199011000-00007; NOWAK MA, IN PRESS MATH BIOSCI; PARRY N, 1990, NATURE, V347, P569, DOI 10.1038/347569a0; PECKHAM CS, 1991, LANCET, V337, P253; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RATNER L, 1989, AIDS RES HUM RETROV, V5, P115, DOI 10.1089/aid.1989.5.115; RICHMAN DD, 1990, J ACQ IMMUN DEF SYND, V3, P743; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; SHRODA T, 1991, NATURE, V349, P167; VICKERMAN K, 1978, NATURE, V273, P613, DOI 10.1038/273613a0; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WAINHOBSON S, 1989, AIDS, V3, pS13, DOI 10.1097/00002030-198901001-00003; WOLFS TFW, 1990, P NATL ACAD SCI USA, V87, P9938, DOI 10.1073/pnas.87.24.9938; WOLFS TFW, IN PRESS VIROLOGY	52	446	453	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 15	1991	254	5034					963	969		10.1126/science.1683006	http://dx.doi.org/10.1126/science.1683006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GP883	1683006				2022-12-28	WOS:A1991GP88300033
J	WOTHERSPOON, AC; ORTIZHIDALGO, C; FALZON, MR; ISAACSON, PG				WOTHERSPOON, AC; ORTIZHIDALGO, C; FALZON, MR; ISAACSON, PG			HELICOBACTER-PYLORI-ASSOCIATED GASTRITIS AND PRIMARY B-CELL GASTRIC LYMPHOMA	LANCET			English	Note							CAMPYLOBACTER-PYLORI; IMMUNE-RESPONSE; MUCOSA; TISSUE	Although lymphoid tissue is absent in normal gastric mucosa, primary lymphomas arise in the stomach and most of these recapitulate the features of mucosa-associated lymphoid tissue (MALT). Gastric lymphoid tissue is known to be acquired in response to local infection by Helicobacter pylori, and we have confirmed this in 450 patients with H pylori-associated gastritis of whom 125 showed mucosal lymphoid follicles. In 8 patients, B lymphocytes infiltrated epithelium, which is a feature characteristic of MALT. We also examined 110 cases of gastric MALT lymphoma and found H pylori infection in 101 of these (92%). We conclude that gastric MALT is acquired in H pylori infection and that this provides the necessary background in which MALT lymphoma might develop.	UNIV COLL & MIDDLESEX SCH MED,DEPT HISTOPATHOL,UNIV ST,LONDON WC1E 6JJ,ENGLAND	University of London; University College London								CHAN JKC, 1990, AM J PATHOL, V136, P1153; CRABTREE JE, 1991, LANCET, P332; HYJEK E, 1988, HUM PATHOL, V19, P766, DOI 10.1016/S0046-8177(88)80259-4; HYJEK E, 1988, HUM PATHOL, V19, P1315, DOI 10.1016/S0046-8177(88)80287-9; ISAACSON PG, 1987, HISTOPATHOLOGY, V11, P445, DOI 10.1111/j.1365-2559.1987.tb02654.x; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; SHALLCROSS TM, 1989, CAMPYLOBACTER PYLORI, P155; SPENCER JO, 1986, GUT, V27, P405, DOI 10.1136/gut.27.4.405; STOLTE M, 1989, J CLIN PATHOL, V42, P1269, DOI 10.1136/jcp.42.12.1269; WYATT JI, 1988, SCAND J GASTROENTERO, V23, P44, DOI 10.3109/00365528809091712; WYATT JI, 1991, SEMIN DIAGN PATHOL, V8, P137	11	1539	1582	2	30	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1175	1176		10.1016/0140-6736(91)92035-Z	http://dx.doi.org/10.1016/0140-6736(91)92035-Z			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682595				2022-12-28	WOS:A1991GP03400007
J	HENDERSON, AF; GREGOIRE, AJP; KUMAR, RC				HENDERSON, AF; GREGOIRE, AJP; KUMAR, RC			TREATMENT OF SEVERE POSTNATAL DEPRESSION WITH ESTRADIOL SKIN PATCHES	LANCET			English	Letter							DISORDERS; IMPLANTS		INST PSYCHIAT,LONDON SE5,ENGLAND		HENDERSON, AF (corresponding author), DULWICH HOSP,MENOPAUSE CLIN,LONDON SE22 8PT,ENGLAND.							COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; DEAKIN JFW, 1988, MOTHERHOOD MENTAL IL, V2, P113; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; MAGOS AL, 1986, BMJ-BRIT MED J, V292, P1629, DOI 10.1136/bmj.292.6536.1629; MONTGOMERY JC, 1987, LANCET, V1, P297; STUDD JWW, 1990, BRIT MED J, V300, P1653, DOI 10.1136/bmj.300.6740.1653-a; WATSON NR, 1989, LANCET, V1, P730; WIECK A, IN PRESS BR MED J	8	38	38	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					816	817		10.1016/0140-6736(91)90697-N	http://dx.doi.org/10.1016/0140-6736(91)90697-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG979	1681178				2022-12-28	WOS:A1991GG97900028
J	KLEUSS, C; HESCHELER, J; EWEL, C; ROSENTHAL, W; SCHULTZ, G; WITTIG, B				KLEUSS, C; HESCHELER, J; EWEL, C; ROSENTHAL, W; SCHULTZ, G; WITTIG, B			ASSIGNMENT OF G-PROTEIN SUBTYPES TO SPECIFIC RECEPTORS INDUCING INHIBITION OF CALCIUM CURRENTS	NATURE			English	Article							GTP-BINDING-PROTEIN; PITUITARY CELL-LINE; ANTI-SENSE RNA; MESSENGER-RNA; ALPHA-SUBUNIT; MOLECULAR-CLONING; GENETIC-ANALYSIS; 2 FORMS; ANTISENSE; CHANNELS	The inhibition of voltage-dependent Ca2+ channels in secretory cells by plasma membrane receptors is mediated by pertussis toxin-sensitive G proteins. Multiple forms of G proteins have been described, differing principally in their alpha-subunits, but it has not been possible to establish which G-protein subtype mediates inhibition by a specific receptor. By intranuclear injection of antisense oligonucleotides into rat pituitary GH3 cells, the essential role of the G(o)-type G proteins in Ca2+-channel inhibition is established: the subtypes G(o1) and G(o2) mediate inhibition through the muscarinic and somatostatin receptors, respectively.	FREE UNIV BERLIN, INST PHARMAKOL, W-1000 BERLIN 33, GERMANY	Free University of Berlin	KLEUSS, C (corresponding author), FREE UNIV BERLIN, INST MOLEK BIOL & BIOCHEM, ARNIMALLEE 22, W-1000 BERLIN 33, GERMANY.							ASANO T, 1988, J NEUROCHEM, V50, P1164, DOI 10.1111/j.1471-4159.1988.tb10588.x; BERTRAND P, 1990, J BIOL CHEM, V265, P18576; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BIRNBAUMER LA, 1990, REV PHARM TOX, V30, P675; CAZENAVE C, 1989, NUCLEIC ACIDS RES, V17, P4255, DOI 10.1093/nar/17.11.4255; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; COLLU R, 1988, ENDOCRINOLOGY, V122, P1176, DOI 10.1210/endo-122-3-1176; CORNISHBOWDEN A, 1985, EUR J BIOCHEM, V150, P1; DREYER C, 1982, ROUX ARCH DEV BIOL, V191, P228, DOI 10.1007/BF00848409; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; FINDLAY J, 1990, TRENDS PHARMACOL SCI, V11, P492, DOI 10.1016/0165-6147(90)90050-I; GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; GREEN PJ, 1986, ANNU REV BIOCHEM, V55, P569, DOI 10.1146/annurev.bi.55.070186.003033; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRISWARRICK RM, 1988, NEURON, V1, P27, DOI 10.1016/0896-6273(88)90206-1; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HSU WH, 1990, J BIOL CHEM, V265, P11220; IZANT JG, 1984, CELL, V36, P1007, DOI 10.1016/0092-8674(84)90050-3; JACKSON DA, 1988, J CELL SCI, V90, P365; JONES DT, 1987, J BIOL CHEM, V262, P14241; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MATTERA R, 1989, J BIOL CHEM, V264, P465; MCFADZEAN I, 1989, NEURON, V3, P177, DOI 10.1016/0896-6273(89)90030-5; MINSHULL J, 1986, NUCLEIC ACIDS RES, V14, P6433, DOI 10.1093/nar/14.16.6433; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; OFFERMANNS S, 1991, J BIOL CHEM, V266, P3365; OFFERMANNS S, 1989, EUR J BIOCHEM, V180, P283, DOI 10.1111/j.1432-1033.1989.tb14645.x; OFFERMANNS S, 1991, MOL ENDOCRINOL, V5, P995, DOI 10.1210/mend-5-7-995; PAULSSEN EJ, 1991, MOL CELL ENDOCRINOL, V76, P45, DOI 10.1016/0303-7207(91)90258-T; ROSENTHAL W, 1988, EMBO J, V7, P1627, DOI 10.1002/j.1460-2075.1988.tb02989.x; SCHULTZ G, 1990, ANNU REV PHYSIOL, V52, P275, DOI 10.1146/annurev.ph.52.030190.001423; SHUTTLEWORTH J, 1988, EMBO J, V7, P427, DOI 10.1002/j.1460-2075.1988.tb02830.x; SILBERT S, 1990, J BIOL CHEM, V265, P3102; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; TOSELLI M, 1989, PFLUG ARCH EUR J PHY, V415, P255, DOI 10.1007/BF00370874; TSUKAMOTO T, 1991, P NATL ACAD SCI USA, V88, P2974, DOI 10.1073/pnas.88.8.2974; WEINTRAUB H, 1985, TRENDS GENET, V1, P22, DOI 10.1016/0168-9525(85)90010-1; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280	47	562	563	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	1991	353	6339					43	48		10.1038/353043a0	http://dx.doi.org/10.1038/353043a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD805	1679199				2022-12-28	WOS:A1991GD80500050
J	KATAYANAGI, K; MIYAGAWA, M; MATSUSHIMA, M; ISHIKAWA, M; KANAYA, S; IKEHARA, M; MATSUZAKI, T; MORIKAWA, K				KATAYANAGI, K; MIYAGAWA, M; MATSUSHIMA, M; ISHIKAWA, M; KANAYA, S; IKEHARA, M; MATSUZAKI, T; MORIKAWA, K			3-DIMENSIONAL STRUCTURE OF RIBONUCLEASE-H FROM ESCHERICHIA-COLI	NATURE			English	Article									PROT ENGN RES INST,SUITA,OSAKA 565,JAPAN; MITSUBISHI KASEI CORP,CENT RES LABS,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN									ARNI R, 1988, J BIOL CHEM, V263, P15358; ARNONE A, 1971, J BIOL CHEM, V246, P2302; CARLISLE CH, 1974, J MOL BIOL, V85, P1, DOI 10.1016/0022-2836(74)90125-9; Crouch R. J., 1982, NUCLEASES, P211; DASGUPTA S, 1987, CELL, V51, P1113, DOI 10.1016/0092-8674(87)90597-6; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANAYA S, 1989, J BIOL CHEM, V264, P11546; KANAYA S, 1983, J BIOL CHEM, V258, P1276; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; MATTHEWS BW, 1988, NATURE, V335, P294, DOI 10.1038/335294a0; MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0; NAKAMURA H, 1987, J PHYS SOC JPN, V56, P1609, DOI 10.1143/JPSJ.56.1609; NISHIKAWA K, 1972, J PHYS SOC JPN, V32, P1331, DOI 10.1143/JPSJ.32.1331; OEFNER C, 1986, J MOL BIOL, V192, P605, DOI 10.1016/0022-2836(86)90280-9; RICHARDS FM, 1971, ENZYMES, V4, P647; STEIGEMANN W, 1974, THESIS TU MUNCHEN; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0; SUCK D, 1984, EMBO J, V3, P2423, DOI 10.1002/j.1460-2075.1984.tb02149.x; SUGIO S, 1988, J BIOCHEM-TOKYO, V103, P354, DOI 10.1093/oxfordjournals.jbchem.a122274; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617	26	332	340	1	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 20	1990	347	6290					306	309		10.1038/347306a0	http://dx.doi.org/10.1038/347306a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ452	1698262				2022-12-28	WOS:A1990DZ45200068
J	DHALLAN, RS; YAU, KW; SCHRADER, KA; REED, RR				DHALLAN, RS; YAU, KW; SCHRADER, KA; REED, RR			PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION OF A CYCLIC NUCLEOTIDE-ACTIVATED CHANNEL FROM OLFACTORY NEURONS	NATURE			English	Article									JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT NEUROSCI,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOMED ENGN,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University								DHALLAN RS, 1990, BIOPHYS J, V57, pA367; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES LW, 1990, BIOPHYS J, V57, pA366; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; JONES DT, 1988, COLD SPRING HARB SYM, V53, P349, DOI 10.1101/SQB.1988.053.01.042; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES DT, 1989, SCIENCE, V244, P730; JURAHASHI T, 1989, J PHYS LOND, V419, P177; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOCH KW, 1985, J BIOL CHEM, V260, P6788; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; PFEUFFER E, 1989, J BIOL CHEM, V264, P18803; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TANAKA JC, 1989, BIOCHEMISTRY-US, V28, P2776, DOI 10.1021/bi00433a006; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	24	558	576	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 13	1990	347	6289					184	187		10.1038/347184a0	http://dx.doi.org/10.1038/347184a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY352	1697649				2022-12-28	WOS:A1990DY35200063
J	CHEONG, CJ; VARANI, G; TINOCO, I				CHEONG, CJ; VARANI, G; TINOCO, I			SOLUTION STRUCTURE OF AN UNUSUALLY STABLE RNA HAIRPIN, 5'GGAC(UUCG)GUCC	NATURE			English	Article									UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720; UNIV CALIF BERKELEY,CHEM BIODYNAM LAB,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley			Cheong, Chaejoon/GWC-3135-2022					ALTONA C, 1982, RECL TRAV CHIM PAY B, V101, P413; BLOMMERS MJJ, 1989, BIOCHEMISTRY-US, V28, P7491, DOI 10.1021/bi00444a049; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; CHATTOPADHYAYA R, 1988, NATURE, V334, P175, DOI 10.1038/334175a0; CHEONG C, 1989, THESIS U CALIFORNIA; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; FREY MH, 1985, BIOPOLYMERS, V24, P2371, DOI 10.1002/bip.360241214; GORENSTEIN D, 1984, 31P NMR PRINCIPLES A; GROEBE DR, 1988, NUCLEIC ACIDS RES, V16, P11725, DOI 10.1093/nar/16.24.11725; HARE DR, 1986, BIOCHEMISTRY-US, V25, P5341, DOI 10.1021/bi00366a053; KIM SH, 1973, SCIENCE, V179, P285, DOI 10.1126/science.179.4070.285; KOLLMAN PA, 1981, BIOPOLYMERS, V20, P2583, DOI 10.1002/bip.1981.360201208; LANKHORST PP, 1984, J BIOMOL STRUCT DYN, V1, P1387, DOI 10.1080/07391102.1984.10507527; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; SAENGER W, 1984, PRINCIPLES NUCLEIC A; SKLENAR V, 1986, FEBS LETT, V208, P94, DOI 10.1016/0014-5793(86)81539-3; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; VARANI G, 1989, BIOCHEMISTRY-US, V28, P7760, DOI 10.1021/bi00445a036; WILLIAMSON JR, 1989, BIOCHEMISTRY-US, V28, P2819, DOI 10.1021/bi00433a012; WITHERELL GW, 1989, BIOCHEMISTRY-US, V28, P71, DOI 10.1021/bi00427a011; Wuthrich K., 1986, NMR PROTEINS NUCL AC	22	415	423	0	22	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 16	1990	346	6285					680	682		10.1038/346680a0	http://dx.doi.org/10.1038/346680a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU728	1696688				2022-12-28	WOS:A1990DU72800070
J	FABISZEWSKI, KJ; VOLICER, B; VOLICER, L				FABISZEWSKI, KJ; VOLICER, B; VOLICER, L			EFFECT OF ANTIBIOTIC-TREATMENT ON OUTCOME OF FEVERS IN INSTITUTIONALIZED ALZHEIMER PATIENTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									EDITH NOURSE ROGERS MEM VET ADM HOSP,CTR GERIATR RES EDUC & CLIN CTR,200 SPRINGS RD,BEDFORD,MA 01730; UNIV LOWELL,LOWELL,MA 01854; BOSTON UNIV,SCH MED,DEPT PHARMACOL,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT MED,BOSTON,MA 02118	Geriatric Research Education & Clinical Center; University of Massachusetts System; University of Massachusetts Lowell; Boston University; Boston University; Boston University			Volicer, Ladislav/K-7576-2019	Volicer, Ladislav/0000-0002-6939-7531				Beauchamp TLC, 2019, PRINCIPLES BIOMEDICA; BERKSON J, 1950, P STAFF M MAYO CLIN, V25, P270; ELLSWOERTH RB, 1971, MACC BEHAVIORAL ADJU; FABISZEWSKI KJ, 1988, CLIN MANAGEMENT ALZH, P87; FILICE GA, 1989, ARCH INTERN MED, V149, P319, DOI 10.1001/archinte.149.2.319; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HURLEY A, 1989, GERNTOLOGIST, V29, pA147; JACOBY GA, 1973, NEW ENGL J MED, V289, P1407, DOI 10.1056/NEJM197312272892607; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; LEE E T, 1972, Computer Programs in Biomedicine, V2, P315, DOI 10.1016/0010-468X(72)90019-0; LIPSKY BA, 1989, ANN INTERN MED, V110, P138, DOI 10.7326/0003-4819-110-2-138; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; PARULKAR BG, 1988, SURG CLIN N AM, V68, P945; VOLICER L, 1986, J AM GERIATR SOC, V34, P655, DOI 10.1111/j.1532-5415.1986.tb04907.x; VOLICER L, 1986, JAMA-J AM MED ASSOC, V256, P2210, DOI 10.1001/jama.256.16.2210; VOLICER L, 1988, AM J ALZHEIM CARE, V3, P11; Volicer L., 1987, J APPLIED GERONTOLOG, V6, P83, DOI DOI 10.1177/073346488700600107; VOLICER L, 1988, CLIN MANAGEMENT ALZH, P167; VOLICER L, 1989, J GERIATR PSYCHIAT, V2, P169; WANZER SH, 1984, NEW ENGL J MED, V310, P955, DOI 10.1056/NEJM198404123101505; 1989, ARCH INTERN MED, V149, P1036	22	112	112	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	1990	263	23					3168	3172		10.1001/jama.263.23.3168	http://dx.doi.org/10.1001/jama.263.23.3168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ231	1693407				2022-12-28	WOS:A1990DJ23100028
J	SOFRONIEW, MV; GALLETLY, NP; ISACSON, O; SVENDSEN, CN				SOFRONIEW, MV; GALLETLY, NP; ISACSON, O; SVENDSEN, CN			SURVIVAL OF ADULT BASAL FOREBRAIN CHOLINERGIC NEURONS AFTER LOSS OF TARGET NEURONS	SCIENCE			English	Article											SOFRONIEW, MV (corresponding author), UNIV CAMBRIDGE,DEPT ANAT,CAMBRIDGE CB2 3DY,ENGLAND.			Isacson, Ole/0000-0001-8091-8302	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; ANDERSON KJ, 1988, NATURE, V332, P360, DOI 10.1038/332360a0; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; ARENDT T, 1985, NEUROSCIENCE, V14, P1, DOI 10.1016/0306-4522(85)90160-5; AYERLELIEVRE C, 1988, SCIENCE, V240, P1339, DOI 10.1126/science.2897715; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BJERRE B, 1975, BRAIN RES, V94, P263, DOI 10.1016/0006-8993(75)90061-X; CAMPENOT RB, 1981, SCIENCE, V214, P579, DOI 10.1126/science.7292000; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7; GAHWILER BH, 1987, NEUROSCI LETT, V75, P6, DOI 10.1016/0304-3940(87)90066-8; GOEDERT M, 1986, MOL BRAIN RES, V1, P85, DOI 10.1016/0169-328X(86)90023-9; GOLDSCHMIDT RB, 1980, J COMP NEUROL, V189, P359, DOI 10.1002/cne.901890210; HARTIKKA J, 1988, J NEUROSCI, V8, P2967; HEFTI F, 1985, NEUROSCIENCE, V14, P55, DOI 10.1016/0306-4522(85)90163-0; HEFTI F, 1986, J NEUROSCI, V6, P2155; HEFTI F, 1983, ANN NEUROL, V13, P109, DOI 10.1002/ana.410130127; JOHNSON EM, 1986, TRENDS NEUROSCI, V9, P33, DOI 10.1016/0166-2236(86)90012-3; KALEN P, 1989, EXP BRAIN RES, V75, P401; KORSCHING S, 1986, TRENDS NEUROSCI, V9, P570, DOI 10.1016/0166-2236(86)90179-7; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LAMS BE, 1988, BRAIN RES, V475, P401, DOI 10.1016/0006-8993(88)90635-X; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; LINDSAY RM, 1979, NATURE, V282, P80, DOI 10.1038/282080a0; NIETOSAMPEDRO M, 1984, P NATL ACAD SCI-BIOL, V81, P6250, DOI 10.1073/pnas.81.19.6250; OTTO D, 1989, J NEUROSCI RES, V22, P83, DOI 10.1002/jnr.490220111; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PEARSON RCA, 1983, BRAIN RES, V289, P375, DOI 10.1016/0006-8993(83)90046-X; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; SCHEFF S, 1977, SCIENCE, V197, P795, DOI 10.1126/science.887924; Sofroniew M V, 1988, J Chem Neuroanat, V1, P327; SOFRONIEW MV, 1987, BRAIN RES, V411, P310, DOI 10.1016/0006-8993(87)91084-5; SOFRONIEW MV, IN PRESS BRAIN RES; SWANSON LW, 1987, HDB CHEM NEUROANAT 1, V5; VILLEGAS-PEREZ M P, 1988, Society for Neuroscience Abstracts, V14, P673; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231	43	257	257	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 19	1990	247	4940					338	342		10.1126/science.1688664	http://dx.doi.org/10.1126/science.1688664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ669	1688664				2022-12-28	WOS:A1990CJ66900042
J	MEEK, TD; LAMBERT, DM; DREYER, GB; CARR, TJ; TOMASZEK, TA; MOORE, ML; STRICKLER, JE; DEBOUCK, C; HYLAND, LJ; MATTHEWS, TJ; METCALF, BW; PETTEWAY, SR				MEEK, TD; LAMBERT, DM; DREYER, GB; CARR, TJ; TOMASZEK, TA; MOORE, ML; STRICKLER, JE; DEBOUCK, C; HYLAND, LJ; MATTHEWS, TJ; METCALF, BW; PETTEWAY, SR			INHIBITION OF HIV-1 PROTEASE IN INFECTED LYMPHOCYTES-T BY SYNTHETIC PEPTIDE ANALOGS	NATURE			English	Article									SK&F LABS,DEPT ANTIINFECT,KING OF PRUSSIA,PA 19406; SK&F LABS,DEPT PEPTIDE CHEM,KING OF PRUSSIA,PA 19406; SK&F LABS,DEPT MACROMOLEC SCI,KING OF PRUSSIA,PA 19406; SK&F LABS,DEPT MOLEC GENET,KING OF PRUSSIA,PA 19406; DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710	Duke University	MEEK, TD (corresponding author), SK&F LABS,DEPT MED CHEM,709 SWEDELAND RD,KING OF PRUSSIA,PA 19406, USA.							CRAWFORD S, 1985, J VIROL, V53, P899, DOI 10.1128/JVI.53.3.899-907.1985; DARKE PL, 1988, BIOCHEM BIOPH RES CO, V156, P297, DOI 10.1016/S0006-291X(88)80839-8; DEBOUCK C, 1987, P NATL ACAD SCI USA, V84, P8903, DOI 10.1073/pnas.84.24.8903; DREYER GB, IN PRESS P NATN ACAD; GALLO RC, 1988, SCI AM, V259, P40, DOI 10.1038/scientificamerican1088-40; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; HENDERSON LE, 1987, HUMAN RETROVIRUSES C, P135; HOLLADAY MW, 1987, J MED CHEM, V30, P374, DOI 10.1021/jm00385a020; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; KATOH I, 1985, VIROLOGY, V145, P280, DOI 10.1016/0042-6822(85)90161-8; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT DM, 1983, VIROLOGY, V130, P204, DOI 10.1016/0042-6822(83)90128-9; MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424; MEEK TD, 1989, P NATL ACAD SCI USA, V86, P1841, DOI 10.1073/pnas.86.6.1841; MERVIS RJ, 1988, J VIROL, V62, P3993, DOI 10.1128/JVI.62.11.3993-4002.1988; MOORE ML, 1989, BIOCHEM BIOPH RES CO, V159, P420, DOI 10.1016/0006-291X(89)90008-9; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SEELMEIER S, 1988, P NATL ACAD SCI USA, V85, P6612, DOI 10.1073/pnas.85.18.6612; Szelke M., 1983, PEPTIDES STRUCTURE F, P579; VERONESE FD, 1988, J VIROL, V62, P795, DOI 10.1128/JVI.62.3.795-801.1988; VERONESE FD, 1987, AIDS RES HUM RETROV, V3, P253, DOI 10.1089/aid.1987.3.253; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279	30	247	326	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					90	92		10.1038/343090a0	http://dx.doi.org/10.1038/343090a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1688646				2022-12-28	WOS:A1990CG61400063
J	MEDAWAR, C; RASSABY, E				MEDAWAR, C; RASSABY, E			TRIAZOLAM OVERDOSE, ALCOHOL, AND MANSLAUGHTER	LANCET			English	Editorial Material											MEDAWAR, C (corresponding author), SOCIAL AUDIT LTD,BOX 111,LONDON NW1 8XG,ENGLAND.							BRAHAMS D, 1991, LANCET, V338, P502, DOI 10.1016/0140-6736(91)90565-7; Greenblatt D J, 1982, Int Pharmacopsychiatry, V17 Suppl 2, P70; TRAPPLER B, 1982, CAN MED ASSOC J, V126, P893	3	5	5	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1515	1516		10.1016/0140-6736(91)92320-2	http://dx.doi.org/10.1016/0140-6736(91)92320-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683931				2022-12-28	WOS:A1991GV07700019
J	MAKI, M; HOLM, K; LIPSANEN, V; HALLSTROM, O; VIANDER, M; COLLIN, P; SAVILAHTI, E; KOSKIMIES, S				MAKI, M; HOLM, K; LIPSANEN, V; HALLSTROM, O; VIANDER, M; COLLIN, P; SAVILAHTI, E; KOSKIMIES, S			SEROLOGICAL MARKERS AND HLA GENES AMONG HEALTHY 1ST-DEGREE RELATIVES OF PATIENTS WITH CELIAC-DISEASE	LANCET			English	Article							CHILDHOOD CELIAC-DISEASE; IGA-CLASS RETICULIN; DERMATITIS-HERPETIFORMIS; ANTIGLIADIN ANTIBODIES; SERUM IGA; ADULTS	Coeliac disease may remain undiagnosed because of the non-specific nature of the presenting symptoms. Several antibody tests are claimed as markers for this condition but a direct comparison of the available tests has not been reported. The probands and healthy first-degree relatives of 42 families with coeliac disease were studied. Histological examination of biopsy specimens revealed jejunal mucosal villous atrophy compatible with coeliac disease in 13 of 122 relatives. Reticulin-antibody-positive relatives with or without jejunal mucosal atrophy were genetically similar to the probands of the families (DR3 gene frequencies 55.3%-60.0%). Gliadin-antibody-positive relatives with normal mucosa were genetically different from the probands (DR3 gene frequency 16.7% versus 55.3%). IgA reticulin and endomysium antibodies detected 92.3% of subjects with silent coeliac disease. The only case that was missed had selective IgA deficiency and was positive for IgG-class reticulin antibodies. By contrast, gliadin antibodies detected only half of the cases. Follow-up of the 7 reticulin-antibody-positive relatives with normal mucosa revealed 2 further cases of coeliac disease and 1 of dermatitis herpetiformis during the next three years. Our family study shows that healthy reticulin-antibody-positive first-degree relatives of coeliac disease patients, irrespective of the state of the jejunal mucosa, are genetically similar to known coeliac disease patients. Reticulin-antibody positivity is an indicator of both silent and latent coeliac disease.	FINNISH RED CROSS & BLOOD TRANSFUS SERV, BLOOD TRANSFUS SERV, HELSINKI, FINLAND; UNIV TURKU, DEPT MICROBIOL, SF-20500 TURKU 50, FINLAND; UNIV HELSINKI, BIOCHEM PHARMACOL, SF-00100 HELSINKI 10, FINLAND	University of Turku; University of Helsinki	MAKI, M (corresponding author), UNIV TAMPERE, DEPT CLIN SCI, TEISKONTIE 35, POB 607, SF-33101 TAMPERE, FINLAND.							AMOS DB, 1969, TRANSPLANTATION, V7, P220, DOI 10.1097/00007890-196903000-00023; BEUTNER EH, 1989, NEW ENGL J MED, V320, P1087; BURGINWOLFF A, 1990, SEROLOGIC DIAGNOSIS, P58; CHORZELSKI TP, 1984, BRIT J DERMATOL, V111, P395, DOI 10.1111/j.1365-2133.1984.tb06601.x; COLLIN P, 1990, SCAND J GASTROENTERO, V25, P245, DOI 10.1080/00365521.1990.12067098; DUPONT B, 1989, IMMUNOBIOLOGY HLA IM, V2; FREEMAN HJ, 1986, GASTROENTEROLOGY, V90, P1992, DOI 10.1016/0016-5085(86)90272-6; GRODZINSKY E, 1990, INT ARCH ALLER A IMM, V92, P119, DOI 10.1159/000235201; HALLSTROM O, 1989, GUT, V30, P1225, DOI 10.1136/gut.30.9.1225; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; MACDONALD WC, 1965, NEW ENGL J MED, V272, P448, DOI 10.1056/NEJM196503042720903; MAKI M, 1984, J PEDIATR-US, V105, P901, DOI 10.1016/S0022-3476(84)80074-8; MAKI M, 1991, LANCET, V338, P724, DOI 10.1016/0140-6736(91)91445-Z; MAKI M, 1988, ACTA PAEDIATR SCAND, V77, P408, DOI 10.1111/j.1651-2227.1988.tb10668.x; MAKI M, IN PRESS GUT; SAVILAHTI E, 1983, LANCET, V1, P320; SCOTT H, 1990, SCAND J GASTROENTERO, V25, P287, DOI 10.1080/00365521.1990.12067105; STOKES PL, 1976, Q J MED, V45, P567; VOLTA U, 1990, CLIN EXP IMMUNOL, V80, P192, DOI 10.1111/j.1365-2249.1990.tb05232.x	20	174	176	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	1991	338	8779					1350	1353		10.1016/0140-6736(91)92234-S	http://dx.doi.org/10.1016/0140-6736(91)92234-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682735				2022-12-28	WOS:A1991GR77300002
J	PEPKEZABA, J; HIGENBOTTAM, TW; DINHXUAN, AT; STONE, D; WALLWORK, J				PEPKEZABA, J; HIGENBOTTAM, TW; DINHXUAN, AT; STONE, D; WALLWORK, J			INHALED NITRIC-OXIDE AS A CAUSE OF SELECTIVE PULMONARY VASODILATATION IN PULMONARY-HYPERTENSION	LANCET			English	Note								The acute effects of inhaled nitric oxide (NO) (40 ppm in air) on pulmonary (PVR) and systemic (SVR) vascular resistance were compared with those of an intravenous infusion of prostacyclin (24-mu-g/h) in 8 patients with severe pulmonary hypertension and 10 cardiac patients with normal values of PVR. 10 healthy volunteers were studied non-invasively. In the patients with pulmonary hypertension, PVR fell significantly after inhaled NO and after prostacyclin. PVR also fell significantly in the cardiac patients after inhaled NO. Although SVR fell substantially after prostacyclin in patients with pulmonary hypertension, inhaled NO had no effect on SVR in any patient or volunteer. Inhaled NO therefore seems to be both a selective and effective pulmonary vasodilator.	PAPWORTH HOSP,DEPT RESP PHYSIOL,CAMBRIDGE CB3 8RE,ENGLAND; PAPWORTH HOSP,DEPT CARDIOL,CAMBRIDGE CB3 8RE,ENGLAND; PAPWORTH HOSP,DEPT CARDIOTHORAC SURG,CAMBRIDGE CB3 8RE,ENGLAND	Papworth Hospital; Papworth Hospital; Papworth Hospital			Pepke-Zaba, Joanna/AGW-3073-2022; DINH-XUAN, Anh Tuan/A-9691-2008	DINH-XUAN, Anh Tuan/0000-0001-8651-5176				BORLAND C, 1985, ARCH ENVIRON HEALTH, V40, P330, DOI 10.1080/00039896.1985.10545943; BORLAND CDR, 1989, EUR RESPIR J, V2, P56; DINHXUAN AT, 1991, NEW ENGL J MED, V324, P1539, DOI 10.1056/NEJM199105303242203; FROSTELL C, 1991, CIRCULATION, V83, P2038, DOI 10.1161/01.CIR.83.6.2038; GIBSON QH, 1957, J PHYSIOL-LONDON, V136, P507, DOI 10.1113/jphysiol.1957.sp005777; JONES DK, 1987, BRIT HEART J, V57, P270; MEYER M, 1989, EUR RESPIR J, V2, P494; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; REEVES JT, 1986, AM REV RESPIR DIS, V134, P342; YOSHIDA K, 1980, INT ARCH OCC ENV HEA, V46, P71, DOI 10.1007/BF00377461	10	870	896	0	13	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 9	1991	338	8776					1173	1174		10.1016/0140-6736(91)92033-X	http://dx.doi.org/10.1016/0140-6736(91)92033-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682593				2022-12-28	WOS:A1991GP03400005
J	SMITH, JC; ELLENBERGER, HH; BALLANYI, K; RICHTER, DW; FELDMAN, JL				SMITH, JC; ELLENBERGER, HH; BALLANYI, K; RICHTER, DW; FELDMAN, JL			PRE-BOTZINGER COMPLEX - A BRAIN-STEM REGION THAT MAY GENERATE RESPIRATORY RHYTHM IN MAMMALS	SCIENCE			English	Article							SPINAL-CORD PREPARATION; INSPIRATORY DRIVE; NUCLEUS AMBIGUUS; NEWBORN RAT; INVITRO; NEURONS; MEDULLA; PATTERN; MOTONEURONS; MODULATION	The location of neurons generating the rhythm of breathing in mammals is unknown. By microsection of the neonatal rat brainstem in vitro, a limited region of the ventral medulla (the pre-Botzinger Complex) that contains neurons essential for rhythmogenesis was identified. Rhythm generation was eliminated by removal of only this region. Medullary slices containing the pre-Botzinger Complex generated respiratory-related oscillations similar to those generated by the whole brainstem in vitro, and neurons with voltage-dependent pacemaker-like properties were identified in this region. Thus, the respiratory rhythm in the mammalian neonatal nervous system may result from a population of conditional bursting pacemaker neurons in the pre-Botzinger Complex.	UNIV GOTTINGEN,INST PHYSIOL,W-3400 GOTTINGEN,GERMANY	University of Gottingen	SMITH, JC (corresponding author), UNIV CALIF LOS ANGELES,DEPT KINESIOL,SYST NEUROBIOL LAB,LOS ANGELES,CA 90024, USA.		feldman, jack/AAO-7505-2021	feldman, jack/0000-0003-3692-9412	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959, R01HL070029, K30HL004095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024742] Funding Source: NIH RePORTER; NHLBI NIH HHS [K30 HL004095, HL02204, R01 HL070029-01A1, R01 HL040959, HL4095, R01 HL070029] Funding Source: Medline; NINDS NIH HHS [NS24742, R01 NS024742] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BIEGER D, 1987, J COMP NEUROL, V262, P546, DOI 10.1002/cne.902620408; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; COHEN MI, 1979, PHYSIOL REV, V59, P1105, DOI 10.1152/physrev.1979.59.4.1105; ELLENBERGER HH, 1990, J COMP NEUROL, V294, P202, DOI 10.1002/cne.902940205; EZURE K, 1990, PROG NEUROBIOL, V35, P429, DOI 10.1016/0301-0082(90)90030-K; Feldman J, 1990, EUR J NEUROSCI, V3, P171; FELDMAN JL, 1990, AM J PHYSIOL, V259, pR879, DOI 10.1152/ajpregu.1990.259.5.R879; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; FELDMAN JL, 1986, HDB PHYSL 1, V4, P463; FLUORENS P, 1851, CR HEBD ACAD SCI, V33, P437; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; HARADA Y, 1985, J PHYSIOL-LONDON, V368, P679, DOI 10.1113/jphysiol.1985.sp015883; HILAIRE G, 1989, BRAIN RES, V485, P325, DOI 10.1016/0006-8993(89)90577-5; LIU GS, 1990, J NEUROPHYSIOL, V64, P423, DOI 10.1152/jn.1990.64.2.423; MCCRIMMON DR, 1989, J NEUROSCI, V9, P1910; ONIMARU H, 1988, BRAIN RES, V445, P314, DOI 10.1016/0006-8993(88)91194-8; ONIMARU H, 1987, NEUROSCI LETT, V78, P151, DOI 10.1016/0304-3940(87)90624-0; OTAKE K, 1990, J COMP NEUROL, V302, P485, DOI 10.1002/cne.903020306; Richter DW, 1986, NEWS PHYSIOL SCI, V1, P109; SCHWARZACHER S W, 1991, Pfluegers Archiv European Journal of Physiology, V418, pR17; SMITH J C, 1989, Society for Neuroscience Abstracts, V15, P505; SMITH J C, 1990, Society for Neuroscience Abstracts, V16, P1130; Smith J. C., 1987, RESPIRATORY MUSCLES, P27; SMITH JC, 1986, FASEB J, V45, P518; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370	27	1590	1635	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 1	1991	254	5032					726	729		10.1126/science.1683005	http://dx.doi.org/10.1126/science.1683005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN474	1683005	Green Accepted			2022-12-28	WOS:A1991GN47400047
J	GOTODA, T; YAMADA, N; MURASE, T; SAKUMA, M; MURAYAMA, N; SHIMANO, H; KOZAKI, K; ALBERS, JJ; YAZAKI, Y; AKANUMA, Y				GOTODA, T; YAMADA, N; MURASE, T; SAKUMA, M; MURAYAMA, N; SHIMANO, H; KOZAKI, K; ALBERS, JJ; YAZAKI, Y; AKANUMA, Y			DIFFERENTIAL PHENOTYPIC-EXPRESSION BY 3 MUTANT ALLELES IN FAMILIAL LECITHIN - CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	LANCET			English	Article							DEFECTIVE ENZYME; PLASMA LECITHIN; POLYMERASE; SEQUENCE; LCAT; CDNA; GENE; DNA	Familial deficiency of lecithin:cholesterol acyltransferase (LCAT) is an autosomal recessive disorder characterised by abnormalities of all plasma lipoprotein classes and by abnormal deposition of unesterified cholesterol in tissues. To elucidate the molecular basis of the disease, the LCAT genes of three unrelated Japanese patients were amplified by means of the polymerase chain reaction. Direct sequencing of the amplified fragments covering all exons and junctions showed that the patients are homozygotes for separate gene mutations. In one patient a 3 bp insertion, which should cause a substantial change in the enzyme structure, was found in exon 4; he had near absence of LCAT mass and activity. Two separate missense mutations were identified in exon 6 of the other two patients, who produced functionally defective enzymes that differed widely in specific activity. The replacement of asparagine228 with positively charged lysine completely abolished enzyme activity, whereas the other, conservative, aminoacid substitution (methionine293 --> isoleucine) gave rise to a partially defective enzyme. These results show that distinct mutations cause differences in plasma LCAT activity and LCAT mass, ultimately leading to differential phenotypic expression of familial LCAT deficiency.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,7-3-1 HONGO,TOKYO 113,JAPAN; TORANOMON GEN HOSP,TOKYO 107,JAPAN; SAKUMA HOSP,HOKKAIDO,JAPAN; JICHI MED SCH,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; UNIV WASHINGTON,SEATTLE,WA 98195; ASAHI LIFE FDN,INST DIABET CARE & RES,TOKYO,JAPAN	University of Tokyo; Toranomon Hospital; Jichi Medical University; University of Washington; University of Washington Seattle; Asahi Life Foundation			Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Shimano, Hitoshi/0000-0002-5562-5572	NHLBI NIH HHS [HL 30086] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS JJ, 1981, J CLIN INVEST, V67, P141, DOI 10.1172/JCI110006; ALBERS JJ, 1982, HUM GENET, V62, P82, DOI 10.1007/BF00295608; ALBERS JJ, 1985, BIOCHIM BIOPHYS ACTA, V835, P253, DOI 10.1016/0005-2760(85)90280-2; CHEN CH, 1982, J LIPID RES, V23, P680; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; GLOMSET JA, 1973, ADV LIPID RES, V2, P1; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; IWAMOTO A, 1978, ACTA MED SCAND, V204, P219; KATO K, 1983, J JPN SOC INTERN MED, V72, P1774; MCLEAN J, 1986, NUCLEIC ACIDS RES, V14, P9397, DOI 10.1093/nar/14.23.9397; MCLEAN J, 1986, P NATL ACAD SCI USA, V83, P2335, DOI 10.1073/pnas.83.8.2335; MERONI G, 1990, NUCLEIC ACIDS RES, V18, P5308, DOI 10.1093/nar/18.17.5308; NORUM KR, 1967, SCAND J CLIN LAB INV, V20, P231, DOI 10.3109/00365516709076948; NORUMKR, 1989, METABOLIC BASIS INHE, P1181; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAKUMA M, 1982, ACTA MED SCAND, V212, P225; SCHAEFER EJ, 1989, HIGH DENSITY LIPOPRO, V2, P79; TARAMELLI R, 1990, HUM GENET, V85, P195; WARDEN CH, 1989, J BIOL CHEM, V264, P21573; YANG CY, 1987, J BIOL CHEM, V262, P3086	20	61	64	1	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					778	781		10.1016/0140-6736(91)90665-C	http://dx.doi.org/10.1016/0140-6736(91)90665-C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681161				2022-12-28	WOS:A1991GG97900004
J	HUANG, E; NOCKA, K; BEIER, DR; CHU, TY; BUCK, J; LAHM, HW; WELLNER, D; LEDER, P; BESMER, P				HUANG, E; NOCKA, K; BEIER, DR; CHU, TY; BUCK, J; LAHM, HW; WELLNER, D; LEDER, P; BESMER, P			THE HEMATOPOIETIC GROWTH FACTOR-KL IS ENCODED BY THE SI-LOCUS AND IS THE LIGAND OF THE C-KIT RECEPTOR, THE GENE-PRODUCT OF THE W-LOCUS	CELL			English	Article									CORNELL UNIV,SCH MED,DEPT BIOCHEM,NEW YORK,NY 10021; SLOAN KETTERING MEM CANC CTR,IMMUNOL PROGRAM,NEW YORK,NY 10021; CORNELL UNIV,GRAD SCH MED SCI,NEW YORK,NY 10021; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; F HOFFMANN LAROCHE LTD,CH-4005 BASEL,SWITZERLAND	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	HUANG, E (corresponding author), SLOAN KETTERING MEM CANC CTR,MOLEC BIOL PROGRAM,NEW YORK,NY 10021, USA.		Huang, Eric J./AAH-7997-2019	Huang, Eric J./0000-0002-5381-3801; Chu, Tang-Yuan/0000-0003-2717-2681	NATIONAL CANCER INSTITUTE [R37CA032926, R01CA032926, P01CA016599] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16599, CA 32926] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; ALTUS MS, 1971, P SOC EXP BIOL MED, V138, P985; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BARKER JE, 1988, J CELL PHYSIOL, V135, P533, DOI 10.1002/jcp.1041350324; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUI DHK, 1978, BLOOD, V51, P539; DEXTER TM, 1977, NATURE, V269, P412, DOI 10.1038/269412a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FUJITA J, 1988, J CELL PHYSIOL, V134, P78, DOI 10.1002/jcp.1041340109; FUJITA J, 1989, P NATL ACAD SCI USA, V86, P2888, DOI 10.1073/pnas.86.8.2888; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1981, GENETICS, V97, P337; Green E., 1981, GENETICS PROBABILITY, DOI 10.1007/978-1-349-04904-2; GREGORY CJ, 1978, BLOOD, V51, P527; HARRISON DE, 1980, BLOOD, V55, P77; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; KAWASAKI ES, 1985, SCIENCE, V230, P291, DOI 10.1126/science.2996129; KITAMURA Y, 1978, BLOOD, V52, P447; KITAMURA Y, 1989, BIOESSAYS, V10, P193, DOI 10.1002/bies.950100604; KITAMURA Y, 1979, BLOOD, V53, P492; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; MAJUMDER S, 1988, MOL CELL BIOL, V8, P4896, DOI 10.1128/MCB.8.11.4896; MANOVA K, 1990, IN PRESS DEVELOPMENT; MAYER TC, 1968, DEV BIOL, V18, P62, DOI 10.1016/0012-1606(68)90023-7; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MCCULLOCH EA, 1970, REGULATION HEMATOPOI, P649; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; ORRURTREGER A, 1990, DEVELOPMENT, V109, P911; PARK LS, 1986, J BIOL CHEM, V261, P4177; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; RETTENMIER CW, 1988, MOL CELL BIOL, V8, P5206; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ES, 1970, REGULATION HEMATOPOI, P649; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARVELLA PATRICIA A., 1956, JOUR HEREDITY, V47, P123; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Silvers W.K., 1979, COAT COLORS MICE, P206; STANLEY ER, 1981, J IMMUNOL METHODS, V42, P253, DOI 10.1016/0022-1759(81)90156-3; STEVENS RL, 1989, IMMUNOL TODAY, V10, P381, DOI 10.1016/0167-5699(89)90272-7; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; TSUJI K, 1990, BLOOD, V75, P421; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YUNG YP, 1982, J IMMUNOL, V129, P1256; YUNG YP, 1981, J IMMUNOL, V127, P794	57	1160	1204	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 5	1990	63	1					225	233		10.1016/0092-8674(90)90303-V	http://dx.doi.org/10.1016/0092-8674(90)90303-V			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EB461	1698557	hybrid			2022-12-28	WOS:A1990EB46100023
J	WEBB, DSA; SHIMIZU, Y; VANSEVENTER, GA; SHAW, S; GERRARD, TL				WEBB, DSA; SHIMIZU, Y; VANSEVENTER, GA; SHAW, S; GERRARD, TL			LFA-3, CD44, AND CD45 - PHYSIOLOGICAL TRIGGERS OF HUMAN MONOCYTE TNF AND IL-1 RELEASE	SCIENCE			English	Article									US FDA, CTR BIOL EVALUAT & RES, DIV CYTOKINE BIOL, BETHESDA, MD 20892 USA; NCI, EXPTL IMMUNOL BRANCH, BETHESDA, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Shimizu, Yoji/0000-0001-9760-0288				BERG EL, 1989, IMMUNOL REV, V108, P5, DOI 10.1111/j.1600-065X.1989.tb00010.x; BIERER BE, 1988, P NATL ACAD SCI USA, V85, P1194, DOI 10.1073/pnas.85.4.1194; BOCKENSTEDT LK, 1988, J IMMUNOL, V141, P1904; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; CHU E, 1984, J IMMUNOL, V132, P1311; CLARK EA, 1989, IMMUNOL TODAY, V10, P225, DOI 10.1016/0167-5699(89)90257-0; DENNING SM, 1990, J IMMUNOL, V144, P7; DONNELLY RP, 1990, J IMMUNOL, V145, P569; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; DUSTIN ML, 1987, J EXP MED, V165, P677, DOI 10.1084/jem.165.3.677; GERRARD TL, 1987, J IMMUNOL, V138, P2535; GILBERT CW, 1988, J IMMUNOL, V140, P2821; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; HALE LP, 1989, J IMMUNOL, V143, P3944; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; HUET S, 1989, J IMMUNOL, V143, P798; HUNIG T, 1987, NATURE, V326, P298, DOI 10.1038/326298a0; JANICKE R, 1990, J IMMUNOL, V144, P1144; LE JM, 1987, LAB INVEST, V56, P234; LEVIN J, 1970, J LAB CLIN MED, V75, P903; LONNEMANN G, 1989, EUR J IMMUNOL, V19, P1531, DOI 10.1002/eji.1830190903; MAKGOBA MW, 1989, IMMUNOL TODAY, V10, P417, DOI 10.1016/0167-5699(89)90039-X; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MIZEL SB, 1982, IMMUNOL REV, V63, P51, DOI 10.1111/j.1600-065X.1982.tb00411.x; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; SHAW S, 1988, CURR OPIN IMMUNOL, V1, P92, DOI 10.1016/0952-7915(88)90058-1; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; TIEFENTHALER G, 1987, EUR J IMMUNOL, V17, P1847, DOI 10.1002/eji.1830171227; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; WEBB DJ, UNPUB; WEBB DSA, 1990, J IMMUNOL, V144, P3643; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WRIGHT SD, 1988, J CELL SCI, P99	38	319	330	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	1990	249	4974					1295	1297		10.1126/science.1697984	http://dx.doi.org/10.1126/science.1697984			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY351	1697984				2022-12-28	WOS:A1990DY35100038
J	HOLLENBECK, PJ; SWANSON, JA				HOLLENBECK, PJ; SWANSON, JA			RADIAL EXTENSION OF MACROPHAGE TUBULAR LYSOSOMES SUPPORTED BY KINESIN	NATURE			English	Article											HOLLENBECK, PJ (corresponding author), HARVARD UNIV,SCH MED,DEPT ANAT & CELLULAR BIOL,220 LONGWOOD AVE,BOSTON,MA 02115, USA.		Swanson, Joel A/P-4362-2014	Swanson, Joel A/0000-0003-0900-8212				BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; BRUCK C, 1982, J IMMUNOL METHODS, V53, P313, DOI 10.1016/0022-1759(82)90178-8; DABORA SL, 1988, CELL, V54, P27, DOI 10.1016/0092-8674(88)90176-6; HERMAN B, 1984, J CELL BIOL, V98, P565, DOI 10.1083/jcb.98.2.565; HOLLENBECK PJ, 1988, PROTOPLASMA, V145, P145, DOI 10.1007/BF01349352; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; HOLLENBECK PJ, 1984, J CELL BIOL, V99, P1251, DOI 10.1083/jcb.99.4.1251; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SCHROER TA, 1988, J CELL BIOL, V107, P1785, DOI 10.1083/jcb.107.5.1785; SHEETZ MP, 1987, BIOESSAYS, V7, P165, DOI 10.1002/bies.950070406; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; SWANSON JA, 1989, J CELL SCI, V94, P135; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1988, J CELL BIOL, V107, P2233, DOI 10.1083/jcb.107.6.2233; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	22	245	245	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 30	1990	346	6287					864	866		10.1038/346864a0	http://dx.doi.org/10.1038/346864a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW488	1697403				2022-12-28	WOS:A1990DW48800062
J	LU, X; LANE, EB				LU, X; LANE, EB			RETROVIRUS-MEDIATED TRANSGENIC KERATIN EXPRESSION IN CULTURED FIBROBLASTS - SPECIFIC DOMAIN FUNCTIONS IN KERATIN STABILIZATION AND FILAMENT FORMATION	CELL			English	Article											LU, X (corresponding author), IMPERIAL COUNCIL RES FUND, CLARE HALL LABS, CELL STRUCT LAB, BLANCHE LANE, S MIMMS, POTTERS BAR EN6 3LD, HERTS, ENGLAND.			Lu, Xin/0000-0002-6587-1152				ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; AUBIN JE, 1980, EXP CELL RES, V129, P149, DOI 10.1016/0014-4827(80)90340-7; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; BADER BL, 1988, EUR J CELL BIOL, V47, P300; BARTEK J, 1985, J CELL SCI, V75, P17; BOWDEN PE, 1984, J SUBMICR CYTOL PATH, V16, P21; BROWN AMC, 1987, DNA CLONING, V3, P189; DARMON M, 1984, EMBO J, V3, P961, DOI 10.1002/j.1460-2075.1984.tb01914.x; DENK H, 1987, EXP CELL RES, V173, P137, DOI 10.1016/0014-4827(87)90339-9; DOMENJOUD L, 1988, EXP CELL RES, V179, P352, DOI 10.1016/0014-4827(88)90274-1; EICHNER R, 1986, J CELL BIOL, V102, P1767, DOI 10.1083/jcb.102.5.1767; FERRETTI P, 1989, DEV BIOL, V133, P415, DOI 10.1016/0012-1606(89)90045-6; GAO Z, 1988, J ORAL PATHOL MED, V17, P178, DOI 10.1111/j.1600-0714.1988.tb01521.x; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; GEISLER N, 1987, FEBS LETT, V221, P403, DOI 10.1016/0014-5793(87)80964-X; GEISLER N, 1985, J MOL BIOL, V182, P173, DOI 10.1016/0022-2836(85)90035-X; GIUDICE GJ, 1987, CELL, V48, P453, DOI 10.1016/0092-8674(87)90196-6; HANUKOGLU I, 1982, CELL, V31, P243, DOI 10.1016/0092-8674(82)90424-X; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HATZFELD M, 1987, J MOL BIOL, V197, P237, DOI 10.1016/0022-2836(87)90122-7; HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; JAHN L, 1987, DIFFERENTIATION, V36, P234, DOI 10.1111/j.1432-0436.1987.tb00198.x; JORCANO JL, 1984, J MOL BIOL, V179, P257, DOI 10.1016/0022-2836(84)90468-6; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; KARSTEN U, 1985, EUR J CANCER CLIN ON, V21, P733, DOI 10.1016/0277-5379(85)90271-8; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; KLINGE EM, 1987, J MOL EVOL, V24, P319, DOI 10.1007/BF02134130; KLYMKOWSKY MW, 1983, J CELL BIOL, V96, P494, DOI 10.1083/jcb.96.2.494; KNAPP AC, 1989, CELL, V59, P67, DOI 10.1016/0092-8674(89)90870-2; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; KREIS TE, 1983, CELL, V32, P1125, DOI 10.1016/0092-8674(83)90296-9; KRIMPENFORT PJ, 1988, EMBO J, V7, P941, DOI 10.1002/j.1460-2075.1988.tb02899.x; KUBOTA Y, 1981, IN VITRO, V17, P965; KULESH DA, 1988, MOL CELL BIOL, V8, P1540, DOI 10.1128/MCB.8.4.1540; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; LANE EB, 1985, ANN NY ACAD SCI, V455, P241, DOI 10.1111/j.1749-6632.1985.tb50415.x; LANE EB, 1981, COLD SPRING HARB SYM, V46, P387; LAUEROVA L, 1988, HYBRIDOMA, V7, P495, DOI 10.1089/hyb.1988.7.495; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MAGIN TM, 1987, EMBO J, V6, P2607, DOI 10.1002/j.1460-2075.1987.tb02551.x; MAKIN CA, 1984, J CLIN PATHOL, V37, P975, DOI 10.1136/jcp.37.9.975; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MCKNIGHT GS, 1988, RECENT PROG HORM RES, V44, P307; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MOLE SE, 1987, PHILOS T ROY SOC B, V317, P455, DOI 10.1098/rstb.1987.0072; NELSON WJ, 1983, MOL CELL BIOL, V3, P1146, DOI 10.1128/MCB.3.6.1146; PURKIS PE, 1990, IN PRESS J CELL SCI; QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x; QUINLAN RA, 1989, J CELL SCI, V93, P71; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; RAMAEKERS F, 1987, EXP CELL RES, V170, P235, DOI 10.1016/0014-4827(87)90133-9; SCHUTZBANK T, 1982, CELL, V30, P481, DOI 10.1016/0092-8674(82)90245-8; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; SMEDTS F, 1990, AM J PATHOL, V136, P657; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; STASIAK PC, 1987, NUCLEIC ACIDS RES, V15, P10058, DOI 10.1093/nar/15.23.10058; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; STEINERT PM, 1985, NATURE, V316, P767, DOI 10.1038/316767a0; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEINERT PM, 1985, ANN NY ACAD SCI, V455, P451, DOI 10.1111/j.1749-6632.1985.tb50428.x; STEVEN AC, 1985, ANN NY ACAD SCI, V455, P371, DOI 10.1111/j.1749-6632.1985.tb50423.x; STEWART M, 1989, J CELL BIOL, V109, P225, DOI 10.1083/jcb.109.1.225; SUNDSTROM BE, 1989, J HISTOCHEM CYTOCHEM, V37, P1845, DOI 10.1177/37.12.2479674; TOLLE HG, 1985, EUR J CELL BIOL, V38, P234; TRAUB P, 1983, J CELL SCI, V63, P43; VANDENHEUVEL RMM, 1987, J CELL SCI, V88, P475; WASEEM A, 1990, New Biologist, V2, P464; WASEEM A, 1990, GENOMICS, V7, P188, DOI 10.1016/0888-7543(90)90540-B; WILLARD M, 1981, J CELL BIOL, V89, P198, DOI 10.1083/jcb.89.2.198	75	168	168	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	1990	62	4					681	696		10.1016/0092-8674(90)90114-T	http://dx.doi.org/10.1016/0092-8674(90)90114-T			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DW306	1696851				2022-12-28	WOS:A1990DW30600009
J	ARUFFO, A; STAMENKOVIC, I; MELNICK, M; UNDERHILL, CB; SEED, B				ARUFFO, A; STAMENKOVIC, I; MELNICK, M; UNDERHILL, CB; SEED, B			CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE	CELL			English	Article									HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114; GEORGETOWN UNIV,MED CTR,DEPT ANAT & CELL BIOL,WASHINGTON,DC 20007	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Georgetown University	ARUFFO, A (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [R01CA035592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027849, R37AI027849] Funding Source: NIH RePORTER; NCI NIH HHS [CA-35592] Funding Source: Medline; NHLBI NIH HHS [HL-41565] Funding Source: Medline; NIAID NIH HHS [AI-27849] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGER A, 1987, J CELL SCI, V87, P133; ALHO AM, 1989, J CELL BIOL, V108, P1557, DOI 10.1083/jcb.108.4.1557; ANDREWS P, 1983, J CELL SCI, V59, P231; ANDREWS P, 1982, J CELL SCI, V57, P277; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BRITZ JS, 1983, J IMMUNOL, V130, P1848; BUDD RC, 1987, J IMMUNOL, V138, P1009; BUDD RC, 1987, J IMMUNOL, V138, P3120; CAROTHERS AM, 1989, BIOTECHNIQUES, V7, P494; CARRERA AC, 1988, J IMMUNOL, V141, P1919; CARTER WG, 1988, J BIOL CHEM, V263, P4193; CATERSON B, 1985, FED PROC, V44, P386; CATERSON B, 1982, J INVEST DERMATOL, V79, pS45, DOI 10.1111/1523-1747.ep12545740; CHEVRIER A, 1982, BIOMED PHARMACOTHER, V36, P100; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DALCHAU R, 1980, EUR J IMMUNOL, V10, P745, DOI 10.1002/eji.1830101004; DARZYNKIEWICZ Z, 1971, EXP CELL RES, V66, P113, DOI 10.1016/S0014-4827(71)80018-6; DENNING SM, 1990, J IMMUNOL, V414, P7; GALLATIN WM, 1989, P NATL ACAD SCI USA, V86, P4654, DOI 10.1073/pnas.86.12.4654; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; GREEN SJ, 1988, J CELL SCI, V90, P145; GREEN SJ, 1988, EXP CELL RES, V178, P224, DOI 10.1016/0014-4827(88)90393-X; HAYNES BF, 1983, J IMMUNOL, V131, P1195; HUET S, 1989, J IMMUNOL, V143, P798; HUGHES EN, 1981, J BIOL CHEM, V256, P7023; IDZERDA RL, 1989, P NATL ACAD SCI USA, V86, P4659, DOI 10.1073/pnas.86.12.4659; ISE Y, 1988, EUR J IMMUNOL, V18, P1235, DOI 10.1002/eji.1830180814; JACOBSON K, 1984, J CELL BIOL, V99, P1624, DOI 10.1083/jcb.99.5.1624; JACOBSON K, 1984, J CELL BIOL, V99, P1613, DOI 10.1083/jcb.99.5.1613; JALKANEN ST, 1986, EUR J IMMUNOL, V16, P1195, DOI 10.1002/eji.1830161003; KALOMIRIS EL, 1988, J CELL BIOL, V106, P319, DOI 10.1083/jcb.106.2.319; KANSAS GS, 1989, J IMMUNOL, V142, P3058; KNUDSON W, 1984, J CELL BIOCHEM, V25, P183, DOI 10.1002/jcb.240250402; LACY BE, 1987, J CELL BIOL, V105, P1395, DOI 10.1083/jcb.105.3.1395; LAURENT TC, 1986, CIBA F SYMP, V124, P9; NAKACHE M, 1989, NATURE, V337, P179, DOI 10.1038/337179a0; NEMEC RE, 1987, BIOCHEM BIOPH RES CO, V149, P249, DOI 10.1016/0006-291X(87)91632-9; NOTTENBURG C, 1989, P NATL ACAD SCI USA, V86, P8521, DOI 10.1073/pnas.86.21.8521; PESANDO JM, 1986, J IMMUNOL, V137, P3689; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHANNON BT, 1980, IMMUNOL COMMUN, V9, P735, DOI 10.3109/08820138009109683; SHANNON BT, 1980, IMMUNOL COMMUN, V9, P357, DOI 10.3109/08820138009052982; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STJOHN T, 1990, CELL, V60, P45, DOI 10.1016/0092-8674(90)90714-P; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; TARONE G, 1984, J CELL BIOL, V99, P512, DOI 10.1083/jcb.99.2.512; TOOLE BP, 1979, P NATL ACAD SCI USA, V76, P6299, DOI 10.1073/pnas.76.12.6299; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; UNDERHILL CB, 1981, EXP CELL RES, V131, P419, DOI 10.1016/0014-4827(81)90248-2; UNDERHILL CB, 1987, J BIOL CHEM, V262, P13142; UNDERHILL CBG, 1983, J BIOL CHEM, V260, P8128; VANNOESEL C, 1988, NATURE, V333, P850, DOI 10.1038/333850a0; ZHOU DFH, 1989, J IMMUNOL, V143, P3390	58	2271	2417	4	144	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 29	1990	61	7					1303	1313		10.1016/0092-8674(90)90694-A	http://dx.doi.org/10.1016/0092-8674(90)90694-A			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM156	1694723				2022-12-28	WOS:A1990DM15600018
J	LETO, TL; LOMAX, KJ; VOLPP, BD; NUNOI, H; SECHLER, JMG; NAUSEEF, WM; CLARK, RA; GALLIN, JI; MALECH, HL				LETO, TL; LOMAX, KJ; VOLPP, BD; NUNOI, H; SECHLER, JMG; NAUSEEF, WM; CLARK, RA; GALLIN, JI; MALECH, HL			CLONING OF A 67-KD NEUTROPHIL OXIDASE FACTOR WITH SIMILARITY TO A NONCATALYTIC REGION OF P60C-SRC	SCIENCE			English	Article									VET ADM MED CTR,IOWA CITY,IA 52242; UNIV IOWA,DEPT MED,IOWA CITY,IA 52242	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa	LETO, TL (corresponding author), NIAID,CLIN INVEST LAB,BACTERIAL DIS SECT,BLDG 10,ROOM 11N112,BETHESDA,MD 20892, USA.		Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Malech, Harry/0000-0001-5874-5775; Nauseef, William/0000-0003-4032-757X	Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER; BLRD VA [I01 BX000513] Funding Source: Medline	Veterans Affairs(US Department of Veterans Affairs); BLRD VA		CLARK RA, 1989, NEW ENGL J MED, V321, P647, DOI 10.1056/NEJM198909073211005; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DRUBIN G, 1990, NATURE, V343, P288; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; GLENNEY J, 1986, J BIOL CHEM, V261, P7247; HAMAGUCHI M, 1987, P NATL ACAD SCI USA, V84, P2312, DOI 10.1073/pnas.84.8.2312; JUNG G, 1989, GENE, V82, P269, DOI 10.1016/0378-1119(89)90052-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LETO TL, UNPUB; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; LOMAX KJ, 1989, SCIENCE, V246, P987, DOI 10.1126/science.2587992; LYNCH TJ, 1986, J BIOL CHEM, V261, P7156; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MCMAHON AP, 1987, DIFFERENTIATION, V34, P68, DOI 10.1111/j.1432-0436.1987.tb00052.x; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; PAWSON T, 1988, ONCOGENE, V3, P491; PERLMUTTER R M, 1988, Biochimica et Biophysica Acta, V948, P245; PERLMUTTER RM, 1988, J CELL BIOCHEM, V38, P117, DOI 10.1002/jcb.240380206; Potts W M, 1988, Oncogene Res, V3, P343; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RODAWAY ARF, 1989, NATURE, V342, P624, DOI 10.1038/342624a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; TANAKA A, 1987, MOL CELL BIOL, V7, P978; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195; VOLPP BD, 1988, SCIENCE, V242, P1295, DOI 10.1126/science.2848318; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P9563; WASENIUS VM, 1989, J CELL BIOL, V108, P79, DOI 10.1083/jcb.108.1.79	39	373	381	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 11	1990	248	4956					727	730		10.1126/science.1692159	http://dx.doi.org/10.1126/science.1692159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC926	1692159				2022-12-28	WOS:A1990DC92600032
J	RODGERS, GP; DOVER, GJ; NOGUCHI, CT; SCHECHTER, AN; NIENHUIS, AW				RODGERS, GP; DOVER, GJ; NOGUCHI, CT; SCHECHTER, AN; NIENHUIS, AW			HEMATOLOGIC RESPONSES OF PATIENTS WITH SICKLE-CELL DISEASE TO TREATMENT WITH HYDROXYUREA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NHLBI,CLIN HEMATOL BRANCH,BETHESDA,MD 20205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	RODGERS, GP (corresponding author), NIDDK,CHEM BIOL LAB,BLDG 10,9N-318,BETHESDA,MD, USA.			Schechter, Alan N/0000-0002-5235-9408	NHLBI NIH HHS [HL-28028] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028028, R37HL028028] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALKHATTI A, 1987, NEW ENGL J MED, V317, P415, DOI 10.1056/NEJM198708133170704; ALTER BP, 1985, BLOOD, V66, P373; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; BERTLES JF, 1968, J CLIN INVEST, V47, P1731, DOI 10.1172/JCI105863; BRITTENHAM GM, 1985, BLOOD, V65, P183; BURNS ER, 1986, AM J CLIN PATHOL, V85, P337, DOI 10.1093/ajcp/85.3.337; CHARACHE S, 1987, BLOOD, V69, P109; CHARACHE S, 1983, P NATL ACAD SCI-BIOL, V80, P4842, DOI 10.1073/pnas.80.15.4842; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Dover G J, 1989, Prog Clin Biol Res, V316B, P295; DOVER GJ, 1986, BLOOD, V67, P735; DOVER GJ, 1978, NEW ENGL J MED, V299, P1428, DOI 10.1056/NEJM197812282992603; DOVER GJ, 1987, BLOOD, V69, P341; Forsythe GE., 1977, COMPUTER METHODS MAT; HUMPHRIES RK, 1985, J CLIN INVEST, V75, P547, DOI 10.1172/JCI111731; LAVELLE D, 1986, BLOOD, V67, P1083; LETVIN NL, 1984, NEW ENGL J MED, V310, P869, DOI 10.1056/NEJM198404053101401; LEY TJ, 1983, BLOOD, V62, P370; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; McDonagh K T, 1989, Prog Clin Biol Res, V316B, P307; MILLER BA, 1987, NEW ENGL J MED, V316, P244, DOI 10.1056/NEJM198701293160504; NAGEL RL, 1985, NEW ENGL J MED, V312, P880, DOI 10.1056/NEJM198504043121403; NOGUCHI CT, 1983, J CLIN INVEST, V72, P846, DOI 10.1172/JCI111055; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; NOGUCHI CT, 1985, J CLIN INVEST, V75, P1632, DOI 10.1172/JCI111870; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; REMINGTON RD, 1970, STATISTICS APPLICATI; RODGERS GP, 1985, J LAB CLIN MED, V106, P30; RODGERS GP, 1989, HEMOGLOBIN SWITCHI B, V316, P281; Schechter A. N., 1987, MOL BASIS BLOOD DIS, P179; SHINAR E, 1987, BLOOD, V70, P158; VEITH R, 1985, NEW ENGL J MED, V313, P1571, DOI 10.1056/NEJM198512193132503	32	246	251	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	1990	322	15					1037	1045		10.1056/NEJM199004123221504	http://dx.doi.org/10.1056/NEJM199004123221504			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CX869	1690857				2022-12-28	WOS:A1990CX86900004
J	INOUE, K; HOSHIJIMA, K; SAKAMOTO, H; SHIMURA, Y				INOUE, K; HOSHIJIMA, K; SAKAMOTO, H; SHIMURA, Y			BINDING OF THE DROSOPHILA SEX-LETHAL GENE-PRODUCT TO THE ALTERNATIVE SPLICE SITE OF TRANSFORMER PRIMARY TRANSCRIPT	NATURE			English	Article									KYOTO UNIV,FAC SCI,DEPT BIOPHYS,KYOTO 606,JAPAN	Kyoto University								AMREIN H, 1988, CELL, V55, P1025, DOI 10.1016/0092-8674(88)90247-4; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BELOTE JM, 1989, GENE, V82, P161, DOI 10.1016/0378-1119(89)90041-3; BINGHAM PM, 1988, TRENDS GENET, V4, P134, DOI 10.1016/0168-9525(88)90136-9; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; GORALSKI TJ, 1989, CELL, V56, P1011, DOI 10.1016/0092-8674(89)90634-X; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HODGKIN J, 1989, CELL, V56, P905, DOI 10.1016/0092-8674(89)90619-3; INGOLIA TD, 1980, CELL, V21, P669, DOI 10.1016/0092-8674(80)90430-4; INOUE K, 1989, GENE DEV, V3, P1472, DOI 10.1101/gad.3.9.1472; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; MAINE EM, 1985, CELL, V43, P521, DOI 10.1016/0092-8674(85)90181-3; MCKEOWN M, 1987, CELL, V48, P489, DOI 10.1016/0092-8674(87)90199-1; MCKEOWN M, 1988, CELL, V53, P887, DOI 10.1016/S0092-8674(88)90369-8; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIYAKE T, 1987, MOL GEN GENET, V207, P29, DOI 10.1007/BF00331487; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; NOCERA PPD, 1983, P NATL ACAD SCI USA, V80, P7095; SALZ HK, 1989, GENE DEV, V3, P708, DOI 10.1101/gad.3.5.708; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; WOLFNER MF, 1988, TRENDS GENET, V4, P333, DOI 10.1016/0168-9525(88)90052-2; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	24	287	293	1	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 29	1990	344	6265					461	463		10.1038/344461a0	http://dx.doi.org/10.1038/344461a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CW478	1690860				2022-12-28	WOS:A1990CW47800073
J	HANSEN, SW				HANSEN, SW			AUTONOMIC NEUROPATHY AFTER TREATMENT WITH CISPLATIN, VINBLASTINE, AND BLEOMYCIN FOR GERM-CELL CANCER	BRITISH MEDICAL JOURNAL			English	Article											HANSEN, SW (corresponding author), RIGSHOSP,FINSEN INST,DEPT ONCOL,DK-2100 COPENHAGEN O,DENMARK.							EWING DJ, 1986, CLIN ENDOCRINOL META, V15, P855, DOI 10.1016/S0300-595X(86)80078-0; HANSEN SW, 1989, J CLIN ONCOL, V7, P1457, DOI 10.1200/JCO.1989.7.10.1457; MCLEOD JG, 1987, ANN NEUROL, V21, P419, DOI 10.1002/ana.410210502; PAGE MM, 1978, LANCET, V1, P14; SAMUELS BL, 1987, CANCER CHEMOTH PHARM, V19, P253	5	44	44	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 24	1990	300	6723					511	512		10.1136/bmj.300.6723.511	http://dx.doi.org/10.1136/bmj.300.6723.511			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ878	1690581	Green Published, Bronze			2022-12-28	WOS:A1990CQ87800021
J	WILLIAMS, GT; SMITH, CA; SPOONCER, E; DEXTER, TM; TAYLOR, DR				WILLIAMS, GT; SMITH, CA; SPOONCER, E; DEXTER, TM; TAYLOR, DR			HEMATOPOIETIC COLONY STIMULATING FACTORS PROMOTE CELL-SURVIVAL BY SUPPRESSING APOPTOSIS	NATURE			English	Article									CHRISTIE HOSP & HOLT RADIUM INST,PATERSON INST CANC RES,DEPT EXPTL HAEMATOL,MANCHESTER M20 9BX,LANCS,ENGLAND	Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research	WILLIAMS, GT (corresponding author), UNIV BIRMINGHAM,SCH MED,DEPT ANAT,VINCENT DR,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND.		Williams, Gwyn/GQY-7555-2022	Williams, Gwyn/0000-0003-4556-9930	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAKSHI A, 1985, CELL, V41, P899; BRONCHUD MH, 1988, BRIT J CANCER, V58, P64, DOI 10.1038/bjc.1988.163; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; DUKE RC, 1986, LYMPHOKINE RES, V5, P289; GABRILOVE JL, 1988, NEW ENGL J MED, V318, P1414, DOI 10.1056/NEJM198806023182202; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LIU YJ, IN PRESS NATURE; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; METCALF D, 1970, J CELL PHYSIOL, V76, P89, DOI 10.1002/jcp.1040760113; PARAN M, 1968, J CELL PHYSIOL, V72, P247, DOI 10.1002/jcp.1040720312; PRATT RM, 1976, DEV BIOL, V54, P135, DOI 10.1016/0012-1606(76)90292-X; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; RUSSELL JH, 1980, J IMMUNOL, V124, P1100; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SPOONCER E, 1989, CURR TOP MICROBIOL, V149, P109; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; UCKER DS, 1987, NATURE, V327, P62, DOI 10.1038/327062a0; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VONWANGENHEIM HR, 1977, BIOMED EXPRESS, V27, P337; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; WHETTON AD, 1983, NATURE, V303, P629, DOI 10.1038/303629a0; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	28	1056	1069	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					76	79		10.1038/343076a0	http://dx.doi.org/10.1038/343076a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1688645				2022-12-28	WOS:A1990CG61400059
J	KAUFMANN, H; ORIBE, E; OLIVER, JA				KAUFMANN, H; ORIBE, E; OLIVER, JA			PLASMA ENDOTHELIN DURING UPRIGHT TILT - RELEVANCE FOR ORTHOSTATIC HYPOTENSION	LANCET			English	Article							VASOVAGAL SYNCOPE; POSTURAL CHANGE; CELLS; VASOPRESSIN	Since plasma endothelin concentration increases with upright posture and decreases with volume expansion, a study was conducted to test whether activation of the baroreceptor reflex releases endothelin into plasma. The effect of passive upright tilt on the plasma concentrations of endothelin and vasopressin was examined in: (1) normal subjects; (2) patients with impaired baroreceptor reflex due to primary autonomic failure; (3) patients with normal afferent baroreceptor function but acute inhibition of vasoconstrictor sympathetic outflow (ie, with vasovagal syncope); and (4) patients with hypophysial diabetes insipidus. In normal subjects, upright tilt did not change arterial pressure and significantly increased the plasma concentrations of endothelin and vasopressin. In patients with autonomic failure, upright tilt induced a considerable fall in arterial pressure, no rise in plasma endothelin, and a slight increase in plasma vasopressin. In subjects with vasovagal syncope, arterial pressure dropped and the plasma concentrations of endothelin and vasopressin rose. In the subjects with diabetes insipidus, arterial pressure fell slightly, without change in plasma concentration of endothelin. The results suggest that activation of the baroreceptor reflex induces the release of endothelin into plasma, probably from the neurohypophysis, and they raise the possibility that impaired endothelin release contributes to the orthostatic hypotension of patients with primary autonomic failure.	COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032	Columbia University	KAUFMANN, H (corresponding author), CUNY MT SINAI SCH MED,DEPT NEUROL,AUTONOM NERVOUS SYST LAB,BOX 1137,NEW YORK,NY 10029, USA.			Kaufmann, Horacio/0000-0002-1851-9981	NCRR NIH HHS [RR-71] Funding Source: Medline; NINDS NIH HHS [NS-07245] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANNISTER R, 1989, AUTONOMIC FAILURE TX, P1; BRIGDEN W, 1950, CLIN SCI, V9, P75; DAVIES R, 1976, CLIN SCI MOL MED, V51, P267, DOI 10.1042/cs0510267; EMORI T, 1989, BIOCHEM BIOPH RES CO, V160, P93, DOI 10.1016/0006-291X(89)91625-2; KALA R, 1974, SCAND J CLIN LAB INV, V33, P87, DOI 10.3109/00365517409114202; KAUFMANN H, 1990, NEUROLOGY, V40, P1115, DOI 10.1212/WNL.40.7.1115; KAUFMANN H, 1990, Society for Neuroscience Abstracts, V16, P221; KAUFMANN H, 1990, Neurology, V40, P211; MILLER M, 1969, ENDOCRINOLOGY, V84, P557, DOI 10.1210/endo-84-3-557; ROSS CA, 1985, J COMP NEUROL, V242, P511, DOI 10.1002/cne.902420405; SAWCHENKO PE, 1981, SCIENCE, V214, P685, DOI 10.1126/science.7292008; SCHERRER U, 1990, NEW ENGL J MED, V322, P602, DOI 10.1056/NEJM199003013220906; SHICHIRI M, 1990, JAMA-J AM MED ASSOC, V263, P661, DOI 10.1001/jama.1990.03440050055027; TOMITA K, 1990, J CLIN INVEST, V85, P2014, DOI 10.1172/JCI114667; WALLIN BG, 1982, J AUTONOM NERV SYST, V6, P287; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YOSHIZAWA T, 1990, SCIENCE, V247, P462, DOI 10.1126/science.2405487; YOSHIZUMI M, 1989, BIOCHEM BIOPH RES CO, V161, P859, DOI 10.1016/0006-291X(89)92679-X; ZEIDEL ML, 1989, AM J PHYSIOL, V257, pC1101, DOI 10.1152/ajpcell.1989.257.6.C1101; ZERBE RL, 1983, AM J MED, V74, P265, DOI 10.1016/0002-9343(83)90625-3	20	135	141	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1542	1545		10.1016/0140-6736(91)92370-H	http://dx.doi.org/10.1016/0140-6736(91)92370-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683970				2022-12-28	WOS:A1991GW03600002
J	CALABRESE, G; VAGELLI, G; GUASCHINO, R; GONELLA, M				CALABRESE, G; VAGELLI, G; GUASCHINO, R; GONELLA, M			TRANSMISSION OF ANTI-HCV WITHIN THE HOUSEHOLD OF HEMODIALYSIS-PATIENTS	LANCET			English	Letter							HEPATITIS-C VIRUS		GEN HOSP CASALE MONFERRATO,IMMUNOHAEMOPATHOL SERV,I-15033 CASALE MONFERRATO,ITALY		CALABRESE, G (corresponding author), GEN HOSP CASALE MONFERRATO,NEPHROL & DIALYSIS SERV,I-15033 CASALE MONFERRATO,ITALY.							FASSBINDER W, 1991, NEPHROL DIAL TRAN S1, V6; HESS G, 1989, LANCET, V2, P987; KIYOSAWA K, 1991, J MED VIROL, V33, P114, DOI 10.1002/jmv.1890330209; MARCHESI D, 1988, NEPHROL DIAL TRANSPL, V3, P795; PEREZROMERO M, 1990, ANN INTERN MED, V113, P411, DOI 10.7326/0003-4819-113-5-411; SCHLIPKOETER U, 1990, 2ND INT C CURR TREND, P145; THALER MM, 1991, LANCET, V338, P17, DOI 10.1016/0140-6736(91)90006-B	7	61	61	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 7	1991	338	8780					1466	1466		10.1016/0140-6736(91)92774-V	http://dx.doi.org/10.1016/0140-6736(91)92774-V			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GT904	1683456				2022-12-28	WOS:A1991GT90400055
J	KOFLER, M; LEIS, AA; SHERWOOD, AM; DELAPASSE, JS; HALTER, JA				KOFLER, M; LEIS, AA; SHERWOOD, AM; DELAPASSE, JS; HALTER, JA			SAFETY OF TRANSCRANIAL MAGNETIC STIMULATION IN PATIENTS WITH ABDOMINALLY IMPLANTED ELECTRONIC DEVICES	LANCET			English	Letter							MOTOR				KOFLER, M (corresponding author), BAYLOR COLL MED,DIV RESTORAT NEUROL & HUMAN NEUROBIOL,HOUSTON,TX 77030, USA.		Kofler, Markus/P-5585-2019	Kofler, Markus/0000-0002-2962-0903				BARKER AT, 1985, LANCET, V1, P1106; BROUWER B, 1991, BRAIN, V114, P1395, DOI 10.1093/brain/114.3.1395; CLAUS D, 1990, ANN NEUROL, V28, P43; CRACCO RQ, 1987, NEUROSURGERY, V20, P199; Dimitrijevic M M, 1986, Cent Nerv Syst Trauma, V3, P129; Dimitrijevic M R, 1986, Cent Nerv Syst Trauma, V3, P145; SPIEGELMANN R, 1991, NEUROSURGERY, V28, P65, DOI 10.1227/00006123-199101000-00011	7	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 16	1991	338	8777					1275	1276		10.1016/0140-6736(91)92144-Q	http://dx.doi.org/10.1016/0140-6736(91)92144-Q			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GQ166	1682672				2022-12-28	WOS:A1991GQ16600047
J	BENZER, A; MITTERSCHIFFTHALER, G; MAROSI, M; LUEF, G; PUHRINGER, F; DELARENOTIERE, K; LEHNER, H; SCHMUTZHARD, E				BENZER, A; MITTERSCHIFFTHALER, G; MAROSI, M; LUEF, G; PUHRINGER, F; DELARENOTIERE, K; LEHNER, H; SCHMUTZHARD, E			PREDICTION OF NON-SURVIVAL AFTER TRAUMA - INNSBRUCK COMA SCALE	LANCET			English	Note							SCORES	421 severely injured patients admitted to a major trauma centre in Innsbruck during the ten years, 1981 to 1990, were investigated retrospectively for early prediction of survival by means of the Innsbruck Coma Scale (ICS). All 79 patients scoring 0 or 1 died within 21 days. The findings of this study indicate that the ICS allows a highly accurate prediction of non-survival in patients with scores of 0 or 1 even at the time of first examination after trauma.	UNIV HOSP INNSBRUCK,DEPT NEUROL,A-6020 INNSBRUCK,AUSTRIA	Medical University of Innsbruck	BENZER, A (corresponding author), UNIV HOSP INNSBRUCK,DEPT ANAESTHESIA,ANICHSTR 35,A-6020 INNSBRUCK,AUSTRIA.							[Anonymous], 1988, Crit Care Med, V16, P807; CHANG RWS, 1988, INTENS CARE MED, V14, P558, DOI 10.1007/BF00263530; JACOBS P, 1990, CRIT CARE MED, V11, P1282; ROCCA B, 1989, J TRAUMA, V29, P299, DOI 10.1097/00005373-198903000-00004; TEASDALE G, 1974, LANCET, V2, P81	5	65	67	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					977	978		10.1016/0140-6736(91)91840-Q	http://dx.doi.org/10.1016/0140-6736(91)91840-Q			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681344				2022-12-28	WOS:A1991GK97400006
J	PANDEY, MR; DAULAIRE, NMP; STARBUCK, ES; HOUSTON, RM; MCPHERSON, K				PANDEY, MR; DAULAIRE, NMP; STARBUCK, ES; HOUSTON, RM; MCPHERSON, K			REDUCTION IN TOTAL UNDER-5 MORTALITY IN WESTERN NEPAL THROUGH COMMUNITY-BASED ANTIMICROBIAL TREATMENT OF PNEUMONIA	LANCET			English	Article							CHILDREN; INFECTION; IMPACT; GROWTH	Pneumonia is a leading cause of death among children world wide but those at highest risk in developing countries have limited access to clinical services; effective and low-cost alternatives are a global public health priority. We have done a controlled intervention trial among 13404 children under five in Jumla, Nepal, which relied exclusively on indigenous community health workers to detect and treat pneumonia according to the World Health Organisation decision strategy, with a five-day home-treatment course of oral co-trimoxazole. No other health services were provided, and referral of children to hospital was not practicable. During the three-year study, 2101 deaths were recorded. The programme led to a 28% reduction in the risk of death from all causes by the third year of services (relative risk 0.72, 95% confidence interval 0.63-0.82), with a significant trend (p < 0.02) of lower mortality with greater duration of the programme. The greatest benefit was among infants. In addition to reduction in deaths due to pneumonia, there was a significant reduction in deaths due to diarrhoea and measles, indicating that reduction in pneumonia morbidity had considerable carry-over effect. Our findings show that indigenous community workers can effectively detect and treat pneumonia, and reduce overall child mortality, even without other primary care activities.	INT CTR PREVENT & TREATMENT MAJOR CHILDHOOD DIS, POB 168, HANOVER, NH 03755 USA; MRIGENDRA MED TRUST, Kathmandu, NEPAL; UNIV LONDON LONDON SCH HYG & TROP MED, DEPT PUBL HLTH & POLICY, LONDON WC1E 7HT, ENGLAND; JOHN SNOW INC, BOSTON, MA USA	University of London; London School of Hygiene & Tropical Medicine								BANG AT, 1990, LANCET, V336, P201, DOI 10.1016/0140-6736(90)91733-Q; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; DAULAIRE NMP, 1990, ALRI CHILD SURVIVAL; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; Gadomski A., 1990, Health Policy and Planning, V5, P235, DOI 10.1093/heapol/5.3.235; KHAN AJ, 1990, B WORLD HEALTH ORGAN, V68, P577; LAUNER LJ, 1990, AM J EPIDEMIOL, V131, P322, DOI 10.1093/oxfordjournals.aje.a115501; Leowski J, 1986, World Health Stat Q, V39, P138; MANTEL N, 1968, BIOMETRICS, V24, P997, DOI 10.2307/2528886; MARTORELL R, 1975, AM J DIS CHILD, V129, P1296, DOI 10.1001/archpedi.1975.02120480022007; Martorell R, 1984, POPUL DEV REV, V10, P49, DOI 10.2307/2807955; MCCORD C, 1978, TROP DOCT, V8, P220, DOI 10.1177/004947557800800420; MOSLEY WH, 1988, CHILD SURVIVAL PROGR; MTANGO FDE, 1986, T ROY SOC TROP MED H, V80, P851, DOI 10.1016/0035-9203(86)90241-5; PANDEY MR, 1989, ANN TROP PAEDIATR, V9, P212, DOI 10.1080/02724936.1989.11748635; ROWLAND MGM, 1988, AM J CLIN NUTR, V47, P134, DOI 10.1093/ajcn/47.1.134; SELWYN BJ, 1990, REV INFECT DIS, V12, pS870; SHANN F, 1984, B WORLD HEALTH ORGAN, V62, P749; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; SHRESTHA MP, 1982, JUMLA COMMUNITY HLTH; ZUMRAWI FY, 1987, HUM NUTR-CLIN NUTR, V41C, P453; 1985, WHORSD85151985 DOC; 1990, WHOARI9051990 DOC; 1986, WHORSD8515REV21686 D; 1990, RATIONAL USE DRUGS M	25	90	90	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	1991	338	8773					993	997		10.1016/0140-6736(91)91847-N	http://dx.doi.org/10.1016/0140-6736(91)91847-N			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681351				2022-12-28	WOS:A1991GK97400013
J	HOLLOWELL, JG; HILL, PD; DUFFY, PG; RANSLEY, PG				HOLLOWELL, JG; HILL, PD; DUFFY, PG; RANSLEY, PG			BLADDER FUNCTION AND DYSFUNCTION IN EXSTROPHY AND EPISPADIAS	LANCET			English	Article								Bladder exstrophy and epispadias are congenital abnormalities of the urinary bladder. Evaluation of bladder function before and after bladder-neck reconstruction has not been done in patients with these conditions. We report the preliminary results of a prospective study of lower-urinary-tract function in 36 children (10 girls, 26 boys; age range 1.5-16 years) with bladder exstrophy and epispadias. Children's bladder function was measured by cystometry and cystography, and their upper urinary tracts were examined by ultrasound imaging. Normal bladder function was seen in children with primary epispadias but this was severely impaired in children who had had conventional bladder-neck surgery for continence, implying that this may not be the optimal treatment. Contrary to current assumption, children with closed exstrophy bladders are not capable of normal function, and the abnormalities we identified may be a major cause of upper-urinary-tract damage and may impair development of bladder capacity. Although unrecognised in the past, involuntary bladder contractions are a primary cause of urine leakage persisting in children with exstrophy and epispadias after continence surgery. Detailed functional testing should become a routine part of the evaluation of children with exstrophy and epispadias.	HOSP SICK CHILDREN,DEPT UROL,LONDON WC1N 3JL,ENGLAND; ST PETERS HOSP,DEPT PAEDIAT UROL,LONDON WC2A 2EX,ENGLAND; ST PETERS HOSP,DEPT MED PHYS,LONDON WC2A 2EX,ENGLAND	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London								ANSELL JS, 1979, J UROLOGY, V121, P650, DOI 10.1016/S0022-5347(17)56924-4; BLOOM DA, 1991, DIAL PED UROL, V14, P2; DECTER RM, 1988, J UROLOGY, V140, P1202, DOI 10.1016/S0022-5347(17)42002-7; GEARHART JP, 1988, J UROLOGY, V139, P790, DOI 10.1016/S0022-5347(17)42639-5; HOLLOWELL JG, IN PRESS BR J UROL; JEFFS RD, 1986, CAMPELLS UROLOGY, V2, P1882; OSTERLING JE, 1987, J UROLOGY, V137, P258; RANSLEY PG, 1988, PAEDIAT SURG, P620	8	36	36	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 12	1991	338	8772					926	928		10.1016/0140-6736(91)91784-R	http://dx.doi.org/10.1016/0140-6736(91)91784-R			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GJ899	1681276				2022-12-28	WOS:A1991GJ89900014
J	FEDER, HM; ABRAHAMIAN, LM; GRANTKELS, JM				FEDER, HM; ABRAHAMIAN, LM; GRANTKELS, JM			IS PENICILLIN STILL THE DRUG OF CHOICE FOR NONBULLOUS IMPETIGO	LANCET			English	Editorial Material							SKIN INFECTIONS; ERYTHROMYCIN; MUPIROCIN; PYODERMA; CHILDREN		UNIV CONNECTICUT,CTR HLTH,DEPT MED,FARMINGTON,CT 06032; UNIV CONNECTICUT,CTR HLTH,DIV DERMATOL,FARMINGTON,CT 06032	University of Connecticut; University of Connecticut	FEDER, HM (corresponding author), UNIV CONNECTICUT,CTR HLTH,DEPT FAMILY MED,FARMINGTON,CT 06032, USA.							Barton L L, 1987, Pediatr Dermatol, V4, P185, DOI 10.1111/j.1525-1470.1987.tb00776.x; BRAUNWALD E, 1987, HARRISONS PRINCIPLES, P547; BRITTON JW, 1990, J PEDIATR-US, V117, P827; COSKEY RJ, 1987, J AM ACAD DERMATOL, V17, P62, DOI 10.1016/S0190-9622(87)70171-6; DAGAN R, 1989, AM J DIS CHILD, V143, P916, DOI 10.1001/archpedi.1989.02150200068020; DEMIDOVICH CW, 1990, AM J DIS CHILD, V144, P1313, DOI 10.1001/archpedi.1990.02150360037015; DILLON HC, 1970, J PEDIATR, V76, P676, DOI 10.1016/S0022-3476(70)80284-0; DISNEY FA, 1983, AM J DIS CHILD, V137, P361, DOI 10.1001/archpedi.1983.02140300039011; EELLS LD, 1986, ARCH DERMATOL, V122, P1273, DOI 10.1001/archderm.122.11.1273; ESTERLY NB, 1991, AM J DIS CHILD, V145, P125; ESTERLY NB, 1970, J AMER MED ASSOC, V212, P1667, DOI 10.1001/jama.212.10.1667; HABIF TP, 1990, CLIN DERMATOL, P188; HAINS CS, 1989, PEDIATR INFECT DIS J, V8, P648, DOI 10.1097/00006454-198909000-00018; MANELL GL, 1985, PRINCIPLES PRACTICES, P598; MCLINN S, 1988, PEDIATR INFECT DIS J, V7, P785; PETER G, 1977, NEW ENGL J MED, V297, P311, DOI 10.1056/NEJM197708112970606; ROGERS M, 1978, MED J AUSTRALIA, V147, P63; SCHACHNER L, 1983, PEDIATR CLIN N AM, V30, P397; 1990, PEDIATR INFECT DIS J, V16, P11; 1988, REPORT COMMITTEE INF, P392	20	4	4	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					803	805		10.1016/0140-6736(91)90679-J	http://dx.doi.org/10.1016/0140-6736(91)90679-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681172				2022-12-28	WOS:A1991GG97900016
J	MANSON, JE; RIMM, EB; STAMPFER, MJ; COLDITZ, GA; WILLETT, WC; KROLEWSKI, AS; ROSNER, B; HENNEKENS, CH; SPEIZER, FE				MANSON, JE; RIMM, EB; STAMPFER, MJ; COLDITZ, GA; WILLETT, WC; KROLEWSKI, AS; ROSNER, B; HENNEKENS, CH; SPEIZER, FE			PHYSICAL-ACTIVITY AND INCIDENCE OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN WOMEN	LANCET			English	Article							GLUCOSE-TOLERANCE; PREVALENCE; EXERCISE; RISK; POPULATION; PACIFIC; WEIGHT	The potential role of physical activity in the primary prevention of non-insulin-dependent diabetes mellitus (NIDDM) is largely unknown. We examined the association between regular vigorous exercise and the subsequent incidence of NIDDM in a prospective cohort of 87 253 US women aged 34-59 years and free of diagnosed diabetes, cardiovascular disease, and cancer in 1980. During 8 years of follow-up, we confirmed 1303 cases of NIDDM. Women who engaged in vigorous exercise at least once per week had an age-adjusted relative risk (RR) of NIDDM of 0.67 (p < 0.0001) compared with women who did not exercise weekly. After adjustment for body-mass index, the reduction in risk was attenuated but remained statistically significant (RR = 0.84, p = 0.005). When analysis was restricted to the first 2 years after ascertainment of physical activity level and to symptomatic NIDDM as the outcome, age-adjusted RR of those who exercised was 0.5, and age and body-mass index adjusted RR was 0.69. Among women who exercised at least once per week, there was no clear dose-response gradient according to frequency of exercise. Family history of diabetes did not modify the effect of exercise, and risk reduction with exercise was evident among both obese and nonobese women. Multivariate adjustments for age, body-mass index, family history of diabetes, and other variables did not alter the reduced risk found with exercise. Our results indicate that physical activity may be a promising approach to the primary prevention of NIDDM.	HARVARD UNIV,SCH MED,DEPT MED,CHANNING LAB,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115; JOSLIN LABET CTR,BOSTON,MA; HARVARD UNIV,SCH MED,DEPT PREVENT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School			Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036798] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline; NIDDK NIH HHS [DK36798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKNIELSEN H, 1989, DIABETES METAB REV, V5, P487, DOI 10.1002/dmr.5610050602; BJORNTORP P, 1982, RECENT TREND DIABETE, P115; BURSTEIN R, 1985, DIABETES, V34, P756, DOI 10.2337/diabetes.34.8.756; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DAHM GL, 1987, AM J PHYSIOL, V252, pE170; DOWSE GK, 1991, DIABETES CARE, V14, P271, DOI 10.2337/diacare.14.4.271; FRISCH RE, 1986, DIABETES, V35, P1101, DOI 10.2337/diabetes.35.10.1101; HARRASS MC, 1985, AQUAT TOXICOL, V6, P1, DOI 10.1016/0166-445X(85)90015-3; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; JARRETT RJ, 1986, DIABETIC MED, V3, P549, DOI 10.1111/j.1464-5491.1986.tb00813.x; KING H, 1986, MED J AUSTRALIA, V145, P505, DOI 10.5694/j.1326-5377.1986.tb139452.x; KING H, 1984, AM J EPIDEMIOL, V119, P396, DOI 10.1093/oxfordjournals.aje.a113758; KOIVISTO V A, 1986, Diabetes Metabolism Reviews, V1, P445; LAPORTE RE, 1983, J GERONTOL, V38, P394, DOI 10.1093/geronj/38.4.394; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RUDERMAN N, 1990, DIABETES CARE, V13, P1163, DOI 10.2337/diacare.13.11.1163; SCHNEIDER SH, 1984, DIABETOLOGIA, V26, P355, DOI 10.1007/BF00266036; SICONOLFI SF, 1985, AM J EPIDEMIOL, V122, P101, DOI 10.1093/oxfordjournals.aje.a114068; STERN JS, 1987, RECENT ADV OBESITY R, P337; TAYLOR R, 1984, DIABETOLOGIA, V27, P578, DOI 10.1007/BF00276971; WASHBURN RA, 1990, AM J EPIDEMIOL, V132, P107, DOI 10.1093/oxfordjournals.aje.a115622; WASHBURN RA, 1987, PREV MED, V16, P636, DOI 10.1016/0091-7435(87)90047-8; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; ZIMMET P, 1981, DIABETES, V30, P45, DOI 10.2337/diabetes.30.1.45; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203; 1979, DIABETES, V28, P1039	28	865	881	0	39	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 28	1991	338	8770					774	778		10.1016/0140-6736(91)90664-B	http://dx.doi.org/10.1016/0140-6736(91)90664-B			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GG979	1681160				2022-12-28	WOS:A1991GG97900003
J	PETERSON, CA; GORDON, H; HALL, ZW; PATERSON, BM; BLAU, HM				PETERSON, CA; GORDON, H; HALL, ZW; PATERSON, BM; BLAU, HM			NEGATIVE CONTROL OF THE HELIX-LOOP-HELIX FAMILY OF MYOGENIC REGULATORS IN THE NFB MUTANT	CELL			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; NCI,BIOCHEM LAB,BETHESDA,MD 20892	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	PETERSON, CA (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305, USA.				NICHD NIH HHS [HD18179, HD20203] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179, R01HD020203] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AKHURST RJ, 1988, MOL CELL BIOL, V8, P2335, DOI 10.1128/MCB.8.6.2335; ALONSO LG, 1986, ROUX ARCH DEV BIOL, V195, P259, DOI 10.1007/BF02438959; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BLAU HM, 1989, TRENDS GENET, V5, P268, DOI 10.1016/0168-9525(89)90100-5; BOTAS J, 1982, EMBO J, V1, P307, DOI 10.1002/j.1460-2075.1982.tb01165.x; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BRENNAN TJ, 1990, J CELL BIOL, V110, P929, DOI 10.1083/jcb.110.4.929; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; CHASIN LA, 1974, P NATL ACAD SCI USA, V71, P718, DOI 10.1073/pnas.71.3.718; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P246; DELPRADO JM, 1984, W ROUX ARCH DEV BIOL, V193, P242; DEMARINI DM, 1989, MUTAT RES, V220, P11, DOI 10.1016/0165-1110(89)90006-7; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Esko J D, 1986, Methods Enzymol, V129, P237; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRISCHER LE, 1986, CELL, V47, P1017, DOI 10.1016/0092-8674(86)90816-0; GARCIABELLIDO A, 1978, GENETICS, V88, P469; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; GRAHAM F, 1973, VIROLOGY, V52, P452; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HARDEMAN EC, 1988, J CELL BIOL, V106, P1027, DOI 10.1083/jcb.106.4.1027; HARDEMAN EC, 1986, CELL, V47, P123, DOI 10.1016/0092-8674(86)90373-9; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JORGENSEN EM, 1987, GENE DEV, V1, P544, DOI 10.1101/gad.1.6.544; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LAWRENCE JB, 1984, DEV BIOL, V101, P463, DOI 10.1016/0012-1606(84)90160-X; LEAVITT J, 1985, NATURE, V316, P840, DOI 10.1038/316840a0; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LIM RW, 1984, DEV BIOL, V105, P48, DOI 10.1016/0012-1606(84)90260-4; LIN ZY, 1989, GENE DEV, V3, P986, DOI 10.1101/gad.3.7.986; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MINTY A, 1986, MOL CELL BIOL, V6, P2137, DOI 10.1128/MCB.6.6.2137; MONTARRAS D, 1989, EMBO J, V8, P2203, DOI 10.1002/j.1460-2075.1989.tb08343.x; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NGUYEN HT, 1983, CELL, V34, P281, DOI 10.1016/0092-8674(83)90159-9; PAVLATH GK, 1986, J CELL BIOL, V102, P124, DOI 10.1083/jcb.102.1.124; PERIASAMY M, 1984, J BIOL CHEM, V259, P3595; PINNEY DF, 1988, CELL, V53, P781, DOI 10.1016/0092-8674(88)90095-5; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; RINGERTZ NR, 1978, EXP CELL RES, V113, P233, DOI 10.1016/0014-4827(78)90363-4; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SAEZ L, 1986, NUCLEIC ACIDS RES, V14, P2951, DOI 10.1093/nar/14.7.2951; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; Strauss WM, 1987, CURRENT PROTOCOLS MO, P631; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TAUBMAN MB, 1989, J CELL BIOL, V108, P1799, DOI 10.1083/jcb.108.5.1799; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; WEISBLUM B, 1974, CHROMOSOMA, V46, P255; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; WRIGHT WE, 1984, J CELL BIOL, V98, P427, DOI 10.1083/jcb.98.2.427; WRIGHT WE, 1983, CELL DIFFER DEV, V12, P299, DOI 10.1016/0045-6039(83)90026-X; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	75	68	68	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 10	1990	62	3					493	502		10.1016/0092-8674(90)90014-6	http://dx.doi.org/10.1016/0092-8674(90)90014-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1696180				2022-12-28	WOS:A1990DU44500011
J	HIGGINSON, I; WADE, A; MCCARTHY, M				HIGGINSON, I; WADE, A; MCCARTHY, M			PALLIATIVE CARE - VIEWS OF PATIENTS AND THEIR FAMILIES	BRITISH MEDICAL JOURNAL			English	Article											HIGGINSON, I (corresponding author), UNIV COLL & MIDDLESEX SCH MED,DEPT COMMUNITY MED,LONDON WC1E 6EA,ENGLAND.		McCarthy, Mark/C-1117-2009; Higginson, Irene J/C-7309-2012	Higginson, Irene J/0000-0002-3687-1313				BARNETT M, 1987, INT C S SERIES, V123, P78; CARTWRIGHT A, 1973, LIFE DEATH; COPPERMAN H, 1988, J ROY COLL GEN PRACT, V38, P411; DOYLE D, 1989, INT C S SERIES, V149, P165; DUNLOP RJ, 1989, PALLIAT MED, V0003, P00197, DOI DOI 10.1177/026921638900300305; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; GILLEY J, 1988, J ROY COLL GEN PRACT, V38, P121; HAINES A, 1986, BRIT MED J, V292, P1051, DOI 10.1136/bmj.292.6527.1051; HIGGINSON I, 1989, J ROY SOC MED, V82, P264, DOI 10.1177/014107688908200507; HIGGINSON I, 1988, SAFER DEATH, P205; HIGGINSON I, 1989, PALLIATIVE MED, V3, P267; HIGGINSON I, 1989, INT C S SERIES, V149, P217; HINTON J, 1979, LANCET, V1, P29; LUNT B, 1985, SOC SCI MED, V20, P753, DOI 10.1016/0277-9536(85)90066-8; MAGUIRE P, 1988, BRIT MED J, V297, P972, DOI 10.1136/bmj.297.6654.972; MOR V, 1988, HOSPICE EXPT; MOUNT BM, 1987, J CHRON DIS, V40, P545; Parkes C M, 1978, J R Coll Gen Pract, V28, P19; PARKES CM, 1984, POSTGRAD MED J, V60, P120, DOI 10.1136/pgmj.60.700.120; SEALE CF, 1989, SOC SCI MED, V28, P551, DOI 10.1016/0277-9536(89)90249-9; SPRENT P, 1989, APPLIED NONPARAMETRI; 1986, LANCET, V1, P1013; 1980, J R COLL GEN PRACT, V30, P466	23	194	196	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 4	1990	301	6746					277	281		10.1136/bmj.301.6746.277	http://dx.doi.org/10.1136/bmj.301.6746.277			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT797	1697189	Green Published, Bronze			2022-12-28	WOS:A1990DT79700025
J	SPRENT, J; GAO, EK; WEBB, SR				SPRENT, J; GAO, EK; WEBB, SR			T-CELL REACTIVITY TO MHC MOLECULES - IMMUNITY VERSUS TOLERANCE	SCIENCE			English	Article											SPRENT, J (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,LA JOLLA,CA 92037, USA.				NATIONAL CANCER INSTITUTE [R37CA038355, R01CA038355, P01CA025803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021487] Funding Source: NIH RePORTER; NCI NIH HHS [CA38355, CA25803] Funding Source: Medline; NIAID NIH HHS [AI21487] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE R, 1989, ANNU REV IMMUNOL, V7, P683, DOI 10.1146/annurev.iy.07.040189.003343; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BOHME J, 1989, SCIENCE, V244, P1179, DOI 10.1126/science.2499048; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BURGERT HG, 1989, J EXP MED, V170, P1887, DOI 10.1084/jem.170.6.1887; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; BYRNE JA, 1988, J IMMUNOL, V141, P3249; Carbone F. R., 1989, Fundamental immunology., P541; CROUSE DA, 1985, SURV IMMUNOL RES, V4, P120; DEWAAL LP, 1981, EUR J IMMUNOL, V11, P258, DOI 10.1002/eji.1830110317; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FINK P, 1978, IMMUNOL REV, V42, P3; FINK PJ, 1988, ANNU REV IMMUNOL, V6, P115; FORD WL, 1975, PROG ALLERGY, V19, P1, DOI 10.1159/000313381; GAO EK, 1990, J EXP MED, V171, P1101, DOI 10.1084/jem.171.4.1101; GAO EK, 1989, J EXP MED, V170, P1947, DOI 10.1084/jem.170.6.1947; GAO EK, UNPUB; HAAS W, 1984, EUR J IMMUNOL, V14, P383, DOI 10.1002/eji.1830140421; JANEWAY C, 1989, IMMUNOL REV, V109, P59; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JENKINSON EJ, 1985, TRANSPLANTATION, V39, P331, DOI 10.1097/00007890-198503000-00030; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KANAGAWA O, 1989, J EXP MED, V170, P901, DOI 10.1084/jem.170.3.901; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAFFERTY KJ, 1983, ANNU REV IMMUNOL, V1, P119; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P525, DOI 10.1002/eji.1830180406; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MILLER RG, 1986, IMMUNOL TODAY, V7, P112, DOI 10.1016/0167-5699(86)90151-9; MORAHAN G, 1989, P NATL ACAD SCI USA, V86, P3782, DOI 10.1073/pnas.86.10.3782; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; OTTEN G, 1986, EUR J IMMUNOL, V16, P217, DOI 10.1002/eji.1830160302; PARKIN IG, 1988, IMMUNOLOGY, V64, P97; PIERRES A, 1984, J IMMUNOL, V132, P2775; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; ROBERTS JL, 1990, J EXP MED, V171, P935, DOI 10.1084/jem.171.3.935; ROSENBERG AS, 1987, J EXP MED, V165, P1296, DOI 10.1084/jem.165.5.1296; SCHUURMAN HJ, 1986, J IMMUNOL, V137, P2440; SCOLLAY R, 1985, RECOGNITION REGULATI, P3; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHIMONKEVITZ RP, 1988, J EXP MED, V168, P143, DOI 10.1084/jem.168.1.143; SINGER A, 1987, IMMUNOL REV, V98, P143, DOI 10.1111/j.1600-065X.1987.tb00523.x; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SPRENT J, 1987, ADV IMMUNOL, V41, P39, DOI 10.1016/S0065-2776(08)60030-9; SPRENT J, 1990, J IMMUNOL, V144, P2946; SPRENT J, 1986, J EXP MED, V163, P998, DOI 10.1084/jem.163.4.998; SPRENT J, 1971, CELL IMMUNOL, V2, P171, DOI 10.1016/0008-8749(71)90036-0; SPRENT J, 1988, J EXP MED, V167, P556, DOI 10.1084/jem.167.2.556; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; SPRENT J, 1978, IMMUNOL REV, V42, P108, DOI 10.1111/j.1600-065X.1978.tb00260.x; SPRENT J, 1985, J EXP MED, V162, P2068, DOI 10.1084/jem.162.6.2068; SPRENT J, 1976, CELL IMMUNOL, V21, P278, DOI 10.1016/0008-8749(76)90057-5; SPRENT J, UNPUB; STEINMAN RM, 1983, J EXP MED, V157, P613, DOI 10.1084/jem.157.2.613; VONBOEHMER H, 1984, EUR J IMMUNOL, V14, P1048, DOI 10.1002/eji.1830141116; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; WEBB SR, 1989, IMMUNOL REV, V107, P141, DOI 10.1111/j.1600-065X.1989.tb00007.x; WEBB SR, 1990, J EXP MED, V171, P953, DOI 10.1084/jem.171.3.953; WEBB SR, UNPUB; WIDERA G, 1987, CELL, V51, P175, DOI 10.1016/0092-8674(87)90145-0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	71	153	153	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 15	1990	248	4961					1357	1363		10.1126/science.1694041	http://dx.doi.org/10.1126/science.1694041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1694041				2022-12-28	WOS:A1990DJ50100029
J	STALEY, JP; KIM, PS				STALEY, JP; KIM, PS			ROLE OF A SUBDOMAIN IN THE FOLDING OF BOVINE PANCREATIC TRYPSIN-INHIBITOR	NATURE			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	STALEY, JP (corresponding author), MIT,DEPT CHEM,CAMBRIDGE,MA 02139, USA.							CREIGHTON TE, 1974, J MOL BIOL, V87, P603, DOI 10.1016/0022-2836(74)90106-5; CREIGHTON TE, 1981, J MOL BIOL, V151, P211, DOI 10.1016/0022-2836(81)90230-8; CREIGHTON TE, 1978, PROG BIOPHYS MOL BIO, V33, P231; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1977, J MOL BIOL, V113, P313, DOI 10.1016/0022-2836(77)90144-9; CREIGHTON TE, 1974, J MOL BIOL, V87, P579, DOI 10.1016/0022-2836(74)90105-3; DEISENHOFER J, 1975, ACTA CRYSTALLOGR B, V31, P238, DOI 10.1107/S0567740875002415; DEMARCO A, 1977, J MAGN RESON, V26, P527, DOI 10.1016/0022-2364(77)90104-4; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EIGENBROT C, UNPUB PROTEIN ENG; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; GOLDENBERG DP, 1984, J MOL BIOL, V179, P527, DOI 10.1016/0022-2836(84)90078-0; GOODMAN EM, IN PRESS CURRENT RES; LESK AM, 1981, P NATL ACAD SCI-BIOL, V78, P4304, DOI 10.1073/pnas.78.7.4304; MARKS CB, 1987, PROTEIN STRUCTURE FO, V2, P335; OAS TG, 1988, NATURE, V336, P42, DOI 10.1038/336042a0; PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1985, METHOD ENZYMOL, V115, P359; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; STATES DJ, 1980, NATURE, V286, P630, DOI 10.1038/286630a0; STATES DJ, 1987, J MOL BIOL, V195, P731, DOI 10.1016/0022-2836(87)90192-6; STATES DJ, 1984, J MOL BIOL, V174, P411, DOI 10.1016/0022-2836(84)90345-0; WAGNER G, 1987, J MOL BIOL, V196, P227, DOI 10.1016/0022-2836(87)90524-9; WAGNER G, 1976, BIOPHYS STRUCT MECH, V2, P139, DOI 10.1007/BF00863706; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WLODAWER A, 1987, J MOL BIOL, V198, P469, DOI 10.1016/0022-2836(87)90294-4	27	110	110	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 12	1990	344	6267					685	688		10.1038/344685a0	http://dx.doi.org/10.1038/344685a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY719	1691452				2022-12-28	WOS:A1990CY71900095
J	CHRISTAKIS, J; VAVATSI, N; HASSAPOPOULOU, H; PAPADOPOULOU, M; MANDRAVELI, K; LOUKOPOULOS, D; MORRIS, JS; SERJEANT, BE; SERJEANT, GR				CHRISTAKIS, J; VAVATSI, N; HASSAPOPOULOU, H; PAPADOPOULOU, M; MANDRAVELI, K; LOUKOPOULOS, D; MORRIS, JS; SERJEANT, BE; SERJEANT, GR			COMPARISON OF HOMOZYGOUS SICKLE-CELL DISEASE IN NORTHERN GREECE AND JAMAICA	LANCET			English	Article									UNIV W INDIES,KINGSTON 7,JAMAICA; MRC LABS JAMAICA,KINGSTON,JAMAICA; ARISTOTELIAN UNIV SALONIKA,AHEPA GEN HOSP,DEPT MED,SALONIKA,GREECE; ARISTOTELIAN UNIV SALONIKA,AHEPA GEN HOSP,DEPT HAEMATOL,SALONIKA,GREECE; ARISTOTELIAN UNIV SALONIKA,DEPT BIOL CHEM,SALONIKA,GREECE; UNIV ATHENS,LAIKON GEN HOSP,ATHENS,GREECE	University West Indies Mona Jamaica; Aristotle University of Thessaloniki; Ahepa University Hospital; Aristotle University of Thessaloniki; Ahepa University Hospital; Aristotle University of Thessaloniki; Laiko General Hospital; National & Kapodistrian University of Athens				Haviland, Joanne/0000-0001-5728-3636				BETKE K, 1959, NATURE, V184, P1877, DOI 10.1038/1841877a0; DELIYANNIS GA, 1955, BMJ-BRIT MED J, V2, P299, DOI 10.1136/bmj.2.4934.299; DOZY AM, 1979, NATURE, V280, P605, DOI 10.1038/280605a0; ELHAZMI MAF, 1987, HUM GENET, V76, P196, DOI 10.1007/BF00284921; EMBURY SH, 1982, NEW ENGL J MED, V306, P270, DOI 10.1056/NEJM198202043060504; EMOND AM, 1980, ARCH INTERN MED, V140, P1434, DOI 10.1001/archinte.140.11.1434; GIBBS WN, 1980, BRIT J HAEMATOL, V45, P73, DOI 10.1111/j.1365-2141.1980.tb03812.x; GRAHAM C, 1986, W INDIAN MED J, V35, P18; HAWKER H, 1982, BRIT J HAEMATOL, V50, P29; HAYES RJ, 1981, BRIT J OPHTHALMOL, V65, P29, DOI 10.1136/bjo.65.1.29; HEYMAN MB, 1985, LANCET, V1, P903; HIGGS DR, 1982, NEW ENGL J MED, V306, P1441, DOI 10.1056/NEJM198206173062402; KAR BC, 1986, LANCET, V2, P1198; KULOZIK AE, 1988, BLOOD, V71, P467; MILLARD DP, 1977, BRIT J HAEMATOL, V36, P161, DOI 10.1111/j.1365-2141.1977.tb00636.x; PERRINE RP, 1978, ANN INTERN MED, V88, P1, DOI 10.7326/0003-4819-88-1-1; SCHILIRO G, IN PRESS ACTA HAEMAT; SEAKINS M, 1973, J CLIN INVEST, V52, P422, DOI 10.1172/JCI107199; SERJEANT GR, 1985, SICKLE CELL DISEASE; STEINBERG MH, 1988, BLOOD, V71, P748	20	31	31	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 17	1990	335	8690					637	640		10.1016/0140-6736(90)90419-6	http://dx.doi.org/10.1016/0140-6736(90)90419-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU314	1690325				2022-12-28	WOS:A1990CU31400011
J	ADA, GL				ADA, GL			THE IMMUNOLOGICAL PRINCIPLES OF VACCINATION	LANCET			English	Article											ADA, GL (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT IMMUNOL & INFECT DIS,BALTIMORE,MD 21205, USA.							ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; ADA GL, 1969, NATURE, V222, P1291, DOI 10.1038/2221291a0; ADA GL, 1989, FUNDAMENTAL IMMUNOLO, P985; ALLEN PM, 1987, IMMUNOL REV, V98, P171, DOI 10.1111/j.1600-065X.1987.tb00524.x; BLOOM BR, 1986, J IMMUNOL, V137, pR1; BUUS S, 1987, IMMUNOL REV, V98, P115, DOI 10.1111/j.1600-065X.1987.tb00522.x; Carbone F. R., 1989, Fundamental immunology., P541; GELL PGH, 1959, IMMUNOLOGY, V2, P64; GOOD MF, 1988, IMMUNOL TODAY, V9, P351, DOI 10.1016/0167-5699(88)91336-9; GOULD K, 1989, J EXP MED, V170, P1051, DOI 10.1084/jem.170.3.1051; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; GUIDOS C, 1987, IMMUNOLOGY, V61, P269; JONES PD, 1987, CELL IMMUNOL, V109, P53, DOI 10.1016/0008-8749(87)90291-7; JONES WR, 1988, LANCET, V1, P1295; PAUL WE, 1989, FUNDAMENTAL IMMUNOLO, P3; SELA M, 1969, SCIENCE, V166, P1365, DOI 10.1126/science.166.3911.1365; SKAZAL AK, 1989, ANNU REV IMMUNOL, V7, P91; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; WHITTON JL, 1989, J EXP MED, V170, P1033, DOI 10.1084/jem.170.3.1033	19	77	82	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					523	526		10.1016/0140-6736(90)90748-T	http://dx.doi.org/10.1016/0140-6736(90)90748-T			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1689787	hybrid			2022-12-28	WOS:A1990CT01500015
J	ROSENGARTEN, R; WISE, KS				ROSENGARTEN, R; WISE, KS			PHENOTYPIC SWITCHING IN MYCOPLASMAS - PHASE VARIATION OF DIVERSE SURFACE LIPOPROTEINS	SCIENCE			English	Article											ROSENGARTEN, R (corresponding author), UNIV MISSOURI,DEPT MOLEC MICROBIOL & IMMUNOL,COLUMBIA,MO 65212, USA.							ANDERSEN H, 1987, J GEN MICROBIOL, V133, P181; Barile MF, 1979, MYCOPLASMAS, V2, P425; BOYER MJ, 1989, INFECT IMMUN, V57, P245, DOI 10.1128/IAI.57.1.245-254.1989; BRICKER TM, 1988, INFECT IMMUN, V56, P295, DOI 10.1128/IAI.56.2.295-301.1988; DEEB BJ, 1967, J BACTERIOL, V93, P1416, DOI 10.1128/JB.93.4.1416-1424.1967; DELGIUDICE RA, 1980, CURR MICROBIOL, V4, P75, DOI 10.1007/BF02602896; DONELSON JE, 1989, MOBILE DNA, P763; DUNCAN JR, 1978, AM J VET RES, V34, P363; FERRELL RV, 1989, MOL MICROBIOL, V3, P957, DOI 10.1111/j.1365-2958.1989.tb00245.x; GOIS M, 1974, J MED MICROBIOL, V7, P105, DOI 10.1099/00222615-7-1-105; GOURLAY RN, 1983, ARCH VIROL, V77, P81, DOI 10.1007/BF01314867; HAY RJ, 1989, NATURE, V339, P487, DOI 10.1038/339487a0; HAYASHI R, 1973, J BIOL CHEM, V248, P2296; KOTANI H, 1986, J CLIN MICROBIOL, V23, P783, DOI 10.1128/JCM.23.4.783-785.1986; KRAUSE DC, 1983, INFECT IMMUN, V39, P830, DOI 10.1128/IAI.39.2.830-836.1983; LISS A, 1983, INFECT IMMUN, V41, P1245, DOI 10.1128/IAI.41.3.1245-1251.1983; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; ROSENGARTEN R, UNPUB; ROSS RF, 1973, ANN NY ACAD SCI, V225, P347, DOI 10.1111/j.1749-6632.1973.tb45662.x; SEIFERT HS, 1988, MICROBIOL REV, V52, P327, DOI 10.1128/MMBR.52.3.327-336.1988; SOLL DR, 1989, MOBILE DNA, P791; STOCKER BAD, 1949, J HYG-CAMBRIDGE, V47, P398, DOI 10.1017/S002217240001473X; Tully J.G., 1983, METHODS MYCOPLASMOLO, P173; VALDIVIESOGARCIA A, 1982, VET REC, V110, P470, DOI 10.1136/vr.110.20.470; WATSON HL, 1988, INFECT IMMUN, V56, P1358, DOI 10.1128/IAI.56.5.1358-1363.1988; WHITTLESTONE P, 1979, MYCOPLASMAS, V2, P133; WOODS JP, 1989, MOL MICROBIOL, V3, P43, DOI 10.1111/j.1365-2958.1989.tb00102.x; WU HC, 1986, CURR TOP MICROBIOL, V125, P127	28	134	138	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 19	1990	247	4940					315	318		10.1126/science.1688663	http://dx.doi.org/10.1126/science.1688663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ669	1688663				2022-12-28	WOS:A1990CJ66900033
J	BERMAN, SA; BURSZTAJN, S; BOWEN, B; GILBERT, W				BERMAN, SA; BURSZTAJN, S; BOWEN, B; GILBERT, W			LOCALIZATION OF AN ACETYLCHOLINE-RECEPTOR INTRON TO THE NUCLEAR-MEMBRANE	SCIENCE			English	Article									BAYLOR UNIV,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030; HARVARD UNIV,DEPT CELLULAR & DEV BIOL,CAMBRIDGE,MA 02138	Baylor University; Baylor University; Harvard University	BERMAN, SA (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT NEUROONCOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.				NINDS NIH HHS [NS00820, NS00965, NS23477] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K04NS000820] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERMAN SA, 1988, NEUR ABSTR, V14, P880; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BRUNER JM, 1986, DEV BIOL, V115, P35, DOI 10.1016/0012-1606(86)90225-3; BURSZTAJN S, 1989, P NATL ACAD SCI USA, V86, P2928, DOI 10.1073/pnas.86.8.2928; BURSZTAJN S, 1985, J CELL BIOL, V101, P104, DOI 10.1083/jcb.101.1.104; BURSZTAJN S, 1984, J NEUROCYTOL, V13, P501; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; CHANG KS, 1985, NUCLEIC ACIDS RES, V13, P1223, DOI 10.1093/nar/13.4.1223; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; EARLEY JM, 1984, NUCLEIC ACIDS RES, V12, P7411, DOI 10.1093/nar/12.19.7411; FONTAINE B, 1989, J CELL BIOL, V108, P1025, DOI 10.1083/jcb.108.3.1025; HARRIS DA, 1989, NATURE, V337, P173, DOI 10.1038/337173a0; HAYWARD LJ, 1986, J CELL BIOL, V102, P1485, DOI 10.1083/jcb.102.4.1485; HOROVITZ O, 1989, J CELL BIOL, V108, P1823, DOI 10.1083/jcb.108.5.1823; HOWE JG, 1986, P NATL ACAD SCI USA, V83, P9006, DOI 10.1073/pnas.83.23.9006; HUTCHISON N, 1985, CELL, V43, P471, DOI 10.1016/0092-8674(85)90177-1; KLARSFELD A, 1985, P NATL ACAD SCI USA, V82, P4558, DOI 10.1073/pnas.82.13.4558; KLARSFELD A, 1987, MOL CELL BIOL, V7, P951, DOI 10.1128/MCB.7.2.951; KRONEBUSCH PJ, 1987, J CELL SCI, V1, P25; LAWRENCE JB, 1985, NUCLEIC ACIDS RES, V13, P1777; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LERNER MR, 1980, NATURE, V283, P220, DOI 10.1038/283220a0; MATTAJ IW, 1984, TRENDS BIOCHEM SCI, V9, P435, DOI 10.1016/0968-0004(84)90151-8; MERLIE JP, 1986, J MEMBRANE BIOL, V91, P1, DOI 10.1007/BF01870209; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; PAVLATH GK, 1989, NATURE, V337, P570, DOI 10.1038/337570a0; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630	28	45	45	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 12	1990	247	4939					212	214		10.1126/science.1688472	http://dx.doi.org/10.1126/science.1688472			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CH520	1688472				2022-12-28	WOS:A1990CH52000036
J	CAIRNS, HS; LEAKER, B; WOODHOUSE, CRJ; RUDGE, CJ; NEILD, GH				CAIRNS, HS; LEAKER, B; WOODHOUSE, CRJ; RUDGE, CJ; NEILD, GH			RENAL-TRANSPLANTATION INTO ABNORMAL LOWER URINARY-TRACT	LANCET			English	Article							ILEAL CONDUITS; DIVERSION; CHILDREN; FATE	Because doubts remain about the safety and efficacy of renal transplantation for patients with primary urological abnormalities, we have studied the outcome of transplantation in a large group of such patients. Between 1977 and 1989, 69 renal transplants were completed in 62 patients with abnormal lower urinary tracts (29 primary vesicoureteric reflux, 13 posterior urethral valves or bladder outflow obstruction, 6 vesicoureteric tuberculosis, 5 neuropathic bladders, and 9 miscellaneous causes). Graft survival in this urological group was similar to that in 150 allograft recipients (157 grafts) with end-stage renal failure of a non-urological cause. No aetiological subgroup had poorer graft survival than the others, although patients with recurrent urinary-tract infections and a history of outflow obstruction tended to have worse graft function. 9 patients (10 transplants) had renal transplantation into a urinary diversion (8 ileal conduits, 1 rectal bladder). These patients had graft survival and renal function comparable with those of the whole urological group. We found no effect of immunosuppressive treatment (cyclosporin or azathioprine), type of kidney donor (living or cadaveric), or donor or recipient age on graft survival time or renal function. Thus, renal transplantation in patients with abnormal lower urinary tracts is safe and effective; patients with ileal conduits do well and have few substantial difficulties. Preoperative assessment of bladder emptying and urodynamics are important in these patients.	UNIV LONDON UNIV COLL,INST UROL & NEPHROL,LONDON WC1E 6BT,ENGLAND	University of London; University College London			Neild, Guy/K-2513-2013					BARNETT M, 1985, J UROLOGY, V134, P654, DOI 10.1016/S0022-5347(17)47370-8; CHURCHILL BM, 1988, J UROLOGY, V140, P1129, DOI 10.1016/S0022-5347(17)41979-3; DUNN M, 1979, BRIT J UROL, V51, P458, DOI 10.1111/j.1464-410X.1979.tb03578.x; GLASS NR, 1985, J UROLOGY, V133, P666, DOI 10.1016/S0022-5347(17)49137-3; MACGREGOR P, 1986, J UROLOGY, V135, P686, DOI 10.1016/S0022-5347(17)45819-8; PITTS WR, 1979, J UROLOGY, V122, P154; REINBERG Y, 1988, J UROLOGY, V140, P1491, DOI 10.1016/S0022-5347(17)42082-9; SCHWARZ GR, 1975, J UROLOGY, V114, P285, DOI 10.1016/S0022-5347(17)67009-5; SHAPIRO SR, 1975, J UROLOGY, V114, P289, DOI 10.1016/S0022-5347(17)67010-1	9	47	47	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 30	1991	338	8779					1376	1379		10.1016/0140-6736(91)92247-Y	http://dx.doi.org/10.1016/0140-6736(91)92247-Y			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR773	1682747				2022-12-28	WOS:A1991GR77300014
J	SIMMONDS, P; BEATSON, D; CUTHBERT, RJG; WATSON, H; REYNOLDS, B; PEUTHERER, JF; PARRY, JV; LUDLAM, CA; STEEL, CM				SIMMONDS, P; BEATSON, D; CUTHBERT, RJG; WATSON, H; REYNOLDS, B; PEUTHERER, JF; PARRY, JV; LUDLAM, CA; STEEL, CM			DETERMINANTS OF HIV DISEASE PROGRESSION - 6-YEAR LONGITUDINAL-STUDY IN THE EDINBURGH HEMOPHILIA HIV COHORT	LANCET			English	Article							HEMOPHILIAC COHORT; INFECTION; AIDS; ACTIVATION	Markers of immune function present before infection may determine the subsequent course of disease in HIV-infected individuals. In 1983, we measured immune function in a group of haemophiliacs in Edinburgh. In 1984, 18 of these patients became infected with HIV-1 from contaminated factor VIII. We have followed-up these patients since their seroconversion. The rate of disease progression, as assessed by the appearance or not of Al DS symptoms or signs within five years of seroconversion, was related both to the concentration of total plasma IgM before exposure to infection and to the pattern of specific IgM and IgA anti-HIV response around the time of IgG seroconversion. Disease progression also correlated with concentrations of plasma interleukin-2 receptor (a marker of lymphocyte activation) and with the number and percentage of circulating DR + ve (activated) T cells. Our findings show that the extent of host immune reactivity, which may be genetically determined, is a powerful factor in the pathogenesis of HIV-associated disease.	WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV EDINBURGH, DEPT MED MICROBIOL, HEPATITIS REFERENCE LAB, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND; ROYAL INFIRM, DEPT HAEMATOL, EDINBURGH EH3 9HB, MIDLOTHIAN, SCOTLAND; ROYAL INFIRM, REG HAEMOPHILIA CTR, EDINBURGH EH3 9HB, MIDLOTHIAN, SCOTLAND; CENT PUBL HLTH LAB, VIRUS REFERENCE LAB, LONDON NW9 5HT, ENGLAND	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; Royal Infirmary of Edinburgh; Public Health England				Test, Tom/0000-0002-4998-5635; Simmonds, Peter/0000-0002-7964-4700				ASCHER MS, 1990, J ACQ IMMUN DEF SYND, V3, P177; BALFE P, 1990, J VIROL, V64, P6221, DOI 10.1128/JVI.64.12.6221-6233.1990; BRIEVA JA, 1985, CLIN EXP IMMUNOL, V59, P491; CARR R, 1984, LANCET, V1, P1431; CHEINGSONGPOPOV R, 1991, BMJ-BRIT MED J, V302, P23, DOI 10.1136/bmj.302.6767.23; CUTHBERT RJG, 1990, BMJ-BRIT MED J, V301, P956, DOI 10.1136/bmj.301.6758.956; EDELMAN AS, 1989, FASEB J, V3, P22, DOI 10.1096/fasebj.3.1.2562947; GEHA RS, 1979, J CLIN INVEST, V64, P385, DOI 10.1172/JCI109473; JONES P, 1983, LANCET, V1, P120; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; LANG JM, 1988, IMMUNOL LETT, V19, P99, DOI 10.1016/0165-2478(88)90126-5; LANGE JMA, 1989, AIDS, V3, pS153, DOI 10.1097/00002030-198901001-00023; LUDLAM CA, 1985, LANCET, V2, P233; MALLAL S, 1990, LANCET, V335, P1591, DOI 10.1016/0140-6736(90)91418-A; MANCA F, 1991, J IMMUNOL, V146, P1964; MAYER L, 1986, PRIMARY IMMUNODEFICI, P181; PARRY JV, 1986, J MED VIROL, V19, P387, DOI 10.1002/jmv.1890190411; PARRY JV, 1986, LANCET, V2, P979; PEUTHERER JF, 1990, LANCET, V336, P1008, DOI 10.1016/0140-6736(90)92470-3; SIMMONDS P, 1990, LANCET, V336, P1469, DOI 10.1016/0140-6736(90)93179-S; SIMMONDS P, 1988, BRIT MED J, V296, P593, DOI 10.1136/bmj.296.6622.593; STEEL CM, 1988, LANCET, V1, P1185; TEITEL JM, 1989, AM J HEMATOL, V32, P262, DOI 10.1002/ajh.2830320406; 1991, LANCET, P253	24	75	76	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	1991	338	8776					1159	1163		10.1016/0140-6736(91)92029-2	http://dx.doi.org/10.1016/0140-6736(91)92029-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GP034	1682589				2022-12-28	WOS:A1991GP03400001
J	RINKEL, GJE; WIJDICKS, EFM; HASAN, D; KIENSTRA, GEM; FRANKE, CL; HAGEMAN, LM; VERMEULEN, M; VANGIJN, J				RINKEL, GJE; WIJDICKS, EFM; HASAN, D; KIENSTRA, GEM; FRANKE, CL; HAGEMAN, LM; VERMEULEN, M; VANGIJN, J			OUTCOME IN PATIENTS WITH SUBARACHNOID HEMORRHAGE AND NEGATIVE ANGIOGRAPHY ACCORDING TO PATTERN OF HEMORRHAGE ON COMPUTED-TOMOGRAPHY	LANCET			English	Article							TERM FOLLOW-UP; UNKNOWN ETIOLOGY; CEREBRAL-ANGIOGRAPHY; ACUTE HYDROCEPHALUS; HEMORRHAGE; ANEURYSM; PROGNOSIS; COMPLICATIONS; ISCHEMIA; ORIGIN	15% of patients with spontaneous subarachnoid haemorrhage have normal cerebral angiograms; they fare better than patients with demonstrated aneurysms, though rebleeding and cerebral ischaemia can still occur. In patients with a normal angiogram and accumulation of blood in the cisterns around the midbrain-"perimesencephalic non-aneurysmal haemorrhage"-outcome is excellent. To test the hypothesis that rebleeding and disability in angiogram-negative subarachnoid haemorrhage might be limited to those with other patterns of haemorrhage on initial computed tomography (CT), complications and long-term outcome were studied in 113 patients with angiogram-negative subarachnoid haemorrhage, admitted between January, 1983, and July, 1990. All patients were investigated with third-generation CT scans within 72 h of the event, and with cerebral angiography. The mean follow-up period was 45 (range 6-96) months. None of 77 patients with a perimesencephalic pattern of haemorrhage on CT died or was left disabled as a result of the haemorrhage (0% [95% confidence interval 0-5%]). Among the other 36 patients, who had a blood distribution on CT indistinguishable from that in proven aneurysmal bleeds, 4 had rebleeds and 9 died or were left disabled as result of the haemorrhage (25% [14-43%]). Thus, two distinct subsets of patients with angiogram-negative subarachnoid haemorrhage should be recognised. Patients with a perimesencephalic pattern of haemorrhage have an excellent prognosis. Rebleeding, cerebral ischaemia, and residual disability occur exclusively in patients with aneurysmal patterns of haemorrhage on initial CT. Repeated angiography in search of an occult aneurysm is justified only in the patients with aneurysmal patterns.	ST ELIZABETH HOSP,DEPT NEUROL,TILBURG,NETHERLANDS; DE WEVER HOSP,DEPT NEUROL,HEERLEN,NETHERLANDS; UNIV ROTTERDAM,DEPT NEUROL,ROTTERDAM,NETHERLANDS; UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROSURG,1105 AZ AMSTERDAM,NETHERLANDS	Elisabeth-TweeSteden Ziekenhuis (ETZ); Erasmus University Rotterdam; University of Amsterdam; Academic Medical Center Amsterdam	RINKEL, GJE (corresponding author), STATE UNIV UTRECHT,DEPT NEUROL,HEIDELBERGLAAN 100,3584 CH UTRECHT,NETHERLANDS.		van Gijn, Jan/A-9444-2008	Hasan, Djo/0000-0003-4610-5433				ADAMS HP, 1987, NEUROLOGY, V37, P1586, DOI 10.1212/WNL.37.10.1586; BOHMFALK GL, 1980, J NEUROSURG, V52, P263, DOI 10.3171/jns.1980.52.2.0263; BRISMAR J, 1985, J NEUROSURG, V63, P349, DOI 10.3171/jns.1985.63.3.0349; DILORENZO N, 1988, NEUROSURGERY, V23, P494, DOI 10.1227/00006123-198810000-00016; DION JE, 1987, STROKE, V18, P997, DOI 10.1161/01.STR.18.6.997; EARNEST F, 1984, AM J ROENTGENOL, V142, P247, DOI 10.2214/ajr.142.2.247; ESKESEN V, 1984, J NEUROSURG, V61, P1029, DOI 10.3171/jns.1984.61.6.1029; GIOMBINI S, 1988, NEUROSURGERY, V22, P313, DOI 10.1227/00006123-198802000-00006; HAYWARD RD, 1977, J NEUROL NEUROSUR PS, V40, P926, DOI 10.1136/jnnp.40.9.926; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; HIJDRA A, 1987, STROKE, V18, P1061, DOI 10.1161/01.STR.18.6.1061; HIJDRA A, 1988, STROKE, V19, P1250, DOI 10.1161/01.STR.19.10.1250; IWANAGA H, 1990, NEUROSURGERY, V27, P45, DOI 10.1227/00006123-199007000-00006; JENNETT B, 1975, LANCET, V1, P480; JUUL R, 1986, J NEUROSURG, V64, P359, DOI 10.3171/jns.1986.64.3.0359; KAWAMURA S, 1990, ACTA NEUROCHIR, V106, P110, DOI 10.1007/BF01809451; KISTLER JP, 1983, NEUROLOGY, V33, P424, DOI 10.1212/WNL.33.4.424; MAMOURIAN A, 1990, AM J NEURORADIOL, V11, P1084; RINKEL GJE, 1990, J NEUROL NEUROSUR PS, V53, P354, DOI 10.1136/jnnp.53.4.354; RINKEL GJE, 1991, ANN NEUROL, V29, P463, DOI 10.1002/ana.410290503; RINKEL GJE, 1990, NEUROLOGY, V40, P1130, DOI 10.1212/WNL.40.7.1130; RINKEL GJE, IN PRESS AJNR; ROSS JS, 1990, AM J ROENTGENOL, V155, P159, DOI 10.2214/ajr.155.1.2112839; SPALLONE A, 1986, ACTA NEUROCHIR, V80, P12, DOI 10.1007/BF01809551; SUZUKI S, 1987, NEUROSURGERY, V21, P310, DOI 10.1227/00006123-198709000-00005; TEASDALE G, 1974, LANCET, V2, P81; VANGIJN J, 1980, NEUROLOGY, V30, P538, DOI 10.1212/WNL.30.5.538; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; WIJDICKS EFM, 1988, LANCET, V2, P68	30	230	243	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 19	1991	338	8773					964	968		10.1016/0140-6736(91)91836-J	http://dx.doi.org/10.1016/0140-6736(91)91836-J			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GK974	1681340				2022-12-28	WOS:A1991GK97400002
J	SHERMOEN, AW; OFARRELL, PH				SHERMOEN, AW; OFARRELL, PH			PROGRESSION OF THE CELL-CYCLE THROUGH MITOSIS LEADS TO ABORTION OF NASCENT TRANSCRIPTS	CELL			English	Article							EARLY DROSOPHILA DEVELOPMENT; INSITU HYBRIDIZATION; RNA-POLYMERASE; MELANOGASTER; DIVISION; EMBRYOS; PHOSPHORYLATION; EMBRYOGENESIS; SEGMENTATION; PATTERNS	Nascent transcripts of the Drosophila Ubx gene were detected by in situ hybridization. Following onset of expression, the progress of RNA polymerase (1.4 kb/min) across the gene was visualized as the successive appearance of hybridization signals from different positions within the transcription unit. Nascent transcripts disappeared at mitosis. Hybridization signals reappeared in the next cell cycle first with a 5' probe, and later, following a delay consistent with the transcription rate, with a 3' probe. Nascent transcripts were observed continuously in expressing cells of a mutant embryo in which cells are blocked in interphase. We conclude that progression through mitosis causes abortion of nascent transcripts and suggest that periodic abortion of transcription contributes to regulation of expression of large genes.	UNIV CALIF SAN FRANCISCO,INST CARDIOVASC,PROGRAM EXCELLENCE MOLEC BIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	SHERMOEN, AW (corresponding author), UNIV CALIF SAN FRANCISCO,INST CARDIOVASC,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.			O'Farrell, Patrick/0000-0003-0011-2734	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037193] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL43821] Funding Source: Medline; NIGMS NIH HHS [R01 GM037193-10, R01 GM37193, R01 GM037193] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAM M, 1985, EMBO J, V4, P1687; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; HARTENSTEIN V, 1990, DEV BIOL, V138, P147, DOI 10.1016/0012-1606(90)90184-K; HIRAOKA Y, 1990, J CELL BIOL, V111, P2815, DOI 10.1083/jcb.111.6.2815; IRVINE KD, 1991, DEVELOPMENT, V111, P407; JACK JW, 1979, P NATL ACAD SCI USA, V76, P1368, DOI 10.1073/pnas.76.3.1368; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LEE M, 1987, NATURE, V327, P287; LEHNER CF, 1990, EMBO J, V9, P3573, DOI 10.1002/j.1460-2075.1990.tb07568.x; LEMAIRE MF, 1990, MOL CELL BIOL, V10, P6059, DOI 10.1128/MCB.10.11.6059; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; MERRILL PT, 1988, DEVELOPMENT, V104, P495; MINDEN JS, 1989, J CELL BIOL, V109, P505, DOI 10.1083/jcb.109.2.505; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; OCONNOR MB, 1988, EMBO J, V7, P435, DOI 10.1002/j.1460-2075.1988.tb02831.x; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TAYLOR JH, 1960, ANN NY ACAD SCI, V90, P409, DOI 10.1111/j.1749-6632.1960.tb23259.x; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4	30	313	315	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 18	1991	67	2					303	310		10.1016/0092-8674(91)90182-X	http://dx.doi.org/10.1016/0092-8674(91)90182-X			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GL470	1680567	Green Accepted			2022-12-28	WOS:A1991GL47000010
J	CRUICKSHANK, JK; COOPER, J; BURNETT, M; MACDUFF, J; DRUBRA, U				CRUICKSHANK, JK; COOPER, J; BURNETT, M; MACDUFF, J; DRUBRA, U			ETHNIC-DIFFERENCES IN FASTING PLASMA C-PEPTIDE AND INSULIN IN RELATION TO GLUCOSE-TOLERANCE AND BLOOD-PRESSURE	LANCET			English	Article							DEPENDENT DIABETES-MELLITUS; BETA-CELL; POPULATION; DISEASE; HYPERINSULINEMIA; BIMODALITY; PREVALENCE; RESISTANCE; DEFICIENCY; SECRETION	The frequency of non-insulin-dependent diabetes mellitus (NIDDM) and of high blood pressure (or hypertension) is higher in some ethnic groups than in others for reasons that remain unclear. To investigate the mechanisms leading to these ethnic differences, plasma C-peptide and insulin concentrations were measured after overnight fast and during an oral glucose tolerance test in subjects aged 45-74 years sampled from the practice lists of two north west London health centres. Ethnic group was defined by grandparental origin as Afro-Caribbean in 106, Gujerati Indian in 107, and white European in 101. The total age-adjusted prevalence of NIDDM was 29% in the Afro-Caribbean, 30% in the Gujerati, and 3% in the white groups, respectively. Fasting C-peptide and insulin concentrations increased from the subgroup with normal glucose tolerance, through impaired glucose tolerance, to new NIDDM, and were lower again in subjects with known NIDDM. The odds ratio for new NIDDM was 1.87 (95% confidence interval 1.26-2.77) per 1 SD increase in fasting C-peptide, which was the most powerful independent indicator of new NIDDM (p = 0.0005) and accounted for the effect of ethnic group. Fasting insulin had a similarly strong effect. There was no relation between any index of insulin secretion and blood pressure or hypertension. There were differences among the ethnic groups in the C-peptide response relative to the insulin response. These results suggest that factors determining insulin secretion and its hepatic clearance, possibly including dietary fat, are the main causes of ethnic variation in rates of new NIDDM.	NORTHWICK PK HOSP & CLIN RES CTR,DEPT MED,HARROW HA1 3UJ,MIDDX,ENGLAND; NORTHWICK PK HOSP & CLIN RES CTR,MRC,EPIDEMIOL & MED CARE UNIT,HARROW HA1 3UJ,MIDDX,ENGLAND; RADCLIFFE INFIRM,DIABET RES LABS,OXFORD OX2 6HE,ENGLAND	Imperial College London; Imperial College London; Radcliffe Infirmary; University of Oxford					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBANO JDM, 1972, ACTA ENDOCRINOL-COP, V70, P487, DOI 10.1530/acta.0.0700487; Alleyne S I, 1989, Bull Pan Am Health Organ, V23, P306; BECKLES GLA, 1986, LANCET, V1, P1298; Bennett P H, 1976, Recent Prog Horm Res, V32, P333; CAHILL GF, 1988, NEW ENGL J MED, V318, P1268, DOI 10.1056/NEJM198805123181909; CLARK A, 1988, DIABETES RES, V9, P155; CRUICKSHANK JK, 1990, DIABETIC MED S2, V7, P52; CRUICKSHANK JK, 1989, ETHNIC FACTORS HLTH, P33; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Ferrannini E, 1989, J NEPHROL, V1, P3; HAFFNER SM, 1986, NEW ENGL J MED, V315, P220, DOI 10.1056/NEJM198607243150403; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; HUGHES LO, 1989, BRIT MED J, V299, P537, DOI 10.1136/bmj.299.6698.537; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; MILLER GJ, 1988, ATHEROSCLEROSIS, V70, P63, DOI 10.1016/0021-9150(88)90100-1; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; ORAHILLY SP, 1986, LANCET, V2, P360; POLONSKY KS, 1984, DIABETES, V33, P486, DOI 10.2337/diabetes.33.5.486; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROSENTHAL M, 1985, J CHRON DIS, V38, P5, DOI 10.1016/0021-9681(85)90003-7; SAAD MF, 1989, LANCET, V1, P1356; STOUT RW, 1990, DIABETES CARE, V13, P631, DOI 10.2337/diacare.13.6.631; TEMPLE RC, 1989, LANCET, V1, P293, DOI 10.1016/S0140-6736(89)91306-8; THOMPSON R, 1990, CLIN SCI S22, V78, P29; VERMA NPS, 1986, BRIT MED J, V293, P423, DOI 10.1136/bmj.293.6544.423; WARD WK, 1984, J CLIN INVEST, V74, P1318, DOI 10.1172/JCI111542; WELBORN TA, 1969, DIABETOLOGIA, V5, P263, DOI 10.1007/BF01212096; ZIMMET P, 1978, DIABETES, V27, P793, DOI 10.2337/diabetes.27.8.793	30	130	130	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					842	847		10.1016/0140-6736(91)91501-K	http://dx.doi.org/10.1016/0140-6736(91)91501-K			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GH945	1681214				2022-12-28	WOS:A1991GH94500003
J	KESSEL, M; GRUSS, P				KESSEL, M; GRUSS, P			HOMEOTIC TRANSFORMATIONS OF MURINE VERTEBRAE AND CONCOMITANT ALTERATION OF HOX CODES INDUCED BY RETINOIC ACID	CELL			English	Article							EMBRYONAL CARCINOMA-CELLS; CHICK LIMB BUD; HOMEOBOX-CONTAINING GENES; MOUSE EMBRYOS; EXPRESSION PATTERN; BOX GENE; SPATIAL-DISTRIBUTION; TRANSGENIC MICE; CODING SEQUENCE; DROSOPHILA	Exposure of murine embryos to teratogenic doses of retinoic acid (RA) induced homeotic transformations of vertebrae. Posterior transformations occurred along the complete body axis after RA administration on day 7 of gestation and were accompanied by anterior shifts of Hox gene expression domains in embryos. Anterior transformations of vertebrae in the caudal half of the vertebral column were induced on day 8.5. We suggest that the identity of a vertebral segment is specified by a combination of functionally active Hox genes, a "Hox code." In this concept the sequential activation of Hox genes defines sequentially more posterior axial levels, while mesodermal cells leave the primitive streak. Exogenous RA interferes with the normal estabishment of Hox codes and thus with axial specification.			KESSEL, M (corresponding author), MAX PLANCK INST BIOPHYS CHEM, MOLEK ZELLBIOL ABT, POB 2841, W-3400 GOTTINGEN, GERMANY.							AKAM M, 1988, DEVELOPMENT, V104, P123; ALTABA ARI, 1991, GENE DEV, V5, P175, DOI 10.1101/gad.5.2.175; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; Bateson W., 1894, MAT STUDY VARIATION, DOI [10.5962/bhl.title.1348, DOI 10.5962/BHL.TITLE.1348]; BELLAIRS R, 1986, ANAT EMBRYOL, V174, P1, DOI 10.1007/BF00318331; BOGARAD LD, 1989, DEV BIOL, V133, P537, DOI 10.1016/0012-1606(89)90056-0; BONCINELLI E, 1988, HUM REPROD, V3, P880, DOI 10.1093/oxfordjournals.humrep.a136802; BREIER G, 1986, EMBO J, V5, P2209, DOI 10.1002/j.1460-2075.1986.tb04486.x; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; CHEVALIER A, 1977, VERTEBRATE LIMB SOMI, P420; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; CHO KWY, 1990, GENE DEV, V4, P1910, DOI 10.1101/gad.4.11.1910; CHO KWY, 1991, CELL, V65, P55, DOI 10.1016/0092-8674(91)90407-P; COLBERGPOLEY AM, 1985, NATURE, V314, P713, DOI 10.1038/314713a0; CREECHKRAFT J, 1987, TOXICOL APPL PHARM, V87, P474; DESCHAMPS J, 1987, P NATL ACAD SCI USA, V84, P1304, DOI 10.1073/pnas.84.5.1304; DOLLE P, 1990, DEVELOPMENT, V110, P1133; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DOLLE P, 1991, IN PRESS MECH DEV; DRESSLER GR, 1989, DIFFERENTIATION, V41, P193, DOI 10.1111/j.1432-0436.1989.tb00747.x; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; ERSELIUS JR, 1990, DEVELOPMENT, V110, P629; FAINSOD A, 1987, DEV BIOL, V124, P125, DOI 10.1016/0012-1606(87)90465-9; FIBI M, 1988, DEVELOPMENT, V102, P349; FRISCHER LE, 1986, CELL, V47, P1017, DOI 10.1016/0092-8674(86)90816-0; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; FUJINAGA M, 1989, TERATOLOGY, V40, P439, DOI 10.1002/tera.1420400505; GAUNT SJ, 1987, DEVELOPMENT, V101, P51; GAUNT SJ, 1988, DEVELOPMENT, V103, P135; GAUNT SJ, 1990, DEVELOPMENT, V109, P329; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GAUNT SJ, 1989, DEVELOPMENT, V107, P131; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; GREEN EL, 1953, SCIENCE, V117, P81, DOI 10.1126/science.117.3030.81; GREGG BC, 1983, J EMBRYOL EXP MORPH, V731, P135; GRUNEBERG H, 1952, GENETICS MOUSE; GRUNEBERG H, 1950, J GENET, V50, P111; HORNBRUCH A, 1986, J EMBRYOL EXP MORPH, V94, P257; IZPISUABELMONTE JC, 1990, DEVELOPMENT, V110, P733; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; KESSEL M, 1990, CELL, V61, P301, DOI 10.1016/0092-8674(90)90810-2; KESSEL M, 1990, SCIENCE, V249, P374, DOI 10.1126/science.1974085; KESSEL M, 1987, P NATL ACAD SCI USA, V84, P5306, DOI 10.1073/pnas.84.15.5306; KEYNES R, 1990, NEURON, V2, P1; KIENY M, 1972, DEV BIOL, V28, P142, DOI 10.1016/0012-1606(72)90133-9; KOCHHAR DM, 1973, TERATOLOGY, V7, P289, DOI 10.1002/tera.1420070310; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MADEN M, 1988, NATURE, V335, P733, DOI 10.1038/335733a0; MAHON KA, 1988, DEVELOPMENT, V104, P187; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; MENKES B, 1977, VERTEBRATE LIMB SOMI, P405; NOHNO T, 1991, CELL, V64, P1197, DOI 10.1016/0092-8674(91)90274-3; NOJI S, 1991, NATURE, V350, P83, DOI 10.1038/350083a0; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; PUSCHEL AW, 1990, DEVELOPMENT, V108, P435; PUSCHEL AW, 1991, DEVELOPMENT, V112, P279; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; RUSSELL LB, 1956, J EXP ZOOL, V131, P329, DOI 10.1002/jez.1401310308; SATRE MA, 1989, DEV BIOL, V133, P529, DOI 10.1016/0012-1606(89)90055-9; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEARLE AG, 1954, J GENET, V52, P68, DOI 10.1007/BF02981491; SHARPE PT, 1988, DEVELOPMENT, V102, P397; SHENEFELT RE, 1972, TERATOLOGY, V5, P103, DOI 10.1002/tera.1420050115; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1991, MECH DEVELOP, V33, P169; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; SNOW MHL, 1987, SOMITES DEV EMBRYOS, P301; SUMMERBELL D, 1990, TRENDS NEUROSCI, V13, P142, DOI 10.1016/0166-2236(90)90006-V; SUNDIN OH, 1990, DEVELOPMENT, V108, P47; TAM PPL, 1987, DEVELOPMENT, V99, P109; TAMARIN A, 1984, J EMBRYOL EXP MORPH, V84, P105; TASSIN MT, 1981, J CRAN GENET DEV BIO, V1, P299; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; THEILER K, 1988, ADV ANAT EMBRYOL CEL, V90, P1; TIBBLES L, 1988, TERATOLOGY, V37, P113, DOI 10.1002/tera.1420370204; VOGELS R, 1990, IN PRESS DEVELOPMENT, V110; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WANEK N, 1991, NATURE, V350, P81, DOI 10.1038/350081a0; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; WRIGHT CVE, 1989, CELL, V59, P81, DOI 10.1016/0092-8674(89)90871-4; YASUDA Y, 1986, TERATOLOGY, V34, P37, DOI 10.1002/tera.1420340106	88	892	909	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	OCT 4	1991	67	1					89	104		10.1016/0092-8674(91)90574-I	http://dx.doi.org/10.1016/0092-8674(91)90574-I			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GJ320	1680565	hybrid			2022-12-28	WOS:A1991GJ32000009
J	MCANENA, OJ; AUSTIN, O; HEDERMAN, WP; GOREY, TF; FITZPATRICK, J; OCONNELL, PR				MCANENA, OJ; AUSTIN, O; HEDERMAN, WP; GOREY, TF; FITZPATRICK, J; OCONNELL, PR			LAPAROSCOPIC VERSUS OPEN APPENDECTOMY	LANCET			English	Letter									MATER MISERICORDIAE HOSP,DEPT SURG,DUBLIN 7,IRELAND	Mater Misericordiae University Hospital; University College Dublin			O'Connell, Patrick Ronan/H-6583-2019	O'Connell, Patrick Ronan/0000-0002-1846-5629				GANGAL HT, 1987, ENDOSCOPY, V19, P127, DOI 10.1055/s-2007-1018257; HOFFMANN J, 1989, BRIT J SURG, V76, P774, DOI 10.1002/bjs.1800760803	2	37	37	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 14	1991	338	8768					693	693		10.1016/0140-6736(91)91267-X	http://dx.doi.org/10.1016/0140-6736(91)91267-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GF105	1679490				2022-12-28	WOS:A1991GF10500029
J	LEVI, S; GOODLAD, RA; LEE, CY; STAMP, G; WALPORT, MJ; WRIGHT, NA; HODGSON, HJF				LEVI, S; GOODLAD, RA; LEE, CY; STAMP, G; WALPORT, MJ; WRIGHT, NA; HODGSON, HJF			INHIBITORY EFFECT OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON MUCOSAL CELL-PROLIFERATION ASSOCIATED WITH GASTRIC-ULCER HEALING	LANCET			English	Article									ROYAL POSTGRAD MED SCH,DEPT MED,DU CANE RD,LONDON W12 0NN,ENGLAND; IMPERIAL CANC RES FUND,HISTOPATHOL UNIT,LONDON WC2A 3PX,ENGLAND	Imperial College London; Cancer Research UK			Wright, Nicholas/HHY-7227-2022	Walport, Mark/0000-0001-7220-5273; Goodlad, Robert/0000-0002-7660-4287; Wright, Nicholas/0000-0002-5525-3457				ARMSTRONG CP, 1987, GUT, V28, P527, DOI 10.1136/gut.28.5.527; GOODLAD RA, 1989, GUT, V30, P316, DOI 10.1136/gut.30.3.316; GOODLAD RA, IN PRESS GUT; GRAHAM DY, 1988, GASTROENTEROLOGY, V95, P327, DOI 10.1016/0016-5085(88)90487-8; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HANSEN OH, 1975, GUT, V16, P23, DOI 10.1136/gut.16.1.23; HAWKEY CJ, 1990, BMJ-BRIT MED J, V300, P278, DOI 10.1136/bmj.300.6720.278; INAUEN W, 1988, GASTROENTEROLOGY, V95, P636, DOI 10.1016/S0016-5085(88)80009-X; ITO S, 1985, GASTROENTEROLOGY, V88, P250, DOI 10.1016/S0016-5085(85)80178-5; LAMY PP, 1987, SIDE EFFECTS ANTIINF, P151; LARKAI EN, 1987, AM J GASTROENTEROL, V82, P1153; LEUNG FW, 1985, GASTROENTEROLOGY, V88, P1948, DOI 10.1016/0016-5085(85)90024-1; OTTO AM, 1982, P NATL ACAD SCI-BIOL, V79, P4992, DOI 10.1073/pnas.79.16.4992; RICHARDSON CT, 1978, GASTROINTESTINAL DIS, P876; SOMERVILLE K, 1986, LANCET, V1, P462; WANG JY, 1989, GASTROENTEROLOGY, V96, P393, DOI 10.1016/0016-5085(89)91563-1; WHITTLE BJR, 1981, GASTROENTEROLOGY, V80, P94	17	183	191	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					840	843		10.1016/0140-6736(90)92341-E	http://dx.doi.org/10.1016/0140-6736(90)92341-E			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1699093				2022-12-28	WOS:A1990EB90100005
J	RIDEOUT, WM; COETZEE, GA; OLUMI, AF; JONES, PA				RIDEOUT, WM; COETZEE, GA; OLUMI, AF; JONES, PA			5-METHYLCYTOSINE AS AN ENDOGENOUS MUTAGEN IN THE HUMAN LDL RECEPTOR AND P53 GENES	SCIENCE			English	Article									UNIV SO CALIF,KENNETH NORRIS JR COMPREHENS CANC CTR,UROL CANC RES LAB,LOS ANGELES,CA 90033	University of Southern California			coetzee, Gerhard/AAT-6203-2020; Coetzee, Gerhard/AAG-8439-2019	Coetzee, Gerhard/0000-0001-8820-8364	NATIONAL CANCER INSTITUTE [R35CA049758, T32CA009569] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA49758, T32 CA09569] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BIRD AP, 1978, J MOL BIOL, V118, P49, DOI 10.1016/0022-2836(78)90243-7; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GRIPPO P, 1968, J MOL BIOL, V36, P195, DOI 10.1016/0022-2836(68)90375-6; HO YK, 1976, J CLIN INVEST, V58, P1465, DOI 10.1172/JCI108603; Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; LEITERSDORF E, 1989, J CLIN INVEST, V84, P954, DOI 10.1172/JCI114258; LINDAHL T, 1979, PROG NUCLEIC ACID RE, V22, P135; LUBBERT M, 1989, ONCOGENE, V4, P643; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; RIDEOUT WM, UNPUB; SELKER EU, 1987, MOL CELL BIOL, V7, P1032, DOI 10.1128/MCB.7.3.1032; SELKER EU, 1985, P NATL ACAD SCI USA, V82, P8114, DOI 10.1073/pnas.82.23.8114; TSAI YC, 1990, CANCER RES, V50, P44; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	26	588	602	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 14	1990	249	4974					1288	1290		10.1126/science.1697983	http://dx.doi.org/10.1126/science.1697983			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY351	1697983				2022-12-28	WOS:A1990DY35100035
J	FORSTER, AC; ALTMAN, S				FORSTER, AC; ALTMAN, S			EXTERNAL GUIDE SEQUENCES FOR AN RNA ENZYME	SCIENCE			English	Article									YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06520 USA	Yale University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019422, R37GM019422] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM19422] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; [Anonymous], COMMUNICATION; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BOTHWELL ALM, 1976, J BIOL CHEM, V251, P7709; CAMERON FH, 1989, P NATL ACAD SCI USA, V86, P9139, DOI 10.1073/pnas.86.23.9139; COTTEN M, 1989, EMBO J, V8, P3861, DOI 10.1002/j.1460-2075.1989.tb08564.x; DAVIES RW, 1982, NATURE, V300, P719, DOI 10.1038/300719a0; FORSTER AC, 1988, NATURE, V334, P265, DOI 10.1038/334265a0; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; FOURNIER MJ, 1985, MICROBIOL REV, V49, P379, DOI 10.1128/MMBR.49.4.379-397.1985; GUERRIERTAKADA C, 1988, CELL, V53, P267, DOI 10.1016/0092-8674(88)90388-1; GUERRIERTAKADA C, 1986, BIOCHEMISTRY-US, V25, P1509, DOI 10.1021/bi00355a006; GUERRIERTAKADA C, 1984, CELL, V38, P219, DOI 10.1016/0092-8674(84)90543-9; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HAMPEL A, 1990, NUCLEIC ACIDS RES, V18, P299, DOI 10.1093/nar/18.2.299; HASELOFF J, 1989, GENE, V82, P43, DOI 10.1016/0378-1119(89)90028-0; HASELOFF J, 1988, NATURE, V334, P585, DOI 10.1038/334585a0; HERSCHLAG D, 1990, NATURE, V344, P405, DOI 10.1038/344405a0; HSU LM, 1984, J MOL BIOL, V178, P509, DOI 10.1016/0022-2836(84)90236-5; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; LEE JY, 1989, MOL CELL BIOL, V9, P2536, DOI 10.1128/MCB.9.6.2536; MARSH TL, 1985, SCIENCE, V229, P79, DOI 10.1126/science.4012313; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; ORELLANA O, 1986, MOL CELL BIOL, V6, P525, DOI 10.1128/MCB.6.2.525; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Saenger W., 1984, PRINCIPLES NUCLEIC A, VDM79; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; USMAN N, 1987, J AM CHEM SOC, V109, P7845, DOI 10.1021/ja00259a037; VIOQUE A, 1988, J MOL BIOL, V202, P835, DOI 10.1016/0022-2836(88)90562-1; WALDER J, 1988, GENE DEV, V2, P502, DOI 10.1101/gad.2.5.502; WYATT JR, 1989, NUCLEIC ACIDS RES, V17, P7833, DOI 10.1093/nar/17.19.7833; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0	36	248	321	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	1990	249	4970					783	786		10.1126/science.1697102	http://dx.doi.org/10.1126/science.1697102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV088	1697102				2022-12-28	WOS:A1990DV08800033
J	MEURS, E; CHONG, K; GALABRU, J; THOMAS, NSB; KERR, IM; WILLIAMS, BRG; HOVANESSIAN, AG				MEURS, E; CHONG, K; GALABRU, J; THOMAS, NSB; KERR, IM; WILLIAMS, BRG; HOVANESSIAN, AG			MOLECULAR-CLONING AND CHARACTERIZATION OF THE HUMAN DOUBLE-STRANDED-RNA ACTIVATED PROTEIN-KINASE INDUCED BY INTERFERON	CELL			English	Article									UNIV TORONTO,HOSP SICK CHILDREN,DEPT MED GENET,TORONTO M5G 1X8,ONTARIO,CANADA; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cancer Research UK	MEURS, E (corresponding author), INST PASTEUR,UNITE ONCOL VIRALE,CNRS,UNITE 1157,25 RUE DR ROUX,F-75724 PARIS,FRANCE.		Williams, Bryan R. G./A-5021-2009	Williams, Bryan R. G./0000-0002-4969-1151				AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BECK TW, 1987, NUCLEIC ACIDS RES, V15, P525; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BISCHOFF JR, 1989, VIROLOGY, V172, P106, DOI 10.1016/0042-6822(89)90112-8; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; BUFFETJANVRESSE C, 1986, J INTERFERON RES, V6, P85, DOI 10.1089/jir.1986.6.85; BURKE DC, 1978, CELL, V13, P243, DOI 10.1016/0092-8674(78)90193-9; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DEBENEDETTI A, 1985, J BIOL CHEM, V260, P3135; DEBENEDETTI A, 1984, NATURE, V311, P79, DOI 10.1038/311079a0; DEBENEDETTI A, 1985, J VIROL, V54, P408, DOI 10.1128/JVI.54.2.408-413.1985; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; DURICA DS, 1987, GENE, V59, P63, DOI 10.1016/0378-1119(87)90267-8; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EDERY I, 1989, CELL, V56, P303, DOI 10.1016/0092-8674(89)90904-5; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; GALABRU J, 1985, CELL, V43, P685, DOI 10.1016/0092-8674(85)90241-7; GALABRU J, 1989, EUR J BIOCHEM, V178, P581, DOI 10.1111/j.1432-1033.1989.tb14485.x; GALABRU J, 1987, J BIOL CHEM, V262, P15538; Golgher R R, 1980, Ann N Y Acad Sci, V350, P448, DOI 10.1111/j.1749-6632.1980.tb20648.x; GUPTA SL, 1982, VIROLOGY, V120, P495, DOI 10.1016/0042-6822(82)90051-4; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNIGAN G, 1986, EMBO J, V5, P1607, DOI 10.1002/j.1460-2075.1986.tb04403.x; HIGGINS RC, 1979, ANAL BIOCHEM, V93, P257, DOI 10.1016/S0003-2697(79)80077-9; HOFFMANN FM, 1983, CELL, V35, P393, DOI 10.1016/0092-8674(83)90172-1; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; HOVANESSIAN AG, 1987, EUR J BIOCHEM, V167, P467, DOI 10.1111/j.1432-1033.1987.tb13360.x; HOVANESSIAN AG, 1987, VIROLOGY, V159, P126, DOI 10.1016/0042-6822(87)90355-2; HOVANESSIAN AG, 1979, EUR J BIOCHEM, V93, P515, DOI 10.1111/j.1432-1033.1979.tb12850.x; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; HOVANESSIAN AG, 1988, IMMUNOL TODAY, V9, P161, DOI 10.1016/0167-5699(88)91288-1; HOVANESSIAN AG, 1978, EUR J BIOCHEM, V84, P149, DOI 10.1111/j.1432-1033.1978.tb12151.x; HOVANESSIAN AG, 1980, BIOCHIMIE, V62, P775, DOI 10.1016/S0300-9084(80)80132-5; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KATZE MG, 1987, EMBO J, V6, P689, DOI 10.1002/j.1460-2075.1987.tb04809.x; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; KLEMSZ MJ, 1987, NUCLEIC ACIDS RES, V15, P9600, DOI 10.1093/nar/15.22.9600; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1986, ADV VIRUS RES, V31, P229, DOI 10.1016/S0065-3527(08)60265-1; KRUST B, 1984, J BIOL CHEM, V259, P8494; KRUST B, 1982, VIROLOGY, V120, P240, DOI 10.1016/0042-6822(82)90022-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Langan T A, 1978, Methods Cell Biol, V19, P127; LASKY SR, 1982, J BIOL CHEM, V257, P1087; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LEVIN D, 1978, P NATL ACAD SCI USA, V75, P1121, DOI 10.1073/pnas.75.3.1121; LEVIN DH, 1980, P NATL ACAD SCI-BIOL, V77, P832, DOI 10.1073/pnas.77.2.832; LEW DJ, 1989, MOL CELL BIOL, V9, P5404, DOI 10.1128/MCB.9.12.5404; Maniatis T., 1982, MOL CLONING; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MARCUS PI, 1988, J GEN VIROL, V69, P1637, DOI 10.1099/0022-1317-69-7-1637; MARK GE, 1986, P NATL ACAD SCI USA, V83, P6312, DOI 10.1073/pnas.83.17.6312; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MATTAJ IW, 1989, CELL, V57, P1, DOI 10.1016/0092-8674(89)90164-5; MEURS E, 1988, EMBO J, V7, P1689, DOI 10.1002/j.1460-2075.1988.tb02997.x; NILSEN TW, 1982, J BIOL CHEM, V257, P4593; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PETRYSHYN R, 1988, P NATL ACAD SCI USA, V85, P1427, DOI 10.1073/pnas.85.5.1427; RABBITTS TH, 1981, NUCLEIC ACIDS RES, V9, P4509, DOI 10.1093/nar/9.18.4509; RICE A, 1985, J VIROL, V50, P229; RICE AP, 1984, J VIROL, V50, P229, DOI 10.1128/JVI.50.1.229-236.1984; SAFER B, 1983, CELL, V33, P7, DOI 10.1016/0092-8674(83)90326-4; SAMUEL CE, 1979, P NATL ACAD SCI USA, V76, P600, DOI 10.1073/pnas.76.2.600; SAMUEL EC, 1984, P NATL ACAD SCI USA, V76, P515; SAUNDERS ME, 1985, EMBO J, V4, P1761, DOI 10.1002/j.1460-2075.1985.tb03848.x; SENGUPTA DN, 1989, NUCLEIC ACIDS RES, V17, P969, DOI 10.1093/nar/17.3.969; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SILVERMAN RH, 1987, LYMPHOKINES INTERFER, P149; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; SZYSZKA R, 1989, J BIOL CHEM, V264, P3827; TAKIO K, 1986, BIOCHEMISTRY-US, V25, P8049, DOI 10.1021/bi00372a038; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; TAYLOR GR, 1989, EMBO J, V8, P2029, DOI 10.1002/j.1460-2075.1989.tb03611.x; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TIWARI RK, 1988, MOL CELL BIOL, V8, P4289, DOI 10.1128/MCB.8.10.4289; WATSON R, 1982, P NATL ACAD SCI-BIOL, V79, P4078, DOI 10.1073/pnas.79.13.4078; WOOD JN, 1979, NATURE, V282, P74, DOI 10.1038/282074a0; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	84	850	881	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 27	1990	62	2					379	390		10.1016/0092-8674(90)90374-N	http://dx.doi.org/10.1016/0092-8674(90)90374-N			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR202	1695551				2022-12-28	WOS:A1990DR20200017
J	YEWDELL, JW; BENNINK, JR				YEWDELL, JW; BENNINK, JR			THE BINARY LOGIC OF ANTIGEN PROCESSING AND PRESENTATION TO T-CELLS	CELL			English	Review											YEWDELL, JW (corresponding author), NIAID,VIRAL DIS LAB,ROCKVILLE,MD 20852, USA.		yewdell, jyewdell@nih.gov jonathan/A-1702-2012					ALEXANDER J, 1990, IMMUNOGENETICS, V31, P169; BECK JC, 1986, J IMMUNOL, V137, P916; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; COX JH, 1990, SCIENCE, V247, P715, DOI 10.1126/science.2137259; DAVIS JE, 1990, J IMMUNOL, V144, P990; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HICKLING JK, 1990, INT IMMUNOL, V2, P435, DOI 10.1093/intimm/2.5.435; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; KJERNIELSEN L, 1990, J IMMUNOL, V144, P2915; MCMICHAEL A, 1990, NATURE, V345, P449; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; PERKINS DL, 1989, J EXP MED, V170, P279, DOI 10.1084/jem.170.1.279; PETERSON M, 1990, NATURE, V345, P172, DOI 10.1038/345172a0; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; WILLIAMS DB, 1985, J CELL BIOL, V101, P725, DOI 10.1083/jcb.101.3.725; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; YEWDELL JW, 1988, SCIENCE, V239, P637, DOI 10.1126/science.3257585	23	254	257	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 27	1990	62	2					203	206		10.1016/0092-8674(90)90356-J	http://dx.doi.org/10.1016/0092-8674(90)90356-J			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR202	1695549				2022-12-28	WOS:A1990DR20200001
J	NAWY, S; JAHR, CE				NAWY, S; JAHR, CE			SUPPRESSION BY GLUTAMATE OF CGMP-ACTIVATED CONDUCTANCE IN RETINAL BIPOLAR CELLS	NATURE			English	Article											NAWY, S (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,L474,PORTLAND,OR 97201, USA.			Nawy, Scott/0000-0003-4679-6756				ATTWELL D, 1987, J PHYSIOL-LONDON, V387, P125, DOI 10.1113/jphysiol.1987.sp016567; COBBS WH, 1985, NATURE, V317, P64, DOI 10.1038/317064a0; COPENHAGEN DR, 1983, VISION RES, V23, P363, DOI 10.1016/0042-6989(83)90083-4; ECKSTEIN F, 1979, J BIOL CHEM, V254, P9829; ERTEL E A, 1989, Biophysical Journal, V55, p458A; HAYNES LW, 1986, NATURE, V321, P66, DOI 10.1038/321066a0; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; KAWAMURA S, 1989, J GEN PHYSIOL, V94, P649, DOI 10.1085/jgp.94.4.649; MATTHEWS G, 1987, P NATL ACAD SCI USA, V84, P299, DOI 10.1073/pnas.84.1.299; MATTHEWS HR, 1985, NATURE, V313, P582, DOI 10.1038/313582a0; MURAKAMI M, 1975, VISION RES, V15, P456, DOI 10.1016/0042-6989(75)90101-7; NAWY S, 1990, NEUROSCI LETT, V108, P279, DOI 10.1016/0304-3940(90)90654-R; NAWY S, 1987, NATURE, V325, P56, DOI 10.1038/325056a0; PFAFFINGER P, 1988, J NEUROSCI, V8, P3343; SATHER WA, 1987, P NATL ACAD SCI USA, V84, P9290, DOI 10.1073/pnas.84.24.9290; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; TRUSSELL LO, 1987, J NEUROSCI, V7, P3306; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0; ZIMMERMAN AL, 1986, NATURE, V321, P70, DOI 10.1038/321070a0	23	380	387	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 19	1990	346	6281					269	271		10.1038/346269a0	http://dx.doi.org/10.1038/346269a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP456	1695713				2022-12-28	WOS:A1990DP45600065
J	GOLD, MR; LAW, DA; DEFRANCO, AL				GOLD, MR; LAW, DA; DEFRANCO, AL			STIMULATION OF PROTEIN TYROSINE PHOSPHORYLATION BY THE LYMPHOCYTE-B ANTIGEN RECEPTOR	NATURE			English	Article									UNIV CALIF SAN FRANCISCO, GEORGE WILLIAMS HOOPER FDN, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco			Gold, Michael/AAF-2081-2021	Gold, Michael/0000-0003-1222-3191				ASHWELL JD, 1984, J EXP MED, V159, P881, DOI 10.1084/jem.159.3.881; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; COGGESHALL KM, 1984, J IMMUNOL, V133, P3382; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; FAHEY KA, 1987, J IMMUNOL, V138, P3935; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLD MR, 1987, J IMMUNOL, V139, P3604; HARNETT MM, 1988, J IMMUNOL, V140, P3135; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HSI ED, 1989, J BIOL CHEM, V264, P10836; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, MOL CELL BIOL, V8, P176, DOI 10.1128/MCB.8.1.176; NEL AE, 1985, J IMMUNOL, V135, P3448; NOSSAL GJV, 1983, ANNU REV IMMUNOL, V1, P33, DOI 10.1146/annurev.iy.01.040183.000341; PAGE DM, 1988, J IMMUNOL, V140, P3717; PATEL MD, 1987, J BIOL CHEM, V262, P5831; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RALPH P, 1979, IMMUNOL REV, V48, P107, DOI 10.1111/j.1600-065X.1979.tb00300.x; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	24	397	407	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	1990	345	6278					810	813		10.1038/345810a0	http://dx.doi.org/10.1038/345810a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL646	1694265				2022-12-28	WOS:A1990DL64600059
J	MOSES, MA; SUDHALTER, J; LANGER, R				MOSES, MA; SUDHALTER, J; LANGER, R			IDENTIFICATION OF AN INHIBITOR OF NEOVASCULARIZATION FROM CARTILAGE	SCIENCE			English	Article									CHILDRENS HOSP MED CTR,DEPT SURG,BOSTON,MA 02115; MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02139; MIT,HARVARD MIT DIV HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139	Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)					NATIONAL EYE INSTITUTE [R01EY005333] Funding Source: NIH RePORTER; NEI NIH HHS [EY05333, EY06047] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AUERBACH R, 1985, MICROVASC RES, V29, P401, DOI 10.1016/0026-2862(85)90028-7; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; Brem H., 1988, ADV NEUROONCOLOGY, P89; CARMICHAEL DF, 1986, P NATL ACAD SCI USA, V83, P2407, DOI 10.1073/pnas.83.8.2407; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; DAMORE P, 1986, PROG CLIN BIOL RES, V221, P269; DAMORE PA, 1984, J CELL BIOL, V99, P1545, DOI 10.1083/jcb.99.4.1545; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; EISENSTEIN R, 1975, AM J PATHOL, V81, P337; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; FOLKMAN J, 1989, SCIENCE, V243, P1490, DOI 10.1126/science.2467380; GABRIELIDES C, 1987, BIOCHIM BIOPHYS ACTA, V924, P238, DOI 10.1016/0304-4165(87)90092-4; GLASER BM, 1980, NATURE, V288, P483, DOI 10.1038/288483a0; HITIHARPER J, 1978, SCIENCE, V199, P991, DOI 10.1126/science.203038; JOHNSONWINT B, 1980, ANAL BIOCHEM, V104, P175, DOI 10.1016/0003-2697(80)90295-X; KALEBIC T, 1983, SCIENCE, V221, P281, DOI 10.1126/science.6190230; LANGER R, 1980, P NATL ACAD SCI-BIOL, V77, P4331, DOI 10.1073/pnas.77.7.4331; LANGER R, 1976, SCIENCE, V193, P70, DOI 10.1126/science.935859; LEE A, 1983, SCIENCE, V221, P1185, DOI 10.1126/science.6193581; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; LUTTY GA, 1983, INVEST OPHTH VIS SCI, V24, P52; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MOSES MJ, UNPUB; MURRAY JB, 1986, J BIOL CHEM, V261, P4154; PATZ A, 1982, AM J OPHTHALMOL, V94, P715, DOI 10.1016/0002-9394(82)90297-5; PAULI BU, 1981, J NATL CANCER I, V67, P65; RIFKIN DB, 1982, PATHOBIOLOGY ENDOTHE, P191; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; SUDHALTER J, UNPUB; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0; THURGIERSSON UP, 1982, J NATL CANCER I, V69, P1049; 1989, NIH ID A20595 NAT BI	36	421	474	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 15	1990	248	4961					1408	1410		10.1126/science.1694043	http://dx.doi.org/10.1126/science.1694043			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1694043				2022-12-28	WOS:A1990DJ50100039
J	RAO, Y; JAN, LY; JAN, YN				RAO, Y; JAN, LY; JAN, YN			SIMILARITY OF THE PRODUCT OF THE DROSOPHILA NEUROGENIC GENE BIG BRAIN TO TRANSMEMBRANE CHANNEL PROTEINS	NATURE			English	Article									UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	RAO, Y (corresponding author), UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299				BRAND M, 1988, ROUX ARCH DEV BIOL, V197, P457, DOI 10.1007/BF00385679; BROEKHUYSE RM, 1979, EXP EYE RES, V29, P303, DOI 10.1016/0014-4835(79)90009-5; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; DELACONCHA A, 1988, GENETICS, V118, P499; Dietrich U, 1984, J Neurogenet, V1, P315, DOI 10.3109/01677068409107094; DOE CQ, 1985, DEV BIOL, V111, P206, DOI 10.1016/0012-1606(85)90446-4; EHRING GR, 1988, GAP JUNCTIONS, P335; FITZGERALD PG, 1983, J CELL BIOL, V97, P1491, DOI 10.1083/jcb.97.5.1491; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; HARTLEY DA, 1988, CELL, V55, P785, DOI 10.1016/0092-8674(88)90134-1; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; JIMENEZ F, 1982, ROUX ARCH DEV BIOL, V191, P191, DOI 10.1007/BF00848335; JOHNSON RG, 1988, GAP JUNCTIONS, P81; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; KNUST E, 1987, EMBO J, V6, P4113, DOI 10.1002/j.1460-2075.1987.tb02757.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEHMANN R, 1981, ROUX ARCH DEV BIOL, V190, P226, DOI 10.1007/BF00848307; LEHMANN R, 1983, ROUX ARCH DEV BIOL, V192, P62, DOI 10.1007/BF00848482; Lindsley D. L., 1967, GENETIC VARIATIONS D; MURAMATSU S, 1989, NUCLEIC ACIDS RES, V17, P4378; PAUL DL, 1983, J CELL BIOL, V96, P625, DOI 10.1083/jcb.96.3.625; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SANDAL NN, 1988, NUCLEIC ACIDS RES, V16, P9347, DOI 10.1093/nar/16.19.9347; SAS DF, 1985, J CELL BIOL, V100, P216, DOI 10.1083/jcb.100.1.216; SCHWARZ TL, 1988, NATURE, V331, P137, DOI 10.1038/331137a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STELLER H, 1986, MOL CELL BIOL, V6, P1640, DOI 10.1128/MCB.6.5.1640; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TECHNAU GM, 1987, P NATL ACAD SCI USA, V84, P4500, DOI 10.1073/pnas.84.13.4500; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; VERMA DPS, 1986, PLANT MOL BIOL, V7, P51, DOI 10.1007/BF00020131; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255	40	142	145	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	1990	345	6271					163	167		10.1038/345163a0	http://dx.doi.org/10.1038/345163a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC833	1692392				2022-12-28	WOS:A1990DC83300068
J	CAWTHORN, SJ; PARUMS, DV; GIBBS, NM; AHERN, RP; CAFFAREY, SM; BROUGHTON, CIM; MARKS, CG				CAWTHORN, SJ; PARUMS, DV; GIBBS, NM; AHERN, RP; CAFFAREY, SM; BROUGHTON, CIM; MARKS, CG			EXTENT OF MESORECTAL SPREAD AND INVOLVEMENT OF LATERAL RESECTION MARGIN AS PROGNOSTIC FACTORS AFTER SURGERY FOR RECTAL-CANCER	LANCET			English	Article									ROYAL SURREY CTY HOSP,DEPT SURG,GUILDFORD CU2 5TH,SURREY,ENGLAND; ROYAL SURREY CTY HOSP,DEPT PATHOL,GUILDFORD,ENGLAND; ROYAL MARSDEN HOSP,DEPT COMP,LONDON,ENGLAND	Royal Surrey County Hospital; Royal Surrey County Hospital; Royal Marsden NHS Foundation Trust				A'Hern, Roger/0000-0003-0593-8391				ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; BENTZEN SM, 1988, BRIT J CANCER, V58, P195, DOI 10.1038/bjc.1988.192; CAWTHORN SJ, 1986, BRIT J SURG, V73, P58, DOI 10.1002/bjs.1800730124; DAWSON PM, 1987, BRIT J SURG, V74, P366, DOI 10.1002/bjs.1800740514; DEMASCAREL A, 1981, SURG GYNECOL OBSTET, V153, P511; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; DUKES CE, 1930, BRIT J SURG, V17, P643; Gabriel WB, 1935, BRIT J SURG, V23, P395, DOI 10.1002/bjs.1800239017; GOLIGHER JC, 1951, BRIT J SURG, V39, P199, DOI 10.1002/bjs.18003915504; GRICOUROFF G, 1967, CANCER-AM CANCER SOC, V20, P673, DOI 10.1002/1097-0142(1967)20:5<673::AID-CNCR2820200517>3.0.CO;2-G; HEALD RJ, 1986, LANCET, V1, P1479; HEALD RJ, 1988, J ROY SOC MED, V81, P503, DOI 10.1177/014107688808100904; HOJO K, 1982, AM J SURG, V144, P350, DOI 10.1016/0002-9610(82)90018-6; JASS JR, 1987, LANCET, V1, P1303; KODNER IJ, 1989, ANN SURG, V209, P194, DOI 10.1097/00000658-198902000-00010; KOKAL WA, 1989, ANN SURG, V209, P188, DOI 10.1097/00000658-198902000-00009; MORSON BC, 1963, BMJ-BRIT MED J, P13, DOI 10.1136/bmj.2.5348.13; PHILLIPS RKS, 1984, BRIT J SURG, V71, P17, DOI 10.1002/bjs.1800710105; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; RAO AR, 1981, CANCER-AM CANCER SOC, V48, P1492, DOI 10.1002/1097-0142(19810915)48:6<1492::AID-CNCR2820480636>3.0.CO;2-K; SILVERMAN DT, 1977, AM J SURG, V133, P289, DOI 10.1016/0002-9610(77)90531-1; UMPLEBY HC, 1984, BRIT J SURG, V71, P659, DOI 10.1002/bjs.1800710902; WILLIAMS NS, 1988, BRIT J SURG, V75, P649, DOI 10.1002/bjs.1800750710; WOOD CB, 1981, BRIT J SURG, V68, P326, DOI 10.1002/bjs.1800680512; 1984, BRIT J SURG, V71, P21	26	264	267	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 5	1990	335	8697					1055	1059		10.1016/0140-6736(90)92631-Q	http://dx.doi.org/10.1016/0140-6736(90)92631-Q			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC568	1691810				2022-12-28	WOS:A1990DC56800003
J	STAMENKOVIC, I; SEED, B				STAMENKOVIC, I; SEED, B			THE B-CELL ANTIGEN CD22 MEDIATES MONOCYTE AND ERYTHROCYTE ADHESION	NATURE			English	Article									HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	STAMENKOVIC, I (corresponding author), HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115, USA.							ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BOSWELL HS, 1980, J IMMUNOL, V124, P989; DAVEY FR, 1983, CLIN EXP IMMUNOL, V54, P771; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DORKEN B, 1986, J IMMUNOL, V136, P4470; DORKEN B, 1987, LEUKOCYTE TYPING, V3, P369; EREMIN O, 1982, IMMUNOLOGY, V47, P321; HEINEN E, 1987, IMMUNOL TODAY, V8, P142, DOI 10.1016/0167-5699(87)90142-3; ITO S, 1984, J IMMUNOL, V133, P1891; JELINEK DF, 1987, ADV IMMUNOL, V40, P1, DOI 10.1016/S0065-2776(08)60237-0; KINCADE PW, 1987, ADV IMMUNOL, V41, P181, DOI 10.1016/S0065-2776(08)60032-2; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAI C, 1987, IMMUNOL REV, V100, P129, DOI 10.1111/j.1600-065X.1987.tb00530.x; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; MCGRAW DJ, 1982, AM J CLIN PATHOL, V77, P177; MOLDENHAUER G, IN PRESS LEUKOCYTE T, V4; MORRISSEY PJ, 1981, J IMMUNOL, V127, P1345; PEZZUTTO A, 1988, J IMMUNOL, V140, P1791; PEZZUTTO A, 1987, J IMMUNOL, V138, P98; SALZER JL, 1987, J CELL BIOL, V104, P957, DOI 10.1083/jcb.104.4.957; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHEN GL, 1988, INT J CANCER, V42, P792, DOI 10.1002/ijc.2910420527; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; ZALEWSKI PD, 1984, J IMMUNOL, V132, P2491	27	188	200	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 3	1990	345	6270					74	77		10.1038/345074a0	http://dx.doi.org/10.1038/345074a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB957	1691828				2022-12-28	WOS:A1990DB95700061
J	WOLFF, JA; MALONE, RW; WILLIAMS, P; CHONG, W; ACSADI, G; JANI, A; FELGNER, PL				WOLFF, JA; MALONE, RW; WILLIAMS, P; CHONG, W; ACSADI, G; JANI, A; FELGNER, PL			DIRECT GENE-TRANSFER INTO MOUSE MUSCLE INVIVO	SCIENCE			English	Article									VICAL INC,SAN DIEGO,CA 92121; UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT & HUMAN DEV,DEPT GENET,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	WOLFF, JA (corresponding author), UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT & HUMAN DEV,DEPT PEDIAT,MADISON,WI 53706, USA.		Malone, Robert/AAI-5317-2021	Malone, Robert/0000-0003-0340-7490	NICHD NIH HHS [HD03352, HD00669-05] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACSADI G, UNPUB; AUSBEL FM, 1989, CURRENT PROTOCOLS MO; BENVENISTY N, 1986, P NATL ACAD SCI USA, V83, P9551, DOI 10.1073/pnas.83.24.9551; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DUBENSKY TW, 1984, P NATL ACAD SCI-BIOL, V81, P7529, DOI 10.1073/pnas.81.23.7529; EGLITIS MA, 1988, BIOTECHNIQUES, V6, P608; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FELGNER PL, 1989, FOCUS, V11, P21; FELGNER PL, 1989, NATURE, V331, P461; FINN GK, 1989, MOL CELL BIOL, V9, P4009, DOI 10.1128/MCB.9.9.4009; Franzini-Armstrong C, 1986, MYOLOGY, P125; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LAVITRANO M, 1989, CELL, V57, P717, DOI 10.1016/0092-8674(89)90787-3; LEDLEY FD, 1987, J PEDIATR-US, V110, P1, DOI 10.1016/S0022-3476(87)80278-0; Malone, 1989, FOCUS, V11, P61; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; MANNINO RJ, 1988, BIOTECHNIQUES, V6, P682; NICOLAU C, 1983, P NATL ACAD SCI-BIOL, V80, P1068, DOI 10.1073/pnas.80.4.1068; NORTON PA, 1985, MOL CELL BIOL, V5, P281, DOI 10.1128/MCB.5.2.281; PAUZA CD, 1989, J VIROL, V63, P3700, DOI 10.1128/JVI.63.9.3700-3707.1989; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; REID TR, IN PRESS J BIOL CHEM; RUBIO R, 1972, Z ZELLFORSCH MIK ANA, V124, P57, DOI 10.1007/BF00981941; SEEGER C, 1984, P NATL ACAD SCI-BIOL, V81, P5849, DOI 10.1073/pnas.81.18.5849; SHIMOHAMA S, IN PRESS MOL BRAIN R; WU GY, 1988, J BIOL CHEM, V263, P14621	32	3001	3822	23	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 23	1990	247	4949					1465	1468		10.1126/science.1690918	http://dx.doi.org/10.1126/science.1690918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV282	1690918				2022-12-28	WOS:A1990CV28200037
J	NEWMAN, PJ; BERNDT, MC; GORSKI, J; WHITE, GC; LYMAN, S; PADDOCK, C; MULLER, WA				NEWMAN, PJ; BERNDT, MC; GORSKI, J; WHITE, GC; LYMAN, S; PADDOCK, C; MULLER, WA			PECAM-1 (CD31) CLONING AND RELATION TO ADHESION MOLECULES OF THE IMMUNOGLOBULIN GENE SUPERFAMILY	SCIENCE			English	Article									BLOOD CTR SE WISCONSIN INC, MILWAUKEE, WI 53233 USA; UNIV SYDNEY, WESTMEAD CTR, WESTMEAD, NSW 2145, AUSTRALIA; UNIV N CAROLINA, CHAPEL HILL, NC 27599 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	Versiti Blood Center of Wisconsin; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill; Rockefeller University			Berndt, Michael C/D-5580-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040926] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-40926] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; EDMUNDSON AB, 1975, BIOCHEMISTRY-US, V14, P3953, DOI 10.1021/bi00689a005; FITZGERALD LA, 1985, J BIOL CHEM, V260, P893; FITZGERALD LA, 1989, PLATELET IMMUNOBIOLO, P9; GEORGE JN, 1984, NEW ENGL J MED, V311, P1084, DOI 10.1056/NEJM198410253111705; GILTAY JC, 1989, BLOOD, V73, P1235; GOYERT SM, 1986, J IMMUNOL, V137, P3909; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HALL R, 1984, NATURE, V311, P379, DOI 10.1038/311379a0; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HUNKAPILLER T, 1986, NATURE, V323, P15, DOI 10.1038/323015a0; HUNTER T, 1982, J BIOL CHEM, V257, P4843; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KEATING MT, 1988, J BIOL CHEM, V263, P12805; KNAPP W, 1989, IMMUNOL TODAY, V10, P253, DOI 10.1016/0167-5699(89)90135-7; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; NEWMAN PJ, 1982, THROMB RES, V27, P221, DOI 10.1016/0049-3848(82)90202-X; NEWMAN PJ, 1986, J CELL BIOL, V103, P81, DOI 10.1083/jcb.103.1.81; NEWMAN PJ, 1989, PLATELET IMMUNOBIOLO, P148; NEWMAN PJ, UNPUB; NOVOTNY J, 1984, NUCLEIC ACIDS RES, V12, P243, DOI 10.1093/nar/12.1Part1.243; OHTO H, 1985, BLOOD, V66, P873; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P511, DOI 10.1016/0006-291X(87)90304-4; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PLOW EF, 1986, P NATL ACAD SCI USA, V83, P6002, DOI 10.1073/pnas.83.16.6002; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; SEEGER MA, 1988, CELL, V55, P589, DOI 10.1016/0092-8674(88)90217-6; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; VANMOURIK JA, 1985, J BIOL CHEM, V260, P1300; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WEINBERGER C, 1985, SCIENCE, V228, P740, DOI 10.1126/science.2581314; WHITE JM, 1989, CELL, V56, P725, DOI 10.1016/0092-8674(89)90674-0; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; 1990, IN PRESS 4TH INT WOR	45	871	922	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	1990	247	4947					1219	1222		10.1126/science.1690453	http://dx.doi.org/10.1126/science.1690453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT096	1690453				2022-12-28	WOS:A1990CT09600042
J	KLEIN, RS; FREEMAN, K; TAYLOR, PE; STEVENS, CE				KLEIN, RS; FREEMAN, K; TAYLOR, PE; STEVENS, CE			OCCUPATIONAL RISK FOR HEPATITIS-C VIRUS-INFECTION AMONG NEW-YORK-CITY DENTISTS	LANCET			English	Article							NON-B-HEPATITIS; NON-A; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; ANTIBODIES; EPIDEMIOLOGY; TRANSMISSION; PREVALENCE	Health-care workers have an occupational risk of infection with hepatitis C virus (HCV). However, neither the magnitude of this risk nor the practices associated with it have been defined. Since dentists have numerous patients and are exposed to blood, they are likely to have the maximum risk. Therefore, we have assessed occupational risk for HCV infection among dentists in the New York City area. Individuals who admitted present or previous intravenous drug use or (men) who were homosexual or bisexual were excluded. Demographic, occupational, and behavioural data were recorded, and sera were tested for antibodies to HCV (anti-HCV). Anti-HCV was found in 8 (1.75%) of 456 dentists compared with 1 (0.14%) of 723 controls (odds ratio [OR] 12.9, 95% confidence interval [Cl] 1.7 to 573). Anti-HCV was found in 4 (9.3%) of 43 oral surgeons compared with 4 (0.97%) of 413 other dentists (OR 10.5, 95% Cl 1.9 to 58). Seropositive dentists claimed to have treated more intravenous drug users in the week (p = 0.04) or month (p = 0.03) before the study than did seronegative dentists. Our findings show that dentists are at increased risk for hepatitis C infection. All health-care workers should regard patients as potentially infected with a communicable bloodborne agent.	MONTEFIORE MED CTR,DEPT BIOSTAT,BRONX,NY 10467; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT EPIDEMIOL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT SOCIAL MED,BRONX,NY 10461; NEW YORK BLOOD CTR,WOLF SZMUNESS LAB EPIDEMIOL,NEW YORK,NY 10021	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; New York Blood Center	KLEIN, RS (corresponding author), MONTEFIORE MED CTR,DEPT MED,DIV INFECT DIS,111 E 210TH ST,BRONX,NY 10467, USA.							AACH RD, 1991, NEW ENGL J MED, V325, P1325, DOI 10.1056/NEJM199111073251901; ABE K, 1987, J INFECT DIS, V155, P1078, DOI 10.1093/infdis/155.5.1078; AHTONE J, 1980, LANCET, V1, P1142; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; ALTER HJ, 1978, LANCET, V1, P459; ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; ALTER MJ, 1982, J INFECT DIS, V145, P886, DOI 10.1093/infdis/145.6.886; ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231; ALTER MJ, 1989, JAMA-J AM MED ASSOC, V262, P1201, DOI 10.1001/jama.262.9.1201; BRUIX J, 1989, LANCET, V2, P1004; COLOMBO M, 1989, LANCET, V2, P1006; ESTEBAN JI, 1990, NEW ENGL J MED, V323, P1107, DOI 10.1056/NEJM199010183231605; ESTEBAN JI, 1989, LANCET, V2, P294; FRANCIS DP, 1984, AM J MED, V76, P69, DOI 10.1016/0002-9343(84)90752-6; KATMITSUKASA H, 1989, LANCET, V2, P987; KEW MC, 1990, LANCET, V335, P873, DOI 10.1016/0140-6736(90)90474-J; KIYOSAWA K, 1991, ANN INTERN MED, V115, P367, DOI 10.7326/0003-4819-115-5-367; KLEIN RS, 1988, NEW ENGL J MED, V318, P86, DOI 10.1056/NEJM198801143180205; MOSLEY JW, 1975, JAMA-J AM MED ASSOC, V9, P967; SCHIFF ER, 1986, J AM DENT ASSOC, V113, P390, DOI 10.14219/jada.archive.1986.0210; STEVENS CE, 1990, JAMA-J AM MED ASSOC, V263, P49, DOI 10.1001/jama.263.1.49; TABOR E, 1978, LANCET, V1, P463, DOI 10.1016/s0140-6736(78)90132-0; TABOR E, 1983, J MED PRIMATOL, V12, P305; TABOR E, 1980, NEW ENGL J MED, V303, P139; WANG JT, 1991, LANCET, V337, P48, DOI 10.1016/0140-6736(91)93365-G; 1987, MMWR S2S, V36; 1988, MMWR, V37, P387; 1988, MMWR, V37, P377	28	148	153	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 21	1991	338	8782-3					1539	1542		10.1016/0140-6736(91)92369-D	http://dx.doi.org/10.1016/0140-6736(91)92369-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW036	1683969				2022-12-28	WOS:A1991GW03600001
J	SEGIL, N; ROBERTS, SB; HEINTZ, N				SEGIL, N; ROBERTS, SB; HEINTZ, N			MITOTIC PHOSPHORYLATION OF THE OCT-1 HOMEODOMAIN AND REGULATION OF OCT-1 DNA-BINDING ACTIVITY	SCIENCE			English	Article							HISTONE H2B GENE; GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; POU DOMAIN; CELL; PURIFICATION; PROTEINS	Oct-1 is a transcription factor involved in the cell cycle regulation of histone H2B gene transcription and in the transcription of other cellular housekeeping genes. Oct-1 is hyperphosphorylated as cells enter mitosis, and mitosis-specific phosphorylation is reversed as cells exit mitosis. A mitosis-specific phosphorylation site in the homeodomain of Oct-1 was phosphorylated in vitro by protein kinase A. Phosphorylation of this site correlated with inhibition of Oct-1 DNA binding activity in vivo and in vitro. The inhibition of Oct-1 DNA binding during mitosis suggests a mechanism by which the general inhibition of transcription during mitosis might occur.			SEGIL, N (corresponding author), ROCKEFELLER UNIV,HOWARD HUGHES MED INST,MOLEC BIOL LAB,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032544, F32GM013752] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 13752, GM 32544] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; BRADBURY EM, 1974, NATURE, V247, P257, DOI 10.1038/247257a0; DAVIDSON D, 1964, EXP CELL RES, V35, P317, DOI 10.1016/0014-4827(64)90098-9; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; HARLOW E, 1988, ANTIBODIES LABORATOR; HEINTZ N, 1984, P NATL ACAD SCI-BIOL, V81, P2713, DOI 10.1073/pnas.81.9.2713; HEMMINGS HC, 1984, J BIOL CHEM, V259, P4491; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LABELLA F, 1989, GENE DEV, V3, P1982, DOI 10.1101/gad.3.12a.1982; LABELLA F, 1991, MOL CELL BIOL, V11, P5825, DOI 10.1128/MCB.11.12.5825; LAMB NJC, 1991, EMBO J, V10, P1523, DOI 10.1002/j.1460-2075.1991.tb07672.x; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; ROBERTS SB, 1991, SCIENCE, V253, P1022, DOI 10.1126/science.1887216; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SAHASRABUDDHE CG, 1984, EXP CELL RES, V153, P439, DOI 10.1016/0014-4827(84)90612-8; Schreiber E., 1989, TISSUE SPECIFIC GENE, P33; SEGIL N, 1991, COLD SPRING HARB SYM, V56, P285; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TERASIMA T, 1963, EXP CELL RES, V30, P344, DOI 10.1016/0014-4827(63)90306-9; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	26	222	225	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 20	1991	254	5039					1814	1816		10.1126/science.1684878	http://dx.doi.org/10.1126/science.1684878			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GW316	1684878				2022-12-28	WOS:A1991GW31600051
J	SMITH, AD; JOBST, KA; NAVARATNAM, DS; SHEN, ZX; PRIDDLE, JD; MCDONALD, B; KING, E; ESIRI, MM				SMITH, AD; JOBST, KA; NAVARATNAM, DS; SHEN, ZX; PRIDDLE, JD; MCDONALD, B; KING, E; ESIRI, MM			ANOMALOUS ACETYLCHOLINESTERASE IN LUMBAR CSF IN ALZHEIMERS-DISEASE	LANCET			English	Letter									UNIV OXFORD,DEPT CLIN NEUROL,OXFORD OX1 3QT,ENGLAND; UNIV OXFORD,DEPT NEUROPATHOL,OXFORD OX1 3QT,ENGLAND	University of Oxford; University of Oxford	SMITH, AD (corresponding author), UNIV OXFORD,DEPT PHARMACOL,OXFORD OX1 3QT,ENGLAND.		Smith, Anthony D./A-4233-2010	Smith, Anthony D./0000-0002-1095-6722				KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; NAVARATNAM DS, 1991, LANCET, V337, P447, DOI 10.1016/0140-6736(91)93391-L; Roth M, 1988, CAMDEX CAMBRIDGE EXA	3	13	14	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1538	1538		10.1016/0140-6736(91)92367-B	http://dx.doi.org/10.1016/0140-6736(91)92367-B			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683967				2022-12-28	WOS:A1991GV07700067
J	MEADE, TW; COOPER, J; MILLER, GJ; HOWARTH, DJ; STIRLING, Y				MEADE, TW; COOPER, J; MILLER, GJ; HOWARTH, DJ; STIRLING, Y			ANTITHROMBIN-III AND ARTERIAL-DISEASE	LANCET			English	Note							HEMOSTATIC VARIABLES	Cross-sectional studies suggest that both low and high antithrombin III levels are associated with the risk of arterial disease, principally ischaemic heart disease (IHD). The prospective relation between antithrombin III and subsequent death from arterial disease has been investigated in 893 men in the Northwick Park Heart Study. Antithrombin III levels were directly correlated with high rather than low levels of factor VII activity and of plasma fibrinogen. There were more deaths from arterial disease in the low and high thirds of the antithrombin III distribution than in the middle third.			MEADE, TW (corresponding author), NORTHWICK PK HOSP & CLIN RES CTR,MRC,EPIDEMIOL & MED CARE UNIT,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND.							BANERJEE RN, 1974, THROMB DIATH HAEMOST, V31, P339, DOI 10.1055/s-0038-1649168; BROZE GJ, 1980, J BIOL CHEM, V255, P1242; FULLER JH, 1979, BMJ-BRIT MED J, V2, P964, DOI 10.1136/bmj.2.6196.964; HAINES AP, 1980, THROMB RES, V19, P139, DOI 10.1016/0049-3848(80)90413-2; INNERFIELD I, 1976, AM J CLIN PATHOL, V65, P64; JORDAN RE, 1982, J BIOL CHEM, V257, P400; MEADE TW, 1990, BRIT J HAEMATOL, V74, P77, DOI 10.1111/j.1365-2141.1990.tb02541.x; MEADE TW, 1977, BRIT MED BULL, V33, P283, DOI 10.1093/oxfordjournals.bmb.a071448; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MEADE TW, 1987, THROMB DIATH HAEMO, P37; MEADE TW, 1987, HAEMOSTASIS THROMBOS, P697; MEILAHN E, 1988, AM J EPIDEMIOL, V128, P908; OBRIEN JR, 1975, THROMB DIATH HAEMOST, V34, P483, DOI 10.1055/s-0038-1651407; ROSENBERG RD, 1984, REV HAEMATOLOGY; YUE RH, 1976, THROMB HAEMOSTASIS, V35, P598, DOI 10.1055/s-0038-1647958	15	57	57	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 5	1991	338	8771					850	851		10.1016/0140-6736(91)91503-M	http://dx.doi.org/10.1016/0140-6736(91)91503-M			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GH945	1681216				2022-12-28	WOS:A1991GH94500005
J	OHNO, R; TOMONAGA, M; KOBAYASHI, T; KANAMARU, A; SHIRAKAWA, S; MASAOKA, T; OMINE, M; OH, H; NOMURA, T; SAKAI, Y; HIRANO, M; YOKOMAKU, S; NAKAYAMA, S; YOSHIDA, Y; MIURA, AB; MORISHIMA, Y; DOHY, H; NIHO, Y; HAMAJIMA, N; TAKAKU, F				OHNO, R; TOMONAGA, M; KOBAYASHI, T; KANAMARU, A; SHIRAKAWA, S; MASAOKA, T; OMINE, M; OH, H; NOMURA, T; SAKAI, Y; HIRANO, M; YOKOMAKU, S; NAKAYAMA, S; YOSHIDA, Y; MIURA, AB; MORISHIMA, Y; DOHY, H; NIHO, Y; HAMAJIMA, N; TAKAKU, F			EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR AFTER INTENSIVE INDUCTION THERAPY IN RELAPSED OR REFRACTORY ACUTE-LEUKEMIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									NAGASAKI UNIV HOSP, DEPT MED, NAGASAKI, JAPAN; MIE UNIV HOSP, DEPT MED, TSU, JAPAN; HYOGO MED SCH, DEPT MED, KOBE, JAPAN; OSAKA ADULT DIS CTR, DEPT MED, OSAKA, JAPAN; GUNMA UNIV HOSP, DEPT MED, MAEBASHI, JAPAN; CHIBA UNIV HOSP, DEPT MED, CHIBA, JAPAN; NIPPON MED COLL HOSP, DEPT MED, TOKYO, JAPAN; KOMAGOME HOSP, DEPT CHEMOTHERAPY, TOKYO, JAPAN; FUJITA GAKUEN HLTH UNIV HOSP, DEPT MED, TOYOAKE, JAPAN; AICHI SHOKUIN HOSP, DEPT MED, NAGOYA, JAPAN; KOBE MUNICIPAL CTR HOSP, DEPT IMMUNOL & HEMATOL, KOBE, JAPAN; HIROSAKI UNIV HOSP, DEPT MED, HIROSAKI, JAPAN; AKITA UNIV HOSP, DEPT MED, AKITA, JAPAN; NAGOYA UNIV HOSP, DEPT MED, NAGOYA, JAPAN; HIROSHIMA RED CROSS HOSP, DEPT MED, HIROSHIMA, JAPAN; KYUSHU UNIV HOSP, DEPT MED, SUKUOKA, JAPAN; NAGOYA UNIV, SCH MED, DEPT PREVENT MED, NAGOYA, AICHI 466, JAPAN; TOKYO UNIV HOSP, DEPT MED, TOKYO, JAPAN	Nagasaki University; Mie University; University of Hyogo; Gunma University; Chiba University; Nippon Medical School; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Fujita Health University; Hirosaki University; Hiroshima University; Akita University; Nagoya University; Kyushu University; Nagoya University; University of Tokyo	OHNO, R (corresponding author), NAGOYA UNIV, BRANCH HOSP,SCH MED,DEPT MED,1-1-20 DAIKO MINAMI, HIGASHI KU, NAGOYA 461, JAPAN.		Hamajima, Nobuyuki/I-7237-2014					ANTIN JH, 1988, BLOOD, V72, P705; ANTMAN KS, 1988, NEW ENGL J MED, V319, P593, DOI 10.1056/NEJM198809083191001; AZUMA J, 1989, RINSHO IYAKU, V5, P2231; BEGLEY CG, 1988, EXP HEMATOL, V16, P71; BRANDT SJ, 1988, NEW ENGL J MED, V318, P869, DOI 10.1056/NEJM198804073181401; BRONCHUD MH, 1987, BRIT J CANCER, V56, P809, DOI 10.1038/bjc.1987.295; BUCHNER T, 1988, BEHRING I MITT, V83, P309; CHAMPLIN R, 1989, BLOOD, V73, P2051; DELWEL R, 1988, BLOOD, V72, P1944; GABRILOVE JL, 1988, NEW ENGL J MED, V318, P1414, DOI 10.1056/NEJM198806023182202; GALE RP, 1987, SEMIN HEMATOL, V24, P40; GANSER A, 1989, BLOOD, V73, P31; GRIFFIN JD, 1986, BLOOD, V67, P1448; GROOPMAN JE, 1989, NEW ENGL J MED, V321, P1449, DOI 10.1056/NEJM198911233212106; INOUE C, 1990, INT J CELL CLONING, V8, P54, DOI 10.1002/stem.5530080107; JAKUBOWSKI A, 1989, BLOOD S, V74, P274; KEATING MJ, 1989, J CLIN ONCOL, V7, P1071, DOI 10.1200/JCO.1989.7.8.1071; KOBAYASHI Y, 1989, AM J MED, V86, P178, DOI 10.1016/0002-9343(89)90265-9; KODO H, 1988, LANCET, V2, P38; LINK H, 1988, BEHRING I MITT, V83, P313; MASAOKA T, 1990, KYONO ISHOKU, V3, P12; MORSTYN G, 1989, SEMIN HEMATOL, V26, P9; MORSTYN G, 1988, LANCET, V1, P667, DOI 10.1016/S0140-6736(88)91475-4; NEGRIN RS, 1989, ANN INTERN MED, V110, P976, DOI 10.7326/0003-4819-110-12-976; NEMUNAITIS J, 1988, BLOOD, V72, P834; OGAWA M, 1989, RINSHO IYAKU, V5, P1841; OHNO R, 1986, J CLIN ONCOL, V4, P1740, DOI 10.1200/JCO.1986.4.12.1740; OHNO R, 1989, NIPPON KETSUEKI GAKK, V52, P287; SHERIDAN WP, 1989, LANCET, V2, P891; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; TESHIMA H, 1989, EXP HEMATOL, V17, P853; VADHANRAJ S, 1987, NEW ENGL J MED, V317, P1545, DOI 10.1056/NEJM198712173172501; VELLENGA E, 1987, LEUKEMIA, V1, P584	33	385	388	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	1990	323	13					871	877		10.1056/NEJM199009273231304	http://dx.doi.org/10.1056/NEJM199009273231304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA113	1697646				2022-12-28	WOS:A1990EA11300004
J	PERARNAU, B; SIEGRIST, CA; GILLET, A; VINCENT, C; KIMURA, S; LEMONNIER, FA				PERARNAU, B; SIEGRIST, CA; GILLET, A; VINCENT, C; KIMURA, S; LEMONNIER, FA			BETA-2-MICROGLOBULIN RESTRICTION OF ANTIGEN PRESENTATION	NATURE			English	Article									MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021; INSERM,U80,F-69374 LYONS 8,FRANCE	Memorial Sloan Kettering Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	PERARNAU, B (corresponding author), CNRS MARSEILLE LUMINY,INSERM,CTR IMMUNOL,CASE 906,F-13288 MARSEILLE 9,FRANCE.							ARCEGOMEZ B, 1978, TISSUE ANTIGENS, V11, P96, DOI 10.1111/j.1399-0039.1978.tb01233.x; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; CHIMINI G, 1989, J EXP MED, V169, P297, DOI 10.1084/jem.169.1.297; FAHLMANN M, 1985, P NATL ACAD SCI USA, V68, P8634; FELLOUS M, 1977, IMMUNOGENETICS, V5, P423, DOI 10.1007/BF01570501; FIERZ W, 1982, IMMUNOGENETICS, V16, P593, DOI 10.1007/BF00372028; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; GASSER DL, 1985, IMMUNOGENETICS, V22, P413, DOI 10.1007/BF00430925; GERMAIN RN, 1987, NATURE, V329, P512; HEATH WR, 1989, NATURE, V341, P749, DOI 10.1038/341749a0; KURTZ ME, 1987, J IMMUNOL, V138, P87; MARGULIES DH, 1983, P NATL ACAD SCI-BIOL, V80, P2328, DOI 10.1073/pnas.80.8.2328; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; PERARNAU BM, 1988, J IMMUNOL, V141, P1383; PLOEGH HL, 1979, P NATL ACAD SCI USA, V76, P2273, DOI 10.1073/pnas.76.5.2273; RAMAMURTHY V, 1982, PRAMANA, V19, P435, DOI 10.1007/BF02847377; RAMMENSEE HG, 1986, NATURE, V319, P268; ROBINSON PJ, 1984, IMMUNOGENETICS, V20, P655, DOI 10.1007/BF00430324; SEGE K, 1981, BIOCHEMISTRY-US, V20, P4523, DOI 10.1021/bi00519a003; SEONG RH, 1988, J EXP MED, V167, P288, DOI 10.1084/jem.167.2.288; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; WALLNY HJ, 1990, NATURE, V343, P275, DOI 10.1038/343275a0; YAMADA A, 1985, J EXP MED, V162, P1720, DOI 10.1084/jem.162.5.1720	25	66	68	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 23	1990	346	6286					751	754		10.1038/346751a0	http://dx.doi.org/10.1038/346751a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV652	1697039				2022-12-28	WOS:A1990DV65200064
J	MASTERSON, WJ; RAPER, J; DOERING, TL; HART, GW; ENGLUND, PT				MASTERSON, WJ; RAPER, J; DOERING, TL; HART, GW; ENGLUND, PT			FATTY-ACID REMODELING - A NOVEL REACTION SEQUENCE IN THE BIOSYNTHESIS OF TRYPANOSOME GLYCOSYL PHOSPHATIDYLINOSITOL MEMBRANE ANCHORS	CELL			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21205	Johns Hopkins University				Raper, Jayne/0000-0002-8723-9748; Hart, Gerald/0000-0001-7812-4351	NIAID NIH HHS [AI21334] Funding Source: Medline; NIGMS NIH HHS [5T32GM07309] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANGS JD, 1988, J BIOL CHEM, V263, P17697; BANGS JD, 1986, J CELL BIOL, V103, P255, DOI 10.1083/jcb.103.1.255; BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; BOOTHROYD JC, 1981, NUCLEIC ACIDS RES, V9, P4735, DOI 10.1093/nar/9.18.4735; CROSS GAM, 1987, CELL, V48, P179, DOI 10.1016/0092-8674(87)90419-3; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1990, J BIOL CHEM, V265, P611; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1984, J BIOL CHEM, V259, P3011; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; KRAKOW JL, 1989, MOL BIOCHEM PARASIT, V36, P263, DOI 10.1016/0166-6851(89)90174-6; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MAYOR S, 1990, J BIOL CHEM, V265, P6164; MAYOR S, 1990, J BIOL CHEM, V265, P6174; MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757; Mead J. F., 1986, LIPIDS CHEM BIOCH NU; MENON AK, 1988, J BIOL CHEM, V263, P1970; MENON AK, 1990, IN PRESS J BIOL CHEM; NIJSSEN JG, 1986, BIOCHIM BIOPHYS ACTA, V875, P450, DOI 10.1016/0005-2760(86)90064-0; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; ROBERTS WL, 1988, J BIOL CHEM, V263, P18776; Stahl E., 1969, THIN LAYER CHROMATOG; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595	29	191	193	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 13	1990	62	1					73	80		10.1016/0092-8674(90)90241-6	http://dx.doi.org/10.1016/0092-8674(90)90241-6			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DN533	1694728	hybrid			2022-12-28	WOS:A1990DN53300012
J	WARD, DM; WELLER, R; BATESON, MM				WARD, DM; WELLER, R; BATESON, MM			16S RIBOSOMAL-RNA SEQUENCES REVEAL NUMEROUS UNCULTURED MICROORGANISMS IN A NATURAL COMMUNITY	NATURE			English	Article											WARD, DM (corresponding author), MONTANA STATE UNIV, DEPT MICROBIOL, BOZEMAN, MT 59717 USA.			Weller, Roland/0000-0002-5244-6499				Atlas RN., 1984, CURRENT PERSPECTIVES, P540; BATESON MM, 1989, SYST APPL MICROBIOL, V12, P1; BATESON MM, IN PRESS SYST APPL M; Brock T D, 1987, S SOC GEN MICROBIOL, V41, P1; Brock T.D., 1978, THERMOPHILIC MICROOR; DELONG EF, 1989, SCIENCE, V243, P1360, DOI 10.1126/science.2466341; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; GRAY MW, 1984, NUCLEIC ACIDS RES, V12, P5837, DOI 10.1093/nar/12.14.5837; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; OLSEN GJ, 1988, METHOD ENZYMOL, V164, P793; OLSEN GJ, 1987, COLD SPRING HARB SYM, V52, P825, DOI 10.1101/SQB.1987.052.01.090; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; OYAIZU H, 1987, SYST APPL MICROBIOL, V9, P47, DOI 10.1016/S0723-2020(87)80055-3; PACE NR, 1986, ADV MICROB ECOL, V9, P1; ROSSWALL T, 1978, ADV MICROB ECOL, V1, P1; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988; STALEY JT, 1980, MICROBIOLOGY 1980, P321; TOMIOKA N, 1983, MOL GEN GENET, V191, P46, DOI 10.1007/BF00330888; Ward D.M., 1989, MICROBIAL MATPHYSL, P439; WARD DM, 1989, LIFE SCI R, V46, P145; WARD DM, 1985, NATURE, V318, P656, DOI 10.1038/318656a0; WARD DM, IN PRESS FEMS MICROB; Ward DM, 1987, ECOLOGY MICROBIAL CO, P179; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; WELLER R, 1989, APPL ENVIRON MICROB, V55, P1818, DOI 10.1128/AEM.55.7.1818-1822.1989; WILLIAMS ST, 1984, S SOC GEN MICROBIOL, V36, P219; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; WOESE CR, 1985, SYST APPL MICROBIOL, V6, P143, DOI 10.1016/S0723-2020(85)80047-3; WOLFE RS, 1981, PROKARYOTES, pR5	30	1010	1105	4	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	1990	345	6270					63	65		10.1038/345063a0	http://dx.doi.org/10.1038/345063a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB957	1691827				2022-12-28	WOS:A1990DB95700057
J	MANCA, F; HABESHAW, JA; DALGLEISH, AG				MANCA, F; HABESHAW, JA; DALGLEISH, AG			HIV ENVELOPE GLYCOPROTEIN, ANTIGEN SPECIFIC T-CELL RESPONSES, AND SOLUBLE CD4	LANCET			English	Article									MRC,CTR CLIN RES,DIV IMMUNOL,RETROVIRUS RES GRP,HARROW HA1 3UJ,MIDDX,ENGLAND		MANCA, F (corresponding author), UNIV GENOA,SAN MARTINO HOSP,DEPT IMMUNOL,I-16126 GENOA,ITALY.		Dalgleish, Angus/AAZ-4450-2020	Dalgleish, Angus/0000-0003-3511-3059				BIDDISON WE, 1984, J EXP MED, V159, P783, DOI 10.1084/jem.159.3.783; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; CHIRMULE N, 1990, BLOOD, V75, P152; CLAPHAM PR, 1987, VIROLOGY, V158; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DALGLEISH AG, 1989, ADV HUMAN RETROVIRUS, V51, P307; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; DIAMOND DC, 1988, J IMMUNOL, V141, P3715; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; GAY D, 1987, NATURE, V328, P626, DOI 10.1038/328626a0; GELDERBLOM HR, 1989, ARCH VIROL, V106, P1, DOI 10.1007/BF01311033; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GOWDA SD, 1989, J IMMUNOL, V142, P773; HABESHAW JA, 1989, J ACQ IMMUN DEF SYND, V2, P457; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; HOMSY J, 1989, SCIENCE, V244, P1357, DOI 10.1126/science.2786647; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; JOUAULT T, 1989, AIDS, V3, P125, DOI 10.1097/00002030-198903000-00002; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; LAMARRE D, 1989, EMBO J, V8, P3271, DOI 10.1002/j.1460-2075.1989.tb08487.x; LANE HC, 1985, NEW ENGL J MED, V313, P79, DOI 10.1056/NEJM198507113130204; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; PATTERSON S, 1987, J GEN VIROL, V68, P1177, DOI 10.1099/0022-1317-68-4-1177; RIVAS A, 1988, J IMMUNOL, V140, P2912; SHALABY MR, 1987, CELL IMMUNOL, V110, P140, DOI 10.1016/0008-8749(87)90108-0; SHEARER GM, 1986, J IMMUNOL, V137, P2514; SILICIANO RF, 1988, CELL, V54, P561, DOI 10.1016/0092-8674(88)90078-5; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; SPICKETT G, 1989, J VIROL METHODS, V24, P67, DOI 10.1016/0166-0934(89)90008-6; TAKEDA A, 1988, SCIENCE, V242, P580, DOI 10.1126/science.2972065; TRAUNECKER A, 1988, NATURE, V331, P84, DOI 10.1038/331084a0; WEINHOLD KJ, 1989, J IMMUNOL, V142, P3091; ZARLING JM, 1988, AIDS S, V2, P3113	36	96	96	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 7	1990	335	8693					811	815		10.1016/0140-6736(90)90935-X	http://dx.doi.org/10.1016/0140-6736(90)90935-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY371	1690832				2022-12-28	WOS:A1990CY37100003
J	HEAPHY, S; DINGWALL, C; ERNBERG, I; GAIT, MJ; GREEN, SM; KARN, J; LOWE, AD; SINGH, M; SKINNER, MA				HEAPHY, S; DINGWALL, C; ERNBERG, I; GAIT, MJ; GREEN, SM; KARN, J; LOWE, AD; SINGH, M; SKINNER, MA			HIV-1 REGULATOR OF VIRION EXPRESSION (REV) PROTEIN BINDS TO AN RNA STEM-LOOP STRUCTURE LOCATED WITHIN THE REV RESPONSE ELEMENT REGION	CELL			English	Article											HEAPHY, S (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		Skinner, Michael A/B-7112-2012	Skinner, Michael/0000-0002-0050-4167				ATHERTON E, 1986, J CHEM SOC CHEM COMM, P1763, DOI 10.1039/c39860001763; BANKIER AT, 1987, METHOD ENZYMOL, V155, P51; CAREY J, 1983, BIOCHEMISTRY-US, V22, P2601, DOI 10.1021/bi00280a002; CULLEN BR, 1988, J VIROL, V62, P2498, DOI 10.1128/JVI.62.7.2498-2501.1988; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; DRYLAND A, 1986, J CHEM SOC P1, V128, P125; EMERMAN M, 1989, CELL, V57, P1155, DOI 10.1016/0092-8674(89)90053-6; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Galfre G, 1981, Methods Enzymol, V73, P3; HEAPHY S, 1987, PROTEIN ENG, V1, P425, DOI 10.1093/protein/1.5.425; HEAPHY S, 1987, BIOCHEMISTRY-US, V26, P1688, DOI 10.1021/bi00380a030; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KNIGHT DM, 1987, SCIENCE, V236, P837, DOI 10.1126/science.3033827; MALIM MH, 1989, P NATL ACAD SCI USA, V86, P8222, DOI 10.1073/pnas.86.21.8222; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; ROMANIUK PJ, 1987, BIOCHEMISTRY-US, V26, P1563, DOI 10.1021/bi00380a011; ROSEN CA, 1988, P NATL ACAD SCI USA, V85, P2071, DOI 10.1073/pnas.85.7.2071; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; VARTIKAR JV, 1989, J MOL BIOL, V209, P221, DOI 10.1016/0022-2836(89)90274-X; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WELLS JA, 1985, GENE, V34, P315, DOI 10.1016/0378-1119(85)90140-4; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	33	331	344	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 23	1990	60	4					685	693		10.1016/0092-8674(90)90671-Z	http://dx.doi.org/10.1016/0092-8674(90)90671-Z			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	1689218				2022-12-28	WOS:A1990CQ72300018
J	AUGUSTIN, S; MULLER, MW; SCHWEYEN, RJ				AUGUSTIN, S; MULLER, MW; SCHWEYEN, RJ			REVERSE SELF-SPLICING OF GROUP-II INTRON RNAS INVITRO	NATURE			English	Article											AUGUSTIN, S (corresponding author), UNIV VIENNA,INST MIKROBIOL & GENET,ALTHANSTR 14,A-1090 VIENNA,AUSTRIA.							CECH TR, 1985, INT REV CYTOL, V93, P3, DOI 10.1016/S0074-7696(08)61370-4; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; JARRELL KA, 1988, J BIOL CHEM, V263, P3432; LAMBOWITZ AM, 1989, CELL, V56, P323, DOI 10.1016/0092-8674(89)90232-8; MICHEL F, 1985, NATURE, V316, P641, DOI 10.1038/316641a0; MICHEL F, 1983, EMBO J, V2, P33, DOI 10.1002/j.1460-2075.1983.tb01376.x; MULLER MW, 1988, NUCLEIC ACIDS RES, V16, P7383, DOI 10.1093/nar/16.15.7383; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; SCHMEIZER C, 1987, CELL, V51, P753, DOI 10.1016/0092-8674(87)90098-5; SCHMELZER C, 1986, CELL, V46, P557, DOI 10.1016/0092-8674(86)90881-0; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; VANDERVEEN R, 1986, CELL, V44, P225, DOI 10.1016/0092-8674(86)90756-7; WOLF K, 1987, ENDOCYT CELL RES, V4, P103; WOODSON SA, 1989, CELL, V57, P335, DOI 10.1016/0092-8674(89)90971-9	15	91	94	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 25	1990	343	6256					383	386		10.1038/343383a0	http://dx.doi.org/10.1038/343383a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK918	1689013				2022-12-28	WOS:A1990CK91800067
J	ROEBACK, JR; HLA, KM; CHAMBLESS, LE; FLETCHER, RH				ROEBACK, JR; HLA, KM; CHAMBLESS, LE; FLETCHER, RH			EFFECTS OF CHROMIUM SUPPLEMENTATION ON SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS IN MEN TAKING BETA-BLOCKERS - A RANDOMIZED, CONTROLLED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY HEART-DISEASE; GLUCOSE-TOLERANCE FACTOR; CARDIOVASCULAR-DISEASE; BLOOD-GLUCOSE; EXCRETION; LIPIDS; DIETS; DEFICIENCY; DIABETICS; AGENTS	Objective: To determine the efficacy of glucose tolerance factor (GTF)-chromium for increasing serum levels of high-density lipoprotein (HDL) cholesterol in patients taking beta-blockers. Design: Randomized, double-blind, placebo-controlled trial. Setting: Mixed primary and referral-based outpatient clinic at a university-affiliated VA Medical Center. Patients: Referred sample of 72 men receiving beta-blockers, mainly for hypertension. Sixty-three patients (88%) completed the study. Interventions: Current medications, including beta-blockers, were continued. During the 8-week treatment phase, patients in the chromium group received a total daily dose of 600-mu-g of biologically active chromium divided into three equal doses; control patients received a placebo of identical appearance and taste. Measurements: Serum levels of total cholesterol and HDL cholesterol were measured. Main Results: Mean baseline levels of HDL and total cholesterol (+/- SD) were 0.93 +/- 0.28 mmol/L and 6.0 +/- 1.0 mmol/L (36 +/- 11.1 mg/dL and 232 +/- 38.5 mg/dL), respectively. The difference between groups in adjusted mean change in HDL cholesterol levels, accounting for baseline HDL cholesterol levels, age, weight change, and baseline total cholesterol levels, was 0. 15 mmol/L (5.8 mg/dL) (P = 0.01) with a 95% Cl showing that the treatment effect was > + 0.04 mmol/L (+ 1.4 mg/dL). Mean total cholesterol, triglycerides and body weight did not change significantly during treatment for either group. Compliance as measured by pill count was 85%, and few side effects were reported. Two months after the end of treatment, the between-group difference in adjusted mean change from baseline to end of post-treatment follow-up was - 0.003 mmol/L (-0.1 mg/dL). Conclusion: Two months of chromium supplementation resulted in a clinically useful increase in HDL cholesterol levels in men taking beta-blockers.	VET AFFAIRS MED CTR, DURHAM, NC USA; UNIV N CAROLINA, DEPT BIOSTAT, COLLABORAT STUDIES COORDINATING CTR, CHAPEL HILL, NC 27514 USA; DUKE UNIV, MED CTR, DURHAM, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of North Carolina; University of North Carolina Chapel Hill; Duke University	ROEBACK, JR (corresponding author), UNIV N CAROLINA, SCH PUBL HLTH, DEPT EPIDEMIOL, CB 7400, MCGAVRAN GREENBERG HALL, CHAPEL HILL, NC 27599 USA.							ABBOTT RD, 1988, ARTERIOSCLEROSIS, V8, P207, DOI 10.1161/01.ATV.8.3.207; ANDERSON RA, 1985, AM J CLIN NUTR, V41, P1177, DOI 10.1093/ajcn/41.6.1177; ANDERSON RA, 1987, METABOLISM, V36, P351, DOI 10.1016/0026-0495(87)90206-X; ANDERSON RA, 1983, J NUTR, V113, P276, DOI 10.1093/jn/113.2.276; ANDERSON RA, 1983, METABOLISM, V32, P894, DOI 10.1016/0026-0495(83)90203-2; Borel J. S., 1984, BIOCH ESSENTIAL ULTR, P175; BOREL JS, 1984, BIOL TRACE ELEM RES, V6, P317, DOI 10.1007/BF02989239; BUNKER VW, 1984, AM J CLIN NUTR, V39, P797, DOI 10.1093/ajcn/39.5.797; DEFLORA S, 1989, ARCH TOXICOL S, V313, P28; ELWOOD JC, 1982, J AM COLL NUTR, V1, P263; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; FLODIN NW, 1988, PHARM MICRONUTRIENTS, P247; Fuller W.A., 2009, MEASUREMENT ERROR MO; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GRANT AP, 1982, ULSTER MED J, V51, P110; HAYES RJ, 1988, STAT MED, V7, P915, DOI 10.1002/sim.4780070903; HELLER RF, 1983, ATHEROSCLEROSIS, V49, P187, DOI 10.1016/0021-9150(83)90196-X; JEEJEEBHOY KN, 1977, AM J CLIN NUTR, V30, P531; KAPLAN NM, 1987, AM J MED, V82, P9, DOI 10.1016/0002-9343(87)90137-9; Kleinbaum D.G, 1988, APPL REGRESSION ANAL; KOZLOVSKY AS, 1986, METABOLISM, V35, P515, DOI 10.1016/0026-0495(86)90007-7; KUMPULAINEN JT, 1979, J AGR FOOD CHEM, V27, P490, DOI 10.1021/jf60223a036; LARDINOIS CK, 1988, ARCH INTERN MED, V148, P1280, DOI 10.1001/archinte.148.6.1280; LI LX, 1990, PROG CLIN BIOL RES, V340, P199; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MACMAHON SW, 1986, PROG CARDIOVASC DIS, V29, P99, DOI 10.1016/0033-0620(86)90038-1; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MERTZ W, 1969, PHYSIOL REV, V49, P163, DOI 10.1152/physrev.1969.49.2.163; MERTZ W, 1975, NUTR REV, V33, P129, DOI 10.1111/j.1753-4887.1975.tb07105.x; MERTZ W, 1982, CLIN BIOCH NUTRITION; MILLER M, 1990, AM J CARDIOL, V65, P1, DOI 10.1016/0002-9149(90)90017-U; MOSSOP RT, 1983, CENT AFR J MED, V29, P80; RIALES R, 1981, AM J CLIN NUTR, V34, P2670, DOI 10.1093/ajcn/34.12.2670; ROEBACK JR, 1989, CLIN RES, V37, pA324; ROHLFING JJ, 1986, WESTERN J MED, V145, P210; TYROLER HA, 1990, EUR HEART J, V11, P21, DOI 10.1093/eurheartj/11.suppl_H.21; VINSON JA, 1984, NUTR REP INT, V30, P911; WALLACH S, 1985, J AM COLL NUTR, V4, P107; WARNICK GR, 1982, CLIN CHEM, V28, P1379; 1986, RECOMMENDED DIETARY; [No title captured]	42	63	65	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					917	924		10.7326/0003-4819-115-12-917	http://dx.doi.org/10.7326/0003-4819-115-12-917			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1683196				2022-12-28	WOS:A1991GU41700001
J	SEERY, JP				SEERY, JP			ACHLORHYDRIA AND GASTRIC CARCINOGENESIS	LANCET			English	Article							HUMAN STOMACH; PATHOGENESIS	The association between achlorhydria and gastric carcinogenesis can be explained by a simple hypothesis based on the known cytological properties of neoplastic cells and the physiology of the stomach. Normal gastric secretions might ensure the rapid elimination of carcinomatous cells. Achlorhydria could be an important permissive factor in the development of gastric carcinoma.			SEERY, JP (corresponding author), ROYAL INFIRM,DEPT CLIN PHARMACOL,LAURISTON PL,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND.							BARET MK, 1967, NEOPLASMS STOMACH, P29; FLEMING S, 1991, J PATHOL, V164, P95, DOI 10.1002/path.1711640202; HILL MJ, 1986, MICROBIAL METABOLISM, P221; LEACH SA, 1987, CARCINOGENESIS, V8, P1907, DOI 10.1093/carcin/8.12.1907; LICHT WR, 1988, CARCINOGENESIS, V9, P2227, DOI 10.1093/carcin/9.12.2227; MIRVISH SS, 1975, TOXICOL APPL PHARM, V31, P325, DOI 10.1016/0041-008X(75)90255-0; NEWBOLD KM, 1989, LANCET, V1, P131; NEWBOLD KM, 1988, J PATHOL, V155, P311, DOI 10.1002/path.1711550406; SANDERS MJ, 1985, NATURE, V313, P52, DOI 10.1038/313052a0; SEERY JP, 1991, MED HYPOTHESES, V35, P179, DOI 10.1016/0306-9877(91)90229-R; SOLL AH, 1990, NEW ENGL J MED, V322, P909; SVENDSEN JH, 1986, SCAND J GASTROENTERO, V21, P16, DOI 10.3109/00365528609034615	12	8	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 14	1991	338	8781					1508	1509		10.1016/0140-6736(91)92312-P	http://dx.doi.org/10.1016/0140-6736(91)92312-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV077	1683930				2022-12-28	WOS:A1991GV07700016
J	CHAN, HSL; HADDAD, G; THORNER, PS; DEBOER, G; LIN, YP; ONDRUSEK, N; YEGER, H; LING, V				CHAN, HSL; HADDAD, G; THORNER, PS; DEBOER, G; LIN, YP; ONDRUSEK, N; YEGER, H; LING, V			P-GLYCOPROTEIN EXPRESSION AS A PREDICTOR OF THE OUTCOME OF THERAPY FOR NEUROBLASTOMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REQUIRING PROLONGED OBSERVATION; MULTIDRUG RESISTANCE GENE; METASTATIC NEURO-BLASTOMA; CARCINOMA CELL-LINES; MONOCLONAL-ANTIBODIES; PROGNOSTIC FACTORS; 30 CHILDREN; IV-S; CHEMOTHERAPY; MDR1	Background and Methods. Multidrug resistance in chemotherapy for cancer is characterized by increased genetic expression of P-glycoprotein, which acts as an ATP-dependent drug-efflux pump. To determine whether P-glycoprotein levels are of prognostic value in such cases, we measured these levels immunohistochemically in a retrospective study of sequential tumor samples from 67 children with neuroblastoma. Results. P-glycoprotein was not detected in pretreatment samples from either of the 2 patients with Stage I disease, any of the 21 with Stage II disease, or any of the 8 with Stage IVS disease, but it was detected in the samples from 1 of the 17 patients with Stage III disease (6 percent) and 12 of the 19 with Stage IV disease (63 percent). Of the 44 patients with nonlocalized neuroblastoma (Stage III, IVS, or IV), 26 of the 31 who were negative for P-glycoprotein had a complete response to primary treatment, as compared with 6 of the 13 who were positive for P-glycoprotein (84 percent vs. 46 percent, P = 0.0232 by Fisher's exact test). Log-rank analysis of outcome, with simultaneous stratification according to tumor stage and age, showed that the group that was negative for P-glycoprotein had significantly longer relapse-free survival (P = 0.0011) and overall survival (P = 0.0373) than the group that was positive. Conclusions. Expression of P-glycoprotein before treatment may predict the success or failure of therapy for nonlocalized neuroblastoma. Neuroblastoma may be a promising tumor to treat with anticancer drug therapy combined with a chemosensitizing agent capable of reversing P-glycoprotein-mediated multidrug resistance.	HOSP SICK CHILDREN,DEPT PEDIAT,DIV IMMUNOL & CANC,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT PATHOL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA; ONTARIO CANC INST,DIV MOLEC & STRUCT BIOL,TORONTO M4X 1K9,ONTARIO,CANADA; ONTARIO CANC INST,DEPT BIOSTAT,TORONTO M4X 1K9,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	CHAN, HSL (corresponding author), HOSP SICK CHILDREN,DEPT PEDIAT,DIV HEMATOL ONCOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.				NCI NIH HHS [CA-37130] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037130] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELL DR, 1985, J CLIN ONCOL, V3, P311, DOI 10.1200/JCO.1985.3.3.311; BOURHIS J, 1989, J NATL CANCER I, V81, P1401, DOI 10.1093/jnci/81.18.1401; BRADLEY G, 1989, CANCER RES, V49, P2790; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; CHABNER BA, 1989, J NATL CANCER I, V81, P910, DOI 10.1093/jnci/81.12.910; CHAN HSL, 1988, LAB INVEST, V59, P870; CHAN HSL, 1990, J CLIN ONCOL, V8, P689, DOI 10.1200/JCO.1990.8.4.689; CHRISTIANSEN H, 1988, BRIT J CANCER, V57, P121, DOI 10.1038/bjc.1988.24; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; DALTON WS, 1989, J CLIN ONCOL, V7, P415, DOI 10.1200/JCO.1989.7.4.415; Deacon J M, 1985, Prog Clin Biol Res, V175, P525; EVANS AE, 1987, CANCER, V59, P1853, DOI 10.1002/1097-0142(19870601)59:11<1853::AID-CNCR2820591102>3.0.CO;2-F; FINKLESTEIN JZ, 1979, MED PEDIATR ONCOL, V6, P179, DOI 10.1002/mpo.2950060211; GEORGES E, 1990, P NATL ACAD SCI USA, V87, P152, DOI 10.1073/pnas.87.1.152; GERLACH JH, 1987, J CLIN ONCOL, V5, P1452, DOI 10.1200/JCO.1987.5.9.1452; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; GERLACH JH, 1986, CANCER SURV, V5, P25; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; GREEN AA, 1981, CANCER, V48, P2310, DOI 10.1002/1097-0142(19811115)48:10<2310::AID-CNCR2820481029>3.0.CO;2-W; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; HANN HWL, 1981, NEW ENGL J MED, V305, P425, DOI 10.1056/NEJM198108203050803; HAYES FA, 1981, CANCER, V48, P1715, DOI 10.1002/1097-0142(19811015)48:8<1715::AID-CNCR2820480805>3.0.CO;2-Y; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; LAUG WE, 1978, PEDIATRICS, V62, P77; LING V, 1989, JNCI-J NATL CANCER I, V81, P84, DOI 10.1093/jnci/81.2.84; LOOK AT, 1984, NEW ENGL J MED, V311, P231, DOI 10.1056/NEJM198407263110405; MA DDF, 1987, LANCET, V1, P135; MANCINI AF, 1984, MED PEDIATR ONCOL, V12, P155, DOI 10.1002/mpo.2950120302; NG WF, 1989, MOL CELL BIOL, V9, P1224, DOI 10.1128/MCB.9.3.1224; ONEILL JA, 1985, J PEDIATR SURG, V20, P708, DOI 10.1016/S0022-3468(85)80029-4; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PHILIP T, 1991, J CLIN ONCOL, V9, P1037, DOI 10.1200/JCO.1991.9.6.1037; POLLARDKNIGHT D, 1990, ANAL BIOCHEM, V185, P353, DOI 10.1016/0003-2697(90)90307-U; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315; TREUNER J, 1984, LANCET, V1, P333; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; ZELTZER PM, 1983, LANCET, V2, P361	43	437	446	0	8	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 5	1991	325	23					1608	1614		10.1056/NEJM199112053252304	http://dx.doi.org/10.1056/NEJM199112053252304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR770	1682809	Bronze			2022-12-28	WOS:A1991GR77000004
J	SHARIF, M; PRIVALSKY, ML				SHARIF, M; PRIVALSKY, ML			V-ERBA ONCOGENE FUNCTION IN NEOPLASIA CORRELATES WITH ITS ABILITY TO REPRESS RETINOIC ACID RECEPTOR ACTION	CELL			English	Article							THYROID-HORMONE RECEPTOR; AVIAN ERYTHROBLASTOSIS VIRUS; DNA-BINDING DOMAIN; RESPONSE ELEMENT; GLUCOCORTICOID RECEPTOR; ESTROGEN-RECEPTOR; TRANS-ACTIVATION; GENE-EXPRESSION; AMINO-ACIDS; BETA-GENE	The v-erbA oncoprotein of avian erythroblastosis virus is an aberrant version of a thyroid hormone receptor and functions in neoplasia by blocking erythroid differentiation and by modifying the growth properties of fibroblasts. v-erbA has been proposed to represent a novel dominant negative oncogene, acting in the cancer cell by interfering with the actions of its normal cell homologs, the thyroid hormone receptors. We report here that v-erbA can actually interfere with the actions of a variety of members of the steroid/retinoid receptor family and that the ability of v-erbA to act in neoplasia best correlates not with suppression of c-erbA action, but with interference with the retinoic acid receptor response. We suggest that v-erbA may act in neoplasia by promiscuously interfering with a retinoid-mediated differentiation process.			SHARIF, M (corresponding author), UNIV CALIF DAVIS,DEPT BIOCHEM,DAVIS,CA 95616, USA.							BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERG JM, 1989, CELL, V57, P1065, DOI 10.1016/0092-8674(89)90042-1; BONDE BG, 1991, J VIROL, V65, P2037, DOI 10.1128/JVI.65.4.2037-2046.1991; BONDE BG, 1990, J VIROL, V64, P1314, DOI 10.1128/JVI.64.3.1314-1320.1990; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DAVIDSON NE, 1987, MOL ENDOCRINOL, V1, P216, DOI 10.1210/mend-1-3-216; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FORREST D, 1990, ONCOGENE, V5, P309; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HANNON R, 1991, P NATL ACAD SCI USA, V88, P3004, DOI 10.1073/pnas.88.8.3004; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; HOLLOWAY JM, 1990, P NATL ACAD SCI USA, V87, P8160, DOI 10.1073/pnas.87.20.8160; HUDSON LG, 1990, CELL, V62, P1165, DOI 10.1016/0092-8674(90)90393-S; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; PAIN B, 1990, New Biologist, V2, P284; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; PRIVALSKY ML, 1990, CELL, V63, P1277, DOI 10.1016/0092-8674(90)90423-C; ROBERTS AB, 1984, RETINOIDS, V2, P209; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; THOMPSON CC, 1989, P NATL ACAD SCI USA, V86, P3494, DOI 10.1073/pnas.86.10.3494; TZUKERMAN M, 1990, New Biologist, V2, P613; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	40	115	116	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	SEP 6	1991	66	5					885	893		10.1016/0092-8674(91)90435-2	http://dx.doi.org/10.1016/0092-8674(91)90435-2			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GE460	1679679				2022-12-28	WOS:A1991GE46000008
J	FOX, JD; BRIGGS, M; WARD, PA; TEDDER, RS				FOX, JD; BRIGGS, M; WARD, PA; TEDDER, RS			HUMAN HERPESVIRUS-6 IN SALIVARY-GLANDS	LANCET			English	Article											FOX, JD (corresponding author), UNIV COLL & MIDDLESEX SCH MED,DEPT MED MICROBIOL,67 RIDINGHOUSE ST,LONDON W1P 7PN,ENGLAND.			Tedder, Richard/0000-0002-9672-5721	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ASANO Y, 1989, LANCET, V2, P1391; BRIGGS M, 1988, LANCET, V1, P1058; BUCHBINDER A, 1988, J VIROL METHODS, V21, P191, DOI 10.1016/0166-0934(88)90065-1; COUMBE A, 1990, Pediatric Pathology, V10, P483; DOWNING RG, 1987, LANCET, V2, P390; EFSTATHIOU S, 1988, LANCET, V1, P63; EIZURU Y, 1989, LANCET, V1, P40; FOX JD, 1990, EPIDEMIOL INFECT, V104, P289, DOI 10.1017/S095026880005946X; GARSON JA, 1987, NUCLEIC ACIDS RES, V15, P4761, DOI 10.1093/nar/15.12.4761; HARNETT GB, 1990, J MED VIROL, V30, P128, DOI 10.1002/jmv.1890300209; JARRETT RF, 1988, LEUKEMIA, V2, P496; JOSEPHS SF, 1988, LEUKEMIA, V2, P132; KNOWLES WA, 1988, LANCET, V2, P912; LAWRENCE GL, 1990, J VIROL, V64, P287, DOI 10.1128/JVI.64.1.287-299.1990; LEVY JA, 1990, LANCET, V335, P1047, DOI 10.1016/0140-6736(90)92628-U; LONGIN T, 1986, VIRCHOWS ARCH, V409, P777; OKUNO T, 1989, J CLIN MICROBIOL, V27, P651, DOI 10.1128/JCM.27.4.651-653.1989; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; STAMMERS TG, 1988, PRACTITIONER, V232, P541; TAKAHASHI K, 1988, LANCET, V1, P1463; TEDDER RS, 1987, LANCET, V2, P390; YAMANISHI K, 1988, LANCET, V1, P1065; YOSHIKAWA T, 1989, PEDIATRICS, V84, P675	23	163	172	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 8	1990	336	8715					590	593		10.1016/0140-6736(90)93392-3	http://dx.doi.org/10.1016/0140-6736(90)93392-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX401	1697399				2022-12-28	WOS:A1990DX40100004
J	ALLEN, CMC				ALLEN, CMC			TRIALS AND TRIBULATIONS IN SPEECH-THERAPY	BRITISH MEDICAL JOURNAL			English	Editorial Material											ALLEN, CMC (corresponding author), ADDENBROOKES HOSP,CAMBRIDGE CB2 2QQ,ENGLAND.							Allen CM, 1988, MANAGEMENT ACUTE STR; CAMPBELL MJ, 1984, J NEUROL SCI, V64, P65, DOI 10.1016/0022-510X(84)90056-X; DAVID R, 1982, J NEUROL NEUROSUR PS, V45, P957, DOI 10.1136/jnnp.45.11.957; FITZGIBBON CT, 1986, BRIT J DISORD COMMUN, V21, P117; HARTMAN J, 1987, ARCH NEUROL-CHICAGO, V44, P646, DOI 10.1001/archneur.1987.00520180064018; HOWARD D, 1986, BRIT J DISORD COMMUN, V21, P89; LENDREM W, 1985, J NEUROL NEUROSUR PS, V48, P743, DOI 10.1136/jnnp.48.8.743; LINCOLN NB, 1984, LANCET, V2, P197; PRING TR, 1986, BRIT J DISORD COMMUN, V21, P103; RICHARDSON KT, 1989, ARCH NEUROL-CHICAGO, V46, P249, DOI 10.1001/archneur.1989.00520390015003; WADE DT, 1983, BRIT MED J, V286, P50, DOI 10.1136/bmj.286.6358.50; WERTZ RT, 1986, ARCH NEUROL-CHICAGO, V43, P653, DOI 10.1001/archneur.1986.00520070011008	12	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 11	1990	301	6747					302	303		10.1136/bmj.301.6747.302	http://dx.doi.org/10.1136/bmj.301.6747.302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU040	1697487	Green Published, Bronze			2022-12-28	WOS:A1990DU04000002
J	GERBERDING, JL; LITTELL, C; TARKINGTON, A; BROWN, A; SCHECTER, WP				GERBERDING, JL; LITTELL, C; TARKINGTON, A; BROWN, A; SCHECTER, WP			RISK OF EXPOSURE OF SURGICAL PERSONNEL TO PATIENTS BLOOD DURING SURGERY AT SAN-FRANCISCO-GENERAL-HOSPITAL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT SURG,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	GERBERDING, JL (corresponding author), SAN FRANCISCO GEN HOSP,MED SERV,5H-22,1001 POTRERO AVE,SAN FRANCISCO,CA 94110, USA.							BROUGH SJ, 1988, BRIT J SURG, V75, P317, DOI 10.1002/bjs.1800750408; Centers for Disease Control reports include, 1988, MMWR, V37, P229; EMANUEL EJ, 1988, NEW ENGL J MED, V318, P1686, DOI 10.1056/NEJM198806233182511; FOURNIER AM, 1989, ARCH SURG-CHICAGO, V124, P1038; GERBERDING JL, 1987, J INFECT DIS, V156, P861, DOI 10.1093/infdis/156.6.861; GOLDMAN B, 1988, CAN MED ASSOC J, V138, P736; HUSSAIN SA, 1988, BRIT J SURG, V75, P314, DOI 10.1002/bjs.1800750407; LAFFERTY K, 1987, BRIT MED J, V295, P392, DOI 10.1136/bmj.295.6594.392-a; LOWENFELS AB, 1989, ARCH SURG-CHICAGO, V124, P1284; MATTA H, 1988, BRIT MED J, V297, P597, DOI 10.1136/bmj.297.6648.597; SHANSON DC, 1988, J HOSP INFECT, V11, P218, DOI 10.1016/0195-6701(88)90190-9; 1986, SUGI SUPPLEMENTAL LI, P269; 1986, MMWR, V35, P221	13	321	326	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	1990	322	25					1788	1793		10.1056/NEJM199006213222506	http://dx.doi.org/10.1056/NEJM199006213222506			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ232	1693174				2022-12-28	WOS:A1990DJ23200006
J	BURKLY, LC; LO, D; FLAVELL, RA				BURKLY, LC; LO, D; FLAVELL, RA			TOLERANCE IN TRANSGENIC MICE EXPRESSING MAJOR HISTOCOMPATIBILITY MOLECULES EXTRATHYMICALLY ON PANCREATIC-CELLS	SCIENCE			English	Article									UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104; YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510	University of Pennsylvania; Howard Hughes Medical Institute; Yale University	BURKLY, LC (corresponding author), BIOGEN INC,14 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.							ADAMS TE, 1987, NATURE, V325, P223, DOI 10.1038/325223a0; ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; BILL J, 1988, P NATL ACAD SCI USA, V85, P9184, DOI 10.1073/pnas.85.23.9184; BOHME J, 1989, SCIENCE, V244, P1179, DOI 10.1126/science.2499048; BOTTAZZO GF, 1986, IMMUNOL REV, V94, P137, DOI 10.1111/j.1600-065X.1986.tb01168.x; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; BOTTAZZO GF, 1983, LANCET, V2, P1115; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BURGERT HG, 1989, J EXP MED, V170, P1887, DOI 10.1084/jem.170.6.1887; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; COLIGAN JE, 1981, NATURE, V291, P35, DOI 10.1038/291035a0; COWING C, 1985, IMMUNOL TODAY, V6, P72, DOI 10.1016/0167-5699(85)90018-0; CRISPE IN, 1985, NATURE, V317, P627, DOI 10.1038/317627a0; DEAN BM, 1985, DIABETOLOGIA, V28, P464, DOI 10.1007/BF00280892; FINK PJ, 1984, J EXP MED, V159, P436, DOI 10.1084/jem.159.2.436; FLAVELL RA, 1986, SCIENCE, V233, P437, DOI 10.1126/science.3726537; FRELINGER J, 1984, IMMUNOL REV, V81, P21, DOI 10.1111/j.1600-065X.1984.tb01103.x; GAO EK, 1989, J EXP MED, V170, P1947, DOI 10.1084/jem.170.6.1947; GASPARI AA, 1988, J IMMUNOL, V141, P2216; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KANAGAWA O, UNPUB; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LO D, 1989, J EXP MED, V170, P87, DOI 10.1084/jem.170.1.87; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; LO D, UNPUB; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MADSEN JC, 1988, NATURE, V332, P161, DOI 10.1038/332161a0; MANGER B, 1985, J IMMUNOL, V135, P3669; MARKMANN J, 1988, NATURE, V336, P476, DOI 10.1038/336476a0; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; MATZINGER P, 1987, J CELL IMMUN, V29, P1; MICHIE SA, 1988, J EXP MED, V168, P1929, DOI 10.1084/jem.168.5.1929; MILLER J, 1990, J IMMUNOL, V144, P334; MILLER JFAP, 1989, IMMUNOL REV, V107, P109, DOI 10.1111/j.1600-065X.1989.tb00005.x; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MURPHY KM, 1989, P NATL ACAD SCI USA, V86, P10034, DOI 10.1073/pnas.86.24.10034; NAPARSTEK Y, 1982, NATURE, V300, P262, DOI 10.1038/300262a0; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PARHAM P, 1988, NATURE, V333, P500, DOI 10.1038/333500a0; PHILLIPS ML, 1986, P NATL ACAD SCI USA, V83, P5634, DOI 10.1073/pnas.83.15.5634; PUJOLBORRELL R, 1987, NATURE, V326, P304, DOI 10.1038/326304a0; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; QUILL H, 1987, J IMMUNOL, V138, P3704; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; ROSSINI AA, 1985, ANNU REV IMMUNOL, V3, P289; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; WIDERA G, 1987, CELL, V51, P175, DOI 10.1016/0092-8674(87)90145-0	60	111	115	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 15	1990	248	4961					1364	1368		10.1126/science.1694042	http://dx.doi.org/10.1126/science.1694042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1694042				2022-12-28	WOS:A1990DJ50100030
J	ROSEN, MK; STANDAERT, RF; GALAT, A; NAKATSUKA, M; SCHREIBER, SL				ROSEN, MK; STANDAERT, RF; GALAT, A; NAKATSUKA, M; SCHREIBER, SL			INHIBITION OF FKBP ROTAMASE ACTIVITY BY IMMUNOSUPPRESSANT FK506 - TWISTED AMIDE SURROGATE	SCIENCE			English	Article									HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138	Harvard University			Standaert, Robert F/D-9467-2013; Standaert, Robert F./AAI-1532-2021	Standaert, Robert F/0000-0002-5684-1322; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038627, R37GM038627] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-38627] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASKIN D, 1989, TETRAHEDRON LETT, V30, P671, DOI 10.1016/S0040-4039(01)80278-1; BEVERIDGE T, 1986, CYCLOSPORIN, P269; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FINDLAY JA, 1980, CAN J CHEM, V58, P579, DOI 10.1139/v80-090; FISCHER G, 1989, FEBS LETT, V250, P267, DOI 10.1016/0014-5793(89)80735-5; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISHER G, 1989, NATURE, V337, P476; GALARDY RE, 1982, INT J PEPT PROT RES, V19, P123; GALAT A, UNPUB; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HARDING MW, TRANSPLANTATION, pS29; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; HATANAKA H, 1989, J ANTIBIOT, V42, P620, DOI 10.7164/antibiotics.42.620; JOHNSON F, 1968, CHEM REV, V68, P375, DOI 10.1021/cr60254a001; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; MACFERRIN KD, 1990, P NATL ACAD SCI USA, V87, P1937, DOI 10.1073/pnas.87.5.1937; MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007; NAKATSUKA M, IN PRESS J AM CHEM S; QUESNIAUX VFJ, 1988, TRANSPLANTATION, V46, pS23; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SCOTT AI, 1986, TETRAHEDRON, V42, P3269, DOI 10.1016/S0040-4020(01)87391-9; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STANDAERT RF, UNPUB; STARZL TE, 1989, LANCET, V2, P1000; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; THOMSON AW, 1989, IMMUNOL TODAY, V10, P6, DOI 10.1016/0167-5699(89)90057-1; TOCCI MJ, 1989, J IMMUNOL, V143, P718; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; WENGER RM, 1986, PROG CHEM ORGANIC NA, V50, P123; YOSHIMURA N, 1989, TRANSPLANTATION, V47, P356, DOI 10.1097/00007890-198902000-00035; YOSHIMURA N, 1989, TRANSPLANTATION, V47, P351, DOI 10.1097/00007890-198902000-00034; 1989, NY TIMES        1018, P1	36	190	197	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 18	1990	248	4957					863	866		10.1126/science.1693013	http://dx.doi.org/10.1126/science.1693013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD972	1693013				2022-12-28	WOS:A1990DD97200043
J	FILBIN, MT; WALSH, FS; TRAPP, BD; PIZZEY, JA; TENNEKOON, GI				FILBIN, MT; WALSH, FS; TRAPP, BD; PIZZEY, JA; TENNEKOON, GI			ROLE OF MYELIN PO PROTEIN AS A HOMOPHILIC ADHESION MOLECULE	NATURE			English	Article									UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT EXPTL PATHOL,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	FILBIN, MT (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205, USA.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARCLAY AN, 1988, T CELL RECEPTORS, P53; BRAUN PE, 1984, MYELIN, P97; FILBIN MT, IN PRESS J NEUROCHEM; JOHNSON PW, 1989, NEURON, V3, P377, DOI 10.1016/0896-6273(89)90262-6; JONES GE, 1979, J NEUROL SCI, V43, P465, DOI 10.1016/0022-510X(79)90025-X; JONES GE, 1981, J CELL SCI, V48, P291; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; LAI C, 1987, P NATL ACAD SCI USA, V84, P4337, DOI 10.1073/pnas.84.12.4337; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; PIZZEY JA, 1985, J NEUROL SCI, V69, P207, DOI 10.1016/0022-510X(85)90134-0; PIZZEY JA, 1988, J CELL BIOL, V107, P2307, DOI 10.1083/jcb.107.6.2307; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; RUTISHAUSER U, 1982, P NATL ACAD SCI-BIOL, V79, P685, DOI 10.1073/pnas.79.2.685; SIEBER F, 1981, J CELL BIOL, V90, P55, DOI 10.1083/jcb.90.1.55; STOLL G, 1989, J NEUROSCI, V9, P2327; STOLL PM, 1989, CELL, V59, P313; TRAPP BD, 1988, J CELL BIOL, V107, P675, DOI 10.1083/jcb.107.2.675; TRAPP BD, 1982, J CELL BIOL, V92, P877, DOI 10.1083/jcb.92.3.877; TRAPP BD, 1979, P NATL ACAD SCI USA, V76, P3552, DOI 10.1073/pnas.76.7.3552	19	306	307	0	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 26	1990	344	6269					871	872		10.1038/344871a0	http://dx.doi.org/10.1038/344871a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA751	1691824				2022-12-28	WOS:A1990DA75100059
J	DOBSON, DE; KAMBE, A; BLOCK, E; DION, T; LU, H; CASTELLOT, JJ; SPIEGELMAN, BM				DOBSON, DE; KAMBE, A; BLOCK, E; DION, T; LU, H; CASTELLOT, JJ; SPIEGELMAN, BM			1-BUTYRYL-GLYCEROL - A NOVEL ANGIOGENESIS FACTOR SECRETED BY DIFFERENTIATING ADIPOCYTES	CELL			English	Article									HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; TUFTS UNIV,SCH HLTH SCI,DEPT ANAT & CELLULAR BIOL,BOSTON,MA 02111; EK SHRIVER CTR,MASS SPECT LAB,WALTHAM,MA 02254	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042420, R37DK031405, R01DK031405] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30290] Funding Source: Medline; NIDDK NIH HHS [DK42420, DK31405] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BANCHER E, 1973, INT J VITAM NUTR RES, V43, P510; BANDA MJ, 1982, P NATL ACAD SCI-BIOL, V79, P7773, DOI 10.1073/pnas.79.24.7773; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BENEZRA D, 1978, AM J OPHTHALMOL, V86, P455, DOI 10.1016/0002-9394(78)90289-1; BIRKHAHN RH, 1977, AM J CLIN NUTR, V30, P2078, DOI 10.1093/ajcn/30.12.2078; CASTELLOT JJ, 1982, P NATL ACAD SCI-BIOL, V79, P5597, DOI 10.1073/pnas.79.18.5597; CASTELLOT JJ, 1986, J CELL PHYSIOL, V127, P323, DOI 10.1002/jcp.1041270221; CASTELLOT JJ, 1980, P NATL ACAD SCI-BIOL, V77, P6007, DOI 10.1073/pnas.77.10.6007; DUNN BE, 1981, ANAT REC, V199, P33, DOI 10.1002/ar.1091990105; FETT JW, 1985, BIOCHEMISTRY-US, V25, P3527; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FORM DM, 1983, P SOC EXP BIOL MED, V172, P214; GOLDSMITH HS, 1984, JAMA-J AM MED ASSOC, V252, P2034, DOI 10.1001/jama.252.15.2034; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1978, DIFFERENTIATION DEV, P13; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; Jaffe E. A, 1984, BIOL ENDOTHELIAL CEL; KULL FC, 1987, SCIENCE, V236, P843, DOI 10.1126/science.2437656; KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; MCAUSLAN BR, 1979, EXP CELL RES, V119, P181, DOI 10.1016/0014-4827(79)90347-1; Moriyusu M, 1984, CHEM ABSTR, V99; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; POSTLETHWAITE AE, 1976, J EXP MED, V144, P1188, DOI 10.1084/jem.144.5.1188; RAJU KS, 1984, CANCER RES, V44, P1579; REICH E, 1974, P351; RIFKIN DB, 1984, CANCER INVASION META, P187; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; SALMON JA, 1982, METHOD ENZYMOL, V86, P477; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; TAUB M, 1980, J CELL PHYSIOL, V105, P369, DOI 10.1002/jcp.1041050220; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; WAGNER RC, 1975, MICROVASC RES, V10, P286, DOI 10.1016/0026-2862(75)90033-3; WANG CS, 1981, J BIOL CHEM, V256, P198; WASSERMANN F., 1965, HANDBOOK PHYSIOL, V5, P87; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; WRIGHT TM, 1988, P NATL ACAD SCI USA, V85, P1869, DOI 10.1073/pnas.85.6.1869; ZICHE M, 1982, JNCI-J NATL CANCER I, V69, P475	43	112	141	1	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 20	1990	61	2					223	230		10.1016/0092-8674(90)90803-M	http://dx.doi.org/10.1016/0092-8674(90)90803-M			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DA752	1691958				2022-12-28	WOS:A1990DA75200005
J	FRANCO, A; LANSMAN, JB				FRANCO, A; LANSMAN, JB			CALCIUM ENTRY THROUGH STRETCH-INACTIVATED ION CHANNELS IN MDX MYOTUBES	NATURE			English	Article									UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHARMACOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco				Lansman, Jeffry/0000-0002-8279-4064; Franco-Obregon, Alfredo/0000-0002-2514-1083				ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BREHM P, 1984, J PHYSIOL-LONDON, V350, P631, DOI 10.1113/jphysiol.1984.sp015222; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; COOPER BJ, 1989, SOC NEUR ABSTR, V15, P4125; FINGERMAN E, 1984, P NATL ACAD SCI-BIOL, V81, P7617, DOI 10.1073/pnas.81.23.7617; FRANCO A, IN PRESS J PHYSL; GUHARAY F, 1984, J PHYSIOL-LONDON, V352, P685, DOI 10.1113/jphysiol.1984.sp015317; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; KNUDSON CM, 1988, J BIOL CHEM, V263, P8480; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; MONGINI T, 1988, NEUROLOGY, V38, P476, DOI 10.1212/WNL.38.3.476; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1	19	342	348	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 12	1990	344	6267					670	673		10.1038/344670a0	http://dx.doi.org/10.1038/344670a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY719	1691450				2022-12-28	WOS:A1990CY71900090
J	ELICES, MJ; OSBORN, L; TAKADA, Y; CROUSE, C; LUHOWSKYJ, S; HEMLER, ME; LOBB, RR				ELICES, MJ; OSBORN, L; TAKADA, Y; CROUSE, C; LUHOWSKYJ, S; HEMLER, ME; LOBB, RR			VCAM-1 ON ACTIVATED ENDOTHELIUM INTERACTS WITH THE LEUKOCYTE INTEGRIN VLA-4 AT A SITE DISTINCT FROM THE VLA-4 FIBRONECTIN BINDING-SITE	CELL			English	Article									BIOGEN INC, CAMBRIDGE, MA 02142 USA	Biogen	ELICES, MJ (corresponding author), HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV TUMOR VIROL, BOSTON, MA 02115 USA.			takada, yoshikazu/0000-0001-5481-9589	NIGMS NIH HHS [GM38903] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038903] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; BEDNARCZYK J, 1990, IN PRESS J IMMUNOL; BERG EL, 1989, IMMUNOL REV, V108, P5, DOI 10.1111/j.1600-065X.1989.tb00010.x; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOYD AW, 1988, P NATL ACAD SCI USA, V85, P3095, DOI 10.1073/pnas.85.9.3095; CLAYBERGER C, 1987, J IMMUNOL, V138, P1510; COLLINS T, 1986, P NATL ACAD SCI USA, V83, P446, DOI 10.1073/pnas.83.2.446; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; DUSTIN ML, 1986, J IMMUNOL, V137, P245; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224; GODFREY HP, 1988, J IMMUNOL, V141, P1508; GROUX H, 1989, NATURE, V339, P152, DOI 10.1038/339152a0; HAMANN A, 1988, J IMMUNOL, V140, P693; HARLAN JM, 1985, BLOOD, V65, P513; HASKARD D, 1986, J IMMUNOL, V137, P2901; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HEMLER ME, 1983, J IMMUNOL, V131, P334; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HSI BL, 1987, PLACENTA, V8, P209, DOI 10.1016/0143-4004(87)90024-5; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KIEFEL V, 1989, BLOOD, V73, P2219; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; LEEUWENBERG JFM, 1989, EUR J IMMUNOL, V19, P715, DOI 10.1002/eji.1830190422; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MENTZER SJ, 1986, J CELL PHYSIOL, V126, P285, DOI 10.1002/jcp.1041260219; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; PALS ST, 1988, J IMMUNOL, V140, P1851; PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1; POBER JS, 1986, J IMMUNOL, V137, P1893; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; ROOSSIEN FF, 1989, J CELL BIOL, V108, P1979, DOI 10.1083/jcb.108.5.1979; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; SANCHEZMADRID F, 1986, EUR J IMMUNOL, V16, P1343, DOI 10.1002/eji.1830161106; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; VANNOESEL C, 1988, NATURE, V333, P850, DOI 10.1038/333850a0; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321	51	1780	1879	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	1990	60	4					577	584		10.1016/0092-8674(90)90661-W	http://dx.doi.org/10.1016/0092-8674(90)90661-W			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CQ723	1689216				2022-12-28	WOS:A1990CQ72300008
J	WALLNY, HJ; RAMMENSEE, HG				WALLNY, HJ; RAMMENSEE, HG			IDENTIFICATION OF CLASSICAL MINOR HISTOCOMPATIBILITY ANTIGEN AS CELL-DERIVED PEPTIDE	NATURE			English	Article									MAX PLANCK INST BIOL, IMMUNGENET ABT, CORRENSSTR 42, W-7400 TUBINGEN, GERMANY	Max Planck Society								BEVAN MJ, 1987, NATURE, V325, P192, DOI 10.1038/325192b0; BEVAN MJ, 1975, NATURE, V256, P419, DOI 10.1038/256419a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; CARBONE FR, 1989, J EXP MED, V169, P603, DOI 10.1084/jem.169.3.603; CLAVERIE JM, 1986, ANN INST PASTEUR IMM, VD137, P425; COUNCE S, 1956, ANN SURG, V144, P198, DOI 10.1097/00000658-195608000-00009; DEPLAEN E, 1988, P NATL ACAD SCI USA, V85, P2274; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; GRAFF RJ, 1979, ORIGINS INBRED MICE, P667; KLEIN J, 1983, IMMUNOGENETICS, V17, P553, DOI 10.1007/BF00366126; KLEIN J, 1986, NATURAL HIST MAJOR H; KRAUSPE R, 1986, ANAL BIOCHEM, V153, P242, DOI 10.1016/0003-2697(86)90088-6; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; LOVELAND B, 1986, IMMUNOL TODAY, V7, P223, DOI 10.1016/0167-5699(86)90109-X; RAMMENSEE HG, 1989, IMMUNOGENETICS, V30, P296, DOI 10.1007/BF02421334; RAMMENSEE HG, 1986, NATURE, V319, P502, DOI 10.1038/319502a0; RUSCH E, 1983, TRANSPLANT P, V15, P2093; SNELL GD, 1948, J GENET, V49, P87, DOI 10.1007/BF02986826; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WETTSTEIN PJ, 1989, HUMAN IMMUNOGENETICS, P339; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	21	199	200	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	1990	343	6255					275	278		10.1038/343275a0	http://dx.doi.org/10.1038/343275a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ682	1689009				2022-12-28	WOS:A1990CJ68200076
